<SEC-DOCUMENT>0001654954-18-012574.txt : 20181114
<SEC-HEADER>0001654954-18-012574.hdr.sgml : 20181114
<ACCEPTANCE-DATETIME>20181113191359
ACCESSION NUMBER:		0001654954-18-012574
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		53
CONFORMED PERIOD OF REPORT:	20180930
FILED AS OF DATE:		20181114
DATE AS OF CHANGE:		20181113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GT Biopharma, Inc.
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		181179918

	BUSINESS ADDRESS:	
		STREET 1:		310 N. WESTLAKE BLVD.
		STREET 2:		SUITE 206
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362
		BUSINESS PHONE:		(800) 304-9888

	MAIL ADDRESS:	
		STREET 1:		310 N. WESTLAKE BLVD.
		STREET 2:		SUITE 206
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91362

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19940916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>gtbp_10q.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
U. S. SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
WASHINGTON, DC 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 24px">
FORM 10-Q</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">&#x2611;</font><font style="color: #000000">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Quarterly
report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
For the quarterly period ended&#xA0;September 30,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td colspan="2" style="vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font> <font style="font-family: Times New Roman; font-size: 13px">For the transition
period from&#xA0;&#xA0;&#xA0;to&#xA0;&#xA0;.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Commission File Number 0-8092</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT BIOPHARMA, INC.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(Exact name of small business issuer as specified in its
charter)</font></div>
<div style="text-align: center">
<table cellpadding="0" cellspacing="0" style="text-align: center; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto;">
<tr>
<td style="vertical-align: top; width: 50%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Delaware</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(State or other jurisdiction of</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
incorporation or organization)</font></div>
</td>
<td style="vertical-align: top; width: 50%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
94-1620407</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(I.R.S. employer</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
identification number)</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 100%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
310 N. Westlake Blvd, Suite 206</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Westlake Village, CA 91362</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
&#xA0;(Address of principal executive offices and zip
code)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(800) 304-9888</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Registrant&#x2019;s telephone number, including area
code)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
100 South Ashley Drive</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Suite 600</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Tampa, FL 33602</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;(Former
name, former address and former fiscal year, if changed since last
report)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d)
of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes&#xA0;</font><font style="color: #000000">&#x2611;</font><font style="color: #000000">&#xA0;No&#xA0;</font><font style="color: #000000">&#x2610;</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Indicate by check mark whether the registrant has
submitted electronically every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes&#xA0;&#xA0;</font><font style="color: #000000">&#x2611;</font><font style="color: #000000">&#xA0;No&#xA0;&#xA0;</font><font style="color: #000000">&#x2610;</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller
reporting company.&#xA0;&#xA0;See the definitions of &#x201C;large
accelerated filer,&#x201D; &#x201C;accelerated filer&#x201D; and
&#x201C;smaller reporting company&#x201D; in Rule 12b-2 of the
Exchange Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Large
accelerated filer&#xA0;&#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Accelerated
filer&#xA0;&#x2610;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Non-accelerated
filer&#xA0;&#x2610;&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Smaller
reporting company&#xA0;&#x2611;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. &#x2610;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Indicate by check mark whether the registrant is a
shell company (as defined in Rule 12b-2 of the Exchange
Act).Yes&#xA0;</font><font style="color: #000000">&#x2610;&#xB7;</font><font style="color: #000000">No&#xA0;</font><font style="color: #000000">&#x2611;</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">At
November 14, 2018, the issuer had outstanding the indicated number
of shares of common stock:&#xA0;&#xA0;50,227,978.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc. and Subsidiaries</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
FORM 10-Q</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
For the Quarterly Period Ended September 30, 2018</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Table of Contents</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td colspan="2" style="vertical-align: bottom; width: 87%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">PART
I:&#xA0;FINANCIAL INFORMATION</font></div>
</td>
<td colspan="2" style="vertical-align: bottom; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Page</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: bottom; width: 87%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
1.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Financial
Statements (Unaudited)</font></div>
</td>
<td colspan="2" style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consolidated
Balance Sheets as of September 30, 2018 and December 31,
2017</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">3<br></font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consolidated
Statements of Operations for the three and nine months ended
September 30, 2018&#xA0;and 2017</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4<br></font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consolidated
Statements of Cash Flows for the nine months ended September 30,
2018 and 2017</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">5<br></font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Condensed
Notes to Consolidated Financial Statements</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">6<br></font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
2.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Management&#x2019;s
Discussion and Analysis of Financial Condition and Results of
Operations</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">14</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
3.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Quantitative
and Qualitative Disclosures About Market Risk</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">19<br>
</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br></font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
4.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Controls
and Procedures</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">19<br>
</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td colspan="4" style="vertical-align: bottom; width: 99%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">PART
II:&#xA0;OTHER INFORMATION</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
1.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Legal
Proceedings</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
1A.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Risk
Factors</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br></font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
2.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unregistered
Sales of Securities and Use of Proceeds</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
3.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Defaults
Upon Senior Securities</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
4.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mine
Safety Disclosures</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
5.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Other
Information</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 10%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Item
6.</font></div>
</td>
<td style="vertical-align: bottom; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Exhibits</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td colspan="2" style="vertical-align: bottom; width: 87%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">SIGNATURES</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">23</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td colspan="3" rowspan="1" style="vertical-align: bottom;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Part 1: Financial Information</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align: bottom;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 1. Financial Statements</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div style="text-align: center"><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div style="text-align: center"><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
GT Biopharma, Inc. and Subsidiaries</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div style="text-align: center"><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div style="text-align: center"><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
Consolidated Balance Sheets</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align: bottom;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Unaudited)</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align: bottom;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
(In thousands, except par value and share data)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">September
30,</font></font></div>
<div><font style="font-size:11px;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">2018</font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">December
31,</font></font></div>
<div><font style="font-size:11px;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">2017</font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
ASSETS</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Current
Assets:</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Cash
and cash equivalents</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">576</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Prepaid
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:12px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
Current Assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,247</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">576</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Intangible
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">25,263</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">253,777</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Deposits</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">21</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">9</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Fixed
assets, net</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">5</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">6</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:12px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
Other Assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">25,289</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">253,792</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">TOTAL
ASSETS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">26,536</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">254,368</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: center; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Current
Liabilities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,251</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,546</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accrued
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">344</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">102</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Line
of credit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">31</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">31</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Convertible
debentures, net of discount of $488</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">10,597</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
Current Liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">13,223</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,679</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">13,223</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,679</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stockholders&#x2019;
Equity:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Convertible
preferred stock - $0.001 par value; 15,000,000 shares
authorized:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
C - 96,230 and 96,230 shares issued and outstanding at September
30, 2018 and December 31, 2017, respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Series
J &#x2013; 1,163,548 shares issued and outstanding at September 30,
2018 and December 31, 2017, respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Common
stock - $0.001 par value; 750,000,000 shares authorized; and
50,227,978 and 50,117,977 shares issued and outstanding at
September 30, 2018 and December 31, 2017, respectively</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">50</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Additional
paid-in capital</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">537,883</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">521,305</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accumulated
deficit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(524,453</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(269,499</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Noncontrolling
interest</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(169</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(169</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:36px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Total
Stockholders&#x2019; Equity</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">13,313</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">251,689</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">TOTAL
LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">26,536</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">254,368</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;color:#000000;">The
accompanying notes are an integral part of these consolidated
financial statements.</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">3</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
GT BIOPHARMA, INC. AND SUBSIDIARIES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Consolidated Statements of Operations</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(Unaudited)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(In thousands, except per share data)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Three Months Ended
September 30,</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Nine Months Ended
September 30,</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">2018</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">2017</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">2018</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">2017</font></font></div>
<div><font style="font-size:11px;">
<!--rule below paragraph--></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Operating
expenses:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Research and
development</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,111</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">526</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">7,835</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">911</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Selling, general
and administrative expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">5,035</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">126,330</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">10,628</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">128,768</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Loss on
impairment</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">228,514
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">228,514
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total operating
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">234,660
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">126,856
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">246,977
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">129,679
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Loss from
operations</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(234,660</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(126,856</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(246,977</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(129,679</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Other
income (expense):</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,123</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(3,769</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(7,978</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(8,467</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total other income
(expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(1,123</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(3,769</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(7,978</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">(8,467</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:-36px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Loss before
provision for income taxes</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(235,783</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(130,625</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(254,955</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(138,146</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Provision for
income tax</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(235,783</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(130,625</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(254,955</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(138,146</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Net loss per common
share &#x2013; basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(4.70</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(8.15</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(5.09</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(24.54</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)<!--rule below paragraph--></font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Weighted average
common shares outstanding &#x2013; basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">50,154,516
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">16,027,687
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">50,130,202
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">5,628,529
<!--rule below paragraph--></font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying condensed notes are an integral part of these
consolidated financial statements.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">4</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
GT Biopharma, Inc. and Subsidiaries</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
Consolidated Statements of Cash Flows</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
(Unaudited)</font> </div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
(In thousands)</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left: 0px; padding-bottom: 2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
Nine Months Ended September 30,</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 5%; vertical-align: bottom; display: inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left: 0px; padding-bottom: 2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
2018</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
2017</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM OPERATING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(254,955</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(138,146</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Adjustments
to reconcile net loss to net cash used in operating
activities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Depreciation</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Loss
on impairment of long-lived assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">228,514</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock
compensation expense for options and warrants&#xA0;issued to
employees and non-employees</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">8,191</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">125,905</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Amortization
of debt discounts</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">7,816</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">4,791</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Note
Allonge</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">100</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non-cash
interest expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,197</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Amortization
of loan costs</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,076</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Changes
in operating assets and liabilities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Prepaid
Expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(15</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Other
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(12</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(7</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Accounts
payable and accrued liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(53</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">1,880</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
cash used in operating activities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(9,433</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(3,278</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM INVESTING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Acquisition
of fixed assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(4</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">-</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
cash used in investing activities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(4</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">-</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
FLOWS FROM FINANCING ACTIVITIES:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Proceeds
from notes payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">15,045</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,991</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Loan
costs</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(533</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Repayment
of note payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">(4,419</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">-</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Net
cash provided by financing activities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">10,093</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">5,991</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">NET
INCREASE IN CASH AND CASH EQUIVALENTS</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">656</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,713</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent: 0px; margin-right: 0px; padding-bottom: 2px; margin-left: 0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
AND CASH EQUIVALENTS - Beginning of period</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">576</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font><font style="text-align: left; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 5%; font-family: Times New Roman; font-size: 13px;">&#xA0;</font><font style="text-align: right; color: rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); vertical-align: bottom; display: inline-block; width: 75%; font-family: Times New Roman; font-size: 13px;">19</font><font style="text-align: left; color: rgb(0, 0, 0); font-family: Times New Roman; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">CASH
AND CASH EQUIVALENTS - End of period</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,232</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,732</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Non-Cash Investing and Financing Activities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Issuance
of common stock upon conversion of convertible notes</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">220</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Acquisition
of intangibles through issuance of common stock</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">253,777</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align: bottom;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font> <font><font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
accompanying condensed notes are an integral part of these
consolidated financial statements.</font></font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">5</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
GT Biopharma, Inc. and Subsidiaries</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Notes to Consolidated Financial Statements</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(Unaudited)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
1.</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Description of Business and Summary of Significant Accounting
Policies</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
accompanying unaudited consolidated financial statements of GT
Biopharma, Inc. and its subsidiaries (the &#x201C;Company,&#x201D;
&#x201C;we&#x201D; or &#x201C;us&#x201D;), have been prepared in
accordance with generally accepted accounting principles in the
United States of America (&#x201C;GAAP&#x201D;) for interim financial
information and with the instructions to Form 10-Q and Article 10
of Regulation S-X of the Securities and Exchange Commission (the
&#x201C;SEC&#x201D;). Accordingly, they do not include all of the
information and footnotes required by GAAP for complete financial
statements. The information included in this quarterly report on
Form 10-Q should be read in conjunction with the audited
consolidated financial statements and notes thereto included in the
Company&#x2019;s annual report on Form 10-K for the fiscal year
ended December 31, 2017 filed with the SEC on March 1, 2018 (the
&#x201C;Annual Report&#x201D;).</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Business</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
1965, the corporate predecessor of GT Biopharma, Diagnostic Data,
Inc. was incorporated in the State of California. Diagnostic Data
changed its incorporation to the State of Delaware in 1972 and
changed its name to DDI Pharmaceuticals, Inc. in 1985. In 1994, DDI
Pharmaceuticals merged with International BioClinical, Inc. and
Bioxytech S.A. and changed its name to OXIS International, Inc. In
July 2017, the Company changed its name to GT Biopharma,
Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
a clinical stage biopharmaceutical company focused on the
development and commercialization of novel immuno-oncology products
based off our proprietary Natural Killer (NK) cell engager
(Tri-specific Killer Engager (TriKE) &amp; Tetra-specific Killer
Engager (TetraKE)) and bi-specific Antibody Drug Conjugate
(bispecific-ADC) technology platforms. Our TriKE and TetraKE
platforms generate proprietary moieties designed to harness and
enhance the cancer killing abilities of a patient&#x2019;s own
natural killer, or NK, cells. Once bound to a NK cell, our moieties
are designed to stimulate the NK cell and precisely direct it to
one or more specifically-targeted proteins (tumor antigens)
expressed on a specific type of cancer, ultimately resulting in the
cancer cell&#x2019;s death. TriKEs and TetraKEs are made up of
recombinant fusion proteins, can be designed to target tumor
antigens on hematologic malignancies, sarcomas or solid tumors and
do not require patient-specific customization. They are designed to
be dosed in an outpatient setting and are expected to have
reasonably low cost of goods. Our bispecific-ADC platform can
generate product candidates that are ligand-directed single-chain
fusion proteins that simultaneously target two tumor antigens. We
believe our bispecific-ADC moieties represents the next generation
of ADCs.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Also,
in connection with the acquisition of Georgetown Translational
Pharmaceuticals on September 1, 2017, we acquired a portfolio of
IPR&amp;D CNS assets consisting of innovative reformulations and/or
repurposing of existing therapies. These CNS assets address disease
states such as chronic neuropathic pain, myasthenia gravis and
motion sickness.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Going Concern</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company&#x2019;s current operations have focused on business
planning, raising capital, establishing an intellectual property
portfolio, hiring, and conducting preclinical studies and clinical
trials. The Company does not have any product candidates approved
for sale and has not generated any revenue from product sales. The
Company has sustained operating losses since inception and expects
such losses to continue over the foreseeable future.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
financial statements of the Company have been prepared on a
going&#xAD; concern basis, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course of
business. Accordingly, the financial statements do not include any
adjustments that might be necessary should the Company be unable to
continue in existence.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company has incurred substantial losses and negative cash flows
from operations since its inception and has an accumulated deficit
of $524.5 million and cash of $1.2 million as of September 30,
2018. The Company anticipates incurring additional losses until
such time, if ever, that it can generate significant sales of its
products currently in development. Substantial additional financing
will be needed by the Company to fund its operations and to
commercially develop its product candidates. These factors raise
substantial doubt about the Company&#x2019;s ability to continue as
a going concern.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Management
is currently evaluating different strategies to obtain the required
funding for future operations. These strategies may include but are
not limited to: public offerings of equity and/or debt securities,
payments from potential strategic research and development, and
licensing and/or marketing arrangements with pharmaceutical
companies. Management has also implemented cost saving efforts,
including reduction in executive salaries and reduced travel.
Management believes that these ongoing and planned financing
endeavors, if successful, will provide adequate financial resources
to continue as a going concern for at least the next six months
from the date the financial statements are issued. However, there
can be no assurance in this regard. If the Company is unable to
secure adequate additional funding, its business, operating
results, financial condition and cash flows may be materially and
adversely affected.</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">6</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Use of Estimates</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The financial statements and notes are representations of the
Company's management, which is responsible for their integrity and
objectivity. These accounting policies conform to accounting
principles generally accepted in the United States of America and
have been consistently applied in the preparation of the financial
statements. The preparation of financial statements requires
management to make estimates and assumptions that affect the
reported amounts of assets, liabilities, revenues and expenses and
disclosures of contingent assets and liabilities at the date of the
financial statements. Actual results could differ from those
estimates.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Basis of Consolidation and Comprehensive Income</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying consolidated financial statements include the
accounts of GT Biopharma, Inc. and its subsidiaries. All
intercompany balances and transactions have been eliminated. The
Company's financial statements are prepared using the accrual
method of accounting.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Basis of Presentation</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The accompanying unaudited interim condensed consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the U.S. (&#x201C;U.S. GAAP&#x201D;)
and the rules and regulations of the U.S. Securities and Exchange
Commission (&#x201C;SEC&#x201D;). Certain information and disclosures
required by U.S. GAAP for complete consolidated financial
statements have been condensed or omitted herein. The interim
condensed consolidated financial statements should be read in
conjunction with the audited consolidated financial statements and
notes thereto included in the Company's Form 10-K for the year
ended December 31, 2017. The unaudited interim condensed
consolidated financial information presented herein reflects all
normal adjustments that are, in the opinion of management,
necessary for a fair statement of the financial position, results
of operations and cash flows for the periods presented. The Company
is responsible for the unaudited interim consolidated financial
statements included in this report. The results of operations of
any interim period are not necessarily indicative of the results
for the full year.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Cash and Cash Equivalents</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company considers all highly liquid investments with original
maturities of three months or less to be cash
equivalents.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Concentrations of Credit Risk</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company's cash and cash equivalents, marketable securities and
accounts receivable are monitored for exposure to concentrations of
credit risk. The Company maintains substantially all of its cash
balances in a limited number of financial institutions. The
balances are each insured by the Federal Deposit Insurance
Corporation up to $250,000. The Company had $982,000 of balances in
excess of this limit at September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Stock Based Compensation to Employees</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company accounts for its stock-based compensation for employees in
accordance with Accounting Standards Codification
(&#x201C;ASC&#x201D;) 718.&#xA0;&#xA0;The Company recognizes in the
statement of operations the grant-date fair value of stock options
and other equity-based compensation issued to employees and
non-employees over the related vesting period.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company granted no stock options during the nine months ended
September 30, 2018 and 2017, respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Critical Accounting Policies</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We consider the following accounting policies to be critical given
they involve estimates and judgments made by management and are
important for our investors&#x2019; understanding of our operating
results and financial condition.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Long-Lived Assets</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
long-lived assets include property, plant and equipment,
capitalized costs of filing patent applications and other
indefinite lived intangible assets. We evaluate our long-lived
assets for impairment, other than indefinite lived intangible
assets, in accordance with ASC 360, whenever events or changes in
circumstances indicate that the carrying amount of such assets may
not be recoverable. Estimates of future cash flows and timing of
events for evaluating long-lived assets for impairment are based
upon management&#x2019;s judgment. If any of our intangible or
long-lived assets are considered to be impaired, the amount of
impairment to be recognized is the excess of the carrying amount of
the assets over its fair value.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Applicable
long-lived assets are amortized or depreciated over the shorter of
their estimated useful lives, the estimated period that the assets
will generate revenue, or the statutory or contractual term in the
case of patents. Estimates of useful lives and periods of expected
revenue generation are reviewed periodically for appropriateness
and are based upon management&#x2019;s judgment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Impairment of Long-Lived Assets</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The Company's long-lived assets currently consist of indefinite
lived intangible assets</font> associated with IPR&amp;D
(&#x201C;In-Process Research &amp; Development&#x201D;) projects and
related capitalized patents acquired in the acquisition of
Georgetown Translational Pharmaceuticals, Inc. as described in Note
2 below<font style="color: #000000">. &#xA0;</font>Intangible
assets associated with IPR&amp;D projects are not amortized until
approval by the Food and Drug Administration (FDA) is obtained in a
major market subject to certain specified conditions and management
judgment. The useful life of an amortizing asset generally is
determined by identifying the period in which substantially all of
the cash flows are expected to be generated.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">7</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company evaluates indefinite lived intangible assets for impairment
at least annually and whenever impairment indicators are present in
accordance with ASC 350. When necessary, the Company records an
impairment loss for the amount by which the fair value is less than
the carrying value of these assets. <font style="color: #000000">The fair value of intangible assets other than
goodwill is typically determined using the &#x201C;relief from
royalty method&#x201D;,</font> specifically the discounted cash flow
method <font style="color: #000000">utilizing Level 3 fair value
inputs.</font> Some of the more significant estimates and
assumptions inherent in this approach include: the amount and
timing of the projected net cash flows, which includes the expected
impact of competitive, legal and/or regulatory forces on the
projections and the impact of technological risk associated with
IPR&amp;D assets, as well as the selection of a long-term growth
rate; the discount rate, which seeks to reflect the various risks
inherent in the projected cash flows; and the tax rate, which seeks
to incorporate the geographic diversity of the projected cash
flows.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company performs impairment testing for all other long-lived assets
whenever impairment indicators are present. When necessary, the
Company calculates the undiscounted value of the projected cash
flows associated with the asset, or asset group, and compares this
estimated amount to the carrying amount. If the carrying amount is
found to be greater, we record an impairment loss for the excess of
book value over fair value.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Income Taxes</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Company accounts for income taxes using the asset and liability
approach, whereby deferred income tax assets and liabilities are
recognized for the estimated future tax effects, based on current
enacted tax laws, of temporary differences between financial and
tax reporting for current and prior periods. Deferred tax assets
are reduced, if necessary, by a valuation allowance if the
corresponding future tax benefits may not be realized.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Net Income (Loss) per Share</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Basic net income (loss) per share is computed by dividing the net
loss for the period by the weighted average number of common shares
outstanding during the period. Diluted net income (loss) per share
is computed by dividing the net loss for the period by the weighted
average number of common shares outstanding during the period, plus
the potential dilutive effect of common shares issuable upon
exercise or conversion of outstanding stock options and warrants
during the period.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The computation of basic and diluted net loss per share for the
nine months ended September 30, 2018 and 2017 excludes the common
stock equivalents of the following potentially dilutive securities
because their inclusion would be anti-dilutive:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 2px #000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">September
30,</font></font></font> <font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">2018</font></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-weight:bold;font-family:Times New Roman;color:#000;">2017</font></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercise
of common stock warrants</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,813,053</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Conversion
of preferred stock into common stock</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,163,659</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,513,659</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Exercise
of common stock options</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,246</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,246</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,977,958</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 2px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,514,905</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Patents</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Acquired patents are capitalized at their acquisition cost or fair
value. The legal costs, patent registration fees and models and
drawings required for filing patent applications are capitalized if
they relate to commercially viable technologies. Commercially
viable technologies are those technologies that are projected to
generate future positive cash flows in the near term. Legal costs
associated with patent applications that are not determined to be
commercially viable are expensed as incurred. All research and
development costs incurred in developing the patentable idea are
expensed as incurred. Legal fees from the costs incurred in
successful defense to the extent of an evident increase in the
value of the patents are capitalized.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Capitalized costs for pending patents are amortized on a
straight-line basis over the remaining twenty-year legal life of
each patent after the costs have been incurred. Once each patent is
issued, capitalized costs are amortized on a straight-line basis
over the shorter of the patent's remaining statutory life,
estimated economic life or ten years.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Fixed Assets</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Fixed assets are stated at cost. Depreciation is computed on a
straight-line basis over the estimated useful lives of the assets,
which are 3 to 10&#xA0;years for machinery and equipment and the
shorter of the lease term or estimated economic life for leasehold
improvements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Fair Value</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The carrying amounts reported in the balance sheets for receivables
and current liabilities each qualify as financial instruments and
are a reasonable estimate of fair value because of the short period
of time between the origination of such instruments and their
expected realization and their current market rate of
interest.&#xA0; The three levels are defined as
follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Level 1 inputs to
the valuation methodology are quoted prices (unadjusted) for
identical assets or liabilities in active markets. The
Company&#x2019;s Level 1 assets include cash equivalents, primarily
institutional money market funds, whose carrying value represents
fair value because of their short-term maturities of the
investments held by these funds.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">8</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<div style="display: table; margin-left: 24px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Level 2 inputs to
the valuation methodology include quoted prices for similar assets
and liabilities in active markets, and inputs that are observable
for the asset or liability, either directly or indirectly, for
substantially the full term of the financial instrument. Fair value
is determined using the Black-Scholes valuation model based on
observable market inputs, such as share price data and a discount
rate consistent with that of a government-issued security of a
similar maturity.<br></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 24px">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">&#x25CF;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Level 3 inputs to
the valuation methodology are unobservable and significant to the
fair value measurement.</font></div>
</div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Research and Development</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Research and development costs are expensed as incurred and
reported as research and development expense. Research and
development costs totaled $7.8 million and $0.9 million for the
nine months ended September 30, 2018 and 2017, respectively.
Research and development costs for the nine months ended September
30, 2018 included non-cash compensation of $6.5
million.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Revenue Recognition</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #000000; font-family: Times New Roman; font-size: 13px">
License Revenue</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">License
arrangements may consist of non-refundable upfront license fees,
exclusive licensed rights to patented or patent pending technology,
and various performance or sales milestones and future product
royalty payments. Some of these arrangements are multiple element
arrangements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Non-refundable,
up-front fees that are not contingent on any future performance by
us, and require no consequential continuing involvement on our
part, are recognized as revenue when the license term commences and
the licensed data, technology and/or compound is
delivered.&#xA0;&#xA0;We defer recognition of non-refundable
upfront fees if we have continuing performance obligations without
which the technology, right, product or service conveyed in
conjunction with the non-refundable fee has no utility to the
licensee that is separate and independent of our performance under
the other elements of the arrangement. In addition, if we have
continuing involvement through research and development services
that are required because our know-how and expertise related to the
technology is proprietary to us, or can only be performed by us,
then such up-front fees are deferred and recognized over the period
of continuing involvement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Payments
related to substantive, performance-based milestones in a research
and development arrangement are recognized as revenue upon the
achievement of the milestones as specified in the underlying
agreements when they represent the culmination of the earnings
process. As of September 30, 2018, the Company has not generated
any licensing revenue.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">2.&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Intangibles</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 1, 2017, the Company entered into an Agreement and
Plan of Merger whereby it acquired 100% of the issued and
outstanding capital stock of Georgetown Translational
Pharmaceuticals, Inc. (GTP). In exchange for the ownership of GTP,
the Company issued a total of 16,927,878 shares of its common
stock, having a share price of $15.00 on the date of the
transaction, to the three prior owners of GTP which represented 33%
of the issued and outstanding capital stock of the Company on a
fully diluted basis. $253.8 million of the value of shares issued
was allocated to intangible assets consisting of a portfolio of
three CNS development candidates, which are classified as
IPR&amp;D.&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
For the three and nine months ended September 30, 2018, the Company
recorded an intangible asset impairment charge of $228.5 million
related to the portfolio of CNS IPR&amp;D assets within Operating
Expenses, which represents the excess carrying value compared to
fair value. The impairment charge was the result of both internal
and external factors. In the 3</font><font style="font-size: 70%; vertical-align: top; color: #000000">rd</font>
<font style="color: #000000">quarter of 2018, the Company
experienced changes in key senior management, led by the
appointment of a new CEO with extensive experience in oncology drug
development. These changes resulted in the prioritization of
immuno-oncology development candidates relative to CNS development
candidates. In conjunction with these strategic changes, limited
internal resources have delayed the development of the CNS
IPR&amp;D assets. The limited resources, changes in senior
leadership, and favorable market conditions for immuno-oncology
development candidates have resulted in the Company choosing to
focus on development of its immuno-oncology portfolio. In light of
this shift in market strategy, the Company performed a commercial
assessment and a valuation of the CNS IPR&amp;D assets, both to
assess fair value and support potential future licensing efforts.
The valuation indicated an excess carrying value over the fair
value of these assets, resulting in the impairment charge noted
above.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
The fair value of the CNS IPR&amp;D assets was determined
using</font> the discounted cash flow method <font style="color: #000000">which utilized significant estimates and
assumptions surrounding</font> the amount and timing of the
projected net cash flows, which includes the <font style="color: #000000">probability of commercialization, the assumption
that the assets would be out-licensed to third-parties for
continued development for upfront licensing fees and downstream
royalty payments based on net sales, and</font> expected impact of
competitive, legal and/or regulatory forces on the projections, as
well as the selection of a long-term growth rate; the discount
rate, which seeks to reflect the various risks inherent in the
projected cash flows; and the tax rate, which seeks to incorporate
the geographic diversity of the projected cash flows.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">9</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
3.</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Debt</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
<a name="_Hlk514084340"></a>Convertible
Notes</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On January 22, 2018, the Company entered into a Securities Purchase
Agreement (&#x201C;SPA&#x201D;) with fourteen accredited investors
(individually, a &#x201C;Buyer&#x201D; and collectively, the
&#x201C;Buyers&#x201D;) pursuant to which the Company agreed to issue
to the Buyers senior convertible notes in an aggregate principal
amount of $7,760,510 (the &#x201C;Notes&#x201D;), which Notes shall
be convertible into the Company&#x2019;s common stock, par value
$0.001 per share (the &#x201C;Common Stock&#x201D;) at a price of
$4.58 per share, and five-year warrants to purchase the
Company&#x2019;s Common Stock representing the right to acquire an
aggregate of approximately 1,694,440 shares of Common Stock (the
&#x201C;Warrants&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Pursuant to the terms of SPA the Notes were subject to an original
issue discount of 10% resulting in proceeds to the Company of
$7,055,000 from the transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Upon
the purchase of the Notes, the Buyers received Warrants to purchase
<font style="color: #000000">1,694,440 shares of Common
Stock</font>. Such Warrants are exercisable for (5) years from the
date the shares underlying the Warrants are freely saleable. The
initial Exercise Price is $4.58. <font style="color: #000000; background-color: #FFFFFF">According to the terms
of the warrant agreement, the Warrants are subject to certain
adjustments depending upon the price and structure of a subsequent
financing, including a qualified financing with gross proceeds of
at least $20 million</font>, as defined in the
agreements.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The issuance of the Notes and Warrants were made in reliance on the
exemption provided by Section 4(a)(2) of the Securities Act of
1933, as amended (the &#x201C;Securities Act&#x201D;) for the offer
and sale of securities not involving a public offering, and
Regulation D promulgated under the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Contemporaneously with the execution and delivery of the SPA, the
Company and the Buyers executed and delivered a Registration Rights
Agreement (the &#x201C;Registration Rights Agreement&#x201D;)
pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities
under the 1933 Act and the rules and regulations promulgated
thereunder, and applicable state securities laws.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Senior Convertible Debentures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 2, 2018, GT Biopharma, Inc. (the &#x201C;Company&#x201D;)
entered into a Securities Purchase Agreement with the purchasers
identified on the signature pages thereto (individually, a
&#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company issued to
the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $5,140,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per share. The
Company used a portion of these proceeds to repay $4.4 million of
the notes issued on January 22, 2018. Additionally, the remaining
$3.3 million of the notes issued on January 22, 2018 were converted
into the Debentures at the same terms discussed above.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $2,050,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 24, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $800,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
issuance of the Senior Convertible Debentures was made in reliance
on the exemption provided by Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#x201C;Securities Act&#x201D;), for the
offer and sale of securities not involving a public offering and
Regulation D promulgated under the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Financing Agreement</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 8, 2010, the Company entered into a financing arrangement
with Gemini Pharmaceuticals, Inc., a product development and
manufacturing partner of the Company, pursuant to which Gemini
Pharmaceuticals made a $250,000 strategic equity investment in the
Company and agreed to make a $750,000 purchase order line of credit
facility available to the Company. The outstanding principal of all
Advances under the Line of Credit will bear interest at the rate of
interest of prime plus 2 percent per annum. There is $31,000 due on
this credit line at September 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
4.</font>&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stockholders' Equity</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the quarter ended September 30, 2018, the Company issued
110,000 shares of common stock upon conversion of $220,000 of
senior convertible notes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">10</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
On September 1, 2017, the Company authorized 2,000,000 shares of
Series J Preferred Stock.</font> Shares of Series J Preferred Stock
will have the same voting rights as shares of common stock with
each share of Series J Preferred Stock entitled to one vote at a
meeting of the shareholders of the Corporation. Shares of Series J
Preferred Stock will not be entitled to receive any dividends,
unless and until specifically declared by our board of directors.
The holders of the Series J Preferred Stock will participate, on an
as-if-converted-to-common stock basis, in any dividends to the
holders of common stock. Each share of the Series J Preferred Stock
is convertible into one share of our common stock at any time at
the option of the holder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
On September 1, 2017 the Company issued a total of 908,502 shares
of</font> Series J Preferred Stock <font style="color: #000000; background-color: #FFFFFF">in exchange for the
conversion and cancellation of debt in the total amount of
$1,090,000.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
On September 1, 2017 the Company issued 5,046 shares of</font>
Series J Preferred Stock <font style="color: #000000; background-color: #FFFFFF">upon the exercise of
warrants on a cashless basis.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
On September 1, 2017 the Company also issued
600,000</font><font style="color: #000000">&#xA0;shares
of&#xA0;</font><font style="color: #000000; background-color: #FFFFFF">Series J Preferred
Stock</font><font style="color: #000000">&#xA0;to one entity as
payment for $720,000 of consulting services provided to the
Company.&#xA0;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
In December 2017, the Company converted 350,000 Series J shares of
preferred stock into 350,000 shares of common
stock.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
5.</font>&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Options and Warrants</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Stock Options</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following table summarizes stock option transactions for the nine
months ended September 30, 2018:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left: 0px; padding-bottom: 2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Number of
Options</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Weighted Average
Exercise Price</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding,
December 31, 2017</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,246</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,428.00</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Granted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Expired</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding,
September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,246</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,428.00</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Exercisable,
September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,246</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,428.00</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Common Stock Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Warrant
transactions for the nine months ended September 30, 2018 are as
follows:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left: 0px; padding-bottom: 2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Number of
Warrants</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-size:11px;"><font style="font-family:Times New Roman;font-weight:bold;">Weighted Average
Exercise Price</font></font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding at
December 31, 2017:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Granted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,813,053</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4.58</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Forfeited</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;"><br></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Exercised</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">-</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Outstanding at
September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,813,053</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4.58</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Exercisable at
September 30, 2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,813,053</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4.58</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
6.</font>&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Commitments and Contingencies</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Leases</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 1, 2017, the Company entered into a three-year lease
agreement for its office in Washington, D.C. In addition to minimum
rent, certain leases require payment of real estate taxes,
insurance, common area maintenance charges and other executory
costs. The Company recognizes rent expense under such arrangements
on a straight-line basis over the effective term of each lease.
This lease was terminated as of June 30, 2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Rent expense for the nine months ended September 30,
2018&#xA0;and&#xA0;2017&#xA0;was&#xA0;$52,000&#xA0;and&#xA0;$9,000,
respectively.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">11</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Employment Agreements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On February 14, 2018, the Company entered into the First Amendment
to the Employment Agreement with Dr. Clarence-Smith, amending the
Employment Agreement, dated September 1, 2017, between the Company
and Dr. Clarence-Smith. Under the First Amendment, Dr.
Clarence-Smith&#x2019;s title was revised to reflect her new
position and included an annual salary of $500,000, paid in equal
monthly installments. All other terms of her original Employment
Agreement remain unchanged. In October 2018, Dr. Clarence-Smith
resigned from her position with the Company. In connection with
this resignation, the Company entered into a separation agreement
which superseded the Employment Agreement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On February 14, 2018,&#xA0;the Company entered into a Consultant
Agreement with Mr. Cataldo. The term of the Consultant Agreement
lasts until August 31, 2020 and is terminable at will and is
subject to automatic extension for successive one-year periods. Mr.
Cataldo will be paid $41,667 per month during the term of the
Consultant Agreement and will be entitled to participate in the
Company&#x2019;s bonus plans. Refer to footnote 8 &#x2013; Subsequent
Events.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If any
of our executive officers&#x2019; employment with us is terminated
involuntarily, or any executive resigns with good reason as a
result of a change in control, the executive will receive (i) all
compensation and benefits earned through the date of termination of
employment; (ii) a lump-sum payment equal to the greater of (a) the
bonus paid or payable to the executive for the year immediately
prior to the year in which the change in control occurred and (b)
the target bonus under the performance bonus plan in effect
immediately prior to the year in which the change in control
occurs; (iii) a lump-sum payment equivalent to the remaining base
salary (as it was in effect immediately prior to the change in
control) due to the executive from the date of involuntary
termination to the end of the term of the employment agreement or
one half of the executive&#x2019;s base salary then in effect,
whichever is the greater; and (iv)&#xA0;reimbursement for the cost
of medical, life, disability insurance coverage at a level
equivalent to that provided by us for a period expiring upon the
earlier of (a) one year or (b) the time the executive begins
alternative employment where said insurance coverage is available
and offered to the executive.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
7.</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Change of Accounting Method</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Adoption of ASU 2017-11</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In connection with the securities purchase agreements and debt
transactions during the year ended December 31, 2017, the Company
issued warrants, to purchase common stock with a five-year term.
Upon issuance of the warrants, the Company evaluated the note
agreement to determine if the agreement contained any embedded
components that would qualify the agreement as a derivative. The
Company identified certain put features embedded in the warrants
that potentially could result in a net cash settlement in the event
of a fundamental transaction, requiring the Company to classify the
warrants as a derivative liability. The Company changed its method
of accounting for the debt and warrants through the early adoption
of ASU&#xA0;2017-11 on January 1, 2018 on a retrospective basis.
Accordingly, the Company recorded the warrant derivative and
conversion option derivative liabilities to additional paid in
capital upon issuance.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table provides a summary of the derivative liability
activity as a result of the adoption of ASU 2017-11 (in thousands,
except per share data):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 3%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 94%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px; font-weight: bold;">
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Consolidated
Balance Sheet</font></font></font></div>
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">December
31,</font></font></font></div>
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">2017</font></font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 3%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px; font-weight: bold;">
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Previously</font></font></font></div>
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Reported</font></font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid rgb(0, 0, 0); font-size: 11px; font-weight: bold;">
<div><font style="text-align: left; vertical-align: bottom; display: inline-block; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; display: inline-block; font-weight: bold;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-weight: bold;">Revisions</font></div>
</font> <font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;"><br>
</font></font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px; font-weight: bold;">
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Revised</font></font></font></div>
<div><font style="font-weight: bold;"><font style="font-weight: bold;"><font style="font-family: Times New Roman; font-weight: bold;">Report</font></font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px; font-weight: bold;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Additional Paid-in
Capital</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">519,702</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,603</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">521,305</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accumulated
Deficit</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(267,896</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,603</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(269,499</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Consolidated
Statement of Operations</font></font></font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">For the Three
Months Ended September 30,</font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">2017</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Previously</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Reported</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Revisions</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Revised</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Report</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Change in Warrant
Liability</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(1,451</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1,451</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Earnings Per
Share</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(8.24</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">0.09</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(8.15</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Consolidated
Statement of Operations</font></font></font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align:bottom;width:36%;">
<div><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">For the Nine Months
Ended September 30,</font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">2017</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:3%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:64%;">
<div style="margin-left:0px;padding-bottom:2px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Previously</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Reported</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">&#xA0;</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Revisions</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Revised</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;"><font style="font-family:Times New Roman;font-weight:bold;">Report</font></font></font></div>
<div><font style="font-weight:bold;"><font style="font-size:11px;font-weight:bold;">
<!--rule below paragraph--></font></font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Change in Warrant
Liability</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">925</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(925</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:64%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Earnings Per
Share</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(24.38</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(0.16</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">(24.54</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">12</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
8.</font>&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Subsequent Events</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Leases</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 1, 2018, the Company entered into a three-year lease
agreement for its office in Westlake Village, CA. In addition to
minimum rent, certain leases require payment of real estate taxes,
insurance, common area maintenance charges and other executory
costs. The Company recognizes rent expense under such arrangements
on a straight-line basis over the effective term of each
lease.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The following table summarizes the Company&#x2019;s future minimum
lease commitments as of September 30, 2018 (in
thousands):</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Year ending
December 31:</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2018</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">11</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2019</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">69</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2020</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">71</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2021</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:5%;border-bottom:solid 2px #000000;">&#xA0;</font><font style="text-align: right; font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;width:75%;border-bottom:solid 2px #000000;">61</font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:2px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: justify; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total minimum lease
payments</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; font-family:Times New Roman;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">212
<!--rule below paragraph--></font><font style="text-align: left; font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
Employment and Consulting Agreements</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On October 18, 2018, the Company entered into a Consultant
Agreement with Anthony Cataldo. The term of the Consultant
Agreement shall remain in effect until September 30, 2019. This
Agreement supersedes the Consultant Agreement dated February 14,
2018 and will pay Mr. Cataldo $25,000 per month during the term of
the Agreement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On October 19, 2018, the Company entered into an Executive
Employment Agreement with Dr. Urbanski, reflecting his current
position as Chief Executive Officer of the Company. Under the terms
of this agreement, Dr. Urbanski&#x2019;s annual salary is
essentially unchanged from his previous positions. Dr. Urbanski is
also entitled to participate in the Company&#x2019;s bonus plans.
Under the Executive Employment Agreement, the Company has agreed
that upon shareholder approval of a Stock Option Plan, it will
recommend to the Board that the Company grant Dr. Urbanski a
Non-Qualified stock option to purchase 2,971,102 shares of the
Company&#x2019;s common stock having an exercise equal to the fair
market value of the shares on the date of the Agreement. The stock
option grant would vest according to the following schedule: (i)
1,250,000 fully vested shares upon signing of the agreement, (ii)
1,250,000 shares on January 1, 2019, and (iii) 471,102 shares on
January 1, 2020.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-style: italic; font-family: Times New Roman; font-size: 13px">
Departure of Directors or Certain Officers</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On November 12, 2018, Mr. Cataldo announced his intention to resign
from the Board of Directors of the Company effective November 13,
2018. The resignation did not involve any dispute with the
Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">13</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Item 2.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Management&#x2019;s Discussion
and Analysis of Financial Condition and Results of
Operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Some of the statements in the Form 10-Q are forward-looking
statements about what may happen in the future. Forward-looking
statements include statements regarding our current beliefs, goals,
and expectations about matters such as our expected financial
position and operating results, our business strategy, and our
financing plans. The forward-looking statements in the Form 10-Q
are not based on historical facts, but rather reflect the current
expectations of our management concerning future results and
events.&#xA0;&#xA0;The forward-looking statements generally can be
identified by the use of terms such as &#x201C;believe,&#x201D;
&#x201C;expect,&#x201D; &#x201C;anticipate,&#x201D;
&#x201C;intend,&#x201D; &#x201C;plan,&#x201D; &#x201C;foresee,&#x201D;
&#x201C;likely&#x201D; or other similar words or phrases. Similarly,
statements that describe our objectives, plans or goals are or may
be forward-looking statements. Forward-looking statements involve
known and unknown risks, uncertainties and other factors that may
cause our actual results, performance or achievements to be
different from any future results, performance and achievements
expressed or implied by these statements.&#xA0;&#xA0;We cannot
guarantee that our forward-looking statements will turn out to be
correct or that our beliefs and goals will not change. Our actual
results could be very different from and worse than our
expectations for various reasons. You should review carefully all
information, including the discussion of risk factors under
&#x201C;Item 1A: Risk Factors&#x201D; and &#x201C;Item 7:
Management&#x2019;s Discussion and Analysis of Financial Condition
and Results of Operations&#x201D; of the Form 10-K for the year
ended December 31, 2017.&#xA0;&#xA0;Any forward-looking statements
in the Form 10-Q are made only as of the date hereof and, except as
may be required by law, we do not have any obligation to publicly
update any forward-looking statements contained in this Form 10-Q
to reflect subsequent events or circumstances.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Throughout this Quarterly Report on Form&#xA0;10-Q, the terms
&#x201C;GTBP,&#x201D;&#xA0;&#x201C;we,&#x201D;
&#x201C;us,&#x201D;&#xA0;&#x201C;our,&#x201D; &#x201C;the company&#x201D;
and &#x201C;our company&#x201D; refer to GT Biopharma, Inc., a
Delaware corporation formerly known as Oxis International, Inc.,
DDI Pharmaceuticals, Inc. and Diagnostic Data, Inc, together with
our subsidiaries.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Overview</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">
We are</font> <font style="color: #000000">a clinical stage
biopharmaceutical company predominantly focused on the development
and commercialization of immuno-oncology products based off our
proprietary Tri-specific Killer Engager (TriKE), Tetra-specific
Killer Engager (TetraKE) and bi-specific Antibody Drug Conjugate
(ADC) technology platforms. Our TriKE and TetraKE platforms
generate proprietary moieties designed to harness and enhance the
cancer killing abilities of a patient&#x2019;s own natural killer,
or NK, cells. Once bound to a NK cell, our moieties are designed to
enhance the NK cell and precisely direct it to one or more
specifically-targeted proteins (tumor antigens) expressed on a
specific type of cancer, ultimately resulting in the cancer
cell&#x2019;s death. TriKEs and TetraKEs are made up of recombinant
fusion proteins, can be designed to target certain tumor antigens
on hematologic malignancies, sarcomas or solid tumors and do not
require patient-specific customization. They are designed to be
dosed in an outpatient setting and are expected to have reasonably
low cost of goods. Our ADC platform can generate product candidates
that are bi-specific, ligand-directed single-chain fusion proteins
that, we believe, represent the next generation of
ADCs.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our most advanced bi-specific ADC, which targets CD19+ and/or CD22+
hematological malignancies, is in the Phase 2 component of a Phase
1/2 Non-Hodgkins Lymphoma (NHL)/Acute Lymphocytic Leukemia (ALL)
trial which is an open-label, investigator-led study. Subject to
the availability of drug supply, we expect to be in a position to
begin a First-in-Class, Phase 1 trial in CD33+ hematologic
malignancies for our most advanced TriKE product candidate in the
first half of 2019. We are initially targeting certain hematologic
malignancies as we believe our product candidates may have certain
advantages over existing and other in-development products. We are
also focused on developing TetraKE product candidates designed to
target the larger solid tumor population and are working towards
beginning clinical trials in 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Our TriKE product candidates are single-chain, tri-specific scFv
recombinant fusion proteins composed of the variable regions of the
heavy and light chains (or heavy chain only) of anti-CD16
antibodies, wild-type or a modified form of IL-15 and the variable
regions of the heavy and light chains of an antibody designed to
precisely target a specific</font> tumor antigen. <font style="color: #000000">We utilize</font> the NK stimulating cytokine
human IL-15 as a crosslinker between the two scFvs which is
designed to provide a self-sustaining signal leading to the
proliferation and activation of NK cells thus enhancing their
ability to kill cancer cells mediated by <font style="color: #000000">antibody-dependent cell-mediated cytotoxicity
(ADCC). Our second TriKE product candidate, GTB-C3550 (OXS-C3550),
is a next-generation version of GTB-3550 (OXS-3550) containing a
modified CD16 component.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Our TetraKE product candidates are single-chain fusion proteins
composed of human single-domain anti-CD16 antibody, wild-type IL-15
and the variable regions of the heavy and light chains of two
antibodies that are designed to target two specific</font> tumor
antigens expressed on specific types of cancer cells. <font style="color: #000000">An example of a TetraKE product candidate is
GTB-1615 (OXS-1615) which is designed to target EpCAM and CD133
positive solid tumors. EpCAM is found on many solid tumor cells of
epithelial origin and CD133 is a marker for cancer stem cells.
OXS-1615 is designed to enable a patient&#x2019;s NK cells to kill
not only the heterogeneous population of cancer cells found in many
solid tumors but also kill the cancer stem cells that can be
responsible for recurrences.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our TriKEs and TetraKEs are designed to act by binding to a
patient&#x2019;s NK cells and a specific tumor antigen enabling an
immune synapse between the now IL-15-enhanced NK cell and the
targeted cancer cell. The formation of an immune synapse can induce
NK cell activation which can lead to the death of the cancer cell.
We believe the self-sustaining signal caused by our IL-15
cross-linker may enable prolonged and enhanced proliferation and
activation of NK cells similar to the increased proliferation of
T-cells caused by 41BB-L or CD28 intracellular domains in CAR-T
therapy but without the need to enhance the patient&#x2019;s NK
cells ex vivo.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">14</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We are using our TriKE and TetraKE platforms with the intent to
bring to market immuno-oncology products that can treat a range of
hematologic malignancies, sarcoma and solid tumors. The platforms
are scalable, and we are putting processes in place to be able to
produce IND-ready moieties in a timely manner after a specific
TriKE or TetraKE conceptual design. After conducting market and
competitive research, specific moieties can then be advanced into
the clinic on our own or through potential collaborations with
larger companies. We are also evaluating, in conjunction with our
Scientific Advisory Board, additional moieties designed to target
different tumor antigens. We believe our TriKEs and TetraKEs may
have the ability, if approved for marketing, to be used on a
stand-alone basis, augment the current monoclonal antibody
therapeutics, be used in conjunction with more traditional cancer
therapy and potentially overcome certain limitations of current
chimeric antigen receptor, or CAR-T, therapy.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
GTB-3550 (OXS-3550) is our first TriKE product candidate.</font>
The GTB-3550 IND will focus on acute myelogenous leukemia
(&#x201C;AML&#x201D;), the most common form of adult leukemia with
21,000 new cases expected in 2018 alone (American Cancer Society)
as well as myelodysplastic syndrome (&#x201C;MDS&#x201D;) and severe
mastocytosis. AML patients typically receive frontline therapy,
usually chemotherapy, including cytarabine and an anthracycline, a
therapy that has not changed in over 40 years. About half will have
relapses and require alternative therapies. In addition, MDS
incidence rates have dramatically increased in the population of
the United States from 3.3 per 100,000 individuals from 2001-2004
to 70 per 100,000 annually, MDS is especially prevalent in elderly
patients that have a median age of 76 years at diagnosis. The
survival of patients with MDS is poor due to decreased eligibility,
as a result of advanced age, for allogeneic hematopoietic cell
transplantation (Allo-HSCT), the only curative MDS treatment (Cogle
CR. Incidence and Burden of the Myelodysplastic Syndromes.
<font style="font-style: italic">Curr Hematol Malig Rep</font>.
2015; 10(3):272-281). We believe that GTB-3550 could serve as a
relatively safe, cost-effective, and easy-to-use therapy for
resistant/relapsing AML and MDS and could also be combined with
chemotherapy as frontline therapy thus targeting the larger patient
population.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The IND for GTB-3550 was filed in June 2017 by the University of
Minnesota. FDA requested that additional preclinical toxicology be
conducted prior to initiating clinical trials. The FDA also
requested some additional information and clarifications on the
manufacturing (CMC) and clinical packages. The requested additional
information and clarifications were completed and incorporated by
us into the IND in eCTD format. We filed the IND amendment in June
2018 and announced on November 1, 2018 that we had received
notification from the FDA that the IND was open and the Company was
authorized to initiate a first-in-human Phase 1 study with GTB-3550
in AML, MDS and severe mastocytosis. Subject to the availability of
drug supply, we expect to be in a position to begin the Phase 1
clinical trial in the first half of 2019.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We also believe our bi-specific, ligand-directed single-chain
fusion proteins are examples of the next generation of ADCs. We
believe GTB-1550 (OXS-1550) has certain properties that could
result in competitive advantages over recently approved ADC
products targeting leukemias and lymphomas and/or have utility in
other niche populations. In a Phase 1 trial, of nine patients that
achieved adequate blood levels, in two heavily pretreated patients
a continuous partial remission (PR) and complete remission (CR)
were observed. One of these patients, who had failed multiple
previous treatment regimens, has been in remission since early
2015.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">GTB-1550
is currently being evaluated in a Phase 2 component of an
investigator-led Phase 1/2 clinical trial in relapsed/refractory
NHL/ALL patients. We recently assembled a Bi-Specific ADC Advisory
Board to work with us to assess and interpret the GTB-1550
pre-clinical and clinical data, including an interim review of the
Phase 1/2 study. Eighteen patients have been enrolled to date,
including 12 NHL and six ALL patients. At the time of the interim
review, 13 patients met the evaluation criteria, including nine NHL
and four ALL patients. More than 50% of patients (seven of 13)
exhibited a clinical benefit, defined as stable disease, partial
remission or complete remission at Day 29. Of the seven patients,
one demonstrated a complete remission (CR), one demonstrated a
partial remission (PR) and five demonstrated stable disease
(SD).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
efficacy signal was more prominent in ALL patients with 75% (three
of four) exhibiting clinical benefit including one CR, one PR and
one SD. In the NHL population, four of nine patients exhibited SD.
Adverse events were mostly grade 1 and 2 and reversible. One
patient had a grade 4 low platelet count, two patients had a grade
3 increase in liver function tests, or LFTs, and one patient had a
grade 3 capillary leak.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company currently expects final data for this trial to be available
in the first quarter of 2019.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Our initial and ongoing work is being conducted in collaboration
with the Masonic Cancer Center at the University of Minnesota under
research agreements led by Dr. Jeffrey Miller, the Deputy Director
and Dr. Daniel Vallera, Director, Section of Molecular Cancer
Therapeutics.</font><font style="font-size: 13px">&#xA0;</font><font style="color: #000000">Through
these research agreements we have access to a range of capabilities
and resources such as construct design and functional testing,
early single-chain fusion protein GMP production, scientific and
clinical expertise and experience including early phase human
testing. Dr. Miller is a recognized leader in the field of NK cell
and IL-15 biology and their therapeutic potential. We have
exclusive rights to the TriKE and TetraKE platforms and are
generating additional intellectual property around specific
moieties.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 5px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Also,
in connection with the acquisition of Georgetown Translational
Pharmaceuticals on September 1, 2017, we acquired a portfolio of
IPR&amp;D CNS assets consisting of innovative reformulations and/or
repurposing of existing therapies. These CNS assets address disease
states such as chronic neuropathic pain, myasthenia gravis and
motion sickness.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In January 2018, we completed a study in healthy volunteers for
GTP-004, our product candidate for the treatment for the symptoms
of myasthenia gravis. We also announced the initiation of an
investigator led study in healthy volunteers for GTP-011, for the
prevention of motion sickness.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">15</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Recent Developments</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-style: italic; font-family: Times New Roman; font-size: 13px">
Financing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 2, 2018, GT Biopharma, Inc. (the &#x201C;Company&#x201D;)
entered into a Securities Purchase Agreement with the purchasers
identified on the signature pages thereto (individually, a
&#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers 10% Senior Convertible Debentures in an aggregate
principal amount of $5,140,000 (the &#x201C;Debentures&#x201D;),
which Debentures shall be convertible into the Company&#x2019;s
common stock, par value $0.001 per share (the &#x201C;Common
Stock&#x201D;), at a price of $2 per share. The Company used a
portion of these proceeds to repay $4.4 million of the notes issued
on January 22, 2018. Additionally, the remaining $3.3 million of
the notes issued on January 22, 2018 were converted into the
Debentures at the same terms discussed above.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $2,050,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 24, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $800,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
issuance of the Senior Convertible Debentures was made in reliance
on the exemption provided by Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#x201C;Securities Act&#x201D;), for the
offer and sale of securities not involving a public offering and
Regulation D promulgated under the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Impairment of long-lived assets</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
In the 3</font><font style="font-size: 70%; vertical-align: top; color: #000000">rd</font>
<font style="color: #000000">quarter of 2018, the Company
experienced changes in key senior management, led by the
appointment of a CEO with extensive experience in oncology drug
development. These changes resulted in the prioritization of
immuno-oncology development candidates relative to the CNS
development candidates acquired from Georgetown Translational
Pharmaceuticals. In conjunction with these strategic changes,
limited internal resources have delayed the development of the CNS
IPR&amp;D assets. The limited resources, changes in senior
leadership, and favorable market conditions for immuno-oncology
development candidates have resulted in the Company choosing to
focus on development of its immuno-oncology portfolio. We are
assessing our options to realize value from the CNS IPR&amp;D
assets. In light of this shift in market strategy, the Company
performed a commercial assessment and a valuation of the CNS
IPR&amp;D assets, both to assess fair value and support potential
future licensing efforts. Based on the results of the independent
valuation, the Company recorded an intangible asset impairment
charge of $228.5 million during the third quarter of 2018, which
represents the excess carrying value compared to fair value of the
CNS IPR&amp;D assets.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Results of Operations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Comparison of the Three Months Ended September 30, 2018 and
2017</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Research and Development Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
During the three months ended September 30, 2018 and 2017, we
incurred $1.1 million and $0.5 million of research and development
expenses, respectively. 2018 r</font>esearch and development costs
increased due primarily to the addition of new employees, combined
with increased consultant costs, and higher preclinical and
clinical expenses and include non-cash compensation of $0.7
million. We anticipate our direct clinical costs to increase in the
fourth quarter of 2018 as we work to be in position to begin a
Phase 1 clinical trial of our most advanced TriKe product
candidate, GTB-3550, in the first half of 2019, subject to the
availability of drug supply.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Selling, general and administrative expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the three months ended September 30, 2018 and 2017, we
incurred $5.0 million and $126.3 million of selling, general and
administrative expenses.&#xA0;&#xA0;Selling, general and
administrative expenses for the three months ended September 30,
2017 were driven by stock compensation related to the acquisition
of Georgetown Translational Pharmaceuticals on September 1, 2017.
Stock compensation expenses totaled $2.2 million and $123.8 million
for the three months ended September 30, 2018 and 2017,
respectively. We anticipate selling, general and administrative
expenses, excluding stock compensation, to range between $1 and $2
million in the coming quarters.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">16</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Loss on impairment</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
For the three months ended September 30, 2018, the Company recorded
an intangible asset impairment charge of $228.5 million related to
the portfolio of CNS IPR&amp;D assets, which represents the excess
carrying value compared to fair value. The impairment charge was
the result of both internal and external factors. In the
3</font><font style="font-size: 70%; vertical-align: top; color: #000000">rd</font>
<font style="color: #000000">quarter of 2018, the Company
experienced changes in key senior management, led by the
appointment of a CEO with extensive experience in oncology drug
development. These changes resulted in the prioritization for
immuno-oncology development candidates relative to the CNS
development candidates acquired from Georgetown Translational
Pharmaceuticals. In conjunction with these strategic changes,
limited internal resources have delayed the development of the CNS
IPR&amp;D assets. The limited resources, changes in senior
leadership, and favorable market conditions for immuno-oncology
development candidates have resulted in the Company choosing to
focus on development of its immuno-oncology portfolio. We are
assessing our options to realize value from the CNS IPR&amp;D
assets. In light of this shift in market strategy, the Company
performed a commercial assessment and a valuation of the CNS
IPR&amp;D assets, both to assess fair value and support potential
future licensing efforts. Based on the results of the independent
valuation, the Company recorded the impairment charge noted
above.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Interest Expense</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Interest expense was $1.1 million and $3.8 million for the three
months ended September 30, 2018 and 2017
respectively.&#xA0;&#xA0;The decrease is due to a reduction in
non-cash amortization of debt issuance costs associated with
convertible debentures and demand notes payable from 2017 that have
since been converted and/or repaid.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Comparison of the Nine Months Ended September 30, 2018 and
2017</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Research and Development Expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
During the nine months ended September 30, 2018 and 2017, we
incurred $7.8 million and $0.9 million of research and development
expenses, respectively. 2018 r</font>esearch and development costs
increased due primarily to the addition of new employees, increased
consultant costs, and higher preclinical and clinical expenses and
include non-cash compensation of $6.5 million. We anticipate our
direct clinical costs to increase in the fourth quarter of 2018 as
we work to be in position to begin a Phase 1 clinical trial of our
most advanced TriKe product candidate, GTB-3550, in the first half
of 2019, subject to the availability of drug supply.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Selling, general and administrative expenses</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
During the nine months ended September 30, 2018 and 2017, we
incurred $10.6 million and $128.8 million of selling, general and
administrative expenses.&#xA0;&#xA0;Selling, general and
administrative expenses for the nine months ended September 30,
2017 were driven by stock compensation related to the acquisition
of Georgetown Translational Pharmaceuticals on September 1, 2017.
Stock compensation expenses totaled $8.2 million and $125.9 million
for the nine months ended September 30, 2018 and 2017,
respectively. We anticipate selling, general and administrative
expenses, excluding stock compensation, to range between $1 and $2
million in the coming quarters.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Loss on impairment</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
For the nine months ended September 30, 2018, the Company recorded
an intangible asset impairment charge of $228.5 million related to
the portfolio of CNS IPR&amp;D assets, which represents the excess
carrying value compared to fair value. The impairment charge was
the result of both internal and external factors. In the
3</font><font style="font-size: 70%; vertical-align: top; color: #000000">rd</font>
<font style="color: #000000">quarter of 2018, the Company
experienced changes in key senior management, led by the
appointment of a CEO with extensive experience in oncology drug
development. These changes resulted in the prioritization for
immuno-oncology development candidates relative to the CNS
development candidates acquired from Georgetown Translational
Pharmaceuticals. In conjunction with these strategic changes,
limited internal resources have delayed the development of the CNS
IPR&amp;D assets. The limited resources, changes in senior
leadership, and favorable market conditions for immuno-oncology
development candidates have resulted in the Company choosing to
focus on development of its immuno-oncology portfolio. We are
assessing our options to realize value from the CNS IPR&amp;D
assets. In light of this shift in market strategy, the Company
performed a commercial assessment and a valuation of the CNS
IPR&amp;D assets, both to assess fair value and support potential
future licensing efforts. Based on the results of the independent
valuation, the Company recorded the impairment charge noted
above.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Interest Expense</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Interest expense was $8.0 million and $8.5 million for the nine
months ended September 30, 2018 and 2017
respectively.&#xA0;&#xA0;Interest expense is driven by amortization
of the original issue discount and the value of warrants issued in
connection with financings in 2018 and 2017.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Liquidity and Capital Resources</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company&#x2019;s current operations have focused on business
planning, raising capital, establishing an intellectual property
portfolio, hiring, and conducting preclinical studies and clinical
trials. The Company does not have any product candidates approved
for sale and has not generated any revenue from product sales. The
Company has sustained operating losses since inception and expects
such losses to continue over the foreseeable future. During the
nine months ended September 30, 2018, the Company raised $15
million through a series of issuances of convertible debentures in
January, August, and September. $4.4 million of the proceeds raised
in August were used to repay a portion of the January convertible
debentures. The remaining proceeds were used primarily to aid in
raising capital, establishing an intellectual property portfolio,
and to ensure continued progression of the Company&#x2019;s
development programs. We anticipate that cash utilized for selling,
general, and administrative expenses will range between $1 and $2
million in the coming quarters, while research and development
expenses will vary depending on clinical activities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">17</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
</font></font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
financial statements of the Company have been prepared on a
going-concern basis, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of
business. Accordingly, the financial statements do not include any
adjustments that might be necessary should the Company be unable to
continue in existence.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company has incurred substantial losses and negative cash flows
from operations since its inception and has an accumulated deficit
of $524.5 million and cash of $1.2 million as of September 30,
2018. The Company anticipates incurring additional losses until
such time, if ever, that it can generate significant sales or
revenue from out-licensing of its products currently in
development. Substantial additional financing will be needed by the
Company to fund its operations and to commercially develop its
product candidates. These factors raise substantial doubt about the
Company&#x2019;s ability to continue as a going
concern.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Management
is currently evaluating different strategies to obtain the required
funding for future operations. These strategies may include but are
not limited to: public offerings of equity and/or debt securities,
payments from potential strategic research and development,
licensing and/or marketing arrangements with pharmaceutical
companies. Management has also implemented cost saving efforts,
including reduction in executive salaries and reduced travel.
Management believes that these ongoing and planned financing
endeavors, if successful, will provide adequate financial resources
to continue as a going concern for at least the next six months
from the date the financial statements are issued; however, there
can be no assurance in this regard. If the Company is unable to
secure adequate additional funding, its business, operating
results, financial condition and cash flows may be materially and
adversely affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Long-Lived Assets</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Company evaluates indefinite lived intangible assets for impairment
at least annually and whenever impairment indicators are present in
accordance with ASC 350. When necessary, The Company records an
impairment loss for the amount by which the fair value is less than
the carrying value of these assets. <font style="color: #000000">The fair value of intangible assets other than
goodwill is typically determined using the &#x201C;relief from
royalty method&#x201D;,</font> specifically the discounted cash flow
method <font style="color: #000000">utilizing Level 3 fair value
inputs.</font> Some of the more significant estimates and
assumptions inherent in this approach include: the amount and
timing of the projected net cash flows, which includes the expected
impact of competitive, legal and/or regulatory forces on the
projections and the impact of technological risk associated with
IPR&amp;D assets, as well as the selection of a long-term growth
rate; the discount rate, which seeks to reflect the various risks
inherent in the projected cash flows; and the tax rate, which seeks
to incorporate the geographic diversity of the projected cash
flows.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Examples
of events or circumstances that may be indicative of impairment
include:</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">A significant
adverse change in legal factors or in the business climate that
could affect the value of the asset. For example, a successful
challenge of our patent rights would likely result in generic
competition earlier than expected.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">A significant
adverse change in the extent or manner in which an asset is used.
For example, restrictions imposed by the FDA or other regulatory
authorities could affect our ability to manufacture or sell a
product.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">A projection or
forecast that indicates losses or reduced profits associated with
an asset. This could result from the introduction of a
competitor&#x2019;s product that results in a significant loss of
market share or the inability to achieve the previously projected
revenue growth, as well as the lack of acceptance of a product by
patients, physicians and payers. For IPR&amp;D projects, this could
result from, among other things, a change in outlook based on
clinical trial data, a delay in the projected launch date or
additional expenditures to commercialize the product.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">While
all intangible assets other than goodwill can face events and
circumstances that can lead to impairment, in general, intangible
assets other than goodwill that are most at risk of impairment
include IPR&amp;D assets (approximately $253.7 million as of
December 31, 2017) and newly acquired or recently impaired
indefinite-lived brand assets. IPR&amp;D assets are high-risk
assets, as R&amp;D is an inherently risky activity. Newly acquired
and recently impaired indefinite-lived assets are more vulnerable
to impairment as the assets are recorded at fair value and are then
subsequently measured at the lower of fair value or carrying value
at the end of each reporting period. As such, immediately after
acquisition or impairment, even small declines in the outlook for
these assets can negatively impact our ability to recover the
carrying value and can result in an impairment charge.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indefinite-lived
intangible assets associated with IPR&amp;D projects are not
amortized until approval is obtained in a major market subject to
certain specified conditions and management judgment. The useful
life of an amortizing asset generally is determined by identifying
the period in which substantially all of the cash flows are
expected to be generated.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
For the three and nine months ended September 30, 2018, the Company
recorded an intangible asset impairment charge of $228.5 million
related to its portfolio of CNS IPR&amp;D assets within Operating
Expenses, which represents the excess carrying value compared to
fair value. The impairment charge was the result of both internal
and external factors. In the 3</font><font style="font-size: 70%; vertical-align: top; color: #000000">rd</font>
<font style="color: #000000">quarter of 2018, the Company
experienced changes in key senior management, led by the
appointment of a new CEO with extensive experience in oncology drug
development. These changes resulted in the prioritization of
immuno-oncology development candidates relative to CNS development
candidates. In conjunction with these strategic changes, limited
internal resources have delayed the development of the CNS
IPR&amp;D assets. The limited resources, changes in senior
leadership, and favorable market conditions for immuno-oncology
development candidates have resulted in the Company choosing to
focus on development of its immuno-oncology portfolio. In light of
this shift in market strategy, the Company performed a commercial
assessment and a valuation of the CNS IPR&amp;D assets, both to
assess fair value and support potential future licensing efforts.
The valuation indicated an excess carrying value over the fair
value of these assets, resulting in the impairment charge noted
above.</font></font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">18</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">The
fair value of the CNS IPR&amp;D assets was determined using</font>
the discounted cash flow method <font style="color: #000000">which
utilized significant estimates and assumptions surrounding</font>
the amount and timing of the projected net cash flows, which
includes the <font style="color: #000000">probability of
commercialization, the assumption that the assets would be
out-licensed to third-parties for continued development for upfront
licensing fees and downstream royalty payments based on net sales,
and</font> expected impact of competitive, legal and/or regulatory
forces on the projections, as well as the selection of a long-term
growth rate; the discount rate, which seeks to reflect the various
risks inherent in the projected cash flows; and the tax rate, which
seeks to incorporate the geographic diversity of the projected cash
flows.<br></font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>

<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Certain Expenses and Liabilities</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On an ongoing basis, management evaluates its estimates related to
certain expenses and accrued liabilities.&#xA0;&#xA0;We base our
estimates on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances, the
results of which form the basis for making judgments about the
carrying values of liabilities that are not readily apparent from
other sources.&#xA0;&#xA0;Actual results may differ materially from
these estimates under different assumptions or
conditions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Inflation</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We believe that inflation has not had a material adverse impact on
our business or operating results during the periods
presented.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Off-balance Sheet Arrangements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
We have no off-balance sheet arrangements as of September 30,
2018.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Item 3.&#xA0;&#xA0;Quantitative and Qualitative Disclosures About
Market Risk</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This company qualifies as a smaller reporting company, as defined
in 17 C.F.R. &#xA7;229.10(f) (1) and is not required to provide
information required by this Item.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Item 4.&#xA0;Controls and Procedures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Evaluation of Disclosure Controls and Procedures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Our principal executive officer and principal financial officer
evaluated the effectiveness of our &#x201C;disclosure controls and
procedures&#x201D; (as such term is defined in Rules 13a-15(e) and
15d-15(e) of the United States Securities Exchange Act of 1934, as
amended), as of September 30, 2018.&#xA0;&#xA0;Based on that
evaluation we have concluded that because a material weakness in
the Company&#x2019;s internal control over financial reporting
existed as of September 30, 2018, that our disclosure controls and
procedures were not effective as of the end of the period covered
by this Quarterly Report on Form 10-Q. The material weakness in the
Company&#x2019;s internal control over financial reporting and the
Company&#x2019;s remediation efforts are described
below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Management&#x2019;s Report on Internal Control over Financial
Reporting</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Management is responsible for establishing and maintaining adequate
internal control over financial reporting.&#xA0;&#xA0;Internal
control over financial reporting is defined in Rule 13a-15(f) or
15d-15(f) promulgated under the Securities Exchange Act of 1934, as
amended, as a process designed by, or under the supervision of, a
company&#x2019;s principal executive and principal financial
officers and effected by a company&#x2019;s board of directors,
management and other personnel, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles and
includes those policies and procedures that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 94%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pertain
to the maintenance of records that in reasonable detail accurately
and fairly reflect the transactions and dispositions of the assets
of the company;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 94%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Provide
reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with
generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with
authorizations of management and directors of the company;
and</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x25CF;</font></div>
</td>
<td style="vertical-align: top; width: 94%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of the company&#x2019;s
assets that could have a material effect on the financial
statements.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
All internal control systems, no matter how well designed, have
inherent limitations and can provide only reasonable, not absolute,
assurance that the objectives of the control system are
met.&#xA0;&#xA0;Further, the design of a control system must
reflect the fact that there are resource constraints, and the
benefits of controls must be considered relative to their
costs.&#xA0;&#xA0;Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute
assurance that all control issues and instances of fraud, if any,
within our company have been detected.&#xA0;&#xA0;Therefore, even
those systems determined to be effective can provide only
reasonable assurance with respect to financial statement
preparation and presentation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="color: #000000; font-family: Times New Roman; font-size: 13px"><br>
</font></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
As of September 30, 2018, management of the company conducted an
assessment of the effectiveness of the company&#x2019;s internal
control over financial reporting.&#xA0;&#xA0;In making this
assessment, it used the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in
Internal Control&#x2014;Integrated Framework.&#xA0;&#xA0;In the
course of the assessment, material weaknesses were identified in
the company&#x2019;s internal control over financial
reporting.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">19</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">A
material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement
of our annual or interim financial statements will not be prevented
or detected on a timely basis.<br></font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Management determined that fundamental elements of an effective
control environment were missing or inadequate as of September 30,
2018.&#xA0;&#xA0;The most significant issues identified were: 1)
lack of segregation of duties due to very small staff and
significant reliance on outside consultants, and 2) risks of
executive override also due to lack of established policies, and
small employee staff.&#xA0;&#xA0;Based on the material weaknesses
identified above, management has concluded that internal control
over financial reporting was not effective as of September 30,
2018.&#xA0;&#xA0;As the company&#x2019;s operations increase, the
company intends to take measures to mitigate the issues identified
and implement a functional system of internal controls over
financial reporting. Such measures will include, but not be limited
to hiring of additional employees in its finance and accounting
department; preparation of risk-control matrices to identify key
risks and develop and document policies to mitigate those risks;
and identification and documentation of standard operating
procedures for key financial activities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Changes in Internal Control over Financial Reporting</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On October 11, 2018, the Company&#x2019;s Chief Financial Officer,
Steven Weldon, resigned from his position with the Company. The
September 30, 2018 10-Q has been prepared under the direction of
the Company&#x2019;s Chief Executive Officer, Raymond Urbanski, who
has acted as the Company&#x2019;s Principal Financial Officer during
this time period. We do not believe the change noted above will
materially affect, or is reasonable likely to materially affect,
our internal control over financial reporting.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">

<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">20</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
</div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
PART II.&#xA0;&#xA0;OTHER INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Item 1.&#xA0;&#xA0;Legal Proceedings</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On February 15, 2017, MultiCell Immunotherapeutics, or MultiCell,
filed an arbitration proceeding against us with the American Health
Lawyers Association, Claim #3821.&#xA0; MultiCell is seeking
$207,783 plus interest and costs of arbitration pursuant to alleged
contract rights against us under a research agreement between
MultiCell and us.&#xA0; Following a hearing held September 1, 2017,
the arbitrator awarded MultiCell&#xA0;the payment amount of
$207,783 plus interest in the amount of $34,699. On September 8,
2018, an agreement was reached between the Company and Multicell
whereby the Company paid Multicell $100,000 in cash and agreed to
issue 75,000 shares of Common Stock in full settlement of this
matter.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 1A.&#xA0;&#xA0;Risk Factors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Not applicable to smaller reporting companies</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 2.&#xA0;&#xA0;Unregistered Sales of Securities and Use of
Proceeds</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In January 22, 2018, the Company entered into a Securities Purchase
Agreement (&#x201C;SPA&#x201D;) with the fourteen accredited
investors (individually, a &#x201C;Buyer&#x201D; and collectively,
the &#x201C;Buyers&#x201D;) pursuant to which the Company has agreed
to issue to the Buyers senior convertible notes in an aggregate
principal amount of $7,760,510 (the &#x201C;Notes&#x201D;), which
Notes shall be convertible into the Company&#x2019;s common stock,
par value $0.001 per share (the &#x201C;Common Stock&#x201D;) at a
price of $4.58 per share, and five-year warrants to purchase the
Company&#x2019;s Common Stock representing the right to acquire an
aggregate of approximately 1,694,440 shares of Common Stock (the
&#x201C;Warrants&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
Pursuant to the terms of SPA the Notes were subject to an original
issue discount of 10% resulting in proceeds to the Company of
$7,055,000 from the transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Upon
the purchase of the Notes, the Buyers received Warrants to purchase
<font style="color: #000000">1,694,440 shares of Common
Stock</font>. Such Warrants are exercisable for (5) years from the
date the shares underlying the Warrants are freely saleable. The
initial Exercise Price is $4.58. <font style="color: #000000; background-color: #FFFFFF">According to the terms
of the warrant agreement, the notes are subject to certain
adjustments depending upon the price and structure of a subsequent
financing, including a qualified financing with gross proceeds of
at least $20 million</font>, as defined in the
agreements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The issuance of the Notes and Warrants were made in reliance on the
exemption provided by Section 4(a)(2) of the Securities Act of
1933, as amended (the &#x201C;Securities Act&#x201D;) for the offer
and sale of securities not involving a public offering, and
Regulation D promulgated under the Securities Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Contemporaneously with the execution and delivery of the SPA, the
Company and the Buyers executed and delivered a Registration Rights
Agreement (the &#x201C;Registration Rights Agreement&#x201D;)
pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities
under the 1933 Act and the rules and regulations promulgated
thereunder, and applicable state securities laws.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On August 2, 2018, GT Biopharma, Inc. (the &#x201C;Company&#x201D;)
entered into a Securities Purchase Agreement with the purchasers
identified on the signature pages thereto (individually, a
&#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers 10% Senior Convertible Debentures in an aggregate
principal amount of $5,140,000 (the &#x201C;Debentures&#x201D;),
which Debentures shall be convertible into the Company&#x2019;s
common stock, par value $0.001 per share (the &#x201C;Common
Stock&#x201D;), at a price of $2 per share. The Company used a
portion of these proceeds to repay $4.4 million of the notes issued
on January 22, 2018. Additionally, the remaining $3.3 million of
the notes issued on January 22, 2018 were converted into the
Debentures at the same terms discussed above.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 7, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $2,050,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On September 24, 2018, GT Biopharma, Inc. (the
&#x201C;Company&#x201D;) entered into a Securities Purchase Agreement
with the purchasers identified on the signature pages thereto
(individually, a &#x201C;Purchaser,&#x201D; and collectively, the
&#x201C;Purchasers&#x201D;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an
aggregate principal amount of $800,000 (the
&#x201C;Debentures&#x201D;), which Debentures shall be convertible
into the Company&#x2019;s common stock, par value $0.001 per share
(the &#x201C;Common Stock&#x201D;), at a price of $2 per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
issuance of the Senior Convertible Debentures was made in reliance
on the exemption provided by Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#x201C;Securities Act&#x201D;), for the
offer and sale of securities not involving a public offering and
Regulation D promulgated under the Securities
Act.<br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 3.&#xA0;&#xA0;Defaults Upon Senior Securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
None.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Item 4.&#xA0;&#xA0;Mine Safety Disclosures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
None.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 5. Other Information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
On November 12, 2018, Mr. Cataldo announced his intention to resign
from the Board of Directors of the Company effective November 13,
2018. The resignation did not involve any dispute with the
Company.<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<font style="color: #000000">Item&#xA0;6. E</font><font style="color: #000000">xhibits</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 47%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align: bottom; width: 24%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 13%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 47%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="3" style="vertical-align: bottom; width: 24%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Exhibits</font></div>
</td>
<td style="vertical-align: bottom; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Description</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Herewith</font></div>
</td>
<td style="vertical-align: bottom; width: 5%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Form</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SEC File No.</font></div>
</td>
<td style="vertical-align: bottom; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Filing Date</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 13%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 47%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 9%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418002596/gtbp_ex31.htm">
3.1</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certificate
of Amendment to the Certificate of Incorporation of the Registrant,
effective as of July 19, 2017.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">03/15/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex101.htm">
10.1</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Securities
Purchase Agreement by and among the Company and the Buyers, dated
January 22, 2018.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">01/23/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex102.htm">
10.2</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Registration Rights Agreement by and among the Company and the
Buyers, dated January 22, 2018.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">01/23/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex103.htm">
10.3</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Note.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">01/23/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418000646/gtbp_ex104.htm">
10.4</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Warrant.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">01/23/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418001758/gtbp_ex101.htm">
10.5</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Executive
Employment Agreement, dated as of February 15, 2018, between the
Company and Cross.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">02/21/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418001758/gtbp_ex102.htm">
10.6</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">First
Amendment to the Employment Agreement, dated as of February 14,
2018, between the Company and Dr. Clarence-Smith.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">02/21/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418001758/gtbp_ex103.htm">
10.7</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consultant
Agreement, dated as of February 14, 2018, between the Company and
Mr. Cataldo.</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">02/21/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbpex4_1.htm">
10.8</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
10% Senior Convertible Debenture</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">08/03/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbp_ex101.htm">
10.9</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Security
Purchase Agreement</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">08/03/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbpex4_1.htm">
10.10</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
10% Senior Convertible Debenture</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">09/07/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbp_ex101.htm">
10.11</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Security
Purchase Agreement</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">09/07/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbpex4_1.htm">
10.12</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
10% Senior Convertible Debenture</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">09/24/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418008406/gtbp_ex101.htm">
10.13</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Security
Purchase Agreement</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">09/24/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418011065/gtbp_ex101.htm">
10.14</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Separation
Agreement between the Company and Dr. Clarence-Smith</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10/12/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418011231/gtbp_8k.htm">
10.15</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Resignation
of Steven Weldon</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10/16/18</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="http://www.sec.gov/Archives/edgar/data/109657/000165495418009126/gtbp_ex1010.htm">
10.16</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Stock
Pledge Agreement</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10-Q</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">000-08092</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">08/14/18</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="gtbp_ex1017.htm"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">10.17</font></a></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Executive
Employment Agreement with Dr. Urbanski</font></div>
</td>
<td colspan="1" style="vertical-align: top; width: 13%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
X</font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="gtbp_ex311.htm">31.1</a></font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certification
of Principal Executive Officer and Principal Financial Officer
pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the
Securities and Exchange Act of 1934, as amended.</font></div>
</td>
<td colspan="1" style="vertical-align: middle; width: 13%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
X<br></font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
<a href="gtbp_ex321.htm">32.1</a>*</font></div>
</td>
<td style="vertical-align: top; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer and
Principal Financial Officer).</font></div>
</td>
<td colspan="1" style="vertical-align: middle; width: 13%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
X</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</td>
<td style="vertical-align: top; width: 5%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.INS</font></div>
</td>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL Instance Document</font><font style="color: #000000">.</font></font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.SCH</font></div>
</td>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL Taxonomy Extension Schema</font> <font style="color: #000000">Document.</font></font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.CAL</font></div>
</td>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL Taxonomy Extension Calculation Linkbase</font> <font style="color: #000000">Document.</font></font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.DEF</font></div>
</td>
<td style="vertical-align: bottom; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL Taxonomy Extension Definition Linkbase</font> <font style="color: #000000">Document.</font></font></div>
</td>
<td style="vertical-align: bottom; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.LAB</font></div>
</td>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL Taxonomy Extension Label Linkbase</font> <font style="color: #000000">Document.</font></font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 13%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
101.PRE</font></div>
</td>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
XBRL</font> <font style="color: #000000">Taxonomy Extension
Presentation Linkbase</font> <font style="color: #000000">Document.</font></font></div>
</td>
<td style="vertical-align: top; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 4%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 5%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
*</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 95%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
This certification shall not be deemed &#x201C;filed&#x201D; for
purposes of Section&#xA0;18 of the Securities Act of 1934, or
otherwise subject to the liability of that Section, nor shall it be
deemed to be incorporated by reference into any filing under the
Securities Act of 1933 or the Securities Exchange Act of
1934.</font></div>
</td>
</tr></table>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly
authorized.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
November 14, 2018</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 51%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">GT
Biopharma, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:&#xA0;<font style="text-decoration: underline">/s/
Dr. Raymond
Urbanski</font>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dr.
Raymond Urbanski</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer, and Chairman of the Board <font style="font-style: italic">(on behalf of the registrant and as the
registrant&#x2019;s principal financial officer)</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 51%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">23</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>2
<FILENAME>gtbp_ex1017.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Untitled Document</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: right; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;
<font style="font-weight: bold"><font style="font-size: 13px">Exhibit 10.17</font></font><br></font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017000.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017001.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017002.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017003.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017004.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017005.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017006.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017007.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017008.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017009.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017010.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017011.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: auto; margin-right: auto; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px"><img src="gtbp_ex1017012.jpg"></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; display: inline-block; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>gtbp_ex311.htm
<DESCRIPTION>CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit 31.1</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL
OFFICER</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
I, Raymond Urbanski, certify that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">1.</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">I have
reviewed this quarterly report on Form 10-Q of GT Biopharma,
Inc.;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">2.</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Based
on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the
period covered by this report;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">3.</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Based
on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in
this report;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">I am
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e))<font style="color: #333333; font-family: Times New Roman">&#xA0;</font>and
internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and <a name="_cp_text_1_178">
<!--anchor--></a>have:</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">a)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure that material information relating to the
registrant<font style="color: #333333; font-family: Times New Roman">,</font> including
its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report
is being prepared;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">b)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Designed
such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally
accepted accounting principles;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">c)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Evaluated
the effectiveness of the registrant&#x2019;s disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation;
and</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">d)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Disclosed
in this report any change in the registrant&#x2019;s internal
control over financial reporting that occurred during the
registrant&#x2019;s most recent fiscal quarter (the
registrant&#x2019;s fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to
materially affect, the registrant&#x2019;s internal control over
financial reporting; and</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 7%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">5.</font></div>
</td>
<td style="vertical-align: top; width: 93%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
registrant&#x2019;s other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&#x2019;s auditors and
the audit committee of the registrant&#x2019;s board of directors
(or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">a)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&#x2019;s
ability to record, process, summarize and report financial
information; and</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 15%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">b)</font></div>
</td>
<td style="vertical-align: top; width: 77%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant&#x2019;s
internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%; border-bottom: 4px double #ffffff">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date:
November 14, 2018</font></div>
</td>
<td style="vertical-align: top; width: 3%; border-bottom: 4px double #ffffff">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/&#xA0;Raymond
Urbanski</font></div>
</td>
<td style="vertical-align: top; width: 12%; border-bottom: 4px double #ffffff">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Raymond
Urbanski</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer, Principal Financial Officer, Chairman, and
Director</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>gtbp_ex321.htm
<DESCRIPTION>CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2018 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit 32.1</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL
OFFICER</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
PURSUANT TO</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
18 U.S.C. SECTION 1350,</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
AS ADOPTED PURSUANT TO</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; background-color: #FFFFFF">In connection with the
Quarterly Report on Form 10-Q of GT Biopharma, Inc. (the
&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000; background-color: #FFFFFF">Company</font><font style="color: #000000; background-color: #FFFFFF">&#x201D;),
for the quarterly period ended September 30, 2018, as filed with
the Securities and Exchange Commission on the date hereof (the
&#x201C;</font><font style="font-weight: bold; font-style: italic; color: #000000; background-color: #FFFFFF">Report</font><font style="color: #000000; background-color: #FFFFFF">&#x201D;),
I, Raymond Urbanski, Chief Executive Officer and Principal
Financial Officer of the Company, pursuant to 18 U.S.C. &#xA7;
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, do hereby certify, to my knowledge
that:</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
(1)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 15 U.S.C. 78m(a) or
780(d)); and</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
(2)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 49%; border-bottom: 4px double #ffffff">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date:
November 14, 2018</font></div>
</td>
<td style="vertical-align: top; width: 3%; border-bottom: 4px double #ffffff">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
Raymond Urbanski</font></div>
</td>
<td style="vertical-align: top; width: 12%; border-bottom: 4px double #ffffff">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Raymond
Urbanski</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer, Principal Financial Officer, Chairman, and
Director</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 49%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 3%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; background-color: #FFFFFF; font-family: Times New Roman; font-size: 13px">
A signed original of this written statement required by Section 906
has been provided to GT Biopharma, Inc. and will be retained by GT
Biopharma, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>gtbp_ex1017000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JT# 2(  A$! Q$!_\0
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M/_W]?_&D_LNT_N2?]_G_ ,:NT4 4O[*M/[DG/_39_P#&G?V9:C^!_P#OZ_\
MC5NBBX6*HT^V'17Y_P"FC?XTX64 & K?]]M_C5BBBXK(K_8H/[K?]_&_QI?L
MD/\ =;_OMO\ &IZ*!V(/LD)_A;_OMO\ &C['!_=;G_;;_&IZ* (/L</]UO\
MOMO\:0V4!ZJW_?;?XU8HH K?88/[K?\ ?QO\:#86Y.=K_P#?QO\ &K-% %;[
M#;X^Z_\ W\;_ !I190#HK_\ ?QO\:L44 5_L4']UO^^V_P :/L4']UO^^V_Q
MJQ10!7^Q0?W6_P"^V_QH^Q0?W6_[^-_C5BB@"#['#_=;_OMO\:/LD/\ =;_O
MMO\ &IZ* (/LD/\ =;_OMO\ &E-K"1C:W_?9_P :FHH K_8X/[K?]]M_C1]B
M@_NM_P!]M_C5BB@"O]B@_NM_WVW^-)]AM_[K_P#?QO\ &K-% %;[#;X VOQ_
MTT;_ !H^P6_]U_\ OXW^-6:* *_V&W_NO_W\;_&@64 Z*W_?QO\ &K%% 61
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M2TP"BBB@ HHHI %)2TE !0:6B@!,444"D 4M%%, HHHH 3O2T4E "TE%(:3
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M\))K.IA;*2)C#>1')\J96VE/4G.,?44V;Q[X=ME<SWDB-'<?970V[EA+C.S
M'7'-<UXB\)W.CZ;XA?3P)-/U*2&1;6*!Y6MI59=TW7)X&3CGC(I=%T/4]8^S
M3LUI&MKJB:BUT+>5#=OM*L"K\@C(YZ=*-0T.JC\;>'I;N*W&HHK2AMC."JEE
M7<RY/1@.2#4+>/O#<8</J&UD:,%?*8G]Y]P@ =&[&LI/A_*)M4LVO+4Z1?/-
M*!]E'VJ-I<[E$G]W))'&>U1Q>!]8;2H+2YO],,EM<6[I)!9^7YB1-N&_!R6.
M/H*-0T-VS\;Z#?7<%K#=.)9I'A420N@61!ED8D8#8&<'M4<GC_PW#',\FH!%
MB19#^[8[D9MH<8'*D\9K+?P)>2W&Z6]MS$VL2ZDZJC E9(RA0'/7!SFJR_#[
M5#X<ET>34M/946..WF2SV.41PP,A!Y;"@<8'>EJ&AM3>/=(22SC@%Q/)<WWV
M$H(6#12;=WS C(XY'K6IK^LIH.C27SH9'W+'%'GF21R%5?S(KFI_ ^HRZM+J
M4>H6R3-JL>HHIB) VQ^6R'GN.<UM>,=&FUK0!#;'-U;W$5W"N<;VC<-M_$ C
M\:>H:&)XC\;7.CV6JVT**=4TRVAN)Y7B/D-O;! Y],\UNP>,-%FMGE6Z.^.7
MR&B,;+(7V[L!2,G(Y^E8>O>$+WQ%/J5W:7L,$&JV4,+QW$+;XVC<L#U]\$5%
MJ7@/4[S6[C68+ZR2\^TQ7$"2PEX\+%Y;(XSR".01T-*S'H=GI^IVFKZ9'J&G
M3)<V\JDQNIX;'&/;D8K(T37=4O[NVAOM%N[-98'=W>/"JZMC:3GCCD>N>U:N
MDV<MAIT5O,T+2KDN88A&F2<_*HZ"C5[>\N])N;:PGC@N94*)+("0F>">.^*8
MC(T3Q9%K'B#4M+\EHOLZK+;.PP+B(DJ7'J P(_*G-XUT"-GW7X $3S!O+8AT
M0X9E('(!XS5"X\&&RU71-4T8Q6\FG1O#/&Y9_/A9>4&3QR,CWKC/#VEZEJ-O
M+IZ0P^9+:W%I^^MYHVT])"25Y^4\XX!Y[<4K,-#O1X^\.&S^V?V@?('+-Y3#
M:O'SD8^[R/FZ5:D\7Z%#>"VDU!/,;(5@I*,P7<5!'!;'.*Q+CP7J0N]-N[2Z
MTXRQ:>FGW4=W;&6-D4Y#H,\,.>#P:33_  1?Z5?7:6UWI\FG32R7$9EM?](1
MW7E=XX"Y.>!D#BBS#0T1\1?"[1&1=2+((1< B"0[HR<;Q\O('<]N]7Y_%FB6
MMW%;S:A&&E**K $J&<912PX!8=!WKEK;P#JMO:6\'VZS8Q:'+I).QN2YSO\
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M.DA5=JH0RK@@<\9Z\T:A9&Y=Z_-)XF/A_2XHGNHK<7-S-,3LA4G"C Y+'!_
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M?A6]O7:6+*%'4YZ5Y9XPT:XEU/Q6;?2+F=M2L;46\UO#N#E7^<;AT.,57O\
M2]1L=8OVM=,U(Z"FI1S26]M'EG1H-I9$;[P#\D?C1=A8]2U/4[31],N-1OIA
M%:VZ;Y'/8?U)Z5G6WB)I;RQMKC2KVU^W!C"\H4CA=V&P?E..QKG=5\,7-_\
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MVR$D(I)Y/4Y/)J[10 E%+24 &*.]%)WQ0 M+244 +24M)0 4M)2T )S2T44
M%0+9P+>M=K&%G=0CL.-P'3/KBIZ* "BBDI@+1110 4444 %17$$=U;O!+DQN
M-K '&1]:EHH 9%%'#$D42*D: *JJ,  =A3Z** "BBB@ HHHH **** "BBB@
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M 4444@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?8US>L>"/$4MQHOB*Q);7[6]:XFAEE01A&/SIN R1C 'XU-XB\"ZAXCO&O\
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M)[W0VDM%UDWV998W/EM!LY4<9W=0.*6H'H&MZ[;:+H-SJK%)DAA:9$64+YH
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M9$D7.,HP(I]<YX2L#;0W=TVD2Z7+=.K20RSB0E@N,_+P!VXZXR:Z.F(****
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M?"K2O=I?_0S7H=>=_!+_ ))5I7^]+_Z&:]#I +124M,!*6BB@ HHHH ****
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MEI,<UO- ),I-%(V?E;'##@\^] :%[4?&MSIL>J02::LVIZ:D<TEM'(?W\+G
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M&Q^/IP/RKGYQ)HGB!9M6@%_I=UJXEM=6MGS+;2EL"&5>ZY^4$<>U 6/32X#
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M !12$9HYI 07EC:ZA;-;7D"3P.061QD'!R/U I4L[>.:>9(462XQYSJ,%\#
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M">VS>"/RA,KLK!.NW@]*TZ6@#&7PIHB36\R6026WB,,+J[ HA.2 <]SR:/\
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M&]*CCF06Q82P_9V+2,Q$?]Q23E1]*TH84MX(X8AMCC4(HSG  P*?10 4444
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M6:8N=JYSR2,5U6O:7?7_ ,))--@M)'O6T^*/[.>&W+MR/KP:>HK([%9 4WY
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M6MY+_9NIM=1Z%9+;G#Y%VA^;'/W@,9-&H)(]@N;RWLXU>YF2)7=8U+G&68X
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MIVJB(:A8V]T(FW1^=&&VGU&:YR3QY;F:7[-IM[=6T;3(;B)/E#1 ELYX ."
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M]UN+3$LY8YG1'9)V$<JAEW;MAY('0D9P:?XH\6Q>&$$D]G++"(FFDD5@ %!
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MW$@\E" -I'S,3@ >Y)K#;QL=T\$.A:A/?6VTW%I$8S)&&)"L/FPP."<@]*-
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M9.^1O((/!JUI7@O4]*U)9%N--GM9A"]P);<F1)8T"YC)X (4=>G.*[9)XWV
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M(]16!X.:_P!%\-67AV]TFX-[8IY&]5!AE4' </TP1R0><]J[-55%"JH50,
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MU]:ZBJ]I8VMC&8[2WBA4]1&H&:L4Q!1110 4444 %%%% !2&EI#0!YQ\"_\
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M);H-J$<44^R7&5C.5QQQS1J&A47QI)F]@ETIHKNTNUMI4:==BADWJVX#N.,
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M()IY6W.X087)[X%:5-""BBBF 4444 %%%% !2&EI#0!YQ\#?^25Z?_UUE_\
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MS_5="-A;:BVJE3%J%I:V5L+1'DD6XC!V-@+Q\V"#VQ77:98ZCIUAIML)()<
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M!1110 4444 %%%% !2&EI#0!YQ\#/^26:?\ ]=9?_0S7I%>;? K_ ))98?\
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M5D(4D#^(<<FKOF:I#KME)?V^I"ZBNO*O6$4CAT-OC<&''EEN@'0\T786/8<
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MZTW4(SHVH-;RZ?:R^2]N_$L<^7!)Y>0+GYN]%V%D>X!E) !!R,CGM0S!>6(
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MY,*-QA7.%^[^7:N/M?B%?0>%;75M0TR,M,D\S>7, -J/C:HQDMC\..35Y_B
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M35-(AM%O;-[BS9;G>)7&,1=.&(85O:EK4ME)I=@+=6U'42RI&7PB;4W.2W7
M]J=PL:ES96MX$%U;Q3B-MZ>8@;:?49Z&HX]+T^$H8K*V0Q@A"L0&T'J!Z9KS
MWPEXKOK/0[.TN8#<SO:WUUYLDY8AH92-A)Y(YX/M4Z>.]<D.H7T.EP36=MIU
MK?"W$A$@60$MSCD@ G'M2N%CO;*PL].@\FQM(+:(L6*0QA!D]3@59K+T;5O[
M86>XA$3V091!/&V?-^4$GZ G'X5J50@HHHH **** "BBB@ I#2TAH \V^!6?
M^%66/_7:;_T*O2:\V^!1_P"+66/_ %VF_P#0J])I +1113 **** "BBB@ HH
MI*0&1J/AVWOM5MM5BFFM-1MT,2SPD9:,G)1@>&&1GV-5[CPK#/=6E\;VZ74K
M5G*7>X%B'&&4@C&W@<8XP*O:CKVF:2VV^NTA(3S&R"=J9QN;'1<]SQ6-)XCN
M[[Q=+HNE/ OV2.*:5IHG995<G(5AP,*,@\Y)I.P]2-_A[IGE20PW-U#%)I[:
M<51A_JV8LQR1]XL2<^]4/$7@>=[2232YKB>[GDLDDW.J[8[=\AAD?>QGZUM3
M>(GL_%]YIUX]O%I\&G+=^:V0P)<J0>V*LKXLT0O&GVY5DDN!:B-D8,)2,A2,
M9!(Y&>M&@:F7<?#^PNKHWC7U\EY*93<3HZ@RB10I4C&!A0 ,<BH3\-[$Z=<V
M+:GJ#17%O;V[DLN=D)RF.*VKOQ5HMEDW%\J8W[OE;@(<.QX^Z"<$]*QKOQP-
M*U+6Q>QB2QLS:"W:W0EG\[U[8SWI:!J7='T6=O$][K^HV,5M=M"MG%LEWF2-
M23YC8  )R..P%1ZQX$LM8U2XOGO[Z!KAH'=(G&W?"<H1D$CZ=*U(?$ND3F41
M7@8Q7(M9%V-E93T0C'6C5/$-II.J:9I\ZRF;49&CB*(2!M4DDFGH&I6MO"=E
M;Z=J]@+BZ:UU22221#)@QF3[^T@9&2<UEI\.;)5DW:IJ+M+]GWEF3DP',?&W
M QQ6_9^(=*O[T6=M>(\[*SHN"/,53ABI/# '@XK(\2^,!I3ZEI]E&6U*UTU[
M]#+$QB(7H"1ZX-&@:FIIOAZWTV35&$\TO]I3F>8.1@,5"G;@<# %8T7P[L(K
M>T@&H7[1VMG-91!G4XBEP".G8 8/M5[2_&>CZAIOGF^C\Z*.+ST"L"'<94*"
M,MDY QG.*T+37=-OM'DU6UN5DLXE<NX!^79G<"#R",'(HN@U,2;X?:?/;36[
MWM[LETZ/3GPZY\I#E>W7WJ>#P5:6NI7%W!J.HPQW/SS6T<VV)Y=NWS,8X;@'
M@XR,XJKINN>(M9\/VNNV5K9B*Z99([)P?,\@MC)?.-VWG&,=JV?^$GT8W9M?
MMJ>8/,Q\IVL4&7"G&&*]P* U*EGX2M[.\:]CO[S[7(T1FF#*K3+'G"O@8.<G
M)ZGUJU?^'8K[7K36/M=Q#=6D3PQ>61MVOC=D$<]!6>/B)X6,1E&J H(A,#Y+
M\QGC>..5'<]N]6+GQSX;L[[['/JD:S9C##8Q"[_N$MC !R,'IS1H%F1WG@NR
MU&VEM[^[O+J.5'#>9(.'8@^8O'RL,  CIBFQ^"K--3^W+?ZB&DC1+N,382[*
M#"M(,<MC@D8SWJU)XQT*.>XB>_53;I([DJV"(_\ 6;3CYMO?%0+X[\-M;RSC
M41Y<31!F,3C_ %G^K/3HW0'I1H%F5X?A]I,.FW>F_:+Y["=&2*W>?*6P8[CY
M8[<\C.<4T?#[3_,FFDU#4I+F6ZANVG>8;A+$-JL.,#CC%=';W]O=R7*0LS-;
M/Y<ORGAL9Q[\'M6+I_C?2K_3_M@%Q$&N9;>.)HF,DAC)W%5 R1@$GTHT#4?_
M ,(7I3Z1JVESF:>VU2=I[@2/SO;&2I[=!1?^#K"]O+6[BN+VQGMX!:[[28Q^
M9"/X&]1^HJ^VN6/]@2:U!+]ILEA:</"-VY0,\#UXKD[;XC0?VXK7S?9M(GTJ
M*^B+0/YB,S[3N(S\HXYQBC0-3J-4\/VVJ2::\DLT7]G3B> 1MQN (&<]1@FL
MEOA_IIU#[6EY?Q;;F2ZCB28;(Y)%(<@8Z')X-:DGBC1HM4BTY[Y!<32^2@P=
MIDQNV;NF['.*FU77M-T1 U_<"+*-)@ L0B_>8@=AW-&@:F8/!-@EIH\$5W>1
MG2%=+:5)!NVLNTJW'(Q58?#G1FL8+*62ZFMH+1[-4>3^!F#9R!G<& (/;%:*
M>,=#EN&@CO?,F4Q#8D;$MY@RA7CD$=QQ56S\=:3=6$]W)Y\"17,MN$>([W,>
M=Q '8 $GTHN@U%@\$VL4FGS2ZEJ=U<6,YGCFN)][,VW;@\=-I(Q[U<USPS::
M[<6EQ--<V\]J)%26WDVL4<8=3[$8JJ?'GAL2*HU-&#+$^]8V*JLGW&+8P 3Q
MFK>B^(H-=EU*.WAFC^PW36KF1<;F7&2/SHN@U,A/ASI4=E<6@N]0,,UE'8MN
MF!(B0Y4 XZ\GFI&^'VEO=K.+J^2,7:WQMUFQ&9U&"^,=QU'0U:3QSX=?4#8C
M4,3B9[<@Q.!YJC)3.,;L=N]):>.O#]]"LMG>/.'.$5(7W28!)VC'S  ')'2C
M0-2F/AUI:Z;>::+W4OL-P"J6YN"4MU+;BL8QP,_6M&\\*VE_=Q37=S=31QO%
M*('<;-\?W6'&0?7&,T^+Q;HMQ+%'!>B4RVK7D9120T2\,P/L>".M5+;Q39&]
MU.674XFM8%@*P^0R21&0< D_>+'& !1H&I2/PTT8Q^6MWJ21^7-!M6X_Y92-
MN9.G SSZU.OP_P!-6&:,WE^WGW$-Q(SR@DO$ $[=.!^55]#\;),FL/JLH06V
MHR6ULBPLKLBH&.5ZD@$YH\2>.K6V\/?;=#NXKF4^0ZL(FD0)(X4;B/NY&<9]
M*+H+,F3X=Z5%=1RQ7FI11PM*UO#'<D) 91\^SC(!SGVK1MO">GP6VJ12--.V
MJ($NY7;#2*%V#D8YQWZU#XRUNX\/Z=97L#QK&U]##/O0L3&[8.,=_P Z=9^-
MM"U"XM(+>Y=IKN22*-&A92'09=6R/E8#G![47L&IG+\-M*!!:_U-V @!+3@Y
M\DYC[=JL2> =->X:Z6\OXKPW,ER+B*;:ZM( '4<?=( X]JW$U>R?1VU4RF.R
M6,R-(ZE<*.IQU[5E-XYT&.U:>:XEC"SI;LC0-O#N-R#:!GYAR/6C0-15\%Z:
MGAJTT*.:\2WLY5FMY1-^]1U;<#N^IKF-8^']S;W-HND_:[FS5Y97#:AY<B2R
M,"6RRL"O!XQG)K>?XB>'$@@E%S<.9S($B2VD:3=']]2H&0P]#6??^,V:\NY;
M/4K>/23H@U""[^SF38WF%2Q .2/;BC0-34L/!T.VYFU:XEO[F^LUM+P2-E)$
M&<< #GD\]ZB_X5]I9TR.SDO=4E>"19+:Z>Z)FMRO"A&[  D>_>KW_"6:5!<V
MMG/=,9IO+0R+$WEAW7*JQZ*6'(!K%\1>/K:+PYJ=SHMP/MMI"MPGG0MMDB\S
M867ID9R,T:!J:T_@S3[J&*"YN+V>W0HSQ2S;A(Z-N#MGG=GJ1BI]8\*Z?K=\
M+RXDN8YOLLEHQ@EV;XGZJ:Q-0\<PSV=M)HTX,J:G;6EW%<0,C*DAQG#8(R.0
M:WH/%.D7.LKI45T#=/O$?RG;(4^^%/0D=Z:L&IFW'P_TBXE25IKU9HXX(XY$
MGP5\DYC(XZC)^N:FM/ ^EV-S:W$$UZLMK<2W$;&<DYDY=3ZJ3SBDO_$4FF>+
MY;6[FB32X]*:]=BAW*RR!3SW&#TQ4L?C31I9(8Q+,LDUU]D"-"P*RE=P4^F1
MR,]:6@:D]QX:MYM=DUE+N[AO)+<6Q:.0 ",'. ,>O.:IW?@;2[VU$%Q->N5$
M?ERF<[XF1MP=6ZAB>I[U>T_Q-INJ"W-I)(_GR2Q+^Z(PT9PX;TP?6B\\3Z78
M:FNGW$[+.SQQD["55I,[ 3T!;!Q3T#4IQ^"-)2^NK@M=/%=DO/:-,?(D=AAG
M*=-Q'7\ZBB\!:5%I!TW[3J$D0:-H7DN2SV^PY0(3T -36GCC0;V]6UBNW#L9
M5#21,B;HOOKN(QD=<5!I7B:35/&EQ80DG3_[.CNHB\!1B2Y&03]Y2,&C0-1\
M'@32K:6&:&>^6>*[DO%E^T$L9)!A\^Q'45*G@K1_^$?CT2:.6XLH[@7*"5\L
M'#[\Y^N?SK'\4^-Y["#7K?3H7BNM)2WD>::+,;K(X! _#O6NGC;1GB=EDN&E
M2?[.8/L["7?MW_=(Z;><^E*Z"S);OPEIMWKO]KE[J&=E59T@G*1W 7[OF*/O
M8I^I^%['5=1:^N);E96M'LR(Y-J^6_WACU/K4&F^,;#5]<BTZQCGECELEO4N
M0F(V5C@#]#6?K7B.ZT_QM%I4FHVUE8OIS7?F2P[FW*^TCKTQS3T#4=_PK;1/
MEQ/J*A9(I0%NB!OC7:K?7;Q6MIWA>PTZXGN \]Q<30+;/+<2;G,0SA<]^IY/
M-4X_%ME916]OJ=RK7DMK]I1H8F"3IG *>IY'RCGFK%QXOT:UU&.RGN_+D>3R
MMS+\BR;=VPGLV*5T&I%HO@G2M!OH;RSDO#)!;FUC$MP758MVX+CT!Z42^"M+
MFAOHGDN]M[=I>38F/,JD$$>@^4<>U(?'.B+%)*\DZQHL;[F@8!DD;:CCU4FH
MKWQQ86VI06$-O<W$SZA]@D"QX$;[-_X\=,470:CF\":,VIK?*;M"MV+Y84N&
M$0GQ@OM]3GFHT^'?A]6^:*XEA"31K!).QC5)3EU"^A/-&C^+K*5;2">^DNIK
MV[GMX)1:F)=R$YC([$ =3UQ4USX[T*TA66>:5$."Y,9_=J6V!F] 3T-%T&HL
M/@C2H;.WMA)>R+;SQSQO+<L[AH_N#)_A&>E5?^%<:!R,7@79-&J?:6VJDIRZ
M@>A/-;FJZW9Z.+1KLR!;N=;>)D0L-[?=!/;/K69)XPTZXT^XDMI+E'22>V+?
M9RQBDC4EB5[@=?>C0-0G\/RW6I:7;2P6K:1I>R:W=V+3F505 Y&  #G.>:TM
M8T&RUL6QNA(LMK+YL$T,A22-L8."/4<$5QEYXMU2*&^:TOXYHX_#J:E!,UL%
MW29(+%<]"!T[5U.J^(1HO@]M<G@DN/+MTE9(AR20/R&335@U*?\ PK_0A9V]
MLBW2)!YP5EN&#%9>9%)ZD$\XI&\)QZ1$)_#\*&\%LED%N[A_*,*\#<!G) )Q
M5G_A,-,^VPV,AGAN)G2$%XCM65TW*A/KC\*SO"_C%+OPY#<ZK,6G2&26ZG2/
M$485V4;B. 2!TZTM U.CT72K?0]&M=-M458;>,* HP/?]<U?K*T?Q%I^N2W4
M5F[^=:E1-&ZX9=PRI^A%:M4(**** "BBB@ HHHH *0TM(: /,_@2?^+6V7_7
MQ-_Z%7I@Z5YI\".?A99_]?$W_H5>ET@"BC%+3 **** "BBB@ HHHI <AK7A>
M^NM;U*^LI+=X]3TW[!/'/G]W@MAQCJ,,<CZ5+H/AV\T;Q!/.7C>Q_L^WLXSO
M)D)B!&XC&.<^M=31GBD.YQ'B;P=?Z]K-[<Q7,,$,MC'!$Q)+"2.42@L.A4D8
M-9WB/2$C35+O59A!JFM&WAL8[56DV3P@F-@<==Q)R<<#%>D#I2=>PXZ46"YP
M/B+P9J^HZ?;V%G<6C6YT^6VG$Y93YS\^;E?O<Y^4\<YJ&Z\%ZY=V>K(TEBDU
MU!8K%AV*[[<@G/'0^M=S+J4$=U:P8DD-RS(C1H652HR=Q'"^G/>K@Z4M NSA
M](MK;5O'MWJEK,3';Q+'?1+&1&;Q<J""P&2%)&?I6QXDT6]U.^T>ZLGA!LIW
M,JRDC<CQLA((_B&<BN@P!TXS13"YQ&A>#;^QN- 6]N(&AT%)H[>2+.^X#C:-
MPQ\N%ZCG)J?Q/X:U34M4NKK3Y+3R[O29=.D6<L"A8Y## YZ\UT46KVD^LW.D
MHS_:[>))I%*$#:V0"#T/0U):W\5W=7=O'',K6KA',D156) /RD_>'/44PU//
M[[P%K-W<BZ273UEAMK,0K(69'E@)R'&/N,&/3D5V.DZ0\6@R6-_!91FX#^=#
M9)MB 88('<^Y/6K7]KVO]NC1LR"\-N;D#8=NS=MZ],Y/2K](1RGA[1M>T#3+
M?1%N+.:RM?W<-VV[S?*!X4ITW <9SCVK+M_ NH0V]C8-=0/::9>3WEI)DB1R
MX?:C^@!<Y(Z@"O0*9)(D49DE=41>K,< 46'<\[@\":O#96T'G6),6@2Z2QRV
M"[G._IT]JS[70KS4=:\1>'0UKY;V&GV]U,<G;L0AB@QST[]#BO5JJ75[#97%
MK&T$S-=2>6K11%@IP3EB/NCCJ: N>=W'P^\03WSSF\TYV\J\MQ*P?<\<ZX4D
M=%*C P.O6I=1T)-&LKB;7GC>QN=)M]("6Z.[F5<[2 !W)X],5WNKZK;:)I5Q
MJ5X7%M;KOD**6('TJ.SUJSO]4N].A+FXM$C>4,A PX)7![]*+!=D/AC39])\
M.V5K=SO/=A UQ,_WGD/+$^]<S9>#-8TW4+2^@N[.22QO+N2%'# 2PW!W$-Z,
M#C!'I7=RR"*%Y6!*HI8X&3@55TK4[;6=*MM2M"YM[E \>]=IQ[CM18#)T;PP
M-)\'OH0GWM*DV^4#@-*6)P/0%N/I7+KX$U]K":":ZTXN^A#2%9=^/E/#G/MV
MKTJEIA<X;1O!^J:5KCR^9I<EC-,MT[20%KB*3: RHQXVDC()Y&:N>)_#%]J.
MMV6L:8^GO/# ]K+;ZA$9(GC8@Y&.0P(_'I76U%+-%#M\QPI<[4!/+'&<#U/%
M&@'&W7A+5CKECK5K<V4=]8;+>'Y"J26N/WB,H'!)Y&.%P*HR>!M9@F%Q:7&E
MS26]_<W$,5W$S1R13G+*X[,#C!'I[UV>CZS::[I<>H67F&!V91YB%6!5BIR/
MJ#6AT!//3TI!=GGVI^!M6NXM7BBN+!1?6EK I"% AB?<3M' !S@ 5T/A[1;W
M1]1UEYYK>2VOKLW<80'>C, &!SQ@8XQ5[1=9M-?TY=0LO,\@N\8\Q-K;D8J>
M/J#6B2/3OZ4@N>:Z+I=QX@N-7A#VZV5OXBEO,D,)'90"H] I/\0[ BM'3?!6
MI:9:>'9HKJU;4-'$T1!#"*:.7K[@C@_A77O?*FJ16/V>X+21-()EC_=K@@8+
M=F.>!5H$YZ4PN<1_PKM%TC1[2&_:.:QN9)9I57'FQRL3+&!V4Y_2C6/!.H:A
MJ^I7]O>VT#226D]F"I(5[?. X[J<GITKN11GBC0+L\W/@'7#?2ZO]LTLZB;]
M[M(9(6> K)&J.C9YS\H((J2^\!ZRT6I6]CJ%@EOJD<)N0\#+Y4L9',87C:0,
M8/2NRUC6[70XK:6[$I6XN8[5/+3=AW.%SZ#WK2HT"[,3Q'HUSK6E6\,,\4=S
M;W,-RI=249HV#8]0#BN3UWP_%N_L]GN1KNK:@M_'/:1-Y=N4"HWS= /+R#GK
MFO1N?2JNFW_]HV8N!;7%OEF7R[B/8XP2,X]#C(]J N0:IITUQX=N=-TZX%G,
MUN88)=N1&<8!Q7F^J^']3\.B&YDEL&DO=6L9%CA23:C1C:Q8DDD=\^]>M44,
M$SS&ZTF]TGQWH<L+P27][<7EU.2K>2A>-5501[*.O4YJTWPYO(;&>TM+ZW$<
MNCR:=ND1L[WD,C/@=LD@"N^N[C[+9S7'E2R^4A?RXEW.V!G"CN?:EMYC<6T4
MXCDC$B!]DBX9<C.".QH"YR5AX7UO3-5EDM-3M5L;M86N8VA+21R(@0F,YQAM
MHZCBL0_#;6+B*Y2ZU6R+7%@UI),L+EY&\S>KMD^V"!P.U>DQSQ3/(L;JS1MM
M< YVG&<'WP14F:- NSA[_P %ZAJ$S7\ES:QW\MS:2R !C&$MR2%'?))/)JWX
M>\+:CH>HO&UW92Z7'-)+;XML7 WDG8S], D\CD\9KK>:C\^+S_($B^=MW[,\
M[<XSCTS1H%V<OXA\+ZEJNLSW]EJ,5H7TQ[)&V$LK%P^[Z<8_&LV+X?WCZ=K5
MO/?6T$E]/#=6TEK&P-K-&J@,-Q.>5_4UWV:6G9!=G,^'O!\/A[6=0O(+AG@N
M54I >D;X_>/]7(!-9WB/P;JNLZVU[#J%JL2S6TT"3Q,QB,39*C!QANYZUV]%
M%D%SSQ_A[?7-O#;75[;>3]KO)Y3$K!BMP&&%]UW?CBM;P_X<UFPUJ&_U._LY
MQ#IRV 6"%E+!6R'.3P3W%=;119!<XKQ#X,O]6O=9DM;ZVB@U2W@C=98V+(T3
M9!&#T(J&]\&:Q<ZM>7L>H6:QW=VD\MN\;E758O+VG!!./O#MZUVT=Q#+++%'
M*CO"0LBJ<E"1D _A3+B\BMRT>=\_EM*L"<NX7K@?B!^-&@79R/A7P;J7AV\T
MZ634+6:.WT\V,JI"5+ .70KSQUP:TK_0;^7Q?'KEM+:%4L6M/(G1CG+AB<CZ
M8QBMRRN3>64-R8)H#*@?RIEVNF>S#L:G[9H"YQ>J^$-6UBVM3/J5K'=V)\^R
MDA@(6"?=P<9Y0+\N/<TV/P1>KJ>H%[VS;3M2=I[F/[-F9)67:XC<GA2>>>17
M;9XK(U37X=,NDM5M;F[N6C\XPVR!F6,,%+8)&>3T'-+0+LYY?!NMS^$Y="O]
M<@F6*..*SD2VV\(P93)SR?E XQWJ(>!M6:^.H/JEI]K_ +534@!;MLXC\MDZ
MYZ<@UT^M^(;'0]/NKJX+R?9HUEEAB&7"$X!QZ9K41PZ*XZ,,\T:!=G&-X#DF
M\+W6E2Z@([E]0>_M[N!,-"[/NXYZX)'T-37G@VZ37A?Z3?6\$,UO';7,-Q;"
M7"IG:T9[-@D<Y'>NINKJ"RM)KJZE2&WA0O)(YP%4<DFLFW\46T[6!-G>QPW[
M;;:9XL*W!()[KD#C/6C0-2QK^B1Z]H%SI<DK1&5!Y<P&6C<'*N/<$ UB6?@6
M+3KK4KFUNV+WMGY)21<J)B,/,1_>;C/TKL**=A7."'@&]^QR0'4;?Y]$&D9$
M)XP<^9U]^E=!JN@/JO@R;07N1')):B S*F0" .<>G'2MO+>8!@;,=<]Z7(/0
MYHLAW.#N_ VLW6J0WSZS:L\-U#=1A[4G88UVE%^;A#R?7)JMIWPRFL=-O--&
MJ*+/48G6\1(R-TI8LLJY/RL. 1T.!7HM+19!=F+X=TO4M-MG75+ZWNICA0;>
MV$*X'<C)RQ[_ *5M444Q!1110 4444 %%%% !2&EI#0!YI\!O^26VO\ U\3?
M^A5Z97F7P%/_ !:VU_Z^9O\ T*O3: "BBB@ HHHH **** "BBB@#SSQL;MM;
MO5BO-1BCCT22:)+9W53.K_+T_B]N]9\M]KEU'<L)+M-:$MI)IP 81RPE4WY'
M3&?,W9Y%>I4M38=SA/B%=W<(M;>U-['));W#1O '*>8$^4';SNS]W/'6LO1]
M3NM0U:VBU:36$GDBM9K%H4=4F7RP)5?C ^;=NW8/3%>G<]J6BP7/)-$-_IUM
MX?L[ WT5PMW?I<12>9L+X<Q[\\8SMP>E1W-WK)\/&YM;G4TN_P"QY_[30[]R
M78QL*^C[MPPO45Z]118+G$^#I9XM?U*S>YO9H&L[6=?M)9@)&4^9@M_P'('2
ML74U\4:5JMZ+-+V[M]-O5U&,F1C]IMY!AK<>I4Y(SV KU"EHL%SR'Q%9WMK>
M:M<13ZB-0MM(MY(GA9_FG\UF(X^]C/W>F#TJY>ZIJ4-[JLS/J4^DKJEL;D1A
MRRVS0_-L'78).H7WKU*BBR"YY%J]FTLIDM)]:98-!N&M9W+K*S^:&C!(&3[*
M>2!S72^)I;RZ\'Z%)'->1SS75IY[6^Y7VDCS,XY QG.:[BBBP7/)K0WMCJ-O
M)#/J\@@UV>V17>1Q]D,9(&#P1NQACWQS6).+[4-)U&%XM5EAFTZ&X,3QR[A,
MD_S[B>KA>N,#TZ5[I11RAS'F,,MS=>))XKFYUBU>*X\VR$,#^7-:&,8!8\ =
M<@_-G%5]#AO;31_"=X+G69;JXO?]-2621OE".,,IZ#.WKWQ7JU%'*%SQ(W.H
MW.GZS&T>JM'=Z-(/(FBD9OM EZ,2,%\'^' Q6[=Z;=:GJ7B8VKW%K<"QLI[6
M<;HU9XU8E<\9'0$>]>H51U32++6;9+:_B,L*R+(%#E?F'3.",CVIV"YG>'C-
M+X>;4[N&2"XOE-S) SE_*R.%'T'I7F=A]OTC1[+R(=9(ET247,,6\$2B4;<9
M'RD*6Z#.,U[4 %  & . !2T6"YX]''?7LT5A-)K"6QUP8,231+]F>'L>H3=Z
M]/:GQ:7=#43F;6MJ>(3;AC+,<V1CP?\ @.>_ZUZ]12L@N>.,-770K:,-J$DU
MM/=QQV<ZR@S1>;\FV4<K(%QM+9!&:Z[QA:>;J?A._EM+F2.UO\RF,,QC#1L
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M;P2W'(P/QKG(+/4]*U>SN&CU.71/MMY% O[R1Q"\0V!AUV^9NVD].*]6 "@
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M>74)+B9[-;5PZ ;MK%MV1[D\>E4&\!V*Z!K6D6]S-#'JLK2,^ WDACG:@/\
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MD- 'EOP!Q_PK"+_K\F_I7J0Z5Y;\ /\ DF,?_7Y-_2O4J0!CFEHHI@%)2T4
M%%%% ">U%!Q2T@$HS6)J?B"2P\0Z?H\=BT\M]'))&_FA5&S&X'\Q5NTU6*6-
M1=^7:7!#'R7F4DJIY8>JXYS2 T:2JW]H6>Z%?M<&9QF(>8/WGT]:1M3L$>5'
MO;=6B_U@:4#9VY]*=P+7>CO67?\ B'2=+"F\OX$+3);A0P)WL?E!':BUUB)Y
M9DNI+6WQ<F&#%RKF7 &/HW/W>M*X6-.L'Q+I$M^=,O[9-UUIEVMS&F<>8N"K
MJ/<J3CW%:DFIV$2[I+VW0;S'EI0/F'4?6I+BYAM8O-N)HXHQU:1@!0!R#^"Y
M#KD>N?VM<-Y-ZU_' UNK2?,FTQ;B<XQT':MCPUI,VG6M_<3A4N]1NY+R1>OE
MEL!5]\*!GWS44?BNR;Q+/I<KP11I;13P7)G7;/O) "^^5K7;4K7S);=+B%[I
M$+>1Y@W' STI(>IPB?":*2QDTZ\UF::PGU,ZG-$D*HSR'^$-DX7Z<U)'\+FC
M\2QZY_PD5VUS'<32H7A1BJR+MV9/.%[5L:#XT_MNXTB+^SV@74;![P,90VS:
MX4IC'/4'-7/^$IMHO%=UHEWY-MY4$4L4TLP'FER1M /<%:>@:G+2_"#3Y+*9
M8[^2VNVNX[R*:"(*D4J#&X1]/FZFNQ;1'D\-R:4]_,)94*M=1JJ.&/.X <#G
MM5_[=:_:_LOVF+[1C/E;QN_*F76K:=9/LN[^V@? .V655// ZFC01R^I_#Z/
M5KJ>^N-2EBU%K)K*.[MXQ&ZJV,LV/O,<8^A-92?"&U33-1L/[:N3%?SV\\F8
M4R&AZ8^N.:[YM2LENA:F[@%P1D1&0;CQGI].:S&\0B#PR^JW2VD<PCD=8DNE
M='*YX#C@]/PHT'J8%O\ #)(?%4'B!]<NYKJ&[DN5$D:GAUV[,]=H'3TJ:/PT
MOA3P/<:+:V5QK<%U.XDB&U&"RD[CSQ@9^M=)I>L17_AVSUB;;:QW%ND[!W&$
MW '!/XU<@NX;R 36LT<R'(#(V1GTIZ 8F@^&GT+PSI&DV=[) ++:92%#&8<[
ME.?4GJ/2KVI:.-3O+&2:;_1[9S(ULT8996Q@$Y],DBN=M_'Y-K97MWI9BM+K
M4&TX-'.'=9 Y0$K@94D=NE=4NJV#SRP+>VYEB!,B"094#J3]._I2T#4P3X+6
M'4M4NK#4#:1:CY1EM5MT:+*<9VGKN'!]:T=)\-V6E:%+HX'G6DID+QN/EPY.
M55?X5YP!VJR=;TO[,US_ &A;^2C;&?S!@'K@_AS5;Q#X@MO#_A^?6909H(@I
M^0\'<0 <]EYR3Z4:!J0:3X=N=)MX+*+6;B33[?B&%T7>JC[JE^I _/'>LV#P
M$MO%91IJLQ^R"Z"$Q+SY^=V?IGBM>TUTL+B34(X+:UC5'CNTG#PS!O[IP.AX
MJ.7Q-$-=TJR@$,UI?P32B[6487RP,C]>N>,4:!J9EIX"_L^>SELM<O;=H[6.
MTNO+5!]JCC^YG(^5@.,K6UHVA?V1?ZK="[>;^T+C[0R,@ 0[0N!CM@#K3_\
MA(]&^SM<'5;,0JX1G,P #'H/QIT/B+1KF&2:#4[66.,J'9) 0I;[N?KVH30:
MF9#X6NK6^UBZM=9EB?5)1))B!3Y9"A1M_ =ZCN?!OGZG;ZG_ &G.+V"7Y92@
M),&W:8&]4/4]\\UT-Y?VFGP^=>7$<$9. SMC)K"UGQ9'::AI^FZ:;:YOK^)Y
MH!)+MC95 Q\P!^]G -&@:E*/X>VXT:XT>;5K^73"/]$MR5'V0[MRE6 RQ4@8
MSTJW+X2GN+:Q,^NWLNH6=QYZ7C(F?NE2NS&T J3^/-0:_P",9]*UW3-%@L8W
MO[U!(%FEVJW7*(V.6R*N:GXI73;K1[0V<C7.H31Q2)N'^C!\\L?J,8[X-+0-
M3-MOAY!9V]O';ZK=JT5I/9L[*K%XY6W'/'!![BM)/!MB;;0(YY999-%QY$@^
M4N NW#8ZC@''J!49\1ZA;^(K.POM',%G?R/%;7"S!G#*"WSICY00#CD^].\-
M^*#XCO;W[-#;?8;=BBRI<[I2P./GCQE,]>:8:DEAX5&FZY<WMKJEW'9W,QN)
M+#Y?+\T]6!QN /7;G&:M:CH,-[JMKJL,K6VHVR-&DZ '=&W5&!ZC(!]C6;>^
M,H[74;U!;[K+3YX;:[G+8*O)C&T=P-RYY[U#'X\MO,CN)X/*TR>>>""YW9):
M$,6)'8':V.>WO1=!9D]QX*M+FPNX6NYQ<WES'<W-U@;Y&C(*CT"C &*?>^#X
M;]];:6]G']L0)!-M5?D" @%??!-.T7Q0VI7UO:7-I]FDO+,7UKA]VZ+(&#Z,
M,J<>]7Y?$>BPZ@MA+JMHEVT@C$+2@-O/(7'K1H&IF0>"X+;59[J'4;Q+:Z"M
M=60($<SA0NX\9&0!D X.*J?\*_B_L*?16UK47L&"K;Q.5/V= P8*./FZ 9;.
M!702:]I,,TT,NHVT<D"%Y T@&U1U/X=_2B+7=*N--EU*'4+>2RA)$EPL@*)C
MKD^U&@:B:SHZ:UH<VF37$T(E509H2 P(((/IU'2L*U\!0VFHQWRZM>/(MZ;[
M#JF#*8]AX Z$=JZ'^V-."[C>0[?*$^=W5"<!OH>U02>)-%2VCN'U.V$,A8*V
M_P#N_>^F._I1H&ISH^&UHEH\$&K7T)FMGM;EDV_OXV8L 1C@@L<$=C717WA^
MRU+PZ-%O0\UMY:IOW8<%<;6!'1@0#FI(]>TB;4_[-BU&V>^Y/D+("_ ST^AS
M5#4O$Z64FHK#;27"Z;&KW1C4L0S?=4*,DG')]J U'2>')[O3+BQO=9N[A)H&
MMPQ55(##!)P.6QW-9MQ\/X+B=)_[5O(Y(XK>-"H7 $)RF1C!ZG(/%,U#QO);
M!/L]@<MJ,5@?M0:(?O!E9 2.1]*NZ7XPM[J;5[>_$5L^ESI#),LF^*0N,KM/
MKS@KUS0&I6M/ %O9M;F'5+PB"6YE0/M/,XP_;W.*M6_@Z*VBT-$U"X_XD\;Q
MPL0N7#+M^;CTK0_X231EMHK@ZC!Y4N=C[N#@X/TP>.>]64UC3GU#[ MY";H@
MXBW<G'7'KCOZ4*P:G+/\-[.33[6R;5+X16UI):H5*JVUV#9)QUR!^%68/ D,
M&H)>C5;QY!=K>L&";3*(]G0#@$=A4NK>*WL_$JZ%;Q0"[:U-S$+J4QBX.2/+
MC..6XY^HK4BUZQ\ZWM+JXBM[^54W6S/\R,PR%/OUQZXIZ!J5].\+V=CX<N-#
MD>2ZM+@R^9YN,D2$EAQ[DU2;P1:RZ?-:S7UU*\EE]@2=L;XX,YVCCD].3Z4_
M2_%]K+I\MQJLUO9.EU/ %WDAA$V"WKCN3T%6[SQ?X=T^Y:WN]9LX9D4,R-(,
M@$9!/MCFBZ#4L7FBP:AX=ET6ZED>&6#R'D! 8C&,_6L27P%!/#>I/JM](UX+
M?S7.S.83E"./;FM34]:FB6$:3##?3>9$9HC(598G/WAP>>_/H:K6?B&\CEM(
M]9LH[7[7</;1-'(64N,E>H'# ''N*6@:C])\*0Z-J,UQ;:A>_99)&E6Q,@\F
M-V.6*C&>22<9P,U)?^'/MFOQ:S'J-S;W,5NUL@C"E0K$$\$=<@5KW-S#:6TE
MS<2+'#$I=W8\*!U)K)MO%_AZ\BGEMM8M9$@"&0J_3=]WZY/ Q3T%J4;?P)IM
MB+62QGNK>\MWF?[4'#/*93F3?D8.3@].,#%5IOAMI3DI;W=]:P%(1Y,,@V[H
MFW(W()SGKV-;L/B/1YYH88M0A>6<.T: \L$^_P >W?TH_P"$DT?SH8?[1A\R
M8*4&>N[[N?3/;/6C0>IF-X'L38&V6[O$D6_;4(;A7'F13-U(XQ@Y/!'>M'1?
M#]OHMC<VBSSW27,TDTIN&#$L_P![H!P?2LC0/&UOJLEUI]S/:0:O%<W$$=NK
M'YQ&< \^W.*GTCQC93^'+#4M5GM[.6YCWLFX[4^8KG/89[FE=!9C[7P7I]I!
M%#'-<F.V@DM[0.P/V='^\%X].!G.!6E9:/'8:!'H\,\WE10^0DC$%PN,#MC.
M*36-2.GQ6;)<6D1GNHX0;@G#ACT7'\1[=JCMO%&B7>H+86^I027+.\8C!ZLG
MWESTR/2GH&I0M/!&GP66GV,]S=7=EI[*UO;S.-@9?NEL ;B.V:<W@VT:^^U_
M;+L/_:']H;=PQYNW;Z?=QVIFL>+H-!\30V6I2V]OI\MF\_GMNW!E8#'';!SF
MII?%-A:7UX;K4K$6,,<+ IN+IYF<%CTVMQC%+0-1G_"%::;R^=IKMK.^+M-I
MYF_T<NPPS!>N3]<9YJ)/ MDNE)82:CJ<WE2QR6\TL^Z2#RSE IQC ]P<UJ?\
M)%I6^=/M:[H)U@E&TY1V&0#QZ<TR/Q1HDWG[-0B+0*K.O.<,<*0.X)X&.M%T
M&I6@\':=;W!:*2<0"Y:[2W+ HD[ @N!CKR3CIDYJ!/!5FNBP:.MW>BT@C>'#
M.K"5'Y(8$8..QZBHY?&=N=<TR.VFMI=*N8+F2:?)W1M%C(QVZ\CK3Y_&%O9:
MY<)>RPPZ3'I\=V+AE8,-SE?F'8=.U&@:FII.DR:7/=8NYI+5]@@@D?<(55=N
M%] <=*U:KP7UO<S2PPR;GB"EQ@\;AD?I5BJ$%%%% !1110 4444 %(:6D- '
MEOP S_PK)/\ K\FQ^E>I5Y9^S^#_ ,*R7G_E]E_I7J?:D M%%%, HHHH ***
M* "BBB@#D/$FBW6H>,-$OO[/-U8V<%PLV) IW.%"X&>>AK,UOPSJ.K:79VUI
MID=C-8"1[.4RAF"@8$+<_=D&0W8#WKN)-0MXM1AL'9A<3HTB+L)!"XSST'6K
M5(=SSEO#NJW6MR2WFAPRVE]';.JF[VC3Y(AC;M'WE!^8%:KQ^$M:G\,ZAHUU
MI5C]KCMIX(-3\T%KH.^]>.JYXSGOTKTS(! R QZ#UJEJ&JV>DBW-[*8_M,ZV
M\7RD[G;H..E2%V>>W7AGQ!>:A>ZB='AC:2\TZY2%KA"S"$$.">@/-6Y?!^HW
M.G>(=EM%;7[ZK_:>ENS @2*%VYQTR5(/L:[G3]3M-3%PUI+Y@MYVMY?E(VR+
MU'/UJT2-V.] 7/.]5\):C]LLY?[+@U>VGLGM[ZW-R8=LKOO:3/=2>".O K>\
M3:-+?:%86D%M.[V\J%7M9@CP%5(#KOX;'3!Z@UTV<4A;! ) )/ />C0+GE-[
MX-U^ZLK]9]+M9;J72;>TB>)D11*DA9B!_#P1R.^:N0>'O$2^*+34GTB)4M[R
MXD;R[A5#1R1;0<=2V<;LGKTKTO)K.U3Q!INBX^WW!CS&TIPC-A%^\QP#@#-/
M0+G(>$?#NL:7>>'3>60C2RTR:UG<2JVUVD## [C _6I/$OA.\U77=6D%C;W,
M&HZ;'9Q3.PS;NK,2Q'7^($8[BNBB\7:+/>VMFER_GW3!8E:%UW$J6'4=P":W
M* U//?#_ (2U#3M>"ZAI\-XEM=/=6VK/<MOPRX(\O^_VSTQ3?$UE'?\ Q">T
M73H+Z6YT"6+9(5&TF0 $Y[<]N:]$J/[/!]H^T&&/S@,"38-V/3/6@+GF$7@[
MQ%::GIO^BV]S'I]]!*)UG">=$L/EDL",E\]R>@&*=9^$_$>GV=J%TZVN%-G=
MV4EL]P (3+(7653C!X(4CKQ7J/-(650"Q R<<GO1H%V<?+HNL1_#*RTB&UM9
M=2M[>"-X9&#(=A7=M)&,X'!/0XJQX*T?4-%M]6COK=8Q<:A)=0XG\PE7 X)Q
MU!%;6G:S9:K;7$]I(SQV\SP2Y0@AT^\,'FG:5JEKK6G0:C82>9:S E&*D$X)
M'0^X- 'G<7@?5VTNTMUL+:TU*+57O!J(G!,,;2ESM '+%3MQTI3X1U^35EN;
MC2[*6%4OH9(ENO+259B"N !\N<<]\G->H4=Z+!<\O'@_Q#;R6]SY$>HVT,DD
M0L;NY"2M"Z*N6E489E*D#(R5.*[)].O+/PI!8:=9V7FQ(D?V5B?)*9&Y.<\;
M<@9K7O;R'3[&>\N"PA@C:20JI8A0,G@4EC>0:C86]];,6@N(UEC8C&589''T
MH \]7P7JFGF[;1K*"WT^6ZMYH]*DG!$10DR/$Q!$;'C&.F#TJ'3O!WB2TM[*
M#[+9 VR:BH9YO,0F<Y3((R1V(KU"BBP7/)!X'\12RNTVFVACGEL))%:Z#8\@
M_.,;<8(Z <=JZ---L+WXA,^ESQ""WB4:I:QQX7S4YASVR-S<>@%=Q2!54L0H
M!;DD#K18+G.Z_I%]<:_HNKV:)<+8F9);61]N]9%QN4GC<"._8FL;0O"6I:-J
M7A_='#+;V,5T)7$G*-,X8*H_NKC%=YFFM(J;=[!=QVKDXR?2@+G'>/-$U'7X
MK>SATZ&ZMQ(CI,)O+D@D&[YL]0/NGCGBJ6H?#Z_N'TVX7Q!?O=)=V\]X3* K
M>6N"RC;D'T'N:] S574;]--L7NY8IY$0@%8(R[G) X Y/6C0+G/0Q>))/$AN
M[K2[$P(6C@E-T28HO4+M^\Q R<U#]@U."^NO$[:9:V^HQV)MUM4GRLYW9R[!
M>W0<$\FM2Z\7:39/>I.\RFSN(;>;]T3AY<;/J#D<U>U+6;/2IK&*Z9PU[<"V
MAVH2"Y!(!/;H:- .2N/"FH7YOXF2..SUBZMKVXW/\]N4"ETQ_%G8,'W-1?\
M" W%Q;VNCW+QKI=G<7,\<JMEY!*'"J1VV^8<GO@5Z#WHH"YR6@^'+^WU:POM
M1\H'3=-&GP^6V?,.1ND]LA5X^M8%UI'_  D'BGQ?I<,-LPFFLC)<EAOAVJ"2
M!C)/''N:],K-TO5+'5)K];1&62SN#;SEH]IW@ GZC!'- 7.'M_ ^JP:=?:=)
M9:9<,D-S%9ZA)(QFD$N<!@1A#S\Q&<XKL((;/1O""1ZI%;P6T%H$NU5<QX"X
M;H.1^%:%A?)J-FMS'#/$K%ALGC*.,$CH?IQ5GAA@C(/K0(\XL_"5]=^!TCL[
MQ9YH[J.>Q^U*45[:)B8HGQR 5[]>12:GX,UJ]L6AMK#2K1+JWN%GAAE9?+ED
MQAB^,N#CD<9..N*]&CECECWQ.KIDC<IR.#@_K2Q2QS1+)$ZO&PRK*<@T:#N<
MIX2\/WVEZCJ%WJ-K:))<);B-X7WD>7$$;D@8SC-3Z'92Z5XLU]9MVS49DN[=
M\<$! C+GU!7IZ&NGI*8CF?&>B7NN6^EQ6D,$HM;^*ZE6=]H94S\O0]<U@2>"
M]9BNM3O;!+&U2[NK>5=.1CLQ&?G?=CY9&]0.,5Z+6/'XDM9I;F."WO)GMKU;
M*41PDE7(!W?[@!'S4AG%6G@;6[?3T@46L-W%//)!>07#;D$DN_:ZL,2)CJ#W
M%:WAWPIJ.E:QB\@TZYMX)Y9[>_.XW'[PDE=O0'DC<#R *[>J&I:O:Z7-8Q7(
MDW7MP+:(HN1O()&?0<&BR"[,7Q1X?N-?-Q:W-C97UA)"! )6*26\W/SJP&1V
MZ'/%<_/X*\2&]LBUS:7B6D]G,+B5V1Y/*7#[@!\S'J&/;BNZN=8M;/6;#2I?
M,%Q?+(82$RIV#+9/;BM"G8+GF=YX+\17-E/;+]@V7#7^Y3(RE?/.4.X#) Z%
M>AXJY8:(-!@U>_\ $\5F+">PMK>4QAI"/+0QMQMS@Y[5Z!522_2.^:UDAF55
M@\]KADQ$!G&-W][OCTHL@N8_@G2Y],\.0BZGDGGDY\R1</Y8XC4^X3'ZTSQ/
M:R:KJ>B65O\ >MKU+Z9L<(B!L9/J6( _&M2UUJUO-9N]+B$OGVL<<KL5PC*^
M=I4]^AI=+UBVU9KU;=95:SN&MI1(FWYP >/4<BD!FSW5[<^!]1FU:WBMK@VT
MX9(V)4C#!2,C/(QP:Y.S\,ZMJVC:3JMHMA;SQ:=;6\<63B5 RN^6QE#Q@8&0
M<UZ-?WD=AI]Q>3([Q01M(ZHN6( R<"LZ\\2V%CX9BU^1)VLI(XY!LCRP5\8)
M'_ AF@#B)?#LUK':Z-+.D.L2:I)?6<EHDC[(7;]Z&8C@%20<GG@UI>(_!^M:
MEJK/9O8"S22TEMQ(64IY+9*D*,-GL3TZ5VMK>?:I[J+[-<1>1)LWRIM63@'*
M'N.<9]:LT6079P]KX+NTN56X:V,4&K2ZK%+'G>S-G"'C@?-R>X%9UGX"UBQ%
ME_R";M6LOL=W%=JS(H#LRNGK][E3UP*])JM!>&>\NK?[-<1^05'FR)A)<C/R
M'OCH:+(+LR?$FBW>J:?IUO9F -:WL%PQDR 5C;) QW.*QK?PCJD=]9S,;0)!
MK4VHMM8Y*2*P"]/O#=^E=S29IV%<YO6]"O+S78M1M3;.OV*6S>.<'C>0=P]>
MG(K-L? ?V<ZA97#Q2Z;<:5!IZ9SO_=AOF/;JV1Z8KMLC&:,C-%D.YPUCX!N8
M;S[1=ZN\S7%B8;T@8,L^W8LH]-J$C\JI#P)K,NAQVTSZ,E]8O$;2:*W;%P(S
MP)NX!'8=^:]'K,T;6[?6X;J2".6,6UT]JXE !WH<'OTYI6079QNJ> ]3U232
MY@^GV$]F)IA]C5E5)VQM(&/G *_-NZYJ[J%A<6UU=:QXC2"6SFTQ;"YALXWD
M9V+<E5QG!W?A7<4F>:=D%S%\*:9-I7A^V@N9I9[@KNDEE&'/90WN% 'X5MTF
M0>E+3$%%%% !1110 4444 %(:6D- 'EO[/Y_XMDOM>R_TKU.O*OV?O\ DF8_
MZ_9?_9:]4%(!:***8!1110 E+12=:0"T4E+0!Q7BS5+NQU^.&'4'MXI-)NY2
M@(P)$"E&''7DUS=OK&JQVBQ#Q$3/=Z1:76Z\?"B9GPR@J,H&'&>W6O57BC<[
MGC5CZE0:3R(".88^1C[HZ4K#N>3+K;Q:K;ZG=W6I6SKI%Z%1G\X^8D@'R8^6
M3 Z'N!DU7_MV6]9K6YU 3Q1:OILMON<OPPRWS$<\]>P/2O8_*C 4>6F%&%^4
M<?2F^1#@#RH\#H-HI6'<\K6^E_M,VMKJTUFEWXHN8IV@8 LGEYZD<<@<U6L]
M>UN"TTVYMM7N=0O)H=0B\B1@P?RL^4<8^]QU[UZ[Y$.?]5'G.?NB@01*P81(
M".A"BBPKGDR:U=7&G6MQ9>+9Y8;J^M(G"(5,!8D2*6;/)[K_  XIMM?R-K>C
MO?:Q>-'9ZGJ-I'</(22JIF/=CACU^HKUOR8L8\I,9W8VCKZTOEH,?NUX.1P.
MM%@N<%X/\0M$]S%K%^TS,8$BNDF,L$[/NVE>,QN>Z'IQ6YX[*)X$UYVPI-C*
MH;'/*\"NA6*-!A8U49S@*.OK3B 5PPR/0T[!<\\UP17,/@1!=- )90#-$VU@
M/L[#@]NO7WKG;+Q+JE]9Z?:WVO7%@7LR;2\$3.TTZRLK @<,VT+\IZY)KV3R
MT(&47 Z<=*/+08PB\'(XZ&AH+G)^,;JZA3PY%%J%Q:FZU**&=HCL+H5;=GTY
MQ]*XZPUK6[4:=+;:K=WUS)/J-JL$[[ED$88PY&/O9"_-WS7KQ56QD X]12>6
MF?N+Q[46"YY%J.MZM%X?FO-,U2]:.71A-=.S$M;W>]0 N1\I.7!7VI=5FD_M
M*6UN-6OIK*RU?3YA(TK$HKK\^2.J[OR)KUW8F#\J\G)XZT;$_NCGVHL%SR;2
M;R6QUJ*[@U&X2"Y\27<4T3,?*:$H3N(QZ@8:FZ#)JMEX7\-W^FR7,L%R9]/G
MM4<A8WDD;RYL>JGK[&O6]B?W5_*J$FC6\NLPZF\EP9(8RD</FD0@_P![9TW<
MD9HL%S%\875YH?A:VDMWN9(HKB!+V:,%I1;[@)'&.<XZD=LUR'B'6'@TI$TO
M5]5EC:UN[BSGE#A78$%%4@;F*]%!XQG.:]9.*0;2!C!QTH:"YY-<:S>W-U/*
MUU/>VMU:2 B-G1K9OLQRLD9&&C)Y##G<<5I?#Z26UU.SL!?W4UM+H-M.89V+
M".4?*0N?N\8^6O1]JYS@=,=* %SP!^5%@N>3ZA<ZFWB77/L&LZB^I6>JVRV5
MCYQ,31LJ%U*]"N"Q]L57TZ[U#7]6N--MM6U& 7]A<E'<R"2*X27Y-QP%4@<;
M1QM]:]/T[0[73=1U&^A>9IM0D$LWF," P4*-O' P!4FJZ=#JNFS64\T\$<F-
MTEO*8G'.>&'(HL@N>=7%[JU[X:TO5)KB_P!/FO-2M;:2&&1OEC4[)#QG@D,<
M^F*IVEWJUA=VSV6H:C<RKJM[8Q17$C,C1"-C$&R.?F"X8_G7K-M!!:V\=K;J
MJQQ*%5 >@J; ]!19!<\:.I7\WA.ZOK;7-5%ZT=JEU;B!T,$_FJ'.3D[B"P('
M&!FK,H9=;ABN;J_FL]/\2*L;R/(Q2-X">3W7>< ]NE>N<48'H*+!<X_QM%J%
MM+I6K6"7=RL,_P!GN;.!R/-CE&T-@=U8J<^F:Y"X_P"$@M?!>J"\N-0CU#1B
MMG%<12/FZ)E5C(/[PV$#\Z]?I-REMN06 SC/-%D%SR?Q&ZR7/BID$C*^HZ6R
ME48[@NS<1QR!@YKIOB);BYL]#9FG2V35H7GF@)!B3:P+9'0<@9]Z[/ ]!1M'
M<4!<\=>XU:W*Z?J.J:K;Z-*;E--OEA>64D./+W$<YVYVENO>NW\5FZ7PS9+'
M?M;W'F1Y:=&"3$*24D*<H#ZCH<5U=-9D ^9@/J:+!<\;U+4]3M=*OCG6+>:Z
MT>VEM(B7D<3+*P?# =<8STR,5;2SO_\ A(]2GL)]0AU-]<ADB@#,L4MLR()&
M9>A&W=SUR!7K2L&&000>A%0WMHE[:26[R31"08\R%RCK]&'2BP7/(Y+^_DT^
MR@O=2U*+2Y9;^$WL4;S2),LQ$0.WD84':3QFMC3+BXG\1_8-9GUI=1BN(FLV
M5"JW%MY8!WX&T G<6YSG%>@Z?86^EV4=I:)LA3)&3DDDY))[DDDU:HL%S@_!
M-HO_  K6?3Q#.LRBYBEBD#A@^Y^!GGICI7,::]ROAZRM)/[0MK5-!'V%HUD5
MA?*2&![[\[< \8S7L(=68JK E3A@#TIU%@N<;KUU?V_@G26U(7(NY)+9+PVV
M<*3C>7V@G9GKBN'LYI+Q]*LM8U+5X(3%J"%4>6)G*2#RL#KP#Q^ KVD,"2 1
MD=1GI5"?2+2;6K;6)&D%S;1/%'\^$"MC.1^ _*BP7/(W369_MD%[J.J#7X=*
MLY;2*.5QFX)89*CC)PNX'CK6S,;^&]OG7[5%(WB6T:0Q*X5X]B!SQU3(.>W%
M>@VVE6,6N7>K0NS7=S&D<O[S*[5SMP.W4_G6E18+GE4=]=?8-4N+J+7_ .W[
M9+E+J&W#!'0O^[921M("XV[>>M4O*N+U7MI_MYL(-<MIED1)5$<#0_,5)^8+
MNSD^_:O8Z1F55+,0%'4D\46"YY&;;6[2YTQ+7[7/)"^I_P!F27 +,(C&!"&8
M^IR!N[8KI? )\]Y[M9]4/F01"XM[R!HTBF'WL;N2Q[XXZ5VRNKKN5@P/<'-'
MF)YFS>N\#)7/./7%.P7/+M9L/$.EZKJ1TZ"\NH;*ZCU>W;S6(E0_+);#GGD$
M@=N*36],N\:GI^V^F\_P]+(T(9V7SS)NP.V['&!V%>J446"YXQJ-N[?VG?:>
MFHI);Z98&S\I)4)D5CNX_B(!Y![&K7E7,6OSZG8"]6ZE\1[4.V01M T."2N,
M;2V,FO7:*5@N>2VJ:H^GV\VR_2Z_LR[CUR.97.Z7:0F >"V[.-O\)K-U87=S
MX:GL[VPU&606%@=+6.%RN%V^:"!P'# Y#=L5[3YL8D$1D7S",A,\D>N*=18+
MGEFH1W4U]?(IU00/XAMF!0R#]R8QYF#_ ',YSV%9S7=U:6UM8W#ZB;<3:C##
M$T<K%%W 0R9 +$+GC->Q/+'&5$DBH7.U=S8W'T%9VI>']/U6[AN[A)5N85*)
M-#,\;;3U4E2,@^E%AW,[PQJMB;6RT>&[GN[B*R24W,D;!9A]UF#'ONZCJ,UR
MGB"&\DU+7XHUU,Q-J6GM'Y7F?=X\W81_#USCBO2+:QM;0*+>!(]J!!@<[1VJ
MQ185SCO!J36EEX@MA'=F"#4)OLB2;MQCV@@(6ZC.<5P<4FOH)9+&PU?R9+&!
M[B!HW#MMGS*NYOO2[#U&,]!7MM%%D%SRZ\\N/^SY8]-UR3PS<O<>;$$<RQR.
M!L8)]Y4!W >A.:;=V.LO_:-N(M0745:U.BS.Q8I& NX,W3.0V_/7->IT4<J"
MYY0-,N[07VJ?8]1ESKC)=H&D+-99S\B$\KNP>.<9K-^RW2Z3>V-OI&K10S7F
MH2VKB!\#<!Y?RYSN/.UB<#!KVFBCE0^8\;NK2^N[:_OS:ZN;Z.RTYK8E9 1,
MIQ(0.F['6M 0:S<_VJJV.J)XEA>Z:WNP2MO+$X_=_-T.!@!>QYKT][B&.:.%
MYHUEESY:,P#/CK@=\5+1RH.8XWP) G^E7D4&KVPF2-98+]/+59%&&V+Z^K=#
M79444TK$A1113 **** "BBB@ I#2TAH \J_9]/\ Q;4CTO9?Y+7JH.17E'[/
MA)^&[CTO9,?DM>KCI2 6BBBF 4444 )2T44@$I:2B@#FO$?B2YT+4;>#R(3!
M=6\IAE=B,SH,K'Q_>&<?2L"[\7?VQX8MK]K"*6W\VT6XA,KQO%.T@#+D?W#C
M(-=U?:;9ZC]G^UVZ3?9YEGBW#[CKT851G\+://8RV36FVWFNOMDBQL5W3;MV
MXX]P#^%*P[HX;4=4UJ^N;221[<RV_B@VENJ,R+M"GAO4=ZZBU\17]_X(U#5$
MA@@U"V6X7826CWQ%AD=R#BK;^#M&>\-V891*;H7G$[ "8#&\#.,U;L-#T_3]
M/N+&")OLUP[O+&[EMQ?[W7UR:07/.O[<UO3]9;6A%;7$W_".0W=RCR.B,-^3
MM'/S$?A736GC#4=3UI8M/T=IM.CN_LMQ,6VF/Y02^<XP"0,=:NKX'T%(Y(A;
MS;)+7[&X-PYS#G.SKTJ>W\'Z);:PNJQVK+=A5!82MM<J,!F7."P'&XC- [HR
M=3E?5/B5:Z%=2.NG0Z:UX(0Q47$F_;SCJ%'./>IFE;0-8CT+2&$MSJ)ENT6[
MD9D@557*CO@DC [<UN:IH=AJ[P2W43>?;DF&>)S')&3UVLO(!]*@F\,:5-'!
MOAD\R!S)'.)6$H8C#'?G/(X/-.PKG(/\1=4N+![NRTRT"0Z:]]*L\K9!CD*.
M@P.>AP:GG\=:S;P7H.EV;W$1LWB59FVF.X. "<?>!_"NDD\(Z%*K*;/;&]I]
MC9$D95\G.2F ?7GUK,U_P3!>Z;+'IB*EQ.;=)'EG?!BB8,%'H>, ^]*P71F7
M7CK6+,7]E/8V0U*RE<.(V9TE01^8I1?O<C@_W>M1S?$+5]L]U!IMG]DMK2SN
MY@\C>85G."JX&,CWKIY_!6@W:I]HLB\BN[F0S/O<N,/N;.6!  P?2F)X#\.Q
MVTUNMDXBFCCBD7SW^9$.4'7H#18+HJ6/B?4;CQ#=:%/!:I?P78RJ[B&M"NX2
MCWS\OUJ+49YO FCQ+:1O/:RW$LDT\N^5;4-EAD EMF>,]LYK8TG2+J#5+K4]
M2DMI;IU\B!H(RNR '*JQ/);)Y-7=0TBSU0Q&Z1RT08(4D9" PPPX/((IV"YC
MZYXCO=/T#2[ZQAM+B:^N+>#F0^6/,XW*1U K-L?&6IWU_'HRVUI'JWFW2,Y+
M>21"0/E[\[A].:Z>ZT'3+RQM;*:U7[-:.DD$:,5",GW2,>E53X1T7DBU82&=
M[@2"5@XD<8<ALY&1U'0T68:',Z=XYUK7+B :=IUE%&=/^VS?:9'W*0[(RC Y
MY7@^E54\>>))+%;@:?IBF31SJJ@NY"JIPR'U)SP>U=K'X:TB&Y^T16@CD^R_
M9!L=@!#_ '< XQ4 \&Z"L:1BQ_=I:FS5?-? A)R4Z]*+!<PQXUO)=:T^!;.%
M[&\N8[9BA):,O#YGS-T# \;>N.:7P7<S67PTEN8 'EMVNW02L2#MD? )ZXXK
M87P/X;29)5TQ Z2)*I$C_*ZC 8<]<<9[U:.A6]IX>N]*TJ*.W2:.0(K$E0SY
MR?7J<T6"Z.0B\=:Y"EK]OM-,C.H6,=W:LDCX0LRJ48'EF^8%0.IXJ6'QYJ$5
MO;WVH6D$.GIJ,VGWDFU@T;+GRWQG@,< @YP36OI?@;2H?#EMINI6<-S(D$4,
MDFYCG9RI4DY7GGC%++X/@CE2TT^.SMM'GE\^_MS$7>=P05P2<+R.>*+!=&7>
M^+?$-C?F.2RT_P BWTO^T[H9?S-H8@HH_O8'4\5F>)_$5Y>^&[_3[V*!DO\
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MDM]UPD*PD-'(L7[Z)PP.Z-P002!C'(K,_P"$$FV1J-79#'?W%ZKI#AE:567
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MU]-<K'=_9X&D4*3.#N4G&2,XY)SBJNJ>#+^;P? J?:+G6#!:6V6=%,$<;J[
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M%;:/<ZA/;RSNU_.;B82OD;R ,CCC@#\JU*$)A1113 **** "BBB@ I#2TAH
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M6BWNF"Z.H0;XUB$ZKG*NX!50.IR>F,YJM<^+#)K&EPZ6]M<6-];W3B7G(DB
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M'JMQJ-I:75K:SS!)KIBL*D'YR!DC\O6K->76?B._CO\ 3[1M<D>.+5KVT=Y
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M%;V,^\VS*H:*150$@R Y1U.<AN,=*W?$FK?V9H1NX+F&)Y)(XXI'7>&+L
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MX4T6\:[:YLA*UXB1SL\C$N$.4[\$'H14/B;P\VMZ/;:=;O'%'#<PRG>6^ZC
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M %)2T4 %%%)0 "EI,4M "4M)0#0 M%%% !1113 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EH **** "BBB@
MHHHH **** "BBB@ I#2TE 'C'[./_(FZI_U_?^R"O9Z\;_9R'_%%:D?6^/\
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M4 +1113 **** $%+2"EI( HHHI@%%%% !124M !1110 4444 %%%% !1110
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#G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>gtbp_ex1017001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#NO!'A+P[J
M6@O>WVB6%Q=/>7.Z:6W5F;]\W4D5U \%>%P,#P[I?_@(G^%4/AU_R*?7_E]N
MO_1SUUE &&/!OA@ @>'M+P>O^B)_A2_\(=X9QC_A']+Q_P!>B?X5MT47 Q!X
M/\,@$#P_I>#U_P!$3_"E_P"$0\-?] #3/_ 1/\*VJ*=V!B_\(AX:_P"@!IG_
M ("I_A2GPCX;+;CH.FYSG/V5/\*V:*+L+&1_PBOAX_\ ,#T[_P !D_PIG_"(
M>&O^@!IG_@*G^%;5%*["QCCPGX=7IH6FC_MU3_"E;PKX?;[VAZ<?K;)_A6O1
M0%C(_P"$6\/AMPT33\^OV9/\*</#&@CIHNG_ /@,G^%:M% &9_PCFA_] >P_
M\!T_PH_X1S0\Y_L>P_\  =/\*TZ* ,P>'-$ P-'L/_ =/\*/^$=T0=-'L/\
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M,.E:LLL<,9EFD6.-1DN[8 ^IK@+G19;'POI^A11B.YN-42>WMEDW?98A*)"
M?15!]N<5T/C"UN[O2H4L[$7A6ZC>1 5W*H/+*&.TD<<'BEJ!>UC6[31M&GU.
M9A)%%&9 J.,R #/RY."<5#J/B*UTV'3Y)$9C?311(BD;EW]"03T]<5YM_P (
MSXACT"XL;KP^]Z)K&>U@C>XC8VTAD9@V20,,&7D<@KCBM"?0=;-\BRZ$UQ(N
MI6EY%>"5"8XE50T?)R"N&X'!S1=CLCOXM;M]\,-X!9W,\LD<$$SKNEV9Y7!Z
M$<U8M;X36<4\\9M&D.!%,R[@<XQP<<UY]I_A_48-1TF[ET0O%;:I?LR,4+1Q
M2\HXR>GMUJM8>'=6ATNRAO\ 2)[BV.G7%HMON7=;SM*S*_7@%2!N'(Q1=BLC
MU(RQJP0NH8G !;DU3U358=*TN\OF5YEM(S))'#@O@<]/I7F<WA76(9Y;F33Y
M[K489]-*7:$9?RQB9@2>G8]S1_9&O>=J4W]AWD7VC2[NV:.-D*^:S[DQ\V6R
M#]X^N.*+L+(]6@F6>WCF7(21 XSZ$9I_F(%9MZ[5ZG/2L74(O^*'N89T((TY
M@ZL<$$1]_2O/;+1+G^SK"^T[1[O['+:VBW<6<F60')F"%L/@<')P<]\4 D>J
MM=D7T-NMO*ZR(7\]0#&N,<$YZG/%0P:M!<:Q=:8@?SK:-)&8CY2&SC!_X":\
MTL-"\216-I##97<%[%9:A"LLKC"EI T0)!QR,X/;-=+X1LY8_$-_>#0[C3()
M[*W3]]M&Z1-P88!/3(Y[]:+L+([6BBBJ$%%%% !1110 4444 %%%% "&B@T4
M@.7^'P(\)1Y[W-R?_(SUU-<M\/L?\(E'C_GZN?\ T<]=30 4444P"BDI: "B
MBB@ HHHH *K7M_9Z=!Y][<Q6\1.W?*X49].:LUS7C:,R:/:E8DE=+^W=4<94
MD..O!XI,$:8\0:0;!+T:E;&U<D+*) 5R.OY=_2D?Q#HR3R6[:I:":,99/-&X
M=.WXC\ZXZ?P-J(U&34H4TZ9KN2;[58W&[R0DFT97'4_+SQ@Y-6U\(7:P:W')
M9Z;,MY+ 844M'A$55/(&4(QE<9QQ2NQZ'3R:[I4:0.]_;JDW^K8OP><?ASQS
M2C7-*^W?8O[1MOM1<Q^3YHW;@,XQZXKCT\%ZTB7 FO+>\^VV+64OGCF(;F*L
M"!\Y ;G@9(!ILG@K44>X\@V99M3MKJ*21CN,<2!3NX^\<?K2U#0Z+5?%EE:Z
M+?7^GS6][): ,T2RXX+;<Y_/\JV)[V"TMA/<RQPIQ\SM@9/:O.F\$>()+:_5
M_P"SQ)<V(M<K*VW(EW[@N,*I!Z#I76>(-+U*[?2;S3OL[S6$V][>X8A)05*G
MD X(SD'%&H:!H?BVQU71K34+F6"S:Y=UCC:4'.URN0?0X'YUK#4[%O,VWD!,
M<HA?YQ\K_P!T^A]J\YG\">(VT--.4Z8P\F0<.R[7,QD&3C++CC'0'FM>QTV/
M4O&E_>VI(MXXQ]LMVB98WO0"H() W +U(]J-0T.RM=0L[TR"UNHIC&<.$<';
M]:AAUK3+F<PVVH6LTBJ79$F4E5'4XSTK$\(Z#>Z&]V)_+CM'5!# )/-,6,Y
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M **** "F[%W;MHW8QG'.*=10 WRT\SS-J[P,!L<X],TO>EHI %%%%, HHHH
M**** (KBWAN[:2WN(UDAE4JZ,,A@>H-%M;0V=M%;6\:Q0Q*$1%& H'0"I:*
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M)P*QH?&>D2:;:WTTDEND]NEPRR1G,*/PI? ^4$]S6SJ%H+_3;JS+E!<0O%O
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M>GZFUH-8OG<$N%\ED.S.#]TG&* L>G9JAJFL6^E)%YB2S2S%O*A@3<[[1N;
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MPL9%3C+,O4 9&:OW-U#:0O-,X541I"!R2JC)P.IXK@-!BDG\7>&[NZ2[:?\
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MH^R3"3[/,T$N 1M=>HYJSGBO*M0UQ[0:K#;ZE);/-J]R R.$!*1 @%^2#GD
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M7MWN=3M+IHC]G4""2)\*?]H'OFG<+'I5175O!=VLMO<QI+!(I61'&593U!K
M\):O>:];->SEDC1%@>%H]I$ZY$ISZ9X_"LU=>UFZ\42V$$D(CBO'AFB,88)
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M;ZC#<269U66WCNVD4K$1&'"8ZXX;FM[0_$::W-(BV-U HC69))(R$=6Z8/\
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M2S1K"H9D"C[Y!XP#CZUC:?XM6"V2YU.[F9ETJVN98O(55W2'&\-[G@CH,4]
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MUG3]1TPZC:W226J[M\G3;M^\".Q&#FA6#4H:GX7AO]:CU6&^O+*Y\KR)C;.
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MD5NTMJ)%^SMC$; GDK@8;VYJ]:>&;RRU.YDBUB06%TPEFMC"NXR;0I(;^$'
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MY.<\CBM[PWHMSI5X[RV\$49L;: >4W5HP=V1CWX-=)[9JI;ZG;W.I7EA'O\
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MJ=@+,79O+<6Q.!*9!M_.EH/4YN?P9<2SWLJZJ2;J6UD)DA!(\C\<?-^E4QX
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MK)T>SOY/#MCJ&G6>JSQOIX6]4ROFX8R#:5R<MM 8G&,KQ7L+HLD;1NNY6!#
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M<6BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ>U%T.S-ZBN8'BQV^'[>)Q9#<MN9C;^9QP<$;L>WI6M;:[IESI_VV._M6A7
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MR)?']Y#"GEQ+Q@E4R=I;J<<9K,7P(_V$6LFI&3[-82Z?92&+F*.0 $MS\S
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M?^AM7?5P'P6S_P *JTC.W_EIC'^^U=_3 **** "DHSSBCH* %HHHH 2EHHH
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M0[K3K.Z@O96:&8X2V,[3"-<8/S$ \YZ553X=Z!%&B(ET%2)(0/M+?<1]Z+]
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M&FE37.6.YEY0/C)4'^(]!D=J5QV.EDUSPTMI8ZH]S9M$ZG[+,$W$ #YMN!D
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M&* .SL=&TW365K*Q@MV6(0@QH 0@)(7Z9)--.B:6;W[7]@M_M&_S#)L&2_\
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MT\^IZG$8U@7!A"ILC,@4XYZD<CD>E'Q!&LR,R:59W[RK8R-!-;98";<,#&0
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M_"K3/9Y1_P"/FO1*\[^"'_)*M,X_CE_]#->B4P"BBB@ HHHH **** "BBB@
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M&U+D,W !'W@RDCV-%PL>G37,-O;27$LJI#$I=W)X4#J:J6>J&]DBV6=PD$L
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M?I0KAH:JZE8O+-$MY;EX!F51(,H/?TIT%[:W5N9X+B*6$9S(C@J,=<FO//\
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MQ'((/4$>HI;'3[;3;806L>R,'/+%B3[D\FK5%,04444 %%%% !1110 4444
M%%%% "&B@]** /._@?\ \DJTW_?E_P#0S7H@KSOX(?\ )*M,Q_?E_P#0S7H@
MI +1113 **** "BBB@ HHHH 2L/Q)K,VF#3[6T16O=1NA;0LXRL?!+.1WP >
M*W.]96NZ+%K=M#&\LD$UO,MQ;SQXW12+T.#P1U!'<&I8&+K]_KWA^SENVNX;
MBU5H KB#]X6:0*ZX'!!4\$<YJS)XYTF*REN62['DRR131F$AHB@!;=G@#!!Z
M\YXJ2^\.W^IV+0WVL%G,D;@QP!478P;[N>22!R367>?#[[;-=R'6)5%U<332
M1^0K)^\0+T/&1CANV32U'H:0\;Z.;P6X^TD%X5,WD'RU\X9C);T;I]:D/C/1
MUF"/+*D;+,Z3-&1&RQ'$AS['BLF#X?RQ6[Q-K3ON-F=QME&/L_W1U[]ZQ;#P
MKJM_/=6E_#+';737"7 D@1?)61BV89 QR<[3]T=.:-1Z'=Z/XAL=<>ZCM?-6
M6U*B5)$P1N&5([$$>E8MMXXTZVTVU:YN+N^EGCGF22&R*EDC<AOE'3;^N,UM
M:)I=YIEJT=YJ;W\V JR-"L8 '3Y5[^I[UA6W@,VT5O&FJ.5@M;JV&Z$<B=MQ
M8\]0>E/46AI>(/$BZ7H-I?6:+/)?30P6N[(4M*?E8]\ <U)+=7VC$W6J7UO+
MIR0_O'$6QQ+D   'D'.,=<XI+OPQ!?\ A>UT6ZN')MEB\JYC 5TDCQL<#D9X
MZ5'J/ARZUG2IK'4]5=PRKL:"(1[74A@^,G)R!QTH#027QII,'R3+=)<"Y6U:
MW\@F19&7<H('8@<'I5<>/-.>ZM4BMKQX)K6:Z>;RC^Z$1PRLO7<#VHF\'O<7
M\.H3:A_IHO(;F9UA #B)2JH!G@?,234$?@:6-D<:LWF".[B=O('SI.VX\9X(
M/>C4-"W%X[T:>T^TQ+>N@C,Q MFW"(8_>8Z[.>M2:3K<VH>)]3M5ECEL([:W
MGM61>2) <G/<<"JO_"&/$;66VU(Q7$>F_P!F3R&($2Q#H<9X8<X^M7=#\,1Z
M'J4]Q;SDV[VL%K% 5_U:Q @?-W)R:-0T$A\30M%>7K!FLXKHV<*Q(6>20'#'
MZ9X_"B'QGHUR+7[/++,URGF*L<19E7?L)(] W%9Q\*W36EUI4-T]K#_:!OHI
M0@=)58[FC=<C(R3^E5X/AX\5C8VCZFC+:2F6.9+81S1DR;SL8'C.<$=,=J-0
MT.@\0ZY'I%A<",NUY]GDEB2.(R$!1]X@=@<50M?&VEI!IL5]= 7EU'#O")PL
MDB@J#Z9JQKGAN;5+\7UGJ3V4S6KV<W[L2*\3<]#C# \@U2T_P7/IE_%<6^L,
M(VCB6YC:V0F1HU"AE;JF0!D#-&H:%2T\47U_JD<QN7L;/^TVL!;3618S$=,/
MGY2<'.:U+?QSH5PYQ/-&@25_,FA9$/EG#@$]QZ56B\'W21PJVJ*QCU8ZG_J,
M9)S\G7ISUJG)\.S<V=O9W6J,]O']JW[8MK,9SG(.>-IQBEJ/0V+?QGH]XD@M
MII))UE$/V=8R9"Q7<,+WXYJA9^(]0N_AG)KVZ%;Y89),M&=OR,1RN?04Y?"&
MI;;"Y?70VIV,A,5P+151D*[65D!Y)'.<]15RP\*K9^#)/#KWKRK(DBFX$84_
M.Q.<=.]/46@VV\;Z+-:.[3R)-&R(T$D3)(S,,KM5L9!P<'VJO#XSM;C6E>.\
M@.BMIC7GG%2&5EDV'/\ +&.M5[WP-/?31ZC)J2+K$#1^1,( 8E5 1M*$\@[B
M3SUZ=*??>!GU.9FN]2)$FGFT<Q0A"&\SS XQP,$#C]:-0T-1?%^D<+)++%)]
MHCMFCEB961Y/N;AV#=CTIR:]9WBL--96O'FEMU#Q$?O(_O*W<?6J%QX,748-
M6;4;PM>:C#%"TT*[1%Y?*,H]0QW4NG^%+?PW?WNK6C7%S-+ JBW)SNE PTG^
M\_&3[4:AH;FD:G%K&E07\(*K*IRIZJ0<$?@0:YR;Q/>+X@UG36O--MOL30"#
MSD;,OF+D \]<\<5<\.:3JFC+:6CRPFR6W9YU"<_:&<L2K9Z<D8QV%1MX=U2+
M6-8U"VO+(G43'A9K<MY(1=H(YY/?ZT!H:,?B33'OGL//)O(Y1#)"$;*L5W>G
MW<?Q=*B3Q?H3R2QC4(]\:[\<_.N[;E?[WS<<=ZSIO"E_)KT6M#4H_MBG[/(?
M*(66U(YC(!^]N^;=_2J,7@&]CTG[ -4MT^R2))I\\=H!(A1MR^:<_/Z'&,]>
MM&H:'01^+-&D(VW9R8I9=IC8';$<2<8Z@]JH7'C;3GCU!;2Y2(VD,$WVJXB;
MR2LOW3QR>/YU'J'AC6;]K2Y;5K87B0SP3M]F^3;* /D&<@@@=2<U4?P-J TR
M[LH]2MRMU86UH[/">&BXR.>A';UHU#0Z-M=TB26>-YD:6TG2&0-&<I(_W<<=
M\]156;Q#97?VR+1I;2YU>" R11R _.N<9!')7/&1WHE\+13>(X]7:=D!MQ%/
M @^65QPC_506 ^H]*K^%?#-YH'[JYN;.>"!3%;-%:A)63/'F-W(Z<8!ZT:AH
M:BZ[9K>16$\H6];:KQJ"P1V7<%)' .,XS3;KQ+H]EJ?]FW-_''=A!(8V!X0Y
M^8G& .#S5&Y\.7,_BR+6([B& (R[FB4K)*@&#&_.UAGD$C([5%JOA*36-4UB
M2XNE2SU#3ULPJ*?,0@D[L]".>GM1J&A=7Q?H;1NRWRLR/L:-5)DSMW?=QG[H
MS]*=%XBLFDO)'O;<VT/E; BMO!D&0&!ZD]@*Y]_!>IW.D"VNWT=[@L-SP6K0
M8VJ0LBLIW!P>>N.U4O$'A[5K&PN91,+R2::RV7"PN[Q&$<RN%Y.?]GUI:AH=
M._C7P['%'*^HI\S2*H\MBVY/OC&,Y'<59/BC11-;Q?;XB;A4:,C)4A_N<]!N
M[9ZURNB:%J5\]K>E+>V6V:[^8Q2(;EIE&9-K<K\WKUJ'_A7NL^1IL)U2R>.Q
M%JT8:%OD:$Y.W!Z-ZGD4]0T.AL?%]GJTMB;*>.*.>YF@*72,LDGEYSL[=1GG
MM5S_ (2W01!<3MJ42Q6Z>;([ @;,XW#CE<\9'%8,?@K4!)9QR7EJUK;WMU<'
M:C!VCF##'LPWGGVJO<> M0NM&2QFOK0R6U@=/M9!&V&0LI+./7"@8'&<FC4-
M#LM-UG3]629["Y680OLD !!4XSR#STY]ZP=-\91W\MQ=R200:='<2VP1T<3E
MT/88Y! )XZ5H:-HUSIVLZQ?32PNE\T3(J @ILC"<_E6-:>$-3L[BTO4O+9KN
MTOKJX12&\MXY_O*>X(XP1Z>]&H:&Z?%6A?:+2#^TX#+>(KVZJ23(K' (QVSQ
M4-SKL\WB.70M+BB:XMX%GN9IB=D08D*N!R6."?850\.^#YM"U.VG$\$L,=I+
M$XV$-YDDOF$KV"@\ 5<N- N;?Q3)X@TN:,37$"V]W;S9V2A3\C CD,,D>XHU
M#0G@\0P0V!GU22WMW$SQ 0R>:'V_Q#'/3G';O4DNO:':R1327MLK7**ZRCG<
MA.%)8=!G@$US]CX,U#3+JWU&VNK5KQ9[J26%D(B99R#@=\J5'/<9%4X/AS/8
M:?=:=:WL<EKJ%FEK=F93N0@L2T?M\Q^7MQ1J&AT&L>*8+#5],TZW:*:6YO5M
MIE).8P5+9!'&>!QZ&H]<\17>F>(+/3(8K/9<VTMQYMQ*4"^7C(Z=]PYK,C\&
M:K;7=M!#>VCZ;;:JNHH958S'@@H3T/7@_A6AXB\)#Q'KMK->+;R:<EG-;2QM
MGS,R;?F4]B-H_.@-"UIGBRQO/#=EK5X#81W49<13_>7&<GZ<9SZ<U=7Q#I#W
MBVB:A;M.X!50^0<KN'/3.WG'I7+7'A'7IDTUYKO3KZXL$DM?]+C;9<P-CE@/
MNN,#IP>?6HKCP3K3:K!/%=:8;>VNXYX$,3(%18RACV+\N.>O)(XHU#0ZT>(=
M):)Y5OHF5"H.,DG=]W ZG.#C'I44_BO0+5(GFU:U198_-C._[R9P6^@/7TKF
M++P1JEE<VEW!=6\/V*X66"RW,\(!5ED 8_,H.[*CD+CWI5\"7T,CR13V;M+9
MWL4FY2 LEP^[Y1V0=,=Z-0T.]5E=%=&#*PR"#D$50_M[2A<2P&_@$L2L[J6Z
M!?O<]\=\=*I^'X]6LS_9M[!;BTM+6".":(G+L%PX.>W (^M<]'X'OTM+:Q:X
MMWAT^6YEM93G?(95<!9/8;SDCK@4]0T.I_X232#HUUJT5[%/96JEI983O P,
MGIUXK)M?&]C+KS65Q)!;VLEK!<VLTDF#+YI(P0>G(_6K=MH,Z> UT)S!'<?8
M/LI>('9NV;=WKCO7-77@G6KNUO [:?YT^F6MFIW,0&B?<3TZ$4M0T.Y&JV#:
MA]@%W%]KP2(MWS''7'KCO5RN+T+PC>:5K;2S)ITULEQ+<0W+*S7*^9R4R>!@
MDC<.H XKM*:$%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **#10
M!YU\#R/^%5:;_OR_^AFO1!7G?P0_Y)5IG^_+_P"AFO0\]J0#J*2EI@%%%% !
M1110 444E( KG?%>J75D=)L+.403:G>K;>>1DQ+M+,1_M87 ^M='6?J^C6FM
MV:V]VK82198I(VVO$Z]&4]B* ,F[EF\,S?:I+ZYO;:Y,=M;V<I!<SLW&'/8C
MKGIBJLGCK$\=G#HUS+J!N9+62 2H!'(B;^6)P5*\@UHW/A.TOK8Q7]W>74@=
M)(YY)0'B9#E2F  "#[<TU/!]BEW;78N+O[1#/)<-)O&99'382_'.%X & *5F
M/0QA\28ET^6]GT:\BC6Q-]$N]"TB!PC#&>"">_45/_PGK)]HAN=$N;:\@:,M
M%+,FWRG!*R;QD8X(QUSQ5?5_A_%_PCTMMILUS+=)I[V, FE !5G#$L<=<CK6
MB?!%E<"&YN;J^_M!2K-<+, _"E=G QMP3VZ\TM1Z%)OB+ ;=;F'2KN6W^R17
MDCEU79$[E>A.201T[UIP^*TN-3N-,^QRI=Q78MMA<9*,F\3#_9Q52+X=Z7%9
M36BWFH&*6U2T^:8$K&KEP <=<D\U<TO1K@^)KK6]0M;:&=8?L=N8I"[/$&SN
M8X&"?3M0DQ:%676KCPK:V5AJ4DNI7=Q))Y4SE8]P!RJ%N%+X/ XSBKVNZ]<:
M5?Z-!%9K+'?SM'*[R;3$H0L3COTJQKGAZWU^'R+JXN$@9"DD4;#:X..H(/(Q
MP1R*?J.A6NI?8/,>:,V,HDB,;8_A*D'/4$$@T[!H8/\ PL*V^Q7-ZNEWTEK%
M")XY44;9$+!<9. &Y!QZ4VX^(#6DMS'<^'M0C:T2.6Y&^,F-'8J#UYY'059C
M\ Z?%I=UIBW^I_8IAMCA-QE;==P;:F1P,COGCBK&H^#K+4I;^2:ZNU:^BAAF
M*.!\L9RN..,GK19AH49O%4=U+:1RPW]C-'JRV,D:.A&\KN4.><H01TYS19^/
MH;IEW:5>11R+<&%B5/F-"<.H /Y$]:NOX-M)+IK@WEWYC7ZZAPRX$JKM';IC
MM51_AYIDEG#:R7E^8HA<  2@$^<<OD@>O2E9AH1#QXUQ-816NG;GGU$64^Z4
M83,>_*D<-Q_6IM.\4QF$06T5[?7DD]R1#.45U6-L-R., X [FI(O EC%(DHO
M]0:5+F.Z5S*.)%39G&,8*\$4^'P39VQADM[V\CN89II4N R[L2G+H>,%2>1Q
MQ3LPT*<GQ&L/*,]O8W<]NEM'=2RKM 2-F*G()SE2""/:M_4]:CL)K*VCA:XN
M[UF$$*L%W!1N8DGH /YUDR> =*-M/;1374$,UFEFRQN.$5MP()'WB2<GWK5U
M+0;?4GL9FEEBN[%BUO<1D;E)&UNHP01U%&H:'+7/B:X\0:QH5CIAN;>SO4N6
MGD1PDL4D1"E2.?NGJ.]6=:U&[MO&%K8&]U 6ITQ[ADM(@SLZN!GIW!/'K6M:
M^$;"RO=.N[>2=)+%950;@0_F'+EN.23SFI;WP\EUKB:O'?75O=I ;=?+*[=A
M.2,$'G('-%@N9[^*!I$MAIMU;WMS<7=N'M9754-R^>8\9X< Y.>P--N/'NG6
MVJ2VLEM<F"%WCEND3<B.J[FS[=L],\5->^"K6_A"W%_?/-&%,$[2 O X;<70
MXX8G@^W%+_PA=D;R\D:\OC:WI9KFQ\W$,CLN&;&,C/4@'&>:-0T%_P"$M"&W
M^TZ5>VZSW,,$;L%*MYH)5@<\],$=155?&GVK5K:P@L)PDRW8EEW+NC: A3@9
MYR3Q4J^![<:7'9/JVIRM#+'+;3RRAG@\L_*%XQCMR#FEMO ]G:2V\T-_>^;"
M]PV]V5BXF.7!XZ9&119AH1:;XNLH['3XI6O9C/I[7D=Q<*H,H7JIP<;^1P*G
M@\965WJD>GQ6]UYKR>2S!,^3)MW$-Z =,],\4^/P7IHTO1K&5II5TB426[L0
M&.,\-@<@YY'L*FM?#$-EK=SJ%M?7D<-S+Y\MFKCRFEZ%^F>>XSC-%F&A437)
MM"%AIFK2/>ZE<[RKQJJ;U#?@"P!' YX-7=>\3V7A\QI<)+--(CR+%$,L57[Q
M_P#K=Z37O#4/B#9'<W,JVX&&A4+@D$$,"1E6&.HI=7\.KJ=W9WL%]<V-[:JR
M)/ 02R-C<I# @C@'V-%F&AFOX_TY9F46.HLBR0QM((. 90#'QG/.0.G!IY\=
M6?EP;--U.2XEEFA%M' &=9(N64\XZ<YZ4^?P9#/-=2'4+G=<7-O<'(4D&'&T
M9QSG'-9MQX5U"TU_3Y-/O)]CW=U=3W)1#Y1D0#;M/4$_E2LPT'VWC6WEU::]
M^U,VC'3(KF.,Q8=9&D*8]=Q.!CUK2'C33TE,$]O=P3I=QVDT;QC,32#*,QSC
M8?[WK51OA[IK120?:;@0/:);!00"I63S!(&Z[M_/I3-8\-2O8WUM]G?4[G62
ML-U=,RQ"%%'RM@?W>HQSFGJ/0M7?CK3K3=NM-0D"Q2SDQ0[AY<;;6?.>G]*=
M_P )SI"QW#2?:(FB\HJDL>TRB7_5E<]CSUQC'-%YX-@N5\N*\E@A&F/IPC5%
M.%;&6R>=W%5[CP'#<O)(VI7*S&"VCBD15!B>#.UQZDY.0>*+,6@YOB!I0@CE
M2UU"7?%+,5CM\E5B;#D\]NON.E7M'\2)K&M7UE#:2K#;10RI<-C;*)%+# ZC
MBJT_A![IQ)<ZO<S2FRFLW9HU&X2XRP &!C P!Q5G1?#0T6^DN8[V659+6&W>
M-D4 F(;0WJ#CM1J&A"/&NE_:X[>2.YB=[]M._>1@!90NX9YZ$<@]ZS;OQH+:
M/4=1ABO+B*"VAD2R:%8^&D*AP^>0<=/;WJ[K/@+2M;NM1N;AYTDO8XT)C;'E
MLAXD7T?&!GT%+J'@N"^;4,7DL,=W9Q6BHB*?*$;;E89ZG/K1J&A2M?&36OB3
M4;'5%N! ;R&"V<0#;"9(PP5V'J<\U?/CC2P&9H[M8V@EG@D,7RW*1_?\OGD@
M<X.,CFH)O!/VF6XDGU6:1KB\@NY,PJ,M$NW;QV..:(/ 5DEK#9S7<\UI:Q31
M6<9 #0+*,'YNK$ X&>@HU#0-2\=6EI%_HMG<W4^;4^6%"_).<*W)^O'K5GQ!
MK-W;:EHVCZ?LCO-3D?\ >RC<(8T7<YQW;H />LT?#XE)C+KET\SI;*DGDH/+
M\ALH< <^X-;NL^'X]8^PS&YEM[^PD\VVNHP,JQ&&R#P5(ZB@-"M+J-]H$LIU
M25KVUE9$M&AA DWD'<'QA0. =QP*9_PG.BG3Y+Y6G>".S%Z2L1/[HL5)'N"#
MD4[4?#5WJD, N=:G\V*=9AMA7RV !&TH<@CG/.><5D-\-U_LL6$6MW*(UDUC
M*WDH2\9<N/H02>1UHU#0V?\ A--'\V[4R2"*T!\^?9\B$ '!/4'!&..>U7=%
MU^QUU;G[&S[K:3RI4=<%6QD>Q&#U%<_>_#RVU*X>6[OY"3$8@\,:Q2%<#:&8
M?>"D C(ZUIVNDZU9"P1=9^T;)MUVSVR()(]N-H"_=.<'(HU#0FU3Q5I^D7-W
M;W27&^ULS>N5BR#$#ABI[D=Q63J_C'R=4T=+#S98)IPDZ)!O,BM"9%"'UX'Y
MUKZWX8L=?NK&>\W_ .BLV54X$J,,&-_53P<>U9UCX'@TV'28;6^F":==R70\
MP;C)N4J%)[  @#V IZAH.C\8:;<7=O<1Z@RV<FGR79B:W/*JP4G=V8'C;5;5
M/&+17>F_9(KE%-_]ENK>2U/F,#$779^0Z5$GPY@-K';SZE-)&EG/:96,(W[V
M3S-P.>"#C%7U\*WTLNF37^O37DUA<^>"T"J' 0J%P.G4DGUI:AH.;Q[H*V<%
MU]HD,4L8D;]V<Q*6VY<=1\V1^!JW%XKTN83X:93!=_9)0\9!5]N[)_V=O.>F
M*Q-/\ S:9-#-:ZT\<H0Q7!^S(PE3>SK@'.UAN(R.W:M:;PC8SZ]=ZI)),?M5
MK]GE@W?(3@KYG^]M.W/I1J&A5;XA^'EAEE,\Q$9CX6%F+"0X1@!U!/%:TNO6
M<&FVM[(LZBZ*K#"8B)78]%V=<]?RK A\"W":3#ITNM-+%;30O WV5%(6)@RA
MB/O'@#/Z5N:[H0UAK">.X-O=V%P+BWDV[AG!!##N""13U#0JMXTT86BW$<LT
MP*NSQQ1,SQ*AVN77JN#P:DE\7:5%<21;IY FX&6.%F0LJ;V3</X@O.*RE\"R
MVFH+J6F:S+::A(9?M<ODJZSB1@Q&T_=((&#^>:LVGA"6SNKY(]8G_LN]D>::
MT,:[C(ZX8^9UP3SC'6EJ&A--XXT*WM3<R3RB(6L-WD0L?W4IVH>!Z\>U36GB
MS3+Z]CM(!<F9B%96@8>42"0'SRN0,\USY^'-P]A);RZX6+64%DI%L %2*3>I
MZ]>,&MJY\+O=>*+;6FNTC>!E(,46V1EVX,;-GYD)YP1D4:AH5/$6O7\.N?V1
M8R/:%;&2[:[:U,R#:0 , ].N<<]*?%XYT>VALX;N^>:XELTNVECM7"&,C_6'
M@[5X/4\5>U#09[S7#J4=XL8-C)9F(Q9^\<[LY[''%9NE^#;O3'1UU-':/24T
MU<VX(^4DAR"<'KTHU#0M?\)G9O>Z9;0VE[)]OF,2L82H7";]W/4$$<BNEKCK
M3P1+97%E/;ZBL/V6Z,Z0)#F%%9-C*BD_+GEN#@$]*ZFRCN8;2..\N%N)QG=*
ML>P-SQQDXXIJ_4'8L4444Q!1110 4444 %%%% !1110 4444 %%%% "9HH-%
M(#SKX&Y_X57IW_727_T,UZ+7G/P-_P"25Z?_ -=)?_0S7HU, %%+10 E%+10
M 4444 %%%% !1244@%HHHH 2BEI#0 4M4;[45LY+:$1F6XN9-D48.,X&6/T
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M'!K3:1$5F9U55ZDGI0 ZBFEU#!2R@MT!/6F37,%O \\TR)$BEV=F  4=3]*
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M+5VM8+::UB:6PBO$-R)!F^$JL%![CD@G/0KQ4 \+:W:.LEMHUL46RL8WC65
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M6B@#RW]G\_\ %L4]KR;^E>HUY;^S\ /ADISG-[+D>GW:]3I )112T %%%%,
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M-/U;2([U+NW#"%)+B-90WDEE!P:- U*]]X6&JVDMMJ>HSW44A=BA554,0-A
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M2L%V<)_PB.MP7PCMI].:P.H07_S(RM&4 #1J!QMX^7TZ5L:[H5YJ6N6%[;M
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M@ HHHH *2EHI )VI:** "BD[4"@!:***8!1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0T4 >
M*_LW9_X136/3[:/_ $ 5[57BO[-Q_P"*5U@>EZ/_ $ 5[52 !2TE+3 ****
M"BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "DI:*0!1113 **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH 0T4&BD!XG^S<1_P (MK(]+U?_
M $ 5[77B7[-F?^$;UOCC[8G_ *!7MO>@!:6DI: "BBBF 4444 %%%% !1110
M 4444 )WI:2@#'O2 6BBBF 4444 %%%% !1110 4444 %%%%( HHHI@%%%)0
M M%%% !24M)S2 6BDI: "BBBF 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "&B@T4@/$OV;/^1:UL?]/B?^@5[;BO$/
MV:S_ ,4_K@P>+J,Y_P" U[>*8"T4E+0 44E+0 4444 %)WHQQ2T@"BBB@ HH
MHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !244
M4@%HHHI@%%)2T %%%% !1165>Z[#8:E!:3VMT$F98Q<B/]T';[JDYSD_3TH
MU:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /#
M_P!FO/\ PCVN=,?:H_\ T"O;Z\-_9L;_ (D>O+CI<QG/_ 37N0Z4@"EI*6F
M4444 %%%% !1124@%HI*6F 4444 %%%% !1110 4444@"BBBF 4444 %%%%
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MJU10!7%A9APXM( P.01&,@_Y)I8+&TM?^/>UAAP"!Y<87J<GI[U/10 4444
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M_LV'%MX@_P!^'_V:O>@QP.!UHHJA=0+8["D#G'0444AD4LA&W&*1I6'8444
M"R,<@TY9&(YQ1128#3*P!X%'FMGL***0#6F8$]*8)F.>E%% #?.8KGBGK(P
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M@X$.E_\ @.W_ ,51131+$_X7GXMY(BTP?]NY_P#BJ:WQT\6_\\M+_P# 8_\
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E_"F_\+9\=_\ 0R7?Y+_A113 8?BMXZ/7Q+>_@5_PHHHHL@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>gtbp_ex1017002.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#UCPQH6CG0
MX)SI=FTLK.\DC0*6=BYR2<<UL_V-I?\ T#;/_OPO^%5O"_\ R+EI]&_]"-:]
M %+^R--QC^SK3'_7!?\ "F_V+I7_ $#++_P'7_"K]% %+^Q]+SG^S;/_ +\+
M_A2#1M+'33;,?2!?\*O447 J?V7I^,?8+7C_ *8K_A1_9>G_ //A:_\ ?E?\
M*MT4!8J?V7I^,?8+7'IY*_X4W^R--_Z!UI_WX7_"KM% 6*8TK3ATT^U'_;%?
M\*7^S+#_ )\;;_ORO^%6Z* *?]E:=_T#[7_ORO\ A3O[-L ,"RMO^_2_X5:H
MH J_V;8?\^5M_P!^E_PI/[+T_P#Y\+7_ +\K_A5NB@"K_9MC_P ^5MQT_=+_
M (4O]G6(&!96^/3RE_PJS10!6_LZR_Y\[?IC_5+_ (4'3K$G)LK<D=,Q+_A5
MFB@+%8:=8CI9V_/_ $R7_"C^S[+_ )\[?G_ID/\ "K-% 616^P66<?8X/^_0
M_P *!I]D#D6=N#Z^4/\ "K-% 617^PV@)(M8,GK^[%*+*T'2UA'TC%3T4!9$
M2VT"C"P1@>R"G"&(=(T'_ 13Z* &>5&>L:_]\T>5'_SS3_OFGT4 ,$48Z(H_
MX#1Y:?W%_*GT4 ,\J,XRB\=/EH\J/^XOY4^B@!OEH>J+^5)Y<><[%_*GT4 ,
M\J/_ )YK_P!\BE\M!_ O/M3J* &>5'_SS7_OF@11@8$:X]-M/HH 9Y<8Z(OY
M4NQ/[J_E3J* &E$/5%_*CRT'\"_E3J* $VCT'Y4;5_NC\J6B@!-H]!^5)L7^
MZ/RIU% ";5]!^5&!Z"EHH 3 ]!^5&T>@_*EHH 3 ]/TI:** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH R/#'_ "+EIQV;_P!"-:]9'AD_\4[:?1O_ $(UK$X%
M "T4F:,T +129R,T9!H 6BBB@ HHHH **** "BDS2T %%%)0 M%)2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12&
MB@#'\+?\BW:?\#_]#:MBLKPTI7P_: ^C?^A&M0XS2 =12#UI:8"44M)0 M%)
MFEH **** $HI:*0"4M)^-% "T44F<4  I:2EH 2EHHH 2EI/:C-%P%HI** %
MHI*6@ HHHH **** "BDI:8!24M)WI +1124 +112=Z "EI,4M !1110 44F*
M6@ HHHI@%%%% !1110 444E(!:**2@!:***8!124M !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*
M6B@#(\,.TGAVT9NIW#I_MFM4BLCPK_R+=I_P/_T-JV*0!BEI,T4 !H%%%,!:
M*** "BBB@ I*6DI  &*6BB@!#12TAH 6BD[48H 6BBDH *,444 %'-+2"@!:
M2EHH 04M%% !1113 2BBEI %%)10 >U%+10 E'>EI* %HI*6@!*6BB@ HHI*
M %HHHI@%%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !HI#12
M QO"?_(LVG(/+]/]]JV3Z5C^%>/#=IC_ &__ $-JV: $Q0*.W%% !FBBBF M
M%%% !1110 444E( I:** $HI:2@ HH-%(!:2EI.U, ^M I:2@ HI:* "BBB@
M HI** %I*":3GO0 O>C-'O10 4M)10 9HHI: $I>]%%, HHHH ***2D M%%%
M, HHHH ***2D M%%% !124M !129I:8!10:3M2 6BBBF 4444 %%%% !1124
M@%HHI* %HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%(:* ,?PK_ ,BW:?\  _\ T-JV*Q?">?\ A&K3)SS)_P"AM6W2 2BEHI@)
M2T44 %%%% !1110 44E+2 ****8!24M(:0",,_2EHQZ4M(!*6BBF 4444 %)
M11S0 44M% !28YHSQ1D 9H "<#-%)UHI **6DH)I@+1113 **** "BBB@ HH
MI,T@%I!UZTA- I7 =124&F M%)2T %(:6B@!/PI:2B@!:0CFBB@!:***8"4M
M)12 6DI:* "BBDH 6BBBF 4E%+2 **** "BBBF 4444 %%%% !1110 4444
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MYX=BLOM4M^8X_M"VS*T3;TD8952N,@D<CUKF;_X4_P!KS%M2UEY5?25TUMD
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M>1@<>]%F&AUU+113$)12TG.?:@ I:** "BBDH 6BBBF 44E+0 4444 %%%%
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M2PW8R%SSBC0!U%)FCFG<!:*3G-)O7=MR-V,XSS1<!:6F[UW;<C<!G&>:4F@
MHI*,^M%P%I:C:1$*AW52QP,G&:?F@!:2C\:,C-%P#O2TTL!UP/QI0<C(H 6B
MDS2TP"BDI: "BBB@!*6BDI +124M !1113 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!#10:*0&/X4_P"1:M/^!_\ H;5L5C^%?^1:M/\ @?\
MZ&U;% "T4E+3 **0D#J<4M !1110 4444 %%)12 6BBBF 4E+2=Z0!7!7FL&
MPA\47DMU);SQW\5LL@4?)&0FT9/"@[C\QZ9S7>YJFVF6[7LUR4!^T1A)HV *
MR8Z$@]QTI,:/.[;7;O4?#5K>FZCN+^S\0"UA=&R60OMVEL#=E"><#.,UWVM0
MV[:5=33QQL88)2KN!\F5(.#VXI\NC6<MY;7!C51;.9$C10%\PC&\XZD#@5=>
M-)8VCD171AAE89!'N*+ V>)^']5GT+]G^TUS2;>.34+96A\[9N:&-IOG/X#G
M]:T+CQ'X@:?PS8VGB>W<:G>S0"[@C64&+8"N20 S G&1Q7J\=G:PPM!%;0QQ
M/G=&L8"M]1TIHTZQ585%G;A8.80(E_=_[O''X46"YXGKGC#Q3I&NZQ91^) R
MZ;=65N-]O'^\\T8<GZ=<"I8O%VJ3)I,=[J,%W)!XK;3_ #IH4+&(#ANF%;T(
M]:]EDTO3IY6EEL+621CEF>%22?4G%-.CZ80 =.M,!MX'DK][UZ=?>BP7/'M
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M'WJV0,[PV"#6]H^DII%H81=75W(S;I)[J3?(YZ<GZ#M0DP=C0HHHIB"BBB@
MHHHH **** "BBB@ -%%% &-X5_Y%JTS_ +?_ *&U;-8OA0D^&K3ZO_Z&U;)I
M +1113 **** "BBB@ HHHH *Y?7KV:;Q5HNA"62"UNTFGF>-MK2>6!B,'J <
MY..PKJ*H:GH]EJZ1"ZC)>%]\,J,5>)O56'(I C'GN)/#VI0Z?;2R7<VJ2G[+
M!<2G; $3+_-R<<=/4UE2_$&Z:U,UIHPE,5K/<7"O<!=AA?8Z#CYO8UT4OA?3
M9XX_,$[3QRB9+HRGSE?&,ANW'&.E1/X-T9^/)D5?LLEH565@&C<Y?/N3SGK2
MLQW1CR>.+V*.XSHP,J?97B07 ^>.<X4DXX8'J*AN/B#<6MM=>?I*QW5C++'=
M1F?</D4,-F!EMP/7  [U>UKP5%<6;+II=+B0VT<CR3L,10L"-O7##G!]ZLW7
M@30KP9FAG,C+(LLBSLKS"3[P<@_,#@?E2LQZ%-O&TZZ@T;:6!9K<V]N9C.-W
M[Y R';CL2 >:GT[Q%-K[3:6UJUK>*T\-VL<WS6^WA6#8_BR"*GC\#Z-%&R*E
MPV989OGN&/SQ#"'KV %6M"TFXL[B^U'4%M/[2O77SFM5(3:@P@YY/'7ZT["T
M,V37)_#][I6A7.;B22)5^V7,FSSFS@A6Q@N!S@D$]JDU_P 17.B:[;HT<1TT
M64]U<-D^9^[QPHZ=ZT[_ ,/6.I7:W%T)7 *$Q&0^6Q0Y4E>F0>]+J6@:?JUY
M;W-Y&SR0*\:@.0K(XPRL.C ^AHL!S\GC748K=7;PY.6EN(88"TNQ)/-!Q@L.
MW0\=^*:/'%^+EH)/#SJ4ODL'(NE.)70,O;[O.":T+?P+H]K:0VR/>M'!<)/$
M9+IW*%/N*"3]T>E32>#]-DNI+@R78DDOTU!L3''FJ,#CTQVHLPNC)7Q2+F[T
MFYDLKF&9DO%,2W/[L/"/F5ACYLXX/:BW\>326WF3:*\,DEE%>P(;A2#&[;?F
M/\.#SWXK3'@K2U\G$EY^Y-P4_?G@S9\S^?'I4,O@+1IX[='>\(M[:.VB(N""
MJHVY#G^\#WI6871G6_C2\U*_L(K>Q06L\5WYQ,A#AH3CY<CH<Y&:2P\:HFAP
M-96%S<FWTY;^Y6:<&1(CG'S$?._RD]NE:D/@728)(98IKY9(I)I%?[2Q),OW
MP<]03SCUH7P+I"6T$$;74:Q6WV1RLQW309SY;GN.3[\T68[HIIX]$E\JII4K
M6)NX;7[5YR]94#(P3KW&1VK6U?7WL;\:?9V?VR\%L]TT9D"8C4XZXY)/ %1-
MX,TLRRR!KE/-NHKLJLN%#Q@!,#L  ./:K6K>'++5[R"\E>>&ZA1HEFMY-C&-
MOO(?4'%.S%H<U;ZK-XK\3V2V\L\.D2:='?0/#.8Y-^\@[@!STVX/'6DU:\NT
M\::I:#^V+BW&GQ2QQ6+C]VY9@2.>X ]>E=+:>&["PU2*_M?.B:*U%HD*O^Z6
M(<@;?KSFF7'AF"?6)]42]O[>YGB6&0PS8&Q<X &..2>?>BP7*3>)IM/UVW\.
MRV,TUW+&C6TSR@?:$'$CGC@KU([YXJK_ ,+ B!EF_LJ\>P D\JZ13M9E;: Q
M( 7<>G)Z5HS>#=-F9':6[$L4D4D,HF.^(QC "MU .3D=\\U%_P ('HI^W1L;
MMK6\WE[0W#>3&S\LR+_"<\^QZ468:#_^$FNX=1LK&]T>2WFNYY($/G*RDJF\
M,#W4]/8BL5_&MQJ'VE4L98K/^QFORT,P$ZG<RD+D8!&TX-;7_"%V/V2UB-]J
M33VTWG1W;W):8';MQN/;:<8J%/ .E16ZP0SWT:_8GL6(GR7B9BV"3W!)P?>B
MS#0;%XOCBE^Q&SN&D%E!<VS22#==+(0O'^T#UI8?%*ZU>RZ99VM[&LT<J17\
M2Y5'7CDD87G..N<5I#PUIQETB:5'EFTE"EM([<@%0O/KP!^-1Z7X6L]'OYKF
MTN;SR9':1;1IR88G;EBJ]LG/MR<46#0IIXADTG4--\/WH>ZOW@0O<,P3S3G!
M*@\,1C) Z5/KOBVUT*\%H;:XNIQ")WC@4LP3=MR!W.<\>U6=2\.6NJWL=Q=3
MW#1H\<@@W#8&0Y5AQD'UP>:9JOABVU35(=1%W>6=U'&87>UEV>;$3G8WMGH>
MHHL&AE'QZAO&@BT:_D47K6 D&P S;=P')X!'<]*:?'\4EK!+:Z/?W+RVTMPT
M:; 4$3[9%.3U!].O:K\?@RQAG$L5S=+C4?[1V[P1YFW;CI]W':LA?!$]KJ]K
M!9W=W'IRVEQ').)$+EI9 Y7!'3KR.E*S#0FLO%D/]H:A<-/-<6EP+,V,1 &6
MF4X4>F2,G/2KD7C6S:YM[>6UN(9'NWLIB^-L$JKNPQST8<@CK2/X#TUO.$<U
MQ$K?9S J$?Z.T'^K9>.O)SG.:@U3PG]HL9-)2W^TQ:C<BXOKZ64*Z,I4@JH'
M7"X&,8HLPT&W/Q"L[:&6:32]1\F"**>60(N%CD8JK=>>1TZU8?QQ9Q12">TN
MH+M+DVPM9  S-LW@Y!Q@KS4VJ^#;753J0DO+B*._AA@9(]H$:Q-N7;QZU'=^
M";>ZNKF\&I7L%Y)=K=Q3Q,H:%PFPA>,%2O!!S19AH59/B)IR0M,;#41$EM'=
MS.8@/+C=BN2"<Y!!R/RK9T+6Y=8N=4C>S,$=E=&W1RX;S %!S[=:S[[P/;ZA
M'>K/J-ZQO+-+25B5+$*Q;=G'WB2?:M72M$32+N_FBNII$O)1,T3XVH^T*2._
M.!3LPT.6TGQ)?7.J37-PUWO:^GLK?3$$9641_P 0/4;0"22>]:EKXZL+^]M+
M6RL=0N'N$+Y2(8B ?8^_G@JW6B+P1;P-'-'J%T+J&^EO8)\+E&EX=<8P5([&
MK6E>$[71]4BOK:XGREN\+1O@AR[[V<G&=Q:BS"Z*USJEYJ/C630+6X-I!:6B
M75Q*J@O(78A57/ 'RDD_2BZ\0R>%K)O[>D>Y*;Y3<PQ!5$(8!<\XW_,.!UP3
M6C?>'X[G68=8M;F6SOTB\EI$ 998\YVLIX.#R#U%96M>!8]<'^DZO?!FMWMY
M2-I#AB#D C"D$#D=N*+,-"W_ ,)CIPE:-HK@%;]=/8A 0)&7<IZ_=((YJO%X
M\TN:U%PL<XCD8) 3MQ,3G@'. 1M.0<$5%)X"B>\%PNK7J+]JAO&C4)AIHU"[
MNF>0!Q4;_#RV>Y-\NI7$.I+(DD=S#&BX9<@L4QM9F#$$D<T:AH;$7BC39?#*
MZ_NE2S8<"1"KYW;0NWU)XJC-XZT^VW1S6=^+M+E;5[1(0\BNREDX!P0P!P16
MA?\ AR#4_#DFCWMS<2A\,;@L/,#AMP8<8&"!QTJ@_@U9=1CU&74)#>_:XKJ6
M01J!)Y:%%3'888].YHLPT&^+=8N[#3=(N[2X>S6YOH(9=\.Y@C]1M[,*2#Q-
M;Z=;?:;Z_ENK*>]-M%<_9_+$!Q@B0\8&X'#8[UJ:]HAUN*S5;M[9[2Z2Z1E0
M-ETS@'/;FJ-]X5EUBWDM=7U22ZLYWS/;+$$1U P%XY'S?-GN0/2BS#0;?^.M
M(TRWAEO!<Q-)%Y[1-&/,CC+;0S+GH3V&3[4Z;QKI</G,(KN:")96^T0P[HV,
M0RZ@^H'KUP<537P/<QW-C=IX@NA>06PM)YVA1C<1 Y7.1\KC^\*EMO!'V9=1
MM%UB[_LF\,K?8MJ_(TH(?Y^I&22!V)HU#09JGCZQL8&:"SN[F0);2;%4 &.=
MMJ-DG]/6GQ^++:TNKI;J>ZF5M46P1?LH46[LJX5CGE3G[WOBJ0^';O!(L^N3
MR2FWMH(W\A $\A]Z''?/?-:#^"X[FPU^SO+UY8]7F\_<D81H&"J 5/J"H(/K
M1J&@M[X^T.PW_:'G7RV</B/.U5?87QGE=W QR<'BIY-7N=(EO+C5I8WL9KB.
M+3Q$F'8N/N'G!YZ$XJI<>"MMY9W6FZG)920VJVDV85E\V,'<#\WW7R2=WN:U
M];TAM6TH6(EBVEAO%Q")4E4=58''7KD$$8HU#0CN_$EA8>'O[;NEN8K,8W!H
M&WIEMO*]1S5 >/=$\Z"*5KB!Y72-A-"4,3/G8K@\@G'''<9QFEG\)22^!T\-
MC4Y2P"C[5*N]OE<,.">G  YZ4R3PC/\ \)))JUMJ8@6YV-=Q&V1RSH,!D<\I
MD  CGI0&@RY\8V5UIJW-E=S6L1N(42Y>U+I*KOMP/J01GMGI5V7QCI,6I"R9
MIRYF>W61824:5%W.@([@ _E6*_P^F>*XQJD<,D\T$T@AMMD3-')OWF/=@.W
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M ****0!24M% !2=Z*.: "B@D]A0.E "T45!<7=O:+NN)XXEP6R[ < 9)_ 4
M3T5#!=6]T@>WGCE4@-E&!X(R#^(HGNK>U$9N)XXA(XC0NP&YCT ]2?2@"6EI
M,T9H 6D/6EI.* "EI,T4 +1124 +14<D\4&SS94CWL$7>P&YCT ]Z?FBX"TE
M%% !2TR21(HVDD=41>2S' %.!'4'@T +129HH 6BH5NK=Y6A6>-I%ZH'!8?A
M4HHN M%,DECB ,DBH"< L<9/I3A1<!:2EI.* %HIH89QD9],TM !2TUB%Y)
M^IIU !1113 **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2B@T4@,7PF/^*9M/K)
M_P"AM6W6'X0Y\+VG7[TG7_KHU;= !SGVI:**8"4M%% !1110 4444@"BBBF
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M4;R%8Y410Q=6(SW"XQU]JN/X*TVYB>._EN;Y?LIM(S/)DQQG!." .<J/F//
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M:NS[5QOPF_Y)9X?_ .O<_P#H35V5 !BBBEI@%%%% !24M% !1124 %+24M(
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MPX?#^LVW@27P4MF'RCVL=_O7RO(9C\Y'7>%/W<<GO7H5%%@/,-2\'74D_B&
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MSN-19IEF0"1)PQ3:N<XY (/>DA\'ZC>K L^F?9[J+PZMI#<R.I$-TI..ASD
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MG-#\1F\NKJTO"GVE;Z:"%84)_=IC#-Z=>M='0F(****8!1110 4444 %%%%
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M+V6T!;[/:2N#';@G)"\9(],DXJO;>"[2TN$:*ZN/L\%Q)=6MNV"D$K@Y8=R
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M444 %%%% !1110 AHH/2BDP.+^$?_)*_#_\ UP;_ -#:NUKBOA'_ ,DJ\/\
M_7!O_0VKM:8!124M !1110 4444 %%%%( K'U?2+F]O[2\M+I(98$EC(DCW
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MMX9D>VN+4W,5WYBB-L.$V_7)%&@:F39>$M3M=>L]3:[M"8;R[E= K?-'.0<
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ML\YU#PSJER-15M):5;LZ:3F1?F,1_>D\]0./>JVH>&-9DMM0L[70\6\US>M
M5E12BR(H3 /"J2#G ST]:]5I:5@NSS.?PYJLNFWZC1OW]RNGR*?,3.Z+;O!.
M>HVDY[U9/AK59-0\N2V'G1ZP]^M^&'SV[ _NSWS@A,=,#->A5!:7MM?+*UM*
M)!%*T+X_A=>HIV"YPOA'P[?:1J6AR-I9M$BTR6"[8,IS(9 5!P?FX!Y[9KH/
M%&F2ZG<Z&JV8NH(+\2S@D85 C#)!Z\D<5T5%%@N>:67AW48[6VBGT68JNGWE
MJZI.BL \NZ- P/'R].PKK/"=E>V&FS0WJC_7$Q.T:I(Z8&#(%XW<8R.N :WZ
M*+!<****8@HHHH **** "BBB@ HHHH 0T4M% 'G_ ,%&)^%.D>WF#_R(U>@5
MY]\$_P#DE.D_67_T-J]!H *3G=VVX_&EHH **** "BBB@ HHHH *X+QO/=KK
M5K;2WE[9:=-:L(;BT@>5A<[A@?+T.WIGCK7>T4FK@CRN;[7_ &F\CZCJP8:[
M%;8+N!Y#1#>,#@ G//8]"*II=-,^DV^HZGJL%D?[1@PLTBL^QQY62/F) /![
M\5ZW'<P2RRQ131O)"0LB*P)0D9 /IQ52?2;6YU:UU*0.;FU5EB(<@ -][CH<
MX'Y4K%7/-/.UJ+S6N1>27@TZP6^,:-YGE>8WFX(_BVD$XYY-6YTU:SL+W5K&
M2[FLM+U)9K"%Y&'VB!E >/GD@,25SW%>G]^*I7VD66I7%I/=Q&1K1_,B&\A0
MWJ0#AOQHL*YYUKUK>V:WD?VW5/M%OI27(\J60J+@RDY&.I /3T[5%J%S?VES
MJ%I%/J)T@7\!GD\N28I&\.6(Z,5\S&=IXKUBBCE"YY%=#4TAO,:EK4XM=&2:
MVE97C,DHE;:VT=\8X/)'6NM\'PK!K?B0-'<)--=I,3('VLK1KRI/'7/ Z5U_
M>EH2"YYIX@6YMO$WB2\TN.Y-XME:@M'O^YYA\S;V+!.<#FH+K[1/?);VNHZE
M'HDVIPK;RQ2.&*-$?-&[KLW8Y/0FO4:,"BP7.4\=:9=W'@F2UL(I;IX'AD,6
M[+S)&ZEE]R0#]:37/$5E=>&[NYL4OII(X&8-;0D2PYX/4<'VZ\&NHGN(+9 \
M\T<2DX!D8*,_C1#/#<(7@ECD4'!*,",_A0!Y?IFIW%O=V[3S7ILK;57C9ECF
M*>3)!E1R,LN_H?7TJ*RU+4VBT6<2WMS.8D5K*3S(I5;S& =21AQT#*W89KU&
M34+*$R"6[@0Q,JR!I -I;[H/H3VJQ1RH+GG?A'4;B*2>_P!3U#43-'$8[ZS:
MS<+'-O\ O9.<GL-O&.:]$I:*:0,Y3Q]N_L>QVJ[%=3M7.Q"Q $@))QV K#\=
M[VU>_GMWO%N+71C+";?>!Y@E!7[OWC[5Z/10T"9Y:ESJ5YK5X]YJ.H6U]$96
M2W@MWV2VYBRAW_=QGGID-Q5<I>Q:?HT$^J:Q#;WUCYOVO9),ZWG'!'!4X' (
MQG->JM<0I/' \J++("40L S8ZX'?%24N5!=GF-GJET_C"V6>;4%BDGN+:Z6=
M'!*B/*DX&U%R,C'/O67I5J]I:>'+JRCNQ=_V??1PJ2Y GSE%(/ /7KUKV%F5
M$+,0% R2>@%)%+'/$LL,BR1N,JZ$$$>H-%@N>3K/=SZ5:R0:WJI6YO+2.:-8
M9(3"QR)1DY.3W[#&:])TN\LW$VG6MQ)-)IY6&;S<[P<<9)ZY'>M&HT@BBDDD
M1 'E(+MW;'2BU@;N>??:!!XU\42G59K!0UJ2%@W"8*G(!QD^G'K3FO[V'QHA
M2XOFT:ZFQ$'W#RKS9GRCZ1$$>V[BO0N,]O:AB%4LQ  Y)/:BP7/);76M6_LR
M34&U/499D6./5+%+9PUM^\_>.">C!<X"_P /-:ESJOV&..6WU74I;">WO%AF
ME5OF; :-5XR<<X)Y.#7H1N+<0"X,T0A(!\PN-I'8YZ5)E>!Q[4607/(#?W-K
MI^JZB+V^BU2;2M/F5V+Y8YPY /'L?K75S?VQ%XNN;"*6\EL[T)?6\P<[(0@P
M\6>P9MO'H37:$#N :6BP7."\!7UYJ%RT]UJUS-.8"MW8RP.OD3!N22W /; X
M(&:DUS4;JV\9Q)]LDDM&,2&WA=D> D,=Q7&)(S_%W7%=MYL7G&+S$\W;N*9&
M['3./2G[5)R0,^N*+!<\;L=4N-*T.U1-0U$1W.E";9&2?+<3@97CY!M)R>N.
M:T])U::\U?1!<W)G-OK%W&K'>=L?E$KRPR1SP3UKU# '8?E1@'L/RHL%SG?
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MUV^:,KG?5#Q)JUUX7L]L=Q96NHS17%TRPQ!$EV ;>6]L9 R37>RP0S@":))
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MYO++PM-/97ILY5GA!F"@X4R*#UZ<&N6L-7FT?Q%JDMO=VGV.XUP03QLG+%H
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M?!$C_A56EX/\4N?^^S7H=>>?!'_DE6E_[TO_ *&:]#H **** "BBB@ HHHH
M*,444 %<IXCUZ^T;7K4KY;:;'8W-U<IM^=C&%P >W6NJJK=:78WT\$]U;1RR
M0;A&S#[H888?0CM2 X^;Q=XAAM()6TBT'VJXMX[9GGPKK+GJ!D_*0.>AI/\
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M^T-,G%DL]E>6T]HSJQ4DQRR 8.,X.,@CJ*T'\"QN@0:I=*HOI+W*JH;<Z%2
M>P /7KFJ\?P]"*X;69VWI;(P\A /W+[E/ ZGOZTK,>AI^&KRZN[KQ#%<73RB
MWU)XH20,QIL4A1],FL'1O'T=CI%LNNI>*S12O'>R(NVY*.05&.AZ=0,UUFDZ
M,-)N=3F6X:7[?=&Y8,H&PD 8&.HX%8<GP_L[G3UL;N]N);>%)5M< *T)=MQ;
M(ZL#TIV8M#7T7Q##KL%VT,$\4EL_ER(Z]3C(*MT88[BL+3O&T"VFE6T-IJVH
MSWD#SJYC3?L5]K%N0 0?3M72Z7I]Y96CQWFIRW\[<>=)&J <8&%7CZ^M8ND>
M"QI%Q82QZE(_V.SEM%#1+\P=]^X^X/:EJ&A5_P"%DZ>+%;I]/OXQ(C2PQNJA
MIHU^\RC/.#QCJ>U5K'QL]OKNJI>1WLVG&Z@6"<1 );"6-2JOT(RQ]#C/-:*^
M"7@MM(^QZS<6U[IL;PK<K$I\V-SEE93QZ$'L14TG@Y);VZ=K^9K2\DAFN864
M%I'C  ^?T.T9&*+,>A'/X[M$TT74-G<R2/!<2QQD!<F$X=2<\5!;>.VDO)8I
M])N8XX[""[RF'9C*< 8!X'N?QIH^'WS;#J\QM52ZCCA$*@JL_P!X%NI(/0T/
MX#F921K<J2-90VCLL"X81-E3CT/0KWHU#0AG\:M/J&EW>GQW=Q;,]U;W-G!&
MKLTD8!X.<<>H.#4T'C.V.L2WQO6.CR:9%<Q(R %7:0ICUR3@8/>GV?@>;3IH
MKBUU<K-'=3W*YME"#SE 9=HQC&,CTI)_A];RP-;1W\D4 LXX(=L8+QR))Y@E
MSW.XG(QBC4-#:L?$EIJ&E7M_%%.%LF=9HROS949.WLW'0@UC#XDZ1]DEN)+/
M4HE6WCNHU>WPTT3L%#*,\X) (ZUKO97UOX:OH;J[DU"[>"0;DB";CM( 51T_
MQKG+#P7=:EX;LS?WKPWPL(;5<VX!A165V4KGEB5 S[4]1:&K_P )UIHOH+26
MWO(II)%AD5XQF%V&55P"3T].!D4^S\:V%Y%!,EM=BWN+A+>&?:I1V<D#D'@@
MCD'D<<4Y?#-U!K]QJ%IJ\MO;7C+)=6JQ*=TB@#<K'E<@#(YZ5GCP&X>XN5U)
M8KR6:&=9(;8*ADC).]H\X+'."1CH*+,-"Q+X^TY HCLM0ED9[A D<0/,!Q)D
MDX]QZTD7Q TF2WEGDBNX$6**6+SHPOGI*<(5Y[GCG&*AM_ LT%PDIU<R;3=L
M0UNHRUQC=T/;'%1R?#TRVT<7]KR(T-G;V\,B0@%'A8LKX)P>IRO2BS#0DO/&
M]O>:%=MID-X;U(9R41%W0^6,%SDX(SC&,YJU=>)+C2_!FF:LUJ]]-<);*ZQE
M5^:3:"W/N>E0W7@V^N76Y/B"47SVLEI<2_9DV21MV5.BX/3KU-:%WX:-SX3M
MM$%\R26RPB.Y\H'YHR"I*]/X>E%F&@#Q98"^CMVCG6*2Z-FMP5'E^>.J9SD'
M@C/3(Q6?K7B>70O%9BFCN[BP_LXW#QV\(<QX?!<]\8[?I4L/@U8[E0]\SV2W
M_P#:0@\L B<\GYO[NXDXQWZU;UCPY)J6HM>0WQMVELVLIAY8;,;-DE?1NO//
M6C4-""+QUHUQK$&G02O,9Y/)29%RF_;NP>XX[XQGBK5_XHL=-U2.PN(YPSO&
MAEVC8&D.%')R>1SC..]4]*\(R:-J;O8ZK-'ICR"4V1C4G?@ XDZ[3@$CUJ'6
M_!D^K:TVH)JQB!>"1(WMUD\LQ-G"DGA6[@=Z-0T-'5O$8TG7+"PEMF,%S#--
M+<;AMB6-03D=>]9G_"R-&\IW$%\[+)%&L<<.]G\W.PC!QSC'J.]:6O>&DUV\
MLYI+EHTABFAEC" ^;'*H5AG^$\ YK-C\'ZBUA96MWKQN/L=U%-&WV55RL?W0
M0#R3W;VZ4:AH3?\ ">:>)C$UCJ:.MPEJP:V^[*ZAE4\]3G'UI$\56E[>:3+%
M)?0+,;E6MC OS/$OS*Y_A(P2,=:27P?</J-Q=KJ2CSM3BU *8,[?+4*$Z]#C
MK3(/!<]O<6LJZF#Y%U=7 !@Z^>",=?X<_C1J&A-9^/-+O8#+%;7ZYMTN8E>#
M!E1FV@J,_P![@YQZ]*;'XWM[R^TVWL[.XD2\>XC>0;?W+0CYAUYY]*IGP%<B
MVM8H]9*&WT];+(MQAPL@?)&>AQ@CT-36/@B>PN;6>/5@7M[BXF4?955=LP&Y
M< \8(X-&H]!]EXSL(M#M;@S7FH$VQNI9!"%D2$,09'4=!P>!SP:L2^.=)BO6
MM]EV\:/"KW*Q9B43 >6V[/0Y K/LO +V%I%%;ZJPD-@^GW#F$8DB+%@P&?E8
M;CSR*DE\"'R;R"VU 103-:>6IAW&-;?&!G/.<#FC46ANZCKMMI=_;6<\4[27
M,<KQ%%!5C&NXKG/#8Z5C7/C&QO-+LKJTN+N"&Y^SRK.D ?:LDFT*PSQDY!]*
MUO$7AZ#Q'96]O//+ 89TF62$X;CJOT8$@^QK&7P%;VFEW5CI]VT*3WZ7B[TW
M")58,(E&?NY!_,T-,%8JWOC.ZDNX3!;74$=OK1T^6,1JYN%"$\>AR!6J/'.E
M/81W<274H,+W$L:1?/!&AVLSC/&"",<G@U ?"%T-1\^/4T$ U7^TUB:#G<5(
M*%L].<YJI:> )K)9&AU0":XMYK6X/D_*\<CE\@9X92Q /Z4:AH:__"9:22^U
MYG19X(?,5,J3, 8V!_NG(YIVE^)TO_#U[K$UG-;16CSAD<@EA$2"1CZ5CR_#
M]HW$>GZG]GLP]I((G@#MFWP%&[/0@<UN:-H!TW3;W3[B=;FUGFE=5\O:0DA)
M*GGGJ>:-0T,W2I_$6JZ#I^M)>PI)=F.X>T,8V+"Q!*ANN[:>OK4I\>:0B7#.
MEV@AB$Y#18+1E]F\#.<;O7!QSBI=(\/ZCH]A!I<&J@Z=;_+"3#^^$8Z(6SCC
MIG&<5@+\-;EX[I+C6@YGM'MFD%L [$R"19&;/+9'/;Z4:AH=#<^,=,M;F:U9
M;AKB*Y^S>4J#+OL\SY<G!^7G]*0>-=&.K0::9)1--*(5)3A92NX(>X./;';-
M9,W@6[NX=1%[?VETVH3K-,LEIA598P@*8;*D$ @YJWI/@^ZT;4))+?5S):RL
MLLBS6ZM*90H!;S.N&P"1CUP:-0T.MHJO91W,5E"EY.D]RJXDE1-@8^H':K%4
M(**** "BBB@ HHHH ***2@!:*** "BBB@!#1110!YW\$#_Q:K3/]^7_T,UZ)
M7G/P/X^%>F^\DO\ Z&:]&I +1113 **** "BBB@ HHHH ***2D 444=* %HI
M** "EHHH **I2:M80WL5G)=Q"YF<QQQYY9@,D?7'-6!/$T[0"13*JABF>0#T
M/TH EHK*N_$NB6%TUM=ZI:03H0&220 @GH/J?2KME?6NHVPN+.>.>$DJ'C.1
MD'!%%P+%%)1D4 +15:*_M)[RXM(KB)[BWV^=$K M'N&1D=LBK&<4 +12;@,
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M6"YXA?>-M;U?08;35Y!865SI-[(;AHAB\="50<CC(YP.O:MW4&C/[-?S ?\
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M;>&[CGMWTE+B-?*&+4><$+<<E0IR<YZ5Z7X6N[F[T^8W&IVNHA)B(Y[?D;,
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M=%(BTVU0[UD!$0X=1A6^H[4[1]+?38IC<7CWMY.^^:X= A?C &!P !Q185S
MN]5NO#FH:;I,80::JPP"YE!D^8G;M<@Y0D8VD@@FH/$'B:^T+7M6D-Q&]G;6
M,#QVQ4#:[R%2[-GH.I]JZR73+":\6[EM(7N5QMD9 6XZ?E1/IEA=7)N+BS@E
MF,1A+N@)*'JOT]J N<B/$?B1KVRL$&D>==7$L:2&0OA%3>K$*< ]L9]#5:U\
M6^(KJXMT TH?:I;R!,*YV-!GYNO.<=.U=A;>'M&LA;K:Z9:PBV8M!LC \LGJ
M1Z9IZ:#I,31M'IULIC9V0B,#:7^^1]>_K3L%SB)O%MTL,FLQ6-@+IO#ZWJNQ
M;.?, *'G[N3D&K3>,-4ANKS3IVL1>13PK&R _.LD1DVJI/+#'4D#'-=2?#6B
M%-ATJU*^3Y&/+&/+SG9_NY[4Z7P_H\S.TNF6KL[(S%HP22@PI_ <4K,+H\_C
M\6:EJ]C<WMP;1K67P_\ ;/L##*%][*V6!R1\M:\WC&\@AOI;2WMQ;Z4UK%);
M,#OE$H4Y0]L;L#KG!KJ/^$=T8QB,Z7:; C1A1$,!6.67Z$]JE.BZ8;B*X^PP
M>="JI&^P94+]T?AV]*+!<Y73_%FK2ZY96]U'9&UNM0NK$"(,'7R@2&))QSC!
M%/U/Q?=VEWJDL$4+0:7=P6TMLP/FS"3;\RG/'WN..<&NG31=,CDCD2PMU>.5
MID8(,K(WWF'N?6GRZ583WR7LMG"]TF-LK(-PQT_*G8+G+^%;-;W5_$%Y?M#<
MSP:E+#%(4PT:;%!7.>F#TK'\#1#_ (1_29Y;>QCB22=8[UIR9-^]@@QW],9/
M2O0K;3;*S$XMK6*(3L7EV+CS&/4GU-5XO#^CV^WR=-M4"9VA8@ ,]<#\:+!<
MX^/QW?QZ9JDUU':BYTX)&T:9VREWVK.I)_U6#U]0>:>WBW6%OX](FETNWO)A
M,\%RTFZ-E100K '"L<\C)X&:[ Z/IF<_8+?_ %'V;_5C_5?W/]WVJ'_A&M#_
M +/BL/[)LS:1/OCA,(VJWJ!ZTK!<YJ;QE>PS7,9:Q8Q7ME I4G#+,!NQD\X)
MX/?%0Z?J][<R:,UZUI>S2ZI=P),4*M#M#A2H!QT7!SV-=?/H6DW5T+F?3;62
M8!5#M$"<*<K^7:@:%I*W"SKI]N)4F-PKA ")#P6^I]:+!<X__A.]0M]+NY;J
MV@-WI>^/48U!54D+A8R"3PI!W$GM6Q8V]SX@,<FKK;I-IUX)K>2TGW;EV\;@
M#P3G&,GBN@:RM'%PKVT1%R,3@H/WG&/F]>.*9I^FV.DV@M=/M(K:!3D1Q*%%
M,+F#H?B2\N]6O;'48XX9HHVFBAC4G?&&P&1\D.#QZ$'C%8B^.M;?0)M92RT\
MVS0^;"'GY!\P+M(!)Z'D\8/&*[:TT[3["622UM(87D^\R+C/.?PYYJM_PC&A
M'[5C2;3_ $MMUQB,?O"#GG\>:071SUOXJUI=6>TNH=/,<&J1V$K1E@7\Q RL
MN>F,X(.<^U9UUXGU?4M D^VVMF+34;:]CC^SNXDC:)6PQ)[$+VZ'%=J?#NC^
M:TW]G6_FM.+DL5Y,JC ?Z@=ZSM"\'6&E:;+;7$4-U),91)*4(WI(Q8J1GWP<
M=<46"Z,&W\7WEIHLAM88)(M'L[-KA)2?,G$B DH>V!TSG)XK27Q5J2W^I:9)
M;6XO[4O.@VML:UV;E<^Y;Y3[YK?/A_2/,MY/[/@W6Z*D1V_=5?NCW [9Z4RU
MT9EFO9M1N1>R7(,8S$$"0\XCXZ]3D]Z=@NCD%\;Z_P#V=]L:STT#^S(M3VAG
MSL9MK1_7N&Z>U:2^+-3NM4NX[*RM?LEI<-;RF:8*RD)N#8SDY)'&.1SFMH^%
M=":(Q-I=L8S;BV*[>/*!R$_W<]JD/AO17O\ [<VF6QNO)\@R[/F*8QC/TXHL
MPNCB[KQGKTN@32JMA;7,FGP7T,B;F"!I0C*0>OL:ZCQ!KL_A^#3KJ<0-8/*(
MKV<Y'E;A\K@>F[ /UJTOA;0EB:(:5;>6UO\ 92NSCRLYV8],]JO'3[1K%;)K
M:)K5551"RY7"].#Z8%%F%T>?7GB^XU;PIJ$EQI5N\ED@%_:2LZ[9/,&U00<\
MKAORINL7NJW>H;3-;NUKXBMX+5=K*$4QYPV#R.:[VZT73+Z"Y@N;&&2*Z8/.
MI7B1AC!;UZ#\JCE\.Z//=?:9=.@:?S$D\PKSO085OJ!WHL%SEK7QGJ=](UC'
M!9QZA!%<RRLY;RI/)DV83G(SU.3Q3'\?71TV[ODM((UB2QE2*9B&*SG#*?<=
MCWKJ#X7T,P+"=,M_+61Y0-O1F^\?Q[^M.N_#6BW]TMS=Z7:S3*@C#/&#\H.0
M/P/3THLPNCG;;6=:/A'Q/>F6*YO;.>[2U6./!79D*,9YZ5)I.E:5_P ([H^L
M)>,+B.)+G[6UP?W[%,L'.>0><CMCVKJ+73;*QFN9;6UBADNG\R=D7'F-TR?>
MJ\'A_2+65Y8-/MXV?.0%XYZX'09]J+!<XV/Q]J*B0RVUJVV2RVL RADG<J2,
MG.!C(8XSZ5<O/&6HQ)</';6_D6U[/;2W #2+&J!2K.H.0IS@L,@8K>B\(>'8
M8IHH]'M%2:/RI (_O)G(!]@>GI3O^$2T 1B-=*ME4$G"KC)( .<=<X&<]<46
M871DZ-XLO=:U-/(LX!IWGR6\DC3*'1E'! SEL^F!Q@TV?QA<1W$LT=O$UG#J
MJZ7)&<^;N.!O],9(XQTYK?AT#2;?5I-4ATZWCOI%"M.J ,0!C^7&:D.C:<=1
M.H&SB^U'!,N.20, _4#C/6BS"Z,?0]1U+7=$NKG48;..&02QQK;LQ;Y693DG
MUQQBN?\ !T$[:#H]Y]ABBE^RL8[V6\)\R7H%=>I!Y/MBNYL](L-/T]K"TMDA
MM6+$Q+G'S?>_/-4HO"6@P1+%'IL*QHI1$R=J@C! &>.#18+G.6GCVZGTJXNY
M+2WCEAN(;)H"Y#+,QP6)/'EG(*GO5@>*=::\.EM:Z?;ZG'#+<;99\QRHKA0
M0?E)!R<YQ70/X;T:5IVDTVW8W$"VTN5SOC7[JGV':HW\*:#):VML^E6K0VC;
MH%*?<)Z_G19A=&&/&5X9GC%O;#9K":=G>2&5D#!A[C/XU3T;6;Z_D\-37D=M
M<W]W'>F*X!9!&5/ V@X(/ _"NLF\-:+<:@+^73;=[H,KB0KR&7[I^H]:+?PW
MH]I<0SV^GPQ2PR/)&R@C8S_>(^M%F%T<M%X^NI=*^TFSA6:%EM;N,L1Y-TTF
MP(<]@/F_$>M;%I;W>M2VM_J49M+S3+F0!()_EE7;@;@#@9!S@YQBMB?1M-N;
M6[M9K&W>"\8M<1E!B4G RWJ>!S[4^QTVSTVR6SLK:.&W4<1J./Q]:+!<Q/#_
M (CN=6NKVUNH8;:ZMHP[6Q#!UR3@^C(<##*<'FL*U\;^(;JUT_;I=@;K4HI9
M;6-)CC$?4,3CDG'3H,^E=E8:%IFF"06=G'%O78Q&2=HSA<GH.3Q[U7D\)Z#-
MI4&ER:7 UE;OOAB(.(V]0>HZFBS"Z,%_%6HS7'V*\T^VMUN+=O+5Y&9)F\HL
MRK*G&001C@XY%5+;Q?>VVCZ=%IVE1$_V;!<QP;V;S-[[-B'D_+UR>M=;_P (
MYI'G&46,08ILP,A0-NW@= <<9ZUSVH_#VWN=1BEMFMXK6.!+>*,HVZW5<G]V
MRL/7/.:+,+H5/%FK)JKQW%I9"S34SI[,DC;^8]X;GCCH:RKOQUK4EG=QP1V<
M-P((+F&8 LA1YO+(&?O<=&''-=?'X3T5(U5[))6$PN&=R27E QO/JV*B7P/X
M92*2,:-;;)(O)<8/*9W;>O3/3THLQW1DOKTFG:Y>626D$=[>:A%;),78QL3#
MOW,#T.!@ =:A/C369CY-M860GC^UI,99&V[X",[<#E6!_ UTS>&='9;A38QD
M7#(\F2<ED&$(.>"!T(I6\-Z.WDDV,>88GBC.3PK_ 'Q^/<T[,5T9FH>*)[/P
MSI6OBVC%G.87O?,8YMXG RX]=I(S[5A7'C"XU?0=7@>Q@>6SCF>ZA9WCW1#!
MC8$<C>O(KN4TJQCTI=+%K&;$1^4(&&5V?W<'M3+C1=-NH;F*:RA9+J-8IQMQ
MYB+P%..PHL%S@/$.L:G<Q:I C1B*RO--^RHA9&&\J2&;N.:[7P[JUUJD-ZE[
M#%%=6=V]M)Y))1L8((SST(HE\*Z'/(TDNG1,[+&C,2<D1_<SSV[5>L]-L]/>
MX>U@6)KF4S3$$_.YZL?>A(+ENBBBF(**** "BBB@ HHHH **** $-%!HH \W
M^!)S\++'_KM-_P"A5Z37F?P'.?A;9^UQ,/\ QZO2Q2 6BBBF E':BC% !12T
M4 )112T@&CBN;UG4)I_%FF>'HKAK:.>"2ZGD0X=U0@!%/;);)/7 KI<5EZMH
M4&JW-G>"62VOK)RT%Q%C<N1AE(/!4CJ#Z"@$85MXABTS4=0TY+B\OYQ>1V\%
MO<+MV.R;MHD/WEP"V><"GKXX2Y!@M--EFU&+SC/9F0*8O*(#?-T.21CUSVJ>
M7P7!.TUS)?W)U"2\CO5N@%'ER(NU<+C&W;P0>N:8W@BV2:*ZM;ZXMK\&;SKE
M0I,XE.7# C'4 C'3%+4>ACZ]XQ?5=%@N-!6?R!<6;2W2R!"GF.OR%>I^4\_6
MM'QS?OI]UH3F[O(+62[=+D6N2SQB)FZ $GE0>*2;X<:?_J[+4+ZQM&6'S;:!
MEVR-$1L8Y!(/ SCK6YJVAKJUYI=T;J6%]/N//0( 0YVE<-GM@GI18+HYG1?%
M-Y9>%;.[U(F\EO[B3^SLM\\D'+(9"H.&VCG ],U;7Q]$'T\RZ7=6\=Z8D'GD
M)(&D8K@)U.".3QU%2/X"ME1DM-3OK-8[LW=H(67_ $1V!#JF1]QLG*G(YIES
M\/X+FY,W]LZDI9H'?+JQ=XFW!B2,\YY XI68:!;>/(+E)'CLB2;A;6%1,-YF
M+%=CKU0\;N>U-;QRYN(K*'19Y=0:XFMI(!,JB.2-=_+'JK*<@U+-X"L[F:2Y
MN;VXDO"8VAN@%62-D;<K$@?,0>,GMQ5B/P=!'>V]\+Z?[7'-+<22;5_>R2)L
M)(QP N, 468:&MHVJQZWHMIJ<",D=S&'"/U7U!_&N-EOICXC\06TMSK3)#<P
M1VQM 66#>BDD]L9.>>U=!H/AZYT*>""/4YY].@M! L,NWE]Q._@<'!Q^5(?#
M%PE]JEW:ZW<P/J3*TNV)#MVKM 4D<<=Z=@(X_%N->FT26PD6\MCOE+. /L^,
M^?\ [N1C'7-48?B+;3-\NFW/ES+&;.3^"=G;:J$D85N^.>*O/X-A?4;;4#J%
MR;J"8OYA"DR0E=I@;CE._P!>:JI\/K3^S)=-EU74I+0$&SC:4?Z$5;<IC(')
M!Q@G/'%&H:%B3QA-;S"WNM&N(+DVMQ<"-I%PWDD9 /HP((-9%SXRGOK+57DL
M9H-.AL[6Y26WN L^)<'TP,?T/K6M<^"ENX[4RZSJ!NHDECDNMR[Y4D #*>,
M<#& ,8J _#^V%C<6D>J7RQ7%G#:2 E3D1'Y7Z<-CBBS#0N-XL6+4K[3I+%UN
M+6>&) 91^^209$@]  &S]#3M#\71:[J/V>"QN%@>$S17)4[&7=C!..">H'/%
M7I/#]C-KEOK$RL]Y#;M;@Y^5E/<CN>N/J:JZ!X73P^[I#J-[<6JY%M;3."EN
MI.2J\9(],YP.*+,-##\0>+'N;'Q#86<<L$UC#+F9)@LL;( 0=O7:V>",@X-6
MX_&,\=I,LVE.EQ;O&C>9.NS:\>\.S=L],8)S4VI^"(-6GN)KG4;HO)%+%$ZA
M0T*28W*&QDCC@'.,TESX'M[F\-V=3O4F\R*160J-K1QF/ICNI_/D468:&#?Z
M]<:FUW>VEU=6UO<>&GO(XA)@QR!N&'OVS6SXBO[NW\&Z7>V[W#W'G6A(B?:T
MNYE!4GT.>:=!X!M8+0VRZG?,AT]].!8J2(F;.<XZCUK7O=!BO=!ATM[F9?($
M9CG7&\-&05;ICL*+!<Y^3XB+&K6[Z/<KJD32">RW E @!X8 AMP8;?7/:MG4
MO$L&G:98W;6\QDOBJPP.I5@Q7<0W!Q@ YJG<^"(9YHKR'5+ZUU-97>2]@90\
MH?&Y2",;>!@8XP*OZQX;@U;3K6V%U<VL]FZRVUW$_P"]C<#&<G(.02"#US19
MAH8+_$11&)%T&_VK9?;90Y5#'&'*-P>201GW%%SXEN+B:^CN;2>*VM=5MK:*
M2UG"LX?:07R/N_,,CTJ]>>"([T7)EU:]+W&G_87=MI8@MN+YQ]XG\!23>"(I
M6N,:I=JD]Q;W+IA2!)$!R./XMHR/:E9AH9;>(-1O9;.:<"R6#7WLV$4N5EB5
M6SNX]LU=L_B#9W:-(NGW0C=5-L^/EG+/M5,]%8]<>G-7/^$.@^TF1;^X\HZB
M=1$#!2H<@AEZ9VG)JI'\/X%TR33GUC49+5'#V*LR_P"AE6W*4..<'@;L\<46
M8:$WA74K^Y7Q$;P2F2UOY%BADD#;%"*0H8<8Y/YU7L/',T^AVUW+I;M=/:->
MSP0R#]W"&(W#/4\'CV-;6A^'_P"QEO\ S+^XO)+Z<SRO,%&&*A3@*!@<5E0>
M!(K6"&.'5;M6CMI+)G*J2]NS9V=.HR<-UYIAH;^GZF-3_>002?9'ACFAN3C;
M*&&>!U!'&<^M7ZHZ?I@TX^7#/)]E2&.*&W(&V(*,9'?)XSGTJ_3$%%%%, HH
MHH **** $YS2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F'
MP$_Y)=;]?^/J;^=>GUYC\!/^26VW_7S-_P"A5Z=0 4444 %%%% !24M% "4M
M%% !1110 4E%%(!:***8"44G.:6D M)2T4 )2T54N]2M;([9Y</Y;2;%!9MJ
MC).!0!;HJM;7]M=MLAER^Q9"A!#!6&0<&H[[5;/35B:ZF""69(%X)^=SA0<=
M,^] %VBBBF 4444 %%%)0 M%%% !156ZO[>S$9E9CYDJP@(A8AFZ9QT^IJS2
M 6DI">:6BX **JZA?V^EV,]]>2>7;0)OD;:3M'K@58CD62-9$.590P/J#2 ?
M249I.:8"T&LFV\2Z3=ZHNFP7)>Y=6= (VVLJG!(;&",^]:P8,,@@@]Q0 M)5
M'4=8L=*$?VR;87SM4*6.!U.!S@9&35X$$ CH: %HI** %HJHNI6;:D=.693=
M"'S_ "_]C.,YZ=:MTP"BJ-YJ]C8SQP3S8FD!98U4LVT=3@=O>IK*]MM1M([N
MSG2>WD&4D0Y![4K@6***3-,!:*** "BBDS0 M%%% !12$X&3VJMI^HVFJV27
MEC,LUNY(5UZ$@D']0: +5%%0W=U!8VDUU<R"."%"\CD?=4<DT 345'#-'<01
MSQ,'CD4.C#N",@T]F5%+,0J@9)/0"@!:*S[+7-,U"X\BUNTDEV[P@R"RYQN&
M>H]Q6A1< HJ"\O;>PM9+FZD$<,8!9L$XR<=JFSD9H 6BBLXZ[I2ZLNE&_@%\
MWW8"WS'C.![X[=: -&BH;JZ@LK:6YN)!'#$A=V/91R33H)XKFWCGA</%*H=&
M'1E(R#0!)1110 457N[ZVL$C>ZF6)9)%B0MW9C@#\:L4 %%%% !1110 4444
M %%%% !1110 44AHH \R^ 9!^%UOCM=3 _G7IU>7_ '_ ))?#_U]S?S%>H4
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M**6B@#RS]G\_\6Q3_K\F_I7J=>6_L_X_X5BF#_R^39_2O4:0"T444P"BBB@
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M* $-%!.!12 \L_9^_P"29#_K]E_]EKU2O*?V?/\ DFI_Z_9?Y+7JU, HHHH
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M)7MD*>:$##>2,*NU< \#@=JN4R0I*6B@ HHHI@%%)2T@"BBBF 4444 %%%%
M!1110 44E%(!:*** $HI:* $H_&EHH 2EHHH *3O2T4 %%)2T %%%%, I*6B
MD 44E% "T444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#10:*0'D7[.Q_XH&['_3\
M_P#Z"M>NUY!^SK_R(=Y_U_-_Z"M>OF@!:2@4M,!*.U+2'% "T4@I: "BBB@
MHHHH **** "BBBD 44E+0 444E "T451N=2BM[M;15:2X:)IO+4@80=R3TR>
M* +U%9)U>Y$6_P#LUL_9/M&W[1'PW_//KU_VNGO4UOJL4U]]AD1H;DPB=48@
M[D/4@CK@\&BX&A167K'B"PT/[']ND9/M=PMO'A<_,>Y]![^]7Y;JW@_UT\4?
M^^X'MWHN!+147VF#+CSX\H</\X^4^_I6=>Z];V&N6FFW"^6+F%Y1.[A47:0-
MISW.ZBX&M14+W5NDL<3SQ+))]Q"X!?Z#O31?6AD:,74!D4%F42#( ZDCVIW
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M>&;NRU:"X316ACCUZXG,@*#;:M&0._"Y/W?TKN1XFT,VTEP-5M!#&P1Y#(
M3T_/MZUFZSXPTZTM]/\ LTMM>K?W$,&P2=4D.-PXY^GI1H&IRWPZT,L/#^JV
MNGBRA@L)4N)@P_TLNV5Z'D#!.3TSBK6K^&-4OM:U?[)8E8;V.X20W+(R9:+:
MDD3#YE). 5.1QFNHT[5+;3K.YCO+.'2;>WN7@A56&R11R&4 #J,Y&.,&MR*5
M)HDEB=7C=0RLIR"#T(IH39Y2_AS7=1,376@,D9DTW<CSH21 6$A.#Z'\15_2
M?#-_I^N6ES'HWDJFM7,Q=&3Y+9T(4=>F3G:.E>E446"X4444Q!1110 4444
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M;ZG\0HY+2:1?L\(&IH(R%DVG=""QX)!)/&>*VHO%&DS7<=LET2\A*H3&P5G
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MR8O+V =/O?I45KX-U>&RMH62Q#16M_"2'.,SME,<=!WKLK#6;+4HI9+9W*Q
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MM5_$.O:AHGC RP037EG%I#W$UNLP15VR#+@'JV./>K3>-X_[;M-/6Q<K>$)
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MFOI;=I2U[.;B;S'S\Y ''H, 52G\(Z-/9ZG:FUVQZE-]HN&1RK&3C#*1RI!
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M1)/-,7E;(QG<>^*YB3QQ<3:;'?V$5M)#,"(5;<9'98]T@"CKAN"<C&#FH/\
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M7B'1+U#!':I>W-N$$A,F50@YYP>03C' Q3N%CN****8@HHHH **** "BBB@
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MF6,&G?V?%:0K9["A@"#85/4$56LO#FC:<D26>FV\"PEC&$3&W<,'\QQ6I13
MRX_#>C1"%4TRV"PQM#&/+&%1OO*/8^E,MO#&AV:6Z6VEVT2V\AEA")C8Q&,C
MWQQ6O12 S+;P_I%E);R6VG01/;!A"RK@H&.6 ^IYJ0Z-IIU!K\V41NF.3(5Y
M)QC/IG'&:O4M &*/"/AY8)H1HUGY<T?E2+Y0^9,YV_3//M3U\,Z(J1HNF0*L
M<+0)A<81OO+]#WK7I,4 49='TZ;2ETN6SB>Q50BP$?* .F/IBJ\7A;0X)-\6
MF6\;#?RJX^^,-^8ZUK4M %*#2-/MHK..&SA1+($6PV_ZH$8.WTXXJJWA?0VN
MKNZ.EVQFNQB=]GW\]<^_OUK7HI@9:^'-(0P$6$):"0RQL1E@Y&"<]3D<<U!%
MX/\ #T%E/91:1;+;3L'DC"\$@Y!'I@],5MTE("C::-IUA826-I9Q0VLI8O$@
MP&+?>)^M5K?PMH=HL:PZ;"J1H41,$JJD8( / XK8HI@<I9^"+&TU74,6]J='
MN[6*#[%L/!0DY)_'\,5K0^&M%@EBEATVWCDBE\]&5<$28V[OKCC-:M%*P7,)
MO#<:W=JELT,&EPR&=K-(1\\V<AMV> #S@"M+4--L]5M?LU_;I<0[@WEN,C(Y
M!JW13 RY?#FCS.[R6$+.\ZW#,0<F1>%?ZBF+X7T)(KV)=*M1'?$FY7RQB3//
M(^O-:]%(#(C\+:'$D"1Z9 JP(\<0 QM5_O#\>]-/A70FB\HZ7;[!;BVQC_ED
M#D)]*V:*+!<K_8;7SX)_L\?FP(8XG*_,BG&0#Z<#\JK6.A:5IEW<7=E806\]
MPQ:5XUP6)Y/ZUHT4P*<>EV42721VZ*MVQ:<?\]"1@D_44VVT;3;2VM;:"R@2
M&T.ZW0)Q$>1\OIU-7J* ,RX\/:1=6\-O/IUN\,+L\:;,!2V=V/KDY]:9:^&-
M$LEE2VTVWC6:$02*%X:,=%(].36M10!B0^$= MXW2#3(8PY4L4R&.W[O.<\9
M-:L-K!;VJVT,2) J[1&HX J:B@"M%IUE#L\JT@39%Y*[8P,1_P!WZ>U4X?#6
MC6]I<6L>G0B"X79(A&05_N\]!Z =*U:* ,>+PKH4!5H=,@1EF6X!48/F*,!_
MJ!QFEM/"^AV&H?;[72[>&ZW,PE1<$%OO8],]\5KT4 95QX:T>[GN9I[")Y+E
MHWF8YR[)]PGGMVIMIX7T.PU 7]IIEO#=@L1*BX(W?>_ ^E:]% &;=>'](O=+
M;3+C3K=[)GWF'9A=V=VX8Z'/.:N6MI;V-K':VL*0P1KM2-!@**FHH R[SPWH
MM_I::;=:9;264;;TA*85&SG(QT/)Z>M)'X:T:*\CNH].@2:,*%*C &T87CID
M#@&M6B@#$/@_PZ4M5.CVFVU=I(!L_P!66.3CV)YQTJ9/#6BIJIU--,MUO2_F
M><$^;=C&?KCO6K10 4444 %%%% !1110 4444 %%%% !1110 E%!HH \0_9L
M/_%.ZX.PNT_] KV\5X=^S8<Z!KR^EU&?_'37N(QVI +1244P%I*6B@ HHHH
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ML'5D'%O9?]\/_P#%4452 C/Q$UC:/]'LNO\ <;_XJFR?$;6 H'V>Q/?F-O\
MXJBBDP15E^)^MQC(MM/STYC?_P"*JF/BSKZ\"VT[_OT__P 5110AR0A^+OB%
M2<6VF_\ ?I__ (NJ<_QI\3Q@;8--YQG]PW_Q5%%)O4(I%%OCGXL4D"'3.#C_
M (]V_P#BJC;XY^+",^5IF?\ KW;_ .*HHJA-$3?'3Q?GA--'/_/N?_BJ;_PO
M;QCGIIO_ (#'_P"*HHH$R)OCMXR/'_$N_P# ;_Z]1/\ 'CQH!P^GC _Y]O\
MZ]%%(:1 ?CSXWZ^=8'ZVH_QII^/'C?/^NL?_  %%%%6(3_A?'C?/_'Q8X';[
M*M,?XZ^.&'%W:+_NVJT45+&AA^.7CL]-1@'TMD_PIK?&_P >-_S%(A]+9/\
M"BBF!$/C1X[&?^)SU.?]2G^%)_PNCQW_ -!G_P @I_A1156)$/QF\=G_ )C1
M_P"_*?X4T_&3QV3G^W7&/2)/\***5M1]!/\ A<7CS.?[>E_[]I_A3#\7O'98
M-_PD%QQVVKC^5%%#2$A&^+OCM@1_PD-P,^BJ/Z5$WQ6\<L23XDO!GT*_X444
M)(;8W_A:?CG_ *&6^_[Z'^%'_"TO' _YF6^_[Z'^%%%.R)N(?BAXW/7Q+?\
M_?8_PIA^)GC4]?$NH?\ ?RBBBR'=C?\ A9/C/&/^$DU#'_76D_X6-XR_Z&34
M/^_IHHHL@NQC?$'Q>QR?$>I9_P"NYII\?>+3U\1:E_X$-113LA7&GQWXK/7Q
M%J7/_3PU1_\ ":>*#_S,&I?^!+_XT44K(=V,/B[Q&>NO:E_X$O\ XT444[(5
#V?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gtbp_ex1017003.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JL# 2(  A$! Q$!_\0
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MHH 3:/0?E2T44 %&!Z444 %)@>GZ4M% "8'I1@>@_*EHH 3:/0?E1@>@I:*
M$VCT'Y48'I2T4 &!Z4444 )@>@HP/2EHH 3 SG HP/2EHH *3 ]*6B@ HHHH
M ,48HHH **** "DI:2@#S/X"?\DMMO\ KYF_]"KTVO,O@,?^+6VO_7S-_P"A
M5Z9F@!:*3.*"<4 +11FD!S0 M%%% !1110 4444 %%%)F@!:*3-&:+@+1110
M 44F:,T7 6BD)Q2YHN 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %)2TE 'F?P&_Y);:_P#7S-_Z%7IF><5YI\"ACX667O/,?_'J]*%(!:*2
MEH **.M+0 4E+24 %+110 444E "T444 %)WI:* "BBB@!**6B@!**** #/-
M%%% !10** %HI*6@!.]!I:* $[4M%)0 M%)10 M%%%, HI*6D 4444 )12TG
M>@!:*** "BBB@ HHHI@)112T@"BBBF 4444 %%%% !1112 ****8!1112 **
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+
M24 >:? @[OA99Y[7$P_\>KTNO,O@,,_"RU'_ $\S?^A5Z:.E(!,\TOTI",X]
MJ .M "TM)BEI@)12T4@"BBBF 4444@"BBD.>U !2TE+0@"BBBF E+24'IQ2
M*04O>C-(!!2]Z** "EI*6F E%%% "T4E% "T4E+0 444E "TG2EI* "BBEH
M**** $HI:2@!:*2EH 3%+110 4444 %%%%,!*6D[TM) %%%%, HHHH ****
M"D[TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !24M)0!YG\!\_\*MM/^OB;_T*O3*\R^ __)+;3_KYF_\ 0J]-
MI )SFG4T9I?PI@+1110 4444 %%%% !24M(12 *,4G.:7H*0"T444P"BBBF
M4F*6BD W^*EQ012 >M(!11113 *6DQDTM "&FC\:<11CBD 444"F M%%% "4
M&BEH 2EI.]% "T44E !2TE+0 E%%+0 44E+0 4444P"BBBD 4444 )2T44 %
M%%)3 ,T44M) %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHTT<!:/,HS&0>X;I]::_@Q?+@,.I313+I_\ 9L\HC4^=".F1T##G!'J:KR^
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MXL_MJ7;0F2.1=P&WJ,<9Y]<5=U;P_+=ZS9:Q8WGV:\MHGMSO3>DD3X)!'J"
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MRU;&UEQPX^[CCD5K+XJ:X$LEGI5S/;1,\;S%E4)(J;B&!Y _A)]:8W@73/\
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MXNRC);R-+Y!V1I-_JV8]@3Q[59\0>&VUN>":+4);-XX9;=]D8??'( &'/0\
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M"M+4R*KW @+RR10;_D@>0$.R>A^8X],FAO!E@Z6B-<W96UL)-/C_ '@_U;@
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MB@ HHHH *2EI* /-_@9_R2S3^/\ EK+_ .A&O1US7F_P./\ Q:S3Q_TUF_\
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M#'+<?:3;B,2@+-M#^6>&0#@@<\YKL?%%TS:;#IMMF2XU)O*5%<(YCQF0C/\
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M@+$':!_%@]37?/X?TEYH)38Q[H+=K2+&0%B88*8Z8(%5/^$.\/):RPFP40/
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M2/;P2,6DAC=B-I+*"<>E%@N>;IXLU.WE>VEU#SDE-C)+<>6H^R).#O./[H(
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MR^)-9,5Q<3:Q;HK:K)I\,*P*" I)^^3@-@=3Q^-8T'B#4[VY.O6NHV-O>+H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *0]:6DH \W^!>/\ A5EC_P!=I?\
MT*O2*\V^!6/^%66/_7:7_P!"KTD4@ ]J6D!I:8!1110 4444 %%%%( HHI*
M%HI*6@!*6DI: "BBB@ HHHH *3-%8GBK5)M*TB-K8A;BYN8K6)B,A6D8+N_
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M\'SD'! ]3FFOJVG1B0O?VRB/E\RK\O..>>.:+@7**KR7UI%Y?F7,*>:,Q[I
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MDEOIUXS:=_9=S>,7D47'G,7VXW%NG;MZ5T%5K[4+73+?S[R98HRP1<\EF/0
M#DD^@IV2"YYW#X9UU]#@MI='M8[[3GA5KA9P?[1CCDW$>P(Y^;^*KUUX4U*6
MQO=0L8HX-1&I+J&GV\N,0G:%921P-PW$X]:[2RU.UOWFCMY"9(2!+&RE63(R
M,@^M6Z+(+L\\O?"5S'K<4;:6=2TZ6&%59+D0B"1'+,S#J02=V1SD8JJOA6_M
M+,O#H4)NIM7GEDEC\OS4A<L492?E[CKG&3Q7IM%%D%SQ.:TN;>*UTC4+"1BF
MDQ07J>=$[Q!92P9 S#D@'D9[5U^DZ)<2>*S>7>F7$B)<O=VE[]JVQK&ZX"F/
MKN ^7;C'>NTGT^SN9XYY[2"66/[CO&"5^A-6:+!<****8@HHHH **** "BBB
M@ I*6DH \U^!6?\ A5MCC_GO-_Z%7I6*\U^!6?\ A5MC_P!=YO\ T*O2 3G&
M,4@'4'IQ113 6BBB@ HHI* %HHHI %07D4D]E/#$RK))&RJS#(!(QFIZBN)X
M[6WDGF;9%&I9F/8"@#C+7P1>V5M;)%J,)F&E_P!EW):$[7C!.UU&>&&3QT.:
MV/#WAUM!NK[9,CVDRPK"FT[D$<83D]\XS4.C>+H-1M([ZZ:TM;*Y4/:2FY!+
MCN&!Q@CC/;FMM=2L'O39+>6[78SF 2 N,#/W>O0TE8;N8%QX<U'_ (2G4-9@
MEL)%NK:.W6&YB9MFPDY.#SDG]*ANO"NK7&JV.L#5(/[3L=L<4AA(5XB/WJ,
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MUO!J%]<.AD0@)(I$?'N2..U<[/!-:K'I.IVC-Y.EVT5ZBW,>^,I(741[CSD
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M;J6&;[,UVC*'CW;OF'0$#IGG KK:88(FG6=D!E12JL1R >N*+!<X;Q3+J?\
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M2.1Y%.U2O& ,=>N<5Z1,76&1DV[PI*[NF<<9K!N/!'A^Z=6DLB,(D;*DKJ)
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M3U@DA74=0V/:&S.74XBW[Q_#U![]33LPNATOB&?2-2UFXN%N+JTBDM%VA@!
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M-L" JNW/?!ZFDF\'QS:C:ZC_ &E<_;+=\+,0"6@VX,+>J'J>^>:-0T&0^/\
M0YY'5))B-F^)A&2)ANV84^I8\ X/>K2>++%ID@DM[V&9A-A)82IS$ 7'OP1@
M]#6:OP_@&D3:2VKZ@UB"#:1@J#:D-N4JP&6P0,;LX%6;GPA-=K9R2ZY>M>V_
MFAKDHF761=K*%QA> ,8[T68:%6Z\;P3VNH-:I=6T,%C%>+?-;^8H63./DSDX
M _G6JGBG3_/NK9C.9[1H4D7RB"YE'R%?4'GZ8-92^ 5BT^6SBU>X6.;3DL)"
MT2,6"9VO]<$C%:[>&+)]=LM7=I#<VMO]GP#A)!V+#N1SCTR:-0T&Z;XNT?5M
M5.FVD[/<>6TJ?(=KH&VD@].M-D\5VD&JZC8SP7$?V+RAYFS(E>3[JH.I-)X?
M\,R: QC75)[BS3<+>WDC0>6I.<%@,MCH,U7U3P:FI:G=WPU"6%IV@E0*@/ES
M0_<<'N,$@CO1J&ALZ7K%IJ\4S6Q</!(8IHI%VO$X[,.W!!_&L.V\9V$-JC7-
MQ/<R2RW B\FR=3B(G<NWGE1^?6M?2-'73)+VX>02W=]*)KB0+M!(4* !V  K
M(MO!IMY[>0:D["&6ZEP81\QGZYY_A[4:AH07OC W&K6UGITJPVLNG_VC]NEB
M+1; 1P>1@8SSV.*T)/&VB6]M--<330^2L;LDD+!MLAPC 8R03QFLZ+X?Q&WB
MMKN^,]NFE-I;*(]I9"<[\YX/ IUYX&DU&V(N]4+W0A@MTF$( $<<@?&,]6(&
M3^5&H:%L^/=!5F5Y;F,H\:2;[60>67^YNXXST%:^EZO::Q:27%H9"L<C12(\
M95T=>JE3SFL74?"4U_>:C<+J/EB\GM9MGDYV>2<XSGG=C\*U-%T=M)?4F:<3
M?;;Q[K[FW9N &WKSC'6GJ&AS[>/H3<:7<B":+3KH7(D$D#&7,7=0.HZ]NU;,
MGC#0HWM5;4(]MSY?EN,[?WGW 3VW=LUD6_@F[MVM1_:B/%:?:UA!@Y"SYX)S
MS@_G4>D>!;K2+FV:+5(6A\B&.Z1[16+M&,*R,3\F1C(Y]J6H:&YK>M36.H:;
MI=E$DE]J#N(S(?DC1!EG..3V&/4T+JEWITDZZPL(CW(MM+;@DSLP.5"<G<,4
MNNZ$=4N=/OK:Y^S:AI\C202E=RD,,,C#NI'\A56_\/ZCJ1LKN?48EO[*Y%Q;
MA(B(A\I4J1G)R"><\4V Z?QSX>MX8I7OB5EC>5 D3L<(</D <%3U':G?\)MX
M>^RW-R=118+98WDD9& VN<(PXY!/&169_P (3.EU]IAOHA(\5V)LQ<-)/C+#
MG@# X[UD>(/"FI6/AZ4P2K=NFGVMA'%' 2Q,<H._&>F,\>U+4-#JQXST)K9I
MEO"P61HV01-O4J-S97&0 .<^E.?QCH$=VMLVI1^:WE' !( D^X2<8 /8UAZC
MX*U#4YYKM]1MEFO&/VJ+R"8F7R]B8&025Z\\'/M4,?@/4A87-L^I6C&6VL[=
M6$!  @;.<9[_ *4:AH=9!X@TRY;;#<AF%TUF5VG(F R5Z>GX53UOQ/!I=S-I
M\:,^H"QEO(U9#Y95.Q8=.:IZ+IJW'B[4];6VN[6)@(A#.NU9)A\K2J/=0JY[
MXJ;Q!X<O-4U,7EI=0Q;K">RD65">),888[@BGJ&A)I_C+2+S2Q=/=(DJ)$9H
M@K$JT@!4 8RV3P,>E6(/%&EW>J6=A;3--)=P/<1.B$IM4X.3V.>,5STO@S5Q
M+!);ZG:IY=I:6[*8C^\\DG<">H!SVY%3^'O"&HZ'?6$S7UK+%;I<1NBPE<K)
M()!CG@@\4M0T.SHHHJA!1110 4444 %%%% !24M)0!YM\"?^2667_7>;_P!"
MKTFO-?@5G_A5EC_UWF_]"KTJD M%%%, HHHH **** "DI:* "JNI7JZ;IEU?
M-&\JV\32LB8W,%&<#-6JJ:E8IJ>F75C)(\:7$31,R?> (P<9[T@.<7Q[9A)%
MGLKFWG'D^5%+M_>B52R'() ^Z<YZ8J+_ (6'9BW>:33;Z+;92W@650A<1MM=
M1D\D=?<&K%UX%M;IWE.H7L=P$@$,T;*&A:$$*R\=<$Y!R#FKDWA.QNQIIOIK
MB[FL)3,LLKY:1B,$-V*GCY>G I68]"?3O$-IJ,-Q<1ADM;>%)7G8C;ADWXX[
M@8S]:Q1\1+'RGD_LZ_9?W1B,:!A(LC;5.<X!R1E>N"*V]'\-Z=HFB2:3;1LU
MI(TA=9#DMO))!/ISCZ5D1^!A'IJV']NZG);Q2QO LK*WDI&P94''(X R><#%
M%F&@^S\<6UU>);OIM] S74EDS2*NU9T!;9D'G('4<5F7/CV+4M#O#:VVHZ=-
M)I\MW93S1J/,"?>V\GD''7J#FM/_ (0R.&1[A+ZY=AJ,FI"/:O,C(5*=/N\U
MF:'X&FF\*VUKJ]U<QWB64EF@^0FW5S\V".&)  R>U*S#0UG\96=LX26*>2"%
MXH+N[4#9!*X& W.?XAD@<9% \;68MIY#97@EMIIH9H-J[T\I=S-C/0C&#WR*
M1O!%H\\^;N?[+=2137=M@;9I(\8;.,C.U<@=<5':^'I-2O=;U&^L_P"SI]0@
M^Q@+()&V $>9Z D$?@!FG9AH0CXBV&QI)-,U.*-8X9V9XE&(93A9#STSQCK[
M5:E\=Z5'J<UDL=S*8C*A>)-P+QKN9>N1QGD\9&*@N? 4-S;S0'4[A4ELK>S.
M$7(6%MRD<=2>M6$\'&"XU VVLWL-K>%Y#:J%*)*ZX9AQG!SG;G&:-0T*ES\0
MK8:9+=6FG7DDJQV\R12J$+Q2OM5QSTSGCK70:CK<&EG3_M44P%[.MLA500CL
M/E#<\9/&?6N>E^'T<T!C?5KG_CRM[16$:@KY+[U?ZYZCI70:QHD.NZ%+I=Y+
M)ME509D^5PP((8>AR,T:AH8-_P"-].F\-W5[;2WD&Q9P\L4*R/!Y3!7)4G'4
M\54UGQE=Q1:C':Q30'3;JR1IBJN;A92-P"]B0?K6E/X!TTV.LVMI));#5(EB
M<J PB &"5![GJ?4\TV[\$"XN;R5-3EB%W):S2*(E/[R#&"/8A1D4K,>AL:7K
MUKJNGW%W%%<1?9I'BFAECQ(C)U&!G]/6LVV\<:9<B9!#=I<QR11BV>,>8YD!
M*8&?0$G/3'-6[7P\UM9:Q;?;YB=2FEF\Q $:$N,?*1Z8XK A^'+0R1W UR87
M4/D-!(MNBA'B#*&QWW*Q!!ZYS3=Q:#-%\>+!H;SZTTLEU]JNE6-$4.(HG(R1
MG' P..IK;/C/2]\!C6XFMY9X[<3QQY19) "JGG.>1GCC/-9EOX >S>&YM=<N
M([^.:=VN/(0ATE;>R%3QPW(/454UCPE>V%Q!-IMS=W-M-JUO>3VFQ3AE(WR%
MNN#@$CUI:AH;R>--):.&3%R%F6X*YA).8#B08'.?3UJNWCFT=[1+:RNI))KY
M+*1"H!A9DW@GG'W:IS_#UI641Z[=PQ1FZ\E8XU#()^6&[J<'I[<4Z#P%+ S2
M#6&\PW<-T +5%16C0QD!1V*G\*>H:&QIOBW2=6U/[!:3,\IC:6-MORR*IVDJ
M?8^N*;<>*;);^73(VECO#YJ0L\7R-(B;B!ZX'/I[U%X<\+R^'CY*ZI+<6,6Y
M;6W:)5,:DYPSCE\=LU0E\#7#Z\VJ+K+%A<2S(LENKD"2,H4+9SM / XQ1J&A
M#H7CU)++3DU:-TEDTE=0N+L)B)1G;CVY_P *T#X^T/R0^^Z+F<V_DI;LS^9M
MW[<#/5>16;_PKA&T^VLY-5D,<>EC3I2L(!<*^]''/!#=N0:T(O"VH&72Y[S5
MXII;&Z-PWEV:QK(-A3;@'CJ3GGFC4-">V\;Z+=7'E)+.OS2IOD@95WQC+KDC
M[P'./:H)?'FF+#%)#!=S,]U#;-$(2'4RC*,1Z$#-5CX'N1&J1ZL8B+VYN_,2
M'YE,RLN!SQMW$YJC;_#R]@,DG]LP^:9;2==MKA1)!D9/S9.X$Y]Z6H:&_9>)
M[(3&&XOA,\VI264.RW9 C@9\ML]P,\]#3Y_&FA6J(\UX45VVDE#\HW[-Q] 6
MX!JA)X*,^C:Q8R7Y6:^OVOX+B-,-;2$J01SV(_6EN/!LJ:K;W6FW=O%"+9+:
MXBN+82Y5"2&0G[K<GKD<T]0T-?4]46RU/3+=KR*$7+29C>)F:4*A.%(X!'7G
MJ*IVWCCP]=P23P:@#$D(GW&-E#H6VY7(Y^;CCN:FUG1+C4M4T>\AN$C&GR2.
M5=2?,W1E.W3&<U@6O@2]M;"PM7NK&Y2VTY[%TG@)67<X;)&>F!C]:-0T.@_X
M2S1P9E>Y='AADGD1X75E2,X<X([&HF\;>'TF>(ZAET + 1.<;@"O;N",>M8+
M^ M16U5+;5DWFTNK(BX5I!'#*055"3D[<8&[M4\'@[6(+#58$U.W26[CM4C=
M(VX\I0I#<]& [<C-+4-#8D\::#%;PS27I3SGDC1#$^\O']]=H&<CTJ9O%6B*
MUJ/[0C(NE1XF4$KASA"2!A<G@9QFN>TWP1J6G7UM,M[9F.&ZNKD(L3+CSDV[
M1R>A[]Z9X?\ !&K>'O)2'4[1X9K>*&]$D)8AHR=K1<\9!P0>G6GJ&AU-MK^E
M7NIM86][')=JI;RQU8 X8K_> /!Q2-X@TJ/438/>HMP-W#9"Y5=S#=TR!R1G
M@5D^%_"MSX?E$<DEC-;0!UMYEM\7#*QR [>WMU[U _@Z^E.L:>VH0_V/J4DL
MQ_=DW$;2+A@&SC;GG/7M0&AK'Q;H:VTUP]^J1Q;"Y=&! <X1L8SM)Z'I5BZ\
M0:59&87-ZB-"P212"2#MW8QWXY..@K%@\'S70F.L302,VF#3%%N" 4!SO.?X
MLX(':JMSX'O6T[22+NUO=1LVD-PU]&3'=>8 &)"\@\#'Y=Z-0T-IO&?AQ)O)
M.L6ID,8EP&S\A&X'CL1T]:M+XCT@VJW(OH_+:0Q#@[MX&2NW&<@<]*YT^#]3
MB3619W%A;M>6EO! 8XBHB:/.?E[*<D#'(ZUSNJZ-J?AV6UFE>U3S-1EN4N8Q
M,RQ!X0A1V 8Y;L<'..U+4+(] ;Q5H:P6T[:G;^3<@&*3=\K G .>P)XR>]5M
M>\3)H&L:5!=&)+*\$QEF<G,910PP!US7+Z9X/O+HV=['9:;':O:1VLEI>H\G
MEB-CMDCS@G<#G# <X-=5K&BWE]KNCW]NT'EV*SAUD)!8R)M&,#M3U#0N'Q#I
M GMX?[0@WW 1HL-D,'^[ST&>WK4UIJ^GW]S);6MW'+-$-SJIZ#.,^XR"*\^_
MX0#Q";"PM&NM-9;,6K1_-( K1/N;@#YL]B>E=/X:\/W^D:G=3RR0Q6DR?\><
M+L\:REB2Z;AE 1U7D9YH5PT%T#QE9ZI=W>GW<]K;ZC!=3PK;B7)=(S][GVYQ
M6FGB+1Y89I8]1MV2 @2$-]W/3CW[>M<K+X%N[M+JRGDMX[=M1GOX[J,9DS(K
M +C'&-W)SSBJY\$ZP=,MG^SZ,FHV,D13RC($NU0$8=NJ\'( S@T:AH=?+XHT
M&%8VDU>S42J'3,H^92<9^F>*OW=[;6-L;BZF2*(8&YCP2>@'K7#77@S49HKA
M8;/3+;S=(ELTCA8[8Y)'W9&1G'J>I/:MS4M%U"XM=!FMVB^U:9*DCP2-\DHV
M%&&<=><@XHU#0+[QC86.J:?'+<VBZ;>6\LJWC3  ,A''IW_2KH\4:/\ VC=V
M)OHEEM84GE9CA0C_ '3NZ'/]:YB'P7?6,]O=1QVETQ>\>6WE8A(_M!!PO'08
MYZ9R:B'@K5]-@FM[!K2YB>QM( 9W(.Z%B2!P0,@\'M@4:AH=<VN6[W-G]FNK
M*2VF$K.[3@, @R=H[X/7TJ6WU[2;M)GM]2M95A0/(4E!"J>A/M7%:=X/UNSN
MX'>&T9([F^F)$Y8E9TPHRPR2#UJFWP_UIM+M;>);.&6VTN&W(#G9-+'*)-K8
M .TXQGK1J/0[N_\ $>GVFB3:E'>6SQJCF/=* '903MS^%6='U#^U=&LM0";/
MM,"2[,YV[AG&:XE_"NLQD7EIIFG1/<6]Q!<60N&(1Y /WN\CYFXP>!Q74^&K
M74M.TJQTZ]A@"6UG%'YD<A;=(!AAC'3@8--7$[&W1113$%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4E+24 >;? G_ ))98_\ 7>;_ -"KTFO-
MO@3_ ,DLLO\ KO-_Z%7I&X9 I .HHHI@%%%% !1110 444F>: %HHHH ****
M "BBBD 4444P"BBDI +249I%='W;'5MIVG!S@^E #J*:74.$+ ,1D#/)IU,
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MQD=,5G>,;I%\9^*I;C7KO3GT[2H)[ 1W90>:0QX3.'R0!C!ZUZW]AM X86L
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M5)M3@L(([V8YDF5<%B>I],GUHL%SBO&.LSZB)8H1"EOIFM64+[L^8SET)([
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M.T3 8R![]QWHL%T9P\>QQ6EQ-=V)ADLI+A;R(2AFB6+HW3G=E<?[U.76M2U
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M$4U_;^'[Z;2XS)>I$3$JC))[X'<XS@5J57OKM+"QGNY$=HX$,C!!EL 9.*3
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M=VD#PZ7936XC"1,GS*4#;A@YYP<D5K6>CZ=8?:OLMI%$+IM\X4<.<8)(Z4)
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MCFK$-YYUW/#]GE6.)599V \N0,,_*>^.].R$>66&I7.DZ-%:C4=1,+:/9RD
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M^"9M)']GS:RES]D<KB"'RBCDC./F;!VCTJ.'P9,E] YT*-47799G.5(^R%"
M,9^[G'RUZ/'?6DR(\5U"Z.2%99 0V.N/I40U73VA$POK;RR2H<RKC(ZCK1H%
MV<K;Z!?3?"V^T.6S"73PW$4,$K C!9B@STQ@C'I6#=>'M0G^UW7_  C\_P!H
M2SL%M!N7,;QM\^TYP"!^=>BC6],;4;?3UO86NKB(S11JP.]!_$/:K3W,$<R0
MO/&DK_<1F +?04] NSB/#6AW\'B9KK4[&\^UPO/_ *<;E?)F1VR,(.2<8&#T
MQQ4<^A7LWC*[GO=/OIP;@3VEW;W(2-8]FW8W\0(YXZ'(KI;3Q$NH:S<65C;K
M/!;3&"XG69<QN%#?=ZD<XSZUJ"\M6,@%S"3$<28D'R'W]*6@79Y?'X=U---E
MMH[.\CC$J/;W#6ZLY(1ALN(\XD49QO&"<@]JL66A:H^M1_VII.H"0".:WDMK
MA?(A01[6B8_>X.?E[YKTE;RU<*5N86#-L!$@Y8=OK[5(LB,"5=6 )!(/0T60
M79Y"OA._'AX6@T>Y:6?1'CN%DY#SK(&4-D_>P#C\JU+^PU'[3JC0Z+?-9SG3
MV6,#[JJ"'PH;YBO&5Z&NLB\4+<ZE?V5K9M<?8Y84:1)DPRR#.X<_P]QUK:%S
M SN@GC+(<, XROUHT"[//_"MAJL&JZ(;VPOD%LM]&SS*,(K2 QC@G@@<5/XG
MTBXO_$6KR6=A,;A]">&*Y52H,VXD*&]<5W0GB8#;*AW9QAASCK40U"T-XEFM
MS$;EXS(L0<%BHXSCTHT"YYK+!J5_=@OIFL10S7.G%CM9,A0PF)P<@=,YZTRV
MM-0M=EI?:7K%SI*S7D$*0;O,A8R Q.,G.W;D*W:O4UD$BAHV#*>X.11YL91F
M$B[5X8[AQ]:+(=SSF33KJSU'5733KZ.675;.X#QHQ#Q[4#98'YL8;=35M-::
M1?.CO5U*.>[%_*H;9- 5?R]O8CE-H'((->C3W=O:6[3W$R1PKC+LV!STJ3>I
M8*&&2,XSSCUHL*YY1::=?VU@+=AK%M'<:+;&XD\N28BY$G)8$\\8W <[:Z-1
MKC?#6Z2UM'AU-=P1(G;,BA^6CW_,NY<X!Y&0*[7<!G)''7FJ6H:M#IKV2RI(
M_P!KN%MT* $*Q!()]N*=D%SSC6+&:\M=1$=E?2Z.U]8O9V[1R;T<,#,0#\P7
M'7MG.*ZKQ;8K+=^&[K[)/<1V>H*S&%68QJ48 D#G&<9-=46 QDCG@<]:S;W7
M+.RGM8F+RM<70M,Q881R$9 ?TXHL%SS:UM=9L]-B;28-234)X-0#HP<+GS=T
M?#?*K$$[3QUKM/!BAK6ZE3^U5AF=6$>H1&/RVVX8(IY'OVSTKIRP''K5:_L(
M=2LGM;GS/*?!)1RC#!R,$<CFBP-W/,H)]1FTVU^W2:E+926-PEI- SLXNQ*V
MW<5YSM VYXX-)+I^LG4[F69M0CU][>P:W>#>L4D@ $I;'RD#G.>W2NSL?$VG
MQK<6UIIM^(+&<VLK+!E4<$9[Y(Y!S[UTM%D.YRWB^VU1)M.U/24GN)(9#!-:
M1R%5ECD&W<?="0V?0&N8'_"0V'AXG49;X75A>V]C')$SDW*+*"TI ZAE..?0
MUZA5"RU>VOM3U&PB$@FL&19MRX'S+N&#W&*+"N><&Q6'4+BQ>&_B:7Q0)2RB
M3_5%"0P;H![BMVUN=;_X5;<26?VJ;5(A*D?F*1,RK(1QNY+;.A[\5W-%.P7/
M+[J74)))ET^\U1-%FNK%89 9/,5F)$ZY/.W;@G/ .:ZKQ-;7UCX?M;C3);V>
M;3)8Y3"LA+W4:\,C?WB1^H%=/5:"\6>YN8!#.A@8*7DC*J^1G*G^(46"YYO)
M)XEMM#UZ*]GOHI-.MY9[>>-V)D:4;HT!ZL4Y7ZXJAJZGS_$;3->K+>?V7)&V
M'8%<IN*]L@Y^E>OUEVVOVEU,8H8[EBMV]HY\DX211DY/8>AI6"YPT&HWL6JR
MV%[>WW]B1:G<0R7!9]Z?NU:(%^NS)?GU %4+O6O$%II<AO[G4(KRXT*1K<QQ
ML2TR2G8V .'*;217KE4UU2U;69-*!?[6D N""AQL)VY!Z'D46"YS/@[_ )#O
MB$RR7!N)98)=LN[&PPIR,\=<]/2N7_M+4;;2HKZ?5]2^QS:G/;7DL@9Q;QAG
M\HX #*#\OS#V[5Z=::I;7M]?6<+.9K)U28,A !9=PQZ\4NIZC;:1IL^H7A9;
M>%=TC*I8@>N!18+GF-UKVH:?>Z=%_:VH7,L#6@>2>%HA/$SD,X0#!!&,ENG&
M*2/Q%JD1FB^V7=W:O/$9]1MW)6.W:4AB4(S%(. 0,C S7J%]J%M861N[AL1<
M 8&2Q8@* .Y)(&*+"Z@OK1;F!&5)"<J\91L@X((/>BP[GG)OM3GUG3[!M9O8
M],EO;R.&X1L/- L(926(YVON ;OBLO\ X2_419Z5<-JUQ]HCCLVG#J0LB-*5
M=@ /FROWB>%KV/8O'RCCIQ2;$QC8OITHL%SRG27N[&\D-MJ%R5>_U 7UBZ_N
MXX/G828QE3G;@]]U&F:[=L^AV(U@Z= UA:/9_N&<7)Z2KZ%LC;@XQUKU;8N6
M;:N6^\<=:-B?+A%^7D<=*+"N/HHHJA!1110 45GVVMZ?>:E+803[[B($L IV
M\'!PV,$@G!&:T* "BBB@ HHHH **** "BBB@ I*6FGK0!YQ\"_\ DE=A_P!=
MI?\ T(UZ37FWP,_Y)9I__7:7_P!"->DT@"BBBF 4444 %%%% !1110 G6L?Q
M/97U_P"'[FVTY+=[EMI5;@?*0&!/K@X'!QP<5LUG:[J\&@Z-<ZG<QRR0VZ[F
M6)"S'G'2DP."LO"?B33]2;45L[*X5KBXWV=Q=%@\<P7YBQ7[P*X/'()J^GA;
M6DN-0L3!IQL[Q_/CO03OM&,>PJB8[?PG/ -:5IXT@'B.]TV_80Q[[=;0B)P3
MYJ9PYQA3G@9Q5J+Q7806K27E]',6N)D06\#DA8SALK@GY>,GI4Z%:G*7?@S6
M[[2=DMI9QW,&EKIRHL@VW)#JV\\<* N0#SEC5V?POJC:O>7<6G6JK)JEI=H5
MD53Y<2@,.!P<BMSQ7XD_X1^SL;C*16MS,(Y;V5"T=NI!(9@.Q.!GH,\TY?%-
MMIVE1W6N75K$SEV5[8ET>(?\M!C/RXP2>U&@:G-V?A#4;>&R5M*M-T3W[/B1
M?^6V=AZ<GGGTJO9^"M;BTBYT^XA@E%_I]M;F0S<VDD7!P>I7^(8[UV<OBW18
MI3$+LRML+KY4;.&PN_:"!@MMYQG-5M/\5VNHS6<Z7,4%K<6+79AGC990H(&[
M)X"CO1H&ISI\+^(H+BVMX[:SN5MM2DO%OI9<,ZNC !EQG() //(%48O!WB(P
M7#2:?;B0PVA6/[2"I>&4LRJ,852#Q^M=PWC#04MI+B2_$:12)$X>-E96?[F5
MQGGL>AJY9:M:ZMI;WNF3K*@W*"RD8=>"&!P1@T:"NSCO^$<UE-;O-46QB,8U
M5;P6OFK^_3R/+/L&!Y&>M5H_!&H"X$LEC;RQM9WRB)W4B%IG#)&,]ACKT&:U
M+;QI=W'AW0[X#3S>:C=QP20+(3Y:NQ&1SDD8K636-3U2"YET2WM'CCN#!'+<
M.P4[<AV('.,C Q]:>@]2QX=74+?3;>ROK00BVMH4$GG!][!<,,#I@CKWKE_^
M$:U.2[NOM.F0RQ2^(4U!-TBD>2% R1ZC'2MC3?%CSZ?I=Y?6J6\=Y*UL[*^5
M28%@,'NC;3@_2KD'BBR.F+J=U(L%I,["VZLTB+G+8';@GV%&@M3-T[P]?1>!
M]7TB2&*&>Y>[\E-P*!9&8ITX'4<=JYR\\)ZO=PWKMHL0F?2K2V@!E0[)(WRV
M#VXYS7>6NN13ZLMEE&2XMQ<VDR-E94X#?B,C\#5N^U&TTV)9+N81J[;%X)+'
MK@ <GH:- NSC=!\-WMKXF:>_TL2-%<S7$.I&[/*R?P^7_>['MQFG:EX:O;GQ
MG-=3Z:M_8SR030S&[,?V5HQC#+U8=QCUYKIAXDT<J[_;XMJ&,,>>/,^YG_>[
M57U/Q/96L&H1VMQ#+J%K;R3+ Y(#%!DC/?'?'2C0-3G)O!.H^3K]E;2P)92B
M233%Y!CDEYD!QR!D8&.S&JT7A&XN9M)N)/#Z6ACU%)[N.6[$Q(6-DW>F.0 !
MR0.:[30]>LM=M=]K<1R31HAGC3/[MF4''/;T-9>H^,(;?Q)8:7:R6\J3"X\^
M1BP\HQINZ]",\'TI:#U,;PWX>U33=9TFYGTU$AAAN[=L.N80TV]#[C;QQTI^
MO>'=5O=1UF*.#S1J#VSVEX' -IY9&X'/(Z$C'7-=):>)+!K2Q-U?6GVBZB1Q
MY!+(=W0@]@3TSUI(O&/AV?SO)U>UD\E#(^ULX4'!/X'KZ4:!J5O"^G3V5]K\
ML]@+;[3?M-"_R_O$*J >.G(/!]:X&X\*>()UOPVAE4GT^:V,4<R;/,,P=2O.
M2".=S<Y]*])U'Q5H^F'$]T&<310,D8+%6D^YG'0'KFK<6L:;-J+:?'>PM=J"
M3$&YXZX]<=\=*>@M3SW4]$6QMM?D>&+3O])M[O2#*RA3.B#A5!SDD8([YKI[
MW1M1'@.ZL;+;_:D\9EDPVT/*S!G&>V>15_5]3TM3)"_V.XU"V1IX8)<$AU4M
MP<'!Q^.*9I7BO2]1T:/4&O;>,K'&TZ>8#Y3. 0I_IZTM!ZG$2Z#JDUUJ-W;>
M'Y;**XO].N8X04! C_UG ../UJOK^C75K9:W/-82M8R#=_I&T2H[3J=B2*?G
M5NHSRO3-=[=>) M]:16*0W5O=6L\Z3"3C='CCIT.<>U5-5UN*;X?)K=WIT-S
M&\,4[VLK?*,D=R.V<_A1H%V8,6@7-CJRZG8://'IRZG'-'9+@.BF%DD<*3P"
MQ&1GMFLNT\,:Y!8QK%I4L.H2:9<6R3[E!C?SRX4L#P&0X!KTN'6])EL#>1:A
M;/;*VPR+("JL.WUJQ+?6L-JMS-=01V[8VRLX"G/3GIS19"NSF_"MB;71]0F@
MTO4+1K@;_LU[*JL7"8(4+P@)QSWZUQUCI&JK;7<<FFZI9)-!:E?+MU=(Y49M
MP9-V9%Y&2>6'->IQZI82O$D=[ [S+OC D!WCU'K35U?3F@DF6_MS'$VUW$HP
MI]#19!=G(ZCI-]>?"Z*SFTD"ZB,<C647S9"RAB%!/< G!/&<5533=5GU3<ME
M<0Z@-42YM[QAA5L\#,9],+E2GKS7577B."VUNPLB(S;7=M+<"[\T;5"8_3GK
MFM$:A:!=QNH,>7YN?,'*'^+Z>]/0+LYWQ=H=Y?7MC>:=$'E=7L;H,Q $$HP7
M]RA (KG5\/ZI]@TN'5[.6XEM]1@M2T63NM8@P$C8/&[()KN=6U^STO1)M3\Z
M"5%B:2)?.51*5&<!NE0W_B-+#0[#5&MRT=U) K*7"^4)"/F)]LT:!=GGG]D:
MFT=O:WUAK;:9NN8;9+0#S8&\TM&26Y4%,!6[8YJX^A2)?RV4FCWI2;7XKF64
M+E7A\OEBP/KG->DQ:A93B,Q7<$GG*6CV2 [P.I'KBE-]:+:?:S=0BVZB4N-G
MY]*+(+L\F&G:M]GM+6^LM=%@/M$$ M%#202><2A^;E04*X?M@@UV/A+2?*UK
M6KZX@O4G%VR1/<.V&C*IG S@C<#SCK72OJEA&B/)?6R*X#*6E4!@> 1STHO[
MN2TAB>*%9B\JH5:54P">3D]<>G4T:!=GG^FJ]IK&LW$\&O+(^LM<006\3>7<
M+A0">,;2<]2.F:IV6C3OJ=L]U:ZMY<VK7R3Y:3;]G924!Y^X6QBO4([RUEF,
M,=S"\N,[%D!; Z\5GVWB"WN==O--385MH$F:X$JE3DD$>Q&.]%D%V>70VT\[
M:?8ZNFK&\.@R+%$C2!UF68A&(!X(&,$UK?8]<M[N_DO+:YEC-U8'4&C4_P"D
M1+"5D*X^\ ^,@=@:[YET5=0366EM5NC"8EN&F S'G)'7&,U>-U LB1--&))!
ME$+C+#V'>BR"[/.)K75M.TA-9M'G_P!"U-S86L\C*9;63";&!]"=RYY  I;C
M3=3@\4PZ=-+JX2+R);&>UCW1OM_UBNY^YEB<@]1C%=W+:Z3J.HV]U(MO/=V@
M+PMO#&,'@D#/ZU7LO$=I>ZOJ=BNU5L%C9Y_,4HX<$\$=,8/6BR"[.7\%1ZA)
MK;S:B=7COXTEBO(Y80MNS;\JP;^/_9([=:KZO'J,FI^((UGNX(_M]NT!EAD>
M!QY7S*VWD(2.J]#BO1#=6X"DSQ#< 5^<<@]*C@U&SN;RYM(+B.2XMMHFC4Y*
M9&1G\*+(+LY/49M0B\ Z7+]BO8U5X/M\"NTDZP9^?!'S,<8]\9K"T=+FVU"U
M%K!JEO:R:Y=R!3&XS"T)VL<]1NQC/>O2;B^AAMYY%997BC:3RT<;B *CT_5+
M;4=-@O4=466-)"K.,IN&0#[\T: >:6US?0VGV>2._N8I;F(&]19@K\/_ *Z+
M[P;. 0IP3MY%4K>'4+^VLKB_DUB#43HKPV\J*\;M<K,VU6]_N\-QC->PO<1)
MG=+&N" <L!@GI445V7N;J-X6BC@VXF9AMDR,G'/&/>BR'<\RN[G4K>_U>69+
MOR?M=DNHM! S$J+?#%0,%E\S .VJNLO<C0;NPO)M<NHFT[.F2M X:9MYW!PO
M\6-H ;^&O6#<G[7'"L3-&\9?S@PVC&..N><_I4HGB*;Q*A7IN##%%@N<CXY2
M"Y\.Z7YR3$&_M7 C#9 #@DG'(P,]>E8RW6J/JX#3WL6I1ZI)'=19;ROL&UL,
M.V NT@CG=FO2058;@001D$4WS8O+\SS$V?WMPQ^=%A7.,\'1W ^'SWTU_J$]
MY<6SM(]U(VY&4,!@'[O:N-MK[69/#"W^EZOJMZ#I,=Q>.[,S).)$(V<=2N_(
M'4 5[%<I#/;R6\S8252C -@D'BH]/L[73-/AL;,!+>W411KNSM [9-%@N>:3
M:E<ZKKOV6'4]5MK&YUH*KQ;TW0M;9X)'"[^GH:CM+K6%O[AM-U;4+S5+;5KB
MV6RGD+1M;JAP6&,<'!W>O%>K[T"ABR[2< YX-9^EVVG6#7D%E*"_G--< R;F
M5WY.?3-%D%SSJ/4]4ET[S+/5KF".;34:^ENU=OL]WYBC:<<KN^92!T !J,ZO
MK,\]I:S7]]I4$D;?9)B'N3).)2&56&-RXP%#=5->M?+[8/ZU''<02RR0QRH\
MD) =5()0D<9]*+!<X[P[?W4OC&\AEN9[F)EE975V"1X91LDC/W&'(!!P1FJ<
MFI:P^MG9/<)J*:R+=K,L?*:R(^_CIC;\V[^]Q7?1302JSQ2(X#%692#R."/K
M4FT;LX&<8S3L%SD_A[!%#H-SY4LTBF_N2#*Y8X\QL$9[$<^]=;2  =!BEII"
M"BBB@ HHHH **** "BBB@ I*6DH \V^!G_)++#'_ #VE_P#0J])'3FO-_@;_
M ,DKL#G_ ):R_P#H9KT9<TNH#Z*2EI@%%%% !1110 4444 %9?B+2GUOP_>Z
M;%/Y$EQ'M60KD*<Y&1Z<5J55U&^CTVQENY4D=(QDK&NYCDXP!2 Y2?PCJES+
MJ$LE[9^9>3V<Q C;"^3C('/?''I45WX)O[FR>#[19^:;V>ZCG =9+<R,"K(P
M.<CG(Z'O6F/'.FLL CAN9+B666+[.BJ7#1XWCKAL9' )S4DGC72XOMCR"=8;
M5BCS%/E+@@;.N0V2,9 S2T*U+VHV.H3QVBVUS"ZQ@K<17,>4N5*XP<=.>>AK
MDXOAY<Z<;6;3+BQ61#.KVMU 9;98Y6#;8USE=I''KDUK0^/])N%58(KJ6<R2
M1F!$!<%,;L<X;[PQM)S6EIOB.UU34KBSMH;@B!F1IB@V;EQN4\Y!Y[@9[4:"
MU,FP\*ZGIUW?6\.I6YTF\=IFC-OB5)&3:P4@X"D\],CI6?)X"U"\L+6RO-1M
MU2'3'L"\*,&!W*R.,G_9&1WJ35_&=VMQ/';6L\"V.KV]G(=@<W"N,L%'8\C%
M:4_C_1;:Q2ZD^TKD2-)"8\20A&VN67/8]ADGM1H/4I7?A#4]0N'OY[FS6_=[
M56V!O+,<+[S_ ,"8G\*V='TB\TRUU9'D@>2[NYKF+&<+OZ!OI[5<O-9M;2WM
MI<23&Z_U$<*9>3Y=W ^G-9C^-M(6%9\W!@\M)9I?*(%NKG"F3/*\Y[>]&@M3
M*M_!=[!X?T"R']F_:].O(YYIPA'F*A)P.,Y.>]%GHVLV?AZY\/Z<\,4L=U(Q
MEN-X62"1RWRLO1N<>V*UD\:Z0^HFS)N$(N'MC,\)6(2*NXKN]QR*Q;SQF\E_
M?/#<7%KIJ:2;N.9K3<0=^!(HSEACL<4:!J6=1T6]U"PT?0YXH$\JY6XE:T1A
M%#%'G:H)ZDG'ZU4L?#>LQ:;HGV*6"#4=%$MJ\=VC-#/&W&X%>>@!'XBKU]XP
MCC@U.(M<V:V MMU\;82*YDP>$ST.0/;/M6N_BC38[];1I).9OLPF"?N_.QGR
M]W]['^%&@:F/>6>K'5(KJSCA>YTO3Y(T=XBL4L[[?E"CG: O;U%:7B'2+C7M
M$@@>W@,P*R,#*T;1/C[T;KR&!_,4NC>,-*UVZCM[-IP\D331&6%D$BJVUBI/
M7!ZTZ?Q7IMOJS::PN#.&**1$=KR!-^P'NVWGT]Z- U.<N?!>O21RQC4+*=KJ
M.S^T33(P8O V3@+V858C\*ZY#I>I:2+NPELI%N/LDLB-YP\W)VL>@ +'D<D
M5KP^(5U#P5)KH$U@K6[R@O%O:+&>=O\ %CKBEA\5:>LD5J\\LTBPI)-.D)")
MN3>"W]W(!-&@]1FA:'>Z=J]S=W+6YCELK:W'E$[MT:D,3QTYXK%M/!VMVUSI
ML;7=E-::;)=F%VW"61)E( ;C&03R>]=!;>+--NFM547"?:Y/+@+Q$!SLWC!Z
M8*CK5>;QUH,%I!=27+B&5=Y/EG,2[MFYQU W#%&@M3$M?!FJVD.C;9;2WN;"
M&&*2[AD;+HC9=&0C#J1TSR#6=H7AR?Q'X;MR/*M$MQ?1PR '<[2LP&Y2!@8Y
M]^*[[4M<LM+\D3F1VF5FC2)"[,JC).!V K/G\8:2;F2P@NP+MDD$19#L,BIN
M*Y]0.<4:!J81\*>()9)KN1M/69I+&1(5=]I\@G(+8[@Y%7?#WA6]TK69);J'
M3IH8YYIH+P;C<8D))7!X7K@D=0!5BQ\;:?%I.EOJMTB7=S!#)+Y:':ADX4G^
MZ">E3:CXXT?3H+R1GFD-M$\NU(B1*$.UMAZ'!.#2T'J9VJ>&=4N-?N;VQ$-N
MDZNL^)25N%,15=R$?*X)^\.U9Y\(:]"]O);+8#R[*SMY%WD;C$Q+[3M^4G/#
M=175'Q7I*75M;37!BFN"JJ'4@*[#*JQ[,1V-4[/Q0-1\9+IEHV^R-BT^\Q,N
MY@X7*L>&7KTHT8M3&TKPIK>G)8QM':E;6.]0^7.Q!,QRG49X[UK3^'KVY^'*
M:$WD)>BUCC8%B8RRD'&<=#CT[U';>,H(/%.IZ/JES%&R74<5IMB;!WH"%9N@
M).<=,ULV'B+3-26%K2X,GG2R1)^[8'=']\'(XQ[T: [G(WW@O4+G57UE+2TW
M23JSZ;YQC1D$>PG>H^]WZ=.*U=8\,377@:UT2UL[1&BD@80*Q\I%20,0">>@
MQ5P:W>:EXDO]*TL0(FG(GVB>92V9'&0B@'L.2?>ID\11:?9VXU]X;.^?_6(A
M+(GS%0V>RGCDXZTPU,#_ (0^X3Q+=RMIMG=64TXNK>:2=D^SL$V[/+'!]B/4
MU4LO".M6-Q9SQQH]I9W"21V,TJL^W8RLHDQRJDY3=R.:ZJ7QAX?@O'M9=3B6
M=)#"RX;AP,[<XQG'0=^U,F\;>&X+6WN9=6@2*X1GB)#98*<,<8SP>OI1H/4P
M=*\(7UIJ&EBZACELT6^-POF K&)V!$8'< <>E0?\(5JUOX>$*R0W=U9W4?V6
M,R&,26L3'9&S]C@YSTR!78'Q%I/VJ*W^W1%Y5#)MR5.5W#YNF2.0.XJM%XS\
M.S033Q:M \4,/GR,,X$><;NG(!ZXZ=Z-!:G)77@_58[65+'2+-8+S3Y[5K-K
MHL+61V+;\L,-G/.,=!BN@U;1;VZ\&:;8BVCGN;1K9Y;<N,2>65+*">.W>NA@
MO[6ZE:*"97=460@=E;[I_&L]O%>A)%/*VJ0+% ,R.Q(4#=MR#W&[C([T:!J<
M7?Z$-/$*VTL-GK=UJ;W-C:#DQ0R )*@QP!MRQQP#BNJ\0:3<_P!@V5EI-E!.
MMO/$3$[!2$7J4)X#>Y]ZMKXDT.:T>^COH'2*3R"X!+!S_#C&<GKP.E5]$\30
MWOA%->U*6WMH/G9Y%)$84.5!YYQQWHT#4XR'P5JYM=EUI4$KQZ9>6L9:=7^>
M24NF"1Z'KVKJ-:TO4+WPOI-M'9"6ZM[BUDD0R+E-C L<G@G@_6M2#Q3H=S;3
MW$&IP2Q0.(Y"A)*L1D#'4Y'(QUIC>+?#ZF(?VM:DS1B2)5?)=3G! _ T:!J<
M7-X/U?=$;.Q2UG>_OY7N%D4%4E5@A)')Y(X[8ILGACQ!>07#QZ/#82"SM8S$
METH6X:&0LR97D!AT)_&NCT7QC'?6B:C?7%E;Z?=+NML,PD7!Y#@C&!Q\W3FM
M:[\4Z#8736UWJ]G#.@!9'E (!&03^'-&@]3@+K1+>W\0:!#-X<0O<_;I6L9+
ME9FRR+DDL<<GL.!FK&F>"M2T^]M(+[3QJ4"K;O'<B\*"U:,8*E>K =L=>]=F
MGB/PW<W<)74;&2Y,GDQG<"P8_P ([C/ZTD7B6QAAFDU'4=/B7[3)#"8YLA@G
M8Y_C'<4:!=G!1>#==ATNQM[.P6TO!#?I+,)%Q^\?=&K$<D$>G3-3W/AS6Y[J
M\O[?0/LL+/9R/9)<(K3B-6#J". 02",\'%>@2^(='M[:*YFU*V2"5/,20R#:
M4_O9].>M6;G4;.RMUGN;F..)ONNQX/?C\*+(5V>9W7@VZ<N4T!_)&C7$4,;W
M E>.=Y-R#<3UZGC@=JZGPII5YI^M:K<W=D8OMD5LXF+*266)5=3CG.X$^];R
MZUICJ66_MR%=$)\P<,XRH_'MZU1UOQ-:Z=INHS6LUO<W=C&9'MS)@X!&?RHT
M#4X33]%:_NKNXTW32EQ:ZI?&2[1@!)&0R^4.><DC@\#&:EA\)Q06<T.JVZ:7
MIDV@V\$TSRJH6Z5B=QYY8'&#WZ5Z'I-WIEW;R-IDELR!_P!Z+<C <\G..],D
MU+1;Z&XCEN;.>* YF5V5E7!ZD'W'YT6079P]QHVKWWABQO)K5I]7N"T\KQ*K
M1[O+V(LD;?>0KW'*DYHNM%UQ)[^>#22R":PFEM4E&RY6-")40D]CC&>NVNY_
MMS2L0-_:%MB<XB_>#YCG''X\5*NK:>TT\*WMN9(!NE3S!E!ZFEH%V<+?:+?^
M9;RZ;X?DAC_LR\C^S-<<!G965&(/!/S' Z=,UFVGAO4I;Z)+W1KM[5]4@NL/
ML"K'Y!1\JIP/FQD<].]>E#6M+*PL-0MMLS%8SYH^8C@@?CQ36U_1T:16U2S#
M1J6<><OR@'!)Y[&GH.[.7M=(UE/AC<Z7:P/;Z@IF6&&23&4\TD+N[ KQ[9JF
MNF7#W%A>)X<N;;26GD:]TUW#L7,859 @., @C ]<XKNFU2P3R U[;K]HP8<R
M#]YGICUJ-];TJ/S0VHVN8HVDD E!*JOWB1[=Z-!79YA/X2U1K!XKO3;J[N(M
M$ECMW$F2DIE+1)G/WU4@;O;K3]5T>6WMKN.33+U;6:\TUPBL097Z2[<'.3T/
MK7IUEJUC?Z3#JEO<H;*6,2+,3A=OJ<]*K7-_HEY-86T\]K.]Q(7M5)#;F3DD
M>XHL@NSSN?PUJ:,T9T_5'T&>>X6&SM9566V#;=K88\ D-C!RN:FNM!U2QNM3
M^S:5>M'+>6EQ.T+JSW$*QA77<?O,&Y(/7%>J44^5!=GE%]X9NGMYDMM-U;:N
MCS+:&>;<Z3^;N0'!P&';T'%=1X2L)K'7]=DN-/FA>\:"<7#+\LO[I0PSG[P8
M'(KKZ*+!<\SL-&O+.ZAAN-(N?[,BU"\:YBC!/F&0YBD&#\R@9'L3[5V_ARWO
MK3P]9P:C(SW2)ARQRV,G )[D# )]JU:*$K!<****8@HHHH **** "BBB@ HH
MHH *2EI* /-_@9_R2NPS_P ]I?\ T,UZ.*\X^!?_ "2RP_Z[2_\ H1KTCO2
M6BBBF 4444 %(:6B@ HHHI %9NO:3_;>CS:?]JEMO,VGS(^HP0<$=P<8([BM
M&L+QCK,^@>%+[4;95,\:JL989569@H8^PSG\* ,>;X?F:RGLI-5+VT\[SLC6
MJ QNV/FC(P488X(Z9J2\\ 0:A<7$]QJ$HG>/9'/$@20$$%&<])"I P2.YJY<
M6LF@6<>K3ZS>20643RWBROO6<;>H'\)!Z8P*I7/CM[(/%<:--]L'V=T@293O
MCF;:K!NF0>"*6@]2;4?!USJNFQV=]K+3C_EHQM44ALC#QXQY;#'4>IJUIWA9
MK+Q VK2WQEE\MH_EB"-(I(QYA'WRN, D9JE9^-;F>^AMKC1)(-]W+8N_GJP6
M=%+ #'52!][L:@LOB#+<V\4TV@W,"75L]Q:9F1O-V'#*?[N,YR>U&@69>N?!
MQGU*:Z347CCEOX;_ ,KR@<21C&,^A 'TJJ/ L\%_]OL=:>"[:68R,;9'5XY'
MW[=I[@]&I(O'S7*P16NDR7%U+/<0;4G4(&B4,3N/8@]<5-#XZBE:/_B73(L]
MBMY;%G ,Q+!3&!_>!(S]11H&IIZUH#ZFNGS6^H2VE]82;X+@*'SE=K!E/!!%
M9=UX(:ZDO ^J2O#J4"0ZB'0%IMG1E/\  <$CITQ5G4-0N/#$=_J=]<27%K<7
M$8ACD8!;;<,'+8^5,]SG'XU=NO$,-CX?BU6XA=/-VJD(8,6=CA0",@Y]1VHT
M#4R+CP/]I5H9;_-LVH->&,18^5H_+,><^G>JX\!W9M)K>77GE!TQM,B9K905
MC)!!//+ #'O5B7QTMM;6T]YI%Y;QS3O;;W&!YP^XHSU#]%;IGK2ZCXX?3+Z>
MUET.\?[+;Q7-W)&Z%84<D$]?F(P<@>E+0-0O_!DUW;ZA NJ&..^BMT<>0#M:
M+'S#GN%'%/7P8BW$D?VO=ISW_P#:(MVCR5FZX#9^[N^;%0R?$&RQ<306-W<6
MD*3.MQ$N5;RAELGHH/8]Z5?'UNEE/<76GSVAC$#*)W4*4F^Z[,,A1G(.>E&@
M:EC1/"4NCW&F2'4//6QMYH=IB"[_ #'WYZ\8QBH;GP9<W/B$:H=5!"7?VB-7
MMPSJI0H8]V?NX)(P.OK4I\;P"YA@&G7CN3&LXB7>83)]W[O##')(Z BMW5F>
M/1[UXG:.1('964\@A20::LPU,NS\.3VW@R3P^]\)"8'MTN/*P54Y R,\D U1
M?P9.][97(U"*.2TB2..:.#;(0J;2C'.&0GG!!]J;8WNH3^"_#5R;Z8W-T]L9
MYN,N'Y8'CH:$^(5DLBM>:?>V=H[31I<RA=K219W+@'/(4X/>C0-2.'P&]J8Y
M;34%MIHKQ;N.*.']PC;"C80GC=DG@X!J.Q\ W6G26TEOK*M(D1@F::T5]Z;R
MZE1_"PW$9YSZ5=N/',-FDBW>F7<=T@A<6X*LSI*VU6!SCKP1VK4L-=_M#2[V
MZ6SEBGLWDBDMY&&=Z#.,CC!XYHT#4K>)?#;>(+>&#SHD2,'!>,ET?C;(C @J
MP_(]ZHV7@VYL+B\5-3CDM+@O(%EME,JNZX;]YUP3SC&>V:B@^(,0TRPFN]/G
M^U3VZ7,T%O\ O#%&YP",?>]<=< U))X^A624+HNJ/%%=_8S*(UVF7<% '/N*
M- U(K+P1=:?<VDL&I0$+;16UR);17+>5G:Z$GY3@X/44+X)O_P"PK_0GUE3I
MDJ2K; 6X\R/>V[#-GY@">V,U9M?&]O=W,%J^FWUO)/)-;J7"\3Q@EHQ@]< X
M/2J5EX[M;;2;']QJNH/)8M>F4PIO,2MM8M@@9'H*6@]26/P9>C4KB:6_LY(+
MT*UTK6@+K($V$Q,3\H( ZYQ4V@^%=1TK5+*XNM2@N(+*R:RA58"KLFX%2QSC
M(  .!5N3QC8)J$5F(IF>?B!B /-;9O  )SC'\6,9K+L/&D5S)IU]?FYL%GTV
M6[>V*JT6U6 W%QSNY& /6C06I:O/"4MWJ5^[W<?V&]NH+J1!'^\5H@,*#TP2
MHYZTOAK2U;7-6UM8+NV@NG_<VURFPH__ "T<+VW$+]<9[TD_CJQM?-6[L[V"
MXC>%3;F,%RLIPCC!Z$\'T-:VF^(+2_TNYOW62U2U>1+A+@8:(I][./SHT#4I
M'0[VP\17NK:1-;XU!4^U6]P#MWH,!U([XX(]A5/5/"=_?75]*M[ RZG9+9W@
M=#A<$_/&/HQ&#[&EU/QM%;Z/J$UK:7'VV&T^UPPRH 9(V.!(.>0#U'45)<:S
M>>'O#\5]=K=ZB]Q<1(D9C1'BWD#!QP<'/YT!J5%\'W\4O[JXM=BZO%?KN#9,
M:($VG_:.,YK)30=6TWQ!I=E&EM/(R:A(TA5O*196! )QUZ_7!K:T7Q8SZK?:
M;?FX>3^T9K:VF6WQ& JA@A(_BQFK.F>+K-[338VFNKZ>ZB,HD6W"-LW[=S(.
M@SQQZ9HT'J9%MX&U2QGT];>]M)K>PDA>'SE<, J%67 XY)R"<GM3K/PU<>'[
M/3Y=1,%Q8Z?I\]M<QP1.[R^8^?E4#D8XQ[UU>NW\^GZ3-+:1K+>L/+M8F. \
MI^Z/IFJ.G^*[2Y\-:=JLV1)>%81"@RQGY#(!Z@AORIZ"U&^#]+FTKP_&D\DS
M32$D&9<.J#B-2/4+@5R\_@37[B.Y$MWILDDUF]J7(<;LRAPV.BC QM KHU\=
M:0XM]JWK&X,@C"VS$_(VU\_[I/-$?CWP_*9PEV28D$@&W_6J6V@KZY/':EH&
MI2F\-:VFNSZM:36 D^V+<10R;MK+Y/ELK$#@CJ",TV_TF\TSX5ZKI]X8)KG[
M/.?]'1MI+$D #KWQ5L_$'0O*213=R,R2OY<=LS,OEG$@..,C-6D\;:*\$\WG
M2*L2QN \14RK)]PIGJ"<C\*>@:G.2^#-2U$PZU&VGQWPCMPELX<PNB*P.X@!
M@3OX..,#K6QIOAJ[LM46Z^SZ;%$NG&W$5N"JK(7+Y (^[SUZ]Z<WQ#T$6R3H
M]U*&25RL5NSE?*($@..ZYY]JT=,\10:KJ]Y86]O.%MHHI1<,N$D$B[AM/THT
M#4YNS\(:S9VEJ ]A++_9;Z;<1.S>7@L2KJ<9[\KW]:1O U['I^MV<36<@N].
MM[.WEE)W!HT*$MP>#GMFM+5/%GD^(=)L[-F:WEN)HKE_))5MD98A6]015_\
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MO"5Q>VOB&&[NH@=3D2:"2)#F!U50K<]<,H(K5TK61>KJ$4X"W&GS&&<(,@X
M8,![J0<5'!XLT:XCADBN]RS6C7D9V-\T2G#'IU![=:- U,BZ\&W2W5A=65S:
M22Q6IM;I;V#S%E#'<9 .S;LGT.:W=8TLZAH3:>L5K,"%5H[A2$901D?+RIXX
M(Z'%9(\76UM<L)+E[U9]12SBCAMF4VY9 VU_7US[T>&_%:W]U<:?J%Q']O%[
M<00JD9576,\#/3=CD\T:!J.F\+7EQX*;1)=28W(8213OE]I5]Z*V>6 P <\D
M5E77@W7+R^GU26[TPWANH[B.$Q.T+8B\ME?)SR.01R#75W.OZ;9ZDMA/<;;A
MB@QM.%+Y"@GH"<'%<_9^)-4DO--BE-LRS:I<V4VV,@E4#%2.>#\O-&@:E*[\
M$:M-<0O%<:8D41@D2)(6C2)XWW,%5>"#ZGD?C5FR\(ZI9:A9RF>SDAM=0NKM
M>&#,)@V!Z @M^E=+J.O:;I+A+VY$9V[V^4G8F<;FQT7/<UDIK]WJ/B^XTK3Y
M(DBL%B><2PL1,'R3M<<#  QUSFC0-2N/"5XWP^M]!>ZA2]MBCI*JDQETDWKD
M'G!Q@U&WA749M9CU:3['YTM_%=7$.2558XC& IQRQSG)H/B/4VUW6[$WVDVX
ML98DMUG!!E\Q00#\W7)QP*WX?$.F2W#6HNE^U1SBVDA .Y9"N['3ICG/2C0-
M2GKVCZC=:IIFIZ7- )K,21M!<9\MTD !(QT88'X9%8%IX+U6"PM;6X&FW2PZ
M4]BZ2;]DK-(&Y[@8'US73IXJT25YT348BT*[V'.2N=H*_P!X9XX[TL7BC1ID
M5DOD.Y)7 P<XC_UG&.J]QUIZ!J<9J7@7Q!?:5+8+>VS02PS1(MQ(S/"&(* R
M 9D QC#>W7%:7_"(:A<7MRMU]D^S7-Y;7KRQL=Z-$JC8N1W*?>ST)K2O/&.G
MO!>I87T$<MM##-]HN(V\G;(?EY'7(_G6H-?TO=<I]L3?;3)!.N#E)&QM4\=\
MC\Z6@:G-Z=X:U>TFTEY%M"MI+>R2JLAY\[.P#CWYJ"PT&?P[:65UJ[6?]GVV
MDO97X^9MHW[@5&/F!S@BNCN?$,$L%[#I$MO=:E;Q>8MN[%0PSC/ R1P1D9YJ
MVNKV7VN.QEF1;QU&83R02,[<],X[4] U.;\/VVIZ)X8MI+:/[=-+.D:B?*.+
M4,0G;J$P>:[2BBC804444P"BBB@ HHHH **** "DI:2@#S?X&?\ )*]/_P"N
MLO\ Z&:])KS;X&?\DKT__KK+_P"AFO2!2 6BDH%,!:*** "BBDH 6BBB@!#5
M>^L;;4K">QO(5FMIT*21MT8&K-9/B'6!H>DF\*JS&6.%-YPH9V"@L?0$T@(%
M\*V;6365W<WM]:F(PB&ZFW*%(QV )..YR:KMX)TUX DEQ>22!H<3-*-^V(Y1
M,X^Z#S[]ZJR>(M735%T4QZ=_:7E37!?>QC:-" O'56.X9&3CKS61)\0-8DM)
MK^TTRT-I#!:3LDLK"1O..TJ,#'!YSW%*Z'9G1/X0LUE6Z2>\>:*]DU!%,HP9
M77:0>/NX[5D:%X"CD\*6EEKAN!=10>2 DP/D?/N^1@.Y ZYXXI)/%VNBXCL(
M[/3FO6U5]/9F=Q'@1>8''?IP145GX[U;4<VMGI4$FHVR%KN+S@$)$A1MK$C
M^4G)SV%*Z'9FU;>!M-M+O[2EU?M)YDTO[R8$;I5VN>G<?K4-MX6$>J:/;M:(
M=-T-,V5Q)-OE=BNW!&!@#U[\53L_&>K7&H;7T^T^S->W-E&$E/F,\:EE)SP
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MC)'2KWAS6U\1:+%J26LULLC,!',.>"1G]*>@:FK1113$%%%% !1110 4444
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MK.IVUY;.8X--^T[T!^T;_E."#\IYZ\]*5PL=\GAC1D>9A81D2B3<C9*_/]_
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M+CH3_">OK3N*QUVK^&=&UZ5)-3L4N'2-H@6)&4;JIP>0?0U7C\&:%!$8XK+
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M:1;QRWD@AB>5(4.TGYV.%''J:M[5#[MHW$8)QS7DC:FVH>'Q=G6GODDN[ M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%)2TE 'G7P0S_P *KTW_ 'Y?_0S7HM>=_!$;OA7I>.SR_P#H9KT.D M+24M,
M HHHH **** "BBB@ HHI.:0"T444 %%%% !1113 *2BBD M%%)0 M%%)0 M%
M)1F@!:***8!1110 4444@"BDHYH 6D[T<T#WH 6BDHS0 M%)FC- "TE&:* %
MI*** %HI** %HHHI@%%)2T %)1F@T@%HI!TI:8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M4M(>M 'G?P/S_P *KTS_ 'Y?_0S7H@'K7G?P/_Y)7IO^_+_Z&:]%I %%%%,
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M$T);F\>\O7E=2L<FS=%N X+# V@Y.3TJ#4?!J:BVNEM2GC&L1QQRA8U_=JG
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M^W:6*&X@N);.0!6FA7JF#QGH<'@XQ6%!X<O(9[!Y-*,EM_;<EY'!\A^R0,A
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MTV[>UN--9+-(3\UM=;CAFVG@D;3N[8(I@=?J>JP:3';R7"R%9[A+=2@SAG.
M3[9J\,5YA<:9K<EQ'#JFFW=[J$6I6D\=Y%S%Y*A=W?C!#9&.<YK7\'V%]#JC
M37\&JQ7L<<D5R\K+]GF._(9<<N?0\8'%%V!T]]KMAIT[0W$NUDC\Q\#A%)P,
MGMD\#UJ*Y\2:9;0-(9_,/VC[,L<0WN\O]U0.I_PK*TZSCG\4>*+/4H$F2Z,$
MB)*H*R0[, 8/4!@WYU!KVA_V?XCT77M-TT2PVLTOVR"VC&]O,0()0/XBN /7
M!HU#0Z+3M9MM2N;JVC2>*XM2OFQS1[2-PR#Z$<=15J\NDLK*>ZD5VCAC:1@@
MRQ &3@=S7,Z[)=W[6,MM87)T];M1?#84DEBVM@@?>*JQ!([US$UAKB65Q;:E
M97]YIDMO>)81Q;FDA8M^[$F#G[O0GITI:A8]-M+N*]L8;N+=Y4T8D3(P<$9'
M%8UOXSTBYV%6N45HFES);LH"J^QLY'&#U'IS7*:;8ZO)J=C'?1ZQ!Y*VKVCV
MZ!4"+& \<A_A^;=N!Z\8KNK^WL+;3KJ:6*-(EMY%=B.B')8?C1J&A<EN(8+5
M[F215A1"[/G@*!G-8\OBW38K!KHK=-B4Q>2ENS2E@ QPH&2,$'/3%9NGVVI+
M\++>VE:)+X6 5OM#;5QC[K$]/EXSVK+T;69=(\-2I:6NHRQK<&VM()86FEL\
M*-XD*Y)13]WU&*+A8Z6;QCHD5G;78NS+#<0M<(T2%L1+]YV]%!.#FK+^(M,2
M^CM/M&YY-GSJ"44OR@+= 6[5YOX@\/R76DZ2NDV5["EK9S^4\D#![J0N";>5
M.HCD^8\UJW&F7[#4M-^PRQ7&HWUI=1&-?DC11'N&[H-FPC\1CK1=CLCTBBN,
M\?->&*TBM8;XEDG*R6X=D$@3Y P3DMG[N3C/6N:$NKR6\U^TFM?:XETUT0B0
M*6.!,=N,'ON'XT-BL>EW.JVMIJ5E83,XGO-_D@(2#M&3D]!Q4UK>07J2/ VY
M8Y&B8XQ\RG!KS%;N^&MZ;>W-AJDNJVL]Z;E?*=HAN4B+;_#M(VX(]\UH:C:Z
MK8+-I^;U?+TU7T^6U)PUWEB^['4EMO!XP31=A8]%JA-K5A;ZG%I\L^VYE("K
MM.,G) )Z G!P/:N>\+VEY)XAU>\U"ZOS-%*J)"\C"  QH6V*>"-V[FJ.H_;K
M?XB13*TL4L[I#;L"&MYX@I+)(/X9%.64]2.!WIW"QV$FL:=#>7%I)=QK/;P?
M:)E)_P!7'R-Q].AJJGBC2'M);G[256)U1D:-@^YON +C)W=L#FN(A\.:U=ZW
MJEEK-O;06U[I;"YOK:1V8N78@C*XR./E[ "G#P_J%_=7&OZAJ#6S6LEL+&5;
M8@3>5NRS1]2&+D#O2NQV1VDGBG1X[.&Z-UF.8L%"HQ8;?OY7&1M[Y'%:T4L<
M\*2Q.'C=0RLIR"#T->9PZ%JVGHVORR%-8NI[HI8B$R+(DNW:I&?E(VJ2<X'.
M:[#PP8M,L;7PY),TE_8VD9E)C(5L]U.,$9XXZ4T)HWZ***8@HHHH **** "B
MBB@ I*6DH \[^"'_ "2O3/\ ?E_]#->B9YKSOX(#_BU6F>[R_P#H9KT2D 4M
M%)3 .]+244 +1110 E+112 *:Q55W,0%'4GM3JYWQA'<S:9;);6,EV/M<9E6
M,;F1,\MM) ;''!X_*A@=!N4#)8 >N:I:EJT&EFT$J.WVFX2W78 =I;H3[5Y9
M!H6IS6(CO]$U"22WTFZB0R#.9O-)B VM@G&,>E7S8:I-J%I]LT*_N+R/4[6Z
M6]XVK % (R3P5.<K[YJ;LJR/2;Z[-G"KK;3W#,X0)"N3SW.>@]ZS]%\1PZXB
M206=W%#(&*2RQ@*VUMI'7@Y'>MAFVJS8)P,X Y-><#3;Z;X5VUC+IMZMT+Q6
M>W"E9 OVC<3P>FT^M-B1Z/N4D ,N3R!GK1O7:3N&!U.>E>;#0KJP\27$*Z5J
M4L<+B;3)+:8) D83'ENQ^9><\=\BLVQTS4S!=Q2Z?J]C%<Q6S*5MU9(I4+;@
MR;B77D YY;K1=A9'K?RDY.*6O);S3]<33YQ_8=WY]YI$<2QVA)1)4E)Y).5.
MT@C\NU::^'8[_3_%%Q=1W5E<R3L]I<7,C+L4*K+@9QC>IS^-%V%D>CYKGKSQ
MGI>GW=]!=I=1)8,@NK@PGRH@_P!TEO0^M2>%5N)-$CU"^01WM^!<3H#D(2
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M5J1S1R6ZSHVZ)D#JP[@C->?Z>+[PYH7B+2)DNTU![BXGL;F*(O\ :3)\R$$
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M,;MYABV@\EM4@LUW,0WERQ*X8_[0+8Q6;_PF^NRZ9),;2Q@>>PO)[9U9GV/
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MB@ I*6D)YH \]^"/_)*M*_WI?_0S7H=>>_!/_DE6D_[TO_H;5Z%0 4E'>EH
M2EHHH **** "BBB@ I#@\$=:6LK7=0ET^UA-NT(FFF6)!("V<_W5'+'CIQ2
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MLK&.&1;M8R)V&'@)'S$C 4C\J=PL=B-,L%QBRMAMQC$2\8Z=JEC@AA#"**-
MQW,%4#)]37 3Z]=ZO+8+/"T$UGK5M&6CW()$>,M]T\XY[_6NFUVZ$&L:%$UN
M)//N757,A7RV$;$' ^\.".:+A8U?[/LL ?8[? !4#RAP#U'TI#IMBV-UE;'
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M;_2K#5;9;:^M(KB!6#K'(N0".A_"N=D\8RV^N6FEW%@OF3R)!O27=B1HR^2
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MY"+QKJ27%CJEQ93/;SZ*U[/9P.I6+#CYP3C/RGI711^,;6?6([&WM+N:-IA
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M_@G0YXW3R)(@;K[8IAF9#%*?O,A!^7/.0.#5ZXUF"QT--3O5>%"B$QXRVYL
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M%X>M8[B>UDDC:,R,0P&T#&0,]6YZ#TJM_P )I#_:C6ATZY$2W<=HUQE=N^1
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M D,[P-YB%3N4X/6C0-2EJ_A#3]9\D337<2QVS6I6&7:'B;&0>OH.>M0#P19
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M0!P/P7&?A3HWTD_]&-7?"N!^"_\ R2G1_I)_Z,:N^S2 6BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%)2T@"BBBF 4444@"BBB@ HHHI@%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !24M)0!Y_P#!;GX4Z/\ ]M?_ $8U>@9%<#\&
M!_Q:G1O<2?\ HQJ[PCFD ZB@=.:6F 4444 %%%% !1110 4444 %%%% !111
M0 4444@"BBB@ HHHI@%%%%( I!2]113 **** "BBB@ HHHH *3-+24@%HHHH
M *3O2T4 %)TI:* $H[T44 %%%+0 4444 %%%%, HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I#UI324 <%\&!_P 6IT7_ '9/_1C5WIZ5P?P:_P"24Z)_
MNR?^C&KO.HH !2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+12 *0TM%
M "44M4I]4L;74;73YKE%N[O<8(OXG"C)/X4 7:***8!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4E+2'K2 X7X-_P#)*=#_ -Q__1C5W5<)\'?^
M25:'_N/_ .C&KNZ "EI**8"T444 %%%% !1110 4444 %%%% !1110 4444@
M"BBBF 4444 %%%% !1110 4444 %%)BEH **** "CZT44@"BBBF 444E( I:
M** "BBBF 5R%SX9U9O&,&L1ZA;O!]H#NDD'SI$$*A%;/3))Z=377T4 %%%%
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M2T44 )BE]J*3O0 M%)2T %%%%, HHHH **** "BBBD 4444P"BBDI %+110
M4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6D/6@#BOA'Q\*M
M_P"N#?\ H;5VM<7\)O\ DE?A_'_/N?\ T-J[/(I +^E-?<1A"-V.]+D9I U,
M!1CIZ4M&:3.*0"TM-W#U%+D4 %'XTF:0L,XS2 =FCK46_&>#Q3@_O^%%P'TW
MI2!Q^M*6YQ0 N?\ ZU&<BF[AC.:0D=31<"3BDINX-QFA3ZX^M%P'"EIN1^-
M/O1<!U%-R*7(HN M%)Q2Y%, '6C-,SSFER,]:5P'9I:;D=Z7([4P"BDSW%&X
M=* %H%-+ "ESQ2 4TTTA<8XY^E,W#;UH ?SV/YT[O4 ?YO84_P S+ 4K@2?C
M2 YJ-G7%(LBCJ<?6G<"?-%1EU!ZT&0=<T7 EI#47F8//6CS!BBX$F*4#WJ/S
M HP32>;Z8_.BX$M'.>O%,W\=?K09 />BX$E-_&F^8*0N/X>?7FBX$G:BH_,
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FX./9O\:**8F(?$=W@'RH/^^6_P :8?$M[G_5P?\ ?)_QHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gtbp_ex1017004.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JP# 2(  A$! Q$!_\0
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M7^2UZQ0 4449H **3-&: %HHHH **** "BBB@ HHHH ***3- "T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !129HS0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M)0!
MY3^SY_R39O\ K^E_DM>K5Y5^SY_R34_]?TO\EKU:D E+113 2C%%+0 4444
M)1112 ,4M%% !24M)0 O:DHYS[4M !1110 4444P"DI:2D M%%%, HHHH **
M** "BBB@ HHHH 2EHHI %%%%, HHHH **** "BDI: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@#RK]GS_DFI_Z_9?Y+7JU
M>5?L^\?#3_M]E_DM>JT %%%% !1110 4444 %)2T4@"BBBF 444E(!:*2EH
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M0!2T44 %)2T4 %)11]: #O1VHSS2T )2TG?%% "T444 %%%% !1113 ****
M"BBB@ HHHI %%%)0 M%%%, HHHH **** "BBB@ HHHH **2BD M%%%, HHHH
M **** "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I*6DH \I_9]S_PK7CO?2_R6O5NU>5?L^_\DT_[?9?Y+7JM( H[T=**
M8"T444 %%%% !1110 E%+12 **** "D)]J6B@!!2T44 %%%% !12&EH *3M2
MT4 %%%)WH *.**6@ I*6B@ HHHH ***2F M%%% !1110 444E(!:*** "DI:
M2@!:*2EH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M)0!Y7^
MS]_R3/\ [?9?_9:]4[UY9^S]_P DS'_7[+_[+7J=( H% HI@+1110 4444 %
M%%)WI +1110 4444 %)110 M%%% '-OXH@A^W7D\FVSM[D6,2 #=+-QGD^YQ
M^!-1+XNAF73;Z!9!97=X;"5)4VM'+R 1ZC(QZ'((IMWX3^V#4+)I98(9;M=1
MM;J%AO@G&,\'KR,^A!(J2XT"[NI-+M;FZDNX;:Z%[/<S  NZYV(JC@#)S^%+
M4>A7^).NZAX:\%W&J:;*D=S%+&H+H'!#,%/!^M96B>/2^J:_)<WL5YX=TRW6
M1M36+9LE_BB('WC]![5TWB_PS'XN\/RZ1+=R6L<KH[21J"WRG('/N!6-=?#7
M3[J]U67[;<16^KVOD7]K& (Y7 XE _A;C- #C\4/#VV(!KDS23&$0B,;MP4/
MZX.5(Q@\]*8?'UC8ZWJ]M?7<KM%<V]M;V:VNV022+E5!S\V>N>,5'=?#==0T
M&#2+_6);N&)=F9+>,<  *5P!M< <-GZUE>*/AY>A;^[TJ[>XFO[NV>59H0_D
MI$N 1@AF/3H0:-0T-K_A:6A&"WD%OJ1^T2311JMMEBT/^L& >U2W'Q-\-VUA
M:W[SSFVN;=;E7$)^2,MM!;\>,#)K#T7P+J6H65@VK316!TV2Y2U2TMA&)4E7
M:7=225;D]_K1>?!Z&\T>RTH^(+M;6TL_LJ)Y*$??W;\'HW;Z4:AH7M9^(J6]
MUXDL8()[?^R+6.5KYH/,16?H=@()7&/KS6L/'FCQWD5E-/*TF^""2<18B6:5
M=R*3V)_3-9NH?#6._FUQSK%Q&NLV<-K<*(E./+  8?7'3WH?X9VLFHK*^H2M
M:-/;W=Q;B,#S9H5VHP;^$'J1[4!H7],^(FA:KK,.EP?:TGFFFMXVD@*HTD7W
MU!]11\0O$]YX6\.Q7=C 99YKJ*W#;-PC#M@G&>3Z#UJAI?PTBTW6+#4!J\\A
ML[ZYO0AA4!VF&&!/8#M6[XM\,CQ5I4-BUVULL5S'<[E0-ED.0.>V:8&/9?$"
MPM+F31]6FN)=3LB%O9HK)EBCRI<,QY"KM[YZU8?XD^'8M-N;Z:6XBBMX8KAU
M>$[C%(<)(!W4U+;^";9-0\2W-S=//'KZ*D\6P+Y8"%/E/T-84WPGANM)O+*?
M5Y3)/:6]BDPA'[N"%MRC'=C@9-(-#6M?B;X=N[^&R#7D4TET+3$MLRA)2,JK
M'MD<BK_C?6;SP_X-U35['RS<6<7F(LB[E;D<'D5SB_"W.I?;9-88N=5BU-E$
M  +(NT)UZ8KJO%NA/XF\,7VC)<BV%VGEM*4W87/.!D<T6 Y30?B'/)+>2ZNL
M9TJ"UMY5U"*)E5II ,P@'.YLG Q^-;S>/] 6.$FXE,TLTD'V<1$RJ\?WU*^H
MR/SI=1\'QZGX-L]!GN</:"!HIT3 WQ$%25]#CD>]<_=_"N.]LKB*6_0W%Y?/
M?3SB'#1RL1AH2#E"H&.^<\T:AH6=0^(D>D2ZJ9T^U^1J,-C#!;PN'C9P#^\)
MX/<@CKTJ[;>.;)+S5UO[N(+;7L=I!!%"XFWNN0A!^\Q.>G&*SK[X:2WCZK(N
ML%)+W4K?4(V,&[RVB& #S\V11/\ #,RZQ>ZK_:2_:Y-3BU*W)A^6-T4KM89Y
M!!_"BS#0U[OXA^&K.WLYY+YREW'))#Y<+,6$?WQ@#@K@Y!]*NP>,-$N;RSM+
M>]$TUW$DT0C4GY'^X3Z9P>M<FWPLEC73OLNJHK6L5X)&>'/F27.=S#G@#/ ]
MJL6'PVDM+GP[,VH1>;HT<<8GAB*2R(H.4)S@JV1P>F.*-0T.XL;V'4+5;F#S
M/+8LO[Q"AR#@\'GM7-6'C&.*;5AK$T426VJ'3[8PQ,3(VT, 1S\QSC\*Z:QC
MNX[4+?31S3[F)>--@(R<#&3T&!7*#P;??:I)FOK?Y];352!$>BKC9U]NM :'
M3Z7JEIK%A'>V,AD@<D E2I!!P00>0001BN:E\<HUQ920P21V;7\]E/YT3>8Q
MC4G* =<D5L^'-(GT:PGM[B:.5I+J:X#1J0 '<MCGTS6/;^$M0M]4MY_MUN]O
M;ZE/?(IC.\B56!4G.."QYHU#0TG\9:!';6MRVHQB"Y19$DP<*K':I;^[D\<]
MZU[N\M[&V:XN)52(8^8]R> !ZDFN%TGX?7^D-;&*_L)?W(AN?/M/,X5V97CR
M?E;#$$'CH:ZCQ/H3:_HWV2*989XI4GA=TWIO0Y 9>ZGH10KAH):>+-%OI88K
M>]5I)O-V)M(.8_\ 6*>."O<&E_X2O10]JK7R+]JV"+<".7Y0'T)[ UEW?@^7
M4M)M(KB>VM;Z&Z^T>98P^6BJ1M= .IW*2"3S^5//A2XA\337]K)8&RN/*:2*
MXMM\D31J%'EMV! '7IC(HU#0ED\?>'EL;J[AO&N%M[9KDK'$V713AMN1S@\'
MTK;COX9-+74,.(3#YV"IW!<9Z=<UQ,7@+4?[+M;&:]M-L5A>6CR(C9)F;<&'
ML.]=I:VTXT>.TNGC\X0>6[1 [<XQD9YHU!V.8@^(-D]]:2W#+;:7=Z=]LCDE
M1A(IWA<,.PP<YK=E\3Z/%=26QO4,R;LJH)R57>5!Z%MO..M<HO@?6?[+-F]W
M8,5T9]+1]K\DL"&(], 9'K3U\%ZV=;M;^6]L'6"X+I\CY6-H?+* 9QQUSU/>
MC4>AV.CZK;:YI%MJ=IO^SW*!X]Z[3@^HKFM'\5ZEJ<T@<Z5&4U"6S%OYS"5P
MC$%A[X&<>U;?A?2[G1/#=EIET\,DEK'Y0>($!@.AY[XK"T?PQJVF&X+1Z2\T
MVHRWBW)1B\0D;) R.N,CK3U$=#;^(](NPI@OXG!61LC/ C.'SZ8/7--'B71C
M"\HU"(A&",.=P)&X#;UY'/3I7-2>"=1EN=5?[9;Q1ZU;R)?+&I^23D1O'^&
MP/7K42>$-=B%AJ$!T:#5;*;)2&%EBN4V%&WG[V<'(],8I:AH=6OB717A>9=2
MMS%'&DK.&X"/PK?0GO53_A*;2YG\JQN(-T6H"QG^T[DRV,E4X^9O3M6!K/@[
M7+T72VMSIBB]L([:;=&RK&R.6&P#^$@XY]*L-X6U@7DQ62S>"368M3R68,
M-R]/4<4:AH=-#KVE7$2RQ7\#1M(\08-QO4$L/J,'-4I/%%I)<6R6)2ZA,C+=
MS!]HM5"%PS@] <#'KFLRX\$-/=Z[MO3%::A$Y@C5>8)I%VR/[YPO'^]ZT[1O
M#NH6FAZA#=V.BK>7$(A(@5]DV%(S(3S@YZ#H*>H:'26.I6>I1N]G<),J-M?;
M_"<9Y'T(/XU#-KFEV]V;6:_@CG )*,^#P,G\0.<=<50\*Z->:+:W,%Q+F!I
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MZMXI88I)HU><D1*6&7(&>/7BGC;SMQUYQ7D=EHNJ?;;.9M*O?,MM3N_LTLL
M'E)+#^[8#/RH'QP.E;WP_P!+N;3SII[;5[:^-JL-R+PKY+2J3\RX^^3R=_IB
MC4+'>O(L4;N[ *@+,?0#FLO3O$-IJ%O)<F*>U@4(RRW*;%D5ONE3WS_6N&T[
M2M49+47%C>)<):7<6LF125NR0?+QS\Y+<C'0<<5>OM&>Y^$-E9?V7,TT,=N[
MVGE_O R.I;"^O!HU"QV>G:O;ZG-?10I*CV4Y@E$B;?FP#D>HP1S5^O*9+"_&
MN76IV6GZC%=/K<8A=HW"B!H0K$KTV9QD^U:_@&RO4NC-?QZQ%>+;>3>)=(JP
M/(&^\I_C)Y^8=J+L+'>1S1S*6BD5P&*DJ<@$<$5)7C?]EZA9VEK8?V?J]OIL
M5U>I="UMM[&5WS%( >J[3PPZ'%3ZEH5^UCXFF"ZY+>0V]NMB6DDW.2BAR IP
MS9ZX[T7861ZY5:RO5OH9)%AGBV2M&5FC*$E3C('H>Q[UYG)IEQ9ZI<2V,&K@
MP:K9M;9,C*(V5?.(SP1][=FE6QN;R[T^"\BU;[*-2U%9?FE4>203'N(/0G&V
MB["R/5:IRZC#'<6T*K++]HD:,/$A94*@D[B/N],<]Z\F2XUN2WT.9[76!=P+
M:;Y##(Y= Y$@[!>/O9R3Q5S2[74=-;2K;3[34+:X35+T3*ZR>40RN8RV>"N=
MG/K1=A9'K-%>0W<>LOHSRV@U>*9M)<:D"TA?[6&79L_VL[ON\;<5VOA2*:TU
M/6;0_:S:HT#PM<,S9+1C?AFZ_-U]Z:8-'4T444Q!1110 4444 %%%% !24M)
M0!Y9^S_G_A62_P#7[+_2O4Z\L_9__P"29KZ?;9?Z5ZG2 *,$GFEHI@)BEHHH
M **** $I:**0!6;K6L1:)9I<RP33*\R0JL0!.YC@=2.]:5<UXXMI;O0H88;:
MYN#]L@=EMA\ZJK@EAZ8 H8(U['4'NY9HI;*XM9(B.)@,/GNI!(/2K9=./F7D
MX'/?TK@]5TZ?4M,GT_3;35H[EKM)[:_NF/[B;KNY.=@"XQWSBL:XTN_O+32T
MO=#U>.T-H\$T%FR^9#=>9DR9;LW4..E2.QZMO7=MW#<!DC/:H;J\MK*!I[F>
M.&)2 7=L $G _,UYW#I&I3W>HVM]H][)J0:?[-J'G8A:)X\(K,#R1P-N.HS6
M1=Z;JNH6\QDT#461-+L8V6:,$O+#*-^%SRVW//>B["QZS;W;3SW$;6TL*PN%
M5Y,;9>,Y7!Z=N:L[AZCTZUYM-HFHWD7B.>VM+N*X@OX;_38YR5$A1%RHYZ'!
M4CWJMJVB:C]HM?M]GJLUK?6SO*NFL"\%V[[CG/W>,*&'3%.["QZD2%&20/<U
MGV.L0WVJ:E8)'*DM@Z)(7  8LNX;?PK!\9V5S<Z%9Q0"Y,R'< 8O.1B$(VR@
M$$@]-PZ'FN0.C:DEU<:C_9%_#?K<Z<8=C,^U54"7!S\P R"31J"1ZAJ^J0Z/
MI5SJ,Z2/%;KO=8AEL>PIEGK%O>ZE>6$:2K+:+&SEUP&#C((KRB:VU?\ XF93
M1]65+K3KF%X?+9_WWFY3+$_.=O\ %TQP*[OP^DW_  ENL2R6]Q&DEM:!))$*
MJV$.X#W!/-%V%CI;VZ-G937 @FN#&N?*@7<[>P'K4R'<BM@C(S@]17E&J6>I
MB3Q((;;4+B.:VG,<GEO'/#)O&%!!Q(IZJ1R!Q2:A87EQJ&K7?E:OYGVRP^S%
M#(N$*J)2H'&,9#4786/6:S&UVRCUJ?2I"\<T%J+IW<8C\O.,[O8UY_!%>Z?<
M0R+9:HVGVNI7L"QA'=O)>/\ =X!.2N[H>U9,FF:A?Z'+!<Z;J,LR^&EB=98F
M#&43;MN>[8YQFC4+(]H5MR@CH>AI:\EDDNU\56EQ:V&LPVL=U$C9AD.;8PD'
M'.%7=CY<9SR35&&T\0VNDV_]EPZO]KGTN3[7YA<LQ68?*-QP'V;L>M%V%CVB
MBO*[>TD5[%Y8M;G\-RO,TL=S$R213%1LP@^8)][&>C'-4KV+Q'9:1+'?6VJ3
MW5UHR)'Y"LY$Z2L06(/#A"N3WHN%CU;4KZ+2]-N;^=9&AMXS(XC7<V!R<#O4
M]O.ES;Q3QY\N5 ZY'8C(KS"]BOQJ&M,L5[=1W%E<;BT<BR6[&, +C[LB,?NX
MY!S5W^SM0&MZ7#;R3FRUFRA%T#(RFV,(4DJ/X=P(4^](+'HPYHKC?%=H]_XK
M\.VAEOX[:3S_ #_LSNB\*"FXKP/F'>N4LCJ4L&H-?ZEK5GJ4<3Q7B_8V, ;S
M!M?(^^,8 V<[2?2G<+'JDE\D>HPV1CF,DR,X=8R44+C@MT!YX'>K->4VU[JD
M#63,]Y9$66H;R'DD@W  QR+N&<'G:#SVK/MM0EN[$&+5=2B>66Q!M8WE\U<-
MB:3D?=;/./3M2N.Q[+6;I^NV>IW<MO;"<^6"PE:(B.0!MI*MT.",5D^#I'.F
M:K;7$MRT-MJ$\,33EMWD@\?,>2.3@UQ6AP2/;>&=-L[W5+6*8WAGC221,LK9
MCW$CC/ZTQ6/64MX(YGF2"-)9/ONJ ,WU/>I:\C?4]8?1_/2[U"*^.GW9U=#N
M'V>91^[*\<'=P .JTD][JUHM_/!K&JN;6/3IXQ(S,K/(0)0>.1CJO:E=A8]=
MHR*XOQUJ%U:7&EQ&^DL--N#(DMW'&S[)<#RP=O('7'8D"N;D\1W]MK]I$FI7
MLLL5Q;V\HN(F3S5:(_-Y8&%5FV_,3G/'%-L+'IFHZG::3;+<7LOE1-(L8;:3
M\S' ''N:M@C)]:\AFU5M4\(SRRZIJ#7Y\A+VUEB.VVN!.N<<<'L ,C S7:^$
M[R>Y37K.6^FN197\D,4LARX3:I'/?!)P:%<+'3&"$W N#"GGA=@DVC<%],]<
M5)^%>,6GB#Q#%HMK?Z9J]WJLTEI,VHQ2 /\ 9E60*)$ '#8W<=\9K6O]8U,&
M]CTS6/-TU+B%K6>XG*&X)C)DA67'!& P)[\&E<+'I$>H6TM]/9K)^_MU5I%*
MD !LXYZ'H:6WO[>ZN+FWA<M);.$E!4C:2 1R>O![5Y3JVJW6HZ+JJ2ZAJ MX
MK/3;C:YVRQEI/G+;1Z<FM.Z\0WD>MWEJ-2G.DG4[>"6Y4\VT30;OO8X!? W=
MLT[A8]+JK?ZC9Z; DM],L,<DBPJ6Z%V.%'XFO+Y-;UB5X[>36[N&);;4&AE3
M"M.D3#RI#D=3R/<"MKQ+?R7WPQTF\GF5+BYDL7:0#^,NA) _.BX6/0:J7NI6
M>G>1]LN$A^T3+!%N_B=NBCW->77OB;5()6TQ_$*VMFMY=VZZG,,L)%VF-&8#
M&<,Q'][&*Z3QA+(?"NA-/>*)WU&RW3B/9N;>,L%/3UQVHN%CN*JQZA9RZC-I
MZ7"-=PHLDD(/S*K9P?QP:\WMO$E[-<C2[S7)8+..2^C34AM#RR1,-B,<8R%)
M./XL53_X234H)KG5KA/L^HOHUB;E@F3"KS,&DV]L*=V.V:+A8]5MK^UO9+B.
MVG25K:3RI@I^X^ <'WP15@&O($U:XL6UYM)UE+C=JNYV,Z)+/&+=2?+8C:6'
M7'?&,UV&KZ[<1:%X?GM[B6*VU&>&*XO70*\2,I.X@\*2<#/09HN%CL**\K_X
M2+7I[ZVL#K!@C+:@B7*QQYN8X0#')R,=25)'!P:U->U6ZU'X2V>JF^:WGFCM
M999K<A0<NN[Z#DT[A8[BVOK6\>=+:XCE:WD,4P1LE''.T^AY%3DUY3%J]UIG
MB;5[JQOD:.37H;9[?"E9P\"Y.[KG(&,5M>!M?U+7KA;FZU:QFBFMM\EC'S+;
MRAL'. -H'3#9.1FE<+'6?V]I/VTV9U*U%R'V&(RC<&]/K[5H5XOXF!N(?B%$
MEUI\4:W,+NDN/-;;$A/EG/#G& <'FMT^,-3*7=U;NT$EE=6MO%I-P@WSQ2!.
M2?O;SN.".!M.>]%PL>EU7N[RVL8#/=W$<$0(7S)& &2< 9/J:\JG^(&J(VI2
M6VK6TD7]G375N[HF-Z3!  G4#:>C<G&>*?XMU6]?2M8TW4M;A/V*.TE57A1#
M="20,3CL%QM&WTR:+A8]7#'./YT^N6\9:W-I=K8I:WR6\URS[>%W2!4+8#-\
MJ]!DGMTYKDE\;:[<::VI1ZI9*D%A973PK"K!GE<JZELY [^M%PL>H2WEM!/#
M!+/''+.2L2,P!D(&2 ._%.CGBE:18Y%<QMM<*<[3Z'WKRR[\2#4->T34KZ\A
MC2TUBZA-GA0T2QQN 23\V2!D]N15R/6-2TX2VD=S%8W3:;)K3-.@83R,Y_=\
M_P *C:#CGD47"QZ74<]S!;!#/-'$'<(I=@-S'H![FN,\*:]K7B'7;MIYXK>S
MMH;>1K+R?G!EB#X+9R,'VK#\037=QJ.N02ZBD@AUC3Q;1RJO[C)0Y ZGK1<+
M'JE17%S;VJ![B>.%2<!I'"C/XUYN_C/73*VF1W.G+=QRWD8NYRL22F%E"C!.
M!PV6 .>.*T/B%(UUX!LII1;/,]W9MP<QEC(O0GG']*=PL=S#/#<1^9!*DJ'^
M)&!'Z4^O*8M9N?#/BSQ!!*EO!/=W%DJBVRUK DA*>8V<8?U!QGBM&^\9ZI:+
M?6GGVYNK.YGC618^9T2(." 3M&,@-S]*5PL>C4Q)8I'=$D1FC.'56!*GW]*\
MWE\<:VL-]J*O8?8[.PM+IHO+8L6F7GYL\*IY^E;?A,.OBKQ2LMS#<R&6V8R1
M*%SF$=0#^M.X6.PHHHIB"BBB@ HHHH **** "DI:0T >6_L__P#),E_Z_)?Z
M5ZG7E?P ./ABA_Z?9?Z5ZF/6D M%%-VBF HI:04M !1110 444GUH 6BBL+Q
M)?3VITZVBE:WCO+D027(QF(;21C/ )(P#2 U+V_M-.MS/>W$<$0_C=L"F7.J
M6%G%%+<WL$,<O^K>20 /WX]:\\L[^^U?7_#']HWQRMS?0C:H"W2QC"OM([C@
M]NM;_C@0QOX81A$L8UF  ,  !ANE*X['1_VMIPLGO?MUO]E0X:42 JIZ8)[=
M15S.1Q7E.O7K67BCQ)?:)+%':0Z= +MUC#Q&X\T <'Y2VP\_A5S5O$>M6-YK
M5U'JT1L[&\@M?*,2A8DE5"79ADC;D\]/6E<=CTJBO,QXAU-)XM+O/$UC;LT4
M\]OJ$>UTD*,-L3D@!B%.3MQFF1:[>6NM7UO_ &O*RWNLQVIE?;_HT;0A@5!'
MR[CP,_SHN*QZ?FC<*\WM-=\0:GJ]EIRZM%: 27D;S&!6-RL+KM8 ],@D''H<
M5L>#M7U&^OKVUU6<O<)&DH50K1,K%@'B=>J' X/((IW"QV%5EU&R:^-B+J$W
M0&XPAQOQ]*XN^\3:HNIZC)!*(_[/U*"T^P-&"9XI-N7SUR=Q((_NFKW@F!6G
MUZ:287$B:O<*K.JDITZ$#/3'Y47"QU]%>=7_ (OOH?$TEM;:C;O 9KFW*E5
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M#ADD7<IR._!!%%T%F;M%%%,04444 %%%% !1110 4E+24 >6_ #_ ))BG/\
MR^3?TKU(&O+/@#_R3&/_ *_)OZ5ZG2 6DI:*8!1110 4444 %%)29YP:5P'5
M%/!#<Q&*>))8VZJZY!J6LC6]8;39].M845KB_N/(B:3.Q<*6)./8<#O0V!?^
MQVH>)_L\(:$8C;8,H/;TI;BTMKH 7$$4P7H)%#8_.N"GU6]\2WNCV4T,$4+7
M=U:WL!9MKO$IY!&#CN/>J&AS?8UTW5]0M5N;@7=Y#YZ32!E2,.1\N<,<)@9I
M7'8]*^P6?V8VWV6#R"<F/RQM)^E(EA9*)0MI !,,2@1CYQ_M>OXUR3>,M1CT
M^ROGTV!X=2\D6)AEW,6DSPR\=!W!Y)Q4UKXEUZXU:QT]]%@MY9XI)9?-GY14
MD"Y  /4$$#MWI7"QTC:3IKV\-N^GVK0P,&BC,*[8R.ZC'!ITNFV,S2M+9V[M
M, )"T8)<#IGUQ6#K7BJ>PO\ 4+6RMHIFTVS6\N5D<J60D\)[X4\GV%4],#Z_
MXQO[FX(:TM$M9K+:[JZ;T+<@'!SGD'VIW"QUBZ?9K)%(MK 'A4I&PC&44]0/
M046MC:6086MM% &.6\M N?RK@=2U/6;RZ;<8&:T\116]JL<C1@KLR0^.HYJW
M%X]O[N)(;+1FN=1C21YX(VRIV2&/Y6XZD$Y-%PL=FUA:27:W3VT+7"\+*4!8
M?C2VUC:V?F?9K>*'S&WOY:!=S>IQU-<SXIU&X-WX<TY'>VM]5NS'<NIPP41E
M_+##H6(QD>AJ6^,?A:[B:TEED.I2QVEO:32DQI)\QWY.2!CJ.^* L;$FA:1+
M<O<R:99O.[;VD,*EBV,9)QUQQ4=SH<'V5DTPQZ;<^6(DN8(4+1H#G: 1C'M7
M-GQOJ,EU%86^DPM?>?<6TP><A$>) ^0<9*L"/>HD^(-[_9LUY+HJJ#IPU"VC
M%QDNNX*RL<8!YR.M%PLSM[.UBL;.*VA!$<:[1GJ?<^]1?V3I_P#:#7XLX/M;
M#:9M@W$=.OTKE9O&FH6QN;:ZTJ&&]A=" )]Z&-U+*>!N+?*5P!UYZ57D^(ES
M]C6]@T;=;+8PW\K27&&".VTJ!C[P]^M%PLSM;.QM-/A,-G;Q6\18L4C4*,GJ
M<>M5VT'27NS=-IMJ;@R>:9?*&[?C&[/KCO63'XIF?7;C1VL52\CN8UC4R_ZR
M!EW><..@P1CU%/UKQ/+87EW;65DMW)8VHO+I3)L/EDG 7CEOE)]./>G<+&B?
M#FBE;8'2K,BU<O #"I\ICR2O'&36BZ+(C(ZAD8896&017.:-XHN-<URZM;;3
M@+"W5&-V9AD[XPZ_)CT//-5KGQG+:ZY+I[:>'4&98RLO),<>_P";C R <#.?
M:BZ"QOVVB:79I(EOI]M$LJ[758QAE]/I[4Q/#VD1VZ6Z:=;"))1,J;!@..C?
M4=O2N:3QU>MID]U_89\Q+"+48X%N Q>%CAN<<,.N.]=!8Z]#>VM]>H%-A;C*
M3HVX2@+N8@>W2BX68DWAC2&B;R;"VBF!D>.01\I(XPSCW/?UJGI'@O2=.\/1
M:5<6EO= 0I%-(T6/-V\@X[<\\=ZSKSQG<MI=QY5FL%U/I<FH6#M)N5D4<[N.
M&&0<<CGK3KB\OO#G@:35X$:XO)5AD>*YN2R*6VJ2"1P.<X]:5PLS9C\)Z!%+
MYD>E6T;X<;D7'WQANGJ.M)9>'A9ZI#*DL:V%I%Y=E9I$ (,C#'=G)S^E8,/B
M6ZTKQ)J4-W!//927\,'FF8%;9GB!VJO4KG/YUL:'XH_MN]\J/3;J.W>#SXKI
ME^1AG&"<<-WQSQ0@LSH*QY?"NA3ZB=0DTNW:\,@E,VW#;P,;OKCO6/I,EYXH
M?6KHZA=6?V>\ELK6.!@!'LXWL,?,23GGMBICXN73U:.[B>>*RFBL[R]0@*)F
M &=O7&6&?3-%PL:<7A?185LUBL(T6RE::V"D_NG;JPYZG^M$'A;1;=X7AL41
MH)9)XR&;Y9).';KU.:Q4\>&62-(]#O6:9[B*(;T&YX2=X// P,@TDOQ!@6,3
M1:1?SV_V*._DD3;\D+$@G&<DK@Y HN%F:,O@7PU-;QP2:3$8HXS$J[FX3.['
M7GGD>G:GW'@OP[=1W$<VF1%9Y5FDPS [U& P(/!QW'6J$WCVRAOI+4V=PQ\F
M::$J5S*L:AB<9X!!X)ZTS_A/K=+2ZN)-+O4^S0P73(Q7)AEX#]>,<Y'48HN@
MLS1N_!7AR]>)I]-C/EQ"$*K,H* Y4, ?FP>1FM/4])L=8TV33]0MDN+64 -&
MV>W3GJ"/6LXW%WJ]U')IMP]O#9WFR<D*4N4V\@'K@$]NXI?$/B6W\-PB>YMY
MI(MI=W3 "J,9Z]6YX YH :G@_0HDA2.RVK##) F)&^[)]_)SR3W)YIC>"= :
MV:#[$5C>U2T8+*XS$IRJGGMZ]:YW7/$>J_VAK\MF+F.+1[6*XA$939-N0GYP
M><'VZ8IEQJNH6.F:P5U34C?+I\-VD<ZQE(=S8.T@<DD'.>@I!8ZJY\(Z-=R3
M236SEYWBDD(E8;FC^XQP>HP.>^*;_P (;H'VN\NEL DUYDS,DC+DG&6 !PK'
M R1@U4D\1QV%_JQD^W7#02V\7D>6H1"ZY!5O[IZDMTJK!\0K.>9)Q:R)IAT]
M[Q[EF&5*OL*[?KQGZ4[A9G4:?IEMIEN\-NK?O',DCR,6:1CU+$]3P*P6^'?A
MIE9?L4@#1O%A;AP C-N* 9X7/.*2T\<6>H1O%;6UV;[S#$EML&YCMW;@<[2
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M-=!I7A_^R]5O+[[9),;F&&(QLH"KY:D C'<YYK:HHL.X4444Q!1110 4444
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MC>&9=%D8VM^L44L_G36\4 6)OEP0JY.S)^8X[UT=%%"$%%%%, HHHH ****
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M AEM;>>)8IH(I(U(*HZ @$=" ?2H/[(TS:%_LZTVC=@>2N!N^]V[]_6KM)2
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M-+112 SM4U/[ UI!&@DNKN7RH8R<#H22?8 $U'_;MI<O/;:=<0W%]&K%82Q
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MR.]6Y/$ND0W;6DMZBS(&W JV,JNY@#C!(7G'6N>B\):[_P (K<:'<:C83*D
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M4[GP7;:/]MCN+Z,PE[B<'#['#'.._&*-0T-!?%6B/JO]EK?H;SSF@\O:P_>
M9*9QC..<9YJ:^U_3-,NH[6\NEBE=0V""0JD[06(&%!/&3WKF6\)ZN]_YYFL]
MG]NC4]N6SL";=N<?>[^E+XP\)ZQXAO)&M;JS%NT,:QK<!\QR)(&S\OW@0,<]
M.U&H:'3:GKNFZ-Y(U"Z6!IMWE*5)+[1DX !SQ5:#Q?X?N8YI(M5MVCAA$[OD
M[0AX# ]^>.._%0ZSI&H7^L:+>P-;;+$RO*KDY8O&5&WVR:Y=/ VOPZ;:V\%S
MI\<MOI366X!B"YE#Y&1P"!C/4$YHU#0ZL^,='^TV-ND[O)>3O;H%B;Y'1<L'
MX^7 ]?6G2^+_  _"DS2ZK!&L(5G+$CY2=H8>JYXR.*Y:P\"ZO:3^8);!(SJ$
MER8T>0XCEA\MQN/.X=0>]1Q^ ]9C\/-I9_L8O#Y44-RL3"2:))%8>8>QPO0<
M$\T:AH=-;^*M/EN[J4ZE9M8QPQ.@57\T%R0,@CD$X  YZTO_  DR7&MZ+;V#
MPS66H"X#2<AE>(9QCMSD'/I6;K'AC6;S6M3OK.>TB2YAMHT1]V6\MRS D#Y<
M@X!'(J#1/"&KZ9J>E22R6!MK*YNYB(B^XK,. ,]P?4T:AH=7<ZWIMI?)93W<
M<=PY4!#VW'"Y/09/3/6L>^\8V=KXCL].2:%[=X[A[F7YLQ>4H)QQ@]3GTK,\
M5>$-9UO66N;>XLC;A[:6)92RLAB?<P^7AL]B>G:C2O"6M66I:.ES+83:?I;W
M05OF\V5)0<;L\;AG!]:-0T.H_M_2C#'*+Z(QR0K<(PSAHR<!AZY/ ]:@;Q;X
M?1H%;5[56GSY:L^"V#M/'L>#Z5S4G@&\30'M8;V&:YM[U)[$3*1&(8V)CA?'
M.,$\COBIK'PG?P:U9ZC)::5&%L[B.6"$-M$DC!@>1\WW>2>3FEJ&ATG_  D6
MD>7))]OBVQD!NN><XP.IS@]/2K0U*R;3AJ"W436;+O$P;*D?6O/&\":VJ6]Q
M +0"TG2:'39IW>+[C+(%DQN5?FRHYQCWK?U+PK=7?@6+2+5;*UNH72:.&,,+
M?<K[]A[[3T)Z]Z>H:%G5/%]G"-/CT^:WGFOYGAA9B=BLH)(; R#QC'O5;1O&
M?]I)-=W*VEM8PR/;R,9B765#@C&/F!^;&.PJ"U\.ZI;WNCW*6&G6RQ7DMS=Q
M6\C'[T>S.2/F;/)/%9<W@S6_LL,H@LYI8-3N;DVCW#)'-%-G^)1D,N?IUHU'
MH=RVMZ8CP(VH6VZX4-"/,'S@]"/KV]:32M9L-;L!?6$PDMMS+YA&.5.#U^E<
MMIOAG5])UDK#8:5)IER()&#$_P"A/&,8C4CYAW'(P<U=L?#VI'P-J&@SO':W
M$GGQPSQ.7!5V)5CQQUY%&HM#<77=)>!YQJ5KY4;A'?S0 &/0'Z]O6K-I?6E]
M;^?:7,4\.2-\;AAD=1D5P&H^$-7U1#<2V=O',8;2V:W64;'\J4.TAX]!A1UY
MK=TO0;V/3_$EI(B68U"YF>V:-@=JN@ .!T.1G%&H:&M/K<!@#V$]G<,)TB<-
M<! NX^OKCH.]9=QXYTL7-H+66*>UDO9+.YG,FP6[JI8YSUZ8KG(?".K'1HUD
MT6S@U!)K19)8[LN9DA<$MEONC X7KR:M+X7U5=4C\W3[>6TBUV;4-_F+\\;H
MV/E/<$TM1Z'9OK&G(EO(U];".XQY+&48DSTQZU)#J5C<W#VT%Y;RSIG?%'*"
MRX.#D#IS7FL/@G6$6RCN=)MKRVDM3:S6\EX46W(E9U?Y?O*0PR!SD5V'A317
MTR759[G3X()[B]DDCE3:6>)L8R1R.G2FKB=@'BFXNHKR[TK2GOK*TD>)I%E"
MO*Z<,(U/4 \9XSCBMI-2LVG6 W,2W#1^9Y+. X&,Y(ZUSF@:?K/AJWN=*CLT
MN[8W4DMK<^:%"H[%L2 \Y4D],Y%9Q\+ZL^HM'+&C*FK_ -I)?JXW-'MYBP><
M_P /IBC4-#KCKVC@,3JMEA0I8_:%X!X'?O4S:G81W"V[WMLLS,%6,RJ&)(R
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M"C)ZGCO4U% !1110 4444 %%%% !1110 4444 %%%% "!5#%@H!/4XZTM%%
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M]J I?;NS*HQGL#G%5[ZZNO#6GZCJ-II=K%=1R(\EDMP9#<0#C*#C#G) &.<
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MKI4\*>'XUE5-(LPLL;1./+'S(3DK],\XJU;:-IMG)<26]G%&]RH28A?]8 ,
M'UP.*+!<Y*X\9:G<36\6D0VDWV]9Y[&21MJR11@ <DCEF.>.B\XIE]J>H^&K
M/^U=@,>HN;J\D),Z69V* ,*<F/(.7'3TYKK+SP_H^H6EO:W>G6TMO;$&"-HQ
MB/ Q\OIQQ3[S1-,U!(DNK.*18E*(,8 4XRO'8X''2BS"Z+*NTMH)(F0LZ;D/
M522./PKS^W^)%TUW:VUQ90I))%)!*JAB(KY6PL!/^T!N'?%>BJJHJJH"JHP
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M1-]H\L$UC%%,\2SJ^Y)'*C!'&1C.*K6GB=]/O]5MYVFO)I=5>&TBR3M41*Y
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M_),8^?\ E]F_I7J./FS7EOP Q_PK%,_\_LO]*]4I (,TM%%, HHHH ***2D
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MLJ-DKQ@YV^_!(R.<53TKQI%;:+HHU,7$DUS;6[2W6T!6>7@8Y^8YZX'%6X?
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M7Q3H4-P\$FJVJS([1LA?D.HR5^N.W6G'Q+HH@MYO[2M_*N%WQ/OX*YP3[#)
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M4Z0"T444P"BBB@ HHHH ****0!65K>N1Z0+6%8FN+V]E\FUMU(!D;&223T
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *2EI* /*_@ V/ADO_ %^RX_2O4<G/>O+OV?O^29C_ *_9?Z5Z
MG@9]Z0"TM%%, HHHH *2EHH ***0\4 +124M(!*6BDSS0 R2*.9=LL:NN<X9
M<BGXQTI:*8!351$&$4*"<X QS3J*0!1113 8\,4CH[QHSIRK%02OT]*?110
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M23VBG?,2FR9]O7'+#!''%=,_@_1Y6!DBE?%S)=8,K8,DBE6/T()X]ZJ+\/\
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MDETR]A=+Q+*5F"D1R.,IT/(((Z=.]5[?XAV4S1E],U***83+!(T0/FR19W(
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MD<SZOJ,MQY<*0W!=0\)B)*,N!U&3G/7/-=+I]FUC:+#)=3W4F27FF(+,?PX
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M$S7!C7+"'.U,= ,DDGJ2:>HM".X\?V=MI?V^6QND2-I4N5;:/(,9PP)SAF]
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M-)J)F"W#0O(L9C'*LHYSG@^E5](\<B6P;5M5GAM[)FEB6$02"0-&Q#,,_>7
M))QQ5J+P[JD6KZ)>@::BV?GM/% AC7,B@808YQCJ>364O@C6HK/39!+I4]Y9
M/<*T-S&SP213/O\ J&4_G1J&AU3^*=&6>"(7JNTZJT112RMN7<H! QDCD#J:
MGT+6[7Q!HL&JV@D6WF!*^:I4X!(Y!^E86G^&M8TO6I6MKRQ.F7+I/.K0'S(Y
M%4*1&/NA2 /]WM6AX?T.YT[PH-%OI8G*K)$)(,C*,3@\]\&GJ&A*WBW0HX[B
M234(TCMXO/=F5@/+SC>./F7/&1FK>F:SI^L),]A<"80OLD^4J5.,C@CN""#W
MKC+CP/JUUHJ6,MS9F2STY].M9!N'F*Q4;WXXPJCY1GG-=/HVDW5AJNJW<[0E
M+PPE%C)RNR,(<Y^E&H:&W1113$%%%% !1110 4444 %)2TE 'E7[/O\ R33_
M +?9?Y+7JU>5?L^X_P"%:?\ ;[+_ .RUZK2 ****8!1110 444G>@ I:**0"
M5#=7EM90^==3QP1@XWR,%'ZU/7,>+=%OM2GTVZLH8;M;5I%ELYIFB$JNNTD,
M.A']30"+=[XDM-,>[GO9[6/3X(8W$RSAG)<X *#H#Q@]\T:?XCM[O5;RPF>W
MAEBG$< \X%IU*!L@?CT]JY2X\$7^-1BL[&Q@AETNVMH$64E0\4F_;DC.W' )
MJS=>&-6N[Z>\^QVT4LNJV]UN$P++$D>UL''4'H*6H]#L#J^F?O@=0M1Y) ES
M,HV$\#//'-5-5\16&E:&=6$@NH698X1;L&\YV.U54].3Q7%#P1JK:#<V4^E:
M:]VD26R7?VEV-Q$)0^2&&$Z9QSR:Z[Q%X>.JZ'#:6'DVL]I/%=6R[?W8=&R%
M('8\CCUHU#0GM=4U%;R.#4M-6VCDA:7SXYMZ(1C*L<#!P>O3BK@U?36MUN!J
M%KY+,55_.7!(ZC.>M8&MV&O>(_#]S9-;V^GS'8Z_O_,$C*P;:2 ,*<8]>:RY
MO"-_>:O'J4MC;*DVI07<MFT@98ECC*$@XP68D'CT%&H:'9QZOILW^JU"U?\
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M([N&V65)K21@-V\ !@3QD8Q]":QO#?@^XTO7;26^M;>XBMM.6%+@D,R2"5G
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MHI@%)WHS12 6BDS2T %%%%, HHI*0"T4E+0 444F:8"TE%%( HHHH 6BBBF
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M2:E_:4<H1<QR;@V .A'UJ32=*DE\47VNW5@UI,8EM(]T@8RJI/[P@<#/ '?
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M6#Y[@@=J9>?$#1[;3[NZB6YG-N@D$:Q$-(A?9O7/5=W&:S[7P-?VWDR0WUO
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MM2TUKR8)9A;F2WVS2#ED8KP??%<B/!NHW%[>27-C;))=W-I<)="4,]MY2J&
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M%%% !1110 4444 %)2T4 %%%% !1112 *3%%'>@!:*:K*V<,#CK@TO7H: #
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MC4V=J+D:E=6,MQ&C.F8E++M3.?F/'M4L7Q!\2MJ-AI<FC6\>I-IZ7]Q#,_E
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MY8+/3Q?,968,_P ^TJ,<#CH:CE\8ZE!<R6$MG UX]Q%% T.2NV2,R#(8CY@
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MT;4%L1)!)&;*/R86@E:-A'@ H2I!*G X-.S"Z,I?&EVVJFV;1PEN+];#SFN
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MU:Y64K<W"6R%%SAW.!GT%2S7HAO[:T^SSN9PQ\U$RB;1GYCVSVHN!:HI,T4
M+1638:_;ZEJ,MI!;W6U Q2X:+]U)M;:P5O4&HK'Q-;:CJ*VEO9WS1NK,ET8#
MY#!3@G?]<C%%QV-NBLG3?$%EJERT5N)=I!:*5EPDP!()0]\$&M:BX@HHHI@%
M%%% !136D1"H9E4L<*">I]JAN+ZWMI[>&5\2W#;8T R6/4_@/6@"Q161!XET
MVXEO%6258[-2TLSQ,L>!UPY&&_"HG\6Z/%:-<27#J$D\MHS&WF [=WW<9QMY
MSZ4KA8W**J#4K5I88DE#O-$9D"#.4X^;Z<U):W4%Y;+/;N'C;H1^H^M $]%)
M2T %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@#RG
M]GSCX;,<=;Z7^2UZM7E7[/@_XMH>>M]+_):]5I +24M)Q3 *6DHH *6BDI %
M%%% "5S&MPO!XV\.ZE*";1$N+9F/2.1PNTGZ[2OXUU%4]2O["PMP^HS111,<
M#S.0<<]/;K[4@.!NM*O(/"_]DB%[>]NM>\ZT0L"0GG"3?P> %S]*Z:&QO(_B
M+>:D;9OL4FFQP+-N'+J[,1CKT;K4>I>)3_PD-KI&DQVES>R6IN@\SD*T>X#"
ML >2,GTXIGB'QK;:3#J26@2>\TXP-<12$JH61@O7U .:!ZG)+X/UQ;6'[%IY
ML[^6/44FN/-4']XVZ(,0>0?_ !W-=7X0TR:RL[ZX.DW&GSW(7=#<7(?<ZKC(
M"\*.G(Y/6MD>(]&:Q-ZNI6QM@[(9 ^1N7J/PJW)J-G#8"^DNHA:E0PFW#:0>
MF#WS0K VSRJ#PUXGC+R1:0T:&" S6AF18Y3',6>(8.3E3PS=>^*O:KI=[;VL
M]V/#;+IDEA=!;0W"DVDK9;S""< $9^Z?EQQUKT"+7=+F6%H[^!A,KM'AOO!/
MOX^G<=JH_P#"4Z#>7D^G&ZBE"VBW,A89B,3' YZ'/I2T'=G!'1=7N]'DDL=.
M>[34M.TR2&99E4*\6"Y.3G=C\ZNWGAO59(-42.RN$=]5N+JVX22)U9  )$)Y
M5CD<8*]:[*'Q)H*7=KIMM=0@R0O+&L8PB(AP<GHN/2IU\3:(T F_M6U$9D\H
M,9 ,MC..>^.:- U.'N?#>J3/?R2Z&KK]ITZ<0*ZLK^6N)=FX]NG.,XJ<:'JB
M:M/.VF/)I?\ ;$EQ-9D@^=$T(57 S@[6!.W\:ZC6/%>GZ=X=DU6WO+68&%Y;
M<&3Y9=HY (S]*2V\2P^9*]_<V%K;I# _,_SH\@SM<'[O;'K1H+4X3_A#M6:+
MR[K3Y;A%TN]2!#(#Y+/)N@CSGEE'?MZUUFN:3>:KX.TFVEM'GFBEM9+J%G 8
MA"-_.>3U[\UN+KNDM9B\74+=K=G,8D#Y!8=1]15A=1LFL/MRW436A&1,&!4C
MV/>C0-3SBXT"72!:M8/#:ZBVHRK864DF66TFPKKC/;E_0=*ZCQ'I,L7AFQTW
M3K%KF.">$,JD92->K;20'_W3QS39_%FC1^)[:.=[$0-9M+%J#N,JWF!#&../
M?GM6\VLZ:MZ;-KZ 7(&3'O&1QG^7/TIZ!J>6P>$-6ELDBO\ 2+B62'3+V",R
M2J?WC2[H>AQD#H>U;$&CO/XFL(%EB9KNSA;6[<R;I$DA *,<="Q.#ZXS79CQ
M-H;6[SKJMH\*':SK*& .,\X]N:=#>:*FJ-%!-:+?7(#-LQOEP,C)'7CGZ460
M79S?C.UL[KQ3X>BN[%KU)([M# IY8;%QQD9&?RK!T[PGK-O=V$&KV=Y?+&EN
MUO<07@46Q0DE')^; XZ?>Z5Z'=W6CPZI;"[DM5OND!DQO&[C@]L]/>LZT\2R
M:GXCNM.T^.WEM[&7R;MFD*R*=N<J,8(!(%%D%V<6/!US'X<1H],N(-3:[N)&
MX65&7<Y19$+<J0V.#E:MIH.O23L)K(PZ@;RUN+:[CDW);PJJB2+.<X&'&WON
MKH)?'6G&XLS:R1R6<EY+9W%P[;1$R*6X]>F*W3K.F)';NU_;A+@ PMY@PX/0
M@^]+0=V<-X:\/WVGZSH=V=-N(&'VY+MV?.$9\Q \GCT]*L:WHFK7>L:JRVTC
MW,LMO)I5\K#%L%(WJ>?EZ,3_ 'MU=/K.NC3;RPT^W@^TZA?NRP0[MH 499V/
M90/;N*=!J\L7VK^UH([!8&4+*9=T<H(ZJ<#OQBGH*[,WPKIAL=6\13MIQM?M
M%^7CD*@>:FU>1CMD&N.3PGK20R/I=K<V6K+)>F:<S;4GC<L8T!R1SD$''RG-
M>CR^(-'MXXY)M4LT22/S$9IE 9,XW#GIGC-._MS2MDK_ -I6FV%Q'(WG+A&/
M0'G@FEH&IP5OX>>0:>RZ1JT,#7\<ES#<RJ0H$;*Y"H<!22,_WNN*HQZ%K#VU
MC;7UCK)T]8I8H8[5T$EO()BR$EC\H*;0&'3&*]+_ +>T@V<=V-2M#;R,5642
MC:2.HS[5(=7TU;I;4W]L+AF"B+S1N)(R!CUQS19#NSS^_P!%ND'B66VTB\2>
M:\M'B>(?-,J%-Y!!Y'#9]:LPV-_)?ZJ+[2-1-^K71BO8I,12PNA\M>N21P N
M.",UUU[K]E;:1-J%O+'=JBOY<<,@)E91RJ^_%6X-1M;B86ZW$7VG8':#>-Z_
M44]!79YB+/7U;0V;2M2\ZSBL=TH^=F .)1G=\N,\CDM74Z-:ZI'X7UV*VAEM
M;^6[NWM?.&TY8DHWT/%=,-0LOWH^UP9B<)(/,'R,>@/H3Z5%/K&FV\=U)+?6
MZK:*7N/W@/E@=R.U+0+LX2/0-2U"VF2UAO;#.EH9%E<C=?(P96'/)X()Z$$4
MVUT3Q%+)?O?VDD=O>PMJ)ABE),%QL*" 8//)#<<9KMK?6X+F<LKV_P!A-NDR
M7)G7YMQX!7J!TY/7-6UU&Q-N;A;RW,*ML,BR@J&],^OM1H.[/,8=+U^QT>**
MTM-4,C:9:M>J7):619/WJJ6.-^SC'<<5>L]!DFO])3R=>&GM]ID99W,>PG:4
M&%/R#<#M!_E7HR7-O)!YZ3QM#C/F*X*X^O2H?[3L/(2?[;;^3(VU7\P88^@/
MK3LA79Y@ND:JUJME<6%]<V[WUI*;DHR2E0Y+B1<XW*.KKP>*N6UCJEO=VD0M
M]2CLX)-2C^=FVK"R_NLG/3T/:O19+ZTBG:&2ZA254WE&<!@OKCTIDUWI\L$D
M<UU;F)D&\-( "K=._0T6079P_@"TNB^EZA ;T6TVE+]M:YD9EEFR-I&XGD#=
MDCC!%216.MOJZR21W*7ZZP6DGW$Q26.#\OITP,=<UT$&L:5HUM)$IM+71[6.
M,0S)<*RG<2 H4<CGIZUH0ZI&S7C3F&&"W8 2^>K!@0#D@?=Z]#19!J8_@O3A
M8^%#;S6<T#-+,7B<$,07;''N,5S_ (=TN\L;?PK']COH((XKP7L1#!1D';O7
M/4]J] -]:!HE-U &FYB'F#Y_IZU+'+',F^*1'3D;E;(XZT6"YYAX=\/O:KX6
M>ZTN[BCC@NX9^&'DL[?*6YX&W/-=#X*M+Z.2X2\E::'3F:RM9_-W_:$SNWGW
M (7\#72O>Z=<6DN^ZMGMR3%(3(NW)X*GG]*?I]O9VEA#!I\<,=HBXB6$#8![
M8HL@N><O;ZC=ZYJK:;<:BVIVVL 0$RN8$B**65A]W;R>.N<8J 6NK2>'KH@>
M(([]A ES&%*@2"4;V0@Y8E=V2.,8KTRTTZTL9;F2V@6-[F3S9B"?G?ID^_%6
MJ.4+GGL=E>V6OW=D8-78I)&VE7$<C-%LV\K(Q/3<3N#<D8Q6,T.MOX?N'SKZ
M:F?(CNH_+*+Y@E&YT8$[LKGD<;>M>MT4<J"YYK_9EV/$6GLUMJ$MG8:W+Y;2
M;VV1/",$$G)3?GGG%='.LD?Q&BFG4FW;2F2W./XQ)EP/?;M_*NGJ.6"*9HVD
MC5FC;<A(Y4^HIV"YYU=Z!<3Z?K%MH4%ZNE7%HL@L[@L )UD#%8PW(#*"".F2
M*EN?#R:UK&MZU=17\-L8H5M1$"DK$1LK@ CH0^W_ /57HE%%@N>?QQ:_HFJ:
M;%#;EA.L7G;(]ZA0VWRMW\"HG.>YS6EHHO@OBQK$#YKR0V6[[ID\M<_AOS^M
M=:RAE*GH1@TR""*VA2&% D:#"JO046"YYE/_ &V=),EH=6B<Z8/MP;?O%WO7
M&SW^_G;QC%=)XEMI['P08M.N=1,JR1%)$D9YB#(">>O0G\*ZVBERA<\T*ZM:
M:C));W.KOY&M+#")6=HS T>3GCE=W<]*K3R>(Y=$6:&35(M0_L^Y74XQNRDX
M&8S'VW;N!MX*UZI11RA<\Q\C58KVQM9]1UR*":UAFM[A8VF8SDYD1O[O;AAC
M&:]-'2EHII6!L****8@HHHH **** "BBB@ HHHH **** "BBB@ I*6DH \J_
M9\&/AH3ZWLO\EKU:O*OV?3GX:8]+V7/Y+7JG/:@!:*** "BD[TM !1110 AH
MI:*0#0><5SNNZ-?7&O:=J]@896MHIK>2VG8A760#Y@>>01^(S71T4 <7X=\(
MWN@:QI;^;%/:6FEM9M(6(<N9-_ _NCH.:C\2>$]4U2ZUHVILS#J,=J!YK,"I
MB?)X .017<48I6'<\ZO?!.K/KMQJD":=*IO99%M)V81R121JC$[1PXV^^02*
MW]2\.W4WA[2[2Q:TAN--N(;A(DC*0/L_@QS@8/'H0*Z;%+3L%S@$\':M!J$>
MK6YM!=O?7%S);LY\N,31"/@@<D8#'CG)J"U\#ZM:VGD3IIU[')I<-E,C2.@+
M1R%LJ0,C(;@]B!7HU%%@N>=Q^$?$<821;FSDE:TN[7-T=YC61@T98@8D(Q@D
M]<]ZK6/@C7(M2BN9XK$QF]M+MU,[2,/*C*,,D<GN.@[5Z912L%V>90^"->LX
M;KR182_:H+RU:)Y"%B661G5U..O."/85/>^"]9NH+U3'8NT\&GQ@.Y()@;+D
M\=^@KT>BG8+GE&O6%]H>IQSE+>%KG5KBY@E,A$:Q/"$*L=I 8XXXKIK#3!J'
MP[M],@TM8HE18EMIIF4%58?,K@ @G&X' YQ78$ C! (]Z.U*P7/.&\&:[(D_
MVDVETTFE7-FCS-\ZM(^Y-Q ^8@=6ZDTO_"(^(1JUC>%+"1;6Y2;!E(W+Y'EL
M,8P6S_$<Y&.E>C4M%@NSS2#P)J=MI.AJ+73IYK2WEMKNTD=ECE5S]X,HZC'0
MCD$BM?3_  OJ%CXBMKJW2UM+6-@)DA<F.9!&%7$9'R.#QN!Z"NTHIV"YQ&M>
M$M0O[_7$CE@>SUA( 9)"=]JT?=?7U'H:UO#VDWNFZQKUQ<K'Y-]=+-"ROEL!
M%7YN.ORY_&NAHHL%S@X?"VKQ:E:L\=G-;0:Q<7N2_+1R*V.,?>!;]*S+#P)K
M%N;5+NSTR]MW@6WGBGE?;#LD9U=0!\P(;[IQR*]/HHL@NSFM>T*ZGUO2=>TW
MRVOM.$D9AE.U9HG #+GL00"#46JZ;K.ISZ7J)AMXY-/NC,+(R9$J%2IRW3=S
MD<8KJJ*+"N>:+X&U*)O^/6TF1K*^0(SC$,D[[E1<C[HZ9]ZS_$/A^[TS2I)[
MJSM$A>+2[=8E8$/)'+\P/'3GK[5ZW2,JL,, ?J*+#N>:7_@O69Y;V:UMK**+
M4&G9[82;?(+1JBD,!T.,L!C/%)%X-UI4N)'L+/SY)-.=6689'D !_FQUXXKT
MVDI6"YQ/AC3[2?Q+JE_83K-I*3%[=!'A8[A^)L9Z]!^)-3:7H>I6GC*>^2W2
MWL97E>93(LBR,V-KQ\;D8X^89Q78  #   ]J6G8+G)W7A667QB=1A>---NHU
M>\BQ\SSQ_P"K?\CS_NBL!?!6KW&E064T4$-Q9V=W;&Z$@;[891A<]QSACGOT
MKTKK1WHL%SS.]\):U>6EVITJW5I]'MK/RS.IS)')N()],=ZAUZTN=#O9+A;&
MWMUGUB.>T5ID2)@(-K[L_*N<'K_.O4J;)&DJ%)$5U/56&12L%SC=%L(;KX;-
MIEKI<C1A7B-O).$\T[LEED7C!))!'%8O_")Z^S1/>6,6IV;+-;FTEN!#(J.5
M(DD9/E9N"#@9QCO7IP 4  8 Z 4M.P7.#L?#6J6]_=VESIMC/ \KSP:DTF6B
M#1[/+VGYCCH#G&/>LB?PGK]UI"V<VCVQ\NPMK7!N%.]HIMQ/3H5Z5ZG119!<
M\\USPA>75QK8L--MX[>>WM/LZ!E4,\4F]EQ_#P< TV^\.:Y)?:C?6^G1A7U"
MWO%MOM(3[0BQ;&7</NL#R,\'%>BT46"YYVOA2^MM0TR33],2T6$Q[XVG$T/E
M[RS*P;Y@ZYR&7N?2MYK:ZU?P9J-E8VHT>XE6:*%01M!R?FRO9NOXUTU%%@N>
M<7GA/4=0A>5M(MXDD2SBDL3(NUVBDW/)GIPO [FO0X((K:!(((TBB081$& H
M] *DHH2%<****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)2TE 'E7[/O_)-#_U^R_R6O5J\J_9]
M_P"2:=/^7V7^2UZK2 ****8!112?6@!:*2COUH *6DI:0"=J2EZ5BZMJLL.L
MZ5I%L0L]ZSR-(1G9%& 6Q[DD#\:0&T*6N,LM=2YNK",:EJ0,^HW5N%DMT&60
M']VWHJXR".3CFMKP_JDNH0WEO<[3=6%RUM*RC ? !#8[9!''UHN.QL4M<3XH
M\47]M-KFG6D,EJUEIRWB7HVMEBV-H4_0BK7_  G>G1P2+<PW$-Y%*(3;2J%=
MR4W@CG&"O-%PL=72URNL>,$M_!,>O:?$S-=&.*V2X0IAY'"#>.H )Y^E6)/M
MV@HNH:CK/GZ?#"QNQ)$H._C!3:.!GC'N*+A8Z*DKF+CQQ8VA>*XL[U+I)H8F
MMQ&"X\WB-NN,$C'L:CM?'FGW5Q%#]BOXFDDFA_>1  31 LT?7[V 2.WO1<+,
MZRBN0M/B%IEW&K+9ZC'YEL+FV62#!N$R%)3GL2,YQ@<]*5?B%I<D,#0VU[/+
M,TZ"*&,,0\/^L7.<< Y]Z+A9G745S2>-=-E+^5%<N!9QWL1V8\Z-S@;,GDY.
M"*N:MJ*VFHZ/$]S/!]IF9=B1!EDQ&6VL?X>F>/2G<+&S16/H7B*U\06S7%G'
M,(0 4=U&'!ST(/7CD'D5S)\:WMQ<Z-=Q65U';3S7D4MFJ*\D@B!P0<\<@]Z+
MA8[ZBN5?X@Z&OV8B25TG2)R53)C$O";AU^N,X[UH:SXFM=%O(+6:VNYYIXI)
MD6WBW95 "W<<X-%PL;5%<S/XXTF&/SU$\ELD<,MQ.B?+;K+]POS^)QT%.@\:
MZ;-JHL?)O(\W4EGY\D6(O.0;BN<]QR#THN%F=)16)J'BK3;&:UA5S=27._RU
MMB'R%QNQSR1D<#FH_P#A+M.\T1E+@'[:]B?W?255WXZ]"!P:+A8WA2US&G^.
M=+U&33Q%;W\<>HL5MIIH-B.0I;KGT!_*HF\86<5Q=7CRWGV6#3EO&M?LO(0N
M1Y@.<GIT].:5PL=917.7_B*W,MG'!<3P[[FW1G%OYBOY@RJ$Y^7(QSVR*9;^
M.M%N+AHBUS$ )\230E48PY\Q0>Y &:=PL=-161I7B*SU>[FM($N(YX8HYG2:
M/;\CC*G/O@UGP>.]%GOOLN;J/][+ )9+=A&98\ED#=VP"0.]%Q6.GHKEF\?:
M)'!)+(;I#')#&T9@)?,HS&<#LV*CA\>Z>XO))[2^MX+:YAM2\L!!WR 8R.JC
M+ <^M*X[,ZVDK.;589;'49HFDC%F9$>1HB<,HY('\0'MZ5C+XXTJS@MTN[B>
M:4VD-S)/':,$,;\"0_W1GKZ4[B.JI:S-6UNTT:!);KS&$F=JQ1ER0H+$\=@!
MFFW?B'3K'1H=6FF8V4_E^7(B%MV_ 7@<\Y%%P-6BN=M?&NC7ES# LD\<DLSP
M?O8&0+*@R48D<-@$X]*A/C_P\%N&-V^(51R1$S;T=MJNN,Y!;BBX[,ZBBN?;
MQAI"",N\Z;C&K!H&!C:0X16&,J3Z5'+XYT"WDNDEO"/LT32L0A(9%.UBN.N#
MUHN@L=)16;IVMVFJ.$MUN 3'Y@,L#(,;MO4CK[>G-,D\1:;%J(LGF8.91!OV
M'8)2,A"W3<?2BXC5HK,TC7M/UQ)7T^1Y$B;:S-$R#/(XR!GD'I6G0 4444P"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "DI:2@#RK]GP?\6U/O>R_R6O5J\I_9\/_ !;4CTO9
M?Y+7JU !1244 +1110 4444 )2T44 %8>KZ7-+KFDZQ;+OELFDCDCSC=%( #
MCW! /YUN44@.5M_!HM;BTG749G-MJ$U_M,:_.T@(*?09.*L:/HEY;7,E]+=-
M!)<W<ES<6Z ,KAE"HI/^R #QWKHJ2BP7.8USP>-9OKZX74I[;[99+9RHL:L,
M*Q8,,]#R:K77@5KC4[C4XM9N+>^>:.:&:.)3Y3)'Y9&#PP9>H-=C118=S'OO
M#UMJGAU]&U&::YCD4!YF;$A8'(<$="#@C'3%5+GPQ/JFF3Z=J^KW%U;R0F+"
M(L9[8<D=6&![>U='1181R,W@AKF9;N?59'OO.MW:?RE^9("65,>Y))-,;P6T
M#QW(U"68V][<WRQB(9<RH04_#)P:[&DHL@N>=Z-X&O;[PKIBZG?36M];6BPP
MJ(E_<?,&8,,_-G:%/M6A8^ #872S)J\CA9+J4(;= -TZ@-T[#&0*[6BBR'<X
MBS\+E-2T&QDMIWAT&+"W[E5%QE<!=H/.#@G/&0*Z'5]&;5+W3+A;HP_89VF
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MZ#ITVE:1%9SRI+(C.2Z*0#N8MT_&M*BBF 4444 %%%% !1110 4444 %%%%
M!1110 4444 %)2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI0+6XF@N%# E/+P-WN&)4#ZT70[,Z^BN4C\:9>%;C2;JW5[T6<DLA 1"PRK
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M=13K22VO_B/KUMJ_EN;6W@%C#/C;Y;*2[*#P3NX)]A1H%B;_ (0:T_MJUDB
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MK>VD<LKZ?:RVSI*3O,C^7AR>^>:- U.[T[3[BSN+YY;V:>*>0-"DC;O)&T#
M]N^*Q_\ A =,>RALYY[N:VBAFAV.X^82L')) SD$ @CIBK,.NZBGAK4]1O\
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M.-KS*  _MG:"0.,BNDHHL*X4444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I*6DH \J_9]X^&GUO9?Y+7J@->5?L_<?#3ZWLO\EKU3Z4@'TE(I)'-
M+3 6BBB@ HHHH ***0T@"BC%<IXMDG?6- L8=4NK%+N>2.7[.P#. A(&2#CD
M#F@#H+O3]/N76XO+6WD:$$B25 =H[\GM69:7?AS6=1N[6"*WGNT5))U:W()
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM<:G8&U^U"]MS;[MOF"4;<^F?6N/\1^&M5O]0UPVMI:RPZC!;*LCR[2IC?+
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M0$]@>M<Q:>$=9MTLHF>Q9+."\A1@6RWG'*DC'&.]0Z-X'U32KR M_9%Q;O'
M;AIXF>2&2-0I,>>"#@8STHU#0[&_U33+&[ABO)$$[#<@V%F4$XSP.!D@9K(T
M/QA:W@N(-2N+>"]AGN%*+N"[(F.3D\9VX)&:/$F@7VK:I9W=DT%O+;@>7=AV
M6:/Y@6&!PZ$#&T]ZRG\(:Z(X?L\]C#+'=7LX<[FQYRD+P1U&>:-0T-Z7QEX<
M6T:>;4HDAWK$?,1ADL,J,$9Y'(]:MV_B+1I[J"S@OH3+*O[I!P&XS@=L@<XZ
MUQMCX-UZWN?/E&F'==6ERZB21CF($-RPY)SD&M+2_"=]IWB>XN6BTJ:Q>[>[
MCN'B)N4+]4'8<_Q=<<4*X:'1WFO:787:6MU>QQ3.5 5LX&XX7)Z+D],XS3$\
M2:/),D*7\9D>Y:T5<'F91DITZXK!U?PG?7M[K4<,L!LM:6'SFD)WP%."5'1L
M@#'3!JOKG@*ZU"_O[JQU$6QD,5S:KCB*[7Y3*?7* #'UHU#0Z!O%_AY)EB;5
MK99"P4*20<DX'T!(QGI4L_B71K6YGMY]1@CE@1GD5CC 49;GH<#J!TKF-7\'
MZE<QZK;6BVAAN+*UMX'D<AMT;[F+<=#_ #JN?!>J1S:O"EGI,T-P+A[>\D+>
M>&E4@H>,#!/WAU Z4:AH=5%XMT&X$7DZI;R"5MJ,I)!.0!SC Y('-9VA^-+;
M5=*G>:>SM]2A6=G@,AVJ(V9=Q.,XX!/IFJ%UX7U5Y]&DLXK>UN+2WAB>YBG(
MX4C?&Z8Q(A XZ$'FJUOX1UF"UL8C;V9,/]H&0B4_\M\[ ..>O-&H]#I_^$LT
M6W2WCOM6L(KF6.-RHE^4[^A&?X2>A-:=[J%IIT(EO)TA0G +'J?:O,TT2\N=
M4NO#QM;.2X/A^UM+AW?(A(+#<.,L.XZ<XKL]6TB]^W:+J%@%N6TX/&]O(^T2
MJZ!<@] PP#]":%<6AH'Q!HXN8+?^T[3S[@*T,8E&9 W0@=P:FNM6T^RN8K>Z
MNX89I3\B.V"<G _7BN5\->$;K1-:MY9H;:2"+3VA\Q3RDC3&3:H(X4 X!SVH
MU_PUJE_?ZU' L,MIK$$,?FN^&M&3J<=P1R,=Q1J&AU":SILDBQI?6[.TQMPH
M<9,H&2G^\/2H!XFT,RB(:K:;RX0+YHSDG &/J,5RVL^!]2N-2O;K3KV*)"T5
MY:J^<K>J-ID;'4%1^)IFJ>$-0:34Q96=LZRV5K;PNSA2S1R;V)XX_P :-0LC
MLYM:TR"XD@FOK>.6)"[JS@84=3^'>HD\0Z/*$,.IVLGF-L0I*"">!C(]R/SK
MBO\ A#M3$VJ02:797(D-S-:7TEP=X,RD;-G0$$X+="!5N3PSJ2?V*]E8QV=S
M:VL,4LL4R^6V"-\<D>,.N!D$<@T:AH;&C>+[;5=+N)'DM(-0A$Q:V:<?*(V*
M[B>H'')QQFKZ>(]+BCM5O=2L(;F=(V\L7 ()8<;?4'L>]<;;^$]7CM[-6TV#
MS$;43*1,N2)L[,G'.<C/I5!="N;F:;P\^GVKWKZ#:6TTC2*3 0S#=TY ZC'<
M"EJ.R/3[N^M;"'SKN>.&/.-SG&36+JOB=8-1LM-TP6UU>W<+3QJ\VU608Z,
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M$4SA7R%SQQZ@G@$=:YJT\)ZLMKX9MIOLZ+IUO/!<O'*2?WB% 4XYQUYK.M/
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M 445DV.O6^H:G=65O;W1^S2-%).8_P!T'&,KG/7GTI :U%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *2EI* /+?V?\ _DF*?]?DW]*]2S7E
MOP _Y)A'C_G\F_I7J5(!:***8!1110 4444 %%%% !1112 **0]*.@XH *6D
M%+0 4444P"BBB@ HHHH ****0!1113 **** "BBBD 444F: %HHHH 2BEHH
M****8!1110 4444 %<K#H-Y_PEJ:FL%K8PQR2-,]O*Q:\## WK@ 8ZD\G(XK
MJJ2DP%HHHH ****8!1110 4444 %%%% !117$Q^*KY=>\1)<,JV.DON&(P!(
MOE!BFXG._))Z=*5[ =M17$/\1!&%:31+M4%@-1D/FH?+@)P#C/)/H*>OCJ2_
MGDT_3=+E;4%BE9]\BB.$I@9)S\PRR]*+H=F=I17(W_B#5+"7PA#*+<3:I.(;
MP!20#Y18[.>.1[U7;QZMMJD.D36LDES(.;A<!%+>84XSD_ZOFBX6.VI*\ZM/
MBK;?\(W8:C/:FYDF5EE-NP 5T3<XP3D8_6K\_P 2],MXWF:RNC;J?EE&.4#B
M-F([ ,12YD'*SMZ*X23XH:<FF6=^NG7C0W)D !V@H8\;P03U!.*M>*/&XT6]
M@L[6%7D#P/<R2\+'%(Y7/J3P>E.Z"S.QHKC+7XBV5[<V]K;:?>2W5PRM'"NW
M+1%=^_.<?=YQUJ!OBCI7V9YDLKQRKH@4*H+%F=1CG_8-',@LSNJ*X>R^)NF7
M[6L45A?_ &FXD"K (P6"%5;?P>@##-,C^)EK<LJ6FEW3R-=PVX61E7<LCLF\
M<] 4/%+F069W=%<MJGCFQTC6I=.N;6YVQ!0UPH!3<R,RKUSDA#55/B/IV;47
M%A?6_P!H1)!YBK\J29\LG!_BP?IWIW069V=%<+:_%+2KI[>&.PU W-P4,=NL
M89S&R[O,P#T ZCK2O\1U<6LMIH.H36]Q+-&DA**7\M6+%!GG[I]*+H+,[FBN
M9D\;Z<OA9?$,<,\MG(\:1A -SER ,<^IQ^!JB/B9HV(]\%XADM'NE4QC)5 2
MP'/7@^U%T%F=I17")\5M%99C):7T31J2JM&"9&#*NT8/7+K^==E8WBW]C#=)
M'+$LJ!O+E0JZY[$=C1<+%FBBBF(**** "BBB@ HHHH *0TM)0!Y=\ /^28)_
MU^3?TKU*O+?@!_R3"/\ Z_)OZ5ZC0 4M(:,T +129YH'(H 6BDI"<4@%ZTM)
M10 M%)FEH *2BB@ I:;G%+0 =Z.] ]Z.] "T49HI@%%%)0 M%)2T %%)2T %
M%%% "4M%% "&B@\T4@%HI,T9H .<TM)2T %%)FC-.X"T449YH **** "BBB@
M HHHH **** "BBD- "T444 %%%% !6<^@Z3++-+)IULTDS%I6,8.\D;<GWQQ
M6C10!3_LK3QS]B@_U M_]6/]4/X/]WVJ.+0]*A7;%86Z QM$<(.4;[P^AJ_F
MEH I2:3I\MK;VTEI$8;8J8%V_P"K(&!M]./2FRZ'I<UPMQ+I]N\R !7,8R
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M $I/K2X%% "9I#GM1D[L4ZD =J*** $Z4M%%, ZT4<T=J $%+10.: "BBEH
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D6->QG[)IO_?M_P#XNF-\6M>!_P"/33?^_;__ !=%%:7,C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gtbp_ex1017005.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JP# 2(  A$! Q$!_\0
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M*T:* ,_^PM'SG^RK+_P'3_"E_L/2!TTNR_\  =/\*OT4 4?[%TK&/[,LN?\
MI@O^%']BZ5C']F67_@.O^%7J* *0T;2QTTVS'_;!?\*7^R=-_P"@?:?]^5_P
MJY13NQ61372=.1MRZ?:J?40J/Z4X:;8 Y%E; ^HB7_"K5%*X616%A9CI:0#'
M_3,4OV"S_P"?2#_OV*L44#(/L=J/^7:'_OV*/L5J?^7:'_OV*GHH A^R6W_/
MO%_WP*/LEM_S[Q?]\"IJ* (1:VXZ6\0^B"E^RVY_Y81?]\"I:* (C;0'K!&?
M^ "E^SPXQY,>/3:*DHH B^S08QY$?_? H^S08QY,>/\ <%2T4 1"W@'2&/\
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MT4 %%%% !1110 4444 %&*** "BBB@!,#THP/2EHH **** "BBB@ HHHH 3
M]*3:OH/RIU)0!\X?LU_\C'K?_7HG_H=?2%?-_P"S6!_PD6N'TM$_]#KZ0S0
M4444 %%%% !1110 4444 %%%% !1110 44E+0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%&:* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EIISFE<#YR_9K_ .0_
MKO\ UZQ_^A&OH^OG']FO_D.:]_U[1_\ H1KZ-I@+1110 E+110 4444 %%%%
M !1112 *,444P"BBB@ HHHH **** "BBDH 6BDS2T@"BBBF 4444@"BBBF E
M+124@"EI*6@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %(:6F,,GI28'SK^S4/^)YKQSS]FCX_X$:^C
M*^<_V:P?[;UXYX^S1C_QXU]&=J %HI*6F E+110 444@H 6BBB@ HHHH **0
MT4@%HHHI@%%%% !1110 4E+12 3I2TE% "T444P"BBB@ HHHH 0T=:*6D 44
M44P$[TM%% !1110 G>EHHI %%%%, HHHI %%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *:<TZFD<TF!\[?LU_\ (7U\_P#3O%_Z$:^BJ^=?
MV:QG5?$!_P"F$0_\>:OHJ@  I:**8!1110 4444 %%%% !1110 4444@"BBB
MF 4444 %%%% !24M(3BD 444M !1113 **** "BBDH *6BBD 4G>BEH ****
M8!1110 E+112 **** "BBBF 4444 %%%% !1110 E+110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %-/6G4TTF!\]?LTJ/[0\0-_TRA'ZM7T/7SQ^S3_Q_^(./^64/
M/XM7T/3 **** "BBB@ HHHH **** "BBB@ HHHH **** $Q2T44 %%%% "9H
MZT44@%HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M(:0'
MS[^S4!Y_B \9V0CWZM7T$*^?_P!FDC/B 8YQ#_[-7T!0 M%)S2TP"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBBD 4444P"BD[TM !1110 G>EHHI %%%%, HHI* %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I#12$TF!X%^S7_J_$'3K#]?XJ]^KP
M']FK_5^(..\//_?5>_4  X%+113 **** "BBB@ HHHH **** "BBB@ HHHH
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M?:K5IX3LK2XL91/=2BP %NLL@;9A-G!QG&.HZ9YHU#0WZ***8@HHHH ****
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M&JK(4BN+>&V@BBW.&DB#E..N#GD^E3R?$#0(XT<37#HULMUN2W9@(BVTL3C
MP>OI574/"&IW5[J%Q%J-N([N^AN3#)$2K1HFS8W//9N.XK-MOA]JL&DW%@=2
MLV#Z8VGQL(67&9"X8C/H<8%+4-#T16#*&4Y!&0?6LEO$NF+J?V S/YAD,0?8
M?+,@&XQANF['.*-'_M9;B\BU 0&VC9%M7C4J2-HW9!///0UB)X.N5G%N;F)]
M/CU0ZI%G=YH<Y;8>VW<2<]<<4]0-W1/$>F>(HI9M+G:>*,@%S&R@YST) ST/
M2DL?$>EZCJ4EA;3EIT#$ H0'"MM8J2,-@\'%)X8TNXT7P[::=<R1230*0SQ
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MKZEJ]GI2(UU(P+YV(B%V8 9) '. .36+=>)WO-:T_3=%E@?[5:F\6X>-GC=
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M$9($DE91A=Q[ ?7M6-I_@F]L#:8U.!Q;)=JN+;;DSG/8_P -79?"<EQX'M=
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M1110 4444 %)2TE 'D/[.W_(@W7&/].?GU^5:]?KR/\ 9X'_ !;VX.>M^_\
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M==K2%!N8>A/I1%86=NZ/#:01NB[%9(P"J^@QT'M3LQ7+%%%%,04444 %%%%
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MBU*U<2S&"/$H^:0=4'O[4706-*BJ;ZKI\5L]S)>VZ0))Y32/( H?.-N3WS4
M\1Z(;9;@:O8^2S,BN9U ++U'7J*+H+&G15-=5T]KB2W6]MS-&F]XQ(-RKZD>
ME07>M6T=@;BTN+2XD:+S84:Y5%D7.,[O3GK1= :=%49]4MH?,B\^W^UK$9!
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MNP5<G &>!ZTRQO(=0L+>\MR3#/&)$)&"01D<4 6**** "BBB@ HHHH ****
M"DI:2@#RW]G_ /Y)BG_7[-_2O4Z\N^ '_),(_P#K\F_I7J- !24M% !1110
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M'N+,VK-YC@'$PD#!=N%&!C:.GO5_7M*-K#JJ3A8;O4;Z*?26MHVD9)T10I(
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M:OK5Q++ S+RBE5121[[<X]#79T46'<\]D\,^)Y[^>^==,C>46BM%&[<B(MN
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MYNUTR]6=4#!A+'(-F2!PVW/U%;4-[J&IRZG9Z1JTQ==(MI[0X!Q)\V>2.<X
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MZKGC-%Q6-6BBBF 4444 %%%% !1110 4E+2&@#S'X!C'PNM_>ZF_G7I]>8?
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MM"IRW3=TZ^]*-%TM5VC3K0+Y1@P(5QY9YV].GM5ZB@"E#H^FVWV?R+"VC^S
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE
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M_+ANN<BBX6/4J*Y#PIK=]>ZQJ-C>7L5V([6VNHRB*I7S%)9>.V0,=^:R=/\
M%FIWW]G,]P@:^^UQWEKL :P\L-AL]L8 .[KN&*=PL=]!?6MU++%!<Q2R0G$B
MHX)0^X[4]9XGE>))4:2/&] P)7/3([5YU8L]G\%9-5L)P-0_LMF6[C1=_ )'
M..<<]?6LV?6;O2M2UG6K#4+9S#9::TP=5;[1N)4@D'CKU%%PL>L1S13%Q%(C
M[&*/M8':WH?0T^O-#XGU&UBUA[060^SZQ<13>0B+*\:QAMX4G#L"06YR0.*Z
MK4==:#PK;7ELXGO+Z...T 7;YLCC@A3T[MCVHN%CH 01D'-+7F&AZY=^%M&\
M1:&P=[S25^UV:WL@WR6\ASECGG#;QU]*N3>)O$.^%+:ZL?*N]46RM9Y8>7C,
M98O@-U#<8[XI7"QZ'17FC^/-9@AOKXII\D%F;B&6V:3;-OCX!"C)YP6(/135
MG_A*/$.=/B%SI#B]OX[=)HV\PB-XV;)"G&05XYY%/F"QZ%17F2?$#5[*VM[N
M^CM+B.6VOCY4"$-OMCC=G)X;N.U6AXN\0)]@1CI,GVZ^A@BD23>0DB,V2JG@
M@CCGD47"QZ'29!)&1D=17GVA>*=7UCQ%HD<MQ;QV\UM=F>.-.)7BE$>02<CU
MQVYJOK6JZEH?C#Q+J6G"TDCMK.TEN()V;=(,N,)C@,1T/<X%%PL>E45R&F>)
M=4N_$<NB3P0+<0SF5R$8#[(4RC]?O%CM^H-,UOQ==Z9XEALH8[>:V-W;VLH&
M2RF4'ECT4C PN#D>E%PL=E17!:=XOU^^EMH3::=YU[#=_9E5G^62!]HW$]F]
MNE;7A3Q%/XD@-SY4:01Q(DH (9;GGS$Y[+P*+A8Z.BBBF(**** "BBB@ HHH
MH *2EI* /-?@3_R2RRX_Y;S?^A5Z4*\U^!'_ "2VSXQ^_F_]"KTND 4444P"
MBBB@ HHHH **** "BBN=\623QIIHV3-I[7:K?&'.5CP<$XYV[MN<4@-34M5M
M]+2,RK+))(2(XH4WN^!DX'? YJRL\;01S%MBR!2N\;3ST&#W]J\VL()IM;\-
MMJ#73JE[>?9'??N^SX_=;S_+/48KH_'D,,FE:?)<QSM!#J5N\OD[LJN[DG;S
MBE<=C?T_4K?4XII+??B&9X'#H5(93@\&K=>2K->V^H_;-,GN_M<^J7T0BR_E
MLOEDH-I&.6VX)[]ZZ#X>327(N)VU._N2\,8G@N+9HU@F&=P^8D[SWQQP*$P:
M.KO]8L]/GBMY6=[F8%D@A0N[*.IP.P]:ETW4K/5K,7=C*)82S+NVD8(.""#R
M""*Y.20Z)\3+[4M3=DL+ZPBAMIRI*(Z,Q9">Q.0?>J>NWHGU-T\R[L-.DL)9
MK*6#=&9+K=U('4XP0#UR:+A8]"I.1FO(KJ\U8S:C<7FK:C!>6TVF@11.0B-(
MJB4!<8(Y.?2I3?*;BWTZYU[4;>RBUFZM#)Y[*[1^7N4%R,D ]#1<+'K&<T%5
M=<,H(ZX(KQH:[JEL--^VZK>I=6_V?#3[E$D)F*[]H'S$IC<6Z<>M:.EWE[<Z
MKIZ?V[J#C4;S4+1]TAPD:[C&5&."#C!I7"QZ9J&HVFE64E[?3K!;18WR/T7)
MQ4\?EL/,0*0X!W+_ !>AKB_"$>H:M97$&MM<M]C0Z;,LCY6XD5LM+^(V_K33
MJ-Q!\0EM3=/-9O((8XK>3!@(CSMDC(Y0]0X/!XIA8[@5'<6T%W T%S#'-"_W
MHY%#*WU!KE/'FHW.G6=HUO=^7\TC/"LOE/,JJ3\CD8#+U"G[V,5S4GBR[BNI
MX3J=RK_VE8FWBE&UVAD1=P(Q]TDG/H:+A8]4 "J%4  < #M1FO*3XMO/[#N]
M3BU>Y;445DO].\G<;+$N&D Q\NU,\?Q=:?J?B&2)+:UL_%F--NFF:#4Y@0JR
M *4B\P#YL9)YZ]*+A8]3)HKS%_$.HV^J&.YUY"SQ%8YXQB.)Q#DB:$C<HS\P
M8?2DT_Q'?75];:5>7UW9Q/+*L]WYJ.BR+&K(J2@893DMSSVI7'RGJ%%>6:;K
M/B#5IT,^OC3Y(-)%V\;0KM=M[J'8$9"D ,<5U?@S4KG4+:\CO)96N+>14='9
M9%4E <I(O#J>OJ,XIW%8ZBBO/KOQ'JB:G=21W16>WUB.R732H_>0-M&X=\D$
ML#TXQ6MX&N=3U#39K_4-66^62:6*-%B50@21EZCJ2 *+A8ZNDKSO5?%MY:>,
MH[>'48/LPOULI(9-JJF8BW.?F8YP=PP,<537Q+X@^RW$;7;M>0M&\\,8B+&,
MJQWV[?=D4X!VGYL BBX6/2H[NWENIK9)XVGA"F2,-\R ],CMFIJ\U_X2J_0:
MM<PW=M+&L.GN+CR%C=4EX=L'ECW /2I/[8\433:?:QZK;0+>3W@BG>W5G,,:
MYC;&<9/>BX6/1JS[*RT[0[?[-;[8(I9F8*\A^9V.3C)ZDY.*XS3?%NL74NA3
MW,D<=G>Q0!GAB#KYK9W*_.Y-V!M/3K6OX[CEDL]'%N\4=Q_:UN(I)$W!&)/.
M*+A8ZP&J,FD6,NKQ:K)!NO8HS''(6.%4^@SC//7&:XE?%^M:?##=:HT$EG;W
ML^G74T$)_>2#_5.HSP"?E(YYKMX&O$T97N73[:(-SD+A0^,]/0&@+%WI0"*\
MQ3QIXEM]+AOKHZ;*MW8?:XA!&P\HK(JLK9/(8-P>Q%:%[XGU[^V+G3M/?3RZ
MZJEE&\J,0%>#S.<'J"/QHN%CO6954LQ  '))Z4HP0&!!!'4=Z\]DUS4]8T/5
M9YY-/^PB*\M)K;D2J\:D97UR03M/08J+3?$NLV6G1Z<[V!F%I8O;.J-PLH*E
M=N<NPVY &,T7"QZ/1@>@KSE/'.KOIVF7DEO!:V\KO%/</$SQ^8LI3:V#F/(&
M03D9.*V?#/B+5M:NTNIK:V32;J-V@<2*)$96QM(W'=D<DX&#Q1<+'6\8QBD(
M7^Z/RJAKE[/IV@W]]:I&\]O \J+*3M)49P<<]JXM_&?B&%[AY+/36A@6TN'V
ML^XQ3G;M'^T#DYZ>U%PL>A@ $G !/7BC8F<[5R?:N$D\::RRZA?6NE0R:7;K
M<A99'V%7AR!GGG<5(P!QQ1=^+O$%E:(9M-LOM;637R1H[LLHR (E./O\\_A1
M<+'=>7'@#RUP#D#'2E,:%MQ12Q[XKCX?%FK7>I21VVD![2WF-O=2%\>4X0,6
MSGD!B%QC/>M/PCJ^IZ[H<.IZA:6ULMRJR0)#(7.TC^+(&#GTIIA8V_(AX_=)
MP,#Y1TK-MM M+77KS6%+-<721HRN 50("!MXR."<TS7-8FT^ZT^PM(XGO;^1
MTA\YBJ#8I9LXYS@<"L.Z\;75K'>S2:?$(]*2$ZDGG;F5I.2(R!AMH.>>O2BX
M'8&WA9MS0QEL[LE1G/K]:3[);%I";>+,O^L.P?/]?6N0M_&>H/JRP2:5#]E:
M]GLE:.<F1G1-ZD @#!''7@U%IOCZ;4G@M([2W&H7,QABA:5E,3*A=Q*I&Y2H
M&.ASGBBX6.UBMK>%B\4$4;$8)1 "131:6V^5_L\6^48D.P9<>_K7G[>(&U;7
M-/OTAGC!TS4([BS\X@>9$RJ1D<=0<-[U5U[Q'-?>!KBVTB!XOLEE:33NURWF
M0^9M*JIZN0O4D\TKA8],CMX(X?(CAC2(@CRU4!>>O%0_V7I^TK]AMMK *1Y2
MX('0=.W:N1O?'=S;ZG>:<EA&)4AN3 S2Y^:%-V7P, $=!G/J*K6_BY+4V&IZ
MQ;R"Z;0ENW>&<^4V74;1'_>)8<^^*+A9G;/I6G2 A["U8%]YS$O+>O3K[U-)
M;6\QC,D,;^4=T>Y0=A]1Z&N6N?&LUE<R6%QI3'4DF@0PQS#:4F)".&('1@01
M6QX>UG^W-->X>V:VFBGDMYH2P;:Z,5.".H]Z=PL-USPY8ZY8W4+HL,]P@0W*
M1J9  0<$D<CCD&JFC>#[#39'GN$M[JX9U<,+9(T0KG!51P#R>>M3^)/$D?AR
M.U:2W,@N9#&'9PD:D#(#,> 3T&>IK-N_&$8U;^Q3:RPS7"R1QR"0%E=8M^2!
MT'8'U'2E?4-3HQI6G"]DO18VPNI5V23>4N]AZ$XR:A@T#1[6*.*WTRTBCBE\
MZ-4A4!'_ +PXX/O7&:'XZ>S\,Z+%-:WNIWAL8)KIXAN?#G:#C'S'@DCC@5VN
MLZQ;:'I,VHW6XQQ[0%4<LS$*H'N20*=PLPCT/2HGB>/3K56BW^65B V[OO8^
MO?UJ*'PUHEO'%'!I5G$D4OG1JD0&U_[PQW]ZY?Q'XNNSIT]G;6DMMJ,%_:VU
MU$)5W+'*PPROT^89&>W-=5DZ%H3NQO+P6Z%L,0\K#KMSWQTS[47 6'P_I%LU
MNT.G6T;6SO)"5C ,;-]XCZ]ZEGTC3KF]6\GLH)+A0 )&09X.1GUP>1GI7-_\
M+#L/)4K:3-,;I[38'3:9$4,0KD[22",#/)J>;QYIMO-?K-#.D5@#]H<[=T;8
M4@%,[ADL #C!-%T%F:NE:5-9W=Y>7MV+NZN&VB01!-D0)*H /3)Y[TEYX9T3
M4+UKR[TRWFN6VYE9>25^Z?J/6L)/'C76IZ=9VFE7!\^Z>"=I,#8%CW[EY^<8
M]/<=:V] \16_B&%Y[2&40#&V1BI#<D8X/##'*G!&11=!J12>%["W@1]*MK>T
MOK=)!:3F,N(6?ECC/.3R:OZ1IPTO3DMS)YLI9I)I=NWS)&.6;';)-9VI^++'
M2[JYBECG>*S$9O)XU!2W#G"[N<GU.,X'-3:3XBAUC4+RU@L[Q!:2/%)-)&!&
M74C(!SSP0?I1H&ILT444Q!1110 4444 %%%% !24M)0!YM\"?^2667_7>;_T
M*O2J\V^!7_)++'_KM-_Z%7I- !1110 4444 %)2T4 %%%% !116-KNJ2V$VG
M6L;B$WUQY'VAAE8CM+#CU.,#-(#79@JEF(50,DD\"E!#*&4@@C(([UYHWB#4
M]0N8XKR]BC@%EJ$<L:Q@1W#1':)%SV(/3ZU%:>+-3T72[2QN)K24R6EDT$H
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MSG:BA1G\*EHH A-I;-<BY:WB,X&!*4&X#Z]:6"V@M8_+MX8XH\D[8U"C)ZG
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M+%!J21I?6Z@$3!.F#_"2.#ZBK^BZ*-&^W8N6F%W=/<X*!=A;'RC'88K5HIV
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MD>GW%MIZ17,E^!!=SW\A9O)VE>,#G / XZU9D\)Z=(UN09X_(L6L(Q&^ (F
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M>>_!+_DE6EY_O2_^AFO0L\4@%I:2EI@%%%% !1110 4444 %%%)FD M%%%,
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M>210%N5<E2>>2.,'\*[CPE:W<>B1W>H[#J-X%FN&08!. %'X #]:+@T;'VF
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M&PDG&WUSWI\UU;VYC$TT<9E<1H&8#<Q[#U->?^--/O[K4=;%I:7TB3:5"BM
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M\=.:;]DMOF_T>'Y\[OD'S9ZYKF)O%<UYJ"V^CBS<+917Q^U2;/-CD) VGM@
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MT=1O-0L+BV-O>V#HLR!MRD.NY65NX(SV[4[A8>/#6BBVFMQIEOY,X D0ID,
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M^XHU7Q19Z-J$-I<Q3XD:-#*%&T%VVJ.3\QSUQG'>BX:FXJA%"@G &!DUD_\
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MER-2>)SY[^0T:[?W7\.1D\TVSU:&2TLVNYK6"ZN4#+"MPK@G_9/\0]Q6C0K
MPHHHIB"BBB@ HHHH **** "DI:2@#@?@N0?A5H_TD_\ 0VKOZX#X+X_X55H^
M/23_ -#:N_H 2EHHH **** "BBB@ HHHH *RM5T"UU:ZMKJ62>*XME=(Y(9-
MIVN &!^H K5KFM?\3#0->TV&Y8"QN(9GE*Q,[@H%((VYXP3GBDQH)_ VDS+,
MBM<PQ2VT5KY<4N%6.-MR@>G/7UI9_!6G3WDEY]HO8[MKDW*SQS;61B@1@O\
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MHI8T"G]V.&R02#VW'-.M?!E[%X.L$M+:TL-?LKDW$4@ 92=[9#$#D%&(KO\
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M1;.6XTJSSX?U>VD:\LUO5D)(+(3O90#T]7'6O4<T4T@N<WX3M[JUT6]M3%-
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M432-IXTZVFFBN+XF(2P+NDB3'S.![?U%;M0-9VSWL=ZT2FYC0QI)W"GJ/TI
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MB_1OLIN5N6>'S%BC=4.)F9=P"'^+CKCI5>/0M:CLH;9-7MXUAM1;JR6G+D
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M;F%)V>.(GRT9MJEAU&3D?A5.\\#M<W=U>QZGY=W)??;(7:W5UCS&(V0J>&!
M]CFL77=%U===Q%;272?9(H@WV-7BN65RV'VLNP XQGC%+4-#J+CQ992/=65I
M+)'>B.;R6EA.QWC7+ >N,C-:6D7SW>@6-]<,@:6V261APH)4$_A7+CP/J,NI
MKJ4VK1FXS.</;[B%E3!3=GD*>G3BNFLM)$'AN'1[F7SE6V%L[J-N\;=N<=N*
M$F#L4XO&&D3)*RRS#8$90T+ RAR0A3CYLD'&*DA\6:3.\*),_F2M*BQF)MP>
M(9=".S <X-8T/@O4/[*L[.YUPSMILT<FGN+<+L\O[HDP?GXX/3UI[>"[E;N/
M48-1CCU!KN6ZG8P[HV\R/RR N>, #!_.C4-"X?'GA[$1^V/B6*.8'R7PJ.VU
M68XX&>.>E6SXITD37$;7)"P;]\A0^7E2 P#="02!BN93X>WR:5/8-JD#"33X
MK(2?9R"-DA?<1GOG&*FO? $VH3W\CW\=K]I4Y^RQD+*X(9&D0DJ2I'4 ;N]+
M4>A?E\7Q7-_I*:9(CQ3W[6=VDB$21L(RV,=CP/P-;^HZI:Z5"DMTS#S'$:*B
M%F=CV ')Z&N?B\+W^_2II[JQ$UI=_:91;VGEH_R%,* >O.<G-:?B+2KS5K:W
MCM+J.'RY@\B2H2DJX(VG!![YX/:GJ+0;8^*=.U'6(].M#+*9+07:3+&?+*$X
M'/KP:L:IX@TW1Y$2^N/+9UW_ '2=J@@%FQT7) R?6L/PSX3O] N+!GOK::."
MR-I(JPE21YA=2O/'7!%.\7^%+_Q(S)#?6\5N]L83'-"6VON#!P01GIC!X[T:
MV#2YHCQ=H;:H=-6^#70E:$J(VP) N[;G&,XY []JLV.OZ9J2VK6=T)1=*[PX
M4C<$.&/(XP>.:YU/"6HQ-Y\EU;,1JZ:FX2-N56,+L'OQ5KPAI2PSZCJB17,%
MO=S,UM;7*;&@4G+X'4!GR<&C4-#9U'7M,TJ>."]NEBD==P!!.%R!N;'09(&3
M6#KOCW3=/B=;"\MI[F"Y2.YC;=^[0N%<YQU&X4OC#PIJ/B-W6WO+:.W>V\K9
M,C95PX;=E3SP,8/ ZU#_ ,(=?/IFJP2W%I]HO-12^1D1MHVE#M;O_!U]Z'<%
M8TO^$LTZZET][#4K1X)Y98W5E?S'**2548X8=<'M3++Q[X>O+*RN'OEMC> F
M&*=2KL VW./K5,>#KIM9M-3>>V64:BU]<*BG&3%Y85??'))ZU'I'A'4["ZTL
MSSV,D=C:3VRNJ,6.]@5;!X[<BC4>AIWOCC0+/3YKS[:)4B9 RQ(2QWMM4CCD
M$]^G%6(?$%NDFHO=WEF+>VG6)?*+%P2H.UQC[W/0=JY'_A7FKR0W7FW]EY\]
MK#"SJKX+Q2[P<=E/3 Z=JU)O">J-JDVJ+/:BX744OH8@6V.!%Y;*_H>X(HU%
MH;DWBS0+>&&:75K94F1I(R6^\JG#$#V/7TK3-U +3[49D^S[/,\S/R[<9SGT
MQ7%Q^"KZ*[6Y62U)=;YY$.<+)<8P%X^Z,<^N36_9V4NE>"H[&X*M):V/E.8\
MD$JF.._:FK@["1^,/#DT4\L>M631VX5I6$HPH8X4_0GO4R>)M%E:W":G;M]H
M_P!5AN&Y('/;)!'/6N M/!U]KGA+3;B.&R@F72XK6.-L@.-ZN2_&1C;C;CJ3
M6]J/@V\NKC68H)+=;/6# TA;.ZV:/&=@ P<XR.F#2U#0Z==;TM[^2Q%_!]JC
M!9X]XR /O?EW]*8OB'1VM)+I=2MS#$^QVW_=;K@CKG'-<F/!>LG2M0T1[FP^
MQR>>UK>[&-POF'=M;MUX)!Y%5I/!6KF*VOH[#1X[^";=+;1S2B.Z&S82TG4$
M=N.!Q1J%D=)XC\7V6BZ3'=P36US)*8S#'YN/,5F"Y!&?7CUQ5M?$%G!]J;4+
M[3X(X[IH(V6X!R0 =K9Z/U^6N/NO!.LPVEY8:;;Z4EI?1VY*[F46KQL"508.
M5/4=,'/K5V7PIJ<NH^>UO:&/^W1J6&DR?+$>W'3[V:-1Z'5OKVDQVMO=/J-L
M+>Y&89?,&UQW(/I5])$EC62-@Z,,JRG((]17CU[I]YHPM=.O8+5#+;7D4ZFX
M*QO#++N"(=A&[VX->G:%+=262"6P6SM5AB%O&7RX&WD,,<8Z>]-,31HS31VT
M$D\SA(HE+NQZ!0,DURX\:%-)M]=N+ Q:)<.@2<R9=4<[5=DQPI)'?@&NDOK2
M/4-/N;.4D1W$31.1UPPP?YUYYJ%C?C0+#P+J5NT5FRQPMJRC=%)$C#"X'*2,
M !SQUY-#!'H":G82.B1WMNS2.T: 2 EF7[P'N.XI@UG3&AEF&H6QCA;;(PE&
M$/H:X:[\'ZW-J#P0Q6L5E_:<]TMR)CO5)82G"XZJ3Z\U#;^#=272E$^C11:A
M$(8?M5KJ!\UA'G;(FX;1C/W3GJ:6H61U]WXJT]3=V]C=6ES>V]NEQY;7"HA5
MC@$OT'_ZJU/[0M%NH[1[J!;J1=RPF0;B/8=37GESX0U_^R;^ 6=C/<7FDQ6Q
M9&6-%E1V.-N.A##D<9%6[GPCJUU=74;I&/M-_;WT=\''F6P0+NCQU)^4@8XP
MQHU"R.VAU;3KB5XH-0M99$7>RI,I*KTR<'I4MK=VU[%YMK<13QY*[XW##/ID
M5YM#X+U")+4?V#:A=M^MRD=PL9D$S90;E&>WX5U_A#3=0TS3[F&_ &Z<M#NV
MF4I@#]X5^5FXZ^F,\T*X-(VC>6PN&MS<1"95W&/>-P'KCTK*T#Q"/$/F7%K;
M#^S\LL=R)02S*VT@J.1TR/:N<@\*ZL+^ 3Q1LUKJ\FH#4%D&^:)@?W1'7)R%
M.>,+6_X,TVYTKPZEK>6B6L_G2NT:,K#YG+#E?8BGJ&AT%%%%,04444 %%%%
M!1110 4E+24 </\ !_\ Y)5H7_7)O_0VKN:X;X/<_"K0_P#KF_\ Z&U=S0 G
M>BDYS[4M "T444 %%%% !1110 4444 %%%% !1110 4E+10 E+112 *3 ]*6
MB@ HHHI@%%%% !1110 4444@"BBBF 4444 %%%)0 M%)2T@"BBBF 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A4'
MJ <'(S2T44 %! (P1FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "D-+24 <-\'FS\*M"Q_SS<?^/M7=5POP>S_PJK0LX_U;]/\ KHU=SWI
M%+124P%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH **** "BBLVRUJ#4+^
M>VMX+EHX25-SL_=,P."H;/)!]L4 :5%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^%6A\D_NWZ_[[5W/>N'^$ '_  JK0<9_U3_^AM7<T )112T -/!YIU)@&EH
M2EHHH 2BEI*0!110: "BC..M&>,T )0*/H:"<4@%HHI.,TP%HHHS0 4M%)0
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MG'M[5(2!0 ZDINX4H84P'44FX49]*8"TM,SSTIV: %I*,T$T +2?04W.:7-
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M$[; V!DT44@!KEU4D!>*A%[(PR53D>_^-%%,8&[=3@*GZ_XTW[=)R-B?D?\
M&BB@0GVZ13@*G!QW_P :%U"5EY5.OH?\:** "34)4B9@J9 R,@_XTGV^4JIV
+IR,]#_C110P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gtbp_ex1017006.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K4# 2(  A$! Q$!_\0
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M:^GZTZB@!GEKG/\ 6EV+_DTZB@!NQ?3]:7:/\FEHH ;L7_)HV+Z?K3J* &E
M3R/UHV+Z?K3J* &[%QC^M&P?Y-.HH ;L7_)HVC_)IU% ";0!1M%+10 FT4
M4M% !1BBB@!,"C I:* $P*7%%% "$ ]:,"EHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!#10:* ,3P@,>%[0<]9.O_71JW*PO!Q)\+6A.?O2]?\ KHU;N: "
MBDS2T %%%)GF@!:*** "BBB@ HHHH **** "BC-% !1129YH 6BBB@ HHHH
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MF 4444 %%%% !1110 4444@"DHHH !12TE !2TF*!0 M%%%, HHHH *2EHH
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M !1112 *2EHH *2EI* %I.,]*6D(H ***,4 +24M% "=J*6B@ HHHI@%%%%
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M;"ST:#4+*YMYUF*,A<D*T9D",P/MFK__  D^BFS:[&H1>0KM&6YR&7E@1C/
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M@XHU#0ZB+Q%:W=_I_P!BOM/FL;J&60/Y_P [;,<J.A YSZ5*OB;1GMYITU&
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M<^F<$9]ZY1-#U6QTN&'3M(OXV.EV;WD: J9G23]XF6."^WMWQBB["R/7PP8
MJ00>A% =2#A@<'!P>]<QX;LC8^%;M+>SU%%D:66*WO'"RG<,[0!_JP3G [5Y
M]'I.JO!+;R:/JRVT_P!@=8UA9 A1SYH)#9)V]6/+4786/6K#6(-0O;^UB219
M+*412;P &)4,"OJ,$4ZTU2*Y2/S8Y+261W2.&XPKOM/) SR._P!*\[F\*/!K
M]XMAIMW!/'?6DNGW*,WEI"JJ).<XQ@,"#R<BH;71[E;O1[RXTB]>."ZU)#NB
M9GC20YB/J%]#VHNPLCU<LHZD#G'6HDNH))98DF1I(<>8H8$IGD9]*\ADT&^M
M_">FVT&BZG]KDT^5YI?FD<7( "@J3\K<<,>G:K_V#4%O+VX.CW@@N;RSN;T>
M40T\'E!7'!Y(?EEZXHNPLCU3.>1TI:\QL="NKG6M,BO;6^_LL7EY);*&D410
M$*8U?!X&X,0#T&*]'L[G[7;B7R)H<DC9,NUN#C./0]130,GHHHIB"BBB@ HH
MHH **** "BBB@!#10:*0&+X2Q_PC%I]9/_1C5MUA>$ /^$8M,?WI/_1C5N4
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M61"\F&!)Y*D<\],T7"QZY0:\XNO$FK0W&O2MKL,=I8W4-K @ME9G,BH0=V<
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M^&2:]1Y(-C9#*O4YHT#4S=6\&QZS=:C/-?RI]MLH[1E6,?)L;>''J<]JAN_
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MP_A*@Y8GKD8KT@,C$A65B.H!Z4[ ZT6"YQW@2YNKNUU"&\FDG=&0?:$F9X9
M4'S1D_,I/4J?NDUQ>G9?1M$BBU&^M+B"PU%G=9")5=6S@DC/49QWKV4  8
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MY&3C+<Y%>D/<0QF)9)44RG;&&;!<XS@>IQ4/]H68U'^SS<QB\,?F" M\Q3U
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M>)8G)+H$ 5B>N1WIV"YY7I>LW]M;Z/86NL6-D1I=K<)/>8S= DAEX'SA1\H
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MU?#4MM@MM8^;X@B@N-D1+3(\(?YLGANQQZ5V\^@Z7<SQ3364;R1((U)_N@Y
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MB^QV;&6&)4._>5*G)SC'/I0P1R__  L.>+3K*\N+. "YL6N-JN?D<2B,9/\
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M.";S'GG;G&<>E2T %%%%, HHHH *2EHI %%%%, HHHI %%%%, HHHH ****
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MH XWX3?\DL\/_P#7N?\ T)J[*N,^$W_)+/#_ /U[G_T)J[.D M%%%, HHHH
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MU:7D:?9/ML(V@F>'(!9>>HR"0><&CF"S.MHK(T;7(]8DO(?LUQ:W%I($EBG
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MQKNC7&JWFD3P7,4(L+K[2RO&6\SY2NWJ,<,>?I6D+^S8S 7<!,'^M D'[O\
MWO3\::=2L!;K<&]MA"X)60RKM..N#FGH&IR=OX#>*"UM'U!9+73Q<?8 8OG0
MRJP^<Y^;:&.,8SWJ.7X>RW=I':W>J!HUTJ+3]T<.U@T;AUDZ^H&179&^LT6%
MVNX LW^J)D&'_P!WU_"I)[F"VC\R>:.*/.-TC!1^9I:!=G,3^#6U*SU<ZE>
MWVI)$C3VZ;1"8ON,H)/(;)S4 ^']O:P:R+"[:.34K06^95W+&Q&'DQW9N"?<
M5JZOXE6QO[/3[.&.\OKN-YHH?.5-R+C.">YSQZTM]K\]MK]II$&GF6:YMGN
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MLYM5FTV.;==PQ+,Z8/",2 <]#G!JYFBR"YY;_8.L1:M_:,6BRB\_MB68R"4
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MDM8R)IB8P$<Q,>"IR#@XSS75^)-'N+OX;?V>MO=WD\:0GRY6#3/M=2<D<%L
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M<7.-[22%@H'90>%'? JU!;PVR%(8PBLQ8X[D]2?>A(&2T444Q!1110 4444
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M&>:+!<\QB\6:Q+!J$$6J0R_9+T807*":2$PAR$D(VLP)SCO@C-;_ (RN5O?
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MBVIW>491D;>.<#DYQQZUL>'-?GU^&>=]->T@CE>)'>57\PHQ5N!T&1^M58/
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M-QW.TLCL<L[L<LQ]R:%<-"Y1113$%%%% !1110 4444 %%%% "&B@T4 </\
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MRP@[5 SQG<23[UL:'I3:/92V[3^=YEQ+.&V;<;V+8_#-/46AIT444Q!1110
M4444 %%%% !1110 AHH-% '#?!W_ ))5H?7_ %;]?]]J[GO7#_!TY^%6A_\
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MU2ZMV\IODD7RP8PQP-Q.2 >,UM^(=5O;3Q-=6UK>V]L?[&:9'G0;8Y!*%!+
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M2.Z1J6=E1>Y8XKD]'\0ZG<ZW<:1>BW6XL)9&O'5"J^01F)AD]3GG_=-3>/\
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MSWZT7069TMII=A81316EI#!',Q:18T"AB1@DU#!H&DVWV;R;""/[+N$&U?\
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MZ+IL\,UEI\,$D._RV0'Y=YRV/J:R+?QY:73V$<5E.);M"PCD94((?8RC)PS
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M[ BJL[7"E6(99&^\P;.1GOZT3>%-"N!()=-A99+=;9UY ,2G(3 [ \U"U^-
MM]/L)7NKZ]O)&6".5U+G +$%NF%'?Z52M?'5OJ%W9VUCIE[</<*[/@*/)V2>
M6X;)ZJ?3KVHN%F=4BJB*BC"J, >U9=YX9T>_EN9;JR21[K9YQ+'Y]ARF>>QZ
M5SOC#Q)J-HVM:=;0O;K;:2;Q+V-QN#[L !?PJ8^/8[:U"3:5?O>+-!!Y"A2S
MF524;KC!P1[4[A9FO<>$-!NTE2XTZ.3S9_M+DELF7&-X.<@XXXILG@WP[+,L
MS:5!YBE&!7*X*#"G@]0.,U33QO:ET:2RN([<W2V+S-MQ'<'^!L'L2%W=,TQ/
M'NG_ &2*YGM;F&*2TGN\E02HB?8RG!ZYZ47069HKX1T%(8H5TZ,1PQ/%& S?
M*C-N8#GN>:TK'3[73H6BM8A&C.7;DDLQZDD\DUQFK>+KF6:".VMKRVN+34;2
M.>$%&$Z3 D*#],>F*ZK1-8BUS3OM<44D)61X9(I,;D=&*L#CCJ*$T%F:5%%%
M,04444 %(:6B@ HHHH **** $-%!HH \]^")_P"+5:7_ +TO_H9KT.O//@A_
MR2K2_P#>E_\ 0S7H= !1110 4444 %%%% !1110 5FZIHT.JS6,LLTT;64_G
MQ>4V 6P1SZC!/%:58'B/Q V@W6DEQ']ENKAHIV969E 0L"H'4Y'I28(I1^ =
M/@MK6"*^OT6VMY[>,^:"=LIR^>.OH>U/_P"$%TLQ0QF:[PEHME,?, -Q O1)
M..<=,C!P34X\4Z<]]%(FJ61L'L3=@8;S"H;&\'IM[8ZYK7L-0MM2A:6V=F5'
M,;AD*E6'4$&EH/4QI/!>G26]];^?=I%>7,=RZI( %9,;0O' ^5>/:FR>";"2
M5W:ZO2'OSJ#+Y@P9"NTCI]W':IIO&GAVW>=9M4BC\A=[E@<%=VW</4!N"11;
M^,_#]U=QVL.H*9WF\@(8W!$F,A3D<$CIGK2T#4H1_#K2(K>6$7>I%7MTMQFY
MY1$?>FWC@J>A_/-6CX*TYVGE:>\-Q+=I>+,907BE5=H9>.XX(YS4-QXYTBYL
M;\:/?PSWT%M--$DB.$8Q@[AG S@CD YJY!XKTU+:Q^VW*13SPQ.X"DI&9 -H
M8]%R3QFC0-2$>"M-5T=)KM&6">!B)/\ 6><<NS<<L3WJU<>%[&YT&STF22X$
M=D4:WG23;+&R?=8-ZXXIP\4:0T4L@N\K%<M:O^[;*RJ,LN,9X S5-?'WAET\
MQ=25DV++N$3XV-P'Z?=]^@IW0:B6W@?3K7[.8[N_+0333JS3Y)>48<DX_+TJ
M&;X?Z9.IDDN]0^W>8DBWZ3[9U*KM&& _ND@Y'/>M*X\5:+:W_P!BFOHUF.>.
M2"0N[;GUV\XJA+\0/#ZZ5<ZA;W3W4=O&DK+%$VYD9MH9<CD9XR*- U))_!&D
MW33^>;IUFM4M65I20%1MRL.^\-SN]:<W@^U:&8&^O?M$[9N)]XW3C9LVN,8(
MV]!CWJQXCU>72_"MWJ]J(]T,0E F4XQQG(Z]*B@\:Z#/%&Z7XR]PEM@QL")&
M^Z"",C/8G@T:!J5X/ >CVUV9(6NTMGC"2V0G/D2D+M#,G<XJ;1?!UCH>H)>P
M7=_-)';_ &6-9Y]ZI%NR% ]NU;5M>P7D<KPON6*1HG.,893@UE#QAH)\_&H1
MDPJK$ '+*S;05_O MQD=Z- U()_!6FSWUS>>==I--<K=J4EXAF"[=Z#'!(X.
M<@U?@T"Q@T2?2=KO;W(D\]F;YI"^=S$^IS4+^+=%CLX[I[S$;EQ]QBR[#ARP
MQD!3USTK/TWQA;R:[?:7J%Q DBW@@LS&K8D5D#KN/0$Y./7%%T&HI\!Z:UM/
M"]YJ+>?;16TCF?YBD9RO..N:NZ?X4L-,U>;4;:6[!E8N;<SDPJY^\X3H&/>E
M\2:\=%CL8((EEOM1N5M;5&.%W$$EF]@ 2:/[1OM*GF;69+7["L:&.XB4JS2$
MXV;<GGIC%&@:B3^&(I=5O-1BU&_MI[N-8Y?)D &U<XQD<8R>?>HI/!NFRF%V
MEN_.@EBEAF\WYXR@P #_ '3SD=\FI)/&6A111.][@RN\:1^6Q<N@RR[<9# =
MJ9'XW\.RQ33)J2>5%;BY9RC >7G&X''.#P<=*- U*_\ P@.B^7?0,;Q[.[#?
MZ&UPWDPECDM&O\)SS[=J?_PA-A]EM(S>ZD\]M*94NWN2TQRNT@L>Q7BIHO&F
M@3V\TL5]O\J01-&(VWEB,C"XR01D@CTI)/&_AV+R]^I)B2))@0C$"-C@,3C@
M9XR>E&@:E-?A]I45JMM%<W\<8L6L&Q-DO$23\V1U&3@^]:__  CNG-=:7=R1
M&2XTR,QV\C'D J <^O2G1>(M*GEGBCNU,D%R+61=IRLIY"].XYHU756L9K&T
M@C$EW>R^7$K=  ,LQ]@!_*@-2OI7A:RT;4)[JTN+P1RLSK:O.3#$S'+%%[9-
M1_\ "(Z?_:,MTKS+'+<B\>V#?NS.!@28]>AQTR,TR+Q7I]M',VH:G:DF\E@A
M$"/GY!DH1C)<#KBK<GBC1(HK:5M0B\NY57B<9(*L< D]@3QSCFC0-1VDZ%#I
M&A?V3#<3R1#?B21@7&\DGG'J36)'\.]-AL9+*"]OHX9H(X9E5QB3RVRKGC[W
M0$]P*OZ7XGCGDN8=0>&&9;^:T@5 ?WGEC/\ WUCG%5=>\;:?I_AQM2T^[MYY
M7B\V!6#$.N[:2<<@9R,GO1=!J33>"[66_FU 7MVEZ]P+F.92N8GV;#@8Z%>"
M#5A?".D"UTZ!X6D%A.;F)G;EI#G+-ZY))--7Q/96TM[_ &CJ%E%'%<) BH6W
MJS(&"/\ [1[8[5-_PE6B&QBO1J,?V>4.4< ]%^^2,9&.^>E%T&I5B\&:=:Q:
M?#://!'8W;WD:J0=SMNSG(Z?,>/I4MOX4LX_"TWAZ2>XFM9=^YW8!_F8L<$#
ML3Q5^ZU"--#FU&WN+<1" RQS2D^7C&0QQSM^E4E\6:-$;>WNM4M1=ND194SM
MS(/E/3A2>A-&@:E#4_#<C:7<6$5N-1?5&6&^NKF0(4C P&P!SCL!CDYK<O-'
MM;W0I='D#+:R0>00AP0N,<'UK"@\7&XUB^57MH=.T^X^S7!F5Q*S;004XP>3
MC;C/>M*;Q=X?MX+>:;5(%2XW>5G.6*G##&,Y!ZCM1H&I0F\#V\\=RLNIW[F=
MK=F8LN08>5[=^]7=(\,6VC:A<7-M>7K0R,S1VCS9A@+'+%%[9/KG&3BHO^$Z
M\,8)&L6Y 0O\H8Y .#C YP>N.G>K9\2Z,MU%;'4(3+,%*!22#N&5&1QDCD#J
M:- U*LOA8MJFH7\.L7]O)?[1,L17 "C VY&1Q39?!UI)>6]Y]LO%NK>821R^
M8"P0+M\HDCE".H[GFF:9XOLM:ET^6QN(8[:Y\_*7*LDKB/C*#I@'KFKA\6:$
MMO/</J4*10!3(SY& QPK<]5)Z'I3T#4RU^'VFC3[O3WOM2>PEY@MVN/EM#NW
M Q\9!#<C.<=*DN/ ]O=6MJDVKZH]Q!Y@:Z,P\R19!M=3QC& .@&,5NZ;JUAJ
M\,DMA<I.L4AC?;D%6'8@\BJY\1:0+^2Q-_"+B,,S*3@#:,MSTR!U':EH&IC'
MX?:>+:2VCO\ 4$AEL(["11*#N2,_*V<?> XS6P_AVPDUNTUB1&:\M;=K=')X
M*G&<CN>/U-1_\)9H0MWF;4HD2.1(GW@J0S_<R",_-V/>E_X2O0_L*WO]I1?9
MV+*&P>"OWLC&1COGI1H&I%H/A:#P_-+]FOKZ2U.?(M9I=T=N"<D(,9QGUSBL
M[_A7]JNH?;(=6U.&199I8@DH_=F7[^.,GGU^E;4OB/28[A;;^T+<3R+F,%N&
M.W<!GIG'..N*KZ;XEL;BSM_M.H63W4EH;MOLQ8QM&.KJ2,E11H&HEIX4LK72
M]3LO-F8ZF6:YE4A&)9=N1MP%.!V[TF@^%H=!N)YTO[RZ>>&.*07#*00@PI
M&..*MCQ%I!N8+;[?")9P#&I.-V1D#/3)'..M4;+Q/%J/BQM+LVAFM19&X\U=
MV[<'VXY&"/<>E/0-2I%X TZ*QO+#[;J#6$Q)@MC-\EH=V[,?&00W(SG%3_\
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M)%[+9F_A%Q$K,Z$] HRW/0X[@=*ETW6-.UF!Y]-O(;J)&VL\39 .,]?H10K
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MC/(Z4^P\)7UGK]KJ;/:N#-=7-S&2?E>8* $]AMY)ZY-=8U[:H%+W,*AP"N9
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MQ\R,?[*CG/0$5Z;--%;P//-(L<4:EG=C@*!U)-9=OK^EW=W:JF]9;I6^S/)
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MN]L[R*^M_.AW[-S+\Z%3D'!X//:K%%D%V>92>"=:-IK,5PMO<Q7MK)<K"I
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M \[^"(Q\*M,XQEY?_0S7HG:O.?@:2?A7I^>TLH'_ 'V:]&H ****8!111F@
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M22-Y,T121HR)4VDD=QZCT-<KK.B2:MXCN)[4R6NI6D$3V5Z4.T,"VY"?XE/
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ME_UWF_\ 0J]*S7FWP)_Y)99?]=YO_0J])I +1113 *2EI* %HI** %I#2TE
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M4ZQN)$$B!MK#H1GO32"YYM;^*?$#:=IC7&KV0?5)+A(YFC6)(C$6 7<<@EL
MX/H<59D\8:E!JFFPOJ5C*3<VMO=B$ 1#S =Q!;YF)P",< 5W+Z)I4EC]ADTV
MT>T#[Q"T*E W7.,8S1+HNE3SB>73K1Y0JJ':%2<+RHZ=NU%@NCSBQ\2ZI;65
MII\>K6ZSW4M\WVV^D4*'CDPJ'CT.<=<#BC5]<EU9K%;V^MEEL]<LHC;( !)T
M/FC/S88DX]A7I$FBZ5-&\<NG6CH\OG,K0J07_O'CK[TZ72M.FN5N9;"V>=0
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M4N8XEMVM7$4[+YL;-N(<]_F).?4FK47A/2XKYKM1.=\J3O$TI*-*BA5<CU
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M/ ECK31W"QW7V=F6WF\MTWNH^]Z GD=Q5N3PS%!'.UA-(MS-9)8[YG+*L:Y
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MGJH\^YL]/BTVWNH7^R!Y$+R%=P&>01C@XQ702>,-,@NKZ!S-ML,K<S!!M1@
M<'G/.1CC!/ K*;X?//%=K<Z[<SM<626.]H4!6-'W*>.K=B>]3ZIX"M=;O)IM
M2O'D66-X_P!W&L;[6  !8<L%(RH/0T:AH2W'B2>:[TT6\=Q9@W_V:ZBNH=I9
M3&7!!Z8Z'(/J*G_X372!&996EB@:%[B&5TPL\:G#%/S'7'!STIL?A:Y:&P%]
MK=Q>RVMP)FDEB4>8 I4+@<#ACDCDFJ]KX(6U@@A74I62RADAL"\2L8%?&<YX
M?@!>>U&H:%Y?%EB98HVANTDEBFE13&#N6, M@@X/!&,<&JP\>Z*9"N+L*MM'
M=/*;<[$C<94D]LXQ]:JIX!2".#[+J4EM)&\Y_=1#8$F #(BG[HX!&.AS1;^
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ML7EC;OY45C9FXN91'O;+!MBJ/^ D^_ K+E\2(FGR3?VO<C;HZ7F\6(/!/^M
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M)Y8_M7EBW6YC9H"/.C)VY3N>3@U#:^#Y;6UT2!-3)_LJ.6-28!^]WJ5R>>,
M]NM5/^$!D%A;VJ:W/'Y%@+(.D2@MB0/N/MQ@CN*-0T+Z^,K:XO\ 3[6TM+B4
MW5Q-;R-@#R'C7+ \\]NE,LO%UC'HMM<27%S?NT#W$CI;[76-6(+LF> ",?A4
M=CX*:QNHKF/5',D5[)=J/LZ!?WB;73 ['&1Z4RT\"_88(?L^INMR+:2TFE\H
M8EB=R^-O9@6.#[T:AH7F\;:.+QK=6GD56A5YDA)C42C,9+>AS6IJ.JV^EFU^
MTB0"YN%MT95R [=,^@/3-<__ ,(+#''=Q6]\\,,[6FQ!&#Y:V^-J^^<<FM[6
MM)@US1[C3KAG1)EQOC.&0@Y#*>Q! (IZAH<]K7C&)_"VH7FD2O'=0>>@,D0/
MEO"1O##T[?C4Y\66UU;0[+BXLYX[R""=)+8DDR %01V5@?O=JCF\ 6'V;5XK
M6XF@;4K=('/#!,?><#^\W&3WQ4DW@UIKNXN#J)#3W-K.P\D$#R% "]>^.32L
MPT&:UXOB71]1;33,D\5M+-!<M 6A?RSAL'OSQ[]LUKZ'KMOK*3(B31W%L$$T
M<T90_,NX$#T(K&_X0F9-+O\ 2H-<N4TZ=9%@MS$K"#><MSU8#)P#TS6OI>B-
MINJ7UZ;HR_:TA4IL V^6NW(/OUH5PT,!_$5TNO:O83:S!:FWN8HK5&M=V[>H
M(#8]SC/%;D7B>QDU&33BLXO(9?+EC,>-@V[O,_ZYX_B_"JO_  C=_%?:M<VN
ML"'^T95D;_1@QCVJ%&TYZX'4]Z:_A%I-9BU5M2E-T-T4K&,?OK8C'DM[ _-G
MKFC4-!\/CG1IWD1&GW*J/'^Z_P!<';:NSU)/;@U*OB_3&(4I=++Y,TWE/"0V
M(CAQCU!(^O:LU/ TXT4Z6VO7+10,CV#^4@:V*-E23_&1TY[5/>^$;J^-K/+K
M<WVV*":WEN/(7YTE R O1<8&.M&H:#+GQE;S6]\T'VJUBM1;/]J-OYBLLN",
M+G/0X]LUICQ18&XN[?;<"6UN4M9%,>#N8;@1ZKCG/L:R'\#2'3[JR35Y!'<V
MUO Y,"D[H<8;\0.E:TOABRG\0C69"YG-L;>2,'"/U&XCU + >QHU#0-)\5:7
MK=_)9V<KM*D0F7<O#QDXW*?3/XU)-XCL8-1^QLMPQ#^4\J1%HT?;NVDCH<57
M\.>'9M C\AM4EN[:-?+MXWB1/+3L"0,N1TR>U,?PO*NK7UU::Q=VMM?'S+BV
MC"\R;=NY6/*\ 9 ]*>H:#/\ A.=(\J9V2[#1-"KQ^02X$IQ&<#L??D=ZV-+U
M.#5K0W$"RIM=HWCE3:Z,IP01ZUREK\/Y;8L?[9+>8+?S,6J#>87W*3WR>YKJ
M-*TS^S%NQYQE^TW3W)RN-I8]*%<-#0HHHIB"BBB@ HHHH **** "BBB@!#10
M:*0'E_P!_P"27Q?]?<W\Q7J%>7_ #'_"L(O^OR;^E>HT )CG-+24M, HHHH
M**** $QS1BCO2T@$Q5/4-4L=)A66^NHX$8D N>N!D_D*NUS'C'1;G6+:V%G;
MAIX2YCG2?RI(&*X!'!#*>C*>HI,$/T_Q9:7&MWFF74UM#*EPL5J%DR9U9 X/
MUY_2KS^)-&C^TA]1@'V5#),2?NJ#@M[@'J1TKDW\*:X[RM)'9M(^I6MRTL;[
M=R1QA7(&.#G) JQI'@^]1M(MM3$#6^E07-MYJ-DW:2C:,C^'CD]>:-1Z'4#7
M]*)E47T1,0C,@S]T2?</X]J9XCU*;1O#M]J4$<3R6T1D"RDA3CKDCVKEM(\!
M7UCJFFWMSJ"S>2AANDYQ+'&?]' ]U[GOFNK\0Z?-JWA[4-/MV19KB!D0R?=R
M1QGVHUL&A!;>*M$N88W34K<[YUML!O\ EJPR$^I[>M:EO<PW0D,$@<(YC8CL
MPX(_"O/M<TF."PU*[U5X['4-32WM[**#,C"XA!,; @<MN_05W6DV;6&E6UO(
MVZ54S*^/O.>6/XDDT*X$,OB'28)9(Y;^%7BG2VD!/W9'^ZI]SVJ&;Q3HD-T;
M5]4MDN0YC$;-@[@<8Q]>*P_$?@F;6=5O+FWO!;PW5LOF1XZW,1S#)]!GGUP*
MDT_PUJ%GK^G7DJP7"0Z:\%Q,6PSSNX=F QT)S^=&H:$Z>.-,MK> 7]S$\[V3
MWK/:*SQ&-3@[6QS_ /6K0@\5:--:V4[7J0B]1'B67*GYON@^A)XYZUREAX.U
MN"PLK9_LB_\ $KNM/G(D)V%VW(R\<CL1Q3;/PAK4=];2W=AI5U%/!;)<+/*S
M?9GA&T,@QAP0,@'&#1J&AV=EXBT?4KL6MGJ-O-.59@B-DD*<-CZ'K5C4M4L-
M(M?M.HW45M 6";Y#@;CT%<CHGAC5M.OM%DEAM=EI/>O,RR9.V9LKCCD^M;GB
MO3+K5M,MX+2."22.\AG99FPI5'#'L>>*-0T+$/B31KB:WABU"%I+A=T(SC?Q
MNP">,XYQUQ2)XET>1)WCU"%E@V^9@G(W'"X'4Y[8ZUS$O@N\FUW4@\.GM8WD
MKW$=Z^XW$#,FTJJ],@]&["F)X9\2S:5IZW TQ+S29H&@,6?]+6+(&\X^7*G@
M<X-+4-#J)?%>@V\,$LVJVZ).6$66Y8J<,,=<@]1VJC-XOM5\4VFF036\EJ\%
MQ)<39/[HQ[>_0CDY],5F6?A/4(/$5GJ;I;E'O+NZN4\S_5>:BJ O'S$;<D\=
M352S\'Z_ ;&"9-,GM].MKNUC9V;-PLN-I=0..F&Y]33U#0[JQU.SU-)&M)Q(
M(VVOP05. <$'V(-0W.NZ79RW,5Q>Q1/:HDDX;_EFK'"D^Q-9_A+1KS1;.XAN
M9#Y+R!K>!I3*8$V@;?,(!89!QGH,"J_B3P<GB#58+AKCRK9[=[:^B YN(_O(
M,]MK<T];!H:EWXCT>QD>.YOXHGC)5U.<K@ G/L 1D]!FI%UO3I-06P6Y5KEL
M@( 2,@;B,],X(.*XG4?!'B"XT.WL/MMG=2O:SQ7<TI9"\K@ /E1DC  V\#O6
MEI/AO5[77[2_D^SVH5-MV+>9F2Y C"KE&'#@C[XZ@8I:AH=)JM\;&&V99[:$
MS7,<.;C(#;CC:N/XCVJ*U\2Z->:C_9]MJ,$MT&=?*4\[E^\/3(]*A\4Z5=:M
MIUK#9^5YD5[!<'S&(&U'#$<=^*Q++PQJMMJ5M,8[01IK5Q?N0YW".12 !Q][
MGGZ4:AH;OBC6)=!T4ZA$D3;)XD?S20 K.%)X[C.:3_A(;2YEL#87]D\,]P\+
M^8Y#,54DJ@_O#'(/:F^+M+N]8T!K.R6)IC/#)B5L+A)%8]O05A)X6U8:O]J\
MNS$?]LR7XS(2?+:'9@C'7/7VH=PT.ML=5L=2,BV=RDQCP7"YX!Z'W!P>:KZG
MXCT?195BU'48+61EWA9&P2N<9^F>]97A'0;_ $62Z\X1V]I(J>79I*95B?G>
M49AD(<C"\XYJAXDCGN?&UM:6L-O/+/I%Q$4F?;M#.HW=#D>W>C6P'4MK>F)>
MQV;7L(N),;$W=21D#/3)'0=ZB_X231]LK?VA#B(_-@GN<#'KR".,]*X^'P)J
M5I92:&DT4FGRW5O="\9R)83'LW+COG9\ISP#33X,U/;>1BTB%E*ZLMFEZP\J
M3<6,L#XS$>1\IXSFC4-#L_\ A(-)'V;_ (F$'^E8,)W</DX'/;)X&>M,_P"$
MDT<F91J$),.-X!)QDX&/7D$<9KC[?P9K<.I6\]W'INI^?%"MS+=,P,#QDX95
M4;7R"#V^89[T?\(;J:I=I]CB-E(ZNMDEX08I0Y8RP28S'USM.1G-&H:'71:[
M:R7<I%]8FR2U6XW"7YP"2-Q'0+QU]<TX^)]$6U6Y;4[986D\H,S8^?&=N#SG
M'.*XZ?P=XBO862ZN;<SG38X?M);EI4G,H#* ,@C )'?)Q5RY\+:I>ZU;ZPUM
M;PRR:C;7$]OYNX(D2,I.<?,Q+?D!1J&AVMG>VVH6<=W9SI/;RC<DB'(854FU
M[2X+F:W>]C\Z%6>1 <D!1N(X[@<XZU6\*:9=:1HGV2\2))!<32 1-N7:\C,.
MPYP:YR]\+:Y=^)UO66S^SQWDDBR"5E/E/$4^X!C<">222?:AW#0[#2M4M=:T
MNWU&R9FM[A Z%E(.#[&L._\ &MG!<!+<HR0:DEA>-*"OEEE)ROKV%:7A>SO=
M.\-6%CJ"1+<6T0A;RG+*P7@'.!U S6'<^'M8;5F*1VCV8UB+45=I#O*A,,N,
M<$'I1J&AOGQ'HZV4-X=1@%M,,I)NX(SC)]!GCFM&29(H'F=L1HI=F'/ &:\Y
M@\$:S#<^?);:7>),UQ%+;W+L41'E,BL,#GK@J>N!S7HGD8L_(&U?W>P;1@#C
M' IJX:&):>*K*^CM;Z*[M8]/EM7N6\XE90H(&[']WKD_2IX_%WA^5PB:O:,Q
MD6/ ?^)ON_GV/2N6B\+>(%T^TMY(;+?;Z3=6!*S'#,^ C?=Z8'/UI)_">LFS
MNDCM+/S)+"QMT_?8&Z%PSYXZ>E+4-#MTU?3Y-0-@EW$;H9_=;N3CJ!ZD9YQT
MJ>YNH+.$S7$JQ1@@;F/<]![FN.T+PK?Z9XCEEGM-.EMEN);B&^+,;C$F24V]
M 1G!8'D <5M^)=*N]2BT^:R=//L;Q+H12'"R@9!4GL<'@]B!3U#0K:QXMMK5
M-,CL)H99M2F:&"1PQC4JI)W8YZC&/>MU)VBL%GOC%"ZQ[IL-\B''/)[5Q\'A
M348M3T^]40 ?VM-J-S'O/[L/&4"KQR>YZ<YKH?$VE3ZUX>N["VF6*>0 QLXR
MN58, WL<8/UHU#0S;7Q7]NO[^""6Q$5O=P01R2.P\P2+DC&/O^@[UM?VUIH:
M9?ML(,*EI/FZ '!^N#Q]:Y)_#NOW=Y=7EQ!81/<7ME<B..8G8(?O\[>3QQ4%
MYX-UJ2:^DT^2&S5I/M,<#2F2&2990X(!&8PP'S <9.<4M0T.DD\2Q-K&D6]F
M8;BUOS.KS!^8VC7.,?SSTJ['KVE2QRR)?0LL6-YSTR< ^X)Z8ZUS5[X<U?6)
M=/ENH+*S.+H7*VSG]V9H]@8' W-GDGBH9/"FI7EO&U]:6LDEO81V B2=E$P#
MJQD# 90C;E?0T:AH=8-=TMHVD%_!L6)IF);HBG!8^P/!IG_"1Z+]J:V_M2U\
MY1N9/,&0, _R(-<A/X6\2&PP);2ZN)K"YL)#<R$&-';*,6 ^<@<'@9ZTO_"&
MZM-INL0R+9)<3K:-;ON+*S0JH*MP"%)7MV-&H:'=6=]:ZA 9K2=)HPQ0E#T8
M=0?0^U43XCTM=3OM/>Y"36,22SEP0JJW3FF>&]/FL+&7[186=E-/*97BM7+C
M<0,DL?O$XK#UWPOJE_K&IW-JUN(YX[62$NY_UD#EMC#'W6!ZT]0T.LLK^UU&
M S6DZ2QABI*]B.H([&L?4]<N[3Q);Z5"MDJ36KW'G7$A7;M(!&/Q_0U)X?TF
MXLK[5M1N@L<NI3K+]G1MPB"H%Z]R<9/X51UW1KR[\56FHKI=K?V<-G) T<L@
M#%G8'(!!&,#]:0&G%X@LHX,:A=VL%TD GEC63< A. P/=2<?G5HZQIRWRV37
MD*W+#(C+8)XSCZXYQZ5R6K^'M<U V%W#:6,-YI:J]K&K_)(2V#$YQG8$ _X%
M@]JBE\':E>:CJ$<]K8_9[MY+B*]:1FFMG=,%0OW20> WI1J&AU<?B31II!''
MJ,#,9E@ W<[R,JOXCIZU#)XKT@7EM9Q7D;W%TLIBQG;^[^]N/;!XKG_["\13
M:+;"XM-+6^L9[9T\F0C[2(3_ !-CY<CH.<4W3_#>O6VHVE[-!9$I<7K21I,<
M!)\%2"1R01@CWHU#0Z33_$-E/:0_:;ZR-T;3[7(MO(63R^[J>Z^]68]<TN6[
MBM4OH3/*H:--W+#&>/?'..M<I#X-U"32/#J/)%;7=DIMKT1MN66W;[R@^Y"D
M?C3K;PUJ-AXDO;EK#3KFT^T/>VUU+(WFQ,5QLV]!@\!O0]*-0T.YK"EU_<]R
M;=K5(8+I+4RW,A0/(2-RK[C.!ZFM#2+FZO=)M;F]MQ;W,D8:2)6R%/L?2N1?
M2=0;2=4T>&*)[E=5%W%YC;0T+2B3=G!R?O#ZBFP1U@UBQF606]W \B3FVQNX
M$V/N'WI^F:@FHVAE52DB.T4L9/*.IP161'H$EMXLN=5-PBZ;(@G: CI< ;"_
MTV?K4_ABW:.WO[ME*K?7LES&I&#L. I_$+G\: -RBBBF(**** "BBB@ HHHH
M **** $-%!HH \N_9_S_ ,*Q3/\ S^38_2O4J\L_9_/_ !;%>?\ E]F_I7J=
M !124M !1110 4444 %%)1SFD 57NKV.T>W219&,\@B39&6 ."><=!QU-6:Y
MSQ.]Y'?>'S:-=!3J*K.(0<&,JV=^/X<XZT,#H68(I9B H&23VK/TS6[35VD%
MJ)L(%8-)$55U;.&4]"#BO.['^T46S:Y;69!=6NH1W2S"1APQ\H8[''3'6DM(
MM2@T"SM&AU."(:*G]GF$.&2]&=P<=CG;C=QC-*X['JU%>5:C;ZV]KX@N))M9
M&I126BPK;O((^5C\WRP.",[\^E61#J-GK#/:'5VC@UQ$B1C(RFW:/Y^O!7=W
M/0T7"QZ3*T4:>9,454YW-T%0P7J7%S=0)',K6[!69XRJMD9RI_B'TKR6:'6;
MVTOHYM/U=K:2UBE,,L4A(E2X!;+9^9]F>F 1TK>NY]5_M6^,<&I-I/\ :-N9
MU8/G[.8OFV#KM#XW <]:5V%D>BBEKRUK36IY(8;AM5-EC4# 59U/E8!@#D<Y
MSG;GGI6U=SZG)X T1KBWOY+N3[.MV$5@Z\?,9%'S$9Z@>W:G<+'5_P!J6W]L
MC2LM]K,'V@+M.-F[;G/U[5<KR.VL-3N[>QEU2/6H[F/3;BV26(.DGGB8F,''
M^S@C/'%:,2>)VE6*\%W_ &['>VS121D^0]MM429_AQ]_<.N<8HN%CTMB%4DD
M  9)/:FH5D175@RD9# Y!'K7E,MMK=];VVER6NJR&*WU*"Z+APCDY,(W9^;C
M&#743:==7_PVLXM.%S:W]O;12P(Q:-_,C .Q@><'!&#ZT:L+'47MY%IUA<7L
M^[R8(VD?8NX[0,G [U#)JL":5%J*QSRP2JC((HRS$/C!VCGOSZ5P:VWB5X]6
M6^MKA+66UEU"%$<NR2R1E?LWOM/..G-4'M]7L]+N[>UCU@ V6G21JHD)$H<"
M4#T.T?,.E%V%D>IWEU%8V4]Y/GR8(VD<J,G:HR>*+.[BO[&WO("3#<1K+&2,
M$JPR./H:X&5+^YGUN*[LM7_M!/M8ADCS]FE@=#Y8]#@8&T<[JM>"+2[T[48[
M9HK]+9]'M6<7&XHLX!# 9Z-C&0* -U/%NGR-=;(;UDM;C[-/(+=ML;Y Y]N1
MS[UO5YYIB7%IJ>LS2KK49;6&GA@AA.RX3"@<X^Z3G.2.E1QV>LV^M7WV."_^
MR7"7#:8TS,1:W!&&WY_@8_<SD#GUHNPL>C45Y;;V^K0V$-VMOKLMN9H1JEE,
MFUB I#&, Y;YL%L'D#BGZC:ZM;QW'V&UUQ[>XT9X;9'8M*)EEW*6P?E;;TSV
MXHNPL>B7>HPVB@D22GS4B984+LA;H6 Z#U-7*\PDL;ZSO-5EMK'4HII]7LKH
M/&K_ #Q;4WD\XP,/D5I2:1K\.KZK9V?FFT4OJ-C<23'!F9"HA//W5?YL=,$4
M786.]I*XSP+;W0%S/<G5U>6*-9H;Z,(B2@$-LY))/<C@\5A3Z5XKT^\Q90SS
MP:?=20Q%YR3=07'\1Y_Y99ZGTXHN%CU"F^6GF>9L7>!@-CG\Z\QE@U:T\1HD
M-MK,=M!+) TJ(TI>/R,*X8G&-_0>O4UL^$UU*VT75XI[:ZD>)1Y$RLZ&Y_=]
M523E'SP>V[D47"QVV:.M>3:?;:_<6FIK;IJD4T$-K?6:RB1!)*F?-C)8_,6Z
M'L3SBKB1>);2#5A=6E^UN(VU"W$$S&5&E 'D Y.3'AC^/%*X6/3J*\IM8M1N
MM1MM/N)-;CLVU5\-&LL2?9V@R!N/(7?ZG(]JUO"T&JGQ.\FI2ZNEW"TT<T;Q
M?Z-+'G]VV_.#@8QCGKFF@L>@56NKV.S>W1XIG-Q*(E,<98*2"<MCH..IKSJY
M^V7'C#5H[2[U-KZWU.V:WC61S"L113*"/N[=N[@\YQBFZ1:ZE:Z7H=RS:T;N
M75V%TDSR'$0:0#<IZ)@I^E 6/4,TCNJ*6=@J@9)8X KRF>'Q#+IC26XU.+5!
M9W:ZJH+X:3!\KR^V[=C;M_AZUN:UHLTGPGN;2)+ZXNI;=)GCDD=I2^5+#U['
MBB["QW63VQCUJMJ&H0:;9SW5PQ$<,32N%&YMJC)('4UP+C6);Y_L\=_'?+?6
M[:>Q#"+[%A=RMV'&_<&YSBKGBW3Y/^$G:^2TNI1)HMU;H\*LR^:<;00..1G%
M 6.VM;F.\LX+J DQ3QK(A(QE2,BIJ\E-OK=C:QQ64&J_9#:V$MZH5G;@%90@
M/<#;E1C@5T\D6JVOP\F73'U*XN0V8S<IMN#$7&X*.H.W.W//2BX6.GL]4MK^
M\OK2$OYME((Y@R$8)4,,>HP:M>8GF>7N&_&=N><>M>4O#.EUJ26&F:S'97>H
M1.KM'+C;Y&"6'WBNX8QD8.,\5%:PZ\E@UZ+#5#J\ND01O(T;;V*2D2KR<;]G
M3U[4786/7:AO+R"PLY;NZD$<$2EG<]A7*:=#J47@W53I,E^]U()'LDOX_+9"
M5^ZH/(&>F>_M7/:M8WEYH&KI;VFI26$UA ?LTJN9/M8?YMHZ]/O=LXHNPL>C
M:?JD&HVS3(DT.V0Q,EQ&8V##M@]>HQBFV&KVNI6,UW;>:T<4DD;@QD-N0D,,
M=>HK \6:?YVFZ"\-M<2QVNI6TKK'N++&,Y) Y(&16%8P7UOJD<Z0ZI&ES>:@
MMR,. (R"8SMZ#)Q@]>:-0T/1+2Y6\LXKF-9%25 ZK(A5AGU!Y!INH:A:Z583
M7U],L-M"NZ21NBBO/+1=95O#D\BZC/*EO;QSVTH=&5LG=('Z$C^-7ZC&*Z;Q
M):3:Y>P:*D*-:F-IKDSQ,8I!]U4R.^3NQ["BX6.E5E=%=3E6&01W%+7F,.I:
MK9>'=*T^_AO7FL;]K*:..%\WL2JVQU(YVXVG/J*2R@U&^FLX;74-2N)8=)D
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MZ?;^7^[NU<+YA/'J6!_NX!JA)J5UIUMJJVLMS;--K-ZP:*,@,1&"N6P3RW0
M?-BE<+'J=W=V]C;/<W4RPPIC<[G '.*E!SR.E>1R:YJ:6.N:D+Z\%Y)I-C<0
M*T1*9Z2%4*XZ]1[UI76O:K%K%Y/%J-PT,&LVMM'!Y8\LPR(N_/&2 23G/&*+
MA8]+HKSSPEK]UJOB"%)]85B$G6>U8X$D@DPAC4C( 0$]:S[WQ5J<>OW<4=[=
M) 3>PD/"<Q.B9BP-N!ST.?FHN%CU"2))EVR(KJ"#AAD9%-GMH;I%6:-7"L'7
M/8CH1[UYM:7OB#4;2]LK76KDWCZ3;:A#+)&HVS<[T^[@ X (ZC-;BZIJ%SX
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MDC=UQFFF2(%LN@VX#9(X]*\P77=6U'5(=6M?L=O>P:9=K+YRLT4GDS 97!&
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M+J.*V0JJ@J.#DDG!R2?2BX6.OHK@+[Q9K5C<2V4<MC<2!K-TNO*(CVSOM*D
M]1U!SR*Z/POJMWJ=MJ$=\8FN+*^EM&DB7:) N,-C)QP?6BX6-VBBBF(****
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MIQ;1&5)Y(T:X1-@EVC=@XR!Z D#BN5D\?VD%O]IN+&X2&:U>[LV&&^T1KC/
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MK)!J-]=W2NK\N0-KMC#K@?*RX&,=*LS^+-#M;F6WGU&))(E=F!S_  #+@>I
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M$92-YPAP1G#=CTK2TW5+/5[=I[*;S$21HWX(*L.H(/(-"L&I<HHHIB"BBB@
MHHHH **** "BBB@!#10:*0'D?[.__)/[G_K^?_T%:]=KR']G?_DG]U_U_/\
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M*04# #!]3QUK8HHL%PHHHIB"BBB@ HHHH **** "BBB@!#10:*0'D7[.^3X
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M:EI\-YII9S^^+XW(>."N2?H*A_X65>W#ZU-9:,9;#3?M,?GL2 )(0#\Q]&Y
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MC]YD9.<$8'H:JZMXS=[=39P7MM/;W=IYT;1*QEBF;A1R>H].11=!9FS<^"]
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M$9K/U72AJJVT<LN+>*82R1% PF Z*<]L\_A6C5>\OK;3X/.NIEB0D*">Y/0
M=S2 Y^?PM/::CJFI:)?&SFO;98_(2)?+$B_=DY[X.#[5JZEI":UH$NF:@Y/G
MQ!))(OE(;^\OH0>15&]\6Z?&RV]E*MS=36<MU;[<F-@G7+#ISQ3M)\7:3J6D
MK>&]@5TAC>>,-_JRXX'OSP,=:5T.S*7_  @.GQ)J@MKB>%]0LUM78$': ,%P
M#_$W&3WQ27W@=;P7(&J3QK<PV\<H$:G)A(*L/3..:U!XKT$R01C5+<R3DB-
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M#''VT8/_   5[77B?[-ISX6UE?2]7_T 5[73 6BBB@!,TM%% !1110 4444
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MQ:V[Z=:Q$JRX,J AA@?7KWKL:*+!<YKQ!I]Z^MZ5J=O:B]M[99HY[3< 3O
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M%, HHHH **2EH **** "BBB@ HHHI %%%%, HHHH *.U%%(!!2T44P"BBB@
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MYP,_2EHH 0@$8(%&!Z#FEHH K'3[4ZBNH&!?M:Q&%9>X0G./IFK&!Z#BEHH
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,B@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gtbp_ex1017007.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JP# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I#2TAH ^5OV?/^2F?]N,O\UKZJKY5_9\S_P ++;_KQE_FM?5
M;M0 ZBDI: "BBB@ HHHH **3/-+0 444F: %HHI,T +1110 44F:"<47 6BD
MS2T %%%% !124M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444E !2TE% "T444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F:"<4 +2;J <T&E<!
M:3-%)1<!U(32&FMDGBBX'RY^ST#_ ,+(E/I82_\ H25]3#I7RU^SS_R4:;I_
MQX2?^A+7U+VH *6F]>AI:8"T4E+0 4E&:*0 3Z4"BEH *2EI*8!12TVD M&:
M** %I#S110 444=J "BDH'6D M%'2EI@)2TE% "TE%% "TG-+2'- !11FB@!
M:2BB@ H-%':@ S124M !1WHS1B@ HH%+0 E%%':@ HHQ10 444M "444#I0
M444&@!:*2EH ****8!1110 4444 %%%% !1110 4444 )12TAY%(!:*3- -
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M@ I*6DH 6DI:2@!:2BB@ H^E+24 +24M% "444M !2444 +24"EH 2BEI.]
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M)I-+U"*Q:RL5<1PL09N5=CD]1E=W]:T_&D,[ZG8M/IMSJ.E/;SQ-%!&9-D[
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M2*1;9BIEB#+E\ME@RL<]\]*6H]#8?Q_IT.L1>9<1C2); W*S^6^\,)=C!AV
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M<2"3RYWD#*,YX;OQPO:NG\16MY>?#F>V6TGGO6M$40+_ *SS!CWZ@CUHN!U
MD4D*2 Q&[:3R!]*I'5;<:Z-(*R"X-L;D,5^4H&VGGUR17(V5C?+\0%O8[*Z:
MWD),S7<>/)_= !HI >03P4/?)J#QI::K+XKM[NTTZXO+&"QQ=0(G%ROF@F-6
MSPP'S8[XQWH"QZ&:45Y;<Z??/K5UJ%M8Z@DYUNW>V?RW 2 Q@.<9P%SG-/TO
M0M1U-[.UNX;VVN&L[FWUN:0L%F<_ZME/1CN^8$=!Q[4!8]/HKR[2=)\4-JMF
MVJ6KK:W\*PW^USF+[,?E?CO*/3VJ?P99WMGJ6AS31:BDUQ:70O3/YA'$N8PV
M[A3C./:BX6/1_,C\WRMZ^85W;,\X]<>E/Z5YIXKM-47Q;J5[I-A<&[ETJ..&
MXC0_,!(3(H;H'V=,^V*Z'PK'.FIZK]G\\:&WE-9K.&!5]I\P+NYV]/QSBBX6
M.JS1VKS4_P!KMJY#->C5(]7?SL%Q$U@5.,?PXQC&.=U=!X#@>'PI!=S2ZA-=
M3INF6\D9G#+D8 ;[M 6.JZ45X]9:I?S_ &P"^U&RCN+,-NGMYG\J83X(D/'\
M)PQ7  /&<5:LM3N9YK2'5?[:LH'@_P! >T>23S)UE.[#8Y#+MV[_ .'-%PL>
MKYI-PSM)&X]!7DKZGJ30:W//K.IVVJ6T-T)[)+=@J_\ /)@W(&/EVE>N3FEN
MS_8VI)J#ZGK-R\GA]YHIO,9V,A<;MHQM&!SC''6BX6/4[B\@M6@69]C3R"*,
M8)W,1G'Z5/7E6G:[J"WUK;-J<SQKKL<( +LK0/!NP6<99=W?UJE::]J-EI<%
M[-K6J327%GJ'F+_K"ICEQ&RJ1@,!W/;Z47"QZQ<ZA:6<]K!<W"12W3^7 K'F
M1L9P/? IS7UJFH)8-.@NWC,JPD_,4!P3],FO(?[0N-2FL[6[U:7R;37T"W,<
MA8PQ-;L0?,<<@L2 Q'TJS)J^KVWDW:RM=ZE;:9?FUF>/YYHEF0(Y4=3M!/OB
MBX6/7:@M+ZUOXY'M+B.98Y&B<H<[77@J?<5S?@>]DO;6[E_MU-7MV=6A=$.(
MLKRN\_>.><=LXKF](DU"#6YTL=1E4W.NW4,]BJ)A(B"?-Z9!! .3QSBG<+'I
MKHD@ =58 Y (SS56?5].M9FAN+ZWCE1=S(T@#*/4CTKF_!E]K-_+/%JDLWF:
M6&L[@L@"W$P;/F#CILVGC^]6;J;2GXC:J+6_TZUE&E0!C>(&!&]^#R,47"QZ
M!'+'-$DL3J\;J&5E.00>A%.KSV[\03V?B'3X+35(TT&\$*/+'$NVS?\ @0''
M24# ST_$50E\8ZVL6HZFE_8@6IN8Y=,8%I4V-A6V@9& -QR<$'BE<+'J#JKH
MRN,JPP0>XK'T_P /:/H(:XMXS$D:G!EF9DA7J=NXX4?2N<_X2&>TO--">([;
M4;.YU!86E$: )&T);#,.,[AD>QP:P[/Q)J.IR&YEU=-I\/7$XC9$,4DBRLN2
MO?@<BBX6/58Y4FB62)U>-P&5E.0P/0@^E.9E1=SL% ZDG K@(=?U:V?1[<31
MF/6-,B^PB. !8[@!2XX_AVG<!_LFI-%UK5=<U8Q7$M@VFO-<6MQ:R.!*-A(7
M"CD'C)SQ@C%%PL=X6 !). .I--CDCFC62*17C895E.01[&N:\)7ES>>#B9Y1
M++ ]Q;K*XR)%C=E4GUX ^M<WIOBG4;;2/#S^7:6>GW%O"'DMX T<4C.1L=0<
MQJ1]UAD9SFG<+'I=9NKZ+!K(LQ<2S(MK<)<H(V #.O3=QR/:LWQ)K%W9ZII6
ME64\%K-J'G%;B==R@HFX+C(Y)_0&L6;QCJJP7]RGV-AI+6J7,2*6%SY@7>T;
M9X'S?+P<X.:+A8[W8O'RCCIQTJAJNF6^I6)LY)YK9)'#$VTOE.QZD9'//>N/
MM?%7B+^T%26/3YHY;R]LX8T5D8M$K,C%B<#.W!^N:A@\275\=,FU&"V>>WU)
M8Y89;9XY[8F%V^[DC/!PP)!4T7"QZ!';6\<44*Q1A(E"QKC.T#CBG+;P*05A
MC!'0A1Q7E4_BJ[AU*R\5SBUDBGT:>:VAC!!0&2,*';.#]X9/&.:WI/$?BN*2
MRM&L=/CN+J\-O'),QPR>67#E5)V\@C&>1@TKA8[7[':A446T.U,[!Y8PN>N/
M2HYM-LYK=H&MX@A4I\J 84]0..AKB+3Q#JT3K::?8:?'<W6LW5I(7>0H"J;_
M #/7G'(_*I#XYU*32K>>#3X/M3V)NC&S,5E<2>68TQSUY_$>].X6.[1%BC6-
M%"HH"JH[ 4ZFQEFB0N '(!8#L:?0(2CO110 GMWHI:/I0 49HZTAH 7/-,84
MM-;/&*0'S?\ LW9_X2K6/3[&/_0Q7TF:^;_V;1_Q4NM'TLU_]#KZ1I@(,XI:
M,T=Z8!]:*** %I*6B@!*6DI: "D/2EHI 1&:,2B,R*'QNVEAG'KCTH$L;!BL
MB';][##CZUYU-HM\_B?46O=+U"XD%S)<VEW',/(\IHRH4_Q9'(V=#P:Q)]*O
M-(T"%5TZ[MG?2K2*55P//N1,/W9Y^8D<'U!I7'8]@^T0B,2&6,1GHVX8.?>G
M,Z!E0NH9ON@GDUY!<64EW:W-M8:/?M<2W-S+.GD;?LC21?NU",<$'LW8YP!4
M;R-+=1QZE:ZDL=O;6!N)C!YC6;1\LA(/R[N"<]CGFBX6/6[6[:X$YDMI+?RI
M6C!D(^<#^,8/0^]6"R@KE@"?NY/6O+%T6:[U&%;K2[V2R.OW5PP*MM-NT6%)
MY^Z3C K$>WO#IMEIM_!J:A='"2MY32/8D3DAL Y!*C'T H"Q[>?UK L?%MKJ
M*AX+#4/)^TM;-*T(VHX;:<\YQGOC%6]'UFSU,3Q6BS*EIL&Z2,J'5E#*R^H(
MKA_"L#V7[Z6/7%N6U2X=++:RQ,DCMAF!& -IW9S0!Z90#D5Y.MGK-F=7@LK/
M4"9[2:716);,"L^9(F)Z.<97/8X[4B(;>.TN_L?B"?0+BY;[9;RVY1XG,>U"
MD2_-M#=3_>P:-0L>M53FU&&%XU599R\XMV\A"_EL1GY\?= [D^HKS35TOK$W
MMO#:ZTWGV5B;;<'E?,<N'+,. P7&?7WI]K;M8WABAM=0MYW\4^;+A)-KPL#R
M3T*8Q[4!8]4_"FL0%)8< 9QC->:OIGB&PCUVRLH;IET[SKC3I_,),YF&0@R>
M2@W@9[[:W/!)3[%J%S#=ZC-:RLKJEY;F(0MMPRJ#\W4<]L]* L=#HVH66JZ3
M!?:>I%K,"4'E[.A(/';D&K3P0RO&\D*.T9RC,H)7Z>E>-Z=_:VEZ+:'2_P"T
MOM=SI=P\T)5VP5F!&Q3PK[2^!QFM*.T6^?1[>UU?7#IUYJ$A8JDD&Q3$?E&<
ML%W8Y/?.*+A8]-U"]@TRPGOKHLL$"&20JI8@#KP.34T,JSPQS)RDBAEX[$9K
MRI3J5[9:XDESJ;:I':W<-Q9?9GVN.?+.\G:3C&TKUR<T^UL]5;3]1ETC4M1E
MM+>TMKR-[B5L-<)DR1@G!VL@ (Z FD%CU0T<US,-S=0>![[5IQ>K/<PR78BC
M^>6 ,,JB \948_'-</9^)+BUL[E)M3F:R34+7<=\I)A>,EPLC '[PR3TX(&*
M L>N;5W[]HW@8W8YQZ4_CZ5Y793:K>W.DVT/B*\GD:PNKC%O.")9$D!C1FQV
M!VGUP:J6WB34O[$_M%=?FFWFW348FMY!]@RW[QR>J_W2!T'-%PL>OT=J\M?6
M+Z"/3V/B.:_AW<M;#RI&5I<(RJP_?*/NGOCFO1-->*1+DQ7SW8%S(&9B/W;9
MYC&!T7I3!HO444=N*!"]:3\:6D-,!?QI"**6@ S1110 <YHHHH **6DH 6DH
MI.: %HH%+0 F!BDVCT'Y4ZDH :41@59%*G@@C@TNU=P.T9'0XZ4HI: &HB1K
MM155?11@5#/:)+%.(SY$TR%#/&H#CC@@^H]ZGI:8%#2-,32=/2U$\UPX):2>
M8@O*YZLV.,U++IMC<2&2:RMY';JSQ*2?Q(JU12 K/86<D;1O:0.C$%E:,$$C
MI^5*ME:K<23K;0B:1=LD@C 9@.Q/4BIZ* *8TC3%LOL:Z=:"U#;_ "! NS=U
MSMQC-(VD::Z*C:=:%5#*H,"\!OO <=#W]:O4E $,5G;0QPQQ6\2) ,1*J ",
M8Q\OIQZ54ET6S$]U>6EO!:ZC<1[&O$A7S/KGO6E24 4[#2[73M)ATR!/]&BC
M\O:W.X=\^YY)^M58O"VA026[Q:7;(UNH6+:F H!R!CT!)(]*UJ6F!1U31M-U
MNU%MJ=E#=PA@X25<@,.X]#44OAW1YKZ"]?3X?M$"JL;@8P%^Z,#@@=L].U:=
M% &,/">A+MQIT0V222KRW#R##GKU(ZT1^%=$B-NR6*[K>87$;%V)$@&T')/.
M!P,]!6S12 YZ+P/X9AGEF31[</*DD;@Y*E7^^NTG !] *FLO"&A:>MHMK8+&
M+24S0?O&)1R-N<D\\<<]JVZ*8&(OA/1X[E+A+=UE2X>Z5A*W$KC:S=>I'%<W
MJ/P\#7UI_9OEQV=M!Y4(-U-') =Y8L"I^;D]#TQ7?T4K!<BMHGAM8HI)6E=$
M"M(W5B!U-2T44P$HHHI %%%+0 E%%)WH 4CBHV'(^E2?2D(SUI ?./[-@_XJ
M#73Z6B#_ ,?KZ.Q7SI^S6/\ B=:^<?\ +M$/_'C7T8*8" <TM&**8"T444 )
M1WHI: "BDI: $HI:* $JM?:?::G:M:WUM%<6[\M'*H8''0_6K5%("I8:=9Z7
M;"VL;:."$'.U!CG^M5;CP[H]UJ2ZC/IUO)>#'[TIR<=,^N/>M2B@!!QU-9M]
MX>TG4KY+R\L8Y;A5V"0Y!*YS@X/(]CFM.B@!D<,4(;RHU3<<G:,9-/\ QHHZ
MT %%&*6@!*6BDH *6BBF E%+10 E4-4T>TUF"*"\61H8Y1+M21D#$=FP>1['
MBM"DI (!@  8 X  K.U?1+;68X!-)<020/YD4MO*493@CZ'@G@@UIT4 5+"P
MAT^V6"'<V#DO(<NQ/4D]S5DJO(VC#=>.M+1GDT 1^5&2I**=GW?E'R_2G@ #
MY0!GT%*.E H 6FYR:=2' H *#1BB@ HHI: "BDI:8!2444 %%':BD 444&@
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MD:S.UTXBA8AI1$Q0X?8<''.&.#4EQXJTBV^T+).YDMY_L[QK$S/O"[B H&2
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M%%( HI:* &XI&.#3J0T@/GK]FH?Z;X@/_3*'^;5]"CK[U\]_LU#_ $OQ"?\
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M5!=1+.%5\X_>'&1@8&!DU=;7Y--O]42/63!%=ZX\5Q<W$W%O'Y0:/!Q\BL>
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M>Q)XP!3Y?A]'):W$"ZK.@GL[:S9A$I(6 Y4CW/>NTHHL%Q!D* 3DXY-+113
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ME[/4].DB=!L8^8X/3)QCMW(/(HN%CU(,&Z$'!QQ2US/@Y$C.OB,87^V)^ >
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M-,OO%S2ZS'!9W M=/2P347O9;?>DB,WW>H(! Z]<G%+;^!I8/LP_M4L(([Q
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MZE8RWKV4=W UU&,M") 6'X5YR?A]J=OIE[9QQVES(VG6EI!/))@[HW+,>02
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MR&*XM)7B?9ND5P/O.$ 5>K$9R>F!6'%JNI&^B7[?,P'B66U*Y&##L)V'CH*
MU/0***3G-,0M)11WI %+3:44 +124M !2$T&D.>U 'AW[-:_\2/7F];F,?\
MCIKW(=*\1_9L'_%.:X?6[0?^.5[<#0 4M)2TP"BDI: $H%%'TI %%!Z4@Y%
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M)P#^8J<UY]+&\'@]-0AUAVNY)5ACO[J)XO-A\PLL9(^95.<!SSW-37^HWO\
MPJ2:_BGOK*[C@WB620-*N'Y.['S#'0XY&*+A8[K-&<]*\O75=2M-7-H^KWD_
MAN:]1#J;/^\C9HBQ3>!@)OQSVSBHDU_71'I<UUJ$SJKE6@@(2>6+SRL<VTC$
M@90 5&".HI7"QZKVHR*\DF\4ZQ9?:?,U%I(6GC$U\C>9;Q0M(PWC W1,,!2I
MSCK5R37]5LSICMKJZA;KCS7M%"R,K2X5]K#]\N/E.T@]Z+A8])N[VVL+<W%W
M.D,((4NYP 2<#\R:E^M>52^*M3BM-06XU%)91)!+'*JQRVTD37 3Y<C*''!5
MN01D&M1O$FK/J>]+P*_]K36$FGE%_=PJK%9?7/ ?/0@XHN%CT*BO/_!OB'5[
M_4],AU'48KM-0TDWNU8E3RW5PORXZ@@\Y]*BN/&-]%XLEMH-1M3:^?<6NRXV
MHD3QQ;E_VN&ZL>#GBG<+'HV:*Y3PIK5]JNGZA'?2LFH6N%DC:-?W1*9!#*2K
MJ>H/IUKFM(\4ZRV@VD0U")[F/2)-2:YN$!\]E<CRNO&,<D<\BBX6/4,T>]<G
MK/B#4H_#>B:A8+;V\^HW%O&ZW*EEC$HYZ$<@UDVGB_6[F^FT:0V<-]:K<LUT
M4/E7'E%0 JD\9W?-R<8HN%CT+-9\FE64FM1:K*K&[CC,4>Z4[0#SD+G&[WQG
M%<?!XXU*>;3Y&LX;:"^MT>W$H^264QEC$9 ?W;9Z;A@CG-%MXBGU6XTM;ZTM
MFN8]46"6"6%DEM6,3-G&2#T.&!(*FBX6/0 P(R""/4&C->1Z-J-_:>$?[+GM
M[:33;^WU(0,C-YD9C,C?-G@@CCCIQ6YH?B35V33]/L-.BN+>TBM(KN228*P5
MXE8N,GMD8&.>:+A8["^T>WU#4=/O9GF$EB[/$J-A267:=P[\$T?V/;'6_P"U
MG>=YQ%Y:(TI,:>I5>@8],U@>+?%EUX>NU2WAMYT2-)98]S&0@N%Z#A!S]X]3
MQBJ4GC75X;R9I--M#8)JDNF*Z2MYF\+E'(Q]W(P>_>BX69W6T'JH/X5SZ^#K
M!=2DNGGN98GG-S]FD8-&)"<YY&[&1G&<5QNJ^+M3U?PC-#>V,=I_:.CO?6LM
MK<,2A1ERK<#!^8$$>XK</B :?KVHVJ62_:Y;BSM(I)+ABDK/&2"1T4  \+UH
MN%CLA;6^<B"/."OW!T/45(JJBA5 "@8  X%<5J'C/4=*$"WNDPQS#:;B)+C>
MV&E\L%=HX&"&RV.N.M5T\1WMU- =1MUV)XA>RB:UN&38J*<%Q_&.#D47"QVO
M]GV.,?8[? [>4OKGT]>:)-,T^9766QMI%D<2.&B4AF'1CQR?>N2_X3YQ:07O
M]F9MKZVN+BQ*S<OY2EBK\?*2HR.OI2?\)]/!8W,UYH[0/"MO)\LWF(L<P.'<
M@94+@YX/:BX6.RAM+:WC:."WBCC;JJ( #^ JO_8VEB!(/[/M1$DGFJ@B&%?^
M\!Z^]5)M=>'PVFKBT\PNJMY:3*5 )QG?TV]\^E80^(7F6T$MOH\\QDBN9&Q*
MJA?(;#C)ZYZCBG<5CMJSTT+24@N84TZV6*Z!$Z",8D![$>E<AXA\8S7FB>?H
M:3*D<UGYUR'53'YK(=NTYS\K#/IFNKU+61IVIV5E]F>5[Q)FC96  ,:[L'Z^
MM P;PWHS!@=-M\,Z.V$ZLGW#]1V]*:?"VA,U\QTFTS??\?1\H?O>_/XUC67Q
M L[Z6S5+*9!<6J73EW4&-&W9.,_,%VG<1TR*:GQ%T]X)IFL[F.-5B>*5QB-U
MD;:N7Z(?7/0$47069UZ1I%&D:*%1 %4#L!TKF-$\%VE@;V:_CAN;JYN9YBZ[
M@%$IY !/!P<9'459U7Q)+8>$)-=BTZ5W55(MI&"MRP7KR,<YXZBLBQ\6S6OB
MC5K+4A<O;"\MX('$:[;<RQ@A&(_VCUYZBD%F;LOA/19K.SM&L5$-FI2W"NP*
M(1@KG.=I'!'2LZ/P=%)XIOM2O8X'LY([>.VMT+ ((LXW+]TC)R/3%,?XC:&@
MNF NI(X(FF#11;A(JMM;;@]CV..*>WC_ $B.>*&:*\@D9T25)8<- 7.$WC.<
M'KD9P"":- U++^"/#TL^H3&P"O?JRW&R1E#;OO$ '"D]R,$U/>:"D;17^F1Q
MC5+2U-O:M/(_EE>PDP?F _.JR^,]-D9A%'<-OCEDM6*86Z\K[_EG/./?&1R*
MC\*:U>:G;6L]ZT[&_MQ<Q(;78L([KO!P>HQGG@T7#4UM!TA-%TM;8;#*[O-.
MT:[5:1R68@=AD\>U+-HEI/K2:LS3"[CMVMU*R$*$8Y/'3.0#GVK1I:8CSW4O
M 5S#<:9'I32/8V,#Q0J;YX98V9]Q8MM.X>W!K;3P7:NKR7=[>374TT%Q-*)-
MNZ2$#80,<#@9'>NGHHLAW,[2=&MM%2Y2U>8QSSO.4D?<$9CE@OH,DG'O65>>
M"=/O-5DU'[5?PS27"716*;""55V!L8_N\5TU%,1R7_"O=)>SBM)I[R6**U>U
M7=(,[6<29R!]X, 0>V*UM&T%-'GNYQ>WEU-=E#*]RX;)5=H(P!C@"M>BD!S&
MN>";/7-0GO)+Z]MWGACBE6!P PC?>AY!Q@^G7O4L/A&VAE21;RY++J+:C\VW
MF1EVD=/N\]*Z*BG8+A1110 E%%%( HH[49H *6D-':@ I#GM3J2@#Q+]FWCP
MSK1Q_P OB_\ H KVT'->)_LW<>%M9_Z_5_\ 0!7M8H 6BBBF M)12T %)2T4
M (:,<4M)2 **6D[T %&**,T %+244 '>CO110 M%%%,!**6DI %+2'BB@ HI
M:*8"4M%% "8XJAK6CVVNZ5+IUVTRP2XW^4^UN"".?J*T** &"-1&$P"N,8(Z
MT%%+!BJDCH<<BG44@&"&)5<"- '.6 4?-]?6FFVA+QN88RT?W#L&5^GI4M+0
M!7-C:8<&V@PYW-^['S'U/K2FUMC*TIMXC(R[2Y09*^A/I4U'2@""*QM(71XK
M6"-D78C)& 57T'H*C?2]/EE:22QM7D8Y9VA4DG&,DX]*MT4 06]G;6<?EVMO
M%"F<[8D"C\A4!T72VCCC.G6FR-RZ+Y*X5CU(X[]_6KU+0!B^(M!&O6MG;-*D
M<,%W'<.C1[A($/W>O'UJ>;P_I,]M!;R:=;O%;DF)2GW">N/KW]>]:=)G% &7
M+X=T>>Y>XETVW>61=C$IU&W;TZ?=X^E)#X:T:#R/+T^)3!*)HCR2K@8!SGJ!
MQ]*U<YHH RE\-Z-&EPB:="JW"LDB@<$,<L .P)ZXQFF#PQHBW]M?+IL(NK:-
M8HI #E57[H]\=L]*V** ,75/">AZW=?:=2T])YC%Y)8LPRF<@'!&<'D>E9>E
M^"DLFU.ZN#%+>W%U//;L&?9#O7:/E)QN XSUKKCP** .2T?P'I]KX9BTO48Q
M<3&U6VGD61\,H.2%R<JI(S@5H77@_1;T7OVFV>0WAC:4F5L[HQA&4Y^4CU&*
MW:* .8N/ 'AZY^_:S+^Y6)BEPXWA6W*6.?F8-SD^M3_\(9I N1.JW 87@O@H
MG;:)L8W8]^<COFN@-+0!S@\%:,L,T"QSK#)'+$D8E.V%9/OB/^[FG?\ "'Z>
MD[3P7%[!,T<,>Z.<_=B!"C!X/!.<]<UT%+0!AS>%-,E\/V^B*LL-I;NDD)BD
MVNCJVX,#ZYYJC#X"TRW9C'=ZA@I<)AY]P F_UG4=<\UU5% ''M\.M)\I((KO
M4(8=L ECCF 68PXV,W'WOE )'7 K:UC08=8FLIGN;BWGM'8QR0, 2&7:RG(/
M!'\JUJ* .2B^'^GI;6%G)=W4]C9;3%!*5;!4$<-C(SGD#KBI;/P8+&Q^QQ:U
MJ,D*82%)V61(XQ_RSVD892..<G %=1118+F ?"=F/![>&XIIH[8IM612-R'=
MNR.W![=.U4F\$J\ES*^JW+2W-[;WDCM&G+1  +C'0X&:ZRBG8+G'+X%DCTN\
MTJ/7KP:=*&6W@:-"+<,VX@'&6]L],U=E\*R_V]+J=MJ]Q;"Z6-;V!$4K.4&
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M?W1];Y__ $%:]=H **!13 **3WHQ2 7O2TE+3 **** $HHI:0"8[TGYTIHH
M*!110 44=J6@!NQ=^_:-V,;L<XI?:EI*8!10:!TI +2=Z,T4 +1113 2EHHH
M **2EH *2EI,\T@"EI*6@ HHHH ****8!1112 ***3- "TE%+3 3&:,444@$
MQZ\TM%% !SZT49H% !2'K2YHH **** %HHHI@%%%% !1124 +24M% "444M
M!1110 4444 %%)2T %%%% !1110 4444 %%%% !1110 4444 %%)2T %(:6D
M- 'DG[/ Q\/;@^M^_P#Z"M>MUY+^SS_R3N8\_P#'])_Z"M>M9I +124M,!*6
MDZTM !1244 +1110 444W-(!:*** $I:;G!Q3J0"]J*2BF M%%%,!.]8GBK4
MY=,T96MWV3W%Q%:QO_=,CA<_@":VZH:SI<>KZ7)9R,4)*O'(.J.I!5OP(%(#
MFK[66T*]UYK2PGNY--M+:1P]T2'C.[) (X8 $GUJ75_$,JZ9-KEFW^B6%S$
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M9R&CQUZGANX!JE<^"=7:=KI&TZ>1=0N;A;>=G$<D4P4$,0,AAM^A!(HU#0[
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M.[&@#L;B\M;39]IN(H=YPOF.%R?;-'VRU\\0?:8?.)P(_,&XG&<8^E<;X_\
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M,BY+QREVQGD  X!]JZ'0=&U.P\7W%T+5H--F$SR13.DFR5F'S0L/F <#+*>
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M&V"M)-90LV& /#%B58KW Q1J%D>I%P%R#D8R,=Z@LKIKNRAN)+>6V:09\F;
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M]:36=.O6M;2U,8@6ZV3^;'(L:$?<*\.#]UE(XZT:AH=C-J=A;SK;SWUM%.2
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M+MH(H4)SMC0*,^O%076D:;?2%[NPMIG/5I(@3^=<K>:_J'AJ6%+F,S0W\SW
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MDEN 1BBX69T7B+P9;:M;R"T6V@EFN4N;CS8BZ7#*" 'P0>_4$=*=I/@O3+&
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M71YM3\(7NCV3())K?R$,SD #IR1STJ*/P?IA%O-*)S=131W'FF=BV]%VKSW
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M6T\:-(D(1@70, 'C?HZ'OT(. :R)O'>I1WU[%%;VDR"TN[BW9=WEY@(&W?\
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M#5C5M7M]&LA=W"R/&98XCY0R078*"?;)%+0-3CK[POX@E\1M?1Q6,D"7<TJ
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MVN)!'G&TPL'(V[LA<9*[3G(XQ3QXNT)IK>)-023[0$\MXU+(2XR@+ 8!8 D
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MUK3;J"?RK6ZCM[B\ @,O$L<YW!N1\K _*1W&:[:]O[:PL+B]N) L$"%Y&SG
M'6HM-U W\+R-:7%L4;:5F Y&,@@@D$<T 5_#.D/H/AJPTN2;S7MHMA<=/7 ]
MAG ^E<4W@S7Y8[>P?[*BVWVQ5U)9?WD@F5MK%<9R"1GGMQ7I8(QGC'K2=>M
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M[N[H364D<T=S$^V0R*,;CVYR<_6C4#FV^),AT\7L&ARR0+8M>RL9U78B2%&
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MH *2EI* /._@D/\ BU6E\8RTO_H9KT2O/?@H,?"K2/<RG_Q]J]"I %'>BBF
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MLDDCR:I<2>;J*Z@X:-/F8)LV=/ND?C5[P]X;?P^AA75;R[M479;P3;<0IZ9
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M<&NP-W;B.:0SQ[(,^:VX?N\#)SZ<54M=?TF\L+6]AU"W-O=?ZAVD \SV&>]
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MUOOM*E$(MO*8B)^!PQ("X/7/M7I]AH=MIUUJ%S#+,TM]*9I&D8'8V OR\<#
M''M1HNB6FAZ6NGVQ>6%2Q+3$,S$L6.3CGDFE8=S@;C6=7M89(9M<NE==)&H6
M5P47%U.>3'P/F ^4!>OS5$OB+Q%)JUZ3JWEWMM?VD4>D>4A#K(B&13QNP-S$
M'MMYKU-H8R%S&AV'*Y4?*?;TK+TWP[::;JNI:BCO+<7\HE<R!3L(4+A>,@8
MHL*YPUEK>J/;Z1?7&N)=)<ZZ;(QO;Q[1&KR 8.,AL <UB:EXQU&_TK6(8M=<
M(VGM=1.@5)%99@I&T#Y!MZJ23W.*]G^S08 \B+"G<!L'!]:;]CM?F_T:'YL[
MOW8YSU_.BP7. M?$]]+XL-I_;MC%;VMPL;6\_,ES;F,,)% '<Y.X'  (K?\
M%M_;WGPZU:^L=006\EC(\=S$X*L-IZ'ISTKH#9VQ<2""(2!/+5P@W*OH#Z>U
M16VEV5IIR:?%;1BU48$14%3SDY'UYIV"YYPVO7NDPZDEA-;QS:;;V<D<!A0'
M4@X&22!D_P!P;>A%=5X8OM5U/5M8EN=2AEL[6\EM8[9(0"N-I!9@>HR170'3
M[)I(9#:0%X!B)C&,H/;TJ2&UM[;?Y$$<6]MS[% W'U..IHL%R6BBBF(****
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M.F!M(7G)S4:ZZVL:]X>U*?452[+ZB#8L%_T4I&P (ZYP!G/7->H_V9I^8O\
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M+;Z;96EQ)<6]K%%-*JK)(B@%@O !/M18+G#IXPU20VMZDL'D7-]<V+69C^>
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M\ *R.SRJNQNP7+ G\:[D>&=$&IS:B-,M_MDZ;)9=O+C&.>V<<9ZU%'X2T")
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M /'Q-:K*Z*$::--^SKGD=#BJ.F^.8;U-)U*_:YT^&YTZ:]:WV*\6Q",L7ZY
M(P!ZUI0^"8(KA)3J-R^W49-0VLJ\LZ%"O3[N#]:JQ?#G3UMK2TGO;JXM+:SF
ML5B?:,Q2$9!(&<C P?:E9AH6)_'NG6<<OVRTO8)H_);R#&"[1RMM1Q@\C=P>
MX-./CO31#&6MKQ;AYY8/LK1@2AXP"PQG!."" "2<\57N/ $5Y;*MSJES+<J(
M(Q<LB[A%"^]4QC'+<D]31>^ Q>PWL$NJR-!>7,EQ+&]NC ,X RIQE67;PPY&
M:-0T-G6?$-KHEI#<7,-RZRAF"QIRH5=S%LD 8'J>>@K-;Q_H@G6-?M;IM@=I
MD@)C19O]6Q/H2<58UWPHNMQ6,?\ :%Q MK&\?19-X9-N3N!^8#HW;)K)@^'A
MAL;BT.LRNLT=I&";= 56W.5Z=<]Z-0T+4WBMI_%^C:?8,QLKB2XBFD:'Y)&C
M3.$?/4,,=.:U+WQ1IUAJT>G7!F6621(M_EG8'?.Q<^IP>F?>LJP\#&PU>RNH
M]7G:TL;B>>VM6B7"^;G>I;J1DG'I1K'@J?5-=;4TUAXL3031QO;K)Y;1]E)Y
M"GJ0.]/4-"Q#X\T2>.1T-UL2"6<$VS#>L3;9 O')4]JU[#6;/4Y EJ[/F".X
MW;3MV."5Y]<#I7-VOA2?08[&[%S)J']FQW6+>.%0\_G-N(&3@8-:G@_05\/Z
M&+?8R22R-*R,^\Q@GY4SZ*, ?2C4-#H****8@HHHH **** "BBB@ I*6DH X
M/X. CX5:'VRDA_\ (C5WGX5PGP<Q_P *JT/G^!__ $8U=W2 *,T4=Z8"T444
M %%%% "44=Z6D E<_P"+]0-AI]L!>O:>?<"/S%(7L3@L?N].N"3T'6N@I'1)
M!AU5@#G!&>: /(8_%VKW>DF]_MUHI+?1([QU1$VF82E3N!&>0,$?RK0;7CJ7
MB/3OM6H%+F/7?LZZ=\N%C$;;'QC=SD'=G!SBO2C:VYS^XBY&#\@Z4"UMQ)Y@
M@C#X W;!G Z#-*P[G >._%%WHNJA+34Q T$4,C0/M56#R[2>>7XSP,;>I-5!
M=6AO\QRPG_BKQCD=3%SBO2I+6WF8-+!%(P& 70$X]*9]AM-V[[+!NW;\^6/O
M>OU]Z+!<Y/Q;J>H6^OV5E:ZVNF6\UE<3.S1(WSQ[=OWOJ<CTKG[;QMJ=SJ>E
M":^CMI+BXAM;JS8*GEEX2Q*@_,3G!#=.<<UW][H-M?ZW::G<8?[+$\2PN@93
MN())SWX%76L;-YO/>U@:7C,AC!;CIS[46"YY3IWBG5HM&TK3X]=MX)Y;.6Y%
M]J#KM>592#$3CG Y*\-S6Q#XDUIM9"OJUN;<ZRNG^2D"CY6A#YR><@]/UKO'
MTRP=%1[&V95D\Q5,*D*_]X<=?>@Z;8[]_P!CM]WF>;GRESO_ +WU]Z+!<X[P
M_K<]O\*GU>ZU3SKF**9VN9U#[&#L &5>O;BLVU\5ZY=S)8QZC;Q2G5ELO->)
M)&\MH#)SM.W<#T_*O1%L+-;>2W6T@6"4DR1B,;7)ZY'0YK'U'PCI]Y/IQAAM
MK:&TG$SPI;+B;"E0I], G%%@N<A%XF\4WBF%-3LK=H;6\<W#6H*SM!)M#@9X
M5@><=,<56EU222/7M5:UMDGGM])GF@GB#KN<@$$'N,\'V%=Q<>$[.ZU^TOY4
M@:UM;5K>*S: %%R0=P/X 8K1GT+2KAYFGTZVD:<J9BT8/F;?NY]<=O2BP7.3
M;Q=<XU.^;5M-M8;2:YMVL[E#O1HQ\C'')SU(QC!&*SH?$^M7]U;6CWRP/#K$
M$$CK&F98WA,A# ' P>V<].]=ZVA:2]W/=/IMHUQ<1^5-*85+2+C&UCCD8J&/
MPMH,41BCT>R1"R,56%0"4^X?J.U%@N<IIVO7CW::-:FRLKB[OK__ $A(/D_=
M,/X<\L=V2<] :H2>.]?DL7O8A8PQP:6+Z2-HF;S&64QL%.>%;&0>HR*[Q_#>
MBR6[6[:;;F)IC.5"8_>'JWU/?UIUQX=T:Z\P3Z;;.)(1 X*##1@Y"'_9![46
M"YAV/B._D\9?V9?!+>"8.;1?+W+.JJI^60'AQD[E(''2J][XLOX?%L%A;FWE
MM)+TV3;4.(V\HO\ ,V>7R.5 QCOFNGMM#TNSO&N[>RBCN&&#(!STQ^'0<]\5
M7N?"N@WEY)=W&E6TEQ(P=I2GS%@, Y]<=Z+ <7;>/M8AL(+G4(K)_M>GK<1>
M6K*L3F98OF))ROS ]L8K>\*)<Q^(/%4<\T4L@NXCNC4JIS"O;)P:TT\(^'TC
M6,:5;^6ENULJL"0(F.2F#VSS5G3-!TO1!-_9=E%;-*!O*Y^<@8&3WHL%SB8?
M'>N06EI>W\&E"VODN5A*NZ^5)$3@OG.5('89!QZTY/%VN7-[90?N;;R]5:UN
M=T!!FC$!E&%R2I_^M6UH7@>PL-$:RU.""]FD65)G^;:RNY8@ GY>W3'2KT/@
MSP]!S%ID:GSUN-V]L^8HP&SG.<<>_>BS'=','Q[K3:'+K4.C0MI\D*S6SRR[
M229 NT@9)X.<X&#P:FE\4:Z==T_3F6RA?^UWL[@Q[F65!#YHQGD'!P?<5N_\
M(+X:$-Y$NEQK'>/OF578 G=NXY^4;N<# -32>$=$FN'N)+,M*]T+LOYKY\T+
MMW#GCY>".A%%A714\,>([K6[N]MKV".TN+;;OM3N$L1)/4'AEP 0Z\&L>V\<
MZM<(H.E6XDN;N:TLQ'*7+-$6WLPP,#"\ 5U>EZ!IVCNSV<3AV01;WD9V"#)"
M@L3A1D\53D\&:))I?]GFWD$ N3=H5F8/'*3DLK Y!))Z'N: T,%M>U"VUF;4
M;BQ>VN!HJR264UP BR><5^]T_+D].M/L/&&I:MJNG6L%I#%&UY=6MT'W MY2
M @ID9&<]^:VKCP7H=U&Z26\FUK9+; F881&WJ1S]X-SGKFBW\%Z/:3QSPK<K
M,EPUT'^TN3YC+M8\GN.HHL%T<W8^-;FVT:Q6QT@R!]/GOB+B]+,JQ/AE+$$L
M3V-:<OCK_252UTYI%+VL95Y-KMYXRI48Y [GV/I5Z'P/HT$4<2+<!([26S4&
M8\12'+CZD]ZQ)/!NJ0Z]YME<RPVZK"D$Z79!C2-0NUXRI#G&>01G/-&H]#4\
M3ZQ?V6J6FG6RQB"ZM+J227>1(A1,C;[Y(K#T'QS-9:!IT&KV4QN7L+>6"3S1
M(UR9"$&<<AL\]^*['5O#UEK-Q:SW#3I-;+(B/#)M)5UVL#Z@C^59<GP_T:6U
MCMI'O&CCLELHQYV"B*P96! R'! (:BPKHK'QM>@VD0\.W0N;AIE"22B,8BP2
MXW<E2IR./:J-[\1;@Z)=ZAINC3-$D*303SY6-PT@3!./O<Y &>*Z&#PC9P7E
MC=_:[Z::S\S#3S;_ #=X ;?D<\ #MTJI'X!TJ+2[K3!<Z@;&==L<#7)*6PW;
MOW8[<@=<],468:#I/&44%QF2S?[''>)837(<8CG;'&WJ5!8#/O73DUSR>#M/
M2^:X\ZZ:-YTNI+=G!CDG4 "0C'7@$@<$@'%;-C:&RMA";B>XPS-YD[;F.3G&
M?09P/:@19I.M+2TP$HH-% !2T44P$H[T4=Z0"T444P"BBB@ HHI* %HI*6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI#0!
MPGP>X^%6A_\ 7-__ $8U=V*X;X/_ /)*M"_ZY/\ ^AM7<]Z0"T4E+3 ****
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MGVI@2T9I$=)(UDC971AE64Y!'J*4\4@"EI*6F 4444 %%%% !1110 449%%
M!1110 4444 %%%% !1110 4E+2'% '#_  ?X^%.A?]<G_P#0VKN!7$_"$?\
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MOO%%UK&F,K1-:2V]Y8.LD$K!725QQG R,9!['M2ZMJEZ=/N8M.C>)G\1+9W
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MN/!&BW3I(ZW*R1K"L;I.RM'Y0(3:>W!(/KDT6"YS%QKDNMS6]\OG6HN-"O\
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M!^%?A_C_ )=S_P"AM7:=!7&?";_DEGA__KW/_H;5VE(!***6F 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6D- '&?"C/_  JSP_\
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MHH **** "BBB@ HHHH **** "D-+2&@#C/A2/^+7>'O^O7_V8UV=<;\*L_\
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M\](IXQO9-LT91LJ2.A[<<'O0!9HI.:* "BFLP R3@#DD]J<I#*"""",@CH:
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M.2"!R.M4?$W@76+/3[W4KQH-6":"FFE1O$DDH<'S.!P!Z^V37L'GP\_O8^"
M?F'4]*>6 .-P!/3FC0+GB.G^'-4\0VUS8Q:8L%XNI6NHW5]->>=%<!.-@95
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M7G-RR/M<A0&A<?,-V/F4\#'%5[SP[J]QK5U&;;,DFKQ7]OJ88?NX%VYC]00
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MOK73[9KB[G2&(<%F/^<T^&Y@N+9+F&5)('7>LBME2OJ#Z46079Y7=Z/*NK7
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MQQT]J0*HSA0-QR<#K3L%SR7^T;^:;3H(/%EY-:30WTHF@C,>0BJR#<P)8 Y
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M739M.DNYO-DAEN1,V[ !/R_*.G;ZUTM ZTK#N<?X8M-6\,Z.-";3&NA;RO\
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MN]K YW&)!(%*J^P;E!XX-4M$T*RT'28=.M$S'&FPNX&YQS]X@#/6E8+G"_\
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M 4AI::: .9^'0 ^'/A\?].,?\JZ>N7^'G_)._#W_ %X1?RKI^O>D M':BBF
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*/_\ %T44@L?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gtbp_ex1017008.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K,# 2(  A$! Q$!_\0
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M  QT*:73;.25X"7=X%+,=[=21S79C0]('32[$?2W3_"N9^$9S\*M _ZX,/\
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M1]EMQ_RPB_[X%2T4 1?9X/\ GC'_ -\"E\B'_GE'_P!\BI** (_(A_YY1_\
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MUHH 6F#F4^@%/IJ_>:@!U)2T4 %%%% !1124 +124M !1113 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** $HHHH XSX3G'PL\/Y/_+L?_0FKLZXSX4_\DL\/?]>W_LQK
MLAQ2 =1113 **** "BBB@ HHHH *3//%+24@%HHHH **** "DI:* "DHH(H
M.]+2=#FB@ HI:2@!:*2EH **2EH *2B@4 %'-%% !12T4 )2TE% "TE%% "T
M444P"DI:*0!2+W/J:6D QQ0 M%%%, HHHH ****0!12=Z6F 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% "4444 <=\*?^26^'O^O;_V8UV5<9\*>/A;X>_Z]O\
MV8UV5(!:*2EI@)SWI:** "BBB@ HHHH **** "BBBD E+110 44E+0 4444
M)112T %%)FEH ****8!24M)2 .U':DYS2T %+24M !1113 ****0!24M)0 M
M%%)0 M%%% !1113 *2EHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHHH
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MUR/I7,W[ZM:ZW;Z;?ZGJEMYEO%):36T+3>9-O)E3(X!Z !N-M%PL>DYI58,
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M7J:@HCTZQ::X2%W:S*G<X^4\%@.<_P J5QV/8,\]>?2FLZ1QL\C!44$EF.
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MIJ/V 2QB\>/SO*_B*9QN_/BN9\;7UU;7WAZVAU5]-@O+QX;B5-H)7RV(&6&
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M5Q=(CM(X+[U*JP.WJN<^G%/UOQ-JT'B&;2]'L8;B2TABN)A-(%#J[$'!)&W
M!.>>>*+A8ZXQ1D8,:'G/W1U]:<RJZE74,I&"",@UYU)\0=2L;EYKZTM&L%N+
MVW(@+>9F!2X;GC! P1^-:7_"2:Y;PZ;-=1Z<\-_=6R1M"S9V2@YX]5(&#T/M
M1<+'7M;0-UAC/R[>4'3T^E#6]N1\T,1' Y4=NE>?_P#";Z])MB@L].\S??HS
MNSX!MF'.!V8'\#6=KGBG4M8\+W(GM+:*1K>QU"U$4K<>9* $<^N1U'8T7"QZ
M)J>BVVJB-99)XD60/(L#[!-C^%_[R^U:&Q-X?:-P& <<@5P7_";:RFJS:!)I
M=N^LQ2'!A8M"\?EAP1G!SR 1VZUIZ3XAUO4]?-C)I=M:PP00RW6^<M(A=3\H
M &"0PZYZ47"QUE%%%4(**** "BBB@ HHHH **** $HHHH Y'X7_\DP\/?]>B
M_P S77=JY+X7\_#'P]C_ )]%_F:ZVD M%%%, HHHH **** "BBB@ HHK"\90
MO/X.U5$EFB;[.Q#P,0XQSP12 U(;ZUN+NXM89E>>VV^<@ZIN&1GZBK%>53WY
ML=7U+4K/59E6.33(QM(*SAAM._(YX/X5I^#]6U'5/$#-=:P?-4S)=Z6T3;HF
M#?*3GA0!C&/O9I7'8]"H[UYO/XCOQ>ZPZ7URNL64MPL6D^5N66()F-L8_P"!
M;@>3Q534?$&HP6<SZ?K<\MJT%G)]J.UC%,\H5DY'0J2=O;%%PL>J45YC;:MJ
M%MK*1'Q!<3QKKC:<(Y=AS$T9;)(')#=#60GB?Q!8Z-:ZA;:Q+JCSVDQO(V16
M%ILD"B3Y1D8&<@]<9HYA\I[)FBO+X-4U"YN=.MX?%ZS6UW<SJLMJ WR"'<$W
ML.6#=QZXJ*P\6ZFT&AWUYJ1DMY;>(3K;%3(LA9AN>+JZL .5Y&#Q2N*QZC-#
M%<0O#-&LD4BE71AD,#U!%0V<MBHDLK(PJ+3$;PQ  1<9 P.G%>0W7BB]OM-U
M""379#";:UNEDCD4."9PKG@?(NWJO..]='-XCN8]5OK3^TL6;:K!;-=H$S!&
MT.X9;_:; W'UHN%CT7/-&:\L?7M;GFBLO[>,")'?E+A(DW7*0D;'Y'O@D<'!
MK=NO$=XW@WPY?M.L+:G);QW5W&!B%7&68=AD\9/3-.X6.V%+7FEMJVNZAJ]A
MI2:X8(VNKN);D1(S7,<6TJPS]2I(X.*U?%&NWMKK%U8Q7XT\6VF-?0N54BXD
M!(V<]0,#('/S47"QV%Q=V]HBO<3QPJS!%,C!06/0#/<U0NO#NCWVH+?W-A#)
M=#'[P@@MCIG'WL>]>7ZC?W5^FL27U^\4K7.E21VDQ7;;,^PDJIYX)-:-QXLU
MB*Y&D'6[2-Q>W4"W]P5BR8PI1&."H/S$D8&0*+CL>I''W>Q[5!;36DB/%:R0
ML(6\MUC((1A_"0.A]JY+P]?ZUJGB:XCGUNU>VM(+>22W@@&)&D0Y(8_,%R,B
ML*74-2TC7]:N],O82/[82.33/)!:X#1IEL_>R!R,<<&E<5CU'IZT<UY,OC/7
MW\/SZM%J^F$21QLL61))#(90C*5P-JX.,-SD5=F\7:Q;WTVBOJ-MYPOI;=-0
ME"1*-L2NJ-U4')/U ]:+A8]#O-1LK *;R\@M@_W3-(%S^=658,H96!4C(([U
MY;J$UU<W6K7UY=6-W+#X=2<V[1++;F0%SE0PSMR,_C5J/6M;_M+5WLKR.61+
M*Q>WL6**%\P?-Y>>-W7&>"<"BX['I#*&4J>01@BDCBCAB6.)%1$&%51@ 5PF
MJ:[?3_"R[U2WU!XKQ3L,_D"-T(E"E64\ CH<?A1-XMU&.>YE@DADBLM3ATZ2
MV*#=,KA?W@/8G=D=L T[BL=WYB&3R]R[\;MN><>N*=7!^*6O[?QF+K2KFVM[
MJ'19I"UQ'O#*L@.WJ,?7M4>B>,M7UV^@EBCLK:W2>.&ZM9Y L@#1AMR]\Y/
MQ@BBX6/0:I:GIEOJ]B]G=&7R7(+>5(R$X[94YQ7)^(?%&L:9KFJ):K9M8Z9I
MZ7TJ2(WF2 [@5!!P/NYSBH8?%6M?:K*QFDTU&U)U^R70<, /++D,H/<C"\\B
MBX6.V-C;$6ZF%=MM@PKV3 P,#V%3#9(,C:W.,CFN(A\5:W=W[VEI%ILLMB;<
M7Q$^(W\S[S(Q.0!VX.3Q5:V\43Z1I]M?/;65MI9U6YM;TQ(WR'<P1QS_ !,
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M>ZA')+&TC'RPJ*">1USD8_.LC1?&&JZ[J5E#:Z9;1P26JW%PTLQW1_O&C=5
M'/*Y'M1<+'7?8K7R?)^S0^3G=Y?EC;GUQ6'JO@VRU*^-T)Y;<M$(7C1$9"@)
M. &4[3R>1535/%\^F^)H-,%G'+!+<Q6Q=&)96D!.YL<+C X/)ZU1LO'&KW@C
M1=)MOM%U837=I&)V.XQ-M*MQQNSQC\:+A9G9VVGVEJL(AMXPT,8BC<J"P4#
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MB\@C:8M@VX],=*X^SUJ[TGX6Z3J<42W=P+:W4K-(5WEBJ\MSSS49\7Z['?\
M]DG2K'^T5O!;,?M#"(JT9D1P<9Z @BE<+'9I8VD;1,MK"IA&V(B, H/0>E+<
M65K>&,W-M#,8VW)YB!MI]1GI7*P>,+N?[#*MG 8-0GEM;<ASE94#8W\?=)1A
MQTXK/O/%\FJ>$KFY?3U=(K4/>Q)<-&T4HDVF,,!G/!/_ .NG<+,[:?2]/NI6
MEN+&VED8 ,[Q*Q..1R?2F/H^F2QR1R:=:.DDGF.K0J0S_P!X\=?>N8U/Q5)]
MMU/2'LT016LLB)),T4D\8CSO1@,$$Y'!R,9IA\:-9Z=+);6/F6VEVMM)>*TI
M,@$B@@(?XBJ\DGK1<+'8QV5K#<R7$5O$D\@ >14 9@.@)[TW^S[/[;]M^RP_
M:B-OG>6-^/KUKE4\9WW]J+#)I4?V5[^6Q1TGR[NJ;U(&, $<<GK6CX;\2_VW
M975Q,D,1MSB2)6/F1'&61U(!5A^1ZBBX6-/^Q=+'G8TVT_?N'E_<K^\8="W'
M)ILNA:3,DR2Z9:2+,XDE#PJ0[#HQR.3[US0\:W,]M"ZV21?VC8SW6GR>83_J
MQG#C'!(P>/I45O=W^B_#:77H0'U*:TCN&26=WCWD#YAGH3G) XS1<+'5OHVF
M2R2N^GVS-+'Y4C&(9=/[I]1[4DNA:3/_ *W3K5L1B($Q#.P<A?H.U<=%XCU+
M2/%&J?:;9[BT:>R28_:.+=I4Q^[4CD;N3TJROC!=,LIF-I(&;4KBV)N[K*!T
M/3?C"[OX0>/>BX6.M&F6(TUM.^QP?8BI0P;!L*GJ,4Q-$TN.ZBN4L+=9XD"1
MN(P"JC@#\.U1ZOJRZ5H4VH2A5*H-JL>-[< 9^I%<SX?\8O#X2U*XU647E]I$
MY@N'@&!+DC8P] 0PY]C1<+'5W^CZ=J;Q/?6<,[1?<9UR1[?3VIC:#I3:NNK'
M3K8Z@B;%N?+&\#TS7/-XYN%G^RKH4\UT;TV2K%.FUG$>_(8X^7'>F_\ "Q+1
M9)7ET^[6S19/](5"P#(<%3Q@9/ .><47069TW]D:?_:$U^;2(W<\0AEE(R70
M=%/J*SE\%>&DTR335T6T6S>02M$$P-XZ$=QCVK.'CEF>"(:'?&XFN3;1ID!6
M;R]X(9L9& 03V-):_$&REM/MEW8W-G:M;/.DLF#N*-L=,#N&( ]:+H+,V&\*
MZ$UU9W)TJV\ZS01P.%QL4<@>X!YYJ6/0-)CL)M/6QB-K/*9I(6&59RVXL<]\
M\UB1^.4E,,<>CWSSRW#6Z(H&TL$W@AC@$$#KV-/T;Q>VN:U9V]M82)97-@;O
MSY& 92'V%=OL0:5PLS5O?#.C:CJUOJMWI\4M[;C"2G.< Y /9L'D9SBH[7PC
MH5EJHU*VT^..[#O(KJS80O\ >P,X&>^!6U15",V;P]I=QJ;:A+:JURVS><G#
M[/NEEZ$CMFH])TRYM[V]U#4'MY+VY(0- A4+$N=B\\D\DGZUKT4 8UWX5T>]
MGNII[4L]U)%+,?,8;VC^X>O:H6\&Z*P<>1*!)))(^)W&XR8\P'GE6P,BM^B@
M#-U#0K#4DM5GB*M:-NMY(F*/%QCY2.F1Q4=EX;TS3M16^M(6BE2V%JH5SM$8
M.0,=.I)SUYK6HI@<Y?\ @;0]1U-]0FAG6Y>5)V:*X=!YB#"O@'&['&?2F+X2
MMM)6&[T>,OJ%G!)#:+=3N8P';<P;OC-=-12L%S,T+21I&DK:_NQ*[O+*8EVJ
M9')9B!]36>O@S3([&QM(Y+M8K*\-["/.)_>Y)Y]1DGCWKHZ*+ >=:1X'U13+
M:WUU<06LXE%V(;TO','SPBE<IUSG-;\W@;2YVG=Y[[S)1;_.)\%##_JRO'!'
M//?-=-119#N8ECX8L['55U'S[J>:-'2+SY-PB#MN8#C/) ZDXIFI^#]&UBZO
MKF\MM\M[9BRF8-C,><\>ASW]A6]10(YC4_ ]AJ@O%DNKR..ZM(K-DC=0$CC;
M< O'!SU-1WG@'3[P7;F]OX[FXNTO5N8Y )()54*"AQP-HP0<YKJZ*=@.2NO
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M***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "44'.:*
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M<]!D=,^]11>+='FO=4LTG?[3I:>9=QF)@8UZYZ<Y[8JG\0- /B3P5J-A$/\
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MR$QID*JC+$GH/IU/:J'_  G.C_;?LW^E'#P*TOD'RU\X9C);T.<4G8-22_\
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MD$9V%G7<J[O4KS1H&I1T_P (AB;K5KB2XN)+)K"2(%0GD$Y"\ <CU&/I2_\
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MW/E&.XN;-[<7<0DVB,2D $,1@XSFC06HDOAB5K^XFFN5DLFOUU$1+'^\\Q%
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M0 4444 %8OBG1I]<T5K2VN%AN$FCGC+C*,R,&"L/[IQ@UM4C,%4LQ 4#))/
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M:,9HT/P/J5GE;Z+3V(T8:>DD9+%9 SD-R,XPP]^*[V*Y5HH#(!#)*@80NPW
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M:MIG]I_;'BOX ;AG(4 DP [N!QT)KU>DHL%SC/"5Q]FA:9UUMA>31Q^5=VY
MADV_-@=0O'+=,]*[2BBFA!2444 +1110 4444P"BBB@ HHHH **** "BBB@
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M%5'\ 7,$@@T_4XH;'S+24QR0[GW0  #.<8.*Z71=?MM7T:UU!MEJ+DLJ1R2
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M77M/T:6QANY6$U],(+:-%+-(_7@#L!WI6079RB^&M9&JP-):6LEK#K4]_O\
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M2XB8QKN=>XXSC)QWKK!J5B8I)1>VYCB.';S5PA]"<\5G^(/$MEH&D-J$C).
M%*1)*H:12P&5R><9SQ1H!S6E_#ZYT6]*6TFG7%B-LD<EU 6N(W$83Y3G !QU
MQD9.*?+X)U-O#NC:>D]E'=:?"8UNH]Z-&V1AE_O*1]Y&X-=C>:I8Z>;5;NZB
MA:ZD$4(=L%W/85.ES!),\*31M*GWT5@67ZCM19!=G%P>"KZ/[/:27D,EG::D
M^HPRX(E9F#'8>P&YCSZ<8JFG@368=.M8(;RP6:#2VLMY1B&8RA\XQP,#'J"<
MUU&M^*;'1X+PJ5NKFS1)9K:.0!U1FVAN:U?MMJUOY_VB+R0<%_,&T'TS1H&I
MQ>F>#-5M+ZSGFGLO+@U66_*HSD[7CV;<MU.3G)J7Q-X3U?4;W5WTZYL_)U6S
MCMY1=;LPE"<%<=0<\CCGFNT,J*@<NH0]&)X-,-W;K%YS7$0B)P'+C;GTS3T"
M[.)L?!6H6>K7$SC3;B%II+J&>57,\4CI@J.V,]&ZXXQ5C0_"E_9W.EG4#:2P
MV^D-I]PJ%CO8L#D C[I [^M=5=:A9V4,DUU=0PQQJ6<NX&T 9S^516^J)=7)
M$4>;4P+.ET'78P/;&<].<].:6@:G(#P%?P:%%;1:A#<7=K>)+;&<,$,$>1'"
MV.>%8\COS5K3?#,VEZW#J=Q;:='9V]C*CQ6T;'#M)YA*@CGIUZDUUQN[<1++
M]HB\MN%?>,'Z&E>6.!-\LJ1KGJ[ "C0+G)^!M(CM%O;Z(S?8YIG&G1S1E&A@
M)W%0#R 7+$9[ 56_X0_4O^/9IH'MX-4DU*"?<1*VX-^[;CU;!;^[VKL(]0M)
M+^2Q2XB:ZC02/$K995/0D>^*SM2\4:;ISQH9!.YO8K*18F!,+R=-WH*- U*F
M@>'IM-\"Q:+*EO%=_96@D>$?*6((W= 3UKFY?"MKIND&;7XX8+9-)3266U0R
M-*V1AS@>H!7C@D\UZ-YT>U&\Q-KG"G<,-]*<SJBEF(4#J2<4!<YG2- O#X*F
MLKZY9=4U"!OM5R%PWF,NT''L,?E6;;^#)]0#)J\4$,?]D#3'6!MPE(((DZ<8
MQD#J"374:UK$&AZ5+J%PCO''C*QX+$$@<9^M)J.M6^F7>GV\R2,]].((R@!V
ML02"WMP:- U.0N/!^MKIVESRO;ZGJ44KM?QO*85N Z;.& X*J!V[FH9O <_E
M:TD.EZ<OVC28K2S ;(C=0P(!8$@?,.?:O12ZCJP_.@'YMN1GKBEH%V>=7'@W
M5?M%R;:RM$B=].=$5P # <R'&.O8>M95JJ7?B:["V?G;-1NS;()E\U9)%V%G
M4C<%')]L@]J]<W+C.1CUS31'&)2X11(1RV.2*=D%SRQ? FK1Z(MG%IMHDG]C
M0VTG[U<2W$<H?GCG@$;CZUV&OZ?J5U)HEY;64,ZVDI:XL'D #!DVY!/!*D]Z
MZ7-,BFCGB62&19(V^ZRG(/XT6"YYA;^"-72WM+>\TN&ZM#;M ULE[Y:V[>:S
MAL@<@@CIR-M:C>&M6-^)/LB%5\0I?AC*.(1&%)^O'2N[CFCE+B.1',;;7"L#
MM/H?0U4U?5[70].:^O2X@5T0E$W$%F"CCTR119!=G'7'@?4"=<M;2XA@LI5D
METS PT,TH_>9QT'''^\:I+X/N+G^SI+CPYY8^W1/>0R7BR@JL;(6QP,<C@<G
M'->@7NIV]A<V4$P??>2^3$57(W;2W)[< U<[T6079P>D:/9MXXO$TJ2W;1X&
M6YF@C7B*\ * #T^7DCUQ4_BSP9<:[JIDM9(H;>_M#::@Q'S!5.^-T_V@V1]#
M73Z9?V5ZUXMF,-;W#0SC9M_>#!/UZCFK],+GGT'AC5_M?AV]U"V@FOEN)9=1
MEB("C,1C48/)& OZUCP>#-1DTRTM+G0E#6FCW5LH\Q-IG9@4(P>^,Y/2O6*I
M_P!J6HUD:46;[68/M 7:<%-VW.>G7M2L@NSE_$&C7NI^&/#]G)8O<S07-J]W
M&7'"J,29.>>_UK#?P=JG]H:A##9S0SJ\[Z=J*786&.-TVHA4?,2/N[3QWKU"
MFJRN,HP89(.#GFBR"[/,9= U272H+BV\.2V6R:(W]C'<IONPBE25&2O!P><;
MN]5]8T2ZT_2+V7[#=6UE'X>FB)GNMY5S)N56;/4#TX'3->KD5'<6T-W;O!<1
M)+"XP\<BY##W%%@N>42>$[J>..^L-%F%BMS8S_897!=W0GS9%!..5(&<\XS7
M5>)M DUGQ9H;O9R2V,4$XF8/A$<A?+W $9P0:Z32]0LM0M&;3V#00R- 0%*[
M60X*X/I5ZBR"YY1;:)X@ATV9ETO4AJ4*HEX3=((KU1(&?R\'+,RY^8X(Z5+I
ML4\EY/>V6EW02SU[<]FCCS(HS  1MW8QD@E<UZE5>"SM+.69H((H9+A_,D**
M 9&]3ZFBR"YY;;Z'KIM;"WU33=6>U,<D<:6LZB2VE\XL&+$\ J5^89Q@BG:S
MX;U>^AUZ"'3[JY6YAE(-R=KAPZD*K XD4X)7(!'XUZQ119!<\T.FZQ)X@N)G
ML]3B#-'+IDT;JL5N@CQY<HSD -G*X.:;H5KJ-EKUCJL^@:DL\&E2PWK'#&6?
M>I^7+<[L$@^]>FTM%@N<WXKT]=;TZQLI;2:6"XN5$ZJO,:%6!8^F"17*C1_$
M(E\/3ZM:R7-S9:BD >(;P+>,,/.;T+DJ3]*]-JM9ZA::@)S:SK+Y$K0R[<_(
MXZJ??FBP7/+1;^(6.I/_ &9K,2W&FW">6K$L)_,S'\V[)./XA@8XJ]J=IK_V
MW4;BUL[[8\&G^<8T^>6-=WFJF3RPR,COS7IU%%@N>67NFZE_9TUG/::Y>Z?/
MI]P+,/\ ZQ)R3@.%.5&" N>@SFM[5[.]E\,^&+9([^-UN+5;I;<LK+&%PX;'
M;UKM:KS7EO;W%O!+*$EN&*Q*?XR!DX_"G8+GFUE#K"0+;7]KJ[::@NXK<(7\
MU)1)^Z).=Q&S[I/'K5:YTWQ#:PZS=26U^=9N=*L]L]KN(:53AP".-W3(^M>L
MTM*P7. _XG,FL:D#;:F-2#NUA.C$6IA,?R!\\<-G((SG%9=O!JS:.\JW>N0S
MN\0EBNK9O*$JYW@[3OVL>K+QTQ7J=5X[ZUFO)[..=&N( IEB!^9 W3(]\4<H
M7.4O?[0F\":>,7MC=EH]Z-NF(P3\LA&&V'N1R,BN7N(=4S<:@EMJ]M?6^GVO
ME*C.^Z03-N4G&7&T]#V/->J6]Y;W;3+;S+(8)#%(%/W6'4'WYJ*ZU2QL;B""
MZNXH99SB)';!<YQQ^)HL@N><3W^L/KMUNM]5%K/%>Q21R1.PSM_=\_= /.W'
MKR<UM^%H9HM>L/-MYTV^'[>)F=" '#'*Y/<>E=Q11RA<****H04444 %%%%
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MI"*0!11BEH ****8!1110 4444 )2T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444 <E\,<_\ "L_#
MO'_+FO\ 6NNKD?AAQ\,O#W_7FO\ 6NNH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6GT^&UEBDC8H[*^YCZ@'/'<'FLF_\ :[>62VIUBWDA\O"I<*\AA(D#KALY?
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MJ*I65U=7,LGFV?DP!$:*7S0WF;ADC Z8/'O5V@04444P"BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "44A/-%*X''?"?/\
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MX8 Y ]AGG XJUI>C:=HL#P:;:1VT;MO94[GU-7J*0!1113 3G-+13<&D M%
MH[T %+110 44E+0 G;% I:* "BBBF 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 E%%% '%_"3_DE7A_\ Z]V_]#:NTKB?A%G_ (57H'_7%O\ T-J[:D M
M%%%, HHHH *3-+24 +24M)0 M)2TE "TG>BEI %%%%, HHHH **** "DZTM)
M2 6BBB@ HHHI@%%%% !1110 44E+0 4444 %%%)2 6BBDH 6BBBF 4E+12 *
M*2EI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )11
M10!Q'PB_Y)5H!_Z8M_Z&U=O7#?"+!^%6@=?]2_\ Z&U=RO2D M%%%, HHHH
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M.176K=VSVOVI+B)K?!;S0X*8'4YZ5*CK(BNC!E89# Y!%.P7%HHHIB"BBB@
MHHHH **** "BBB@!**** .%^#G_)*=#_ -Q__0VKNJX7X-_\DJT3_<?_ -#:
MN[I (.E+113 *2EHH **** "BBB@!#7,^-9Y8=/L@D5PR272K(8@[*HP?OA/
MF*YQP,<XKIJ*0'C8_MB]THR7,VN)-!H990/,C/VI)2 <#JV,<<Y%:9EU.SU2
M\A3[?)H_VNSFN"^]CY;QGS"IZXW[=P'2O3HYHYU+12I(%8J2K @$=1QWIX^M
M*R'<\KFM-2N;A()Y=5^P^1?M;[7D4F,$&'=C^+.[;GDC%59-5NI[BVAU+4;V
MW=K>QE-T8Y4$&!F5&VC&6[YQUKUZL:X\+:3=:E+?R0R>;,5,RK,X24KP"R X
M./I2L.YE>/09;311&9QC58)6D@0L8T4DEN < 5DZP]Y<:<(-&U#4KG6(;QI;
M.>9&2)^-S1O@ % O'/<C%>B=.!13L*YY9->7%X-+1)M>LM/FLE%N\=NTDR7(
M?YU<]F]"W&,U,L^HW8UBVF76DUZ);H!8PRPO&5/E,&^[QQC:<YS7I0FB:9H1
M*AE4!F0,-P!Z$CTI]%D%SQ[4+JYUFV>66'5IK2*#3)9%:.5?G63$K =20.N*
MVKC^UY+;7;ZT;4)I=,U5+JVMRS+Y\(1"T0SU4C=@>M>D4R21(D9Y'5$49+,<
M #ZT607/,M8&K)>V5O>W>IVD%Y;-/%-:1-*T=T7W%..A"[0,_+UKIO%]S-!I
M>G)MNB)9U661 V%^4_?"?,03C@=\<XKI8YX985FCE1XF&0ZL"I_&I"P49) '
MO18+GC*7.KW.B-=27>L"\MM(BE51YB9G69AG;CEMN,CN*U);J6]\2V'VY-0;
M4(M<#*HC?REMMC>6PQ\NTY'/7.:]3IB2QR%@DBL4.&"G.T^AHL%SCO%D21^+
MO#]])'.8TANT+H'*AB@V@@<<\\FN-LY]9TW2X8],?46\W0XIIHBK,483 /L4
M]&$>[Y1Z5[***+!<Y;PHC7&BWQMM2O;F&XD8V\EU"T?E97&U WS;0?7WK/\
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M\=:C%<)9W=M:+<W2V9MF1FV(;C=P^>NW:>G7-2Z/J5UHW@SQ-?2XFN+*\O7
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MDM/!6B6.K1:E;PS)-"\CPKY[>7$7^_M3. #Z468713U3Q9<V>O7.DI;112)
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MD$N@W$:PBWDE;SD.V*<X1O<YZK[5)-X\59[LP:/>W-K;_:%-Q&/EW0@[@2>
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MX;I;U;%[EP"H:VVL5YSP3N5N!V!K0LO D-GJ$5Z-6OI94N5NF\S9AY!'Y?(
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MBLO5?"<LEO>Z7'#)=P:Q>_:KBX9UC%H1MY&/F.0N!CO71ZUH<6L:(=,$SVR
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M[# UW'>O!\K!IDQ\V2,_-CD>M.S#0;KOB:YT/Q7#"T-S<V!T]YY(;:$.RE7
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M[49YM/O+Z1(4LWN L?V;RWN%E W,XW':V<]SFFI\/)1H;Z0^N2M:PLK6&+9
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MFK?VHEXTMB536'U +\WW#'L"_P"\.N:D7P??'X=MX=:ZMUN]YD650QC)\WS
M#WQV-&H:%S3_ !C9S:[?Z5>SV\$T5RL-L,G,H:,.,Y'!Y/'M6O::WIE_>26=
MK>Q2W$:[S&#R5SC</49XR.*Y.]\':M>S7DCRV(-SJ=O>G;NX6- K <=>.*O>
M$?"U[X?=8KK^S)(K:,PP7$,!$\J%LC>QZ?0<$\TE<-#KJ***H04444 %%%%
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MO%,P0%3&Q )0GUY!R*Y1=8U:XT*.ZM];U(7$D]I'/ ;1E:"0R 2C+ ]LY X
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MCGN8(B6BMV<;\''4#G'..M8C:AJSZK;6:ZG?KI<VIM#;W2CYY(3"6(+8Z!^
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M24"EH ****8!1110 4E+24@%HHI#TXI@+1244@%HHHH ****8!1110 4444
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MI*6@ HI*6F 4444 )2TE+2 ****8!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 )1110!YC\!/\ DEMM_P!?4W_H5>G5YA\ \_\ "KK?_KZF
M_G7I]( R:***8"T4E+0 4444 %%%% !1110 4444 %%%% !2 YI:*0!1110
M4444P"BBB@ HHHH *2EHH **2BD M%%% !1110 4444P"BBDI %+244 +111
M3 ***PM4\3VVE7K02V\[Q1!#<SH 5@#MM7=SGD^G2@#=HHHH **** "BBB@
MHHHH **** $HHI:0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!**** /+_@"<_"^+VNYOYBO4
M*\M_9_Y^&*>U[-_2O4J0"TE'M2TP"BBB@ HHHH **** "BBB@ HHHI %%%%
M"4=J6DH 6BBBF E+110 4444 %%%% !1110 4E+12 ***2F M%)2T@"BBBF
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M]E_]EKU.O*_V?O\ DF8&?^7Z7^2UZIDT@#O2TG:BF M%%% !1110 444F10
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 )1110!Y1^SW_P DW?\
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M/</GH*** 0TW+@@ +^M)]LDV]%_6BBD,B>_E"CY4X]C_ (TAU"4#.R/\0?\
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%E079_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gtbp_ex1017009.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K8# 2(  A$! Q$!_\0
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MX4ZB@!-J^@_*C:O]T?E2T4 -V(.BK^5+M7^Z/RI:* $VKG.T?E1M7T'Y4M%
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M^45)10!'Y$7_ #R3_OD4>3%_SS3_ +Y%244 ,\N/^XOY4>5'_P \U_[YI]%
M#?+3^XOY4H55Z*!]!2T4 (P!'(!^HHI:* .5\ $KX2B_Z^;G_P!'/74!L]JY
MCP#_ ,BG#D_\O-S_ .CGKIZ0#J3-)2T +2#/>CMQ0/>F M%)2T %%%% !11V
MHH **** "BBB@ HI,TN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ***3- "T4F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP'_R*4'.?](N/_1SUTW:@ -%-!)SQQ3O:@!:0TM%, [444E "T444 %%%%(
MHI.G-&:+@+124M !1113 **** "BBDS2 ,TM)10 M%%%, HHHH **3O2T )W
MHHHS2 6BDS10 M)GGI110 4M)2T %%%% "4M%%, I*6BD 4444P"BBB@ HI
M<BEI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B@T4 <SX$)/A*#_KO<
M?^CGKI17-^!/^12M_P#KO<?^CGKI:0!2&EHI@)12T4 %%%% !1110 &BDHI
M-.=PQT[T[%%+0 4444 %)2T4 %%%% "4@!SDXIU%%@"BBB@!*6DHH 6BBBF
M44E%(!:2EHH ;TI:6DH ***6@ HHHI@)WI:**0!24M% !24M%,!**6BD 444
M4P"BDI:0!1113 **** "BBD^M(!:***8!1110 4444 %%%% !1110 4E+10
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MDOLM:) WGFU;]V8S]!\^,=:=PL>ET5YD;V2X\57#W-]>Q6L.J@BY"2B-HO*
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M@#D5W7A8SMH,)GOIKX[FV7$T/E,ZY^7CKTXR>O6FF%C8I:**8@HHHH ****
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MJ_EL8X)9"UZ9A &C(R8CAP?3%;->:^'XIDU'PR'MKE/*NM1\PM"P";B=I/'
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M_J/BOQ!8/-91O83W.;22*X>-@A6=BA4@'J",@YY%7?&,5\VBZ"LSVIU,:I;
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MUY9J.F:P8]>2VL[Z<3Q2M%*Z,D\3^8I" @XD4X)4]5 P:T'L-;FU.8&VN4U
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M' <7=Q'?E[Q+^T9>+>-5;8ZC'&,)@_Q;JZ?PG'=WG@NTENM2NI[F\MED:>3
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M7EMHYEU&2V:ZBC9I7CRD61D]\D"N&@\=ZNZS1+%9R3(]FRR,K(C).VWY1G)
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MK]_HMKJ5_8WLQE6>Q9VA,;[<%EVG/KQ7.ZQXZAB\/ZE=Z;!<-=VC0H8IH2I
ME(VO@]5(/'TJW9>)(;)EL]2O9+J3[2+<W0M]B1R-RD3X. ^"!Z9(HN@LQ8_
M>AQV]O;F*>2""UDM%BDF)4QNVYL^ISW[8J63P7I,UN4E^U/-OCD6Z,[><C(,
M+A^HP,C\3FH+?QYI-XS+;0W\DGG-!&OV9@977.]5SUV[3GTI\GCO0D:U!GE
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MEBTP+=7=^T32--=06T6Y24VA1%E1M(SD@]:['3-?TG66D73-0@NFC"LXB;.
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MVUO<QOYC8),B +CCID<UTE%%@N<9X8\,ZCI.JV%S<I;+%!HL=@XB;),BN6)
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M)X&#G-6J**8AI&<<T;<#&:=12L W! I /G)YI](>E%@"BEHH ****8!1110
M4E+12 .]%%% !1113 *2BEI %%%%, HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0T4&B
MD!Q_PJ_Y)=X>_P"O4?S-=C7'?"K'_"KO#W_7J/YFNQH ****8!1110 4444
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MM6_@SP];?9A!IL:K;!!$F]BHV$E>"<'!)()Z4C^"/#3YW:1!S=_;2 6 \_\
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MEL8YG5HPX//?D\>U7;_Q+9I8:DVGW5O/>VEM).L3,<-L!SSW&>"11H&I5O\
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MNQ I '>EHHI@%%%% !1110 4444 %>?>/]:N]-U"-;2ZO(I([83*D:G8W[P
MG@'><9R#@ <UZ#12:N-.QYE;:K?/K*S'5KYXI==DLTB/"?9VCR,#'8]&[5N>
M$SJTNH7%KJ4UR_\ 9)>V,SOQ=ECN63'LA ^N:ZZ2-98V1LX92IP<''UJKI6E
M6NC6*V=HKB-223(Y=F)ZDL>2?K2L%SSN;4=6?Q9JBV.K74M]:ZI'%!IQ8>4T
M#1J7R,=.ISGC%9RZMJK:%?W@U_45NPL:W-M]F=&MYO- /+ XX)&%X(&:]2L-
M'M=.O+ZZ@\PRWTHEF+N6^; ''H, <5H46"YY?J=UK&D:[)!IE]>:M)%$RV\;
M2-YD;^66'F+C;(AX.X<@X%5;S5=472KB32]4U VLMK:N\[ F2&Z:4!T&1W7.
M5[8KUG%& *+!<Y#P[>7XMO$EK%-/>RV%RZ6AN3EG_=A@"V!D;B1FN4N=9U9-
M"N+JTU+4=SZ7YM[N4EK6[#J %&."<L-OH,UZUQ1@=J+!<X_Q*USI/PYN)K/5
MKSSHT21;QV#28+KD].F">U<S?:IJ=FT\(UB^;P\UYM74W1I'3,6=I*@'9O[_
M (5Z3JVE6^M:=)879D$$A!<1N5)P<@9'N*NJH50H[#%%@N>71S:G->:EYOBC
M4D-GIL$T<OV<JC.P8%S&!D\;20.G6FV>J:A,EO;ZA-J%G8C[0&NXIV=7G 79
MLDQDH020".O'.*]4I,#&,<4<H7/)9+_Q RWMW>:AJ,%U9V5C*L$8(0RLQ#@C
M'.1C([9KI= O+V3QE>Q2W$]U"PE9)$<B./# !)(V'RL/X2#AAS7;4F!18+GG
M'B!_$FG:M?Q:>+ZYBAECU:)O,.TQ+Q+;CU)(R![UGZNE]%?7-ZUWJ,%Y'H;W
M8,1.Y9&EW+'G'(' VUZQ118+GF[ZGK4^HW#QR7::HM[;BTM\'R9K5@NYL=,8
M+DGJ"!5[QS=2B[DL+E[V*PFTV8P-:JW[RX_NL5&?N]!T.37=44[!<\HAN[N*
MTU.X^WZPB6&FVABMK<$ ,T>U\ CMP3Z<FHK>YDU7^SX+NZOV%MXA"PLID&(6
MC)!W$9*YZ$^M>N44N4+GCR3W-C8I8?;M1LK-K^\6\NC'+(\,V_\ =#CD CGN
M"<9I^K7UY<$VVJ7&HM>6U[8M:QB)E2XAW(3(5 QDG<2.V!7KU%'*%SA/B'JE
MY9"&"SFO(9GMIY8VB5MA=0"O*@DMZ+T/.:P]3NFO;#7I\2O+<0Z6<^41N;<"
MV!CG'?TKU:BBP7.9\4W4\-]I,,DL]OI4\DBW=Q Q4HP7,8)'0$]_7%<_X>EU
MW4O$6GQ:IJ%_$L>G^>44;%F99B%+C'5DP2*]&(!&",CWI:=@N>>>)==NK+Q8
ML4%W=1B&>T#QE6V&-VPY4 ?,,=23P0*HZ'>ZK?75A ^M7[?VC_:$+,P_U8C?
M]TR\<$#OWKU&J]Y:1WMG-:R%T25"A:)BC 'T(Y!I6"YSO@V;5+VW>?4WF66V
M46+QN<K))&2'E'^\<5R4.K^(-T\^G:E=7^H17][ U@X#((E#%#TZ@A<'/.<5
MZ=8V,&G645I;(5AB7"@DD_4D\DGUJ#2M(MM'@FBMC(1-,\[F1MQ+,<GGTSVH
ML%SS:ZUG5H])EFLM8O6M7M+662X9<R0W+2A709'=<DKVQ4FIFYT"[\3&/5=2
M>Z%M:/!-,Q<NN_#$<8]N*]4"J,X &3D\4N!THL%SSN;6-6?79!'/.M['JZ0K
M9X/ER6) ^?IZ9;=V(Q2>%=3U!M8T7S]6N[M+^WN_-2=1M!CDPA& -IQGZUZ)
M@9S@9QC-&*+!<\^U35]9_MK48HIIXM0MKZW2QM%7]W<6[;=S'UZOD_P[16GX
M)MXE_P"$@"7%Q)NU6<'S')V].5^OK[5UV!G.!GUHP/2G8+GC.G[S8Z+ -2U"
M"YMX=3::3<?-1PV0"6'L/K6LFN:I>VLS#5V@EETJQFS*K"-968AQ\HRN[ !/
M;.:]0QFC P1@<TK!<Y;2-=%KX(;5K];E/($FX3OYC$AB %8#YE)P <<C%<]H
MXOO#/B^ WZQ(?$-NQD>-VD4W2?,&;@;05;;_ ,!%>E8 &,#CM3)88YX7AD7,
M;J58>H/!IV"YXV/$NH3Z'J%[#XBG2Z33U+Q*^YOM/FX9T3;]W;V]ZW+JZU6S
M\1II9\07<*JD,MC+-;M*;O<29%^4 ,>BX/08-=KI7AVQT@Q^0UQ)Y2;(1/.T
MGE+Z+GH*UZ5@N>0S:]KDFCZK=C6KJ'4H+>43V*VK;H9!*-K9/ &.!C[P-7)]
M1U.PU2Y$>L:A.EIJEG%&DARKI,H\Q6^7Y@"3C^[7J-&!Z"BP7/(KC7=;?0M8
MNQK=Q!JMO;3&>P2W8F"42?(02, 8P!C[P-6[N]NTU+R9]4OI;2SU:RD,I)RJ
M21$L"0.5W8^F:]2P.N*./2BP7(;6[@O$=X'WJCM&QVD88'!'-3T450@HHHH
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M*0T4@.-^$YS\+/#_ /U[?^S&NSKC/A/Q\+/#_P#U['_T)J[.@ HHHI@%%%%
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M)R2.JG@Y7GC%>E:CJ=II5E/=W<FR*!/,DP,D+ZX'.*LHX=%=3E6&1]*- N<
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M3.64#'3@].U;%A>PZEI]M?6Q)@N(UEC)&"589'%6:$%PHHHIB"BBB@ HHHH
M***2@!:*** $-%%%(#C/A-_R2OP__P!>Y_\ 0VKM*XOX3'=\+/#_ /U[D?\
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ME H.02"-O0<9.:!;ZI?)-<E=5AUN>PL'LW570/,H(<OVX/W@W:O7ZAN+JWM
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M='L95/95/(4<X!YK9%Y;->M9"XC-TJ"1H0PW!2<9QZ9J>FD#84444Q!1110
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M -=0WFCZ7?I;I>6%M<+;L&A$L081D=-N>E+8Z3:Z?>7UU!&%EO9!),0 ,D#
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MEE*]<=!GU%31?$"VDC\P:9>B*4)]ED*869G;:J9/"L>O?CFIAX"TU9XW6[U
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M_:T#J4FTMHHL0F+RL;)&/W<-G<IY/&*KK%>R^&WGAT[6XM3@^RM>AV;#21R
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MG/S8YK*U;Q7<:WX.NX-1U$6[KID<L:JJ@7K>85<\]<;0"!TSFO818VBE2+6
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M#3UU"U)"[I"LC;TVX^4%0!MY(XYJ]8>)]:U*[NHQ<36<,T1U2SGN(1MBMMF
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MFDW<<=O%IGV?%P9,B3S1\HQV.>/QHNAV.GHK/U6YO[6%9+*""15#-*TTA4*
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M?OQ)_P"AM7?BO/\ X*_\DJTC_MK_ .AM7H%(!:***8!1110 444E "T4E%(
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MY*]..AZ5N6NIVMW?7ME"[&XLF59U*D;=PR,>N1Z52M_%.DWA'D3NZF?[-O\
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MRQ.B[1&IDP.!GH%Y[\5A77B.XU'3]4MVU>[DADL%N<;B)5=9P&S@83"]4&<
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MVXN);NYM6:=V0 Q)O#;<9Y'8\BMMO!/AY[:.W?3E:**W^S("[?+'NW8'/]X
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MHHH **** "BBB@!#10:*0'G?P0_Y)5IG^_+_ .AFO0@!GWKSSX'G_BU>F_\
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M:.@&+X=TFYTN75FN!"%O+Y[F,1$\*P P>.O%8E_X1U.XUFZGCDLWM9M4MM0
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M)K+?P-I!N+>XB:\MY8D,<C07!0W"EMQ$F/O<Y/XFM?5M(L];TJ;3;Z,O;R@
MA6*E2#D$$="" 0?:EJ/0PKCQ7?P7 T]M("ZKY4MP86G&QHHR!N5L?Q$@ $#W
MJ@/B(\ZBZM=(:33Q%;3O,TP5@DQV\+CD@UL?\(5IGE0?O;TW,0=?M;3DS.K@
M!@S'J" /RXHF\$Z/*ES&%GCBN(X8FCCE*JJQ'*!1VP?SHLPT,6[\27=UKFE7
MMI&5T\&]50)B//\ *C/WEZ 94XJTWCU46U+V.TW=E;W$&9.KROL"'C@ ]ZT(
M?!&C6^I+>QK<!DEDF2'SV\I6D&'(7I\V3D577X=Z (9(72ZE1[86H\RX8^6@
M;<NW^Z5/0CI19A=$-SXGU>TU>QBO;""TM_+NI+D&3>S+$ 0R8[$'//-)!XTN
MY5AWZ/)$;QHELI)&VQREP3@D\Y4#)P.>U:2>#M)1;+<+F22U9R)9)V9I=XPP
MD)^\",<'TJK%\/\ 0XK%K,"[,>]7A9KERUMM.5$1S\@'M2U#0D\$2W4NEWWV
MQG,R:E<(0TA?: _ !/;TK$T[Q#J>E:G>Q3637&G3:U):)<O<9:-VQM&W'W,\
M=>,UV&C:)9Z%:26]D)=DDK3.9)"[,[=3D^M5QX;L8[Z2]C1S*TQN1&\A,8FQ
MC?M]:=@N5/#WB>3772(VJPS1K(+R/S,FWD5]H3ISG!/TK8U.\;3]+N;M8UD:
M&,N$9P@)]"3P*QK?PW)-H^I)>^3;ZCJ;>9<RV+,@5@ %*G@D@ <UK7VD6VIZ
M))I5]OGMY(A'(2V&;'?([Y&:-0T.8C\:ZA<206UMI<4MQ+>R699I2B K&) W
M(S@@XZ4U?'[K;6%S<6"PP7]G)) QESNN$./)Z=^H/>M6T\$:/972747VLSI/
M]H#O<NQ,FW86.3U(ZU$GA-(YM,L8XK?^Q=/D^TQ+(6>;SLDC!/ 4;B?6BS#0
MV[N6Z71IIHU1+L6Y8*QRJOMS^6:X'1M=O["UMEL]-FU'5;FPAO+I4G8JX8D
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MW>G75WK=S=3V9E):2)0)-Z;.@Z8'IU-98^'"J+=1K=WM@2!5'EH<&)MRD9Z
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MLED5%VO+MW*!ST([]/6IKSP9;W4]TXOKJ-+V!(+U<@_:%4\$D]#@D$CL:/\
MA#XQ<><FH3C&I#453:N P3:$_P!W'XTM0T*K?$*T\FW:'2]0FDFMI;DQHBY0
M1-MD!).,@_G45]XVM)],OV\O4;(VZV\P=$0NT4K *X!R,9R"#R*GA\#6]OY>
M-1N24M[FW&57I.VYCTZ@]*9<> +>YAN(9-2NML]G;V9PJ\+"VY3]2>M&H]"S
M<>-K*WN=2C:VG:/3MWGR+M.TJ >5SD YX)&#S4+^*K8ZAIEQ.UY:V\D-S)QL
M>"144$L6&<\<@CWJQ<^$1=:H=2;4IDNU1TBF2) Z!L<$X^91CA3ZU!#X!T^/
MR0T\AB1KAGA1 D;^<H5P%'W1@< 4:BT&W'C^SLH)'NM/O$<117$48"EIHI&"
MAQSV)&0>1D5N:-K,>L17)%M-;2VT[02Q3 9##![$@@@@UAR^ ;>XLO(GU*ZD
MD2".VAG8+NCB1PX7IR20,D\\5<C\/WUGJOVJTU281SWIN;J-E7:RE NWIG'
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MZ^VZ;:W979Y\*2;<YQN ./UK!OO%<D.NWNE65FES<V4*3/ TNR296_YYC'S
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M'8QG3RRZ-_9Y.6 \SS V[I]W ^N:-0T.NO?$^D:<LXNKV-9+>)I9$7+$ #)
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M=6C:P:XC9S"REB N=S 8SMP-V<="*3Q'X3'B/6]/GNA;R:=!!-#-!(IW/Y@
MRI[$8K,G\'ZZYTV5M3L;NXTX20(UW;EEG@;'WP#]\8'(X/.>M/4-#3M/%D3:
MEJWVF>$V$)MOL<D*EC+YJ9 &,[B3TQ3I?&FFR/'#:2.QGLYKI+DPL8HQ'P=W
M?(/4=>*SIO!^K++>O::A:(MP]J=IA*AEB&&4A?NAL\;>F,5%IO@?5--@@B2_
MLV6.*\A/[IA\DS;EQSU!Z^U+4-#;3Q;I=O96+7M]&TD]O',\L4;>6JO@!S_<
M4D\;J>/&&A'4VTX7P^TK,T# HP59 -Q4MC&<<^]<^/ -ZMA/9_;X#'?Z=#87
MN8SQY8*AX_<J3P>_-69?!VH&;,5Y:B--674(PR,3M$>S8?4]\T:AH='I.N6&
MLB0V4KN$"MEHRH96SM92>H.#R*S?&6MWF@V%C<6CVR":^BMI6N%)55<X+<$<
MCK2^%O#LV@&[+RQ".<J5MK?=Y4;#.YD#?=W9^Z.!BI/%6B7>NV=E#:36\36]
MY%=$SJ65MAR%P/6GK8.IGZ+XS2X;6$OIK>6+3KA($N[0$I<,XR$"\G>"<$#/
M45H2^,M%AM%N6GDV$R!U$+%H_+^^77&5"\9SZUB2^ [FXO;K57OH+?49+B"X
MA2WB(@1HB<;ESEBP)!/';TJ/4? >HWRW&-3ME^VO/)=1/ 60-(H5649!RH4=
M>#G-+4-#H)?&6A1:A+8M>'SH5#28C8JH*AAEL8Y!X]:=X>UJ75[G5E=2J6MU
MY48:(QL%V*WS ]\D\UB+X(OY+/5H9M3B22\6U:*6&(CRY(%4 D$\@E1Q6YH.
MDW^GW&HW.H7<$\U[*DI$,114(0*1R3GI3U#0VZ***8@HHHH **** "BBB@ H
MHHH 0T4IHH \N^ 7_)+X?^ON;^8KU#.*\M^ 8S\+X?\ K\F_F*]2Q2 6BD Q
M2TP$YI:** "BBB@ HI*6@ JM>WT&GPK+.Q 9Q&B@9+L3@ #N:LUS/B8-'KOA
MJ[?_ (](;QUE)Z*SQE4)_'C/O2 T(O$ND32"-+V+=MD;EQPL9PY_"F6WB2VN
MGMMEI>B"Z;;!<-"1&_&0?4 XX) JIXE\)VFL>'-2L;*WMK6\N89%CG6, J[]
M3D<_-@9K)E?7=1M?#UM!9ZAI]U;7"+?@-B/RPA#?,.'&0I&*6H]#N-Z<@L..
MO/2DW(B]550,]< 5YSI7AO4+XVEKJ-K<0/\ 9;FWU:9F^6Y9C\C*<\G/S ]N
ME,;1/$0\/V]Q?6LDUU#<1PW%O:R#?-:QAE4C/!))#D47861Z5N4 '<,'IS1O
M4D@,#CKSTKS:'PF9;J!)],OWM8M*E$'VJ?>R2^860-@XW8/ [=*RY/"^J1:0
M;>#2KX?:-&MXYT$ARURLH)).[[P7//X47861ZX'4XPRG/3!ZT"1"6 =25.&&
M>GUKS(>'+VTU6XFL=,NXTBUJ&6V(/"0&/$A49X&[.1WK./A;57T#4(9M)U-M
M5$0BFE^TJ8[@^:&W( 022,G)P1TI:CLCUF6]M8#$);F)#,_EQ[G WMZ#U-/F
MFCMK>2>5@L<:EW8]@.37G+>&YH-5>2+0Y7LK?68;BWC&#MC,.UV4$_W\$_G7
M6^);>[U&*UTRW218KF8&XN%4,(T7YL$'KN( _.F(TM-U.TU?2[?4K*426L\8
MDC?ID58,T0C\PR)L/\6X8_.O,+^TU+P_H'B#2I$N#9B[CN;"<;(UE+R*7AQG
MA=V>.,@FH!87%Y$#:Z;?30+>RR:A81,B%?-0!#'DE2%P>,YYS1<=CU<RQA@I
M=0Q. ,\FHKFZ6""=T4S21(7,2,-QXX')[^]>8W/A6_B-_)#HMRUQ&MA]C<S^
M8ZF,_/AR>H7@GO5K^Q=4FT_5[6[\/N^H>3=HNH+.,7*R9* #.2WW1S@+CBB[
M%9'HT5RDB0[OW<DB!A$Y&X<=,>U4M3UJ#3($F,4MRIG2!Q;@.8RQQEAG@ ]:
MX:+P[J4FM6[WVE7<ZF.UDMYX[L1BW:.,!D?OUR>,AL\UK^#='O+#4+PSV;I:
M-&OE/=*OGJP9CL)4X<#.0Q&><4:AH;FG>)+6_ECB:"XM9)7DC1;A-I9T/S*.
M>N.1ZBM2YF,%K+,L9D9$+! 0"Q Z9/'/O7.>*(GN-3T"UM%!GBOOM;;>-L:*
MV[/IN)"_C5F:YE\0>"KN3^S94FN;65!9RD;MV",9Z=>],#7ANXY(86D*PR2*
MI\IW&Y21T]S]*9>7\-G:W4Q/F-;Q-*T2,-Y &>E>:W_AC4KFWN)QH;O>+I=E
M' YD4,)HV^?!SP0._>M*TT75$DU**[T03W8%T\&I^< 94E4X3&<[APN#P,9%
M*["R.WLM2MKZPM[M)%5)HTD 9AE0PR ?>J^H:W;V&I6%BRF22\D:,;6'R$*6
MY&<X.*X"]\.:[_9\\,6C^=)>Z991DB95\J6%LL&R>N.A'I5NWT+6$UVQ>ZT7
MSI+?4YKB6_$J?O(9$8+U.<C(7;TXHU"R.[M=12:QBN+A1:M(N3%+(N5YQU!(
M_(U8>XAC<))+&KGD*S $UY;_ ,(?J$NEVT,^B;VBT:ZMD!=?DE:3,8Z^G0]J
MJ,W_ !/FAU*V>9+9K%YP)8WF26-!E0I;<5)()P#GFB["R/79[B.V@>:5E55&
M?F8#\,FLW2M=358;6XCMGCM[BV^T>8[K\G.-I&<^^>E9WBFQO[J]TJZMK)=0
MLX6E%Q:,R@G>F%<;N#M.>#V)KFK+POJD5E:07.D2#9HCV4WD7"AMWF!@JM[
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M1'7/\/I@T:AH=I;ZC97<ACMKRWF<+N*QR!B!Z\=J62^M8KE+:2YB2>3[D;.
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M:'83:Y PLI+&2UNH;BX,3R"Y50@ )8C^\1C[HYJ"T\8Z!?RV<=MJ,4C7K2+
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MOI[%!#;7SP@73^5''+C]XW7 '<\?I5NN8\7RQQW'A[S"HSJL6,_[K4F".F
M&!17EEAXCUO5[R\M+'5SYDVGR7-L7B 83))C:5Q\N5X*Y)[U?T?Q)K6J:U&L
MJ75MI]^J7]M(Z#]U"@Q+&W'!+8QGG!I7'8]$I"P52QX &36)J5S+K/A2:\\.
MWX,KQ^;;31\ARISMY['&/QKEM(US7-4UDPRF[MK&^5=0M9'0 P0JN'C;CJ7P
M1[&BX6.W&LZ<VC'5Q=I_9XC,IGYVA1U-7(I8YX4EB8/'(H96'0@]#7DC:G<7
MNFQW5YJ$[?:/#ET A&V.64.0?EQC=BK%MKNI:8J:=_:%S+9%;!IK@J-UK%(I
M#E<#[N0H_P!G-%QV/5J2O-(_$&K6U[:_;-1E_LQKF]MXKH+_ *^,1@Q$\?>#
M9 (^]BI_!E_-?>(;6[O;^ZDN+G1H'$;Y5&8,P<A<<'IGZT7%8]$JO8W]KJ=J
M+FSF$T)9E#@'J#@]?<5PUQKUP_C673FUH6K0WZ+L9@L;6YCSMP1RY8CFJ]IK
M.N1:'IFLBXN;Q4NY[.ZMTC W;G98W( _A.W/L<T7"QWLLNGZA/<:7,(IW1%>
M:"1-PVMG!.1@]#4MI96MA (+.VBMX@<A(D"C/T%>>:SJ6LZ9_;-HNK7)FM;2
MR=)/+!(=I,28XYR.H[4EUX@NM,DN+:XU6Y>SAU4PF1^)6C,.X -CH'[^G%%P
ML>F45PU[J6HP_"E[Z+5O.U)(0?M< #9?<.,8YQT/%9[:OJ-MJ<UA)J-W)IBZ
MA&D]Y_'%&\.X#<!PI?C/;I1<+'HTDB0Q/)(<(BEF/L.M1VEU#?6<-U;/O@F4
M.C8(R#TX->;6EUJ4FJZ?=7]Y>JWV._CM9,$"8*X\MF4#&XKSD]<4^SUV]GDT
MR'4]0U2VDDL;:6TE@@)%S+G]ZK#&,]!@XP#FBX6/2]B;R^T;B,%L<XI1CH.W
M:N#\,:EJ%_XEE6\U&Z2YBDF2YTYK9MBKN_=L'/ &,8(ZY-5]6N;K3/$>L- ;
MX)-=6AN67<WEVQ7#NG88/!QT&:+A8]%I*Y/P]K3V\LEEJ-S(\-Q?20Z7+*K%
MIHPH."V/7< 3UQ6?XFU#4XM7U*".XNK::.WB?21$I*3R$G<&X^8YP,'L<T[A
M8[VDKD_"XO;K6=9N;R_O'\B[:&.W<XB52JGY1CG!W '-<U=:AJMO:7FHMJFI
M-:#5WMKG*,PM[?)VLJJ V,X&X=C2N%CU&J%[%I]L'U6YM8FDMT+F;R0TB@#M
M@9_*O/H-8O8[ZULM2U/6FBDAC?3KN&S*FX?S#N#K@\[=H^;&1DTQ-5U>5=8E
MEU'4H-2M[>Z$UFMJVQ",F)U8\>F-O7)S2N%CU"&99X(YH\[)%#+D8.",CBH;
M._M[\3&W+GR96A?<A7#+UZ]1[CBN+']O-J&EB&XO9+76;*(32AN+.5 &=@/X
M=ZY'U%4$O]3N]2@MI=1U**"37KJW8IE3Y CR@SCA0>AIW"QZ;17DAU_5)=.T
M^"XU>Y@FFL)/*FVLK1RK*5$DF!R-H'&/7UKK/%>I/;Z3I@M[FY9;AL"X@SL;
MY"1N*@MR<8QU/%%PL=?5*\U.SL)K6*YEV/=3>1"-I.Y\$XXZ< ]:\T?Q'K(T
MJ::2YU(33Z5;20!+=LF=7(EP,<'&,BGS0.=2-MYM^LC^)5D9QN)2)HCA@2.
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MH \F_9Z_Y)S-G_G^D_\ 05KUJO)/V>?^2=SXZ_;Y/_05KUJ@ I:2BF M%%%
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M-Z/?"$7=C'/Y((0ODD9QGGOG _*M6B@#$;P?X>:=YSI-N97;>S8.6;=NR?\
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M:TLX8&$8B!1 "$!R%^F2>*N44 %%%% !1110 4444 %%%%( I*6B@!#10:*
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MQ]*#,P]*** $\Q@M'FMM[<444"$$K;N:0L0..]%% ")(QX//UJ3<>!V.:**
M$!XI<G]:** (V<[B*0\$T44#&[CCZ#-,CD8MCC%%% ",3F@G.#WHHH A>1MA
M/I40N'"@@"BBD-$4M_+&.%0_7/\ C6?)KURI/[F Y)'(;_&BBL[NYHDK$/\
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M_COXP!X33!Q_S['_ .*JN_QZ\9YX.F_^ O\ ]>BBIZE)$/\ POOQJ.C:</\
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944K(=V,/C7Q03D^(=3R?^GI_\:***8C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>gtbp_ex1017010.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ K0# 2(  A$! Q$!_\0
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M0NO_ $<U=A7'_#7_ )%67_L(77_HYJ["@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!**** .0^&Q_P"*5D_["%U_Z.:NOKD?AO\ \BK)_P!?
M]U_Z.:NOH 3FBEHH 0=.E%+10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHH
MI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M&B@T4 <C\-_^15?_ *_[K_T<U=?7(?#?_D57_P"O^Z_]'-77T )2T44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4E+10 E+244@%HHI*8!2T44@"BBBF 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 (:*** .2^&^!X4;WOKK/\
MW^:NNKD?AQSX4;VOKK_T<U==0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4E+10 4444 %)2TG>D M%%%, HHHH **** "BBB@!#12TF
M*0"T444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *0YXP0.>:6B@!**#12 Y'X<MCPHW'_+_=?^CFKKZY#X;X_P"$
M4?\ Z_[K_P!'-77"F M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1124 +124M( HHHI@%%%% !1244@#-+3>:6@!:***8!1124@
M%HHHI@%%%% !124M !1110 4444 %%)2T@"BBBF 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC3;E)G@U"UE6'!E,<JL$STS@\9K"LM/GL? 5U_:3K)?SVDDMW(5QOD*8Y'T
M&*Y&Q\(ZAJGA[2]1L;>UMGBTRU18!)A;LHZO\Y4?+P, ]02:=V*R/2CK.EJD
M;MJ-HJRC,9,RC=SCCGGGB@ZSI8W$ZC:#8 6_?+P#P#UKC;+P>RZWI5W+X>L8
MK:,7,D\33"9EDDVX.6'))4DXX&:S;;P+J$>GV4$ND69>/2[VWD.]3^\D;,?;
MD>_:GJ&AWEYK]KILET]^\5O:6ZQG[0TRG<7. NWJ.V/7-3PZUIEQ)=I%?0,;
M-@MQAQB,D9&3]*X.Z\)ZU-IM\BV$37#Z98Q+OE7]Y+ V6!/TZ$TV_P##.NO=
M:G<0:3$8Y=0@O_)CN5C,Z"((T>X=&4\\\&C4-#M=?\16F@:%/JLC),D<?F)&
MDB@RC_9SUIU]K]OI\^EI,C!-0<HLA8 1D(6^;/L*\_U'PEK"Z1=V-EH$4EO>
MZ>8;>![I7-C)N9CEFZALY^7H1BNI\1Z--?P>'WDTU;V*RF$ES;,5)(\LKP#P
MV"11J&AU'VF#./.C^[O^^/N^OT]ZH:KKEMI?V-"#-/?2^3;1HP'F-@MU/'0$
MUP3>'&L)=#L;2YM8=68S6\UJ#N:.QE9F*C_<P,$\9XKK?%&E07NE6NGRZ-_:
M&GAMLD<;;9(0%^5XSD$$''0YHNP-33M6BO[/[0T4MIB5H3'<@(P93@CK^7K5
MQYXHV*O*BLJ[R"P&%]?I7E]SX?U]K.P34;34-5L%2XMQ"MPBW,:,P\IG)X)V
MC!8'(X-7;;0=1_M.XL]1T)[N0R&2UU-KD%8XC%L$;G[S$=,8P<YI7861W-OJ
M<5W/"MLK36\T1E6Z0@Q]<8ZYR?I5M9$==RNI7.,@YKRV#0M=%CI\-AI<MC=0
MZ#+9L[,JJ)0RX7@_Q8;!]ZFO=#N[II9;?1[NWTZ>:QS9 ;661'S+)@'@;/E.
M.M.["QZ1<W26UG)<D/(D:%\1+N9L=@!U-9>B^)K?6[NZM8[+4+2>V5&D2\@\
MLX;.,<^QJ/PE;26=A>6S6LUM%'?3?9XY!P(BV5V_[.#3O#]G=)!J%_<Q&"\O
M[AY"C\E%'RQ@_P# 0#^- C::1$5F9U"H,L2>@]ZS;#7K6^MI+G9+;VJA72><
M!4D5NC*<_P#UZXK3])U(I:FYLKE;F.UNH]7!RRW;,/DQ_>)/(QT'%6KO1'F^
M#T6G)I4GVB.VB)M"F'#JREAC/7@T:CT.RL=6MM0N[ZVA$@DLI1%+O7 R5##'
MJ,$5>KR^73;T:Y=ZG::=?PRG5;7[.Y1@%A\L*Y*Y^[U!S6QX)M;Z.^EFOXM6
MCO%C,5U]H"B!W#9W)C[Q/8CMP:$V&AW%%%%,04444 %%%% !1110 4444 (:
M*#12 Y+X<9_X11L_\_UUC_O\U==7)?#G_D5#_P!?MU_Z.>NMI@%%%% !1110
M 4444 %%%% !4%YY@LYC%)Y<@0E7VYVG'7'>IZ9-&98)(PVTNI4-C.,CK2 X
M72O%VI7VC1VM^8['78W@,@"!DGBD8 2(#V(//H:UK_QQIUG!?&.&YFGM8)9U
MAV;3*(SM;;GL#W/X9J2X\'65Y:Z*MS([W6DR(\-R@"LP7&58#JIP,BLM_AVL
MLT[S:Q._FQ7,))B7<5F.>6ZDJ0,>PQ2U'H:,7B>W2_N3<SS)LMK>06A@Y5I"
M0-K?QDGC';%/?QMI*&./%TUP\[VQMT@+2+*J[BA Z''([&JEQX(:[9Y9]6E:
MX\BW1)5B52CPMN5P/<DY'I3T\&E-4AU,7Y^V?:VN[AO*&)6\ORU &?E 'YT:
MAH6E\9Z,PM&6:0QW2QLDGEG:/,;:H)[$D$8[5)X6U.[U.TOVO'C>2WU">W5D
M7:"B-@?CBN=C^&TZ06L7]NNPMA'LW6JL%*2%P5R?ESG!QUP*ZC0-&?1;>[CD
MNOM#7%W+<EMFW;O.<8]J%<-#5?.QMIP<<'%<_P"%M;GU+PA%K&J/$K,)'D,:
M$*JJS#IR>BYKH) QC8(0'(.TD9 -<A8^$]:L/#T>B0Z^L4""0?:(K;$QW$GJ
M20.6].U&H#M2\;VL5M;W-E)\J7L$-U'+"V\)("00O7)&".M:">,]#ELDNH[I
MW5@Y9%B8R1A#ARZXRNWOD5@6WP_OK8M*-6@,XEMKA,6N%\R$$<_-DA@>><YJ
MV/!-Q;Z@^IVE_&M]=+,EYOBS&XD()*C/!7 QUSWHU#0VHO%.CSZNFEPW9EO'
M19 B1L1L9=RMNQC! ZYK9KG/#_AI] U"9H[E9+0VD%M%&4^=?*!&2W?.371T
MT#. U[QIJFD:MK<,:V$B:='!+#;MN$USYF?D7!^]QQ@=ZZF;Q'IEI+##>7*V
M\TNS*2?\LV?[JL>@)/ SUK!U+P1)JFM:KJ,UU#%+.(&L9HHSYMI+%G:V2><Y
M.1W'%)_PB.J2ZX-2N+K3)3<+$;Q9+/>0\? :(L?ER,<'.#R*0:%O3?&$"Z;)
M/K,L4$J75Q"!"K,-D3D%R.2 !C)Z"G7?C.Q\V^MK:ZC@ELYH(Y)KJ)_*;S,$
M!2.I(/';D5BWO@/5[NP:T_M.T6*9[MY4,3E<S-E6Z@DKTP>#UQ4DW@C5I;;4
MH?[0LL7HLV)\IOE> *#WZ$+^M&H:'5OX@TJ._P#L3WB"?<5Q@X+ ;BH/0L!S
MCK56U\8^'KR*62WU6&1(HA,S#/W"=N1QSSQQWXK)_P"$.O3=/$UU;M8+J3:I
M#\I$HE()V$]-NXDYZXXJE;^!=2AL+*UEGTVY2#3WLY4EC?;+NE#D\'(X'USS
M1J&AW%E>V]_;^?;2;TW%3E2I!!P00>0:L5D>'-+N='TD6EU=O<LLCLA=BY1"
M?E3<>6P.,GFKFI1WDFFW$=A)''=NA6)Y<[5)[G%,1F:-XHM]8UO5--2%XFLB
MIC=CQ<(<@NOL&!7\*2\\9Z!9VMQ</J,3K RJXCRQ^9MHP.XSQGI62W@A[+4]
M*N])F$0A@>TO!-,[%X7'(3T(;YA56/P?KI\,-I,\^EN]K'%%:3I&RO*L<@<>
M8>W"]!GDYI:CT.]5@Z!E.01D&A]PC;9@M@[=W3-5K,WQ>?[:MNJAAY/DL22N
M!G=GOG/3M5E\[&V@$XX&<9IB.1T_QRFH:#>7:V1BU"R<)<64CX(!;:'5L<H>
MH..U=$^KZ?'=/:R7L"W,:%WBWC< !D\?3FN3N?!5W=:/ITB216NL6K".1T8L
MD\!DW-&W'([CT(IR>$M1-\L$S0M;1ZN^IQW@;][AL_NR,=><$YQMI:CT.AL/
M$VC:E:1W5MJ-N8I(3.I9PI\L'!;!Z#WJ6[U:.*6UCMVMYVGD0$&X52$;/SC/
MWNG0=:Y"#P/J#Z%H=J[V]M=6)DM;ED.X36DF0X''!/! /0TZS\'ZK86&FQ.T
M=Y-::G$ZR,P!2TCR(QDCE@IY]31J&AM'QKICWEBMO+%-97$LT+W?FA4B>(9(
M.?YUMR:E8Q%%>\MU+KO4-*!N7U'J*X>T\*:G%-90W&GVDMM;WU].Q,@(=90V
MP[2.OS8/IBH-)\(:S:'16>VBCFMHH8;K=,LD4B+NS\I&0RY^4C\:-0T.XM==
MTJ]M+>ZM[^W>"XSY+^8!OP<<9ZU:6\MFG$*W$)F.?W8<;N.O'M7E<_@SQ(_A
M^VTU-+M%:&R, D2X4,7$H?DX^Z0,@#G/6M(^$M6-U/<06$5K<SZU)="Y65=\
M,30E,CU^8_=HU"R.INO%$46L7.F6UN+J:&S^U92= "=^S823P><\UM"Z@,@B
M,T8E/'E[QNSC.,5Y==>$/$%U87$)T6UBF;1ET\NMPI$TJR!M_P!" 3D\Y-:5
MSX9U ZY=:BFEIEM6M+J.0.H<11H!(<]0>#QWHU#0] 6XA>1HTFC:13AE# D?
M45+7D7A>\6VO(=0%@]U/'#=):>7-&S2@R%\RG.Y3@8!8=_>O5[28W-G#.T3Q
M-(@<QO\ >3(S@^XH3N#0R[N9+80E+9Y_,E6-@A V _Q')Z#VYJ82QL^P.I;&
M< \U@^+-.N]1M]+6SB,C0:G;W$F&"[45LL>?;M7-Z%X:OM.UZPO6TUXG%_?/
M/*L@_P!5(28\\\CIQVIZ@>BTA*]"1SQ@TM><>*?#U[J&IZY<P:=<R3,UC]DF
M23'W6_>%?FX.WJ>]#$>B[T5-VY0OKGBJ5MJT%SJ]]IJI(LUFL;.S#"L'!(P?
MP->=WN@ZHJ7MC:Z)<FS-_<-;8D7$:M" K!6;&"^[D_=Z@<U'ING>(8=8L;R\
MTF\FLX[6RAN[=R-[R(K R @_-L8Y(/4'/:E=CLCT^VNOM/G9@FA\J5H_WJXW
MX_B7U4^M3G!X(!^M>:?V'?7>J)'=:;>M:'7[B9\R,!]G:+ )P>5+=JQI(;]K
M"'3;T:DCII>V3!+26?[YB'&&SDH .?0>]%PL>R%592" 0>H(H5510J@*HZ #
M %0V4L4]C;RP,6A>-61CU*D<5S7CA+V:"Q@M+*ZN$D>02/!DB,[#MW*",Y)X
M). >:8CK**\?6Q\12:1+=26NM#4X+"P$1+/_ *]9")2%!P3MQD]Q75Z78W,7
MC*^L$F>32TE&I(WGEF21@5,)YX4$%@.G-%QV.UHHKAM?34/^$SM'MUO+FW<Q
MQO;KOC$8^;,B.ORD?WE;T&#0V".YJE<ZI:6FHV5A/(5N+TN(%VDABHR1GH.*
M\MAN/%(TRU@MX-8:]MM.EBN6=6^9Q.I(!/!?R]VT^_6M"YLX=2O/#Z0PZZFF
MFZN9"UQYB21*8<  _>5=W SW)I786/2A;P_:#<"&/SRNPR;1N*^F>N*EK#\'
MSW=SX1TR2^,QNO) E,ZE7R./F![\4WQA<7]KX>DFL$F8K+'Y_D#,@AW#S"@[
ML%STIB+4>OZ9+,8HYV:079LV C;Y90,E3QQQWZ5J5Y9I4LUM<;K"34DAF\1E
MF+QO^\@:'^+<,E<@=:@35M;MH9/-DU&YL1<1&\O+</N\AB^3L(W1R [=P7(V
M\C%*X['J)U"U&I#3C*/M9B\X1X/W,XSGIUJS7EUY=:E;7D$NE2:A>7":)<&"
M6YA_>2'S5*Y&/O;<X!Y.*ENM2U4"\_LW4YCI9^S-!/>;AOE.[S(2X&Y 0 <X
MX)Q1<+'IE%>57'B/4X-*GS<:I%<36UE/9QRH7D/[PB7E5P1C&?KFI)]4U:"U
MO-1_MF^:T&K/:3$Q96WM\Y#@*-W7 W>AHN%CU&BO-(]8U6VNM)0ZQ/J<9\L.
ML<1AF<-(0) A&)$Q@'D$ 9[UZ733$%%<5XHU;4;?5KNU2XELXX].-Q8R(H(N
M+@,<H<CG^'Y>^[-3^&;C5-0\0:G)>ZC+LMO*7[$$4)&SQ*S#.,G#9[T7'8ZZ
MBBBF(**** "BBB@ HHHH **** $-%(>**0')_#C_ )%1O^OZZ_\ 1S5UN:Y+
MX<_\BFW_ %_77_HYZZT4 +1113 **** "BBB@ HHHH *1F"*68A5 R23P!2U
M1UG3SJNB7VGK*86N8'B$@_A+ C- $,7B/1YX)IHM1@>.%E60AN06^[QUY[>M
M,G\4Z%;0Q2S:K:I'+&9(R9/O*#@D?0]?2N:70/$<D&E7=Q;Z9'>:9+&3% YQ
M=*JE"2Q P<'*@@X-0CP=J<-Z+E(+9_-2^=T\S C>?&U5R.@QR?>INQZ'6#Q1
MH313RC5K3RX"HD?S1A=WW>??M2V_B;1+N6.*WU2UDDE+!$60$L5^\,>H]*XF
MY\&:Q+9"!+.TP=/L;8IYHP'AE#MVZ8Z5=;PWJJZK]I2P@"G7EOV82@$P^7L]
M.N>U%V&AUCZ_I"6XG;4K583$9@YD &P'!;/IGBH)?$%K+;Q2Z;>V%P&NDMW+
MW 4 GJ >[8Z#O7#MX0\1'21I\EE:2)%I]U9*PG'[QI) RM@C@8[5=F\+:M_:
M-U+%8Q"&34+">,"51M6%0'./7CCUI:CLCM?[:TOSYX/[0MA+;J6E0R#* =2?
MI59_%&C)-8Q"_B=KYVCM]ASN*C)^F*X[_A'/$4.@7.F_V1IMQ<0&407KN"\Z
M/)NP 1\K8Z[N,@4[1_#NN:?J-K<2::&CCU6:X(:[5W\N2(+N)QR01R/RIZBL
MCLK77+8Z;!=7US9P><S*I2X#HQ!(X;O[^E6I-5T^*Y6VDOK9+AF"+$TJAB2,
M@8SG)%>?Z?X7UFP@@\W38[B-[.ZM'MO-7$)DE+JX[8(.#CD57/@O5;>UNX18
M)=72QZ<D5VSIN?R2#(03R,>_6C4-#TJ*^L[BYEMX;J&2>'_61JX+)]16?X@U
MN718[%HK/[4UW=):@>8$VLV<$Y[<5R]I'JOAN\U'51I4LEF0<6LDL9DC=I>?
M*<<E"#NVGG/ K9\9Z?<ZK9:7'!8/=QQ7\5Q.BN%(C7.>I'/(XH UK'4Y)6:+
M4($LI_,*1(9U83 #)*^ON.U6?M]GB)OM=OMF.(CY@PY_V>>?PKA]7\/W.IZ/
M_9>G:/)INVX:>TNWD#/;N!N+\,2-Q^7&>A)-9]SH&I:A/I[WOAJ<V<]E%;M:
M6]TL0LY$<DYP>4/!!7GBC4-#TEKZT222)KJ!9(UW2*9 "@]2.PJ"^UK3--0-
M>7UO"#(L?S.,[F^Z,>]<&GAW5+C3]6TRZT"(WVR[$.J-,I699<[1_>)^Z#N&
M!MJI/H>KWWF7;^'9D"G33LD:,R2>2Q\SC.,@'UY%&H6/2;?4%EEECF"0E9C'
M%F53YH '( /'7IUJ;[7;90&XAR[%%&\?,PZ@>IK@'\-ZE+8ZW<6NGB'4H-9_
MM'31+M ? 48R.@8!@:CU3PO<KJMK;3:3<W]C/;J#):7"QB*X\PNY?/(!)!W#
MGC%&H:'HTLT4"AI9$C4G +L "?3FAIHED5&D0.PRJEAD_A7&>/M/O]1BM(+7
M3);I?)G'FQ;6:-RF%&&( !_O<D8XZURL#@:NAU&QO/)MS8-<3/$)6MY(T&Z/
M(;Y021G@]31<+'KIGA56+2H O+$L./K3BZ JI906^Z,]?I7E1\-3VMG#?Q:'
M=X.J3F]AA ,TL+,WEL%8D, 2#MJ2/P[>1ZG;VT^GZTVGF*#^SS%,I>V*,2RR
MN>4R<'([<4786/4 Z,6564E>& /2HHKVVG\X13QOY#^7+M8?(WH?0\UQWA&Q
MN[3Q)?2/:S?97B8I/<PF.:-C(28V/20?Q!NH'!K)_LJ>VUBZWZ-.=._MJ6>^
M58<B>)H_W;@#[X#=11J%D>F2S1P0O-*ZQQHNYG8X  [DT+(CQB1&#*R[E*\Y
M'M7$'1]0D^%NK:=<6\D\LL=Q]EMI.7$98F-#[@8_05SDRWHUG3);/3=4M8K:
M:RR1;R',(0A\=D7)P5QDGDT7"QZ=H^JV^MZ9%J%J)!#*6 $B[6RK%3D?4&KU
M>/Z1_;T'AW4;;[#>+J+6TK:=)'&R[(_-)>+G@28R03U!&*[+PJL<6@ZC=61U
M6:&8M+'#<Q>4P.WE8U/(Y'?C- -'0ZMJMMHM@;V\WB$.B$HNX@LP4?ADBBQU
M6UU&>]AMV8R64_D3!EQAL \>HP1S7DT$MY+I>J0-%?\ D316#QH\$O#B8>9D
MMU88^8C XKO_  PNW5_%#LCJ'U#<&9"NX>4@R#W'!Y%"86.F(I:\AB%S;:-I
M]W-?:NMG=W%Q%?2N)93%AF\GY?O*.>H]LU8GU*[M-:TZ/[5JTC6D]K'-+/$^
M^6(H<L%4;0I.,YR<^E%PL>K45Y-:ZCJ,;I!,]U-I_P!LB%]J,3R /$P?&5/,
M;[MH?'&,=*'FU&5HXKC5-3CMUM=0>W=)&5I(T8>26P.3C..Y HN%CU)+6UMF
MEGBMHHW?EW2,!F^N.M5%U_36T ZX+C.G",RF78>%'4XZ]J\TC\1:B^MZ+*;N
M\63S[..[617PRO%\V% V["QY)YW>F*J6J7=KX3N!%=7CP2:3>#4+64ED@D#$
M1A5Q\K9)&.XYHN.Q[-%(LT22QG*.H93Z@T^O,[._OIO%T%H^K3V?D/ ;:U2W
M=A<VQC&>?NX)SD]1BK?C*XE'B5K5=?O-.7^R9;B&*"0 23*XV]N>O3OTHN*Q
MZ#25Y)/J^OI!K&IOJMXLUD;19[8+F.!9(T\YMH&?ERQXZ<U,-<FCEM[2\\5R
M)I=S%/)::E!&<>:&79%N8'?@$D _>Z=J+A8]5HKR^;Q)=R>*E@@U2X*R3S6D
MD3CRV7%N67;'CCYQD,3DDXK)OO$5UJ?AV2!M:N)/^)#;W%P8FVLDPG"N2<<'
M'##VHN%CV"*\MY[F>WBE5IK<@2H.J$C(S^%5KW1=,U"X2XN["WGF085Y(P6
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MD\@MP!C..:L^'I[NY\8WEQ=& &?3+:95A)QAF?KGJ1ZBBX6.PHHHIB"BBB@
MHHHH **** "BBB@!#1110!R?PY'_ !29Z<WMU_Z.>NLKE/AU_P BG_V^W7_H
MYZZR@ HHHH **** "BBB@ HHHH ***J:I')+I-Y'#N\UH'";#AMVTXQ[YH M
MT5Y1!?ZC=0@-<:E;M_9%JLDL\,IB\]7.\-CGG&&(YP<TVWN=3O+FSAO7U?34
MDAC:Q\A'GW.'.\!SZC&-_P#":FX['K-%</XKN+U=8DAE-W%:G3G:QDMMW-WG
M@';_ !8Q@'CK2^%(]0NO$NI7&J7=[]HMXK=3!YC" .T0\S"]#\V?H:+A8ZNZ
MU*ULKNUMIY"LMT6$*[2=Q49//TJ6TNHKZTBN8"QBE7<I92IQ]#R*\P%S/=^(
M],EO3J,>I0WMXMRFV3RXU\MA&5XV@8Q@COFG6>J:O)!X?E:ZNKIVM81-;EGC
MFWES\X.-K],,IY YHN%CTN^OK;3;*6\O)1%;Q#+N0<*.G:K ((!'(/(KR>;4
M9;[P;JTMS/JC:H+5X[^SDC;RXY?,&",CKCH%X(K1N-5U4ZG=+#<7":C%J,"6
MMJ ?+EM"%R<=",;R6Z@@47"QZ/2UY0=;U:*VNI?MMW,+>>WF-["[>6\)F(;<
MA&48+D%>F #4UOJM]K.NV]K!K>H6]O+J5Y&NP;2T:HK1C++TSG!].*+A8]0P
M#UHK@?!.JW^IZL[W>KR2RK$Z7>GM;L/)E#\$D\+QP .".:AL-9U.XU2R,EY<
M"]>_N(+^Q;A(;<!MKX_AP A#=]U%PL=O::QI]]>36EM=)+/",NBYX&<9'J,\
M<5>K@='NXM,^%DM_#>S_ ")*1<(OFO'^\/0'\^?K6)I_B.^O[ZUTW_A()$#:
ML]N6A<.S0&#>/G9>?FZ,!1<+'K-5KF^M;26WBN)TC>YD\J%6/WVP3@?@#7GM
MIK>NMH_A_4DNY[Q+Z.33Y50+\DY8B.4X'^R0>W>NDUV[FTV]\,V_VY@9;P0R
MEPN9@(V))XX.0#QBBX6.FJI9:K8:B\R6=U%,\) D"'.W/3\.#S7F6E^(-1DB
ML3>Z]--'J%OJ F1MBB,1$["I R#CN>M1Z?JUQ9>&K.WM]4EMFAT);NTD^5C<
MS G,9./F"\#;U^:BX['KM9KZ#I,FJ#4WT^W:]&/WVSYCCIGU->>W.N:\;?Q#
MJ+:\UFU@\"):".-EC:1(RP)(R<$G'XU/'K>KV6MS12Z^9[>UUJ*S"21QYDCD
MC#,&P.H)XQZ=Z+BL>F5%'=6\T\T$4T;RPD"5%8$ID9&1VR*\@O?%]_=Z9J2)
MK;E'LXKJ.2-D612;@(W 'R+MZJ22.IKH)_$US;:UJ5K'>QF!M0L[3[4L:Y@2
M2(DL2!R20 ">!FBX6/1#1BO-$\2:Y<7<>G+JJ0[9+Z(77D(QN$A"E9 #QG)P
M>QP:T]3U>[O?!WAS4!J'V.2[NK0SS1$!2&/S YZ T7"QVL4\-PK-#*D@5BI*
M," 1U''>I*\IT_7KC1KN[FBU"VCT^XU74$:-HLJA1"^\D').1T'8TC^*M6OH
MU@.L+!Y6H6(\U FYXY02P;!P!D9QUQP:%(?*>K4M<9XHUS5[+78['3KJVAC.
MEW%XS21;R6C*XQR.#FLZ/Q=JPB9)KRS\ZZM[.>W*Q?<,Q(,:C/S'C()Q[T7%
M8]#[TM><Q>-M633=+U.X6 V=S)<64HCCW,MP&983P<88K@^Y%=%JFL7>FKHE
MC+-!%>ZBYB>Z=/W:.$+$8SU)& ,T7"QTE%<!<>,M4AM-2E!L9)='AADN4BR5
MNM_7RSG@<8!YYXJ6+Q5K/]J#S%L3:'5)-/$>&5_]475B2< C&#Q3N%CNJ0%6
M'!!YQQ7G:^*=9OIM.MS.EE=#4XH;JW> AE5D9L9SAE.WY6'4>E+8ZQJ!U33[
M:S%K912ZG?I<1I&6$WE@D-DG()ZFE<+'H=&%YX'/7WKS74/'.KR^&TN;86MM
M//HTEZ'P6\N1)%7@'L0WZ5LV/B75[O5FMH+:VEM[.XCM+R1Y C9*!C(HSZD8
M7OSS1<+'8\#T%9SZ+;OX@7679VG6W^SA#@H%W;LXQUSWK 0#5_B+J=EJ#;[>
MPM('M;9CA6+[MTF.Y! 7V_&HY]8ET*6]TG2=EP-,LGOY?M4A+,I9L1J?;!Y.
M<<"BX6.R\M/F^1?F^]QUH,46Q4\M-JD%1M&!CTK@I/'>J/.SVNGVAM?M-I"G
MFR,'(N$!4GC P3SZU+'XPURZN+.PM=/L#?2S7<$ADF81AH".1QD@Y_"G<+'<
M>5$7+F--QP2VT9XZ4S[+;X9?(BPP(8;!SGKFN'L_B%<7SZ9(EA&(;N6""1 Y
M9XGD+ EB!A0"O /+#FGV/C+6[P1)_95IY]U'=&U1)V.YX&P0W' ;MZ4KA8[3
M[);%74V\1608<;!\P]#ZT&SMCM_T:$[%V+^['RJ>H'M[5A>'_$S^(+5[RWMT
M^S);(Q(8[A.02\>/]G@?4UD^%+2;Q+X.M-9NM2NDU*]/GM-%,P6(AS^[5<XV
M@#:1WYS3N%CL8["SCD65+2!)$&%98P"!Z U(]O#)*LKPQM(@(5V4$J#U /;-
M<BOCEV2UO%L5;3[Z6:WM'$GSF2,,1O&. VQOIQFLV]\<:K/X7U&XCL(K*Y.D
M+J-J_G;]J-P=W'##J*5PL=_;VL%I'Y=O!'#'G.V-0H_(5D:'X6L]&M[I&$=S
M)<S2RO*\*@D2,6*>XYKF]/U6/P_>7D7D7,ET]O:,%>]9XFDF8J H;[G())J+
M3_$^I:=>:K9RVSWFI3ZE,(+996=41(D8X.,@'=P/4T7"QW,FDZ=+#!#)86KQ
M6YS"C0J1&1_=&./PJUY4?G>=L7S0NW?CG'7&?2N,;QY<K-*DN@3PK +5K@2S
MJ'C$YP!M]5/7GI3$\17MS+&;ZU=4CU\V,1M)]O ! +@CYAG.1[CTIW"QTW_"
M/Z,(Y8QI5F%FE$TBB%0'<<ACQR0:?_8FE>89/[/MMYG^T[O+&?-Z;_\ >]ZX
MK6_&<U[HFO6L,<MA=V]DUQ#+#,&9=LFS!(XW9'0$\'%:_BVXO(-/\/M;7LT$
MDVI6T$K1MC>C?>!^N*+A8W[[1-*U.59;[3[:YD5"@:6(,0IZCGM4#>'-* +0
MV%M%,)//201@[9<8#_6LBQ\:M>ZK'9?V3-$LUQ<VD<K2J0TL.21@= 0#@UC^
M'O$E\8(;F:*ZN]4O;>:Y:S%R/*6.-\;ER/E/10!U[T7"S.UTC3GTVS*3W)NK
MJ1O,GN"@0R/TS@< 8 &/:F7/A[1[R\-W<Z;;2W!*L96C&[*_=.?4>M<Z?B)#
M*ES/9:1>75M;64=])*KHH$;J6 P3G/RD8I[^/5ADF$VCWD<=N]N)WWH0B38V
M-UYY/([47069L_\ "*: 8$@_LFU\I$=%39P%<Y8?0GDT@\)>'Q&T8TJV"M(L
MI^7DN!@-GUQQ6-J/CU+.74K:/3I&NK2TN+F-'D4;Q%P=P_ASG(SU%$7C"&WN
MIYK];J.06-K+]FRK(6E8JH3ON+<'/'2BZ"S-EO"/A]H5A_LFV$:QM"JA< (Q
MRR\=B><5++X:T>8S%["(M-Y>]N=Q\O[ASU!7L162_C>*.Y2R;3+LZ@UVUFUN
MA4[7\OS%.[.-I7H:DN_%^WP4GB*RL9)@Y51;R,$929-A!/L<T7069K1:%ID,
M]M/%:(LMJ&$+C.5W?>^N>^>M5/\ A$-#!A*6(C:$2+&R2,I0.<N <\9/)J"3
MQA:Q7HBDMYEM1="R>[R-B3G'R'OU(&>F:FU?Q3:Z+J-O:7,$^V9XT$V %W.V
MU0,G+'/7'0470:CHO".@P7[7L>FPB=HQ&S')# +MY&<$XXR>:ETCPUI&A2/)
MIMFL#N@C+;F8[ <A>2< 9X%9EMXXM+J]%JEA?J[R7$,1:, 22PY+(.>N!QV-
M:.B^(;;78;::UBE$<]L+C+@ IDXVL.S<'CVHN@U-BBBBF(**** "BBB@ HHH
MH **** $-%%% '*?#G_D4_\ M]NO_1SUUE<E\..?"C?]?UU_Z.:NMH ****
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M%</ME907C^X< \8]*RKSP/&VN:=/9EHK.*:YN+DBX<2%Y5P=I[#N1FNRHI6
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%,
MHHHH **** "BBB@ HHHH **** $[TM%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&B@T4@.3^' QX4;WOK
MK_T<U=9BN3^'&?\ A%&S_P _UUC_ +_/764 +1113 **** "BBB@ HHHH **
M** "BBBD 4444P"BBB@ I.:6DI +1113 **3/-+2 ****8!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHY>R\::U,8C+I%N_VB*[,$4$IW&2!L8)/&&[46?BO5-3U+3(H6L?)E-RMS$
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M[Q1?/XNNKJ)=0BG&CWGV>UDMW18RC#:W(P2<$EOH*]*LM#TS398Y;.RCA>.
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MM]0 9GR(H]^8SZ$$=>].;QQJPTHZ@OA\M!*('MG:8*L@E<*%SZ@$'/3FM_\
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M7=8@T'29;^=2RJRHJ@XW.S!5'MDD<UIU4U'3K35M/FL;Z%9;>9=KH>_^!S2
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MX;@/7%><ZGX7U1QJT,.CQ-Y]]974,T4B ;4V;QSSQM/7KFK"^&M6-TJ2V_\
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MM%<7#GR3D@<E>?;ZUR]YX6\2W]CI\]S_ &,VH:=*I2$*XBN5"%"7;&5)!R,
MX_&M?5?#MY=?#Z30[2#3X;ET51'$"D"?.&('!.,?F:>H:&DGBC1'U/\ LP:G
M;F^\PPF'=SY@&=OUQVJQJ&N:9I+1K?WL5N9/N[SVR!D^@R0,GCFN4E\*ZL^I
MW%TL=GB77(-1'[PY$2(%(Z?>R*T-:T/5W\4+JFFBPN(+BT%G<P7N<( ^X.H
M.>IRIQGCFC4-#:_MW2Q?/9&^A^TH&+1[O[HRP^H')'45!%XL\/SP3S1:Q9O%
M!&LDKB481&. Q/H37-IX/U/=%:2/;O;VNHRZA%=;CYC[U;]V1CCE\$YZ 5D2
M^ ]<.@V]DEM9>8-#.G28FP/,,JMG[O(POYFC4-#T&/Q%H\UE)>1:A ]O')Y3
MNK9P_P#=^M*^OZ3$]JCZC; W0#0?O!AP3@$'W/ ]:XG4/"&MR:W=:I;6MDZB
M[CECM))RJ3)Y/E/DJ/E8=0>:M6WA?6--U("VL=(FT^[A@22!P0EBT3$@HI'S
MCG/;YAFC4-#?MO%%GJDMO_9EQ;/&;R2UE\YBC$H#G8,?,<C\LU>&OZ2?M'_$
MQMA]F&9B9  @SC)]L\9KCT\)ZV+BQC<0>5;:M=7)G67#&*57 (&/O OT]JHR
M>"-;FT6.SDBM3-9:7-IZ,).+PNRX8\?* %R0<\DT:AH>C6FHV5^DCV=U#.L3
M%',;A@I'8XJ*/6=-F\ORK^V?S4:1-L@.Y5^\1Z@=_2LCP]H]WI^OZW>36\4%
MO>"V$*HX/W(]K9 Z<USMQ\/]4-\SVM]#%;V]Z[648S\MO/\ \?"-[Y)V^F*-
M0T.IF\46-B9I=0N;2*U-Q';V\D<V\R,X! 8#[IY_+FG:)XCM]7EN[=_*@NK>
MZE@$'G!F=4(&\#K@YKF[GPQJ:WVK2V]C$\3:G9W=O&957S$B558>QX[]:73_
M  WJ<&M6M]-IT2NNM75U)(LB[A#(A"GWZCCVHU#0[9KZTC>6.2ZA5X5WR*T@
M!1?4^@]Z!?V9G: 74'G(N]D\P;@OJ1Z5Q^OZ=:ZGXXLH;.ZA%T\7E:K !DM;
M [TW>GS# SU#&JUKX4U3[5;6\T2AK75)[S^T PS-"X;"$=<_,%(/&%%&H61W
M7V^SVAOM<&"H<'S!RIZ'Z&H;S6-.L+ 7US>0QVI8*)2XVDDX ![G->6GP?X@
MET.*SGT5"8-*%C@3H=[K.KY'^R5'%=OXLT,W?A#[#IFGQ'RIH9DM555&%D5F
M [ X!HU#0Z/[3;[RGGQ[U7>5WC(7U^GO33>6H7<;F$*#C/F#&:\W_P"$7OVU
M+56N](NIYC]IEMKH72^64E0@1[.NX<+@_+QFJTW@J7[):+'H&,>'I89%&W(N
MR%QGGEL@_-1J%D>F7E]Y%J\MO";QT<(8HG4$$D ]3@8SFK(EC+;!(I;G ##-
M>87?AS41I^H16VC3J9H-/=54J-TT;@R-U^\!U)Z^]2R^'KZ/5FOK;1YO/.NR
MS!PVTM T)7J#PI;'\Z-0L>AW.I65G 9[FZABB#B,LSC&XG 7ZY/2BWO&E:Z\
MZW>W2"38KR,-LBX!W#GISCGTKR6/PYK#6ER9=!NO+*V$RVY5"%>*0^8%&>3M
M[GEJW)=,U%-1GG;2[J32UUEKB>UV F:)H0JL%S\P5^2OXT7861Z064+DD =C
MFD) R20 /6O)Y?"^HFT>&YL;VX']E7BVPW$^4[2[H4//W@.GIZUU6L6^I3:+
MX<9K:>XAAFA;4;<#,C+L(.1_%AB"1WQ1J%C<U76HM*^SQ^3)<7-RS+!!%C=)
MM4L<9.. *OP3">WBEV/'YBA@D@PRY&<$>M>?:=HUW%JN@/>:?<3117UY)"SQ
M[C:P,#Y:N>W/0=JL>)M,OKSQ8/M$&J36$L,7V233RO[F57RVXG[F?E^8=LBC
M4-#O:*\KM?#TS:E:O=:?J)A?4[X7(8OAH&4E,\_<)QCWK-339KI;6TU"#5OM
M_P#8+"%%:0/',LI$;$ \$<8)XQ1=A9'JUCK-KJ&I:C81"03Z?(J3!UP,LNX$
M>HQ6C7EALM;35+^2>TNI+9KVR.H;$(\^)8-KE<?> ?!('45*VG:OI^G6NHVQ
ME::#4)H;*VGE96:TF.U0P)ZJ3N&>0!BBX61Z;1WKRK6-$NX+[5(K?^UC]G73
MQ:R1/+C(;$K+VSMZTR^CU*%[NS":LNAIJ4T;"*!YG56C785!^8IOW<@\'%%V
M%CUFF)+'+N\MU;:VUL'.#Z'WKRNXMM2MKJ^E$NM326<.G&W:7?EGWXD)5?E+
M;?O#I73>#[-;?3-=LX[>>";[?<$AU==VXDJ5)Z@@CD47"QV-4[_5+73#:BZ<
MI]JG6WBPI.7;H..G2O*FU#5&T3R]^MQ3Q:(8G<I*I^TK,O0XY;&>>XK2G\^&
M^DL@]]<6\&NV<L!G#R8!0%B&(^[NSGL*+A8]/INQ=X?:-P& V.<5Y592ZK<V
M=[+=:KJ=GJBI)%=P-:2&%6\SY6R/X<< I_"34B:AJF-.E"W8V2E'LQ-(2_[T
M#S()"/G7_9?^'\Z+A8]3HK@/B)J=[92K'92WT4RV4LT31*Y0N"N  HRS]>#Q
M@FLR34]0_M>XO[?4-1D6/5;6.*%BWE>7)$-XVXZ9S]#3N%CT>34K2+5(=->7
M%W-&TL<>#\RK@$YZ<9%6Z\Q\-7<NH>,-%NKJ2];4!:727T<H8)!+N7Y0",+P
M.,=0*L:]KEYI^NZA9_:KY&_M"Q>!$5B/); DP0,;,YS2N%CT:L^]UK3M/>5;
MNZ6+RK<W+DJ<+$#@MD#UKS1+W4Y!!NU;49_MQU.V>/=]U8PQCVX PW P>^:<
MNI >')+:*_N)K5_"Q<1298^:#ANHSN[8HN%CU:.1)HDEC8,CJ&4CN#TI]<KK
M"WY\#VMWI=S+%/:0Q7.V(X\Y$ +1G/\ >7(^N*QKG5K]Y+7[9J%WIUM?6<]]
M#(,#;)D>7$3C'"'.WN<T[A8]#JO)?6L5[#923QK<SJS11$_,X7J0/:O-)?%.
MKVT-VVI7<UI=/;Z?<10A/XF;;+@8^[ZCM6WXS1YO%/AQ(KZ2S?R[QO.B +*!
M&#QD8HN%CN*8T:,ZNR*63.TD<CZ5Y2OC34)7TF<:J X%FMS&0$4B0D.VW'S9
MXYR M:CZOXBL(M9MO-N;FYT?SKCS7B!6XC<9A' YP,Y _N^]+F"QZ+4-S=6]
MG#YUS-'#&"!O=L#). /SKF?"FJ37=G?3OK-OJ5NJK)#)$A)C!7+!C@!CGG Y
M'2N*E\43:GHNKVUSJ"7,36MM=1,Y7.YI@#P/N]!\N211<+'L-%>;:OXMU32]
M0U3_ $@RJ%D^S&%5DB55*@[@/F5T!).<AJZGP]?7,VH:C9277VVUMQ$T-W@9
M?>N2I(X./;UIIA8Z"BBBF(**** "BBB@ HHHH **** $-%%% 'G/P,S_ ,*K
MT_/_ #UEQ_WV:]'KSGX&_P#)*]._ZZ2_^AFO1J "BBB@ HHHH **** "BBB@
M JM?W,EG837$4(FDC7*QF01[CZ;FX'XU9K$\7:=<:MX2U33[6%)KBX@,<:.V
MT$GWI :0O;;S$B>XA69N!$9!NSC.,=Z7[=:!I%^U0;HB!(/,&4)Z9]*X&[\*
M:D^IWUY%IL32RW=A+%*95#JL0 D(/8\?C3!X1U:3P]?Z;/I5BU^L$L4>H^=S
M=9D#KD8R"<<D]#TI:CLCT)KVUCW%[F%=IVMF0#!QG!_"D-]:;6;[5!M1=S'S
M!A1ZGT%>?-X4U/4-8DNM0T:W^SW&J07;1-,K[8U@,;9&.3G''>HI/!%]!;W5
MS9Z7"+@:PUR84E5#<6O9 W08X(4\9%&H61W.M:W;Z+HLVI/MF2./S%1)%!D
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M<DQ1*A*A?E'8< ?05PEW+?6DOC:00W4MV98#"ML<2&'8H!7O@'?G'/7O3 ]
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MFTZU,EH-MNQB7,0]%]*!H6E+=+<K80"=9C.'"8(D(P6^I'>JWB/7#H%A'=&
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MG'.DZ6D"S(FQ)!& RKZ ^GM3[FUM[R+RKF"*:/(.R1 PR.^#7.:QX@O;+4]
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M'6[:[MV:[FO8(+:T^T;D0F'>Q#8X& 2>*=PL=1;>&M$LY8I;;2[:%H@ FQ
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M1XVGN8?M-ZL(\E%8.=I.U\]%..HYXK,@\?:;,OFM:WL-N89Y8YI(AB3R3B0
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M^?'N+!),?> )./K6KI7B'3-:FN(;*XWS6X5I(R,$*PRK?0CH:J1^,]!?4?L
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MB@!**** /-_@3C_A5ECCM--_Z%7I%>:_ C_DEEGS_P MYO\ T*O2Z "BBB@
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M,E]YQ[GO5["X^Z,8QTHL%SS#[?JT^H6]B=9O8K-KB^C@F0@-/"D89&+8[-D
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M\8P*])VCT&/I2\=<=.E*P[GD%GXLU:Y>[@BUD(LEO;S0-=Y7<Q=@Z%PN(V(
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MH%*1HR9"J3DCZ9YQ2LQW1L6_-M$?5!_*N;T5Y!XZ\4(TTAA1;5E1W)524;)
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MZ33H$\NVN67[4S,6>5%Z)N/..WL*E@\/Q6]QJ*HY%C?GS)(%)4K)@!BI'0$
M9'K18+G&P>(+JUT34]:MWN39:?JXA@28DEX69%D3GJ S'!ZC%>F5CWF@07-O
M8V$:QPZ;:R+(8$7[Y0Y5?IGD^N*T+.R@L(Y([=2JO(TK L6^9CD]??M32!EB
MN&U2]O[7Q/XD>TN)-UOHR301/(?+5R7RV/7Y1^5=S63<^'-,N[N]NI86,U[;
M_9IV$C#='_=Z\=3T]30T"(O"UJ\6AVUS,[M<74,<LH,K.NXJ,E<],]3[UR?B
MK7=9:37+:+9%'I]W8"W:&0H[^8ZDACTP0<5Z!9VD5C90VD (AA01H&8DA0,
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M 8SBF[@K'::7<7=S9^;>1P(Q8[&@D+*Z=FY QGTIJ:YI3QW$B:A;,EN0)2)
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M ' $ D9/04M<9K%A>R^-+6YM[6>>/=$LJS)^Z"@G+HX.59<\J1AN*Y;^S?%
MLK2UM=,O4O+6PNK=YFD 1V\T,J@Y[H" W;-%V%CTV[U>UL]1T^QEWF6_9UA*
MKE<JNXY/;@5<DE2&)I975(T!9F8X  [FO.VTF/4K[0YDT#4;73S=S23V\^<I
MF K]T'Y5+<>_6M*WTR]O/A-/I=S;3->-8RQ""?[Y/S; <_A1J&AV<<B2QK)&
MP9' 96!X(]:=7F%IIMY)K%@MWI^LQ0I':O9&VPB1!5Q)')W3G)(_B!IMAX<*
MP:(\]AJGF2ZC-]KS))_J?WFW>-W"\K1=A8]1JN+M3?M:>5-N6,2>84.P@G&
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MWG1H)H&!O!&LT2W&X@+(1]U",$'\S6O/XYT_3':UOTNI)K:*![N>WA+0H).
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MM[_95R7:.T7:!"S'=D-C<<-R 3Q5E?"UP\FG37NMW5W<65Q]H$DD:@.=A0#
MX P23CJ:98>(=6U73HM8L=-BDTZ>4"*,R$3-"6V^9C&/?;Z5L'7-+$LT9OX
MT"L\@+XVA?O'\._I1H&IB0>"8XHK*)]0DDCM;V:\VF)1O,@8,I]!\YQBH(O
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M2L35_!M_K4E]?7-U;+?SQ16\**&,4,22"0CU9F(Z\=J[*.>&:/S(I4>/^\K
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M0+LY#_A$M??PT=)FN=*=X$B@MYEB96>-'# N>QP.@XR<U/JWA75=2_MP"6S
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M%-5E8?*00#C@]Z$K W<=1113$%%%% !1110 4444 %%%% "4444 >1_L[_\
M)/KG_K^?_P!!6O7:\B_9V_Y)_=#/2^?_ -!6O7: "BBB@ HHHH **** "BBB
M@!*R/$=A>7UE;?8!"TT%W%/LF8JK!6Y&1T-:]&<#FD!Y[<>"]5O!'$XMH5-_
M>3R2)(2529&52..6&[D>U:WA7P]>6%I.FJ6.F02O MLSV18M,J@C<Q;H,=%[
M<UUE%%AW.4\/Z7KVA:7;:"HM9;2U.R*^+G=Y.> 4Q]\#C.<<9K&/@S6#IUO8
M2?9W734NQ;3^9AK@S*RJ&X^7&[YNN<"NXU/4[?2;%[RYW^2C*K;%R1N8*/U(
MJS)-'$Z+)(JM(VU QP6/7 I:!=GF]UX,UM[:XCAM+%6;2+.Q3][CYXWW.>G
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MNA J/5/"FKWVJ:O]DB2UM;Z*XCE#RB2.5FCVI(JD9C?. V."!78/K-G'I/\
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M:EU#(V0 0<LVW VG&-O7FHK71;IWMSJ&A7\VGPZK),\4L*Y,;P!00BG&-PY
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M]ZH6L-P^G6!ENM8S/IE[)/F67+.C_NL^A';U]Z]@,T2S+"9$$K E4+#<0.I
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M.M>G-!;NX+Q1,VW:,J,[?3Z4W[%:^2(?LT/E*<A/+&T'UQ18+G(^)'GN-/\
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MI1J&AD2?$6231I[RWT:=)39K=VR3R*!*I<(<XZ$$CZUNV7B9;OQ#+HXLW6:
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M&@W]S'!;:@C22*[+E64?)]X9(P&&.1UI@\:^'MK$ZG$N)$B*LI#;G&4XQG#
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MYR".E3_\(=?1W5C<6<>GZ?-%L+R6FY4V[RSQM&>'7!X)P0233U#0[2ZNX+*
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MX,#36Z^;A9@!V(S^=89\)ZW=:U%J5Z--_P"0C#>M'&6. D)C*Y(Y.3G-4_\
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M)=;ETT(+=>$";@PSSN!]?QJ&'QSJ][#9VZZGIUG,UL\HNKD82X=92A4  \X
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MFS/_  CVN>GVM/\ T"O<*\/_ &;,_P#"/:YZ?:TQ_P!\5[?0 M%%%, HHHH
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M:A"D,O\ 9]I>6US;W#,Q7S$4ASP=W/T.376:=XFU#4M;:*#3 =,2YEM9+AI
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M[;;7 @OVA6.5L [I,@#;UX(P3V-0VGBD-I4T-LE_<WSR785960.@B8ACG[N
M< ?A1=!9FN/!N@_89K-[$26\L?E;)'9MB9W!5R?E /(Q6AI6D66BV8M+&(QQ
M;BQW.69B>Y8DDGZUD:3KDT7@+3M7O5DN9GMHWDV@ DM@9/8#G)/UK'OO%UQK
M T:'2(ITBOKJ>WFDCD175HU;A2>",C.?047"S-6;PDE[XOO-5O2)+.>UAA$
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MXP<'(HN@LSJM/TJUTV*58%9FF;=+)*Q=Y#C'S$\GCBJ&D>$=&T1[EK&V=5N
M5:-Y6=$4G)5%)PJD]A3M \1QZ\UPBV=Q;M!M.9%^1PPR-K="?4=JJKXSLA',
M]Q;S6_V>::*X5R,PB-=Q<X/W2",>N13T#4FN_!VBW>G6-B+>2WBL/^/5K:5H
MGB&,$!E.<$=139?!FD2^<"MP%E>!V G; ,/^KQ]/U[U6B\;VTUI/-'87A:&1
M4(*A5PRE@V\_+C Y]#Q4FG^-K/5-2L[.RL;Z7[3;)="81C8D;$@%CGU4BE=!
MJ:=EH5EI\%]#;^:L=[*\TJF4G#/][;_=]>*ST\&:6ES;W)DNY+B"9)EE>8EF
M**50,?X@ 3U]:75?$$6D:M=>>UT\5OIYNF@CB4@J'P6!SDGVJWHVOP:U+=PI
M;W%M-:LN^.=0"5895A@G@B@-3)E^'6B30&%I=0"%&C?;=,"ZL_F8..N&Y%7/
M^$.TPRM(9;MG-ZE\29R?WR#:I^F!TIJ^,]-^U06\B3PR2WLEC^\4#;*B[L'G
MH1R#WK+@\:M#KEXMW#=-IY6V:(K /]'$N1ESGH3CUZT70:FWK?A73O$$HEO#
M<J_D/;L8)FCWQM@E3CMD U77P5IL8)2:\+?:H[S+SDYDC4*N3Z8 XJ*W\4P1
MI=+NN[ZY6\GA2!855QY?+ #." ._4YJK;^,7A\0W\-U'<O88M6A*V^#;B4?\
MM._WL?2BZ"S-C0=*EM)[[4KVWMH=1OW5IQ;DE<(-J\D DXY_&B[\+:;?'51=
M":5-35%G0R' VC"E?[I'J.]/UG6WTN^TJU6SDG^WW!@WHP B^4G)SUZ5@Z#X
MZA.DJVM>='<1PS3//Y.V.14D*';SU'RTPU-6+PA8QFR9KF^FELW>2.::X+N6
M9=AW$]?EX%0KX%TM+1+9)KU8DL7L /._Y9.<GMU]ZT='\0V6MQ73V_F(;5]D
MPD7&#C.0>A&#U!K,7Q[I4D-Q-'#>2QPQ>?F.+=OBW;2XQV'7'7'.*6@:DR^"
M],6X\S?<E&6%9H3)\DWDC$98>V!]<<U!)X!TE[EYA/?(&,Y6-)R$3SAB0 8[
M]:L7'C/3H+6VN$@O+B*[G-O;-!%N$S!<@KST.#@^U53\1- %O%/YDV& ,B>7
M\\/S;,.O7(;@@9Z9HT#4N3^$+"YM+6TEGNFM+>**(0-("KB,Y4GCKP.1@U4_
MX0'3!9WUDEWJ*VEUD+;BX)2 ,VYA&"/ER?K[5-'XXTF2[,!CO(P))HO-> A-
M\0W,N?7 R/6G#QMI)L(KO,VR?F$;1F4;=Q*\X( ]_;K1=!J+<>#K&YN)YWN+
ML23W4%T^)!C?$,+VZ<<CO5=O 6F-97EC]KU 6=SNVVXN/D@W-N;RQCC)]<XS
MQ6I+XBL(O#G]O9E>P\H2[EC.X*>^T\\=ZB_X2K2_.NX@\C26DJ12HJ9.67>I
M '4;><BC0-2O/X.L;BYFN6NKQ9Y)X;@2+( 4>)=JXX[KD&M#5-$BU2>SN3<3
MV]Q9ES#+"P!&Y=K#D$'(K/B\;Z/*DIW3(\;Q(8W3:Q,@)3O@9 /7%7=3U58/
M#-QJB2O;*L/F;Y("YC'J4ZG'I3T#4H0^"--M;Z*YLKB^M L:13103E4N F=I
M<=SR>1C.:;KNC7NI>*=(N8'E@MX(+A)9XG4,N\*  #G/0\]JG;QAI4-Y]CED
MF\Q'BCDD$+;%,@RA+= &I9?&&E11RRL;@PQQM)YHA8JZJVUBI[X-&@:F?)\.
MM),Z/!<WUNB-!(L4<HV[X?N-R"?KV.<U(/ EF@C:'4+^*XCFGD$Z.NXK,<R(
M>,%2>1QD5=OO&&D:=/+!.\YECG2W*1P,Y+NF]0,#G(J)?&^C-+-&6N4:%A&Y
M>W90)#C"9(QN.X<4:!J23>$[.7PK;: +FZ6"V\ORI0X\P%""N>,'IT(P:@L_
M!5K97-K,E_>N;:[EO$$C*1OD&'!XZ')X[9J'4O'%C_8%U=Z4[W%TD4S+&(68
MQF/AMX'0 \?RKI;*8W-C;SMC,L2N<=.0#1H&IS$?@"SMOLK6>J:G;2VQD6.2
M*4!O*=MS1'CE<\@]1ZUM:5HL>E7=_/'<3R?;)%D9)""$*J%X.,] .N:JS^,-
M(M[BXAEDF4P1RR%O);#B/[^WUQFD@\8Z-<PRR1S2@QB(A&A97D$GW"H(RV[G
M&/2C0-2N_@R$ZD]W%J-U$CZ@NHF !2OFA=IZC.#Z9JO!X!AM7AGMM8U&"Z22
M8O/$R@R)(^]HV&,8W=#U'K6AX8UR;6-)N[RZ01^1=SPXV%"%1B!D'H<=:KV7
MB1[U-(N'EAMH]2DD:"%HF9Y(U4D<CA6P-W/;BC0-31U;0XM6M[&%KB:);2XC
MN$*$$L4Z DYXK!@^'RVLXEM]>U)&1)8T_P!6<([A\'*_-R.IR2.#5O3/$3:B
M=,C@U.UEEO+6:5/]%D02E6QD9^Z!T(/-:%AXA@O- GU0QN/LWFK<0H-S*\9(
M91Z]./J*- U,_2O!%IH]_97EK=SI);^?O1541R"5@S#;C"@$# 7%-UKP/!J]
M[>7$>IW=DE\(OM<,(0K*T9!1OF!P> #CJ*J0^/[;[?!-=*\&EW.FI>1EH7,B
M$OM)?&<+TYK=/BG1QK,>E&\7[5*YCC&#M9P-Q4'IG'.*+H-3&B\&-H^H_P!L
M6=]>WD]N]Q-%:.8P)/-Y9"Y&>H&"3QTK7\+:,NC:2T9@6"2XF>XDA5MPC+G.
MP'T'3THU/Q3I>F:FFEW%PZ7TL>]$$#N-I.-Q('3/6JL7C+2K?2K6XO;]93);
MK</+! ^P(3M#D8)52>.:- U&V/@NVT^XA,5Y,UM:32SV=NR@K!))G)!ZD#<V
M >F:U- TC^PM%M]-^U27*PY"R2* Q!)/...]9&G^,K9]7OM-U!UCN([QH+<)
M&^'&P.H)QC>03QWQ6QH.LPZ_H\&I6\4T44V=JS)M;@XZ4*P:FE1113$%%%%
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MHH$<>WP]LF2-#JFIX1(4/[X?-Y+9C)X[>G0U9E\#V,URUR]Y>?:)898+F59
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M,U_GGSHN,^S5[M7@G[-0_P!&\0'_ &X?Y-7O=,!:*** "BBB@ HHHH ****
M"BBB@ HHI* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D&<<\4M% !1110 4444 %%0W?V@6LOV3R_M&T^7YN=N??'.*Y
M"U\0:Y=?#RUUI&LQ>Y)G+(=A42%3M /4X[FE<#M:***8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 (:*#12 \$_9J(\CQ ,?Q0\_\ ?5>]
MUX#^S5GR_$ R,9AX_P"^J]^I@%+110 4444 %%)2T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!#<VXNK62!I)(Q(NTO&VUA]#V-8"^!],3P\NAI<:@MBKEPJW
M3!NN<;NN,\X]:Z6BBP#(8A#!'$'=]BA=SG+''<GN:?110 4444 %%%% !111
M0 4444 %,$L9?8)$+?W=W-/KSN'1-=LM2\475M9L9KRXDDL&W)B-O* $F3R#
MD8V^^:3 ]$HSCK7"/I/C!2/L^J7'R:8&7SI$.Z[)^8'CH!T[9Q20:9XIO+UE
MU*>Y_LH6LX$*2('E);"*Y]=I/(]J+CL=WN7CYASTYZT!@1D$8]<UR-WH]U'%
MX2:UM)?*TV5?.B,@,B)Y17DYPV"1FJ-YIWBH:YY5MO72/)"&)'0*2R2;_?[Q
M2BX6.\R",@Y!I:\KM+'Q];>';*RCBDM[BUC*GRIT99 %78/FYZ[LUI36WCZ9
MKL17*Q.KATY78Q\WA5[A?+//N*5V%CT*D) ZD#-><WUI\08M.TT17?FW:&3[
M28=@5L,HCSGU7<2!W-7/&%EXDO\ 6[--/BD>TBDAFA*.%175FWF3/)&-N />
MG<+'=45Y[9CQP;JQ%VURMIYP\YT\LR!M@SD=#&7W#UP:H@_$233IHG6YCN/.
M0*ZF+)4&3<0?3_5TKL+'J.:*\VT\>/A=6,5W).ML+EC-,4C=R-BD*0"/DSO&
M>HXI-.A\<S7%F-2:[$*7L$LFQD!V$/O4XZJ#LXIW"QZ517G>K:AXJE\2ZW;Z
M)++)]D4!(2B>6 T!88)Y+;\>U+=-XSTY5?[5)/%';"5YI$3 ^1S(& 'W@VW;
MBBX6/0Z*\RT2\\;WL>CSO-<'3[AUE>=H$,A!C4X9>,(6W#/4<4^>+Q=%8:;=
MWNKW5JWDW+W,A6,1P28_=!P!RO\ C1<+'I5%<7>S>*Y/!5A/:AQJ]Q-$UPL8
M4F*,_> R,<5D)??$)MX:SE7.FD [(\BY 7!'XD]:+A8]+HKS19OB!!;W",)Y
M.5 D,49=5\T@E ,9.S!P:] T^XFGMSY\$L<D;>63(H7S, ?. "< T)A8MT44
M4Q!1110 4444 %%%% !1110 E%%% '@/[-/W?$'_ &Q_]FKW^OG_ /9I(_XJ
M =_W)_\ 0J^@* "BBB@ HHI,T %+29I: "BBB@ HHI,T +129H-(!:*04M,
MHHHH **2EH ***0&D 4M)10 M%%)3 6BBB@ HHHH **** "BBB@ HI*,\4@%
MHI,\44 +1244 +1244 +13<\XI><T +124M, HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $"J&+!0">IQR:, C!%+10 @
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M9Q0 [--8D"EW#'%,9ASGI2 >/THSS30X].*,C(.:+@.S2Y]*9N'-&X?3VHN
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MU3]<_P"-0-?RAU&U.?K_ (T44,"-M3F4MA4_7_&HI=8N @^2/T[_ .-%%(9
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D$_C29/J?SHHH ,GU-)FBB@ HHHH *6BB@ I*** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>gtbp_ex1017011.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ J<# 2(  A$! Q$!_\0
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M>B@#F/\ A77@W_H6M,_\!UH_X5UX-_Z%G3/^_ KIZ* .8_X5UX-_Z%K3/^_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BC-)0 M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!Q7PF"GX6>'\?\^Y_]":NTP*X
MSX3-N^%GA_VMR/\ QYJ[/K2 *6D'O2TP"BBB@ I*6DS2 6BBB@!,TM)BB@!:
M**2@!:*2EH **2EI@%%%% !1112 ****8!1110 4444 %%%% !1110 4444
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MWFT2[NY8[ZSFM+D2"0Q0)MRC,2#N7#9]<YHU'9'I]S?VUI)%%-,BS3$B&,L
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M;LSV2-F:"4/CD8&T <$'O4WB75]8M_%D-AIUZL4:Z;+?&W\E7:9HV'R9/(#
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M&I7]]_:EOJ+PR36-ZUN)8DV!UVJP)&3@_-C\*+A8WL@'KUZ4T2(S,JL"R_>
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M8A;FWEA" S?ZV%T+&4<= %;(]1BJ3_$.9-,EU+_A'[Q[+9%+!*#M$BNX0#+
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M,<YC.,Y]3Q^IK%_X5YIPTRXTY-0U1;.1U:.$W.Y;<!@^V,$<#('KTQ77T46
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MK=% %/\ LG3?W/\ Q+[7]RYDB_<K\C'JR\<'W%2W5E:WJ*EW;0W"HP=5EC#
M,.A&>]3T4 9_]A:1MD7^R[+;(FQP(%PRYS@\<C/-/&D:8+L78T^T^TC&)O)7
M>,# YQG@5=HH R[_ $F34-4LYY+UQ9VYWFT"#$D@/RL6Z\>E69-+L);]+^2R
MMWO$0HL[1@N%/;/7%6Z* ,I?#&A*FU='L57T$"COGT]>:U    .@Z4M% !11
M10 4444 %%%% !1110 4444 <G\,1CX9^'O^O-*ZRN3^&1_XMIX>S_SYI764
M %%%% !1110 4444 %%(*6@ HI*6D QHD?&Y%;!R,C.*/)BY_=IR<GY1R:?1
M0!&8(F!#1(<G<<J.3Z_6D-O Q):&,ECDDH.34E+0 R2*.4 21JX!R-PS@T-%
M&TBR-&A=00K$#(S[T^B@"%K2V>,1M;Q% VX*4& ?7'K4N 3DBEHI@,\M-RML
M7<HPIQR![4^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MBD 4444P"BBB@!#2T44@"BBBF 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <G\,_^2:>'N<_Z&E=97(_## ^&?AX9_Y<U_K76T@%HHHI@%%%% "&
MBEI* "EII[?XTH/K2 6DI:2@!:2BEH ****8!1110 4444 %%%% !1244@"E
MI*.^* %I*6B@ HHHI@%%%% !1110 4444 %%%% "4M%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HI:* "BBBF 4444 %%%% !1110 4444 %%%% "4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!RGPU&/AMX>_P"O)*ZNN2^&9S\-?#V<_P#'DE=92 6BBBF 4444
M %)2TE "T444 %)2T4@"BBB@ I#[4M% !1110 4444P"DI:*0!1113 ****
M"DI:*0!1113 **** "BBBD 4444P$I:**0!1113 **** "BBB@ HHHH ****
M "BBB@ HHI* %I*.<44@%HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <E\,U ^&GAX?\
M3FE=8*Y3X9@#X:>'@,X^Q)75YYI +1113 **** "BD[TM !1110 4E+12 *2
MEHH **** "BBBF 4444 )2TE'6D M%(*6F 4444 %%%% !1124@%HHHI@%%%
M%( HHHI@%%%% !1110 4444 %%%% !1110 4444 )1VI:*0!1113 **** "B
MBB@ HHHH **** "BBB@ HHHH *2EHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .4^&XS\-_#V/^?)/Y5U/:N7^&PQ\-O#P_P"G
M)/Y5U/ I %+24M, HHHH **** "BBB@ HHHI %%%% !1113 **** $I:**0"
M=J6DI: "BBBF 44E+0 444E(!:*** "BBDH 6BBB@ HHHI@%)WI:*0!1113
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M***8!1110 44E+2 ****8!1244@%HI*6F G:EHHI (!BEHI* %HHHI@%%%%
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MX<\?#GP]_P!>,?\ *NHSD5S'PZ)/PY\/9_Y\8^GTKI\8I  %&.:6BF 4444
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MNH%/O(!5<ZUI8./[1M2?03*3_.HX?#VC6Q)ATNT0GJ1"N:N1V5I#_JK6%/\
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MVEE#Y"R>S-DL1[ BNBMK:&TMH[>VB2*&-0J1HN%4#L!67]DU_G.KV@^EG_\
M9TW[)XBQ_P A>RS_ ->1_P#BZ -NBL+[)XFS_P A:P^GV)O_ (NG);^(QC?J
M6GMCKBT89_\ 'Z=P-NDYK&%OXCR<ZCI^/3[*W'_C]*(/$.?^/_3\?]>S?_%4
M"-FBL<P>(,<7UA^-LW_Q5+Y.O9'^FV'O_H[?_%4 :]%9!A\08.+S3\]LP/\
M_%4P1>),\W>F8_ZX/_\ %4P-JBL;R_$>/^/C3/\ OT_^-.">(>,SZ:?7]V_^
M-*X&O165MU_'^MT[_OA_\:3;K^!^]T[/?Y'_ ,:+@:U%9.WQ!G_6:;C_ '7_
M ,:3'B+/#Z8?PDHN,UZ*QS_PD>>&TO'TDI/^*DY_Y!1]/]91<1LT5D ^(N,K
MI1]?FD_PHSXAQ]S2_P#ON3_"@#7HID7F>4GF[?,Q\VSIGVI], HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?A\#_ ,*]\/9/_+A%_P"@
MUTHKG/  V_#[P^!_SX1?^@BNC%(!:***8!1110 G.:.]+12 **** $I:2EH
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M)+>VD\L5H;T^6\>U&!?Y?O D@<=^M7[?XA-<S:2Z:;BUOWABYES(CR!NH P
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M/4&MB_T(73L\-Y=6\CW$4S&.9@!Y?\('0 C@CH:GO=$M;_5=/U&9IO/L&9H
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M &?#_P"@"NA K!\#Y_X030,C!_L^'@?[@K?I %%%%, I#12T ,!]J?2=Z6D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW"%MA,,2'<TK=@H'7)K ^'^G7:^'[/6-;N$:XF5ID3HL?F-N+$]W.0,]AP*
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M* "BBB@ HHHH **** "BBB@#&\*QF'PCH\9 REE"#C_<%; .:QO"9+>#]%+
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M<QN-RG&,B@!ES=P6<1DN)5C4 G+'T&36++KSWWA&]U*RBEMYE61(UE4;E8'
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M .,T#P9%!HUK*=3U:&ZF033M'>M\SMR<Y_+\*[)%VHJY+8&,GJ:6B@ HHHH
M**** "BBB@ HHHH R?#2[?"VD+Z64(_\<%:HK-\/<>&M*!.2+.+_ - %:=)
M)2TG>EI@)2T44 %%%% !1110 444E(!:2BEH **2EH ****8!124M( HHHH
M****8!1110 4444@"BBBF 444E "T444@"BBBF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9GAX@^'-
M+*]#:18_[Y%:59^@J%\/:8HQ@6L0&/\ =%:%) %+113 **** "BBB@ HHI*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 4])&-&L0#D?9X^?^ BKE5--Q_95G_P!<$_\ 015NA %%
M%% !1110 4444 %%%% !1110 444E(!:***8!1110 44F><4M !1112 ****
M$ 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHI* %HHHH **** "BBB@ HHHH **** "BBD^M "TE+10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5TT8TNT'_
M $P3_P!!%6JKV/&GVW_7)?Y"IZ %HHHH **** "BBB@ HHHH ****0!1113
M**** "BBB@ HI*6D 4E+10 E+110 E+113 **** "BBB@ HHHH **** "BBB
MD 4444P"BBB@ HHHI %%%%, HHI* %HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *]E_QX6PY_U2_P A5BH;3_CS@XQ^[7^534@"BBBF 444
M4 %%%% !1110 4G.:6BD 4444 %%%%, I*6BD E+24M !2=*6B@ HHHI@)12
MT4@"BBBF 4444 %)2TE(!:3%+13 **** "BBB@ HHHH *0>XI:*0!124M !2
M4M% !124M !1113 **** "BBB@ HHHH **** "BBB@ HHI* %HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&V/^B0]
MOW:]?I4M1Q<01@]0H_E4E "T444 %%%% !1110 4444 %%%% !1110 4444
M)2TF:*0"T444P"BBB@ HHHH **** "BBB@ HHHH 2EHHI %%)SFEH ****8!
M1110 4444 %%%% !24M% !1110 44E+2 ****8!1110 4444 %%%% !1110
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M*2EH ****8!1110 4444 %%%% "4444@"EI** %HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 1H,*N#V%/I !M'L*44@"EHHI@%%%% !1110 G>EH
MQ12 **04M, I/PI:* $&:*6BD 444E "T4E%%P%HHHI@%%%% !1110 4444
M%%%% !1110 4E+24@%HHHI@%%%% !1110 4444 )2T4E "TG-+10 W%+2T4@
M"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U3D#Z4N<"FK]T ^E.%
M( !R*6BCM3 **** "BBB@ HHHH **** "BBB@!._6EHHH *0TM%( HI*6@!*
M6BB@ HHHI@%%%%( I#2T4 %)1CFEH ****8!1112 ****8!1110 4E+12 **
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M W' IU(.E%(!:3%+1VI@%%(,]Z6@ HHHH **** "BBB@ HHHH **** "BBBD
M 4444P"BBB@ HHHH ****0!1110 44G>EH ****8!1110 4444 %%%% "4M%
M%( HHHI@%%%% !1110 44F!2T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% "#I^%'>C' HI +124M, HHHH *0\C I:* &]%^E+12T@"CO113 **
M** "BBB@ HHHI %%%%, HHHI %%%%,!*6BBD =J0&BC^5 "T444 %%%%, HH
MHH **** "BBB@ I.]+12 ****8!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 G:EIH_I3J0!1113 **** "DI:2@!:*3O2T@$
MI:2B@!:**3/- "T444P"BBBD 4444 %%%%, HHHI %%%%, HHI,T@%HHHI@%
M%%% !1110 4444 %%%% !1110 4444 %%94VN1P^(K;1VM;C?<1/(D^T>7\N
M,KG/)YJ'3?$#7NL3:7<Z;<V5PD(N$$I5@\>XKGY2<'(Z&E<#;HHHI@%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 Q<_C@4[FD&,?A2@YZ4@
M%HI*6F 4444 %)2T4 )2TE%( HI:2@ H[T44 +1110 4444P"BBB@ HHHI %
M%%)0 M%(>HI: "BBBF 444A.* %HHHH **** "BBB@ HHHH **** "BBB@#"
MO]*U2Y\3Z=J,-U:)9VBNIA>(EVW@ _-GCH,<55\.:%J^EZGJ%YJ=]:WKWC%F
ME2%ED !^1.20%4<8'UKIZ*5@N%%%%, HHHH **** "BBB@ HHHH **YKQOJU
M[HVC6T]@^V:2]A@( 4EE9L$#=P"?6LRX\;R:7)=6S6_V\6-@;ZYN1,BX7+#9
M@<%@5P2.*5QV.XI*X6;XD+9';>Z3)$PB61E2=7(WHSKCCD;4.3V)K6T35]5U
M74HYYXX+6QGT]9X[;S%>56+<,2.Q7';K1<+'2T5Y]I/C6_7P9;Z]J6V9E%P9
MXHE";MLNQ1ST]ZC@^)2S^(M-MGB6"WO89%6&1AN\Y)BG#],8!^M',@LST6BN
M M/BI87=OO&G7"R'YEC,BG*!&<MGM\JGBK%I\2K&\UH:7'IUX+AM^-P & H<
M?FAW?A1S(+,[>BN.TOXAZ?J7A_4M7-K/#%8*C.C%26#J"N"#WR/I6=8?$I(V
MFBU6U<2I=.C>3@B&+S B9Y^8YZXHN@LST*BN)?XE6$5E:W<VG7J172M) ?E.
M] RKNZ]]XJ-?BAIGV][>2QO(XUE,9G.TJ,,RYP#G&5-+F0<K.ZHKAS\3]+2&
MQFDL-02*\R8V:,#Y-RJ'Z\@[QT]ZNP^-HV\.SZQ-I\ZI'?-91Q(RLTA$GE@]
M@,FG=!9G5T5Q2_$S26$K"SOO+@@$T\@C&V++% IY^\64CBAOB9HR3(DEO>(H
MXN)"@*VYWE,-S_>&.,T<R"S.UHKCH?B+I]R;=+;3=4EDN%D>-1 !E$QE\DXV
MX(YJ;P_XZM->FMK;[#=VMU<0+<)%( 08VSAP0>1Q@^Y%%PLSJZ*X^;XCZ+!<
MZC!)'>!K L)&\GY6*L%.#GL2*CNOB?H%JPRE]*AC23?';DC#)Y@[]=N3^%%T
M%F=I16+I'B?3M<OKJUL3,YMP-TC1$(WJ W<@]16U3$%%%% !1110 4444 %%
M%% !1110 T?=&?2BE[49I +124M, HHHH **** "DHHS2 *6DH/I0 M)110
M&BBC- "T4E+0 444E "TAHS2T %%%% !1124 +1124P%HI,T9I %+3<TN:+@
M+249%% "T44A- "T4F:6F 444E "T4FZC-(!:*3-&13 6BDSFEH **** "BB
MB@ HHHH **** (KBU@NX_+N88YD!#!9%##(Z'GO4*:7811M&EE;JC)Y;*(@
M5ZX/MR>*MT4 57TVQE</)9P.P3RP6C!.WIM^GM3TL[:.<3QV\2RB,1!U0!M@
MZ+GT]JGHH J#3+ )-&+.WV3$M(OEC#DG)R/K3&T72WQNTZT.WIF%>.=WIZ\_
M6KU% &:?#^CF,Q_V7:;20Q A49(Z=O<U9_L^S\UI?LD/F-]Y]@R>-O7Z<?2K
M-)SFD!0M]"TJTMI[:WTZVB@G4++&D8"N , $=^.*BB\-:)!Y/E:7:IY+%H\1
MC@GDG\^:U:*8&,WA/0'CAC;2;4QPN7B79PA)R<#Z@<4J^%=!6;SAI-J)-_F;
MMG\62<_F2?QK8HH Q#X0\/M;PV[:3;F*'/E*0<)E@V!Z#(!Q[4S4O"6FW^CR
M:9&AM8);I;M_)XS('#D_B16]12 R$\,:)'#/$FFP*EQ"()0!]] 20#^))^IK
M/3P'HJZ['J7V=3'%;B&.V(^0$.7WG^\V3WS73T4[!<R+3PQHU@\+6UBB- CQ
MQ$LQV(_WE&3T.!Q4>E>&++2;\7%N (XH!;VL6T?N(\[F4-U()YYZ5MT46 YZ
MY\#>&[N2:2?3$9IG+R'>PW$MN)//<U"_P^\,.FQM,4@((Q^]?A0NP#K_ '>*
MZ>BBP7,>W\+Z1:3>9;V[Q_Z0+D*LSA1(!C=MSCD=?6MBBB@ HHHH **** "B
MBB@ HHHH **** $'3\*/>CM12 6BD)HI@+124M "4M)G-(<T@%X-)BEI#U_K
M0 O:@T"@T % I.]'.:0"GI0*0FD&>* '444=Z8!12TG>@ HHHH 6BBB@ I*6
MDH 6BD%+0 E%%% !2<X-+10 WOCO2TO:BD 44E+0 4=J2CGM0 M%%%,!#12T
MF.]( [4F *6EQ0 "BBBF 48HHH .]+124 +1WI,TM !1129H 6DHHH 6BBBF
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% #1T'TI:8.![XI=XI .HIN_P!:"X!]:8#J*B,O _QIV\=<
M]:0#^]%-#J>XJ/S !V'XTK@34&H?,!7@TOFJ%'I]:+@24A.*C#C/+4OFKDT7
M D[4W(SUIOF#')%,,BXSGM2N!-G- Z<U!YO..:>)1Z_6BX$P-(347F]QBG+(
M".N:=P'YYHW4S<O'I06!/;%%P),T"HC(N0!SBD\T ^V>2*5P)Z*B$H/>E#YI
MW ?13&8#ZFE4@T7 =032;J:Q[YHN ^BF%QZT!^N>,47 ?0:86!Z4WS0 ?:BX
M$GO2]ZB,F>E(90.X_.E<";BBJS3\\$XS3O.'J/SIW GI*B\]<'FE$H*YS0!+
M0.M5VG&.3CZ4"9.N:+@6":3J*B\Y, YZTTS#FBX$XZ=:6H%D'7=D4[S5]>*+
M@2FC-0^:O8_G1YH]>E%P)OQH]ZA\Y<XZ^]+YO/%%P):6HA(#TIV\'CTHN ZB
MF^8,XIOF*!UIW D-(,>M1^:#Q_6G#&.>M*X#Z*;FC<.QIW =FBFE@*3?^-%P
M'TM1EZ"X[GBBX$E%-#<9HWBBX#J2DWCUI-P/0T7 ?12;A2;AC.:+@.HIN\>M
M&ZBX#J*:''J*7</6BX"T4W>/6ER*+@+13,\TH8>U%P'44F:3=1<!U%)GBC-%
MP%HI,B@&BX"T444P"BBB@ HHHH ^9E^.WB[/,>F'@?\ +N?_ (JF)\=O%Y?F
M/3#R?^78_P#Q5%%979I9#S\<_%ID(,6F8Q_S[G_XJI#\<?%848ATSJ!_Q[M_
M\5111=CLAK_'#Q6' $.F8(Z?9V_^*IP^-_BKRV)ATSC_ *=V_P#BJ**2;"R!
M/C=XJ*@F'3#S_P \&_\ BJCD^-_BOG]SI@QT_P!';_XJBBA-W'9#_P#A=WBL
M1J1%IN6ZGR&_^*I9/C7XI$JJ(-,PQ&?W#?\ Q5%%*[%9#6^-GBD''D:9C/3R
M&_\ BJ;_ ,+O\5!O]3IG_@.W_P 5115 TAW_  N[Q5C_ %&F<G_GW;_XJG'X
MV^*1M_<:9R/^>#?_ !5%% K(/^%W>*03B#2^G_/!O_BJD7XU^*&'-OIG3_G@
MW_Q5%%,5D2CXT^)M@/V;3!G_ *8-_P#%T#XT^)C_ ,NVF?\ ?A__ (NBB@&B
M<_&3Q(C)BVTWYE!.87_^+I#\9O$N2?LVF?\ ?E__ (NBBD#0]?C)XDR/]&TW
MG_IB_P#\733\8O$>?^/;3?\ OR__ ,7110%D.B^,7B/D_9M-Z?\ /)__ (NI
M!\8_$G)^S:;P>/W+_P#Q=%% [#G^,?B/R5?[+IF2?^>+_P#Q=*?C'XC4*!:Z
M8,C_ )XO_P#%T447"R%_X7)XC)'^B:9TS_J7_P#BZ&^,?B(E?]$TSGK^Y?\
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M.I*H(M[/)./NO_\ %4I\<ZDI;%M9\?[#_P#Q5%% )$B>-]2(4_9[/IG[K_\
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-2D6#['_&BBBFA'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>gtbp_ex1017012.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 gtbp_ex1017012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .$ JP# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*2EI* /FK]F__D;=6_Z\A_Z&*^EJ^:OV;O\ D:M8/I9#_P!#%?2FX4 +129H
MH 6BBB@ HHHH **** "BBB@ HHI,T +1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1112 **3O2TP"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:0T ?-G[-W_(SZR?\
MIS7_ -#%?21P:^;OV;A_Q4NM'TLU_P#0Z^D._P!:0#J*3G'%+3 *6DQ2T %)
M2T4 %%%% !1110 4E+12 0_3-+113 ****0!24M)0 M)110 M%%% !1124P%
MI#10>E(!N>YIV!FFX':E%(!U%%%4 E+110 4E+12 **** $I:** "DI:*8!2
M4M%(!*.E+10 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@#
MYM_9N/\ Q4VM?]>:_P#H=?2(()KYN_9N_P"1GUGG_ES7_P!#KZ0Z'K2 =10#
M1TI@+1110 444E "T4GTH!I7 6BBBF 4444 %%%% !1112 *2EI#0 M%%)0
MM%)10 M)11T% "TG7K2'CM0* %Q0.*** %HI*6@ HHHI@%)2TE( HI:2@ H[
M444 +1110 4444P"BBB@ HHHI %%%%, HHI*0!2T4E "T444P"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *2EI* /FW]FX9\3:U_UYK_Z'7T@.!7SA^S;_ ,C)K?\ UZ)_Z'7TCUI
M(*6BEI@)12TF.<Y- "T444 %)[TM%( HHHH ***2@!:*** "DQS2T4 %)C-+
M10 4AYHI: "BBDH 6BBCO3 2@4M)2 **.]&: "EI.U% !1110 M)2TE "TE+
M24 %+24M !1113 **** "BBB@ HHHI %%)F@4 +1124 +12=Z6F 4444 %)2
MT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !24M)0!\X?LV?\C%KG_7HG_H=?1]?.'[-F!XAUPG_GT3_P!#
MKZ/P=V<\8Z4 +1110 4444 %%%% !1110 4444@"BBBF 4444 %%%%( I*6B
M@ HHHI@%%%% !1110 4444 %)BEHI )10*6@!**6DQS0 M)12T %%)10 444
M4 +112"@!:**2@!:*** $HHHH .E%'3BEH **2EH ***2@!:***8!1110 G>
MEI,4M( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4E+24 ?.'[-@_XJ#7#_TZ)_Z'7T?TYKYQ_9L'_$]UX_\ 3K'_
M .A&OHX4@%HHHI@%%%% !1110 44&B@ HHI* "EI**0"T444 %%%)0 M%%%
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M+JUN+6[0R0R DAD'5N.@!(&363H?Q"L=1\1:IH]\\%I<6]^;.T&\DW'&0>F
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MOX:ZM-K4U['-8K&^N6^I 9;(CB7;LZ=3UKJO!GAR_P##DNN)=2V\D%YJ,EY
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M4 %%)TI:0!1113 **3'.<]:*0!2T44 )2TE+0 4444P"BBB@ HHHH 2EHHI
M%)110 >U%&,T=* "C%%+0 44E% "T444P"BBB@ HHHH **** "BBB@ HHHH
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MO!\Q!)'39QU]0:+A8V:*YO3/%]E?R:N\DUO':6%PL*3B3(?*!O3KSC'M6O\
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MNKO_ $:1;N>>SGL;[</]$1 F^-N>,8?@<-NKT:WMH+2!8+:&.&)?NI&H51]
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M/#%-$L[C=-*+?=\YZ[FX_'&:Z^BBP7/*)HI76WBAUG5IK,V-]/"PWP[B-IC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ J*XN(K6WDN)Y%CAB4N[L<!0.IJ6J.KZ;%K.D7FFW#.L5U$T3,A^8
MC&1[TF!D-X\T)&*/-,)?.2'RQ Q8LZEDX /# '!HMO'.A7:;XYYP/)DF^>W<
M9$?^L4<<LO=>M4D\'ZD8=-6XU>"62QO([@,EFL8=4! !"GJ<\G]*HW7@V[L=
M,27[8+DV:7[B**$[I3< X4<]B?QI:CT+FH^/;*;0[RYT:<M<VZP2A9X&7=%(
MZJ'4-C*G)Y'>MU_$NEQZA]B,[>89#"&$9*&4#<8PW3?CM7(P>#-0U?PW:-=W
M45O>G3[:U53 1Y:(RNP89R6)4#T&*TQX-E@F=&O ^F+J7]JK"L9\T2_>V!L_
M=W<],]J-0T-6'Q=HDVFP:@MWMM9XWD1W1E^5&VMG(X.3C!ZFJ[^._#<<4<DN
MHA-\CPA#$Y<.N"RE0,@@$'%8-IX.&M:5K<P%UIRZG,LMI!=1@FVVL'.4[!G!
M)7T-:EIX7U*/4M(OKBXTX/9S3231VMKY2-O39\O/7ODYHU#0N:9XF0P6\.K[
M+;4IF.8$1CL5G*QEO[NX =:T==NY]/T#4+VU$9GM[=Y4$F=I*@GG';BLC6/#
M-YJ/B2VU2WN(+5H3'^_CW"8H&RT;<[75O<<=16YJUC_:>CWU@)/+-S \(?&=
MNY2,X_&@#(TGQIHFHV,$G]I0>>QBCD0!AMDD'RCD="<X/3WJVWBK0TB,AU&/
M:)7B;"DE60@,",9&"1D].:YR3P5J4\,=S)<V2ZA;PVL,*JK&)A"^_+]^3^7O
M59O FL/!,6N+%;R2]GNXKN!I(WMVD*G Z[EX.5/!XHU#0Z=?$MA;/='4-2L$
MC2[-M%L<YW!0=C9_CZ\#MBIW\3Z)':6]V^IVXM[D9BDW<,,XS[#/&37.GP?J
MG]I"Y\^S=?[;34FW;@2BQ!,=,!LC/I6;%\/]7M[B*?.DW8D6:&X@N1(8PCRF
M167'4_-@J>#1J&AW+:_I27$T#7\ EA4O(I;H!C/UZCIZU:LKZVU"W%Q:3I-$
M25W*>XX(^M<5<>#-1>]OC&ED+*Y1A+:&1Q'.Q*[7 QF%P%Y*D@G''%:V@P:]
MI4MII]T8[NU?S9))W<F6$9'EJ6P YZ@L>30KAH=%<7$-K \]Q*D42#+.YP!5
M&7Q'HMO;17,^JV<4,I(C=YE4,1U SW%5?%6DW>KZ;;K92(MQ:W<5VB2'Y)=C
M9V-['^>*Y\>#[V37[34I[:TDB?4I;RX@=MPB5HA& N1R<C<>E-AH=WO7;OR-
MF,[L\8JA'KNE36LUU%J%L\$)Q)(L@POIGZU8O8I)=/N8(!'YCQ,B>8N4R1@9
M'I7F</@KQ/!*+Z.*R%Q$;280-<LR3-"&4H?E 4$-E<#C I:@K'??\)-HIO([
M4:E;&62 W*XD&#&#C=GIC-77U&RC60O>0*(P"^9!\H/3/U[5Q-QX2U2XN,I8
MZ=;176E7%E)'$WRV[R-N!''S<GDC'-4#X8\3-="Z.FV8_<V43(+D%_W);<RD
MC ;D8)SQ[T:A9';'7XSXDL]*BC$L=U:/=)<HX*_*P&,?\"ZUK22)%&TDCJB*
M,LS'  K@/"?AC6M*U/1GO;:-(K*UNH7=;@/S)*&3W/ KI/%NF7NJ:1''8[6E
MANHIVA9MJSHC F,GW'\A1J!K"_LS"DXNH/*?[K^8-I^AJ?((R.?2O/&\&376
MIV\MQI<3Z?+JCW;VCNNVW0P[.G0EF^8@<5W-];2RZ3<VUG(()6@:.%QT0E<
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M]<6L&IZ?:!)I;<VD@W3* O[MU7'.>&R3@@TKZA8]"J,S1"983*@E8%E0L-Q
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M4@%HHHI@%)2T4@$ILD4<T31RQK)&PPRN,@CW%/HH 8B)'&J(JJBC 51@ 4I
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MJ9+*A 9U&>1DX]34D?C71IM5M]/BF>1YY/*1U3*[RN[:>XX[XQGBG=!9G0T
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MXV@[20>X!.#CI6A8:A:ZG:+=6<HE@<D*X!&<'!ZT70BS1113 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* /&/V<!_Q1^J'UO?\
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MPGSCBWC,F_;*K("#V[]/QKT;P]H]WINMZY=300107CPM"(F_N1A3D8X.170
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MY25[=CS7;^$;Q[W3KV:34TO8OM<GDD.&:&+^%6/KCG\:UM5TFUUBS^S7/F*
MZR(\+E'1@<A@1W%.T[3+?3(62$R.TAS)+*VYW.,<GZ46"YYA!K>L1Z+IE[=^
M(;E;?49;B*:YEBPELR%A$/E&5W>IZX'K4EUXIU6$M#<ZQ+%?6\ME'; 0>6M[
M'(RAY2I!ZY88SQCWKU78A4KM7:>HQQ6?K6BVVNV0M;IY402)(&A8*V48,.<=
M,@46"YQ$OBJ\&M6.G+J3*XU.]M[E&0$K$J.8BW&!T4@]ZAL=<UR[CTTVNIL7
M70?[0-K' G^D2JV-O3@-T('X5Z88HR22BDGJ=HYH$42L"J(& P, <"BP7/+;
M;QAJ)L;6?^W()K6^F@2XG2,[M.W []Q( 7) 4 _=/-=)X"99?#^J^3=^?G4K
MO;<*H!;YN&P!C/>NM\B H\?E1[7.77:,,?<4]$2-<(JJ/11BFD%SRO1O$FH?
MV1869UMT;^S9[L7LZ*QEG5R#$V>/E')'4Y]JW?%]W/J'PDFO+F 07$]M!(\;
M+D1L70GCT%=D;.V90K6\)4-O *#&[U^M2NB.A1U#*PP589!I6"YYO/XHUNPO
MY=*GU&V>$W:0Q:NR+&BYB+^6>JYS@ ^_K722ZW<V?@%]7NKVQ:ZC@RUQ"K-
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M?N@8/7FM/1;][77=2F%O--9ZGJ9C@EBP50K& S'G[I92,C/2NP2-(XQ&B*J
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MXO &FPG<M[J)8RV\I9YP<M#]SMTQQ19A=$_A.ZN;B37Q-/+,(=6FBB$C9VJ
MN%'MR:H0?$%)[:*;^Q[J/[0\B6ZNPS+Y9(D/&< 8_'(KH=*T6#2/MWD33/\
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M'4G'O4HN8#+Y0FC,G/R!AGCKQ7.:]:RZSX(CCT^R>5Y!!)%#(P1E 93R3T(
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M6-_(L=K.)6>!+E< X,;_ '6S[XIJP:EZBDI:8@HHHH **** "BBB@ I#2TE
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MKV6>R9GCDFN6<L6&TEL]>.*FU?PW9:S=VMY++=6]U:[ECGM9C&Y5OO(2.JG
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MD&GP.\J7UNXV("(U5P2Q&1P .E06O@UH-;M-5.H!ITN)[FY40X$S2($P.?E
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MJ%U+/$D9C5-BJP4IM*[P,[?XMO3-26GA_5;""UBC\17MRT4ZL[W"H=T(&-A
M'Z]<U:/B_0!:2W+ZG$D,3HCLX*[2WW>",X/8]#47_"8Z)YVGQQ79F^WO(D+)
M&Q4%!EMW'&/>C0-2[KVC_P!N:;]D^URVI$J2AXP#DJ<X(/#*>X-85IX#6TR!
MJ]Q(I2Z4!H4&//QNZ =".*TH_&OAJ6%I8M9M9$4X)0DXXSGCL!U/05<F\0:3
M;W<=K+?P+/*NY$W?>&,C'N0,@=Z+H-3FE^'?E1""#6KF.W8V\DR>2A\R2':
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M'VN#R'.%D\P;6^AZ5+-<0V\1EGE2*,=7=@H_,T6079G^(])?7- NM.CF$+S
M;9"N0"&##(].*Y__ (0R\DDFMYKR%K"?48]2<!")%E7!95_V2R@YZ@9%=:UY
M:HZHUS"'8@*ID&23TQ]:5;NW:+S!<1%,D;@XQD=1FC0-3,\3Z+-KNC_9K:Y%
MM=131W$$C+N4.C!@&'=3C!KGM1\(:Q?WMMJ4LFCS79B>&YMYK=C!L8@Y7G)8
M$<YZYYKJ)-81-=L],$+.+J!YDG5@4^4C(_\ 'A5T7,#+N$T97=MR&&,^GUHT
M#5''S>#M0DT[7[=;BT5[Z>&6W8(0%\L(,,!T!V=NF:AD\)Z[-XBBU.6XT]UB
MN)I5 WC"21[-N!QD'OU-=P98QG+J,'!R1P:=N&<9&?2BR"[/.H? >JQ:=]F>
M6Q=O[".EY);&\L3NZ?=P?K7:R(UMX=>.;&Z*T*OMY'"<_6M ,I8@,,CJ,]*,
MC!.1@=:+!<\NTKPSJ>K^&=)O[6.QM9X=/C@C0@_O5WJQW?+\I 7C@X))JY;^
M"-:C6.-GM$4R7RLRRNS*EP!A@2,E@1^/K79Z;K=MJ-I=W*JT$=K/)!*9<#!0
M\GZ46FN6M[K-SID2R>9!#'/YA V.CYP5/?H:5D%V<2O@C57TVSCET_2([JWN
MK0R2Q2.QFCA.<G<./9>V3S5F/PGJL>J177V2R:);J^9H3*0#%.!MZ#KD<CWK
MO^*S;77+6\N]2MHHY_.T]@LZM'CDC<-OKD46079E^#M%O]&ANX[O"PLR"WC:
M0221J%QM,F!N4?PYY K(U_PYK=[XG%_;VEK);Q7EO<QE9_++JBD,'&/F;G@D
MXQ7:Z??1:EI\-[ '$4R[D#KM;'N*;%J$3S7$;I+#Y,@BW3+M60D C83]X<X^
MM.R"[/-_^$%UO^S;"&UM;2RN$L[N*>1'&&:20,JG R00,'TS75>&--U*VUO6
M+^]TV"PBO5@,<44H?:43:P. !74U2M-5MKV_OK*$OYUDZI,&0@ LNX8/<8HL
M@NR[1113$%%%% !1110 4444 %(:6D- 'G/P-_Y)7IW_ %TE_P#0S7HU><_
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M);#^R;B!;B>\>WMIHMI96R4P*P;_ $RXECN;VWTW4(YK;3]/6S*Q.A5UD^?
M'4@=<]J]>HIV"YYYX6@OF\63RZD-6&H12SB1BFVUDA8YC.[^+C;@=0<UHQ3G
M1/$?B1KNWN=MZT4MJ\<3.)<1A2HQW!'0^M=E118+GDVM6%W#%>?\A)+FQT6W
M>%86DV"<.>0%X+ 8&*GU-)+JZGFNX;Z>WM=?M9CE9#LC,0RR@?P[O3I7J5%+
ME07/)(YM9$6HW"RZV=;@65;FT$)$;1F0$,K="=GW-O-=3X+6 ZWXAGLTN!93
M/;M \RO\X\H D%^3S7944TK V%%%%,04444 %%%% !1110 4E+24 ><_ _\
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M4E "T4A( Y-(K*ZAE8,IZ$'(- #J**2@!:*2EH **** "BBB@ HHHH ****
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M "BBB@ I#2TE 'GWP5_Y)5I/'>7_ -#->@#Z5P/P6_Y)5H_'_/3_ -#:N_I
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M^PSWRZ@]J4!_?#!^]UVD@''M6EX?TA]#T:/3VNC<E'=A*4"?>8MTSVS18-#
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M44 %)2TE ' _!C_DE6C8])/_ $-J[^N ^#(Q\*M&_P!V3_T-J[ZD M%(*6F
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M=O<SV]S*)YTMU2%06#.<#//KQ699^.;*ZN88&L+Z!Y9)H!YL8 $T0):/@]<
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M96S'+@G!&,CU&:-0T.^TK58=4TJQOE'E"[B65(W8;N1G'O5YW5%+.P51U).
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M2ZP[6=U!!<33I$ X=HGA*>6%7C=[]3ZT:AH=7_PE&A!)'.JVBK$ 7+2   G
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M[5;6L=_;R3W2.T"JX(;8/FYZ#%<%'X'UQ-)$:Z?IL>I6)00W7VAV%ZJ2!PK
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M$LT4,\<DD#!955@2AQG!]#BN'\,>(M1UC7_WVK60437$,^F;29H]C$(<8RO
M!).0<\5F7][J&D^+/$E[IMXD<HO[%#9&(-]J#HJGGKG!)!'I3N%CTRZMHKRT
MFM9UW0S(8W7.,J1@C\JAACL]&TN.(.L%G:QA0TK\(@X&6/\ 6O-_^$VU);&U
M#:K!]K(U))$*)D>3N,;$=B,#ZU!JVN:C<>'[C3]4UN$"XT%M2\UK=$$I88\L
M \$+^?S#TI7"QZPK*ZJZ,&5AD$'@BG5YEIOBC5+B^6TMM0TZTALV@MS;SG+R
MHT2G>HZDDGC''RG-6_!WB;6=0U72H-1O8+A-1TR2[*I"$\MDD"\8/((/.?2F
MF%CT*H!=VK79M1<0FY4;C#O&\#UQUQ7$7OBW4H=0N)86C9+;6(M--AL&^1'V
M_O,]<_-N'; JSX+M \NNWUQ/%=7,6JW4<<S1+NB (!&1SCIQ1<+':TF >M>4
M'QIXIM]#M]2>ZT^X^V6-S<(JVY7[.83P3\W*L.#TP:T;CQ9K]FFII+<V;7&E
MV,=^P$!47*N2=@YR  ,9'<T7"QW.J:5;ZO8O9W#3)$Y!8P2F-C@YQE><58@:
MWCQ:0M&#"H'E*PRJ]N*X:#QGJ5U+'?Q)$+-M673&LFCQ*NX#Y]V>H)SC&-M7
MO EB'M+G4;MH[B^^V7,:W/E@/L\T_*3GD<#Z47"QV-%%%,04444 %%%% !11
M10 4E+2&@#AO@_G_ (55H?\ US?_ -#:NX'7%<1\'_\ DEFA?]<F_P#0VKN:
M0"&EHHI@%%%% !124M !1110 4UG1,;W5<G R<9-.KC_ !K87M[+:&RM);B1
M <(RAH),L,J_(*' R''3%)@CH-+U:+5$N"D;Q-!<26[*^,DH<$C':DU76(-*
MMH9Y$>5);F.W_=D':SMM!/L#7GZZ)J,5\E[!HUV+MM5NY)&W[=T+1D*"V>%)
MQ_.J5GI.M1"9/[&U 0R7&GS(C(H"E&_><;CT]3R>M3=CLCTO3M7AU(7_ )4,
MJM9W+V[JP&69<'CV.:?HNK0:YI%OJ5NDB13J65)!AAR1S^59?A>UN;=M=\^V
MEA\_4YI8O,&-Z$###VXK@K/PQK=OH<?]E6-W9ZC%:RQ7ZM(5%S^\!54R<$[=
MV&'3-/4-#V ," 0<@]Q0"#T(..#7(:)87$/AK5AI-MJ%C/<AWMDU!@"DA3 P
MH^XN<?SKE-0T?5Y]$N/L-EJ%LK:;#'=0 L'DNQ*I++SDD#=EAU!%%V%CUKH*
MSEUJT?4[:QC+2/<Q/+'*@S&0A 8;O7)K$\*Z>UG=>(K);>YCL6N@;99RQ#*T
M8W%23G!;-<;:Z'(-(TVR;2M1MVM+"^WK&KH/.)&SD'G../I1J%CUT_\ ZZ >
M*\NT>'6KO6;$ZL-;69%MI;=XHP(RHC =9&/W?FW;E/7C%:?BV*^E\3Q13#55
ML)($%I+IL>XQS!\MN_NDC&&/&,TM0L=_2UY8FG7LFI1M.=9VRZY-%(?,D"_9
M2G?'1"V.1WJC$UQ<KI5IJ=SK43#2KH"*)I%D,BS8C) Y) Q@GKWIW"QZG;:K
M:W6IWNG1%_M%F$,P*$ ;QE<'OP*NUY6G]OV\EW)<0W3S-_9JZD\2'<\84B4H
M1U()&<>]6KA=;L;"35[.2[GM[#4R;*VEE*FYMW 4J<\D!B2N><"BX6/2J*\S
MN8M9M?$$6G7FH:G$L:P/936L#2B9LYE5FS@?-Q\W\/2KGA&;4KOQ TNH7FII
M?1B5+NSDMBL'WOD8,3@C&-NWUYHN%COI'$<;.<[5!)P*JZ7J=KK.FP:A8R&2
MVG7=&Y4C(SCH?I7'I=S/XNNX=2;5H;N"Z+VH@5OL\MKLXW?PX!SGOD"N/;4M
M3L?#6E16C:E;SP68E0+%)M8^>=P"@<MMZ[N #P*06/8[2_@O);J.'?NMI?*D
MW(5&[ /&>HYZBIIYDMX))I,A(U+M@9. ,GBO-Y[^_N-2>W74]22*7Q L2F,L
M"(&AR0#CA-WY50TW4]4ABL)'U?4I6G@U&*43$G BSY1 QPW'WNIIW"QZI:74
M-]9PW4!+0S('0E2"0>1P>14V:\BU#6]6_L^2YAUC4$D@T*UNPB X:<O@Y&WG
M(ZBM6U\17%WXS6Q;6%B*:B0R%]J2P>4"L:J1][>:+A8] OK^UTVQFO+R98;>
M!"\DC=%4=34D4J3QI+&P:-U#*P[@\@UYYXX9(=?U S7D\:2>';A8HMQ\MWW<
MC'0G%9#^(-3T>%;--6E>QC%D;FYD&?LJ21-GE1D*6"C/;-%PL>K7U_::99O=
MWLZ06Z8W2.< 9.*G# @$'@]*X35Y;JY^$6H227_]H3-;/BZ2$KO&[@A>^!W[
MXS6-<^(M6TZ62V36C/HSSPH=7E48@+1DE-RC&-P7G'&[!HN%CU:H+JUM[ZTE
MM;J)98)E*21N,AE/4&O+[WQ'KMI;73#Q+%,]GI27F^.W54F?S2N<$9VE<#WZ
MBKMIXCU74M>O89-:L[..&6>.2P8?O?*"91UXX_O;R2.U%PL=II^JZ&+A='T^
M\LQ- F%M87&55>.%'85JUY#HMY/::#H4-M?HTEUH-W*)1$AF#( 5VOC. 2>*
MTM*\27L*^'8_[6%S82VUJDDD12202OU$J_>VMT#+T(.:5QV/3:K37]G;7,-O
M/=0QS3G$4;N 7/H!7(^*?$>H6.IZA:6EQ':-::8;Z#S$#"Z<,04Y[# &!S\P
MH\/@ZGXRU>XO) [+;V<OV215/DL4+<<9!!S^=.XK'917,$[RI%,CM$VR158$
MHV,X/H<&I*\VUC5[R.[G2WU".SV>)+:VEDAC12T;*IPY[_4_2MWP]KE_>Z_<
M6.H3QD^6\D @56ADC#[0R..<@8#*W.>E%PL=9G-+7GG_  DFO)J<[K>6<MM%
MK+:=]E\G#^65R'W9ZKUZ8(!J'2?$^O7L>E6]UJ5G#+J=I-=QW2V^(T\O \OD
MG/7<3Z"BX6/2*:LL<C,$D5RAVL%8':?0UY[;^,-<D?3#-'''_;-B/L2>7PMT
M&^<$]U*_./8&D?Q!J5D^N&SM;8M!JK1SO;1#S6C$*MYFPGYV!QG!SM'%%PL>
MA++&TC(KJ73&Y0>5STR.U/-><Q^*W@U&[>&.P,MY+I\/VZ.(J,3(<.X)R0,8
M4''4"I#XLUZ;5(])A:R2<7EU:/</$Q5_+B$BNHSUYP1ZT7"QZ$*HZMI%KK-F
M+6Z\P*LBRH\3E&1U.0P([BN/T_QIJ=U-HDMQ'!;6=]%!F4(9$,KY#(Q!S&3@
M;<C!SUKO5970,C!E/0@Y%""UBEINDV^F"9HFEDFG8-+-,^YW(&!D^PJ]M'H/
MRI:*H0FT>@Z8Z4GEIMV[%V@Y QQ3J* &&-"VXHI;&,D<XH$48((C0$="%Z4^
MB@"(6T"HR""((PPRA!@CWI!:VZE"L$0,8VH0@RH]!Z5-10!5L].M+"S^RV\*
M)"2Q*XX)8Y)/US2G3K$@@V=N00 08E[=.U6:* (8[2VBN)+B.WB2:0 /(J ,
MP'3)ZFFM8VCW:W;6L)N5&!,4&\#Z]:L44 47T;2Y'D=]-M&>5BSLT"DL2,$G
MCDXHFT;3+B*"*;3K22.#/DH\*D1Y&. 1QQ5ZB@"BVC:6]S'<MIUJ9XX_*23R
MEW*G]T'' IMKH6E64T,UKI]M#) ACB9(P"BDY('H,]JT#10!2;2-/?4UU)K*
M WJC:)R@WXZ=:;9:/8Z7!<1Z;:PVOGL7?8N SG^(^IJ_10!RV@>!M,TKP_\
MV9=V]O>M(ACN)3%CSE+%L$9/&3TK7G\/Z3<RVTD]A#(]L@2(LOW5'(7W&0#@
M\5I44 9W]@Z7_:C:G]AB%ZW68#!)QC/IG'&>M2:9I-AHUJ;;3K9+>$N9"B=-
MQY)_&KM% !1110 4444 %%%% !1110 4E+24 </\(./A7H7_ %R;_P!#:NWS
M7#_",?\ %J]!Z_ZIO_0VKN!TZ8I .HHHI@%%%% "4M%% !1110 4444 %%%%
M !1110 4444 %%%%(!*6BB@ JJ^G6KZG'J+1_P"E1QF)9-QX4G)&.G4"K5%,
M JE=:597M[:W=S#YDUJ2T)+'"D]\9P3]:NT4 %%%% !124M(!*,#T%+13 3
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MK$D,*?=1!@#G-344 %%%% !1110 4444 %%%% !124M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 <3\(\#X5Z![P-_Z&
MU=MBN)^$G_)+- X_Y8'_ -#:NV&<T@#%+124P%HHHH **** $HI:*0!1113
M**** "DI:* "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ I*6D- '%_"3'_"J_#_ /UP/_H;5VE<7\)?^25^'_\ KW/_
M *&U=IWI +1124P%HHHH **04M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444@"BBBF 4444 %%%(: %HHHH **** "BBB@
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M%)WI: "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 =Z*** "DI:2@#C?A3S\+?#W_ %[?
M^S&NQSS7'?"G_DEOA[_KV_\ 9C794@%HHHI@%%%% "4M%% !1110 4444 %%
M%% !1112 ****8!1110 4444@$_&EHHH ****8!1110 4444@"BBB@ HHHI@
M%%%% !24M%( HI*6@ HI*6@ HHHI@%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBT4)"J,5"@/O P#_ 'AFC4/!^B:IJ1O[RS\V9@-X+L%?Y2N2N<$[6(K=H[T
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M)S3J2@ HH[4M !24M%, I***0!^-%&** "BD^E&:0!0<9I:3CO0 8[TM%%,
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M3C(%+O/H*** !96W8XIQD..@HHIH!CRL#@ 4X2' .!R:**0";^>@I"Y#444
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B4C2$8HHH :)6R>!3Q(WMTHHH 3>2<X'%#N<C@=*** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>18
<FILENAME>gtbp-20180930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:GTBP="http://gtbiopharma.com/20180930">
    <link:schemaRef xlink:href="gtbp-20180930.xsd" xlink:type="simple" />
    <xbrli:context id="From2018-01-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_SeriesCPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_SeriesJPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GTBP:SeriesJPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_SeriesJPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">GTBP:SeriesJPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_us-gaap_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-09-30_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForChangeInAccountingPrincipleAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_custom_ExerciseOfCommonStockWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ExerciseOfCommonStockWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_ExerciseOfCommonStockWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ExerciseOfCommonStockWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_custom_ConversionOfPreferredStockIntoCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ConversionOfPreferredStockIntoCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_ConversionOfPreferredStockIntoCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ConversionOfPreferredStockIntoCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-09-30_custom_ExerciseOfCommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ExerciseOfCommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-09-30_custom_ExerciseOfCommonStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000109657</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">GTBP:ExerciseOfCommonStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2018-01-01to2018-09-30">GT Biopharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2018-01-01to2018-09-30">0000109657</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2018-01-01to2018-09-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2018-01-01to2018-09-30">2018-09-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2018-01-01to2018-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2018-01-01to2018-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCurrentReportingStatus contextRef="From2018-01-01to2018-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2018-01-01to2018-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalYearFocus contextRef="From2018-01-01to2018-09-30">2018</dei:DocumentFiscalYearFocus>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">15000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">15000000</us-gaap:PreferredStockSharesAuthorized>
    <dei:DocumentFiscalPeriodFocus contextRef="From2018-01-01to2018-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">576000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1247000</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">15000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Assets contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">254368000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">26536000</us-gaap:Assets>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">253792000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">25289000</us-gaap:AssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">6000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">5000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">9000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">21000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">253777000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">25263000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">2679000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">13223000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">10597000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:LineOfCredit contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">31000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">31000</us-gaap:LineOfCredit>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">102000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">344000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">2546000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">2251000</us-gaap:AccountsPayableCurrent>
    <us-gaap:Liabilities contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">2679000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">13223000</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="-3">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="USD" decimals="-3">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-09-30_custom_SeriesJPreferredStockMember" unitRef="USD" decimals="-3">1000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-12-31_custom_SeriesJPreferredStockMember" unitRef="USD" decimals="-3">1000</us-gaap:PreferredStockValue>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">254368000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">26536000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">251689000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">13313000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">-169000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">-169000</us-gaap:MinorityInterest>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">-269499000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">-524453000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-12-31_us-gaap_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="-3">-267896000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-12-31_us-gaap_RestatementAdjustmentMember" unitRef="USD" decimals="-3">-1603000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">521305000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">537883000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-12-31_us-gaap_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="-3">519702000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-12-31_us-gaap_RestatementAdjustmentMember" unitRef="USD" decimals="-3">1603000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">50000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">50000</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">96230</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">96230</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-09-30_custom_SeriesJPreferredStockMember" unitRef="Shares" decimals="INF">1163548</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-12-31_custom_SeriesJPreferredStockMember" unitRef="Shares" decimals="INF">1163548</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">96230</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-12-31_us-gaap_SeriesCPreferredStockMember" unitRef="Shares" decimals="INF">96230</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-09-30_custom_SeriesJPreferredStockMember" unitRef="Shares" decimals="INF">1163548</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-12-31_custom_SeriesJPreferredStockMember" unitRef="Shares" decimals="INF">1163548</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">50117977</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">50227978</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">50117977</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">50227978</us-gaap:CommonStockSharesOutstanding>
    <dei:EntityEmergingGrowthCompany contextRef="From2018-01-01to2018-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="From2018-01-01to2018-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2018-11-14" unitRef="Shares" decimals="INF">50227978.</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">488</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:Depreciation contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">5000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">2000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">8191000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">125905000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">7816000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">4791000</us-gaap:AmortizationOfDebtDiscountPremium>
    <GTBP:NoteAllonge contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">0</GTBP:NoteAllonge>
    <GTBP:NoteAllonge contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">100000</GTBP:NoteAllonge>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">2197000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">1076000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-15000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">12000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">7000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-53000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">1880000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-9433000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-3278000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">4000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-4000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">15045000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">5991000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:PaymentsOfLoanCosts contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">533000</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:PaymentsOfLoanCosts contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">10093000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">5991000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">656000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">2713000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="-3">576000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">1232000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-09-30" unitRef="USD" decimals="-3">2732000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="-3">19000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <GTBP:IssuanceOfCommonStockUponConversionOfConvertibleNotes contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">220000</GTBP:IssuanceOfCommonStockUponConversionOfConvertibleNotes>
    <GTBP:IssuanceOfCommonStockUponConversionOfConvertibleNotes contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</GTBP:IssuanceOfCommonStockUponConversionOfConvertibleNotes>
    <GTBP:AcquisitionOfIntangiblesThroughIssuanceOfCommonStock contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">0</GTBP:AcquisitionOfIntangiblesThroughIssuanceOfCommonStock>
    <GTBP:AcquisitionOfIntangiblesThroughIssuanceOfCommonStock contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">253777000</GTBP:AcquisitionOfIntangiblesThroughIssuanceOfCommonStock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 1, 2017, the Company entered into&#13;an Agreement and Plan of Merger whereby it acquired 100% of the issued and outstanding capital stock of Georgetown Translational&#13;Pharmaceuticals, Inc. (GTP). In exchange for the ownership of GTP, the Company issued a total of 16,927,878 shares of its common&#13;stock, having a share price of $15.00 on the date of the transaction, to the three prior owners of GTP which represented 33% of&#13;the issued and outstanding capital stock of the Company on a fully diluted basis. $253.8 million of the value of shares issued&#13;was allocated to intangible assets consisting of a portfolio of three CNS development candidates, which are classified as IPR&amp;#38;D.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the three and nine months ended September&#13;30, 2018, the Company recorded an intangible asset impairment charge of $228.5 million related to the portfolio of CNS IPR&amp;#38;D&#13;assets within Operating Expenses, which represents the excess carrying value compared to fair value. The impairment charge was&#13;the result of both internal and external factors. In the 3&lt;sup&gt;rd&lt;/sup&gt; quarter of 2018, the Company experienced changes in key&#13;senior management, led by the appointment of a new CEO with extensive experience in oncology drug development. These changes resulted&#13;in the prioritization of immuno-oncology development candidates relative to CNS development candidates. In conjunction with these&#13;strategic changes, limited internal resources have delayed the development of the CNS IPR&amp;#38;D assets. The limited resources,&#13;changes in senior leadership, and favorable market conditions for immuno-oncology development candidates have resulted in the Company&#13;choosing to focus on development of its immuno-oncology portfolio. In light of this shift in market strategy, the Company performed&#13;a commercial assessment and a valuation of the CNS IPR&amp;#38;D assets, both to assess fair value and support potential future licensing&#13;efforts. The valuation indicated an excess carrying value over the fair value of these assets, resulting in the impairment charge&#13;noted above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the CNS IPR&amp;#38;D assets was&#13;determined using the discounted cash flow method which utilized significant estimates and assumptions surrounding the amount and&#13;timing of the projected net cash flows, which includes the probability of commercialization, the assumption that the assets would&#13;be out-licensed to third-parties for continued development for upfront licensing fees and downstream royalty payments based on&#13;net sales, and expected impact of competitive, legal and/or regulatory forces on the projections, as well as the selection of a&#13;long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the projected cash flows; and the&#13;tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Convertible Notes&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2018, the Company entered into&#13;a Securities Purchase Agreement (&amp;#8220;SPA&amp;#8221;) with fourteen accredited investors (individually, a &amp;#8220;Buyer&amp;#8221; and&#13;collectively, the &amp;#8220;Buyers&amp;#8221;) pursuant to which the Company agreed to issue to the Buyers senior convertible notes in&#13;an aggregate principal amount of $7,760,510 (the &amp;#8220;Notes&amp;#8221;), which Notes shall be convertible into the Company&amp;#8217;s&#13;common stock, par value $0.001 per share (the &amp;#8220;Common Stock&amp;#8221;) at a price of $4.58 per share, and five-year warrants&#13;to purchase the Company&amp;#8217;s Common Stock representing the right to acquire an aggregate of approximately 1,694,440 shares of&#13;Common Stock (the &amp;#8220;Warrants&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;Pursuant&#13;to the terms of SPA the Notes were subject to an original issue discount of 10% resulting in proceeds to the Company of $7,055,000&#13;from the transaction. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon the purchase of the Notes, the Buyers received&#13;Warrants to purchase 1,694,440 shares of Common Stock. Such Warrants are exercisable for (5) years from the date the shares underlying&#13;the Warrants are freely saleable. The initial Exercise Price is $4.58. &lt;font style="background-color: white"&gt;According to the terms&#13;of the warrant agreement, the Warrants are subject to certain adjustments depending upon the price and structure of a subsequent&#13;financing, including a qualified financing with gross proceeds of at least $20 million&lt;/font&gt;, as defined in the agreements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The issuance of the Notes and Warrants were&#13;made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &amp;#8220;Securities&#13;Act&amp;#8221;) for the offer and sale of securities not involving a public offering, and Regulation D promulgated under the Securities&#13;Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Contemporaneously with the execution and delivery&#13;of the SPA, the Company and the Buyers executed and delivered a Registration Rights Agreement (the &amp;#8220;Registration Rights Agreement&amp;#8221;)&#13;pursuant to which the Company has agreed to provide certain registration rights with respect to the Registrable Securities under&#13;the 1933 Act and the rules and regulations promulgated thereunder, and applicable state securities laws.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Senior Convertible Debentures&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 2, 2018, GT Biopharma, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto (individually, a &amp;#8220;Purchaser,&amp;#8221;&#13;and collectively, the &amp;#8220;Purchasers&amp;#8221;) pursuant to which the Company issued to the Purchasers one year 10% Senior Convertible&#13;Debentures in an aggregate principal amount of $5,140,000 (the &amp;#8220;Debentures&amp;#8221;), which Debentures shall be convertible&#13;into the Company&amp;#8217;s common stock, par value $0.001 per share (the &amp;#8220;Common Stock&amp;#8221;), at a price of $2 per share.&#13;The Company used a portion of these proceeds to repay $4.4 million of the notes issued on January 22, 2018. Additionally, the remaining&#13;$3.3 million of the notes issued on January 22, 2018 were converted into the Debentures at the same terms discussed above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 7, 2018, GT Biopharma, Inc. (the&#13;&amp;#8220;Company&amp;#8221;) entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto&#13;(individually, a &amp;#8220;Purchaser,&amp;#8221; and collectively, the &amp;#8220;Purchasers&amp;#8221;) pursuant to which the Company has issued&#13;to the Purchasers one year 10% Senior Convertible Debentures in an aggregate principal amount of $2,050,000 (the &amp;#8220;Debentures&amp;#8221;),&#13;which Debentures shall be convertible into the Company&amp;#8217;s common stock, par value $0.001 per share (the &amp;#8220;Common Stock&amp;#8221;),&#13;at a price of $2 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 24, 2018, GT Biopharma, Inc. (the&#13;&amp;#8220;Company&amp;#8221;) entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto&#13;(individually, a &amp;#8220;Purchaser,&amp;#8221; and collectively, the &amp;#8220;Purchasers&amp;#8221;) pursuant to which the Company has issued&#13;to the Purchasers one year 10% Senior Convertible Debentures in an aggregate principal amount of $800,000 (the &amp;#8220;Debentures&amp;#8221;),&#13;which Debentures shall be convertible into the Company&amp;#8217;s common stock, par value $0.001 per share (the &amp;#8220;Common Stock&amp;#8221;),&#13;at a price of $2 per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;The issuance of the Senior Convertible Debentures was made in reliance&#13;on the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;), for&#13;the offer and sale of securities not involving a public offering and Regulation D promulgated under the Securities Act.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Financing Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 8, 2010, the Company entered into&#13;a financing arrangement with Gemini Pharmaceuticals, Inc., a product development and manufacturing partner of the Company, pursuant&#13;to which Gemini Pharmaceuticals made a $250,000 strategic equity investment in the Company and agreed to make a $750,000 purchase&#13;order line of credit facility available to the Company. The outstanding principal of all Advances under the Line of Credit will&#13;bear interest at the rate of interest of prime plus 2 percent per annum. There is $31,000 due on this credit line at September&#13;30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the quarter ended September 30, 2018,&#13;the Company issued 110,000 shares of common stock upon conversion of $220,000 of senior convertible notes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 1, 2017, the Company authorized&#13;2,000,000 shares of Series J Preferred Stock. Shares of Series J Preferred Stock will have the same voting rights as shares of&#13;common stock with each share of Series J Preferred Stock entitled to one vote at a meeting of the shareholders of the Corporation.&#13;Shares of Series J Preferred Stock will not be entitled to receive any dividends, unless and until specifically declared by our&#13;board of directors. The holders of the Series J Preferred Stock will participate, on an as-if-converted-to-common stock basis,&#13;in any dividends to the holders of common stock. Each share of the Series J Preferred Stock is convertible into one share of our&#13;common stock at any time at the option of the holder.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On September&#13;1, 2017 the Company issued a total of 908,502 shares of &lt;/font&gt;Series J Preferred Stock &lt;font style="background-color: white"&gt;in&#13;exchange for the conversion and cancellation of debt in the total amount of $1,090,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On September&#13;1, 2017 the Company issued 5,046 shares of &lt;/font&gt;Series J Preferred Stock &lt;font style="background-color: white"&gt;upon the exercise&#13;of warrants on a cashless basis.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On September&#13;1, 2017 the Company also issued 600,000&lt;/font&gt;&amp;#160;shares of&amp;#160;&lt;font style="background-color: white"&gt;Series J Preferred Stock&lt;/font&gt;&amp;#160;to&#13;one entity as payment for $720,000 of consulting services provided to the Company.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;In December&#13;2017, the Company converted 350,000 Series J shares of preferred stock into 350,000 shares of common stock.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;The following table summarizes stock option transactions for the&#13;nine months ended September 30, 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding, December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding, September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable, September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Common Stock Warrants&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;Warrant transactions for the nine months ended September 30, 2018&#13;are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 53%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at December 31, 2017:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 26%; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 2%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 1, 2017, the Company entered&#13;into a three-year lease agreement for its office in Washington, D.C. In addition to minimum rent, certain leases require payment&#13;of real estate taxes, insurance, common area maintenance charges and other executory costs. The Company recognizes rent expense&#13;under such arrangements on a straight-line basis over the effective term of each lease. This lease was terminated as of June 30,&#13;2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for the nine months ended&#13;September 30, 2018&amp;#160;and&amp;#160;2017&amp;#160;was&amp;#160;$52,000&amp;#160;and&amp;#160;$9,000, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Employment Agreements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On February&#13;14, 2018, the Company entered into the First Amendment to the Employment Agreement with Dr. Clarence-Smith, amending the Employment&#13;Agreement, dated September 1, 2017, between the Company and Dr. Clarence-Smith. Under the First Amendment, Dr. Clarence-Smith&amp;#8217;s&#13;title was revised to reflect her new position and included an annual salary of $500,000, paid in equal monthly installments. All&#13;other terms of her original Employment Agreement remain unchanged. In October 2018, Dr. Clarence-Smith resigned from her position&#13;with the Company. In connection with this resignation, the Company entered into a separation agreement which superseded the Employment&#13;Agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On February&#13;14, 2018,&amp;#160;the Company entered into a Consultant Agreement with Mr. Cataldo. The term of the Consultant Agreement lasts until&#13;August 31, 2020 and is terminable at will and is subject to automatic extension for successive one-year periods. Mr. Cataldo will&#13;be paid $41,667 per month during the term of the Consultant Agreement and will be entitled to participate in the Company&amp;#8217;s&#13;bonus plans. Refer to footnote 8 &amp;#8211; Subsequent Events.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If any of our executive officers&amp;#8217; employment&#13;with us is terminated involuntarily, or any executive resigns with good reason as a result of a change in control, the executive&#13;will receive (i) all compensation and benefits earned through the date of termination of employment; (ii) a lump-sum payment equal&#13;to the greater of (a) the bonus paid or payable to the executive for the year immediately prior to the year in which the change&#13;in control occurred and (b) the target bonus under the performance bonus plan in effect immediately prior to the year in which&#13;the change in control occurs; (iii) a lump-sum payment equivalent to the remaining base salary (as it was in effect immediately&#13;prior to the change in control) due to the executive from the date of involuntary termination to the end of the term of the employment&#13;agreement or one half of the executive&amp;#8217;s base salary then in effect, whichever is the greater; and (iv)&amp;#160;reimbursement&#13;for the cost of medical, life, disability insurance coverage at a level equivalent to that provided by us for a period expiring&#13;upon the earlier of (a) one year or (b) the time the executive begins alternative employment where said insurance coverage is available&#13;and offered to the executive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Adoption of ASU 2017-11&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the securities purchase agreements&#13;and debt transactions during the year ended December 31, 2017, the Company issued warrants, to purchase common stock with a five-year&#13;term. Upon issuance of the warrants, the Company evaluated the note agreement to determine if the agreement contained any embedded&#13;components that would qualify the agreement as a derivative. The Company identified certain put features embedded in the warrants&#13;that potentially could result in a net cash settlement in the event of a fundamental transaction, requiring the Company to classify&#13;the warrants as a derivative liability. The Company changed its method of accounting for the debt and warrants through the early&#13;adoption of ASU&amp;#160;2017-11 on January 1, 2018 on a retrospective basis. Accordingly, the Company recorded the warrant derivative&#13;and conversion option derivative liabilities to additional paid in capital upon issuance.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;The following table provides a summary of the&#13;derivative liability activity as a result of the adoption of ASU 2017-11 (in thousands, except per share data):&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Consolidated Balance Sheet&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;December 31, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td rowspan="2" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td rowspan="2" style="width: 18%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Revisions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Additional Paid-in Capital&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;519,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,603&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;521,305&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Accumulated Deficit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(267,896)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1,603)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$ &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(269,499)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Consolidated Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;For the Three&#13;        Months Ended September 30, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Revisions&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Change in Warrant Liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$ &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1,451)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Earnings Per Share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(8.24)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(8.15)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Consolidated Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;For the Nine&#13;        Months Ended September 30, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Revisions&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Change in Warrant Liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(925)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Earnings Per Share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(24.38)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(0.16)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(24.54)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 1, 2018, the Company entered&#13;into a three-year lease agreement for its office in Westlake Village, CA. In addition to minimum rent, certain leases require payment&#13;of real estate taxes, insurance, common area maintenance charges and other executory costs. The Company recognizes rent expense&#13;under such arrangements on a straight-line basis over the effective term of each lease.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the Company&amp;#8217;s&#13;future minimum lease commitments as of September 30, 2018 (in thousands):&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;71&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; border-bottom: Black 1.5pt double; margin-bottom: 0; text-align: right"&gt;$ 212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;i&gt;Employment and Consulting Agreements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On October&#13;18, 2018, the Company entered into a Consultant Agreement with Anthony Cataldo. The term of the Consultant Agreement shall remain&#13;in effect until September 30, 2019. This Agreement supersedes the Consultant Agreement dated February 14, 2018 and will pay Mr.&#13;Cataldo $25,000 per month during the term of the Agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On October&#13;19, 2018, the Company entered into an Executive Employment Agreement with Dr. Urbanski, reflecting his current position as Chief&#13;Executive Officer of the Company. Under the terms of this agreement, Dr. Urbanski&amp;#8217;s annual salary is essentially unchanged&#13;from his previous positions. Dr. Urbanski is also entitled to participate in the Company&amp;#8217;s bonus plans. Under the Executive&#13;Employment Agreement, the Company has agreed that upon shareholder approval of a Stock Option Plan, it will recommend to the Board&#13;that the Company grant Dr. Urbanski a Non-Qualified stock option to purchase 2,971,102 shares of the Company&amp;#8217;s common stock&#13;having an exercise equal to the fair market value of the shares on the date of the Agreement. The stock option grant would vest&#13;according to the following schedule: (i) 1,250,000 fully vested shares upon signing of the agreement, (ii) 1,250,000 shares on&#13;January 1, 2019, and (iii) 471,102 shares on January 1, 2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Departure&#13;of Directors or Certain Officers&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;On November&#13;12, 2018, Mr. Cataldo announced his intention to resign from the Board of Directors of the Company effective November 13, 2018.&#13;The resignation did not involve any dispute with the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0.05pt 5.7pt 6pt 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s current operations have focused on business planning, raising capital, establishing an intellectual property portfolio,&#13;hiring, and conducting preclinical studies and clinical trials. The Company does not have any product candidates approved for&#13;sale and has not generated any revenue from product sales. The Company has sustained operating losses since inception and expects&#13;such losses to continue over the foreseeable future.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 5.5pt 6pt 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The&#13;financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets&#13;and the satisfaction of liabilities in the normal course of business. Accordingly, the financial statements do not include any&#13;adjustments that might be necessary should the Company be unable to continue in existence.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0.05pt 5.45pt 6pt 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;The&#13;Company has incurred substantial losses and negative cash flows from operations since its inception and has an accumulated deficit&#13;of $524.5 million and cash of $1.2 million as of September 30, 2018. The Company anticipates incurring additional losses until&#13;such time, if ever, that it can generate significant sales of its products currently in development. Substantial additional financing&#13;will be needed by the Company to fund its operations and to commercially develop its product candidates. These factors raise substantial&#13;doubt about the Company&amp;#8217;s ability to continue as a going concern.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Management&#13;is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include&#13;but are not limited to: public offerings of equity and/or debt securities, payments from potential strategic research and development,&#13;and licensing and/or marketing arrangements with pharmaceutical companies. Management has also implemented cost saving efforts,&#13;including reduction in executive salaries and reduced travel. Management believes that these ongoing and planned financing endeavors,&#13;if successful, will provide adequate financial resources to continue as a going concern for at least the next six months from&#13;the date the financial statements are issued. However, there can be no assurance in this regard. If the Company is unable to secure&#13;adequate additional funding, its business, operating results, financial condition and cash flows may be materially and adversely&#13;affected.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The financial statements&#13;and notes are representations of the Company's management, which is responsible for their integrity and objectivity. These accounting&#13;policies conform to accounting principles generally accepted in the United States of America and have been consistently applied&#13;in the preparation of the financial statements. The preparation of financial statements requires management to make estimates and&#13;assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosures of contingent assets&#13;and liabilities at the date of the financial statements. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying consolidated financial statements&#13;include the accounts of GT Biopharma, Inc. and its subsidiaries. All intercompany balances and transactions have been eliminated.&#13;The Company's financial statements are prepared using the accrual method of accounting.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited interim condensed&#13;consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&amp;#8220;U.S.&#13;GAAP&amp;#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). Certain information&#13;and disclosures required by U.S. GAAP for complete consolidated financial statements have been condensed or omitted herein. The&#13;interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements&#13;and notes thereto included in the Company's Form 10-K for the year ended December 31, 2017. The unaudited interim condensed consolidated&#13;financial information presented herein reflects all normal adjustments that are, in the opinion of management, necessary for a&#13;fair statement of the financial position, results of operations and cash flows for the periods presented. The Company is responsible&#13;for the unaudited interim consolidated financial statements included in this report. The results of operations of any interim period&#13;are not necessarily indicative of the results for the full year.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all highly liquid investments&#13;with original maturities of three months or less to be cash equivalents.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's cash and cash equivalents, marketable&#13;securities and accounts receivable are monitored for exposure to concentrations of credit risk. The Company maintains substantially&#13;all of its cash balances in a limited number of financial institutions. The balances are each insured by the Federal Deposit Insurance&#13;Corporation up to $250,000. The Company had $982,000 of balances in excess of this limit at September 30, 2018.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its stock-based compensation&#13;for employees in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 718.&amp;#160;&amp;#160;The Company recognizes in&#13;the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees&#13;and non-employees over the related vesting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company granted no stock options during&#13;the nine months ended September 30, 2018 and 2017, respectively.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy>
    <GTBP:LongLivedAssetsPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our long-lived assets include property, plant&#13;and equipment, capitalized costs of filing patent applications and other indefinite lived intangible assets. We evaluate our long-lived&#13;assets for impairment, other than indefinite lived intangible assets, in accordance with ASC 360, whenever events or changes in&#13;circumstances indicate that the carrying amount of such assets may not be recoverable. Estimates of future cash flows and timing&#13;of events for evaluating long-lived assets for impairment are based upon management&amp;#8217;s judgment. If any of our intangible&#13;or long-lived assets are considered to be impaired, the amount of impairment to be recognized is the excess of the carrying amount&#13;of the assets over its fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Applicable long-lived assets are amortized or&#13;depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or the&#13;statutory or contractual term in the case of patents. Estimates of useful lives and periods of expected revenue generation are&#13;reviewed periodically for appropriateness and are based upon management&amp;#8217;s judgment.&lt;/p&gt;</GTBP:LongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's long-lived assets currently consist&#13;of indefinite lived intangible assets associated with IPR&amp;#38;D (&amp;#8220;In-Process Research &amp;#38; Development&amp;#8221;) projects&#13;and related capitalized patents acquired in the acquisition of Georgetown Translational Pharmaceuticals, Inc. as described in Note&#13;2 below. &amp;#160;Intangible assets associated with IPR&amp;#38;D projects are not amortized until approval by the Food and Drug Administration&#13;(FDA) is obtained in a major market subject to certain specified conditions and management judgment. The useful life of an amortizing&#13;asset generally is determined by identifying the period in which substantially all of the cash flows are expected to be generated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates indefinite lived intangible&#13;assets for impairment at least annually and whenever impairment indicators are present in accordance with ASC 350. When necessary,&#13;the Company records an impairment loss for the amount by which the fair value is less than the carrying value of these assets.&#13;The fair value of intangible assets other than goodwill is typically determined using the &amp;#8220;relief from royalty method&amp;#8221;,&#13;specifically the discounted cash flow method utilizing Level 3 fair value inputs. Some of the more significant estimates and assumptions&#13;inherent in this approach include: the amount and timing of the projected net cash flows, which includes the expected impact of&#13;competitive, legal and/or regulatory forces on the projections and the impact of technological risk associated with IPR&amp;#38;D assets,&#13;as well as the selection of a long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the&#13;projected cash flows; and the tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company performs impairment testing for&#13;all other long-lived assets whenever impairment indicators are present. When necessary, the Company calculates the undiscounted&#13;value of the projected cash flows associated with the asset, or asset group, and compares this estimated amount to the carrying&#13;amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes using&#13;the asset and liability approach, whereby deferred income tax assets and liabilities are recognized for the estimated future tax&#13;effects, based on current enacted tax laws, of temporary differences between financial and tax reporting for current and prior&#13;periods. Deferred tax assets are reduced, if necessary, by a valuation allowance if the corresponding future tax benefits may not&#13;be realized.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic net income (loss) per share is computed&#13;by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted&#13;net income (loss) per share is computed by dividing the net loss for the period by the weighted average number of common shares&#13;outstanding during the period, plus the potential dilutive effect of common shares issuable upon exercise or conversion of outstanding&#13;stock options and warrants during the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;The computation of basic and diluted net loss per share for the nine&#13;months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities&#13;because their inclusion would be anti-dilutive:&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 63%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: center; width: 16%"&gt;2018&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 4%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: center; width: 17%"&gt;2017&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Exercise of common stock warrants&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,813,053&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Conversion of preferred stock into common stock&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,163,659&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,513,659&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Exercise of common stock options&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: right"&gt;1,246&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,246&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt"&gt;2,977,958&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt"&gt;1,514,905&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Acquired patents are capitalized at their acquisition&#13;cost or fair value. The legal costs, patent registration fees and models and drawings required for filing patent applications are&#13;capitalized if they relate to commercially viable technologies. Commercially viable technologies are those technologies that are&#13;projected to generate future positive cash flows in the near term. Legal costs associated with patent applications that are not&#13;determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing the patentable&#13;idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident increase in&#13;the value of the patents are capitalized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Capitalized costs for pending patents are amortized&#13;on a straight-line basis over the remaining twenty-year legal life of each patent after the costs have been incurred. Once each&#13;patent is issued, capitalized costs are amortized on a straight-line basis over the shorter of the patent's remaining statutory&#13;life, estimated economic life or ten years.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fixed assets are stated at cost. Depreciation&#13;is computed on a straight-line basis over the estimated useful lives of the assets, which are 3 to 10&amp;#160;years for machinery&#13;and equipment and the shorter of the lease term or estimated economic life for leasehold improvements.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are expensed&#13;as incurred and reported as research and development expense. Research and development costs totaled $7.8 million and $0.9 million&#13;for the nine months ended September 30, 2018 and 2017, respectively. Research and development costs for the nine months ended September&#13;30, 2018 included non-cash compensation of $6.5 million.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;License Revenue&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;License arrangements may consist of non-refundable&#13;upfront license fees, exclusive licensed rights to patented or patent pending technology, and various performance or sales milestones&#13;and future product royalty payments. Some of these arrangements are multiple element arrangements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Non-refundable, up-front fees that are not contingent&#13;on any future performance by us, and require no consequential continuing involvement on our part, are recognized as revenue when&#13;the license term commences and the licensed data, technology and/or compound is delivered.&amp;#160;&amp;#160;We defer recognition of non-refundable&#13;upfront fees if we have continuing performance obligations without which the technology, right, product or service conveyed in&#13;conjunction with the non-refundable fee has no utility to the licensee that is separate and independent of our performance under&#13;the other elements of the arrangement. In addition, if we have continuing involvement through research and development services&#13;that are required because our know-how and expertise related to the technology is proprietary to us, or can only be performed by&#13;us, then such up-front fees are deferred and recognized over the period of continuing involvement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Payments related to substantive, performance-based&#13;milestones in a research and development arrangement are recognized as revenue upon the achievement of the milestones as specified&#13;in the underlying agreements when they represent the culmination of the earnings process. As of September 30, 2018, the Company&#13;has not generated any licensing revenue.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2018-01-01to2018-09-30">&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 8pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 0.5pt solid; text-align: center"&gt;September 30,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 63%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: center; border-top-color: Black; border-top-width: 0.5pt; width: 16%"&gt;2018&lt;/td&gt;&#13;    &lt;td style="text-align: center; width: 4%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: center; border-top-color: Black; border-top-width: 0.5pt; width: 17%"&gt;2017&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Exercise of common stock warrants&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,813,053&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Conversion of preferred stock into common stock&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;1,163,659&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,513,659&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;Exercise of common stock options&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: right"&gt;1,246&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 0.5pt solid; text-align: right"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,246&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt"&gt;2,977,958&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt"&gt;1,514,905&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2018-01-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding, December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding, September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable, September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,428.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2018-01-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Number of Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; width: 53%"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at December 31, 2017:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 26%; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 2%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 11%; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; font-size: 12pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Outstanding at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-top: Black 1pt solid; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&lt;font style="font-size: 8pt"&gt;Exercisable at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;4.58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Consolidated Balance Sheet&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;December 31, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td rowspan="2" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 4%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 5%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td rowspan="2" style="width: 18%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Revisions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Additional Paid-in Capital&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;519,702&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,603&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;521,305&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Accumulated Deficit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(267,896)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1,603)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$ &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(269,499)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Consolidated Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;For the Three&#13;        Months Ended September 30, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Revisions&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Change in Warrant Liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$ &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(1,451)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Earnings Per Share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(8.24)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;0.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(8.15)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;font style="font-size: 8pt"&gt;Consolidated Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;For the Nine&#13;        Months Ended September 30, 2017&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Previously&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Reported&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Revisions&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Revised&lt;/p&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid"&gt;Report&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Change in Warrant Liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(925)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;Earnings Per Share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(24.38)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(0.16)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(24.54)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock contextRef="From2018-01-01to2018-09-30">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;11&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;71&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 36.25pt"&gt;&lt;font style="font-size: 8pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;61&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;font style="font-size: 8pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#13;        &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 1.5pt double"&gt;$ 212&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-09-30" unitRef="Shares" decimals="INF">2977958</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-09-30" unitRef="Shares" decimals="INF">1514905</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-09-30_custom_ExerciseOfCommonStockWarrantsMember" unitRef="Shares" decimals="INF">1813053</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-09-30_custom_ExerciseOfCommonStockWarrantsMember" unitRef="Shares" decimals="INF">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-09-30_custom_ConversionOfPreferredStockIntoCommonStockMember" unitRef="Shares" decimals="INF">1163659</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-09-30_custom_ConversionOfPreferredStockIntoCommonStockMember" unitRef="Shares" decimals="INF">1513659</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2018-01-01to2018-09-30_custom_ExerciseOfCommonStockOptionsMember" unitRef="Shares" decimals="INF">1246</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2017-01-01to2017-09-30_custom_ExerciseOfCommonStockOptionsMember" unitRef="Shares" decimals="INF">1246</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">1813.053</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-12-31_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">1246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <GTBP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</GTBP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-01-01to2018-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-09-30_us-gaap_StockOptionMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">1246</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">4.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-12-31_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1428.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_us-gaap_StockOptionMember" unitRef="USDPShares" decimals="INF">1428.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">1428.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <GTBP:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">1813.053</GTBP:ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross>
    <GTBP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">1813.053</GTBP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">4.58</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-09-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <GTBP:ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">4.58</GTBP:ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:LeaseAndRentalExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">52000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">9000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-09-30" unitRef="USDPShares" decimals="INF">-24.54</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-09-30_us-gaap_ScenarioPreviouslyReportedMember" unitRef="USDPShares" decimals="INF">-24.38</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-09-30_us-gaap_RestatementAdjustmentMember" unitRef="USDPShares" decimals="INF">-0.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-07-01to2017-09-30" unitRef="USDPShares" decimals="INF">-8.15</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-07-01to2017-09-30_srt_ScenarioPreviouslyReportedMember" unitRef="USDPShares" decimals="INF">-8.24</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-07-01to2017-09-30_srt_RestatementAdjustmentMember" unitRef="USDPShares" decimals="INF">0.09</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-01-01to2017-09-30_us-gaap_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="-3">925000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-01-01to2017-09-30_us-gaap_RestatementAdjustmentMember" unitRef="USD" decimals="-3">-925000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-07-01to2017-09-30_srt_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="-3">-1451000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings contextRef="From2017-07-01to2017-09-30_srt_RestatementAdjustmentMember" unitRef="USD" decimals="-3">1451000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">11000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">69000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">71000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">61000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:CapitalLeasesFutureMinimumPaymentsDue contextRef="AsOf2018-09-30" unitRef="USD" decimals="-3">212000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">7835000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">911000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">1111000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">526000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">10628000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">128768000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">5035000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">126330000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">246977000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">129679000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">234660000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">126856000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-246977000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-129679000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-234660000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-126856000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">7978000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">8467000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">1123000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">3769000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-7978000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-8467000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-1123000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-3769000</us-gaap:NonoperatingIncomeExpense>
    <GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-254955000</GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes>
    <GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-138146000</GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes>
    <GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-235783000</GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes>
    <GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-130625000</GTBP:ParentPortionIncomeLossBeforeProvisionForIncomeTaxes>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-254955000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">-138146000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-235783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">-130625000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-09-30" unitRef="USDPShares" decimals="INF">-5.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-09-30" unitRef="USDPShares" decimals="INF">-24.54</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">-4.70</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-07-01to2017-09-30" unitRef="USDPShares" decimals="INF">-8.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-09-30" unitRef="USDPShares" decimals="INF">-5.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-01-01to2017-09-30" unitRef="USDPShares" decimals="INF">-24.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-07-01to2018-09-30" unitRef="USDPShares" decimals="INF">-4.70</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-07-01to2017-09-30" unitRef="USDPShares" decimals="INF">-8.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-09-30" unitRef="Shares" decimals="INF">50130202</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-09-30" unitRef="Shares" decimals="INF">5628529</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">50154516</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-07-01to2017-09-30" unitRef="Shares" decimals="INF">16027687</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-09-30" unitRef="Shares" decimals="INF">50130202</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-09-30" unitRef="Shares" decimals="INF">5628529</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-07-01to2018-09-30" unitRef="Shares" decimals="INF">50154516</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-07-01to2017-09-30" unitRef="Shares" decimals="INF">16027687</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NonoperatingGainsLosses contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">-228514000</us-gaap:NonoperatingGainsLosses>
    <us-gaap:NonoperatingGainsLosses contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:NonoperatingGainsLosses>
    <us-gaap:NonoperatingGainsLosses contextRef="From2018-07-01to2018-09-30" unitRef="USD" decimals="-3">-228514000</us-gaap:NonoperatingGainsLosses>
    <us-gaap:NonoperatingGainsLosses contextRef="From2017-07-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:NonoperatingGainsLosses>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2018-01-01to2018-09-30" unitRef="USD" decimals="-3">4419000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2017-01-01to2017-09-30" unitRef="USD" decimals="-3">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;The accompanying unaudited&#13;consolidated financial statements of GT Biopharma, Inc. and its subsidiaries (the &amp;#8220;Company,&amp;#8221; &amp;#8220;we&amp;#8221; or &amp;#8220;us&amp;#8221;),&#13;have been prepared in accordance with generally accepted accounting principles in the United States of America (&amp;#8220;GAAP&amp;#8221;)&#13;for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and&#13;Exchange Commission (the &amp;#8220;SEC&amp;#8221;). Accordingly, they do not include all of the information and footnotes required by&#13;GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction&#13;with the audited consolidated financial statements and notes thereto included in the Company&amp;#8217;s annual report on Form 10-K&#13;for the fiscal year ended December 31, 2017 filed with the SEC on March 1, 2018 (the &amp;#8220;Annual Report&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;&lt;i&gt;Business&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;In 1965, the corporate predecessor&#13;of GT Biopharma, Diagnostic Data, Inc. was incorporated in the State of California. Diagnostic Data changed its incorporation to&#13;the State of Delaware in 1972 and changed its name to DDI Pharmaceuticals, Inc. in 1985. In 1994, DDI Pharmaceuticals merged with&#13;International BioClinical, Inc. and Bioxytech S.A. and changed its name to OXIS International, Inc. In July 2017, the Company changed&#13;its name to GT Biopharma, Inc.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;We are a clinical stage biopharmaceutical&#13;company focused on the development and commercialization of novel immuno-oncology products based off our proprietary Natural Killer&#13;(NK) cell engager (Tri-specific Killer Engager (TriKE) &amp;#38; Tetra-specific Killer Engager (TetraKE)) and bi-specific Antibody&#13;Drug Conjugate (bispecific-ADC) technology platforms. Our TriKE and TetraKE platforms generate proprietary moieties designed to&#13;harness and enhance the cancer killing abilities of a patient&amp;#8217;s own natural killer, or NK, cells. Once bound to a NK cell,&#13;our moieties are designed to stimulate the NK cell and precisely direct it to one or more specifically-targeted proteins (tumor&#13;antigens) expressed on a specific type of cancer, ultimately resulting in the cancer cell&amp;#8217;s death. TriKEs and TetraKEs are&#13;made up of recombinant fusion proteins, can be designed to target tumor antigens on hematologic malignancies, sarcomas or solid&#13;tumors and do not require patient-specific customization. They are designed to be dosed in an outpatient setting and are expected&#13;to have reasonably low cost of goods. Our bispecific-ADC platform can generate product candidates that are ligand-directed single-chain&#13;fusion proteins that simultaneously target two tumor antigens. We believe our bispecific-ADC moieties represents the next generation&#13;of ADCs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.45pt 0 0; text-align: justify"&gt;Also, in connection with the&#13;acquisition of Georgetown Translational Pharmaceuticals on September 1, 2017, we acquired a portfolio of IPR&amp;#38;D CNS assets consisting&#13;of innovative reformulations and/or repurposing of existing therapies. These CNS assets address disease states such as chronic&#13;neuropathic pain, myasthenia gravis and motion sickness.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0.05pt 5.7pt 6pt 0; text-align: justify"&gt;The Company&amp;#8217;s&#13;current operations have focused on business planning, raising capital, establishing an intellectual property portfolio, hiring,&#13;and conducting preclinical studies and clinical trials. The Company does not have any product candidates approved for sale and&#13;has not generated any revenue from product sales. The Company has sustained operating losses since inception and expects such losses&#13;to continue over the foreseeable future.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.5pt 6pt 0; text-align: justify"&gt;The financial statements&#13;of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of&#13;liabilities in the normal course of business. Accordingly, the financial statements do not include any adjustments that might be&#13;necessary should the Company be unable to continue in existence.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0.05pt 5.45pt 6pt 0; text-align: justify"&gt;The Company has incurred&#13;substantial losses and negative cash flows from operations since its inception and has an accumulated deficit of $524.5 million&#13;and cash of $1.2 million as of September 30, 2018. The Company anticipates incurring additional losses until such time, if ever,&#13;that it can generate significant sales of its products currently in development. Substantial additional financing will be needed&#13;by the Company to fund its operations and to commercially develop its product candidates. These factors raise substantial doubt&#13;about the Company&amp;#8217;s ability to continue as a going concern.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"&gt;Management is currently&#13;evaluating different strategies to obtain the required funding for future operations. These strategies may include but are&#13;not limited to: public offerings of equity and/or debt securities, payments from potential strategic research and&#13;development, and licensing and/or marketing arrangements with pharmaceutical companies. Management has also implemented cost&#13;saving efforts, including reduction in executive salaries and reduced travel. Management believes that these ongoing and&#13;planned financing endeavors, if successful, will provide adequate financial resources to continue as a going concern for at&#13;least the next six months from the date the financial statements are issued. However, there can be no assurance in this&#13;regard. If the Company is unable to secure adequate additional funding, its business, operating results, financial condition&#13;and cash flows may be materially and adversely affected.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The financial&#13;statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity.&#13;These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently&#13;applied in the preparation of the financial statements. The preparation of financial statements requires management to make estimates&#13;and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosures of contingent assets&#13;and liabilities at the date of the financial statements. Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Basis of Consolidation and Comprehensive&#13;Income&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying consolidated financial&#13;statements include the accounts of GT Biopharma, Inc. and its subsidiaries. All intercompany balances and transactions have been&#13;eliminated. The Company's financial statements are prepared using the accrual method of accounting.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited interim condensed&#13;consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&amp;#8220;U.S.&#13;GAAP&amp;#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). Certain information&#13;and disclosures required by U.S. GAAP for complete consolidated financial statements have been condensed or omitted herein. The&#13;interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements&#13;and notes thereto included in the Company's Form 10-K for the year ended December 31, 2017. The unaudited interim condensed consolidated&#13;financial information presented herein reflects all normal adjustments that are, in the opinion of management, necessary for a&#13;fair statement of the financial position, results of operations and cash flows for the periods presented. The Company is responsible&#13;for the unaudited interim consolidated financial statements included in this report. The results of operations of any interim period&#13;are not necessarily indicative of the results for the full year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all highly liquid&#13;investments with original maturities of three months or less to be cash equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's cash and cash equivalents,&#13;marketable securities and accounts receivable are monitored for exposure to concentrations of credit risk. The Company maintains&#13;substantially all of its cash balances in a limited number of financial institutions. The balances are each insured by the Federal&#13;Deposit Insurance Corporation up to $250,000. The Company had $982,000 of balances in excess of this limit at September 30, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock Based Compensation to Employees&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its stock-based&#13;compensation for employees in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 718.&amp;#160;&amp;#160;The Company&#13;recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued&#13;to employees and non-employees over the related vesting period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company granted no stock options&#13;during the nine months ended September 30, 2018 and 2017, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Critical&#13;Accounting Policies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;We consider&#13;the following accounting policies to be critical given they involve estimates and judgments made by management and are important&#13;for our investors&amp;#8217; understanding of our operating results and financial condition.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Long-Lived&#13;Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our long-lived assets include property,&#13;plant and equipment, capitalized costs of filing patent applications and other indefinite lived intangible assets. We evaluate&#13;our long-lived assets for impairment, other than indefinite lived intangible assets, in accordance with ASC 360, whenever events&#13;or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Estimates of future cash flows&#13;and timing of events for evaluating long-lived assets for impairment are based upon management&amp;#8217;s judgment. If any of our&#13;intangible or long-lived assets are considered to be impaired, the amount of impairment to be recognized is the excess of the carrying&#13;amount of the assets over its fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Applicable long-lived assets are amortized&#13;or depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or&#13;the statutory or contractual term in the case of patents. Estimates of useful lives and periods of expected revenue generation&#13;are reviewed periodically for appropriateness and are based upon management&amp;#8217;s judgment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Impairment of Long-Lived Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company's long-lived assets currently&#13;consist of indefinite lived intangible assets associated with IPR&amp;#38;D (&amp;#8220;In-Process Research &amp;#38; Development&amp;#8221;) projects&#13;and related capitalized patents acquired in the acquisition of Georgetown Translational Pharmaceuticals, Inc. as described in Note&#13;2 below. &amp;#160;Intangible assets associated with IPR&amp;#38;D projects are not amortized until approval by the Food and Drug Administration&#13;(FDA) is obtained in a major market subject to certain specified conditions and management judgment. The useful life of an amortizing&#13;asset generally is determined by identifying the period in which substantially all of the cash flows are expected to be generated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates indefinite lived&#13;intangible assets for impairment at least annually and whenever impairment indicators are present in accordance with ASC 350. When&#13;necessary, the Company records an impairment loss for the amount by which the fair value is less than the carrying value of these&#13;assets. The fair value of intangible assets other than goodwill is typically determined using the &amp;#8220;relief from royalty method&amp;#8221;,&#13;specifically the discounted cash flow method utilizing Level 3 fair value inputs. Some of the more significant estimates and assumptions&#13;inherent in this approach include: the amount and timing of the projected net cash flows, which includes the expected impact of&#13;competitive, legal and/or regulatory forces on the projections and the impact of technological risk associated with IPR&amp;#38;D assets,&#13;as well as the selection of a long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the&#13;projected cash flows; and the tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company performs impairment testing&#13;for all other long-lived assets whenever impairment indicators are present. When necessary, the Company calculates the undiscounted&#13;value of the projected cash flows associated with the asset, or asset group, and compares this estimated amount to the carrying&#13;amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes&#13;using the asset and liability approach, whereby deferred income tax assets and liabilities are recognized for the estimated future&#13;tax effects, based on current enacted tax laws, of temporary differences between financial and tax reporting for current and prior&#13;periods. Deferred tax assets are reduced, if necessary, by a valuation allowance if the corresponding future tax benefits may not&#13;be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Net Income (Loss) per Share&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic net income (loss) per share is&#13;computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period.&#13;Diluted net income (loss) per share is computed by dividing the net loss for the period by the weighted average number of common&#13;shares outstanding during the period, plus the potential dilutive effect of common shares issuable upon exercise or conversion&#13;of outstanding stock options and warrants during the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"&gt;The computation of basic and diluted net loss per share for&#13;the nine months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities&#13;because their inclusion would be anti-dilutive:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;September 30,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="width: 67%; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; text-align: center; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Exercise of common stock warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,813,053&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Conversion of preferred stock into common stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,163,659&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,513,659&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Exercise of common stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,246&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,246&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;2,977,958&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 107%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;1,514,905&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Patents&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Acquired patents are capitalized at their&#13;acquisition cost or fair value. The legal costs, patent registration fees and models and drawings required for filing patent applications&#13;are capitalized if they relate to commercially viable technologies. Commercially viable technologies are those technologies that&#13;are projected to generate future positive cash flows in the near term. Legal costs associated with patent applications that are&#13;not determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing the&#13;patentable idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident&#13;increase in the value of the patents are capitalized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Capitalized costs for pending patents&#13;are amortized on a straight-line basis over the remaining twenty-year legal life of each patent after the costs have been incurred.&#13;Once each patent is issued, capitalized costs are amortized on a straight-line basis over the shorter of the patent's remaining&#13;statutory life, estimated economic life or ten years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fixed Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fixed assets are stated at cost. Depreciation&#13;is computed on a straight-line basis over the estimated useful lives of the assets, which are 3 to 10&amp;#160;years for machinery&#13;and equipment and the shorter of the lease term or estimated economic life for leasehold improvements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fair Value&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying amounts reported in the&#13;balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair&#13;value because of the short period of time between the origination of such instruments and their expected realization and their&#13;current market rate of interest.&amp;#160; The three levels are defined as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. The Company&amp;#8217;s Level 1 assets include cash equivalents, primarily institutional money market funds, whose carrying value represents fair value because of their short-term maturities of the investments held by these funds.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Fair value is determined using the Black-Scholes valuation model based on observable market inputs, such as share price data and a discount rate consistent with that of a government-issued security of a similar maturity. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; line-height: 107%"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; line-height: 107%"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Research and Development&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are expensed&#13;as incurred and reported as research and development expense. Research and development costs totaled $7.8 million and $0.9 million&#13;for the nine months ended September 30, 2018 and 2017, respectively. Research and development costs for the nine months ended September&#13;30, 2018 included non-cash compensation of $6.5 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;License Revenue&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;License arrangements may consist of non-refundable&#13;upfront license fees, exclusive licensed rights to patented or patent pending technology, and various performance or sales milestones&#13;and future product royalty payments. Some of these arrangements are multiple element arrangements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Non-refundable, up-front fees that are&#13;not contingent on any future performance by us, and require no consequential continuing involvement on our part, are recognized&#13;as revenue when the license term commences and the licensed data, technology and/or compound is delivered.&amp;#160;&amp;#160;We defer&#13;recognition of non-refundable upfront fees if we have continuing performance obligations without which the technology, right, product&#13;or service conveyed in conjunction with the non-refundable fee has no utility to the licensee that is separate and independent&#13;of our performance under the other elements of the arrangement. In addition, if we have continuing involvement through research&#13;and development services that are required because our know-how and expertise related to the technology is proprietary to us, or&#13;can only be performed by us, then such up-front fees are deferred and recognized over the period of continuing involvement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Payments related to substantive, performance-based&#13;milestones in a research and development arrangement are recognized as revenue upon the achievement of the milestones as specified&#13;in the underlying agreements when they represent the culmination of the earnings process. As of September 30, 2018, the Company&#13;has not generated any licensing revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2018-01-01to2018-09-30">&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying amounts reported in the&#13;balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair&#13;value because of the short period of time between the origination of such instruments and their expected realization and their&#13;current market rate of interest.&amp;#160; The three levels are defined as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. The Company&amp;#8217;s Level 1 assets include cash equivalents, primarily institutional money market funds, whose carrying value represents fair value because of their short-term maturities of the investments held by these funds.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Fair value is determined using the Black-Scholes valuation model based on observable market inputs, such as share price data and a discount rate consistent with that of a government-issued security of a similar maturity. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 24px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"&gt;&lt;font style="font: 8pt Symbol"&gt;&amp;#183;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;font style="font: 8pt Times New Roman, Times, Serif"&gt;Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>19
<FILENAME>gtbp-20180930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /6kps7xRiXgen8uKYXQsSaGMKaPtxZp8uZlBuWpwbQkKfy4o/xsH5iNn4hjWkT4P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:GTBP="http://gtbiopharma.com/20180930" elementFormDefault="qualified" targetNamespace="http://gtbiopharma.com/20180930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://gtbiopharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" id="Note1-CompanyAndSummaryOfSignificantAccountingPolicies">
	  <link:definition>00000006 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note2-Intangibles" id="Note2-Intangibles">
	  <link:definition>00000007 - Disclosure - Note 2 - Intangibles</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note3-Debt" id="Note3-Debt">
	  <link:definition>00000008 - Disclosure - Note 3 - Debt</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note4-StockholdersEquity" id="Note4-StockholdersEquity">
	  <link:definition>00000009 - Disclosure - Note 4 - Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" id="Note5-StockOptionsAndWarrants">
	  <link:definition>00000010 - Disclosure - Note 5 - Stock Options and Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" id="Note6-CommitmentsAndContingencies">
	  <link:definition>00000011 - Disclosure - Note 6 - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" id="Note7-ChangeOnAccountingMethod">
	  <link:definition>00000012 - Disclosure - Note 7 - Change on Accounting Method</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note8-SubsequentEvents" id="Note8-SubsequentEvents">
	  <link:definition>00000013 - Disclosure - Note 8 - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" id="CompanyAndSummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000014 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" id="Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000015 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" id="StockOptionsAndWarrantsTables">
	  <link:definition>00000016 - Disclosure - Note 5 - Stock Options and Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" id="Note7-ChangeOnAccountingMethodTables">
	  <link:definition>00000017 - Disclosure - Note 7 - Change on Accounting Method (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" id="Note8-SubsequentEventsTables">
	  <link:definition>00000018 - Disclosure - Note 8 - Subsequent Events (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" id="Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails">
	  <link:definition>00000019 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" id="CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000020 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" id="StockOptionsAndWarrantsDetails">
	  <link:definition>00000021 - Disclosure - Note 5 - Stock Options and Warrants (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" id="Note5-StockOptionsAndWarrantsDetails1">
	  <link:definition>00000022 - Disclosure - Note 5 - Stock Options and Warrants (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" id="Note6-CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Note 6 - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" id="Note7-ChangeOnAccountingMethodDetails">
	  <link:definition>00000024 - Disclosure - Note 7 - Change on Accounting Method (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" id="Note8-SubsequentEventsDetails">
	  <link:definition>00000025 - Disclosure - Note 8 - Subsequent Events (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="gtbp-20180930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gtbp-20180930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gtbp-20180930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gtbp-20180930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
    <element id="GTBP_NoteAllonge" name="NoteAllonge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes" name="IssuanceOfCommonStockUponConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" name="AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_LongLivedAssetsPolicyTextBlock" name="LongLivedAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" name="ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note1Member" name="Note1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note2Member" name="Note2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note3Member" name="Note3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note4Member" name="Note4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note5Member" name="Note5Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note6Member" name="Note6Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note7Member" name="Note7Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note8Member" name="Note8Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note9Member" name="Note9Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note10Member" name="Note10Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note11Member" name="Note11Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note12Member" name="Note12Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note13Member" name="Note13Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note14Member" name="Note14Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note15Member" name="Note15Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note16Member" name="Note16Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note17Member" name="Note17Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note18Member" name="Note18Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note19Member" name="Note19Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note20Member" name="Note20Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note21Member" name="Note21Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_SeriesIPreferredStockMember" name="SeriesIPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_SeriesJPreferredStockMember" name="SeriesJPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ExerciseOfCommonStockWarrantsMember" name="ExerciseOfCommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ConversionOfPreferredStockIntoCommonStockMember" name="ConversionOfPreferredStockIntoCommonStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ExerciseOfCommonStockOptionsMember" name="ExerciseOfCommonStockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_ChangeOnAccountingMethodAbstract" name="ChangeOnAccountingMethodAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" name="CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" name="Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_StockOptionsAndWarrantsTablesAbstract" name="StockOptionsAndWarrantsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note6ChangeOnAccountingMethodTablesAbstract" name="Note6ChangeOnAccountingMethodTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note8SubsequentEventsTablesAbstract" name="Note8SubsequentEventsTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesDetailsAbstract" name="Note1CompanyAndSummaryOfSignificantAccountingPoliciesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" name="CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_StockOptionsAndWarrantsDetailsAbstract" name="StockOptionsAndWarrantsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_StockOptionsAndWarrantsDetails1Abstract" name="StockOptionsAndWarrantsDetails1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" name="Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note6ChangeOnAccountingMethodDetailsAbstract" name="Note6ChangeOnAccountingMethodDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="GTBP_Note8SubsequentEventsDetailsAbstract" name="Note8SubsequentEventsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>20
<FILENAME>gtbp-20180930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:href="gtbp-20180930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheets" xlink:href="gtbp-20180930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:href="gtbp-20180930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note2-Intangibles" xlink:href="gtbp-20180930.xsd#Note2-Intangibles" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note3-Debt" xlink:href="gtbp-20180930.xsd#Note3-Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:href="gtbp-20180930.xsd#Note4-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethod" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingGainsLosses" xlink:label="loc_us-gaapNonoperatingGainsLosses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapNonoperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:label="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_NoteAllonge" xlink:label="loc_GTBPNoteAllonge" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GTBPNoteAllonge" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingGainsLosses" xlink:label="loc_us-gaapNonoperatingGainsLosses" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNonoperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaapProceedsFromMinorityShareholders" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapProceedsFromMinorityShareholders" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note2-Intangibles" xlink:title="00000007 - Disclosure - Note 2 - Intangibles" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note3-Debt" xlink:title="00000008 - Disclosure - Note 3 - Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:title="00000009 - Disclosure - Note 4 - Stockholders' Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:title="00000010 - Disclosure - Note 5 - Stock Options and Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:title="00000011 - Disclosure - Note 6 - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:title="00000012 - Disclosure - Note 7 - Change on Accounting Method" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:title="00000013 - Disclosure - Note 8 - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000014 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000015 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:title="00000016 - Disclosure - Note 5 - Stock Options and Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:title="00000017 - Disclosure - Note 7 - Change on Accounting Method (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:title="00000018 - Disclosure - Note 8 - Subsequent Events (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000019 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000020 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000021 - Disclosure - Note 5 - Stock Options and Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:title="00000022 - Disclosure - Note 5 - Stock Options and Warrants (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Note 6 - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:title="00000024 - Disclosure - Note 7 - Change on Accounting Method (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:title="00000025 - Disclosure - Note 8 - Subsequent Events (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>21
<FILENAME>gtbp-20180930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:href="gtbp-20180930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheets" xlink:href="gtbp-20180930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:href="gtbp-20180930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note2-Intangibles" xlink:href="gtbp-20180930.xsd#Note2-Intangibles" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note3-Debt" xlink:href="gtbp-20180930.xsd#Note3-Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:href="gtbp-20180930.xsd#Note4-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethod" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_SeriesJPreferredStockMember" xlink:label="loc_GTBPSeriesJPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GTBPSeriesJPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapDepositsAssetsNoncurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssetsNoncurrent_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableCurrent_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLineOfCredit_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapConvertibleDebtCurrent_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapMinorityInterest_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_SeriesJPreferredStockMember" xlink:label="loc_GTBPSeriesJPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GTBPSeriesJPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note2-Intangibles" xlink:title="00000007 - Disclosure - Note 2 - Intangibles" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note3-Debt" xlink:title="00000008 - Disclosure - Note 3 - Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:title="00000009 - Disclosure - Note 4 - Stockholders' Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:title="00000010 - Disclosure - Note 5 - Stock Options and Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:title="00000011 - Disclosure - Note 6 - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:title="00000012 - Disclosure - Note 7 - Change on Accounting Method" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:title="00000013 - Disclosure - Note 8 - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000014 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000015 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:title="00000016 - Disclosure - Note 5 - Stock Options and Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:title="00000017 - Disclosure - Note 7 - Change on Accounting Method (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:title="00000018 - Disclosure - Note 8 - Subsequent Events (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000019 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockWarrantsMember" xlink:label="loc_GTBPExerciseOfCommonStockWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPExerciseOfCommonStockWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ConversionOfPreferredStockIntoCommonStockMember" xlink:label="loc_GTBPConversionOfPreferredStockIntoCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPConversionOfPreferredStockIntoCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockOptionsMember" xlink:label="loc_GTBPExerciseOfCommonStockOptionsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPExerciseOfCommonStockOptionsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000020 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000021 - Disclosure - Note 5 - Stock Options and Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_GTBPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_GTBPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:title="00000022 - Disclosure - Note 5 - Stock Options and Warrants (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Note 6 - Commitments and Contingencies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:title="00000024 - Disclosure - Note 7 - Change on Accounting Method (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaapChangeInAccountingPrincipleMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="loc_us-gaapChangeInAccountingPrincipleMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaapChangeInAccountingPrincipleMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="loc_us-gaapChangeInAccountingPrincipleMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapChangeInAccountingPrincipleMember" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapChangeInAccountingPrincipleMember" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted_100" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:title="00000025 - Disclosure - Note 8 - Subsequent Events (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>22
<FILENAME>gtbp-20180930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">WarrantMember</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_SeriesJPreferredStockMember" xlink:label="GTBP_SeriesJPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_SeriesJPreferredStockMember" xlink:to="GTBP_SeriesJPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_SeriesJPreferredStockMember_lbl" xml:lang="en-US">Series J</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis_lbl" xml:lang="en-US">Adjustments for Change in Accounting Principle [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Revisions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockWarrantsMember" xlink:label="GTBP_ExerciseOfCommonStockWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ExerciseOfCommonStockWarrantsMember" xlink:to="GTBP_ExerciseOfCommonStockWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ExerciseOfCommonStockWarrantsMember_lbl" xml:lang="en-US">Exercise of common stock warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ConversionOfPreferredStockIntoCommonStockMember" xlink:label="GTBP_ConversionOfPreferredStockIntoCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ConversionOfPreferredStockIntoCommonStockMember" xlink:to="GTBP_ConversionOfPreferredStockIntoCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ConversionOfPreferredStockIntoCommonStockMember_lbl" xml:lang="en-US">Conversion of preferred stock into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockOptionsMember" xlink:label="GTBP_ExerciseOfCommonStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ExerciseOfCommonStockOptionsMember" xlink:to="GTBP_ExerciseOfCommonStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ExerciseOfCommonStockOptionsMember_lbl" xml:lang="en-US">Exercise of common stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_DocumentAndEntityInformationAbstract" xlink:label="GTBP_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_DocumentAndEntityInformationAbstract" xlink:to="GTBP_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Fixed assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible debentures, net of discount of $488</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' Deficit:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock - $0.001 par value; 750,000,000 shares authorized; and 50,227,978 and 50,117,977 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Convertible debentures, current, discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingGainsLosses" xlink:label="us-gaap_NonoperatingGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingGainsLosses" xlink:to="us-gaap_NonoperatingGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NonoperatingGainsLosses_lbl" xml:lang="en-US">Loss on impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:label="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:to="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted Average Shares Outstanding &#8211; basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingGainsLosses" xlink:to="us-gaap_NonoperatingGainsLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_NonoperatingGainsLosses_2_lbl" xml:lang="en-US">Loss on impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation expense for options and warrants issued to employees and non-employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_NoteAllonge" xlink:label="GTBP_NoteAllonge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_NoteAllonge" xlink:to="GTBP_NoteAllonge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_NoteAllonge_lbl" xml:lang="en-US">Note Allonge</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Non-cash interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of loan costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Acquisition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="us-gaap_PaymentsOfLoanCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl" xml:lang="en-US">Loan costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="us-gaap_ProceedsFromMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl" xml:lang="en-US">Minority Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - Beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-Cash Investing and Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes" xlink:label="GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes" xlink:to="GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes_lbl" xml:lang="en-US">Issuance of common stock upon conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" xlink:label="GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" xlink:to="GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock_lbl" xml:lang="en-US">Acquisition of intangibles through issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">The Company and Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_lbl" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="us-gaap_GuaranteesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GuaranteesAbstract" xlink:to="us-gaap_GuaranteesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GuaranteesAbstract_lbl" xml:lang="en-US">Guarantees [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options and Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ChangeOnAccountingMethodAbstract" xlink:label="GTBP_ChangeOnAccountingMethodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ChangeOnAccountingMethodAbstract" xlink:to="GTBP_ChangeOnAccountingMethodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ChangeOnAccountingMethodAbstract_lbl" xml:lang="en-US">Note 7 - Change On Accounting Method</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">Change on Accounting Method</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xml:lang="en-US">Company And Summary Of Significant Accounting Policies Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Basis of Consolidation and Comprehensive Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy_lbl" xml:lang="en-US">Stock Based Compensation to Employees</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_LongLivedAssetsPolicyTextBlock" xlink:label="GTBP_LongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_LongLivedAssetsPolicyTextBlock" xlink:to="GTBP_LongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_LongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income (Loss) per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" xlink:label="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" xlink:to="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract_lbl" xml:lang="en-US">Note 1 - Company And Summary Of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_StockOptionsAndWarrantsTablesAbstract" xlink:label="GTBP_StockOptionsAndWarrantsTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_StockOptionsAndWarrantsTablesAbstract" xlink:to="GTBP_StockOptionsAndWarrantsTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_StockOptionsAndWarrantsTablesAbstract_lbl" xml:lang="en-US">Stock Options And Warrants Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Summary of the stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Summary of the warrant activity</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note6ChangeOnAccountingMethodTablesAbstract" xlink:label="GTBP_Note6ChangeOnAccountingMethodTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_Note6ChangeOnAccountingMethodTablesAbstract" xlink:to="GTBP_Note6ChangeOnAccountingMethodTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GTBP_Note6ChangeOnAccountingMethodTablesAbstract_lbl" xml:lang="en-US">Note 7 - Change On Accounting Method</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Adoption of new accounting standard</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note8SubsequentEventsTablesAbstract" xlink:label="GTBP_Note8SubsequentEventsTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_Note8SubsequentEventsTablesAbstract" xlink:to="GTBP_Note8SubsequentEventsTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_Note8SubsequentEventsTablesAbstract_lbl" xml:lang="en-US">Note 8 - Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock_lbl" xml:lang="en-US">Future minimum lease commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Anti-dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:label="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:to="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract_lbl" xml:lang="en-US">Company And Summary Of Significant Accounting Policies Tables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_4_lbl" xml:lang="en-US">Cash and cash equivalent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_lbl" xml:lang="en-US">Diluted shares excluded from calcuation of EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding as of December 31, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding as of September 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable as of September 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding as of December 31, 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding as of September 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable as of September 30, 2018</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2_lbl" xml:lang="en-US">Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_lbl" xml:lang="en-US">Exercisable as of September 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Exercisable as of September 30, 2018</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" xlink:label="GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" xlink:to="GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract_lbl" xml:lang="en-US">Note 6 - Commitments And Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_2_lbl" xml:lang="en-US">Additional Paid in Capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in Warrant Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note8SubsequentEventsDetailsAbstract" xlink:label="GTBP_Note8SubsequentEventsDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_Note8SubsequentEventsDetailsAbstract" xlink:to="GTBP_Note8SubsequentEventsDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="GTBP_Note8SubsequentEventsDetailsAbstract_lbl" xml:lang="en-US">Note 8 - Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingGainsLosses" xlink:to="us-gaap_NonoperatingGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingGainsLosses_3_lbl" xml:lang="en-US">Nonoperating Gains (Losses)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:to="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes_2_lbl" xml:lang="en-US">Series I - Preferred stock, issued shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfLoanCosts_2_lbl" xml:lang="en-US">Payments of Loan Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>23
<FILENAME>gtbp-20180930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 4.24a -->
    <!-- Field: Doc-Info; Name: Source; Value: 182382 09302018 10Q3.xfr; Date: 2018%2D11%2D13T23:23:05Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:href="gtbp-20180930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheets" xlink:href="gtbp-20180930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:href="gtbp-20180930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="gtbp-20180930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note2-Intangibles" xlink:href="gtbp-20180930.xsd#Note2-Intangibles" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note3-Debt" xlink:href="gtbp-20180930.xsd#Note3-Debt" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:href="gtbp-20180930.xsd#Note4-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethod" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:href="gtbp-20180930.xsd#Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:href="gtbp-20180930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:href="gtbp-20180930.xsd#Note5-StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:href="gtbp-20180930.xsd#Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:href="gtbp-20180930.xsd#Note7-ChangeOnAccountingMethodDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:href="gtbp-20180930.xsd#Note8-SubsequentEventsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_DocumentAndEntityInformationAbstract" xlink:label="loc_GTBPDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_SeriesJPreferredStockMember" xlink:label="loc_GTBPSeriesJPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GTBPSeriesJPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="loc_us-gaapSeriesCPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesCPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_SeriesJPreferredStockMember" xlink:label="loc_GTBPSeriesJPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_GTBPSeriesJPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingGainsLosses" xlink:label="loc_us-gaapNonoperatingGainsLosses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapNonoperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:label="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_GTBPParentPortionIncomeLossBeforeProvisionForIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingGainsLosses" xlink:label="loc_us-gaapNonoperatingGainsLosses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNonoperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_NoteAllonge" xlink:label="loc_GTBPNoteAllonge" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_GTBPNoteAllonge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaapProceedsFromMinorityShareholders" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromMinorityShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes" xlink:label="loc_GTBPIssuanceOfCommonStockUponConversionOfConvertibleNotes" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_GTBPIssuanceOfCommonStockUponConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock" xlink:label="loc_GTBPAcquisitionOfIntangiblesThroughIssuanceOfCommonStock" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_GTBPAcquisitionOfIntangiblesThroughIssuanceOfCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note2-Intangibles" xlink:title="00000007 - Disclosure - Note 2 - Intangibles">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwillAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note3-Debt" xlink:title="00000008 - Disclosure - Note 3 - Debt">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note4-StockholdersEquity" xlink:title="00000009 - Disclosure - Note 4 - Stockholders' Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants" xlink:title="00000010 - Disclosure - Note 5 - Stock Options and Warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="loc_us-gaapGuaranteesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGuaranteesAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies" xlink:title="00000011 - Disclosure - Note 6 - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod" xlink:title="00000012 - Disclosure - Note 7 - Change on Accounting Method">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ChangeOnAccountingMethodAbstract" xlink:label="loc_GTBPChangeOnAccountingMethodAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPChangeOnAccountingMethodAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEvents" xlink:title="00000013 - Disclosure - Note 8 - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000014 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansDirectorPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_LongLivedAssetsPolicyTextBlock" xlink:label="loc_GTBPLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_GTBPLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000015 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" xlink:label="loc_GTBPNote1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsTables" xlink:title="00000016 - Disclosure - Note 5 - Stock Options and Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_StockOptionsAndWarrantsTablesAbstract" xlink:label="loc_GTBPStockOptionsAndWarrantsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPStockOptionsAndWarrantsTablesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPStockOptionsAndWarrantsTablesAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables" xlink:title="00000017 - Disclosure - Note 7 - Change on Accounting Method (Tables)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note6ChangeOnAccountingMethodTablesAbstract" xlink:label="loc_GTBPNote6ChangeOnAccountingMethodTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote6ChangeOnAccountingMethodTablesAbstract" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsTables" xlink:title="00000018 - Disclosure - Note 8 - Subsequent Events (Tables)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note8SubsequentEventsTablesAbstract" xlink:label="loc_GTBPNote8SubsequentEventsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsTablesAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000019 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesDetailsAbstract" xlink:label="loc_GTBPNote1CompanyAndSummaryOfSignificantAccountingPoliciesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote1CompanyAndSummaryOfSignificantAccountingPoliciesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockWarrantsMember" xlink:label="loc_GTBPExerciseOfCommonStockWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPExerciseOfCommonStockWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ConversionOfPreferredStockIntoCommonStockMember" xlink:label="loc_GTBPConversionOfPreferredStockIntoCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPConversionOfPreferredStockIntoCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ExerciseOfCommonStockOptionsMember" xlink:label="loc_GTBPExerciseOfCommonStockOptionsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_GTBPExerciseOfCommonStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000020 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:label="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails" xlink:title="00000021 - Disclosure - Note 5 - Stock Options and Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_StockOptionsAndWarrantsDetailsAbstract" xlink:label="loc_GTBPStockOptionsAndWarrantsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPStockOptionsAndWarrantsDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_GTBPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_GTBPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1" xlink:title="00000022 - Disclosure - Note 5 - Stock Options and Warrants (Details 1)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_StockOptionsAndWarrantsDetails1Abstract" xlink:label="loc_GTBPStockOptionsAndWarrantsDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPStockOptionsAndWarrantsDetails1Abstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_GTBPShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000023 - Disclosure - Note 6 - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract" xlink:label="loc_GTBPNote5CommitmentsAndContingenciesDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote5CommitmentsAndContingenciesDetailsNarrativeAbstract" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails" xlink:title="00000024 - Disclosure - Note 7 - Change on Accounting Method (Details)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note6ChangeOnAccountingMethodDetailsAbstract" xlink:label="loc_GTBPNote6ChangeOnAccountingMethodDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote6ChangeOnAccountingMethodDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis" xlink:label="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ChangeInAccountingPrincipleMember" xlink:label="loc_us-gaapChangeInAccountingPrincipleMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForChangeInAccountingPrincipleAxis" xlink:to="loc_us-gaapChangeInAccountingPrincipleMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingPrincipleMember" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingPrincipleMember" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://gtbiopharma.com/role/Note8-SubsequentEventsDetails" xlink:title="00000025 - Disclosure - Note 8 - Subsequent Events (Details)">
      <link:loc xlink:type="locator" xlink:href="gtbp-20180930.xsd#GTBP_Note8SubsequentEventsDetailsAbstract" xlink:label="loc_GTBPNote8SubsequentEventsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CapitalLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_GTBPNote8SubsequentEventsDetailsAbstract" xlink:to="loc_us-gaapCapitalLeasesFutureMinimumPaymentsDue" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6792797376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Nov. 14, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GT Biopharma, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000109657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting Status Current?</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502,279,78.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793302336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,232<span></span>
</td>
<td class="nump">$ 576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">1,247<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">25,263<span></span>
</td>
<td class="nump">253,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Other Assets</a></td>
<td class="nump">25,289<span></span>
</td>
<td class="nump">253,792<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">26,536<span></span>
</td>
<td class="nump">254,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,251<span></span>
</td>
<td class="nump">2,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debentures, net of discount of $488</a></td>
<td class="nump">10,597<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">13,223<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">13,223<span></span>
</td>
<td class="nump">2,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $0.001 par value; 750,000,000 shares authorized; and 50,227,978 and 50,117,977 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">537,883<span></span>
</td>
<td class="nump">521,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(524,453)<span></span>
</td>
<td class="num">(269,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="num">(169)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Deficit</a></td>
<td class="nump">13,313<span></span>
</td>
<td class="nump">251,689<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT</a></td>
<td class="nump">26,536<span></span>
</td>
<td class="nump">254,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized:</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember', window );">Series J</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized:</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793768224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Convertible debentures, current, discount</a></td>
<td class="nump">$ 488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">50,227,978<span></span>
</td>
<td class="nump">50,117,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">50,227,978<span></span>
</td>
<td class="nump">50,117,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="nump">96,230<span></span>
</td>
<td class="nump">96,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="nump">96,230<span></span>
</td>
<td class="nump">96,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember', window );">Series J</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued</a></td>
<td class="nump">1,163,548<span></span>
</td>
<td class="nump">1,163,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="nump">1,163,548<span></span>
</td>
<td class="nump">1,163,548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=GTBP_SeriesJPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793184352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
<td class="nump">$ 7,835<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">5,035<span></span>
</td>
<td class="nump">126,330<span></span>
</td>
<td class="nump">10,628<span></span>
</td>
<td class="nump">128,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingGainsLosses', window );">Loss on impairment</a></td>
<td class="nump">228,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">228,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">234,660<span></span>
</td>
<td class="nump">126,856<span></span>
</td>
<td class="nump">246,977<span></span>
</td>
<td class="nump">129,679<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from Operations</a></td>
<td class="num">(234,660)<span></span>
</td>
<td class="num">(126,856)<span></span>
</td>
<td class="num">(246,977)<span></span>
</td>
<td class="num">(129,679)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,123)<span></span>
</td>
<td class="num">(3,769)<span></span>
</td>
<td class="num">(7,978)<span></span>
</td>
<td class="num">(8,467)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(1,123)<span></span>
</td>
<td class="num">(3,769)<span></span>
</td>
<td class="num">(7,978)<span></span>
</td>
<td class="num">(8,467)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes', window );">Loss before provision for income taxes</a></td>
<td class="num">(235,783)<span></span>
</td>
<td class="num">(130,625)<span></span>
</td>
<td class="num">(254,955)<span></span>
</td>
<td class="num">(138,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (235,783)<span></span>
</td>
<td class="num">$ (130,625)<span></span>
</td>
<td class="num">$ (254,955)<span></span>
</td>
<td class="num">$ (138,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="num">$ (4.70)<span></span>
</td>
<td class="num">$ (8.15)<span></span>
</td>
<td class="num">$ (5.09)<span></span>
</td>
<td class="num">$ (24.54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="num">$ (4.70)<span></span>
</td>
<td class="num">$ (8.15)<span></span>
</td>
<td class="num">$ (5.09)<span></span>
</td>
<td class="num">$ (24.54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted Average Shares Outstanding &#8211; basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">50,154,516<span></span>
</td>
<td class="nump">16,027,687<span></span>
</td>
<td class="nump">50,130,202<span></span>
</td>
<td class="nump">5,628,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">50,154,516<span></span>
</td>
<td class="nump">16,027,687<span></span>
</td>
<td class="nump">50,130,202<span></span>
</td>
<td class="nump">5,628,529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ParentPortionIncomeLossBeforeProvisionForIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6792920848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (254,955)<span></span>
</td>
<td class="num">$ (138,146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingGainsLosses', window );">Loss on impairment of long-lived assets</a></td>
<td class="nump">228,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense for options and warrants issued to employees and non-employees</a></td>
<td class="nump">8,191<span></span>
</td>
<td class="nump">125,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discounts</a></td>
<td class="nump">7,816<span></span>
</td>
<td class="nump">4,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_NoteAllonge', window );">Note Allonge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of loan costs</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid Expenses</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">1,880<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(9,433)<span></span>
</td>
<td class="num">(3,278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of fixed assets</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="nump">15,045<span></span>
</td>
<td class="nump">5,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Loan costs</a></td>
<td class="num">(533)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="nump">4,419<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">10,093<span></span>
</td>
<td class="nump">5,991<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">2,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS - Beginning of period</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS - End of period</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes', window );">Issuance of common stock upon conversion of convertible notes</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock', window );">Acquisition of intangibles through issuance of common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 253,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_AcquisitionOfIntangiblesThroughIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_IssuanceOfCommonStockUponConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_NoteAllonge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_NoteAllonge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfLoanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784206912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - The Company and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">The Company and Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify">The accompanying unaudited
consolidated financial statements of GT Biopharma, Inc. and its subsidiaries (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;us&#8221;),
have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;)
for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and
Exchange Commission (the &#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by
GAAP for complete financial statements. The information included in this quarterly report on Form 10-Q should be read in conjunction
with the audited consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K
for the fiscal year ended December 31, 2017 filed with the SEC on March 1, 2018 (the &#8220;Annual Report&#8221;).</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"><i>Business</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify">In 1965, the corporate predecessor
of GT Biopharma, Diagnostic Data, Inc. was incorporated in the State of California. Diagnostic Data changed its incorporation to
the State of Delaware in 1972 and changed its name to DDI Pharmaceuticals, Inc. in 1985. In 1994, DDI Pharmaceuticals merged with
International BioClinical, Inc. and Bioxytech S.A. and changed its name to OXIS International, Inc. In July 2017, the Company changed
its name to GT Biopharma, Inc.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify">We are a clinical stage biopharmaceutical
company focused on the development and commercialization of novel immuno-oncology products based off our proprietary Natural Killer
(NK) cell engager (Tri-specific Killer Engager (TriKE) &#38; Tetra-specific Killer Engager (TetraKE)) and bi-specific Antibody
Drug Conjugate (bispecific-ADC) technology platforms. Our TriKE and TetraKE platforms generate proprietary moieties designed to
harness and enhance the cancer killing abilities of a patient&#8217;s own natural killer, or NK, cells. Once bound to a NK cell,
our moieties are designed to stimulate the NK cell and precisely direct it to one or more specifically-targeted proteins (tumor
antigens) expressed on a specific type of cancer, ultimately resulting in the cancer cell&#8217;s death. TriKEs and TetraKEs are
made up of recombinant fusion proteins, can be designed to target tumor antigens on hematologic malignancies, sarcomas or solid
tumors and do not require patient-specific customization. They are designed to be dosed in an outpatient setting and are expected
to have reasonably low cost of goods. Our bispecific-ADC platform can generate product candidates that are ligand-directed single-chain
fusion proteins that simultaneously target two tumor antigens. We believe our bispecific-ADC moieties represents the next generation
of ADCs.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.45pt 0 0; text-align: justify">Also, in connection with the
acquisition of Georgetown Translational Pharmaceuticals on September 1, 2017, we acquired a portfolio of IPR&#38;D CNS assets consisting
of innovative reformulations and/or repurposing of existing therapies. These CNS assets address disease states such as chronic
neuropathic pain, myasthenia gravis and motion sickness.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0.05pt 5.7pt 6pt 0; text-align: justify">The Company&#8217;s
current operations have focused on business planning, raising capital, establishing an intellectual property portfolio, hiring,
and conducting preclinical studies and clinical trials. The Company does not have any product candidates approved for sale and
has not generated any revenue from product sales. The Company has sustained operating losses since inception and expects such losses
to continue over the foreseeable future.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.5pt 6pt 0; text-align: justify">The financial statements
of the Company have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. Accordingly, the financial statements do not include any adjustments that might be
necessary should the Company be unable to continue in existence.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0.05pt 5.45pt 6pt 0; text-align: justify">The Company has incurred
substantial losses and negative cash flows from operations since its inception and has an accumulated deficit of $524.5 million
and cash of $1.2 million as of September 30, 2018. The Company anticipates incurring additional losses until such time, if ever,
that it can generate significant sales of its products currently in development. Substantial additional financing will be needed
by the Company to fund its operations and to commercially develop its product candidates. These factors raise substantial doubt
about the Company&#8217;s ability to continue as a going concern.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify">Management is currently
evaluating different strategies to obtain the required funding for future operations. These strategies may include but are
not limited to: public offerings of equity and/or debt securities, payments from potential strategic research and
development, and licensing and/or marketing arrangements with pharmaceutical companies. Management has also implemented cost
saving efforts, including reduction in executive salaries and reduced travel. Management believes that these ongoing and
planned financing endeavors, if successful, will provide adequate financial resources to continue as a going concern for at
least the next six months from the date the financial statements are issued. However, there can be no assurance in this
regard. If the Company is unable to secure adequate additional funding, its business, operating results, financial condition
and cash flows may be materially and adversely affected.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; background-color: white"><i>Use of Estimates</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; background-color: white"><b>&#160;</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The financial
statements and notes are representations of the Company's management, which is responsible for their integrity and objectivity.
These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently
applied in the preparation of the financial statements. The preparation of financial statements requires management to make estimates
and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosures of contingent assets
and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Basis of Consolidation and Comprehensive
Income</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial
statements include the accounts of GT Biopharma, Inc. and its subsidiaries. All intercompany balances and transactions have been
eliminated. The Company's financial statements are prepared using the accrual method of accounting.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><i>Basis of Presentation</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited interim condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S.
GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information
and disclosures required by U.S. GAAP for complete consolidated financial statements have been condensed or omitted herein. The
interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and notes thereto included in the Company's Form 10-K for the year ended December 31, 2017. The unaudited interim condensed consolidated
financial information presented herein reflects all normal adjustments that are, in the opinion of management, necessary for a
fair statement of the financial position, results of operations and cash flows for the periods presented. The Company is responsible
for the unaudited interim consolidated financial statements included in this report. The results of operations of any interim period
are not necessarily indicative of the results for the full year.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cash and Cash Equivalents</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid
investments with original maturities of three months or less to be cash equivalents.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's cash and cash equivalents,
marketable securities and accounts receivable are monitored for exposure to concentrations of credit risk. The Company maintains
substantially all of its cash balances in a limited number of financial institutions. The balances are each insured by the Federal
Deposit Insurance Corporation up to $250,000. The Company had $982,000 of balances in excess of this limit at September 30, 2018.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock Based Compensation to Employees</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its stock-based
compensation for employees in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718.&#160;&#160;The Company
recognizes in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued
to employees and non-employees over the related vesting period.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company granted no stock options
during the nine months ended September 30, 2018 and 2017, respectively.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Critical
Accounting Policies</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We consider
the following accounting policies to be critical given they involve estimates and judgments made by management and are important
for our investors&#8217; understanding of our operating results and financial condition.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Long-Lived
Assets</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Our long-lived assets include property,
plant and equipment, capitalized costs of filing patent applications and other indefinite lived intangible assets. We evaluate
our long-lived assets for impairment, other than indefinite lived intangible assets, in accordance with ASC 360, whenever events
or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Estimates of future cash flows
and timing of events for evaluating long-lived assets for impairment are based upon management&#8217;s judgment. If any of our
intangible or long-lived assets are considered to be impaired, the amount of impairment to be recognized is the excess of the carrying
amount of the assets over its fair value.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Applicable long-lived assets are amortized
or depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or
the statutory or contractual term in the case of patents. Estimates of useful lives and periods of expected revenue generation
are reviewed periodically for appropriateness and are based upon management&#8217;s judgment.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Impairment of Long-Lived Assets</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's long-lived assets currently
consist of indefinite lived intangible assets associated with IPR&#38;D (&#8220;In-Process Research &#38; Development&#8221;) projects
and related capitalized patents acquired in the acquisition of Georgetown Translational Pharmaceuticals, Inc. as described in Note
2 below. &#160;Intangible assets associated with IPR&#38;D projects are not amortized until approval by the Food and Drug Administration
(FDA) is obtained in a major market subject to certain specified conditions and management judgment. The useful life of an amortizing
asset generally is determined by identifying the period in which substantially all of the cash flows are expected to be generated.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates indefinite lived
intangible assets for impairment at least annually and whenever impairment indicators are present in accordance with ASC 350. When
necessary, the Company records an impairment loss for the amount by which the fair value is less than the carrying value of these
assets. The fair value of intangible assets other than goodwill is typically determined using the &#8220;relief from royalty method&#8221;,
specifically the discounted cash flow method utilizing Level 3 fair value inputs. Some of the more significant estimates and assumptions
inherent in this approach include: the amount and timing of the projected net cash flows, which includes the expected impact of
competitive, legal and/or regulatory forces on the projections and the impact of technological risk associated with IPR&#38;D assets,
as well as the selection of a long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the
projected cash flows; and the tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs impairment testing
for all other long-lived assets whenever impairment indicators are present. When necessary, the Company calculates the undiscounted
value of the projected cash flows associated with the asset, or asset group, and compares this estimated amount to the carrying
amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over fair value.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes
using the asset and liability approach, whereby deferred income tax assets and liabilities are recognized for the estimated future
tax effects, based on current enacted tax laws, of temporary differences between financial and tax reporting for current and prior
periods. Deferred tax assets are reduced, if necessary, by a valuation allowance if the corresponding future tax benefits may not
be realized.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Net Income (Loss) per Share</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net income (loss) per share is
computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period.
Diluted net income (loss) per share is computed by dividing the net loss for the period by the weighted average number of common
shares outstanding during the period, plus the potential dilutive effect of common shares issuable upon exercise or conversion
of outstanding stock options and warrants during the period.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">The computation of basic and diluted net loss per share for
the nine months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities
because their inclusion would be anti-dilutive:</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 107%">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">September 30,</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 67%; line-height: 107%">&#160;</td>
    <td style="width: 15%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">2018</font></td>
    <td style="width: 2%; text-align: center; line-height: 107%">&#160;</td>
    <td style="width: 16%; border-bottom: black 1pt solid; text-align: center; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">2017</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Exercise of common stock warrants</font></td>
    <td style="text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">1,813,053</font></td>
    <td style="line-height: 107%">&#160;</td>
    <td style="text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Conversion of preferred stock into common stock</font></td>
    <td style="text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">1,163,659</font></td>
    <td style="line-height: 107%">&#160;</td>
    <td style="text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,513,659</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Exercise of common stock options</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">1,246</font></td>
    <td style="line-height: 107%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,246</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="line-height: 107%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">2,977,958</font></td>
    <td style="text-align: right; line-height: 107%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">1,514,905</font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Patents</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Acquired patents are capitalized at their
acquisition cost or fair value. The legal costs, patent registration fees and models and drawings required for filing patent applications
are capitalized if they relate to commercially viable technologies. Commercially viable technologies are those technologies that
are projected to generate future positive cash flows in the near term. Legal costs associated with patent applications that are
not determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing the
patentable idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident
increase in the value of the patents are capitalized.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Capitalized costs for pending patents
are amortized on a straight-line basis over the remaining twenty-year legal life of each patent after the costs have been incurred.
Once each patent is issued, capitalized costs are amortized on a straight-line basis over the shorter of the patent's remaining
statutory life, estimated economic life or ten years.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Fixed Assets</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets are stated at cost. Depreciation
is computed on a straight-line basis over the estimated useful lives of the assets, which are 3 to 10&#160;years for machinery
and equipment and the shorter of the lease term or estimated economic life for leasehold improvements.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Fair Value</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts reported in the
balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair
value because of the short period of time between the origination of such instruments and their expected realization and their
current market rate of interest.&#160; The three levels are defined as follows:</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; line-height: 107%"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="text-align: justify; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. The Company&#8217;s Level 1 assets include cash equivalents, primarily institutional money market funds, whose carrying value represents fair value because of their short-term maturities of the investments held by these funds.</font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; line-height: 107%"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="text-align: justify; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Fair value is determined using the Black-Scholes valuation model based on observable market inputs, such as share price data and a discount rate consistent with that of a government-issued security of a similar maturity. </font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; line-height: 107%"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="text-align: justify; line-height: 107%"><font style="font: 8pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.</font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Research and Development</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed
as incurred and reported as research and development expense. Research and development costs totaled $7.8 million and $0.9 million
for the nine months ended September 30, 2018 and 2017, respectively. Research and development costs for the nine months ended September
30, 2018 included non-cash compensation of $6.5 million.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue Recognition</i></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>License Revenue</u></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">License arrangements may consist of non-refundable
upfront license fees, exclusive licensed rights to patented or patent pending technology, and various performance or sales milestones
and future product royalty payments. Some of these arrangements are multiple element arrangements.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Non-refundable, up-front fees that are
not contingent on any future performance by us, and require no consequential continuing involvement on our part, are recognized
as revenue when the license term commences and the licensed data, technology and/or compound is delivered.&#160;&#160;We defer
recognition of non-refundable upfront fees if we have continuing performance obligations without which the technology, right, product
or service conveyed in conjunction with the non-refundable fee has no utility to the licensee that is separate and independent
of our performance under the other elements of the arrangement. In addition, if we have continuing involvement through research
and development services that are required because our know-how and expertise related to the technology is proprietary to us, or
can only be performed by us, then such up-front fees are deferred and recognized over the period of continuing involvement.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Payments related to substantive, performance-based
milestones in a research and development arrangement are recognized as revenue upon the achievement of the milestones as specified
in the underlying agreements when they represent the culmination of the earnings process. As of September 30, 2018, the Company
has not generated any licensing revenue.</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6620830912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 2 - Intangibles<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Including Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangibles</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1, 2017, the Company entered into
an Agreement and Plan of Merger whereby it acquired 100% of the issued and outstanding capital stock of Georgetown Translational
Pharmaceuticals, Inc. (GTP). In exchange for the ownership of GTP, the Company issued a total of 16,927,878 shares of its common
stock, having a share price of $15.00 on the date of the transaction, to the three prior owners of GTP which represented 33% of
the issued and outstanding capital stock of the Company on a fully diluted basis. $253.8 million of the value of shares issued
was allocated to intangible assets consisting of a portfolio of three CNS development candidates, which are classified as IPR&#38;D.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three and nine months ended September
30, 2018, the Company recorded an intangible asset impairment charge of $228.5 million related to the portfolio of CNS IPR&#38;D
assets within Operating Expenses, which represents the excess carrying value compared to fair value. The impairment charge was
the result of both internal and external factors. In the 3<sup>rd</sup> quarter of 2018, the Company experienced changes in key
senior management, led by the appointment of a new CEO with extensive experience in oncology drug development. These changes resulted
in the prioritization of immuno-oncology development candidates relative to CNS development candidates. In conjunction with these
strategic changes, limited internal resources have delayed the development of the CNS IPR&#38;D assets. The limited resources,
changes in senior leadership, and favorable market conditions for immuno-oncology development candidates have resulted in the Company
choosing to focus on development of its immuno-oncology portfolio. In light of this shift in market strategy, the Company performed
a commercial assessment and a valuation of the CNS IPR&#38;D assets, both to assess fair value and support potential future licensing
efforts. The valuation indicated an excess carrying value over the fair value of these assets, resulting in the impairment charge
noted above.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the CNS IPR&#38;D assets was
determined using the discounted cash flow method which utilized significant estimates and assumptions surrounding the amount and
timing of the projected net cash flows, which includes the probability of commercialization, the assumption that the assets would
be out-licensed to third-parties for continued development for upfront licensing fees and downstream royalty payments based on
net sales, and expected impact of competitive, legal and/or regulatory forces on the projections, as well as the selection of a
long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the projected cash flows; and the
tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784272656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 3 - Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>Convertible Notes</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2018, the Company entered into
a Securities Purchase Agreement (&#8220;SPA&#8221;) with fourteen accredited investors (individually, a &#8220;Buyer&#8221; and
collectively, the &#8220;Buyers&#8221;) pursuant to which the Company agreed to issue to the Buyers senior convertible notes in
an aggregate principal amount of $7,760,510 (the &#8220;Notes&#8221;), which Notes shall be convertible into the Company&#8217;s
common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;) at a price of $4.58 per share, and five-year warrants
to purchase the Company&#8217;s Common Stock representing the right to acquire an aggregate of approximately 1,694,440 shares of
Common Stock (the &#8220;Warrants&#8221;).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">Pursuant
to the terms of SPA the Notes were subject to an original issue discount of 10% resulting in proceeds to the Company of $7,055,000
from the transaction. </font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon the purchase of the Notes, the Buyers received
Warrants to purchase 1,694,440 shares of Common Stock. Such Warrants are exercisable for (5) years from the date the shares underlying
the Warrants are freely saleable. The initial Exercise Price is $4.58. <font style="background-color: white">According to the terms
of the warrant agreement, the Warrants are subject to certain adjustments depending upon the price and structure of a subsequent
financing, including a qualified financing with gross proceeds of at least $20 million</font>, as defined in the agreements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The issuance of the Notes and Warrants were
made in reliance on the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;) for the offer and sale of securities not involving a public offering, and Regulation D promulgated under the Securities
Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Contemporaneously with the execution and delivery
of the SPA, the Company and the Buyers executed and delivered a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;)
pursuant to which the Company has agreed to provide certain registration rights with respect to the Registrable Securities under
the 1933 Act and the rules and regulations promulgated thereunder, and applicable state securities laws.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Senior Convertible Debentures</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 2, 2018, GT Biopharma, Inc. (the &#8220;Company&#8221;)
entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto (individually, a &#8220;Purchaser,&#8221;
and collectively, the &#8220;Purchasers&#8221;) pursuant to which the Company issued to the Purchasers one year 10% Senior Convertible
Debentures in an aggregate principal amount of $5,140,000 (the &#8220;Debentures&#8221;), which Debentures shall be convertible
into the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at a price of $2 per share.
The Company used a portion of these proceeds to repay $4.4 million of the notes issued on January 22, 2018. Additionally, the remaining
$3.3 million of the notes issued on January 22, 2018 were converted into the Debentures at the same terms discussed above.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 7, 2018, GT Biopharma, Inc. (the
&#8220;Company&#8221;) entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto
(individually, a &#8220;Purchaser,&#8221; and collectively, the &#8220;Purchasers&#8221;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an aggregate principal amount of $2,050,000 (the &#8220;Debentures&#8221;),
which Debentures shall be convertible into the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;),
at a price of $2 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 24, 2018, GT Biopharma, Inc. (the
&#8220;Company&#8221;) entered into a Securities Purchase Agreement with the purchasers identified on the signature pages thereto
(individually, a &#8220;Purchaser,&#8221; and collectively, the &#8220;Purchasers&#8221;) pursuant to which the Company has issued
to the Purchasers one year 10% Senior Convertible Debentures in an aggregate principal amount of $800,000 (the &#8220;Debentures&#8221;),
which Debentures shall be convertible into the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;),
at a price of $2 per share.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The issuance of the Senior Convertible Debentures was made in reliance
on the exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), for
the offer and sale of securities not involving a public offering and Regulation D promulgated under the Securities Act.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Financing Agreement</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 8, 2010, the Company entered into
a financing arrangement with Gemini Pharmaceuticals, Inc., a product development and manufacturing partner of the Company, pursuant
to which Gemini Pharmaceuticals made a $250,000 strategic equity investment in the Company and agreed to make a $750,000 purchase
order line of credit facility available to the Company. The outstanding principal of all Advances under the Line of Credit will
bear interest at the rate of interest of prime plus 2 percent per annum. There is $31,000 due on this credit line at September
30, 2018.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622315488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 4 - Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarter ended September 30, 2018,
the Company issued 110,000 shares of common stock upon conversion of $220,000 of senior convertible notes.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Preferred Stock</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1, 2017, the Company authorized
2,000,000 shares of Series J Preferred Stock. Shares of Series J Preferred Stock will have the same voting rights as shares of
common stock with each share of Series J Preferred Stock entitled to one vote at a meeting of the shareholders of the Corporation.
Shares of Series J Preferred Stock will not be entitled to receive any dividends, unless and until specifically declared by our
board of directors. The holders of the Series J Preferred Stock will participate, on an as-if-converted-to-common stock basis,
in any dividends to the holders of common stock. Each share of the Series J Preferred Stock is convertible into one share of our
common stock at any time at the option of the holder.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On September
1, 2017 the Company issued a total of 908,502 shares of </font>Series J Preferred Stock <font style="background-color: white">in
exchange for the conversion and cancellation of debt in the total amount of $1,090,000.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On September
1, 2017 the Company issued 5,046 shares of </font>Series J Preferred Stock <font style="background-color: white">upon the exercise
of warrants on a cashless basis.&#160;</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On September
1, 2017 the Company also issued 600,000</font>&#160;shares of&#160;<font style="background-color: white">Series J Preferred Stock</font>&#160;to
one entity as payment for $720,000 of consulting services provided to the Company.&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">In December
2017, the Company converted 350,000 Series J shares of preferred stock into 350,000 shares of common stock.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784227328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Stock Options and Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options and Warrants</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i>Stock Options</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The following table summarizes stock option transactions for the
nine months ended September 30, 2018:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Number of Options</b></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Outstanding, December 31, 2017</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Granted</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Exercised</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Outstanding, September 30, 2018</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Exercisable, September 30, 2018</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>Common Stock Warrants</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Warrant transactions for the nine months ended September 30, 2018
are as follows:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><font style="font-size: 8pt"><b>Number of Warrants</b></font></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 53%"><font style="font-size: 8pt">Outstanding at December 31, 2017:</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 26%; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; width: 2%; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="vertical-align: bottom; width: 11%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Outstanding at September 30, 2018</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; border-top: Black 1pt solid; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">&#160;$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Exercisable at September 30, 2018</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">&#160;$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>



<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6613271248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Leases</i></b></p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1, 2017, the Company entered
into a three-year lease agreement for its office in Washington, D.C. In addition to minimum rent, certain leases require payment
of real estate taxes, insurance, common area maintenance charges and other executory costs. The Company recognizes rent expense
under such arrangements on a straight-line basis over the effective term of each lease. This lease was terminated as of June 30,
2018.</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for the nine months ended
September 30, 2018&#160;and&#160;2017&#160;was&#160;$52,000&#160;and&#160;$9,000, respectively.</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b><i>Employment Agreements</i></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On February
14, 2018, the Company entered into the First Amendment to the Employment Agreement with Dr. Clarence-Smith, amending the Employment
Agreement, dated September 1, 2017, between the Company and Dr. Clarence-Smith. Under the First Amendment, Dr. Clarence-Smith&#8217;s
title was revised to reflect her new position and included an annual salary of $500,000, paid in equal monthly installments. All
other terms of her original Employment Agreement remain unchanged. In October 2018, Dr. Clarence-Smith resigned from her position
with the Company. In connection with this resignation, the Company entered into a separation agreement which superseded the Employment
Agreement.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On February
14, 2018,&#160;the Company entered into a Consultant Agreement with Mr. Cataldo. The term of the Consultant Agreement lasts until
August 31, 2020 and is terminable at will and is subject to automatic extension for successive one-year periods. Mr. Cataldo will
be paid $41,667 per month during the term of the Consultant Agreement and will be entitled to participate in the Company&#8217;s
bonus plans. Refer to footnote 8 &#8211; Subsequent Events.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If any of our executive officers&#8217; employment
with us is terminated involuntarily, or any executive resigns with good reason as a result of a change in control, the executive
will receive (i) all compensation and benefits earned through the date of termination of employment; (ii) a lump-sum payment equal
to the greater of (a) the bonus paid or payable to the executive for the year immediately prior to the year in which the change
in control occurred and (b) the target bonus under the performance bonus plan in effect immediately prior to the year in which
the change in control occurs; (iii) a lump-sum payment equivalent to the remaining base salary (as it was in effect immediately
prior to the change in control) due to the executive from the date of involuntary termination to the end of the term of the employment
agreement or one half of the executive&#8217;s base salary then in effect, whichever is the greater; and (iv)&#160;reimbursement
for the cost of medical, life, disability insurance coverage at a level equivalent to that provided by us for a period expiring
upon the earlier of (a) one year or (b) the time the executive begins alternative employment where said insurance coverage is available
and offered to the executive.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6628204768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Change on Accounting Method<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ChangeOnAccountingMethodAbstract', window );"><strong>Note 7 - Change On Accounting Method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Change on Accounting Method</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Adoption of ASU 2017-11</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the securities purchase agreements
and debt transactions during the year ended December 31, 2017, the Company issued warrants, to purchase common stock with a five-year
term. Upon issuance of the warrants, the Company evaluated the note agreement to determine if the agreement contained any embedded
components that would qualify the agreement as a derivative. The Company identified certain put features embedded in the warrants
that potentially could result in a net cash settlement in the event of a fundamental transaction, requiring the Company to classify
the warrants as a derivative liability. The Company changed its method of accounting for the debt and warrants through the early
adoption of ASU&#160;2017-11 on January 1, 2018 on a retrospective basis. Accordingly, the Company recorded the warrant derivative
and conversion option derivative liabilities to additional paid in capital upon issuance.</p>

<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p>

<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">The following table provides a summary of the
derivative liability activity as a result of the adoption of ASU 2017-11 (in thousands, except per share data):</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Consolidated Balance Sheet</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 31, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td rowspan="2" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Reported</p></td>
    <td style="width: 4%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 5%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td rowspan="2" style="width: 18%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Revisions</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Additional Paid-in Capital</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;519,702</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,603</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;521,305</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Accumulated Deficit</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;(267,896)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,603)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$ &#160;&#160;&#160;&#160;&#160;(269,499)</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Consolidated Statement of Operations</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">For the Three
        Months Ended September 30, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Reported</p></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Revisions</p></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Change in Warrant Liability</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,451)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,451</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Earnings Per Share</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8.24)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.09</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8.15)</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Consolidated Statement of Operations</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">For the Nine
        Months Ended September 30, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Reported</p></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Revisions</p></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Change in Warrant Liability</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;925</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(925)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Earnings Per Share</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(24.38)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.16)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(24.54)</font></td></tr>
</table>
<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b>&#160;</b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ChangeOnAccountingMethodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ChangeOnAccountingMethodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6621298864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Leases</i></p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 1, 2018, the Company entered
into a three-year lease agreement for its office in Westlake Village, CA. In addition to minimum rent, certain leases require payment
of real estate taxes, insurance, common area maintenance charges and other executory costs. The Company recognizes rent expense
under such arrangements on a straight-line basis over the effective term of each lease.</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the Company&#8217;s
future minimum lease commitments as of September 30, 2018 (in thousands):</p>

<p style="font: 8pt/12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Year ending December 31:</font></td>
    <td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2018</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2019</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;69</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2020</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;71</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2021</font></td>
    <td style="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;61</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Total minimum lease payments</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">
        <p style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; border-bottom: Black 1.5pt double; margin-bottom: 0; text-align: right">$ 212</p></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><i>Employment and Consulting Agreements</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On October
18, 2018, the Company entered into a Consultant Agreement with Anthony Cataldo. The term of the Consultant Agreement shall remain
in effect until September 30, 2019. This Agreement supersedes the Consultant Agreement dated February 14, 2018 and will pay Mr.
Cataldo $25,000 per month during the term of the Agreement.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On October
19, 2018, the Company entered into an Executive Employment Agreement with Dr. Urbanski, reflecting his current position as Chief
Executive Officer of the Company. Under the terms of this agreement, Dr. Urbanski&#8217;s annual salary is essentially unchanged
from his previous positions. Dr. Urbanski is also entitled to participate in the Company&#8217;s bonus plans. Under the Executive
Employment Agreement, the Company has agreed that upon shareholder approval of a Stock Option Plan, it will recommend to the Board
that the Company grant Dr. Urbanski a Non-Qualified stock option to purchase 2,971,102 shares of the Company&#8217;s common stock
having an exercise equal to the fair market value of the shares on the date of the Agreement. The stock option grant would vest
according to the following schedule: (i) 1,250,000 fully vested shares upon signing of the agreement, (ii) 1,250,000 shares on
January 1, 2019, and (iii) 471,102 shares on January 1, 2020.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white"><i>Departure
of Directors or Certain Officers</i></font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">On November
12, 2018, Mr. Cataldo announced his intention to resign from the Board of Directors of the Company effective November 13, 2018.
The resignation did not involve any dispute with the Company.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6792880880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - The Company and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract', window );"><strong>Company And Summary Of Significant Accounting Policies Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0.05pt 5.7pt 6pt 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The
Company&#8217;s current operations have focused on business planning, raising capital, establishing an intellectual property portfolio,
hiring, and conducting preclinical studies and clinical trials. The Company does not have any product candidates approved for
sale and has not generated any revenue from product sales. The Company has sustained operating losses since inception and expects
such losses to continue over the foreseeable future.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 5.5pt 6pt 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The
financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of business. Accordingly, the financial statements do not include any
adjustments that might be necessary should the Company be unable to continue in existence.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0.05pt 5.45pt 6pt 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">The
Company has incurred substantial losses and negative cash flows from operations since its inception and has an accumulated deficit
of $524.5 million and cash of $1.2 million as of September 30, 2018. The Company anticipates incurring additional losses until
such time, if ever, that it can generate significant sales of its products currently in development. Substantial additional financing
will be needed by the Company to fund its operations and to commercially develop its product candidates. These factors raise substantial
doubt about the Company&#8217;s ability to continue as a going concern.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 5.4pt 6pt 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Management
is currently evaluating different strategies to obtain the required funding for future operations. These strategies may include
but are not limited to: public offerings of equity and/or debt securities, payments from potential strategic research and development,
and licensing and/or marketing arrangements with pharmaceutical companies. Management has also implemented cost saving efforts,
including reduction in executive salaries and reduced travel. Management believes that these ongoing and planned financing endeavors,
if successful, will provide adequate financial resources to continue as a going concern for at least the next six months from
the date the financial statements are issued. However, there can be no assurance in this regard. If the Company is unable to secure
adequate additional funding, its business, operating results, financial condition and cash flows may be materially and adversely
affected.</font></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The financial statements
and notes are representations of the Company's management, which is responsible for their integrity and objectivity. These accounting
policies conform to accounting principles generally accepted in the United States of America and have been consistently applied
in the preparation of the financial statements. The preparation of financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosures of contingent assets
and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation and Comprehensive Income</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements
include the accounts of GT Biopharma, Inc. and its subsidiaries. All intercompany balances and transactions have been eliminated.
The Company's financial statements are prepared using the accrual method of accounting.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited interim condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S.
GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information
and disclosures required by U.S. GAAP for complete consolidated financial statements have been condensed or omitted herein. The
interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements
and notes thereto included in the Company's Form 10-K for the year ended December 31, 2017. The unaudited interim condensed consolidated
financial information presented herein reflects all normal adjustments that are, in the opinion of management, necessary for a
fair statement of the financial position, results of operations and cash flows for the periods presented. The Company is responsible
for the unaudited interim consolidated financial statements included in this report. The results of operations of any interim period
are not necessarily indicative of the results for the full year.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments
with original maturities of three months or less to be cash equivalents.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's cash and cash equivalents, marketable
securities and accounts receivable are monitored for exposure to concentrations of credit risk. The Company maintains substantially
all of its cash balances in a limited number of financial institutions. The balances are each insured by the Federal Deposit Insurance
Corporation up to $250,000. The Company had $982,000 of balances in excess of this limit at September 30, 2018.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy', window );">Stock Based Compensation to Employees</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its stock-based compensation
for employees in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718.&#160;&#160;The Company recognizes in
the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees
and non-employees over the related vesting period.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company granted no stock options during
the nine months ended September 30, 2018 and 2017, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_LongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our long-lived assets include property, plant
and equipment, capitalized costs of filing patent applications and other indefinite lived intangible assets. We evaluate our long-lived
assets for impairment, other than indefinite lived intangible assets, in accordance with ASC 360, whenever events or changes in
circumstances indicate that the carrying amount of such assets may not be recoverable. Estimates of future cash flows and timing
of events for evaluating long-lived assets for impairment are based upon management&#8217;s judgment. If any of our intangible
or long-lived assets are considered to be impaired, the amount of impairment to be recognized is the excess of the carrying amount
of the assets over its fair value.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Applicable long-lived assets are amortized or
depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or the
statutory or contractual term in the case of patents. Estimates of useful lives and periods of expected revenue generation are
reviewed periodically for appropriateness and are based upon management&#8217;s judgment.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long Lived Assets</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's long-lived assets currently consist
of indefinite lived intangible assets associated with IPR&#38;D (&#8220;In-Process Research &#38; Development&#8221;) projects
and related capitalized patents acquired in the acquisition of Georgetown Translational Pharmaceuticals, Inc. as described in Note
2 below. &#160;Intangible assets associated with IPR&#38;D projects are not amortized until approval by the Food and Drug Administration
(FDA) is obtained in a major market subject to certain specified conditions and management judgment. The useful life of an amortizing
asset generally is determined by identifying the period in which substantially all of the cash flows are expected to be generated.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates indefinite lived intangible
assets for impairment at least annually and whenever impairment indicators are present in accordance with ASC 350. When necessary,
the Company records an impairment loss for the amount by which the fair value is less than the carrying value of these assets.
The fair value of intangible assets other than goodwill is typically determined using the &#8220;relief from royalty method&#8221;,
specifically the discounted cash flow method utilizing Level 3 fair value inputs. Some of the more significant estimates and assumptions
inherent in this approach include: the amount and timing of the projected net cash flows, which includes the expected impact of
competitive, legal and/or regulatory forces on the projections and the impact of technological risk associated with IPR&#38;D assets,
as well as the selection of a long-term growth rate; the discount rate, which seeks to reflect the various risks inherent in the
projected cash flows; and the tax rate, which seeks to incorporate the geographic diversity of the projected cash flows.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs impairment testing for
all other long-lived assets whenever impairment indicators are present. When necessary, the Company calculates the undiscounted
value of the projected cash flows associated with the asset, or asset group, and compares this estimated amount to the carrying
amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over fair value.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes using
the asset and liability approach, whereby deferred income tax assets and liabilities are recognized for the estimated future tax
effects, based on current enacted tax laws, of temporary differences between financial and tax reporting for current and prior
periods. Deferred tax assets are reduced, if necessary, by a valuation allowance if the corresponding future tax benefits may not
be realized.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) per Share</a></td>
<td class="text"><p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic net income (loss) per share is computed
by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted
net income (loss) per share is computed by dividing the net loss for the period by the weighted average number of common shares
outstanding during the period, plus the potential dilutive effect of common shares issuable upon exercise or conversion of outstanding
stock options and warrants during the period.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The computation of basic and diluted net loss per share for the nine
months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities
because their inclusion would be anti-dilutive:</p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="width: 63%">&#160;</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: center; width: 16%">2018</td>
    <td style="text-align: center; width: 4%">&#160;</td>
    <td style="border-top: Black 0.5pt solid; border-bottom: Black 0.5pt solid; text-align: center; width: 17%">2017</td></tr>
<tr style="vertical-align: bottom">
    <td>Exercise of common stock warrants</td>
    <td style="text-align: right">1,813,053</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Conversion of preferred stock into common stock</td>
    <td style="text-align: right">1,163,659</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,513,659</td></tr>
<tr style="vertical-align: bottom">
    <td>Exercise of common stock options</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: right">1,246</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,246</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt">2,977,958</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt">1,514,905</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Patents</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Acquired patents are capitalized at their acquisition
cost or fair value. The legal costs, patent registration fees and models and drawings required for filing patent applications are
capitalized if they relate to commercially viable technologies. Commercially viable technologies are those technologies that are
projected to generate future positive cash flows in the near term. Legal costs associated with patent applications that are not
determined to be commercially viable are expensed as incurred. All research and development costs incurred in developing the patentable
idea are expensed as incurred. Legal fees from the costs incurred in successful defense to the extent of an evident increase in
the value of the patents are capitalized.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Capitalized costs for pending patents are amortized
on a straight-line basis over the remaining twenty-year legal life of each patent after the costs have been incurred. Once each
patent is issued, capitalized costs are amortized on a straight-line basis over the shorter of the patent's remaining statutory
life, estimated economic life or ten years.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Fixed Assets</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fixed assets are stated at cost. Depreciation
is computed on a straight-line basis over the estimated useful lives of the assets, which are 3 to 10&#160;years for machinery
and equipment and the shorter of the lease term or estimated economic life for leasehold improvements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value</a></td>
<td class="text"><p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts reported in the
balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of fair
value because of the short period of time between the origination of such instruments and their expected realization and their
current market rate of interest.&#160; The three levels are defined as follows:</p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. The Company&#8217;s Level 1 assets include cash equivalents, primarily institutional money market funds, whose carrying value represents fair value because of their short-term maturities of the investments held by these funds.</font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Fair value is determined using the Black-Scholes valuation model based on observable market inputs, such as share price data and a discount rate consistent with that of a government-issued security of a similar maturity. </font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font: 8pt Symbol">&#183;</font></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 8pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.</font></td></tr>
</table>
<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed
as incurred and reported as research and development expense. Research and development costs totaled $7.8 million and $0.9 million
for the nine months ended September 30, 2018 and 2017, respectively. Research and development costs for the nine months ended September
30, 2018 included non-cash compensation of $6.5 million.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>License Revenue</u></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">License arrangements may consist of non-refundable
upfront license fees, exclusive licensed rights to patented or patent pending technology, and various performance or sales milestones
and future product royalty payments. Some of these arrangements are multiple element arrangements.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Non-refundable, up-front fees that are not contingent
on any future performance by us, and require no consequential continuing involvement on our part, are recognized as revenue when
the license term commences and the licensed data, technology and/or compound is delivered.&#160;&#160;We defer recognition of non-refundable
upfront fees if we have continuing performance obligations without which the technology, right, product or service conveyed in
conjunction with the non-refundable fee has no utility to the licensee that is separate and independent of our performance under
the other elements of the arrangement. In addition, if we have continuing involvement through research and development services
that are required because our know-how and expertise related to the technology is proprietary to us, or can only be performed by
us, then such up-front fees are deferred and recognized over the period of continuing involvement.</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Payments related to substantive, performance-based
milestones in a research and development arrangement are recognized as revenue upon the achievement of the milestones as specified
in the underlying agreements when they represent the culmination of the earnings process. As of September 30, 2018, the Company
has not generated any licensing revenue.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_LongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_LongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for director stock option and stock incentive plans. This disclosure may include (1) the types of director stock option or incentive plans sponsored by the entity (2) significant plan provisions and (3) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansDirectorPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6627461216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - The Company and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract', window );"><strong>Note 1 - Company And Summary Of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potentially dilutive securities</a></td>
<td class="text"><table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font: 8pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="3" style="border-bottom: Black 0.5pt solid; text-align: center">September 30,</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 63%">&#160;</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: center; border-top-color: Black; border-top-width: 0.5pt; width: 16%">2018</td>
    <td style="text-align: center; width: 4%">&#160;</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: center; border-top-color: Black; border-top-width: 0.5pt; width: 17%">2017</td></tr>
<tr style="vertical-align: bottom">
    <td>Exercise of common stock warrants</td>
    <td style="text-align: right">1,813,053</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>Conversion of preferred stock into common stock</td>
    <td style="text-align: right">1,163,659</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,513,659</td></tr>
<tr style="vertical-align: bottom">
    <td>Exercise of common stock options</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: right">1,246</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 0.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,246</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt">2,977,958</td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; border-top-color: Black; border-top-width: 0.5pt">1,514,905</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_Note1CompanyAndSummaryOfSignificantAccountingPoliciesTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775215936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Stock Options and Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_StockOptionsAndWarrantsTablesAbstract', window );"><strong>Stock Options And Warrants Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of the stock option activity</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Number of Options</b></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Outstanding, December 31, 2017</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Granted</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Exercised</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Expired</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Outstanding, September 30, 2018</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Exercisable, September 30, 2018</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,246</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">1,428.00</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of the warrant activity</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><font style="font-size: 8pt"><b>Number of Warrants</b></font></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><font style="font-size: 8pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; width: 53%"><font style="font-size: 8pt">Outstanding at December 31, 2017:</font></td>
    <td style="width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 26%; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; width: 2%; text-align: right"><font style="font-size: 8pt">$</font></td>
    <td style="vertical-align: bottom; width: 11%; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Granted</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Forfeited</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Exercised</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; font-size: 12pt; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">-</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Outstanding at September 30, 2018</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; border-top: Black 1pt solid; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">&#160;$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom"><font style="font-size: 8pt">Exercisable at September 30, 2018</font></td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">1,813,053</font></td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">&#160;$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt">4.58</font></td>
    <td style="vertical-align: bottom">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_StockOptionsAndWarrantsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_StockOptionsAndWarrantsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784298304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Change on Accounting Method (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_Note6ChangeOnAccountingMethodTablesAbstract', window );"><strong>Note 6Change On Accounting Method Tables Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Adoption of new accounting standard</a></td>
<td class="text"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Consolidated Balance Sheet</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 31, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td rowspan="2" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Reported</p></td>
    <td style="width: 4%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 5%; border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td rowspan="2" style="width: 18%; border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Revisions</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Additional Paid-in Capital</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;519,702</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,603</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 5.25pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;521,305</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Accumulated Deficit</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;(267,896)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,603)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$ &#160;&#160;&#160;&#160;&#160;(269,499)</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Consolidated Statement of Operations</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">For the Three
        Months Ended September 30, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Reported</p></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Revisions</p></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Change in Warrant Liability</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1,451)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,451</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Earnings Per Share</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8.24)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0.09</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8.15)</font></td></tr>
</table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">Consolidated Statement of Operations</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="5" style="padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">For the Nine
        Months Ended September 30, 2017</p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Previously</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Reported</p></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Revisions</p></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">Revised</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: Black 0.5pt solid">Report</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Change in Warrant Liability</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;925</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(925)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">Earnings Per Share</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(24.38)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(0.16)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 8pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(24.54)</font></td></tr>
</table>
<p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b>&#160;</b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_Note6ChangeOnAccountingMethodTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_Note6ChangeOnAccountingMethodTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6631865120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 8 - Subsequent Events (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_Note8SubsequentEventsTablesAbstract', window );"><strong>Note 8 - Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock', window );">Future minimum lease commitments</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Year ending December 31:</font></td>
    <td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2018</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2019</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;69</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2020</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;71</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;2021</font></td>
    <td style="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 36.25pt"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;61</font></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 8pt">Total minimum lease payments</font></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: right; border-bottom: Black 1.5pt double">$ 212</p></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_Note8SubsequentEventsTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_Note8SubsequentEventsTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum lease payments as of the date of the latest balance sheet presented, in aggregate and for each of the five years succeeding fiscal years, with separate deductions from the total for the amount representing executor costs, including any profit thereon, included in the minimum lease payments and for the amount of the imputed interest necessary to reduce the net minimum lease payments to present value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783279648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - The Company and Summary of Significant Accounting Policies (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">2,977,958<span></span>
</td>
<td class="nump">1,514,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockWarrantsMember', window );">Exercise of common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">1,813,053<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ConversionOfPreferredStockIntoCommonStockMember', window );">Conversion of preferred stock into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">1,163,659<span></span>
</td>
<td class="nump">1,513,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockOptionsMember', window );">Exercise of common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ConversionOfPreferredStockIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ConversionOfPreferredStockIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=GTBP_ExerciseOfCommonStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793297632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract', window );"><strong>Company And Summary Of Significant Accounting Policies Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (524,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (524,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (269,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalent</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">$ 2,732<span></span>
</td>
<td class="nump">$ 1,232<span></span>
</td>
<td class="nump">$ 2,732<span></span>
</td>
<td class="nump">$ 576<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Diluted shares excluded from calcuation of EPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,977,958<span></span>
</td>
<td class="nump">1,514,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="nump">$ 526<span></span>
</td>
<td class="nump">$ 7,835<span></span>
</td>
<td class="nump">$ 911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793299648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Stock Options and Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable as of September 30, 2018</a></td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable as of September 30, 2018 | $ / shares</a></td>
<td class="nump">$ 1,428.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of December 31, 2017</a></td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of September 30, 2018</a></td>
<td class="nump">1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of December 31, 2017 | $ / shares</a></td>
<td class="nump">$ 1,428.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of September 30, 2018 | $ / shares</a></td>
<td class="nump">$ 1,428.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775234608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 5 - Stock Options and Warrants (Details 1)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Warrants Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable as of September 30, 2018 | shares</a></td>
<td class="nump">1,813.053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Exercisable as of September 30, 2018 | $ / shares</a></td>
<td class="nump">$ 4.58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">WarrantMember</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Warrants Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of December 31, 2017 | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">1,813.053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of September 30, 2018 | shares</a></td>
<td class="nump">1,813.053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of December 31, 2017 | $ / shares</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">4.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding as of September 30, 2018 | $ / shares</a></td>
<td class="nump">$ 4.58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ShareBasedCompensationArrangementByShareBasedPaymentExercisableAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784205536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 6 - Commitments and Contingencies (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract', window );"><strong>Note 6 - Commitments And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expense</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_Note5CommitmentsAndContingenciesDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775144112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 7 - Change on Accounting Method (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 537,883<span></span>
</td>
<td class="nump">$ 521,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (524,453)<span></span>
</td>
<td class="num">(269,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Change in Warrant Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Earnings Per Share</a></td>
<td class="num">$ (8.15)<span></span>
</td>
<td class="num">$ (24.54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(267,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Change in Warrant Liability</a></td>
<td class="num">$ (1,451)<span></span>
</td>
<td class="nump">$ 925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Earnings Per Share</a></td>
<td class="num">$ (8.24)<span></span>
</td>
<td class="num">$ (24.38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_RestatementAdjustmentMember', window );">Revisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Change in Warrant Liability</a></td>
<td class="nump">$ 1,451<span></span>
</td>
<td class="num">$ (925)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Earnings Per Share</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in the income statement of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6755183680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Note 8 - Subsequent Events (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_GTBP_Note8SubsequentEventsDetailsAbstract', window );"><strong>Note 8Subsequent Events Details Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent', window );">2018</a></td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears', window );">2019</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears', window );">2020</a></td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears', window );">2021</a></td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_GTBP_Note8SubsequentEventsDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">GTBP_Note8SubsequentEventsDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>GTBP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>49
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_A=A:W79F?^L?%%L&OAUUUT7U!+ P04    " #;F6U-F5R<(Q &  "<)P
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M/19#SQTFBG?C?0)-EYK\#U!+ P04    " #;F6U-/2-A=9D#  #;$   &
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MKJ9%(9ZD:^9^NCGW;O[.53NXN^\[2#?1^Y1GE12+!&XE]XJ246172>3&OYH
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M_N6&2049'Y*[0QN"X%4&5:7CN6[D5+"H[2R5<R>2I?C!RJ)&)V+11U5!\N^
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M\U^#H%@02^J8T]L)5JZ""Q##0R>;NTYNPHS07$6M?32TE[A]C-K'K7T\M$]
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M-&-!$WH-/(NV\R' RKSG+?P _[,_6?38PE(+!=H)HXF%IJ"/R>&8A?R8\$O
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M1N=?-O:_1G3@I>RN_ BU_H,MAH+:A>.-/YMIS";#83__(+9\X^(/4$L#!!0
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M]K\TQ@-*65WA"-7XP29#0>G#\1;/=ABSP?"F'7\0F[YQ]A]02P,$%     @
MVYEM36! "]&U 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M;5-A;]P@#/TKB!]0$G+KNE,2J==IVJ1-.G5:]YE+G 050@;DTOW[&9)F69<O
M@(W?\[,Q^63LL^L /'G1JG<%[;P?CHRYJ@,MW(T9H,>;QE@M/)JV96ZP(.H(
MTHKQ)+EE6LB>EGGTG6V9F]$KV</9$C=J+>SO$R@S%32EKXY'V78^.%B9#Z*%
M[^!_#&>+%EM9:JFA=]+TQ$)3T/OT>#J$^!CP)&%RFS,)E5R,>0[&E[J@21 $
M"BH?& 1N5W@ I0(1ROBU<-(U90!NSZ_LGV+M6,M%.'@PZJ>L?5?0.TIJ:,2H
M_*.9/L-2SSM*EN*_PA44A@<EF*,RRL655*/S1B\L*$6+EWF7?=RG^2:[76#[
M +X ^ JXBWG8G"@J_RB\*'-K)F+GW@\B/'%ZY-B;*CAC*^(=BG?HO98I_Y"S
M:R!:8DYS#-_&K!$,V=<4?"_%B?\'Y_OP;%=A%N'9-GN6[!,<=@D.D>#P#T'Z
MIL2]F+<JV::G&FP;I\F1RHQ]G.2-=QW8>Q[?Y&_X/.W?A&UE[\C%>'S9V/_&
M& \H);G!$>KP@ZV&@L:'XWL\VWG,9L.;8?E!;/W&Y1]02P,$%     @ VYEM
M34R#1<>V 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL;5-A
M;]P@#/TKB!]0[I)<5YV22+U.52=MTJG3ML]<XB2H@#,@E^[?#TB:I5V^ #9^
MS\_&Y".:%]L!./*JI+8%[9SKCXS9J@/%[0WVH/U-@T9QYTW3,ML;X'4$*<F2
MW>Z6*2XT+?/H.YLRQ\%)H>%LB!V4XN;/"22.!=W3-\>S:#L7'*S,>]["=W _
M^K/Q%EM8:J% 6X&:&&@*>K\_GK(0'P-^"ACMZDQ")1?$EV!\J0NZ"X) 0N4"
M _?;%1Y RD#D9?R>.>F2,@#7YS?VQUB[K^7"+3R@_"5JUQ7TCI(:&CY(]XSC
M$\SU'"B9B_\*5Y ^/"CQ.2J4-JZD&JQ#-;-X*8J_3KO0<1^GFT,RP[8!R0Q(
M%L!=S,.F1%'Y9^YXF1L<B9EZW_/PQ/MCXGM3!6=L1;SSXJWW7LM]FN;L&HCF
MF-,4DZQCE@CFV9<4R5:*4_(?/-F&IYL*TPA/WRG,M@FR38(L$F3O" X?2MR*
MN?V0A*UZJL"T<9HLJ7#0<9)7WF5@[^,CLG_AT[1_XZ85VI(+.O^RL?\-H@,O
M97?C1ZCS'VPQ)#0N'#_YLYG&;#(<]O,/8LLW+O\"4$L#!!0    ( -N9;4T"
M1UG%MP$  -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;&U3VVZ<
M,!#]%<L?$+.&=K<K0,JFJEJIE5:IFCY[80 KOE#;+.G?US8L(2DOMF<\Y\R9
M\3@?M7FV'8!#+U(H6^#.N?Y(B*TZD,S>Z1Z4OVFTD<QYT[3$]@98'4%2$)HD
M'XED7.$RC[ZS*7,].,$5G VR@Y3,_#V!T&.!=_CF>.1MYX*#E'G/6O@)[E=_
M-MXB"TO-)2C+M4(&F@+?[XZG+,3'@"<.HUV=4:CDHO5S,+[5!4Z"(!!0N<#
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M>CY0,A=_#Q=0/CPH\3E*5#:NI!RL0SVS>"E:/$^[[.(^3C?\TPS;!O 9P!?
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M5Q^"',M/8+GN200HI@: ((<#"*YKL@ 4LZT'@1PF(+C\":CM>&H#"'+Y .\
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MD#S@)5EZ\>,PQMG,BP6'_3O<G:#4*BA="%)3STZ060FR!QQE2Z5!-#M9V_^
M!BGHYBPWP$]F[ FG9.=6ZE-SDYTFZW.@9\$LOU$3=QB0'S3#N/Y.^*ENA;-G
M4DT:,P^.C$E0&KTG):]2-\044#A*O4W4G@]S<@@DZ\8K $WW4/$74$L#!!0
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ME1DF>BS<4>\FBC?M-2;H[E+K?U!+ P04    " #;F6U-C>$.@-@!  !?!
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M$=-7F.O)4#07_QTNP(S<9F(8M6#*?:/ZK+3@LXM)A=,WW_:#:R>_DI$Y+!Q
MY@"R!!!?BP>YS#]33:M2BBF2?N]':H\XV1*S-[6==%OAUDSRRLQ>*I*2$E^L
MT:S9>PVYT6P6#3;^"X0$(<09;&X,TK#!)FBP<0:9,QB\09P\KM+THN)*E"1A
M2!J$I"'(TPIR+\J?PI L",D"$!*O(/>BXH-*\B D#T&2%>1>E'\ *8*0PL6G
M-X>:K1C%W9&0A*P@^.JJVI?@!Y6G?E#146ASZ]W=;(708/SB!Y-N9QZ?9<"@
MU;9;F+[TOZ ?:#'.KPM>GKCJ/U!+ P04    " #;F6U-&OAX"4]#   %\0
M%    'AL+W-H87)E9%-T<FEN9W,N>&UL[7UI<QM'EN#GR5]1T:,=DQ%%F"!%
M291[>@,B*;?:LJ06Z>Z9V-@/!2!)E@54H>L@A8G]\?O./*H*!^WVQ.Y,?[ ,
M E5YO'SY[N/W==TD7Y>+HO[7W]TWS>KUM]_6LWN[S.I1N;(%_');5LNL@3^K
MNV_K566S>7UO;;-<?'MR?/SBVV66%[]+VB+_6VLORK9H_O5W)\]?_.X/OZ_S
M/_R^^<-E.6N7MFB2K)@G5T63-^OD7<%CYF61'"7U?5;9^O??-G_X_;?X#K]W
MGOQ8%LU]#>_,[;S[Z[5=C9+3XS0Y.1Z_ZO[XH7P8)>/GPS^Z]4P&U]-]7)[X
M;._RNJDR>.]#MK3=I[Z_2=[DY0HVLLQ2&&XVVC#.!<Q<90MX9&Z_)C_8]<;E
MW:Q7O6G&QT=_WOC")UOE)6YIGEQF3>]=A9CYIW\: LL$QIC3.&\7V5WWU]ML
M4?=&O&BKBE[(ZQELZ=]M5FV<_>AH?')T.NY^_:Z6(_BF!A"ORJK)B[ODNLF:
MMDYD_/_9?>G?^\@BT'V;+VR57,#\=V75 ^V'LCC*9C,+S\ 3<WYZPTA72UO=
MX5J^K\K'YCZY*)>KK.@-*4]?+[/%(GG3UGEAZ][BFJKMP4/1H5PNX0Y<-^7L
M2YI<TT5(/K9-W<!M@>DW'K; 7,[\+7S=F_;/I[O>IA,;?/>B+.IRD<\)3F^R
M15;,+"P/;GT-%_:GZ\ODX-EA\BS)B^3FOFQK6&UOC$L[ X0;TRU\N0EW)G4-
M8[[N_9S5]T0P9OC!_JW-'[(%/-^;Y%-E5UD^3^Q7H%5U'S%NR@8V&L_60\("
MH'V73Q<VR08?N 3,K//^]V_SKP >?B=-"ML,S_ZQN0>L')[[YN/-Y'TRN;Z^
MNKG>!*/W>3;-%WF3VSZ@)K,9DMPZ667K#'8P\#M@WV;XO >,3<K;9%;9>=Y;
M/Z#!@X4[B:"9VRDLI@4$I:WB2W- (YP=/S][_JI'4V+@!]L8?G"Q^0&Z(/?E
M8FZK^IODTM[FL[SI8PW?IAH?!C1]=CPZ/AX#9*H$L*>UWR4OSX[3XV/Z3[A.
MDK7-?5GE_V'GWQ'"P1,G)R_3\Y>O],_Q&/]\J2_D=8T Q1]+?U&3K$F PC9V
M.86S5L9$3\$]D&_E+J0)C+.RLR9_L(L>29G,X2" $0% $+./X(K-LE4. !HX
MVW;9+NB.SADD R1O!ERT*A<+7&1>-!;FWH"G@T >1MCW[R9OWKU_=_/NZCJ9
M?+A,KF\^7OSPQX_O+Z\^7\.K5V_?7;R[Z7.@"HXVN=B&92!>W%K E_F64QR?
M;3[$'D[(I']Z"H4[^)0AQM[;)@<R>>@IWK[W8\8HG[H;,D"VPFVF?GL[G_1[
MW8;^6T:,']MW.$;[[<^4FQE7;QO#X_4>VS)D=((H,ECD;342HX\K9/%PB> L
M?RJR%FZ4G1_NS;E.]Q8]>WQ-9H:[=B44MX>1GVT-?'?&_&UN@0:4*UQY?QZZ
MM&ER9PN+,B,^G\V7>4&2*%*/'C4O:]A_D>0@K.35T*!\TTNWRHU\ 4>ZK<IE
M ,O>7HFOY4!AEC8YD)%Z=^2=T!R=:L.*]AJ+5C6U(*PCI2@?\AHU"/A3WVRR
MK_V]?-K[R0_ UQ9E7X*C>0$.3&^ZO[[)ZGS6DQGR1=OTD>>O-K^[1X2= .'(
M[NR S)?\RS^_.AF/OTNF."YCR?!@6VX "5!O%^7C+[L!%Y/K/R9OWW_\ZW7R
M]O/''Y./GZX^3V[>??@^F5S<O/L+$?Z^+#+_N:T;7D)3 I,#UC,#&9O$!00K
M?HN?2:AK:U@TK,'C8H8<<5C, 0D,ALL'-;0^TB, %F5Q=[2 .S+?(-01MTL
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MH2YA$4/H/'&^9JT,CHS]M3-HH%MVS5>1Z23($PPUG7F&DJ/S#YH !U(QR,]
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M*MT4F-D@EY5YQH;X_'Y(/MQ>O&CHAQR(,4%KOI(3PU;'!5!A#HKJ*QI"(&3
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MT_3G4&S:I$9M$^?\L]_6=?.'_PM02P,$%     @ VYEM38!X@7I, @  !0P
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M*>W'+:2FX^*O^#3U)T+=_3 X?0-02P,$%     @ VYEM3?BUU5-X 0  )Q$
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M<R\N<F5L<U!+ 0(4 Q0    ( -N9;4TGZ(<.@@   +$    0
M  "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ VYEM360Q'KWN
M    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ VYEM39E<G",0!@  G"<  !,              ( !M@(  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #;F6U-/U1$0GT"  #@"
M&               @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ VYEM33TC8769 P  VQ   !@              ( !J@L  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( -N9;4W4Z9DYI0(
M * *   8              "  7D/  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " #;F6U-94RFP<<#  ";$0  &               @ %4
M$@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ VYEM3:_@
M*<O> P  M1$  !@              ( !418  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( -N9;4T] O,[L@$  -(#   8
M  "  64:  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #;
MF6U-4:^R][<!  #2 P  &               @ %-'   >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ VYEM39%0S)BU 0  T@,  !@
M         ( !.AX  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( -N9;4WIZ)S M0$  -(#   8              "  24@  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #;F6U-8$ +T;4!  #2 P
M&0              @ $0(@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( -N9;4U,@T7'M@$  -(#   9              "  ?PC  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ VYEM30)'6<6W
M 0  T@,  !D              ( !Z24  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " #;F6U-&^)/;;8!  #2 P  &0
M@ '7)P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( -N9
M;4T]8\V_?P(  -P)   9              "  <0I  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ VYEM3?1E7J^V 0  T@,  !D
M         ( !>BP  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " #;F6U-G9(S[L0!   W!   &0              @ %G+@  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( -N9;4UG<B<6M@$  -(#
M   9              "  6(P  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ VYEM31?@Z6:W 0  T@,  !D              ( !3S(
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #;F6U-Y-5F
M5#$"  "3!@  &0              @ $]-   >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( -N9;4W5HPXBCP(  )L(   9
M  "  :4V  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
MVYEM3:=./(E/ @  %0@  !D              ( !:SD  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " #;F6U->%"AK7\"  !7"0  &0
M            @ 'Q.P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( -N9;4V-X0Z V $  %\$   9              "  :<^  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ VYEM36S94;G< @
MYPH  !D              ( !MD   'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " #;F6U-5!4^-MP!  #N!   &0              @ ')
M0P  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( -N9;4T:
M^'@)3T,   7Q   4              "  =Q%  !X;"]S:&%R9613=')I;F=S
M+GAM;%!+ 0(4 Q0    ( -N9;4V >(%Z3 (   4,   -              "
M 5V)  !X;"]S='EL97,N>&UL4$L! A0#%     @ VYEM3=[D=&?: @  K!$
M  \              ( !U(L  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M -N9;4V]N$4Q4@$  $ 0   :              "  =N.  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -N9;4WXM=53> $  "<1   3
M              "  660  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     B
- "( ( D   Z2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>31</ContextCount>
  <ElementCount>127</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>9</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Note 1 - The Company and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Note 2 - Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note2-Intangibles</Role>
      <ShortName>Note 2 - Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Note 3 - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note3-Debt</Role>
      <ShortName>Note 3 - Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Note 4 - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note4-StockholdersEquity</Role>
      <ShortName>Note 4 - Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Note 5 - Stock Options and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants</Role>
      <ShortName>Note 5 - Stock Options and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Note 6 - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies</Role>
      <ShortName>Note 6 - Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note 7 - Change on Accounting Method</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod</Role>
      <ShortName>Note 7 - Change on Accounting Method</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Note 8 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note8-SubsequentEvents</Role>
      <ShortName>Note 8 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Note 1 - The Company and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Note 1 - The Company and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Note 5 - Stock Options and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/StockOptionsAndWarrantsTables</Role>
      <ShortName>Note 5 - Stock Options and Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note5-StockOptionsAndWarrants</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Note 7 - Change on Accounting Method (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables</Role>
      <ShortName>Note 7 - Change on Accounting Method (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethod</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Note 8 - Subsequent Events (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note8-SubsequentEventsTables</Role>
      <ShortName>Note 8 - Subsequent Events (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note8-SubsequentEvents</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Note 1 - The Company and Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/CompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note1-CompanyAndSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Note 5 - Stock Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/StockOptionsAndWarrantsDetails</Role>
      <ShortName>Note 5 - Stock Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Note 5 - Stock Options and Warrants (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note5-StockOptionsAndWarrantsDetails1</Role>
      <ShortName>Note 5 - Stock Options and Warrants (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Note 6 - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note6-CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Note 6 - Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note6-CommitmentsAndContingencies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Note 7 - Change on Accounting Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodDetails</Role>
      <ShortName>Note 7 - Change on Accounting Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note7-ChangeOnAccountingMethodTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="gtbp-20180930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Note 8 - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gtbiopharma.com/role/Note8-SubsequentEventsDetails</Role>
      <ShortName>Note 8 - Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://gtbiopharma.com/role/Note8-SubsequentEventsTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gtbp-20180930.xml</File>
    <File>gtbp-20180930.xsd</File>
    <File>gtbp-20180930_cal.xml</File>
    <File>gtbp-20180930_def.xml</File>
    <File>gtbp-20180930_lab.xml</File>
    <File>gtbp-20180930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001654954-18-012574-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-18-012574-xbrl.zip
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MXYL(AK20L!(S>,PQ53^%78[!5C:;28@'X4L[:@"Z'L,$6!+7V.*:C,RJ759
M8ZMG<#(B6*O6Z;K@:FZYH#NDTL@N7#K+%$8>BW@4D+:TM9#1Y@[1'9G]NEFW
M89JAEF @["S?9R-_( #,WGTMV;J/ KFA *VO8GNR0JRE>V.K7E%FO#A4GK+J
MCYTN5[.+67F?X2K "?(<.EFZ+:&.5/3MB8N[D9B47BGLV.K^5%IFP'];S>++
M1%N>K:C$HK05(NH(CM46IY+%"8(BTK*07A]DD5?312!.+%8(V%T4?@^2R*9J
MZ^)'7TQBHYD5V'GVV[E78U:YN%(B$GR8=1-7N++1?66%P6/^^L;&RAUDEZ4
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MOF\F\\NE<H[X7;N[<^2M5Z_DM%DUTG!$.]-LNU7KR!HA1<@[;(G2[R?CA.M
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M]L79V47W/%WP1L#;V9K/C#6?E5USJ]LZN6AVG^J:"_;Y'WV0'\'X'ZKB]>T
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M!1@J$\OYR>G9AF%8P=)J=S:/AVIDT3G+^7Q+8/@2^$&6:C9)&?49TI@[WUJ
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M?*M.AM/I_@O?QM+Y\;F[2)P4\^"*1[T(OFK'0?\)WT+$:=4UPXK\]-+-Z"Q
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M#8+:@]+YU.U--327&W)EZ$6&2!K@O\EEFNNC]= =1+HP:$@R0(QMR>@CWF3
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ME_9AP?G]V[L?O=!SW^,_X<__'U!+ P04    " #;F6U-S,.HY[$)   :7P
M$0   &=T8G M,C Q.# Y,S N>'-D[5SK<QJ[%?_<SO1_4)GI-/VP7A;\OO:]
MXT?LTOA! FG2?+DC=@6H7E9$TMKXO^^1=A=8$ +6N-X69S()2.?]DW2.9,DG
MOXT&(7HD7% 6G5:\G6H%D<AG 8UZIY6O+>>L==%H5-!OO_[ICPC^G/S9<= 5
M)6%PC"Z9[S2B+OL%W>$!.4;7)"(<2\9_0?_$80PMG[\W(@EMOJ2/!%H3-<=H
M=Z>VBY'CK""TQ6+ND[%$[[!6/ZRAZE&]6JMZA\BK?J[OC+J@\A)+Z%>-?ZE=
M>I[ZI]ZNU8_A;W7OQXK*)):Q&"NKCJKIG]78;ZGPQ\SN_L-0'(R^T.\]$AW&
MG_[U_;-HX>O;3[@I1S^&A_&/\#S^-GSJ?'[XU'W>9>Y(_'V/WD6[_7]_>VCO
M-A.5)\+ODP%&@%(D3BM]*8?'KOOT]+3S5-]AO.?6JE7/_7Y[T])TE83P>!32
MZ,%$[AT=';FZ-R.=HQQU>)B)KKNJNX,%&4N&7FJAIY&0./)S]($<,TP3[[E)
M9XZ4&DGW$U*:D09DADX0?Z?''EWH<-48<*J>4_<R\E@X/8R'8Y8N%ATM.NTP
MLW 6$F'DT3T&IHA%43PP1R>0W)7/0^("D0-4A%-_S+><*<\ -JAFLW6ZQV#=
M=?N\.6;HR0YEPS[F [SCLX$F5[,*IG](!B225XP/+DD7QR&@]S/&(>U2$E20
MQ+Q'I!KP8HA]LEQ@-G%P%#&87[  I"VJ;3BD,(&@X0\G:J0=J\BVP7ZD/GS]
MTE@H7O6[, %C9>M9%'R,))7/:C8"A5)2030XK5@IE%HP0BL.2)=&5%N7SGD/
M.2ACG_Z(HP ELM"4L!-W5LR4\%B0X#[Z57\><B) C&:Z@8:4,259P.3CT(_#
M]7@FIAA9TH8LX$4A.,>AFNZM/B%2)#'/-]F#7(/(JE67I%&^8)%@(0V@)4"I
M()1(>H\P!*&).;C6)Y*"P89PY_OML:^O'GOT(2?X;]N*Q72(QJ$3]]W[H:I\
M0'DZ!5:@LV.S:\-F(A&Q+IK(1!^^1C@.*-"\(S03^0LL^E<A>UH"T(3,CL_>
MZO@HD4C+?,>'N'=,$L^Y8(,ACIXA*[?BP0#SY_MNB_8B*#%\#,G:]UD,&3;J
M-2&F/B4I: 5Y[4CNJ]P.A7O(1,P)?%%:D$K^[3Y!J3*=]%-U"M,IA6BB$64J
MMQG<&FR)8 ?0HYUP&K=\LQV2 R,DJE28DK'-,:X[EZ0C)\%-O]NC>FB,JBH"
M%/,VAW/7:4GF/_19&! N/OZ,H;:?!-?8:P_UD3'424Z?B/HK2H1M<^CWDN#>
M#W4! VOZ-\PYK*I3*\=B$BL(7M4(PEX& DH%ZJ4]$[G-4.RKS#J@4A<N$&8H
M:512(U$^ =O)[)!X1DCV=?TTEJD!R4G=9E0.G(L^I#QR'TWJC%LB^RR80&*A
ML>-1,^*ATF\B$+%HNKQ)9&XS&H=.*^X(\C,&OSX^DMPZ9>BS1[]NC+Y*TQ-!
M*)&TK3%?M];/[Q<*<]MQVWV%'0/ZD'UZWQFNA5D;Y_<9A278,=][%<P3U5N+
M^(*Z;AI2.XD=,_/.WEX ;CTF]GIB=K8MI;0C9-[H+ZD_WB$R%ANST"RDL$-B
M/B4P%B7O0!3*-Y=$8AJ^*&5E(NQ0FD\A7IJS4MU;"WI!K.Y4@E'78(J5IG-2
MK-#7S&<?&X(>C:W8VD&PH"S)3>TE-'8 S2<ERVJ7;9^;UN/"-#C>"B>+8U([
M2.;CDQ5!0MY6PV0]1C2OF>NSV>$SG[\L/8U\7P=7W2W,53K+2>V(F4]>ENX7
MWI=%TW9@#IW%)'94S&<C"[8,_W]8J'_4#=DOI(OTS=IC=0'SM"+H8!BJ>["Z
MK<])][0"\ R=[&;D[^#:SF@09B1*M.5FK89R-AJIXDP$YOZ<E+F;OR"$#0F7
ML):YF?&9 $FE8F].J4%*#PP3=Q,NA[BSKLO 0L)7]/5&R=^HDS#ZUG5R9L"^
MDJL7$RT;=1BFSKH.YV?;*_E[.58R[6YZ]]B=7#Y.O\]>4#X!QQF7*)J[[&R[
M]Y[<V+]AOA9E85'?G(S/44V.5W/JWLY(!!-+US%B$H;UC,CX"AAAO7UOLD(L
M8E(?G GWJ@98[_(O"(/6;V1T22A%UO)":^;OX1<W1\LJ8,\*3Q!6&2K3G'<)
MHQHK1VJL>/LO-*:8(86MR T^72OR9Q7L@U50,O%E7YR)D+6'B^!R_9&2,26C
M!+XM'B#IHPY=ZZEW(+^K&NTL#!E4S15M6%(#3IIH&*K3W=.*Y+%:5]6[GV-8
M;RD+VCHM!#%/'UHD?9WDQCATD Z5%90DCZ1OP"*H^_AS0Y*!X@8'H32$53I6
M$JXYBX<9*042F^$-(6*EY[ZK=FDLTEOMKT,6P28M?<>FNM1GJ2X**J]$YF)1
MYN+!\#D)7C$:9_[/F J=XNZ[4[<CVWV0TNL;_<V"49"WM+&X@9%[ [OQX$P(
M]11"G5L^M\E(GH=37B^E6L._Q)'DU=>QS&1LP)46[.#(.63D0)W5DDAHA6?J
M"*F7W"P_?Y[0-/&S?N/TA'F0GCE=Z\.F1M34=H-N,9X#KR1[[; E%$)I$O^-
MD!F\$IL*63'9_XLATU[=P8JA'4LNL#:@AN7Z<9SX."+<IT*Y!75"A_"7A+"
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M4Z1C2[[E08TX=<81=;_/J.^QB??F1\P2H(Y),KF#&GBV[.AAD8Q5%D3_AD'
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MKGOV"?'Z;IW5%^*R*PB[GN/:\VR7W#ZB]_QMO#AT?1K& 6*_<.6 OZ[W<89
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MX1%7/"433!Y%N@K"O_ #IMDG_P-02P,$%     @ VYEM3980Z5\5#P  C?@
M !4   !G=&)P+3(P,3@P.3,P7V1E9BYX;6SM75MSV[@5?N],_P/KG4YW'V1=
M;">V-^Z.(CL>=1);:R?=G;YX(!&RT*4 +4#ZTE]?@!>)E  2E$B!=)C))+:$
M WSG? >W@T/BPR\O<\=Z@I0A@B\.NH>= POB";$1?KPX^';?ZM\/AL,#B[D
MV\ A&%X<8'+PRS__^A>+__GPMU;+^H2@8Y];EV32&N(I^=FZ 7-X;EU##"EP
M"?W9^C=P//[)K[\/L<L_F[CH"?)/@U;/K>/#WC&P6BV-2N^)1R=P66/WM'=T
MVK,Z9T>=7J=[:G4[OQX=ODQYDY? Y=^+#__>N^QVQ3]'7WM'Y_QOY^0_FHVY
MP/78LK'.2R?\$XA_<!#^XUS\,P8,6MR0F)V_,'1Q,'/=Q7F[_?S\?/A\=$CH
M8[O7Z73;OW_Y?#^9P3EH(2P,.H$'D92H12;7/3L[:_O?1D4W2KZ,J1.U<=2.
MX"QKYM_:[E(@7OBD'7P9+XI2JHZ!9NB<^9I\)A/@^JZ3B<A2EA"_M:)B+?%1
MJ]MK'74/7YA]$/'D&YL2!][!J27^_W8W7+;ZZ(X16<P G8/#"9FWQ?=M3J<W
MA]CM8_L*N\A]%=SR$@(OU\&O<$;A].* BR]:PE>$(XE6?]"1=5\7O#<P-%\X
MW";M[8%^!(ZPZ_T,0I=E(9,6+@?*"%!N@AETT00XN7!))0L#.2"8$0?9O(O;
MHH]"P12[G=XNQ(##&<HTHGX-I8,> #;[Y)#GK3%O5% 8Y!OBPFYK0.8+@%]Y
M3[CWYG- 7V^G]^@1HRGGEG>0R81XO(?@QQ$'-T$P4X_=:BU4N1X?[OF0]HC&
MCAYNJ4"AD(Y:EW#LZF!)EBP4Q''KWB63/V;$L?D<??6GQP= '4AI<H4"/ D:
MNEWX?94[T6^ 4NXW6B1F"A<*]9UP]3ER_=[*&^/=6/@U7V1I]A6M"@J%_+XU
MF'$GA[=XU0^_0'=&;!V\V=*%@CUMW7MC!O_TN'FNGJ"F#ZBE"ASP\XUPNN/G
MKO4:GAZ^ MW!=M>Z"U-4,5SH::(EO*?NJV][W3I*[LKZ@+-D#7O])70!<DIR
M^[7*C8U@(8X;X>)BBU_T2*:JO^R.KDF>GO1^UD%AH]V=UD/KE>QO7937D[:N
M<$\#;X[NKUU)R4-O#LB9PFE0 9U$:&6%XZTK DA1'$M$CDY\4#->!9UX8]BR
M$7<'Y@=MPH;BYEC6@K#;YD7;89FVM(+R<2\;:]ED#E!.T)O2>T#LM]2:P_D8
MTIQPDZ+E8P6.DP^A+U ^+DS<?EYHD<Q>?1).@>>X6SME))[$S#]&&(FIYS/_
M-8$;OK@0VW"Y;Q05[A[RY1^+:L)0?M=J69%4_$> ;2NHPDK442)X>60W@;;'
M(2YC?_SG>$S0"N6ML((0: 35(9,$/D=$[@F5>H7/YA2PL4^IQUJ/ "S:8MQO
M0\=ET2?^3-#J=,-0_0_AQP]+A-PH<,A_7&KC@#%T_+8?PL*RLNT*0/=W#QJP
MPW+KD%>.T:<1^+!+:(X[03\\G_!5#'>E*\=OC?=E^"A^B)!-*9EGVC.T'4G5
M(&Y@#N3 (M2&].*@VUEA<0B#]L6!2SV)RB98&CB ,;YK$.O7_@O2\;--D4*Y
MDZX<LKA*4J#@2:6KA#*CY,1Q7H8+$14KLK*%TK&Y)LKB0FEFDHE<Q4>O4V-"
M'KH2]$5Q$BT)=AWLMB;-UT[%VY%9WNXAY3O7P8A7"2D5AWX<]I=PN:P<Y]1"
M#S(_W(W)Y!)>P5)*5R&YL"O[U[8#WN9V]OKKQU%H^']I&EZ(I$@\'%?5ZCK
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MN)'09%I8J"<_\LB*339AGR;L\^;#/L^ VE]Y*QF!FF2QBH=69#I5+1@2[.\
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M@GIB\3]?P5 Y\<\8,,@_^3]02P,$%     @ VYEM36W?HLQ.)@  FRT" !4
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M*J64PF!(U8:P2:M2'A4*0.(DKW&*21G2](.G^!Z',4M[DH-41JAH=>Q& QG
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M;6$&Y780-X J%M!__>;=F^/C[]$M;1AY*,0^<EW7TW:T 9'ERIZYDP&K_":
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MJE32Q7A3 E4VL*R(01U!BA#%($A8>Z+7>%5B-VB U.)VL_;K0=<3]LMEP31
M+0#%-/VY.)UIT/8'5O-CWHEO/0J .CS;;EBV%S,--6[E3&.5FT"W3V2"G*N#
MFVU41P.?@RA.@NR)!23?Q:&/$V57VJKF:GRF<T(U3I/I@&DN#8$V>5B(HB*O
M+0R^T<HUBGSZ%UUDNO="VA%<X22(_>;&EZ) NIFP>KU<#^=JU\UUT(?5;/9
M+C2<9S=H?'ER?3::GJ&7IV?\T]?D.\3FMZ/+4_[A["]?QC^-+LXN;Z:.3CC)
MO1V1GB-)GD@KSRZB-7_!#47+AX17["5-,R_)NK]A%73I"H7L#:)#]!$O@HCF
MXJ(#/([F>;[7MP[>ZUFDG<=U ][EK9('F[U/NWT/38IQ29A /FY6CR-?,KZC
M >9AG*Y;4X%N;]9V'S5$(33IOXU-,&.M@1R1G45@*5G&FUT'4CU*DVAC<^ME
M6L4I*'K;,'D8GLPKU\5^6<7124PP)2D+>N>?LX!,KMG$O%%*VQBR=K)J*T?+
M,UB]K#BG\=;0A3LQ<ENT)9]5[@Q&:V*/?%,8Y+^7)ODR\8Z87-E[GLS)Y(;@
MI<],;^Z2>+VXD[HO*Z=^=JSQ>!LW2QKW,0*#Q5L@;PE6"#;&4,:ML1/2,I[#
M&+=,DH47Y<>,2,5-XS#PV3](MW1%2IT,V>JGEKRPS ;6>MOQ,+:MWGHU9''4
M+L4:PK#SZK,+;X1P^8KM U2SSD8V5?NT3I5/V-P3#B\SW58%5AD+1OXT6$3!
M/)C18"H>?TT&>5?$WHR,\&[P8_8Q%#LE=S#VIO)N4<B#U?,>&)Y'D]#?<>%B
MK#N,:*H3+WIBK<5TO5QZR1-M*"IVT<8P*BS#:"@VPQ%^IHBG PO7--_KISCV
M'X*P_6!M%Q.6K_OK[%SC+D!C?3 5HP=HR?6!N0G$;1P@NA7XLK2#"D-?@^OY
MFNYOJGI;9V6DZ9*^&E=TK)6H@26K&JN:HT!:TB)UD-$ZJTK8;MI '>!Z D&9
M)!@2:>&)205O,[21!M=^U9UI:[.4TNZ(I&V;%*) J=36!E%I&*RA&U[94]L]
M;PTAJ[<M20'6+EFJ28!AA!16DPA<"%Q;PE82\] :#I$ND)NW+AWT[5Z3T-&M
M^IT)ALI@&-@5L33-9J[_%>(68/#ST]JC63UQZ_$?F:!-QJF!5JDE2H'AD!):
MDRP;07"MV8;Q;*>D3!I[C4,:XL\"]S?Y9\MSH6TCJ&VM6AUI#5,$M1'9=B;!
M,'P8/^0IBB>53,0_YYF(8=0)NF,8\$3[-/0I9DN,.)IUBOGI9L-J@$\?]VK1
M/%T,@.%R']1"/-O&!N-MS0KD";"1\VVM>E<CX$BM;;.[6=@O6K>UR%I>[RA,
MAR><G$2;79S/.+N+?47#:JAC+?S&%'X9:M.FX)Q175!*\WM_APX1UT>3J+H[
MQTW : DO\4-E0S*)(_)QALOZP[.@CJ.J3$"JP2ILWY@?QK3=(WS#%4;]<-_V
M=IW7AQTX(T^Z2Z^  5I;INO;%/^Z)KZ>W1L$BZG%K2YEM8"NK5PI9,&PKP6@
M,+<JQ1&7!S<4;3K4NEZJEG=)*OUZJ$H8+*U:Y^Q-7NUJ5,C#?F@$$0_ZF<RU
MH43%W]I1X]8V[8TJ!W)_,^K<TJ!SP@[IA63:PV+,1I48LTEKC!FP8#-:,S,"
M-?#"TWA]FXUNXW7V*68W4Q"R)9%) VMJP':+V\VQ9A-LINV<XKTA"_L,5!;E
MPC#8^27%D_E9F@5+3SPOIA*RR3(YP"J3ZA)@V"*%U60$$:)1LZ48#%+40HM9
M:_K4OO:H4[&[TM@.OKZNJ)8'0R8#D$UJ??32(*7D$D]WT'XUP7<X2H-[C/A-
MR#"8QT!/YHT1PY,9!TV5;;*QFT-57III@F%H)[A*KE8/,<!@I"(QBEFC:*8+
M(,.-03-IH@B&C5W0"K,.>M"?-9/T0T4=""'I2XZRA&_T!^D_3Q+L!QG]I.X\
MU!J6N^8VZ(V>624.AVBM&,5);46#=]!,!5$=&!237VC- T)(K1HS!\C0@6:;
M3T^#!,\($%ZY5%.G;2RZOY2\D^OM-Y<;F0-#\>U]D <8,9.H:I/><'XVU'WF
MB@7,BSA:7!"T/C][H^_(C32L+3Z:02^7%O7BSNEECE',2!PM#IE6?E(/1JLY
M7JZ\(*'[CI/D-$A7<>J%-+UR![YM9\KJ,;TMG*V=V^MAQSEU!P OG.PK3=$1
M 36! #*<K13<>(^&+%:*6[Z64 NZ<?&@5!8.X_0 Q?.B5!P1>2A+BV=>0C-%
MTLRB;%QAQJ16+:NGNLQ<J!WSTJN H9<93EG&[)QI+R_B-/V:)HU$S  ,TC4/
M7)\'49!AUKYJ9RT&>BZ/QBO=T!V,%Y3 D,\4J7#!B9?!69U17L1FUM"9JUM.
MS][)J4::=B-=,#3L"+C)QG-VE1ZD4=LY&5BR-,"?L4>#S3>^F'&R@[Y-4G9V
MJ\I*8V4PM.R*6. ET4?,  Q67N,4DZ*DJ_2G^!Z',:MC9_Q":VVO;*1I]W(?
M8U?J]_RTJH%AGSE6\?8?KLEV5"JZ4%AXCZ,UOL:S>!$%YN$.!GIV&6CH1IU_
M+4J V&>&5.0>TT,5Q1VM*M/S-<==HR!OZ"58VLC80<Q:6Y\>L!#*1>P!;#JG
M\<".2,]V'=.S7;W"96$TQ-/9'?;7(9[,1P2>'X1KNJ4TQ;-UPM+JGSW2+'S8
MIY<H43_71:++YI)%:S3M#AYD=8-R9P55V[<<_"G.:^'.71/6)6*Z+A%X8?B$
MBL>@M'S.CGHBMK>:YVX@#4&1N:&]KS%4M-:;='*D["^,M)QSL3-4?8J.425%
M!^+ZT%IU>1!!K0CX%2I/#+]Y*][?L)M6>]N"D+?2?:TZKPF#NR(>C"MS4V=W
M.+_])%[Q6.C<$+C*(DU^5M3P27(=+.X,#F;VM^>H:O1S6U$CNAF#6!%Z>=#"
M_P>N/ACU-?/AWZER59C->XW5K<YO.SI5F\<:ZEJEXCU.;N,47^BFK=UP[V_J
MD4W5.TN2.#F)$QK+F _/KI(@3OA]J"/_'^LT,TJTMYU)-\UP?^?E+7%W>P ;
MX]Y.")=9^?G@@S3($7X@#7%9%^CA4M]+MJX-FC;YG9!7P*@M;E6SV@8;.E%K
M>UMTG#.N(U!I(_N.-+*#YX$8NFD]7V?K!'\.HF"Y7E[0ZZ2+M)3GI()YJX!>
M5$V_3CM.!/L;=M/,;EL0\L:VKU7G%6!P5X0-<&8.+;D]%%)-=E=@GE@/1D79
M<DURM*2=B:)H![)ML[H,6AS5&C.(83"59DAOA $+L7UH;_VZZQ;9*<Z\($PO
MZ;R6(APRT9#:-MB$0VW%T3OQD,JP\SJP"V\&2D34OA2_PZ93?@1ZE)T0GY\(
M3!8+)FL:C11_^0;*,D4_V,I#W_3:>(1+ XY>'O!^[PVTES^L6\*51]0R]E%*
M95.$<[.(OC-"F'"V+B_*/;N:PAA(RK=11G3U=\&"1S\^"3<#C!Z\Q,\W62;K
MC*U'D&*ZCL.0#+GICZI!^XX>YO[D]U %UGXH?-LG.>^(K;@G7&2=;X%7E)Y=
M_;M<+V]QLOO2+IZSI[6N7DP[JG#\(5;KVHHM,4\S+\ET7>"NG!1JW$8.>2Q_
MR2F>8:J WAX?(%(=OMM5:%.;AVF+BY_8SNDXXHOVGY(X;68\W.%S[ 5.[;"8
M-G%6.WB(\QYLUYX)^4#9K6-0=C^W;#](/SW' 5UC+7W?44LE?=(^=5J:HAJR
MVY(\QGD5V[UOPKH_EP13S6A4SSA-U]@_)=/4:,'!,V?3:I3;V2-.9@'Q7E6"
M/0Q9O["TEZ/"S:6=K,"A>%_HPD6[Q>^.%J/V=(QN=Y&*C]+/(M_N&%VU9"6.
MTJ?D+>?#]",V3'\'I$'<LDSRVD&7VG<Z498\9Y_&',IB&K(2"@^!TQCOR#-%
M6TWEGGF]J[0P/V,:BHS]T3U.O 4N^JNK))AANH0WM[5X; QDGVIN_X+>4?]J
MB.+9U/W>KC<;AT(;Y>JHT$?,P+]4N^#V73W+%L!AM7_F"^(&KCM8)K=4W[NM
M=^ZBS@^) %2]'[YH.]7]X1X/+1[$ONO[O;;?5AR2Y587%;TSC+VJ[3T+>= J
MWQ'#LZOW_?R'ON>P;:D4/CNM_!U![%75[U7 @U;\3@B>7;7OX_TSWJ:!.LM\
MWELZ1J[__T;/;8@=+"P9/QU4OS-LD>YHJ^A9]32#NCWT[A)@*CH/GP=WIF7'
M?@J;$T4"N0%#Z?L&\DH\2W<1R-OK.7 ">;<H)O- WAX/@5*3=NU@CS4_P"VP
MPZA42VWO>\Z8""\\\IIVV?;JG-S98M& K2WSY;*XY9-GGQM':9:L6?5HB[FR
M^%S0K7'?8MRJ=>[ZT+UOK7LZ[")T:\ J6H'+"D#P>Y+=X>3FSLO+)24E=(]3
MTLXT)AZLUSHE+6)YQ<Q0+V:G$$%7? LO9ZLV8H?X]KXYV7W9 &IY:.*X;T\V
M6;!H!HV8I3'!4=?T.OUM64T?N(V[M9R"?0PY#XH< KTT^^#O^ TDA4F6*Z=F
M%,8J-,L81[!=$Y!>F-]@I9@%*&1MKO!JX5:G95)!YVPS02?>VA1E"',15^EW
M?)_=%N6%5U[@CZ,\VZ"LW!6B\)83VX"*B6H+>4054!"A7,712[FFC5*$_2)Y
MSV@V6R_7(9W*G^)Y, ND"8_:M>"]J@Z8A;>V$46Y+(QVMQP#7>+L%"?!/>]8
MZ#VI%X%W&X1DC)5?;>E/HFN:PXF>F20#LR#]$L6W*4[NZ0!I'*W664IO=".=
M2ABP\=PG4EKTXNEQQ!,SC:.BY!0%[ J,D_M1G12X]+)5JTC ]'U.W1?RW/$D
M_*0QS_=[4(D!1CO13,U&BV%&KQWE.=@49=RJ9;/F&;I0K2(M*F"X;(93F-_F
M6HBH(:9G,\5]/IGIG.->T'.;Y%[AAC[+?4,)RD"G*^!]2W=?RTY>RV->;#">
MKO$):>>Q,EEW-Q,VF[<^SM7SRYKK@VGX>H!NDA9.))Z1,^/HYB'^&_82U2"Z
MLQ5P)!5=[,S3C8G]HJJ 6\+6]_O%5O),/ 1?*W8@,E9PLP]G2R-[Q]HF<I&W
M;X[VBK?GI!@'H&W%#$#6"D[V(&UI8]\XVP0NH>SQ'E%VF\( 2,[>C-PO&BJX
M=Q,3S<:E2*M<R]7F"UT92S43B)J Y=5[W7N0XQ)6Z)G4 <KEG!;R)1%L*^>-
M#+BBED!3E?9&U&F!JXL97.&V%*FC8BQ6JP.L:R%$*4#%JP'7+.J*J.L&HP*E
MI<1A%K5)&;L*W!<N^I:5L"@%J* UX(0+R2NB7R$NC$99E@2WZXR%P&4QNO)@
M4)U>*&;T=MIT +TK8ZB:FL*NRN+BCEX2Z=#C%:;A:=&"[H*F=!M4WC8I1']Y
M"^:5M"$4]S\V\H@IH)=<Y6M'KV-2P,ECNZ0O0A "5"O4V,0KAXJ2+T1=E_DX
MFL5+?-$XWJ<1@UCN$G3JDN?"G/2N*#^.,DQ*(],$939$ !6["EFSR NY@NL
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M-:SZU07Y1+XNOB)_T($0^>;_ %!+ P04    " #;F6U-/SP=>X\;  "LSP$
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MFT1VMR\RU:3:!'<T\1J8OS81RU.OP9"5G65#G1.0T"[YJ?N*_F*M"WA. 8K
M<N?(QMO<Z4-_S<B4'KINT D6O:H_AB@*"A)!E48Y^,7P8SQ:&W','&*8J,1V
M>?_UYH=LK+V')&7NSP6A.'P <4[^!^NKU_6HSF"9=!,JWMQ'EX#1VPE^/(H
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MHF."U AP A5>V[*[7N_:9M,B>_G]J08C93N5Y6SI8KOF8R3>=0L2,%1=&7W
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MQ<73>K,]DOW&R/VXW.$']O:854^*:KY?7[:*Z.><K-A!$<L+U;D0LO,U/W2
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MV-;:&Y=_8?]XH,3I;_X?4$L! A0#%     @ VYEM38B;N#HO:0  [V$# !$
M             ( !     &=T8G M,C Q.# Y,S N>&UL4$L! A0#%     @
MVYEM3<S#J.>Q"0  &E\  !$              ( !7FD  &=T8G M,C Q.# Y
M,S N>'-D4$L! A0#%     @ VYEM3;<0FW>L"@  RWP  !4
M ( !/G,  &=T8G M,C Q.# Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( -N9;4V6
M$.E?%0\  (WX   5              "  1U^  !G=&)P+3(P,3@P.3,P7V1E
M9BYX;6Q02P$"% ,4    " #;F6U-;=^BS$XF  ";+0( %0
M@ %EC0  9W1B<"TR,#$X,#DS,%]L86(N>&UL4$L! A0#%     @ VYEM33\\
M'7N/&P  K,\! !4              ( !YK,  &=T8G M,C Q.# Y,S!?<')E
:+GAM;%!+!08     !@ & (H!  "HSP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
